<?xml version="1.0"?>
<rdf:RDF
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:vocab="file:///home/yin2/Downloads/d2rq-0.8.1/vocab/"
    xmlns:obo="http://purl.obolibrary.org/obo/"
    xmlns:owl="http://www.w3.org/2002/07/owl#"
    xmlns:db="file:///home/yin2/Downloads/d2rq-0.8.1/mpevidence.rdf"
    xmlns:map="file:///home/yin2/Downloads/d2rq-0.8.1/mpevidence.rdf#"
    xmlns:d2r="http://sites.wiwiss.fu-berlin.de/suhl/bizer/d2r-server/config.rdf#"
    xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#"
    xmlns:j.0="obo:"
    xmlns:meta="http://www4.wiwiss.fu-berlin.de/bizer/d2r-server/metadata#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#"
  xml:base="file:///home/yin2/Downloads/d2rq-0.8.1/mpevidence.rdf#" > 
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/4dd05737-c49d-481a-839b-5e6a55041eaa">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/32823fc3-3217-47bd-a04b-6f780ad810d6">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/4e99a836-2764-428c-b1ba-1c2862615073"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/f70dbb81-2094-4a0a-b74b-409c12860972"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/8aa2f21b-d302-4143-a7b9-db99b3826086">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/3355dfb4-584f-4310-b633-aa5843593e15">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/0e6485b5-dfbb-4be6-9e81-8dfe1026d478"/>
    <rdfs:label>27 Percent </rdfs:label>
    <obo:OBI_0001937>27</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/8e4570d5-1470-404a-a6cb-7f2c3301c557">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/4425159b-77cc-4e30-9962-10f2b193f166">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/f70dbb81-2094-4a0a-b74b-409c12860972">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/2d2c0b67-bba0-4c31-989c-919ced3e9609">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/5743131c-fc58-45fb-8c7d-29bc162ce9a0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/28d2e995-b0ff-4a6a-9de8-356399d985fe">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/b44d89c7-e780-407b-b9bc-59e3c47b35ac"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/29c4a2de-1aef-4c28-ae1a-def5f85ec284"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/57773bb5-20c9-4468-a41f-3d30520f4af4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/17aa437b-fc8e-4a6e-9733-d16959c01a87">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/c8636f34-740b-4aa6-9bd2-0544c8f8392f"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/18535d33-5a6a-4182-85ea-18b0d448d0cc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/d8f16922-7f5e-42cd-bfc7-42058cd32fa0">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/2d5dc1d6-65a2-4d69-b7a8-70ce65bd6b0d"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/0dd4a8cb-6943-4b88-afb6-759d5064cd7c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/48f2cc6f-47a7-4701-99a7-1882bf2b66dc">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/439bc0fc-ec7e-4651-a1ac-685347b576a6"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/f66c5b9d-0b1e-49c4-9daf-08829e896209"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/8c473a33-5720-41c7-994c-5ae314b12547">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/bc8ccea4-cca9-4740-bb00-02ee3537564d">
    <obo:OBI_0001937>1</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/c3aa8619-8ec3-4e18-981b-3bf3a77e2024"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/62b92f22-a725-4bb1-8f77-d641f6fc263c">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/190222e9-4a35-4eac-b74e-d6c07cfafeaf"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/d595a596-cda4-4644-aebd-c7efb3cbefd6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/c18e2947-611b-476b-94a8-f84e22d89795">
    <rdf:type rdf:resource="obo:RxNorm_6960"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/11765265-4e66-418b-961d-544360d2b5a0">
    <rdf:type rdf:resource="obo:RxNorm_36567"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/dece938d-3071-4ff7-9c87-3f112244a3a4">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/e07fadbc-e6ae-48f0-b9ea-01af0877c53f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/10803817-e092-4270-a8a4-131d6929a611"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/4b09cfda-aa68-465f-a97e-26eaaf11118d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/84b6902c-3a1f-4e93-af50-8f97ca904d75">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/4b82b1d5-b5cc-48d7-809b-7a293dcac340">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/e984aa27-a228-4be0-9a11-15faeaba58de"/>
    <rdfs:label>iloperidone-dextromethorphan drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/fd486a4d-fd47-47e5-a0ea-e7217cdd980a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/319df08d-419d-4905-810e-39748b128047">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/96edffaa-7216-4510-90c6-bdf8c5af5fa9"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/1823fc66-8687-4b5c-aa84-52dd6aa94c9d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/473e1b48-3b5e-4996-a21d-258463e407ac">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/47a3a6f7-a66a-49ce-a912-7b877a18b70d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/49494a2a-0d10-4b34-9164-6a2d7694b970">
    <rdfs:label>Cyclosporine-atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/2b644ada-9385-4b20-8ed8-d85908b0f2d2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/c6982837-4e56-4b6e-9cd8-69a17153eda4">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/ef0a709d-8600-4ba1-a7cc-c7a867a2a412"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/47405f55-e4a8-4ae7-86d3-f84ba80290b7">
    <rdfs:label>paroxetine-phenytoin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/1c7ecdbe-21ee-4e1f-9d3e-f8b3a193f8a4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/339ad4d2-c8a0-4e04-b345-23af15a639ee">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/4130df86-0991-49fa-be01-81cdf2a993a8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/6f0b5de3-32f7-454a-9512-f40b60b7dccd">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/146043aa-5d98-4ca7-945e-929af9ec403a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/b17d593c-14db-431e-8ddb-6e5e37c3fbf1">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/06b96a01-5102-4d8e-9525-6798594fb53a"/>
    <rdfs:label>2.79 Fold </rdfs:label>
    <obo:OBI_0001937>2.79</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/fc702945-bb3a-4995-83b7-8017210cc3b8">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/8d7ba354-ceaf-4543-bb7e-a83fe6e22de1"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/30fc839b-3270-4c87-b386-049e8c3a7846"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/95998749-941f-47b7-86a0-83b5ebc4ad75"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/8dbbcebc-84c7-4128-8591-3018b9972bef">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/6a6ab9bc-7520-4911-ab7c-93c94594984c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/eae5ec03-7b64-4dd3-a791-edd8f57d14ae"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/5fe698a5-c07f-4e62-b217-0cec804fe81b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/52b52560-7d25-45d4-8f26-210516f060f8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/20dccf97-75fa-4a35-90fa-2797f530a88e">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/3e2bf812-a637-4989-b368-6cb3e0c3fa26"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/ff5b5e10-25c5-48f6-87de-d19214739d82"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/f1134523-5ac7-41ca-ba72-248a9853b605"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/ee916793-4530-417c-a8b5-7ce6a4c0af29">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/a8cf233f-ff15-453f-b7a0-ab1818c98330">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/77175608-77a7-4e12-bd33-01af965a98c6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/342614af-5152-4805-8004-9770602ee3c4">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/1ebe46f0-634d-4953-aee1-5949489aa244"/>
    <rdfs:label>citalopram-pimozide drug package cmax UNK information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/9cb1d3e9-03b1-4718-86ec-b9676d5da89a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/749e3c27-506a-4e1b-9f15-81c2ce9e2b8e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/d84e69e4-7d89-4cf7-b1f6-32f6beae2cb0">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/47d7e59c-fb10-479e-82bf-abc63c1892c3"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/55e87634-d6b1-4e17-8bd9-c75c13b93fdf"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/73ca1515-579d-46b3-b9dc-0debf49f9fad"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/fca95edd-70fb-4ec1-92d7-326c6c9d8433">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/9b65cc83-886c-40dc-9b3c-9cd1fd267eb7"/>
    <rdfs:label>Lexapro-metoprolol drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/5eff0dc9-843d-4283-8753-70b7a110edf1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/3db8d14d-7b31-4285-8d7f-e62c5f98667f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/3c13db7e-c88a-4300-b1c2-077552f8d5cc">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/10fa8ffb-5a53-47f4-aae2-113183a3a791"/>
    <rdfs:label>nefazodone-4-hydroxypropranolol drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/389b0365-b00e-48b1-8b81-29790973edea"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/3e2e5543-7b0e-403c-9894-22d7cb9f8dad">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/7325e51f-454b-432b-8d2d-5e9ba12a2ece"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/82433fac-bcb3-438c-b6c7-6b26b0c5941e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/d267641d-130e-4270-a9a1-583d8a82b745">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/407db4f9-b8f8-4f39-9425-c013d23f38a6"/>
    <rdfs:label>phenytoin-paroxetine drug package halflife Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/e2914380-8fd5-4fe7-a6c1-b91157b4bc69"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/a8bcd855-c65a-4423-aa00-00d2c120bc19">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/d306d761-f8f3-420e-bfaa-08dff5a1c418">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/7074aaf2-33dd-4ddb-b346-687ad6f52adc">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/25e7329f-c8ae-4710-8d8b-c2be1a25b053"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/1571a5e1-0ee2-479b-831e-50176ac03800">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/3b5edb47-8198-4663-baf1-c94a7c4ed0e5">
    <rdf:type rdf:resource="obo:RxNorm_15996"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/d8e1ce2b-3c98-40db-9727-a9d85e991ea6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/6d65d0df-1472-4804-bee3-57653f99ec44">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/efd6e333-e805-4dcf-b0a6-d6c7c2080a8c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/6e935df7-52d2-4c30-92e6-d2d4da1b8b97"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/80fe17a3-4115-46cc-886a-826f20892fbe"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/13688c99-42b8-4dbf-b06f-f50943e4b04d">
    <rdf:type rdf:resource="obo:RxNorm_1191"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/676d343f-384e-4682-a6bc-02e71159b01a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/336cd96f-08a9-40d1-9176-75634268f039">
    <rdf:type rdf:resource="obo:RxNorm_593411"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/ef414ee6-782d-4371-bd44-7c43aa1c05a6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/29ea69c0-242a-45bc-bef7-9aef1a687979">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/d9ba6f19-b414-48f9-922c-8e22f1ba72ae"/>
    <rdfs:label>22 Percent </rdfs:label>
    <obo:OBI_0001937>22</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/d6c57296-1965-4313-9436-8a618b7249f1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/4ff41aa7-659c-4ef7-896d-93f536028099">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/35f97716-56de-4d89-b833-b738148a268e">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/3f4a19f0-4843-4a55-b3b9-01953cab36cd"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/2a60b81b-5f9c-467f-9397-e1ddeb2b99ef"/>
    <rdfs:label>vildagliptin-simvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/93e7a327-6af8-4ec8-a8c8-b6de5a9eb70c">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/8da394da-9ac8-4345-aae1-eb3dbc1cdf9b"/>
    <rdfs:label>unchanged None </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/8c12c56c-cfc7-4ea4-a95f-251dadcd9c83">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/c3570118-7fe1-47e1-ab61-a9bacb16975f"/>
    <rdfs:label>3 Fold </rdfs:label>
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/921a3700-bdcb-4de0-afe5-e57917d64c55">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/fe350716-6358-4cf2-9dfa-bad0dc32adf4"/>
    <rdfs:label>amiodarone-dabigatran drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/b033b57e-a5ce-4cdf-a9b1-9a1fa79cbf9f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/b7e8b71a-5bbe-4168-a384-87b7551a1500">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/b7f49d1f-7a04-454d-b630-9c4a1d5b0294">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/134c5d95-d687-4844-992d-e776e0099ab5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/aa63a3d9-4e44-4fad-9e84-3b4d3909da1e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/8826b977-fac7-48cc-8e63-e036f5f34299"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/8baad700-1b1c-4234-8178-105554ee73d4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/5d4cf547-4b33-4da6-86e5-ff4cddc48c01">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/e8012f46-95df-4fa8-8afa-84b5ef9d8510"/>
    <rdfs:label>10.6 Fold </rdfs:label>
    <obo:OBI_0001937>10.6</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/2494402c-54b3-4b8f-a2de-89903d5d299e">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/9682cd16-6a36-4018-82dd-c0330e98d893"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/a3992698-0cb9-4342-aab4-c30f85cfcd07"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/c77d2d2b-4356-4fa2-b863-bd1f091c47f4">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/53c57cc8-82aa-44a7-b2c7-d41bd3624b7f"/>
    <rdfs:label>S-warfarin-nefazodone drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/1903c307-b673-433c-862d-4a8614a90bdd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/c094d320-c94c-4055-a74b-17f08352fc8e">
    <rdf:type rdf:resource="obo:MeSH_C062257"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/d6428c27-d4c7-48d3-a7fb-09443deb6339">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/1ebe46f0-634d-4953-aee1-5949489aa244">
    <rdfs:label>citalopram-pimozide DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/7faaf42e-e110-4fec-9a26-317cdf6367cc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/61a1c694-2fd1-41c1-bdc2-925ccc57c6b6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/67935f9b-055a-47ca-ab06-c45b6a38eb6a">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/2c837e51-d6ad-4009-a9c4-f39a350143c2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/19673d55-90dd-4e1b-a0af-3b4b2ff69c68"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/660f023a-b1d1-41c8-bf45-527e2bc2ac3b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/d2324817-5b39-4249-a6f1-d906b334e32c">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/6e62a11c-dff5-4b13-974b-3f9c9c61ca5b"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/882f2e52-1cbc-483e-b66f-7da9b8a61227"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/2b9b0c9b-6408-4a9e-b046-3838c77172f4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e10396ce-4516-4371-a4c9-a6646fbf36ac">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/f71de8b1-7e5e-4299-b4dc-e29309891e38"/>
    <rdfs:label>cimetidine-zaleplon drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/6abe4b81-d32f-48e6-8360-d8818ec55dae"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/5cc4cbdc-d8ce-4edc-94e1-de564bd905d3">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/aeba037f-90ec-4539-85c0-141ccfed3056"/>
    <rdfs:label>UNKUNUNK UNK </rdfs:label>
    <obo:OBI_0001937>UNKUNUNK</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/e04174d3-de8f-445f-833c-6b66f04e5611">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/dcded61e-9b7c-4534-90e8-ad6558776e28">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/e30a30b8-4d54-41fa-bf29-3d6f160147b2"/>
    <rdfs:label>5.4 Fold </rdfs:label>
    <obo:OBI_0001937>5.4</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/03c6b76c-13f0-4040-9eb4-4d1e7fbac5f5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/0841e0f6-f327-48be-a809-ab248b17c3f2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/d48bdef6-9308-4c65-abda-36e20779086c">
    <rdfs:label>lopinavir/ritonavir-Rosuvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/096daee5-9194-4a44-ab3a-26fb09bf8501">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/26234cc5-f402-45db-988b-17b3864fb882"/>
    <rdfs:label>fenofibrate-atorvastatin drug package cmax  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/9dfe6820-b2a7-4fba-b255-9bb0c21d1dfd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/372cbacc-1c62-4fa2-bdbb-5f93512ced16">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/51785bef-ce62-49b6-b985-a3442dffc942"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/e4da6686-88b7-400b-b7a3-97e2dbaead54">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/fbcf1fd2-fa50-492e-852b-2b7dc036ada8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/86a6fc05-80d1-4d50-83dc-1589ce0f1f30">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/57b53531-30a6-46a9-8990-8156d06bf308">
    <rdf:type rdf:resource="obo:RxNorm_203143"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/d8d00567-296b-4691-9ced-6148da13beb5">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/906d28ef-c192-4d2c-8965-5d0f9f0395c2"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/7e52bdc7-d155-4ced-ba6f-c17a0bf7cacb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/a339d72a-8be6-4c31-8be3-ab6147b3b298">
    <rdf:type rdf:resource="obo:RxNorm_11289"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/0905571e-1f7b-4310-ab8a-ca050c2b7fdc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/3f33f523-92c1-4b2e-af96-14ed65d3e4de">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/c36a7ed9-b010-4321-b6ba-79415f270b6b">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/a37c03ac-eada-4432-bb68-0da629eeba9f"/>
    <rdfs:label>Nelfinavir-simvastatin drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/205ec66b-2948-4065-88ef-56e8dd9a99b6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/8c380678-4ae1-4d6c-a238-3f7f887e1489">
    <rdfs:label>rifampin-zolpidem DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/1177a5ac-c1be-4977-a27c-c29909e971c6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/823967a1-1d6d-4ec1-914a-e538e92e7e9f">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/5e2eb378-f006-415d-8d4a-7cd81d16eef3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/02836239-35c6-435f-ac6e-4cc26b49d1d6">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/9533c96c-0e80-4a8e-b223-814d3f01106c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/6211e5d5-0af0-43e7-8352-1da77bf7a873">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/d584a94a-928b-4ef0-be27-9a6cd2fe1f79">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/09072007-f93f-4117-88a6-3c8aecd7c0ee"/>
    <rdfs:label>nefazodone-atorvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/c0dc15ea-fef2-4a2d-b868-bace191fca2c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/d9c4e63a-ce76-44de-a58a-bfe80bd21f2f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/797bd6dc-9240-48b0-ad9d-3fb184074020"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/4a72e9d4-0b7a-4450-8d56-1183c7c4fba0"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/56e1f074-4231-4404-a86f-8bd6f64c6294"/>
    <rdfs:label>duloxetine-theophylline interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/5049c0a9-cbf0-4e11-a05f-182154fb2b28">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/565dfdb0-bb37-457a-8a65-c93e60aa6227">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/294918a2-e63e-4d83-b450-3da65fa0ad45">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/db9f4281-a1f0-4289-996b-8268d5d851d8">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/63e1d459-e9c2-40a7-9a00-579960f74151"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/94c5f522-8b5d-4809-8a0e-1922fac422d0">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/edd2d142-238c-4f6c-a213-1fc3906d4481"/>
    <rdfs:label>ticagrelor-dabigatran drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/47e49e63-5dce-49ca-8f1a-9ead1233b2fa"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/c9c078be-2d2d-49b1-bf9f-2b70d9a4abe1">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/e984aa27-a228-4be0-9a11-15faeaba58de"/>
    <rdfs:label>iloperidone-dextromethorphan drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/ee48db5b-69ec-49ed-8e33-a68fc1ed99b2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/76df9d4f-2900-44da-a58c-ea282804c996">
    <rdf:type rdf:resource="obo:RxNorm_596554"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/acb0c86e-e4cb-43ba-9180-3a590451de6e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/26bd67bf-f893-4755-be45-bafa7c057c5d">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/5c252e97-feec-4d02-84ec-96d3a557dcd9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/3fb6bd24-2719-4322-b0f5-0030a32f2006">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/c4a04170-d295-4f58-8774-7a3ddd66601b"/>
    <rdfs:label>sitagliptin-simvastatin drug package cmax  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/89cfb125-78bc-4212-ad77-cb984481ef8a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/0ac35503-cb4e-406b-980e-62b68500bf90">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/f935914f-7c10-40c1-8ac0-d725156f4ded"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/01867df7-52fd-4ea6-872d-9439d8e22e92"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/52fbb5b1-02c1-4afc-8613-ebfc4aa0f729">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/35d474ce-ccdc-4e0d-b756-09aeaa3e1d34">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/45a1147e-717c-418d-8df1-fbecf2b74b43"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/b553c597-bd5f-478c-8448-9efa69b073b6"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/e54e7fe2-9447-42b3-bf73-cf44d6733917"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/e2ffea60-47e0-49a2-95df-362f009bdf63"/>
    <rdfs:label>fluvoxamine-tacrine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/b111beed-733d-49f7-8cf9-4d3297e21b1a">
    <rdfs:label>clopidogrel-bupropion DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/65afed72-2397-4a88-a150-e4489eb99419">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/e4db57c3-b310-46c0-aff6-9063e74956cb"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/f8270c98-059d-4fc9-af22-64b05687f349"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/d83bdcc4-8264-4b14-84e7-7656e5a0234b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/30267eef-25b7-4e66-892e-5f33b8ff2184">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/fa67ad8f-572f-47d9-9e23-c1778aa27f59"/>
    <rdfs:label>62 Percent </rdfs:label>
    <obo:OBI_0001937>62</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/62f4c577-1f44-4f68-bd5f-254b0dbd9fa2">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/af4c7a74-b57d-48e2-973b-ae624185a923"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/8013dd26-f65c-4422-a48e-7a45e07d8294">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/e7ffaef4-6681-4f66-8d1b-f317b6d319c7"/>
    <rdfs:label>atorvastatin-aliskiren drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/c22afad0-d23b-4221-9a9d-b111217d8ecc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/707b10b9-f6d2-4fd8-b61d-8e2a661b627f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/eeed3ae7-2f8b-4c2f-9fed-e835e63e05ca">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/6e51dd3f-b260-4b8d-99f7-e7b0f5512836"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/3b5e8446-e2be-4458-b69c-eb2ac89b30dc"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/9a52e84d-a5b0-427b-aa09-22c8a4122403">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/f82851ec-34aa-4e28-8664-25f79d166bab">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/b2e22f69-1ca2-445c-b25b-d11bff6ade5b"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/c35e6440-4b58-4981-9f02-15f04f869cce"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/8ed6b213-c5b4-4177-9dc2-a1abd0221f3b"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/bad13316-d674-4da3-8064-45db77b6249e"/>
    <rdfs:label>lopinavir/ritonavir-bupropion interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/67492b9a-f7e9-4173-9bdb-080fd6f125d9">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/5189dfce-4bdb-425e-9076-b77f6c9c7899"/>
    <rdfs:label>135 Percent </rdfs:label>
    <obo:OBI_0001937>135</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/e619c50d-8cfd-4f8b-8ba4-641923290a29">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/4ab2d7d6-c996-41a3-bd6c-3157a73ffb1d"/>
    <rdfs:label>9.4 Fold </rdfs:label>
    <obo:OBI_0001937>9.4</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/5e7cefaa-1167-4229-b9a8-7371092c637b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/85cb8f1b-9167-4755-b2c6-f097714ede15">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/739802b8-a323-43de-bd77-b555546cb273"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/52a33c45-107c-444b-a9d1-2f36ea58f403"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/0b045096-4312-42ee-b0ba-c5113456b9a3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/02e738d2-5d13-4a8b-a83b-a085a0f9cbf0">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/2007378c-8b3d-47bf-a288-a6bc1c712757"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/ca420835-89a9-4cdd-8a88-6d62dbc09621"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/a0457665-fef5-4dfd-b028-cb4894c2ac71">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/630c7748-9cd3-46ac-8375-257c0bdc9c8e"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/bfbcd0d6-19f6-410c-8045-77e473731863"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/f9e9552c-dba2-422f-ab68-78f5aa85c7ba">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/c4573061-3704-4b35-aad7-324543e101a9"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/fce2e6e7-4080-4dfa-8ad1-eeff66411960"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/11df427c-7461-466d-8f56-9fab9df72cf2">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/8af4cac2-58b0-4765-a2e7-e8c2d86d53be"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/3c4bfe87-7899-4c79-98ca-425e698f8dcb">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/b0fe8722-e98a-4910-8dce-d3a95e5cd68a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/8018d4ba-5664-4245-88bb-02b42aaba797"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/a07bb575-0600-4c49-a0b7-4abd82380b01">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/f958e431-876e-4192-9548-3bec862d15a8">
    <rdfs:label>rosuvastatin-Lopinavir/Ritonavir DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/2d307a50-c47c-4013-a2b0-3f7b64383509">
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/f3e9b9a8-618e-47fd-b074-e199248a7156"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/9b6c25fd-c8de-4494-b2c7-b7baedb3daad">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/910c708d-284e-4c25-b2af-e075993ec8d2"/>
    <rdfs:label>16 Percent </rdfs:label>
    <obo:OBI_0001937>16</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/c750da45-20fe-4cd7-9b06-f030886cbb4a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/01d05631-4987-4de7-98b8-5c8f1d36804b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/14046930-f72e-48db-b375-e91ce6786037"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/16b9c2a1-3f5c-46ff-b030-7ced14d1011f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/96754039-e998-4309-b66e-e06b85400184"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/3a86ad2c-9736-48ee-9ae7-69d6886c947a"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/a650d9bf-5cb7-4a6e-bd9b-7c086154f9f3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/9d2b401d-1210-4aa8-9fc8-1581a8273bc2">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/99755f07-86d4-4d1e-9c08-9cf22be15ace"/>
    <rdfs:label>sertraline-zolpidem drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/0240b3d9-a715-4551-8d3a-3d5ea2bfe23e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/5e58a28e-0826-473f-a733-20deff44ccdc">
    <rdf:type rdf:resource="obo:RxNorm_74667"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/a79bd1a1-2429-444f-a2ff-339d49e8fc67">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/70673163-3e88-49af-a827-9ab49f3beb7a">
    <rdf:type rdf:resource="obo:RxNorm_3407"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/487c9325-874a-4af1-9402-0d9136f3b64e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/10e6f848-f35e-4db6-8c91-41f433d13fbb"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/096daee5-9194-4a44-ab3a-26fb09bf8501"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/fc8f44f2-47ac-4390-90d8-b7067d5af45c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/8317c55f-493f-4070-9af3-20da6a712026"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/48b43afe-383a-4ae4-8744-310596ee792a"/>
    <rdfs:label>fenofibrate-atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/28acf257-965d-44c6-8739-7901df3a0b84">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/0447b9dc-6ea6-4f19-a4b9-fb04aae2535f"/>
    <rdfs:label>8 Fold </rdfs:label>
    <obo:OBI_0001937>8</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/c743aaea-5fcd-44c7-87da-539e6a5dcfad">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/8438644b-2810-4b71-bd38-ed7e79294982">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/1f4e29f0-d09e-4059-a644-323545877472"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/597452f9-f464-4993-8ea5-bc8afd8d577a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/c317f10b-f7d2-42f7-bfd2-6c4d13fad164">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/d8d00567-296b-4691-9ced-6148da13beb5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/a1c82d8a-f6ab-414f-8e05-27b1b1c5dbff"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/95fc1218-52f6-409b-8ff0-2b303d49e8c1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/71f548ba-6022-4234-b2cf-4ceec39f69d0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/d70393db-c7f9-4be9-bd4f-8a14aea0096f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/5ed4533d-484c-4540-85a1-170f0d98994f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/1ef3ca94-922d-404d-be5e-82be8d69df4b"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/263bd40b-2f1d-4832-8664-abf50baf8865">
    <obo:OBI_0001937>1</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/4726d705-307c-4831-83d5-ccdb38ff1021"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/47930a2f-4cd1-4f22-a6d2-535b4796fc5b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/7e53bf3e-d7b6-4de7-b252-e9c2ceb39315">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/b7312ad0-efab-4e48-b0e3-9f52fa73cf5e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/74666a98-2fcf-4902-a679-18a68a41a414">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/c8e12b9a-cf7f-484c-aef7-8a61358eda90"/>
    <rdfs:label>23 Percent </rdfs:label>
    <obo:OBI_0001937>23</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/8879ae1a-3e60-47f8-b24a-89ee98475fc2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/c11489c4-3075-4975-8788-77b27f940664">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/f2c30be2-dbab-416e-8811-e2bfea0d5f02">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/3d948339-524f-4e19-8704-7f98e6373716"/>
    <rdfs:label>Fluvoxamine-thioridazine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/1c3bfc0e-0847-4b41-9301-ece72ce83105"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/dc2c43d0-89cc-4a80-bd11-bd5aefeb7290">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/53a02392-cc8f-4f2b-97d4-a20036470300"/>
    <rdfs:label>Gemfibrozil-Atorvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/f32c4ad5-8b69-413e-b600-9074ce878f61"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/8506fd63-1b6b-4906-bcfe-b01c07a5132e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/35ac071d-c487-472b-a362-323aefe24db1"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/1903f1b6-cd14-4bd2-938a-e78c5f4aef8b"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/2a7c0a3c-4531-4436-83ec-aa5a266c8860"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/a4d81889-cb2a-495a-a259-e0711e293ff9"/>
    <rdfs:label>nefazodone-buspirone interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/25bb4a71-e97e-40ba-ad57-c2fbb9d495b7">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/0e04198b-12d1-42f6-89d0-18aa0586124c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/324fced3-f6a0-4328-bfaa-797077112bfb"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/2bd0239b-08f5-4532-97e1-ed40d0570808">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/3b695ee7-2167-4937-9dc3-7e9880f0d189">
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/6abb3d8f-7c59-431b-8ea3-4a02aef0d384"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/638194f6-c60d-4a3e-88f7-06ed8812214a">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/f00ab04d-d9c3-463f-9fff-82d5a8355594"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/58426bae-b1fa-4330-9acb-18b3c6a57ee0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/588d39ed-4850-4434-92f7-fc51a6ebbb0d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/cd778fb2-08ab-4736-87bf-0fb92c7df096">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/1c0bdcea-eb5d-4ac8-9b1c-bb744dc5c187"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/b16c5da7-94a9-428f-acb9-3150e3b571cd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/6e7aa333-5a9a-4086-973f-8b6bc4b96d6f">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/54263a1a-167c-4bd1-93b4-9215320ad1c6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/e40b7333-b582-4a58-b88d-26621d119971">
    <rdf:type rdf:resource="obo:RxNorm_6135"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/1d042c23-6abc-465a-bfc2-bae36b311e58">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/a4f6bb3e-f0ae-4829-99de-3cfd5fc1e28a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/4b18820b-734f-44f1-bea3-468edabb542f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/3f4a19f0-4843-4a55-b3b9-01953cab36cd">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/5dd24465-c3b4-4ac4-9940-f84cd1cb77fe"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/7c74e5a0-3dc7-4085-b464-30888c2f1154"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/2816af32-28b3-40e3-92f1-bdb4bd6f6ae1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/756c4569-7b31-4f49-8735-c271fe295084">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/e40b7333-b582-4a58-b88d-26621d119971"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/36015d36-7b70-4453-8522-9f678a7c4b54"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/c59dd7f2-8986-4406-a08f-dd55a1636f6d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/6e32deb2-f476-409c-a407-783bb6cfc581">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/bbb3f8aa-21dc-41a0-a3e9-b0124c14ee6e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/83eae040-7d22-49e8-97c0-2e3d90167e72">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/1e6f23e4-430c-4be7-8038-4f29930fbdae">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/efd6e333-e805-4dcf-b0a6-d6c7c2080a8c">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/d5257dbc-082e-4fda-af4e-f64d6b2c5d5a"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/e0603c30-a1a5-4f76-9334-5c5618166daa"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/fcde0f36-327d-40ab-a776-2970478e0932">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/79470e73-458f-4fe0-af9d-084dc7ea7b15"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/4be94b4d-3da8-454b-a717-061b01f324bc"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/6312cc91-6070-4deb-942e-0becbaca8e63">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/45545b80-5de4-4f89-a5c2-e838342c95f9">
    <rdf:type rdf:resource="obo:RxNorm_28031"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/2c281ea3-2f51-4a1e-aafd-606a6083e594">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/e9ac6386-ff65-4950-b290-abae7c5fa988">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/5b8b3b54-b138-476d-98ba-9f982e31c208">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/f87af97e-841c-4f9a-b508-941ee2b8bea3"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/3b76ed99-9534-4471-960d-474edde68553"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/e1e675d0-789d-4732-844e-e4761a918b01"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/53fdae2c-e2ba-499a-98ae-17b9f5b1b21e"/>
    <rdfs:label>warfarin-ambrisentan interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/bcf9167b-e524-4862-97b3-3a23c9eb3590">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/d8f79f24-a60f-4870-97fe-f98e0b8e5c09"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/9ba223fe-322c-4378-8a01-ef05705e1042"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/905a430b-02bd-4627-ba57-3116ccd6ca07">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/6739abec-9485-4cad-8ca8-822396183eb6"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/9ee3efe2-7471-4e10-9194-1d2a1102642e"/>
    <rdfs:label>pravastatin-indinavir interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/9a7071e5-bb4c-4538-a35a-f127cdd2b2cd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/ea02796b-bcd0-43de-8d4f-96f23e4c6acd">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/20eb0136-4f3d-41b0-b39f-1c5a6c26d894"/>
    <rdfs:label>propranolol-m-chlorophenylpiperazine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/f97080f7-626c-4481-979d-4bd4e581d4b4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/5dd688d5-a8c3-47bf-90ee-272d9ae5fb92">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/0544fcf0-8f76-4b58-9899-a06e724a34e2">
    <rdfs:label>ketoconazole-iloperidone DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/3c00d3b4-d7f3-48b9-a480-901958819cbe">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/d9ce6a6a-a8ef-4fc3-8e14-158e87d49289">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/5b31006f-cfbb-48fe-b921-e381637db04b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/c2439d71-5952-40bb-bcc8-65f5f075944d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/a168c0fa-7d1f-4f4f-859b-747403203a4d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/021a023e-00e2-4c29-8bda-1d9d4afa82f0">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/fdd2641a-70e3-4f6a-b96d-1c446012f548"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/5f4430ba-3aae-4f9f-8951-82ddab607017"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/d526b9d0-ecfd-45c6-bec3-cb90998ce687"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/ee44cb6f-8af2-4d9c-89f2-34037b16ef1b"/>
    <rdfs:label>Fluoxetine-olanzapine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/3ccbbc46-c879-4a7d-8c29-b8e2c4be68e9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/68410877-e6f6-4323-aac7-c246e523ccb9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/7a4fad78-5603-402a-a18d-b5a31c9bd682">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/4757df67-4c15-4bb6-9109-3f2d7a7624e8"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/78f6b038-5536-42af-8273-2110062fc9b3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/cf64fe92-f635-48bf-952e-552af28df189">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/2daadf57-d274-41e1-933b-61cc59b1aefb"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/e0afe98c-76f5-471c-9fd9-0da6fc1df7db"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/fb282331-5b12-4fd1-a1fc-edd5c370f3a7">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/b8ef45bf-be19-446d-8997-300ae423b3a7"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/6019fc85-e344-426c-bb22-239c8edc99b9"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/bcabacc6-b90a-4feb-b82f-3959c39b1039">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/b656ed9c-83f0-434f-b0ff-fa461f160d29">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/4289efbf-116b-4df3-85f9-2e1d3ee7c460">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/0ee8874f-3196-4ae2-8574-6c1dc907aa0d">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/0301e6d4-6fbe-43b5-9464-b122778216b1"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/77077830-8316-4281-9af4-d4551b2104f5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/3cc35099-cae6-457c-82b5-b82e40fefdf2">
    <rdf:type rdf:resource="obo:RxNorm_134527"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/24710782-a92f-474c-854e-4e85a80b7a58">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/1dd883c9-3ce4-4896-a516-920c0a2094e6"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/b13313d4-bde4-41d2-94b7-1fbfef243c9c"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/9e695a25-a1d0-42d7-8bee-d4f6865c926b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/309c852d-d0d8-4aef-be9d-2dd67166879e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/9e1e4f71-437a-4764-9044-24d353da9754">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/b23c5332-cdff-40e9-bab5-7555db5693ad"/>
    <rdfs:label>37 Percent </rdfs:label>
    <obo:OBI_0001937>37</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/fc3bbacd-c3c7-44e5-83cf-b4af74e93f05">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/a5c6df1c-7ef4-48fa-9e37-22ba3a28318c">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/91fffbaa-7f14-480e-a972-e5a12a65cad6"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/8bd57248-84ad-42d8-8b37-df0dc994096b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/4e304e90-4fc6-4afa-8743-920556cc216d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/a53a311d-d9ea-4c19-9fd2-39066b4d7a01">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/39f438f8-ab6e-45e9-8047-f830cc9b82b9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/699dc9cd-1667-4f15-9813-6e24aef64385">
    <obo:OBI_0001937>80</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/9a0a954e-87d3-4f68-a7c9-36e913ea8e0d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/09408d51-636d-40fc-bd84-91fe7fd9a2e9">
    <rdf:type rdf:resource="obo:RxNorm_4493"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/f941b014-9cd5-44af-9df1-e650890788c4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/3fe1f91c-e110-4ccc-b047-65b61656a705">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/b61aa132-a910-491d-8dba-2c3999109bce">
    <obo:OBI_0001937>80</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/68a09574-39cf-4566-823c-2f2be3909c21"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/eed6e205-0141-401e-a1c1-e3a545dfc694">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/d21085fb-c2d5-422f-acce-e8aa4d95c8b0"/>
    <rdfs:label>0.09 Fold </rdfs:label>
    <obo:OBI_0001937>0.09</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/257b9d19-0353-4a4b-9871-653968575dfa">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/2663f552-9701-4cb9-9b80-b521c3791da4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/e67c7cdb-709f-4f4b-b394-e1448b757ea7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/9efc9721-9932-46a7-9a15-aad314287456">
    <rdf:type rdf:resource="obo:RxNorm_2556"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/9091803e-3e0d-492e-ad48-d42d1d62abb7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/e6d4b86b-0c11-4844-9156-67e16a9bab6b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/89080a0c-19e5-44af-8b6b-ae22d485264b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/c7219f73-b04b-43f5-af31-03eb24dc241a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/3ef2e2d5-629b-4def-9bab-e58f6321eb3d">
    <obo:OBI_0001937>5</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/6c06765d-5425-4227-b77c-ee4b8a574503"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/c2651de3-ee6c-46d4-9d44-967a8e6c5671">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/511e9506-b3e5-4d5d-90b1-5fd7c383825a">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/26e2cd76-41bc-41ab-b7a6-a47f71c98f9b"/>
    <rdfs:label>cimetidine-mirtazapine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/c23ff75e-8e0a-4b79-b15b-b41de736c6f1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/6154f1be-96a8-4913-927d-807d0c79314a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/a5adad81-a2a9-4cd0-92b1-9cfa54ea209c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/14a80ffd-70d1-4771-86f8-cdfc8ef393d9">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/0868e290-daaf-4e99-856a-a6dafa5ced2a"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/30cae3a2-bf2f-4bbe-af27-5f314bf1c837"/>
    <rdfs:label>simvastatin-Nelfinavir interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/512191b6-62c4-4fb9-b67c-be3ccd63de83">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/8590bb29-d893-45a5-9d33-75322649f05d">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/7b6cc899-bef9-4c0c-87ec-79ac610b8106"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/8c473a33-5720-41c7-994c-5ae314b12547"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/be2e2e5a-a1c7-4946-882d-c3a6068072e7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/5a155ff2-c209-42fb-aa0f-4d5939d9587e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/c362fc08-c7dd-4d83-b10b-b8935d17fb2c">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/72f390bd-f783-4a65-b67d-0537905c58c3"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/101bba84-6979-49eb-9eb3-419b60dc97f4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/46c59b66-3890-4075-982b-4ca1b83db1e7">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/6a3ac0e2-6256-4164-a4cb-ab00405d5b55"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/3612db29-6cae-4373-9817-75f008ee0216"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/ac42e97d-317e-4df4-9275-ca20165d797c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/3dc69caa-756b-40c2-beb8-1c3ca466121a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/552ff003-a599-486e-8cd8-4a1ad90e05fd">
    <rdfs:label>simvastatin-ramipril DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/dcfce6a8-674c-4f60-a544-6f5dcb2415ca">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/c4554bda-2a56-4e32-b6cd-fe016f204c4a">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/b4615096-f2f3-4c02-a00a-280c9f98764c"/>
    <rdfs:label>213 Percent </rdfs:label>
    <obo:OBI_0001937>213</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/bf354f90-d962-4546-9ed1-80a666ffdcc1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/e757c9b9-dba6-437e-b33c-84175a869a46">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/6fcd2524-755d-4624-9ab1-9b59473bccf1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/40f52669-6887-4d4e-8954-2c1c270d5ac9">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/758dde50-adac-42f0-93a7-bdf61a2107dc"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/862db85c-a27a-45d8-9f9e-5f84ad7699d5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/244e9fa4-0973-404d-95e6-d64b4ffcfb37">
    <rdf:type rdf:resource="obo:RxNorm_2002"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/4325d443-a47d-4725-8698-f880a3c4565c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/956c9954-fad1-459d-8cf1-1cb4639390f1">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/bb4f87ee-1def-4170-a620-79e1a0e21552"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/2c352a88-4cda-45db-bc5f-8b712a2de52c"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/b033b57e-a5ce-4cdf-a9b1-9a1fa79cbf9f">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/184b8ddf-5469-4b49-8018-3294a681f765"/>
    <rdfs:label>50 Percent </rdfs:label>
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/9dc8e7cc-10a4-47bf-aef8-4aaac0f39dd8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/0c590691-a65c-4cce-a1c3-5fefb7d74865">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/57542bcf-c8af-46a2-9b08-f5702d3b270e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/146043aa-5d98-4ca7-945e-929af9ec403a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/32c89a5e-c054-46d3-a8ff-863db621cf02">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/3f33f523-92c1-4b2e-af96-14ed65d3e4de"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/a36569a9-b7ec-426d-929a-f40b50ef7e25">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/edd2d142-238c-4f6c-a213-1fc3906d4481">
    <rdfs:label>ticagrelor-dabigatran DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/bcc8063e-583a-4b27-ae14-2fd3dbbf5a63">
    <rdfs:label>ticagrelor-dabigatran DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/7d9237cb-b5fc-4ce7-8378-b7941424eef7">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/2c6c4251-9ffc-4df5-ab03-25c5f7fa1444"/>
    <rdfs:label>66 Percent </rdfs:label>
    <obo:OBI_0001937>66</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/36cae759-aa95-403b-ade1-1aaf55360dc4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/cff6bc11-ea05-41fe-8826-73a7cd514640">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/a86698c6-4dfb-40f8-9909-c0bb2067b84b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/83eebaa0-14bf-4783-9f88-5b491fbace73">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/f4b1f2d0-9184-4135-9cb8-eb5c9169cb7d"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/bc8ccea4-cca9-4740-bb00-02ee3537564d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/02b01aaa-305a-4887-a8f5-f58365578cdf">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/499da48d-b36d-422f-9844-82ff27d99bd6">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/b1ff57dd-323b-4e0f-8193-6603d711b6d3"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/b0a4475e-c19a-45d7-bce0-40dd088aa5df"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/30fc839b-3270-4c87-b386-049e8c3a7846">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/6898592d-7245-4f92-b206-2424e8cee982">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/9cdbc204-f85a-4593-91e8-496520ecd937">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/5dbfd6c7-07c0-499a-8ed6-24b9d036c8c3"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/823c276d-fa6a-4241-ace6-0159e0e5ed00"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/2fe4907e-2b4f-41d1-a432-3541d9552909"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/e91d4345-07cc-4e46-9885-ac9ec47caae5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/4d43ee61-4e96-404c-84f5-10a05afd855c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/986670d5-3e75-41de-9f5b-5f3e127c4d3b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/3ec97292-2d4d-44fc-adcd-77ab780c6bfe"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/a24c4e07-41af-43bc-89b4-1cb905e62619"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/08feefa3-9ca4-46e1-bfae-0af35aaf7c1a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/59065a10-03e8-4242-ab82-96545716e2f2">
    <rdfs:label>ABILIFY-paroxetine CR DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/c898936a-fa7c-4803-965b-7ed01f14cf21">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/6650b385-5ad6-4ceb-8747-45f63756c46e">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/6211e5d5-0af0-43e7-8352-1da77bf7a873"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/4e7e5f57-71ac-48f0-9ce3-10d46760c93a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/a7f27b0a-9a28-4d9d-8088-6668769cbfa2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/0e993b40-c341-4e29-ad1f-631c4eb6893d">
    <obo:OBI_0001937>120</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/fcd923f7-32c6-4297-8b0c-e673ec770ca4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/c9ce42e4-af36-4960-bc90-396d8cead16f">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/3b33fab1-7222-4f7a-97e0-6255c633af93"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/0633a538-0476-42ec-ad0d-0023f85af11e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/102c6784-0900-4be9-8b1f-ad2b61d1dd0e">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/55a118c6-34a2-4c62-bc72-a3d6f56edbf4"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/c8f0614d-628a-45a9-a708-b80b73e1eb29"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/1011ac46-c9a3-448e-9d29-f1da7996c517">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/93ccd46a-4e27-44c3-836e-0f344c224ed5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/2ca53930-b90e-44ae-bd73-442516c8ed7d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/382ee97e-f8f1-42f5-a40b-88a3cacdf517">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/21c5f36d-2a12-45f7-87ac-3229b278b4f5"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/c36a7ed9-b010-4321-b6ba-79415f270b6b"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/25bb4a71-e97e-40ba-ad57-c2fbb9d495b7"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/167b2513-2400-408e-a8cc-d7eeaea310f4"/>
    <rdfs:label>Nelfinavir-simvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/d0de8477-806b-4cf6-a18b-c31971212737">
    <rdfs:label>sertraline-tolbutamide DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/e54e7fe2-9447-42b3-bf73-cf44d6733917">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/f1e25bae-69dd-42d1-9147-205276794730"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/9ade9383-85a5-473d-95c9-46110281f417"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000221">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/9aa5d131-7ef9-4ef6-a3af-75dff0799df7">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/16e1c976-8f3b-4933-8978-1a1db04ffb46"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/0d7a1c50-fc14-4536-933b-46ec527aa71e"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/7ce292b6-c5d7-4ff8-9de8-15704189cfb4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/3ba648ff-8715-4528-bc70-86d667b9af3a">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/18e9547c-6d53-4764-ac66-21495ebec9d4"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/00731e97-2cf4-4ef4-a9df-c314863175ba"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/d7368420-5e12-498b-b90f-0fd808f8e1cf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/23c4541f-71f1-42ac-b950-1fe114220c9b">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/be95d368-7265-4758-9ff6-5c2019dcafed"/>
    <rdfs:label>unchanged None </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/b661e049-941d-4e61-b8ef-32d9abd58ac1">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/3baf6ac8-9bf3-439e-bbe7-25cd745dd3d9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/31ab8765-b24f-4dea-ba21-2a6ac20ce1b8">
    <rdf:type rdf:resource="obo:RxNorm_9384"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/1ead40d3-fdb7-4a28-8d28-eebe8656de67">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/86fc0f5b-a5b1-42b1-846a-6d62410d393d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/45170352-85d3-404b-a98c-b170bce6f4f1">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/b646bef2-73cd-41fd-a6ab-1a77af3f3e9b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/d2114b2a-957d-4baf-8ef1-76a2032c4c24"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/d9f7c72f-4a8d-4eb6-aab0-77374cb1753c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/477b7abf-6c3b-45c0-ad1d-7ca104c87c2c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/caf641dd-15e7-4eba-9a64-2667ce41d3d7">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/23bf996c-f205-4eaf-889c-2503cf3276c8">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/4c167fd3-114e-4bb2-840d-41a5b0f95227"/>
    <rdfs:label>8.6 Fold </rdfs:label>
    <obo:OBI_0001937>8.6</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/3710fe50-dc59-4215-addd-ae32cee5f93b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/067e8f19-b78b-4c5f-b554-23770339c645">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/aa48c14a-8e25-491f-b1b1-fb70e633ba1b"/>
    <rdfs:label>7.88 Fold </rdfs:label>
    <obo:OBI_0001937>7.88</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/4359bb8b-0c09-487a-bf9a-7b5c24a6fc79">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/6e85b090-17b5-4778-b940-a123d2cbd482">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/9f5a9e6b-dac5-4371-b3a1-248b5307badb"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/c3c6cf5f-cb30-409e-99a8-ac870af540ae"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/26085036-e046-49d5-89ce-a0967dbb8623"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/ef4d07e6-2c8d-4421-916a-d9f2e9083df5"/>
    <rdfs:label>efavirenz-bupropion interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/dfb1ea55-02d8-4c11-b003-350ee4005f28">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/dc2c43d0-89cc-4a80-bd11-bd5aefeb7290"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/29beb17c-fb9b-4bec-ab0e-a27c19e2dcce"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/45ead715-9daa-4da9-ae20-7fed6d66b1fd"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/7b1e1995-dc2e-4792-a43a-5df9f8dc1e22"/>
    <rdfs:label>Gemfibrozil-Atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/136bbad5-3e91-4130-9b5b-3d2c136aeac6">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/2aaeb02c-b8e3-4e6e-9021-2ad4657fcc13"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/ab7f62cc-042f-4179-bd4e-cff38ee6cad5">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/c77d2d2b-4356-4fa2-b863-bd1f091c47f4"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/2e24d004-7c77-450a-9125-994ab2b30d4b"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/4a255375-62be-4afd-b0ba-03a27914937a"/>
    <rdfs:label>S-warfarin-nefazodone interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/2df84982-5672-4f59-9d72-b3af73878881">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/6f4baa9d-04f8-4d39-9f39-f575a410f9e1"/>
    <rdfs:label>no change UNK </rdfs:label>
    <obo:OBI_0001937>no change</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e4582cb1-d3ec-44dd-8e3a-e58ddffa4ae2">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/3338a9ec-af3c-49f1-9cd7-531438bc93a7"/>
    <rdfs:label>nefazodone-simvastatin acid drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/af2aa48e-c48c-41d1-a769-9f7615c13a79"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/579793eb-5b25-475f-acec-2f6d58d5a474">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/8879ae1a-3e60-47f8-b24a-89ee98475fc2"/>
    <rdfs:label>65 UNK </rdfs:label>
    <obo:OBI_0001937>65</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/9a35d398-c859-41c6-b687-ef9fef1ac3d0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/e892a313-1a7b-45ae-820b-b5d22aed1f95">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/6de7c537-719b-46ea-9fd1-f0f9a0ba4362"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/449e918b-2b9b-4dd3-aa22-aa52ca3aec8f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/1d6460be-8c00-49dc-ae05-7636245f69c2">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/3db8d14d-7b31-4285-8d7f-e62c5f98667f"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/9287be4a-5085-4a13-8ce1-94fad5c3b3f8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/2ee7e184-265e-47da-ba06-72237884def7">
    <obo:OBI_0001937>75</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/996b48d6-c3c6-471f-baa3-abd2415730d2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/0b0f22bc-252e-451e-b22a-72c3a315f00e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/a85a0917-ecf2-41fc-a1ce-b71527b9980d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/006519e9-247c-4a76-bfba-fe90bbaedf65"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/39506e3e-afff-4c14-9615-2f2fe80a101e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/20f50b74-00f5-4206-bb49-fde769f1b5e1"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/bf570f6a-92c4-401c-bcc9-f49092c896c0"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/c3bbd85e-f826-44f0-aaba-b40080827bf3">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/b26732a1-7d13-4013-bad2-da84143048cc"/>
    <rdfs:label>divalproex sodium-INVEGA drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/5843a2d0-089b-44ad-a4f9-ad7da5fec795"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/9d42a203-def7-469d-88ef-206ab22ff820">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/1aa25c2c-7538-42d3-929d-20fcedfce169"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/15483d5b-743e-4e06-ab98-b7c4e00fb57c">
    <rdf:type rdf:resource="obo:RxNorm_32937"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/bfd53510-e800-41f8-96ba-6deafb85224c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/11c6f2c7-ed48-4069-840c-8da242b14a9b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/35c1fa25-b22e-4ccb-87f8-fbafbbc0cfbd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/df8c89a1-02d5-43a3-9b5b-381ddd9770a3">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/081b0047-9743-4b4e-9fb9-9a7a165ef0f4"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/5d1b44c0-557e-474a-8fa1-b6c3e85898ff"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/6409a91f-4b27-4897-94b3-20ca1951a877"/>
    <rdfs:label>ritonavir-threohydrobupropion interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/ca49b711-a5d1-4993-b14d-2cfb0844276c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/082986ac-555b-4eec-9239-1e538789d4b6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/16177e48-c49c-424d-a0bc-8201e2004e41">
    <rdfs:label>Cimetidine-Atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/928af2c3-7965-45e4-86e6-55463e56ef9b">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/0ed4a684-acf2-43ed-829f-bd5457ee3390"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/f843a8b6-579e-4b84-8a46-6c8a2add6d2a"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/466a1d9b-ee2b-4905-9a00-50bafa3a4960"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/909df765-16ae-4e11-b000-9348a0146a2a">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/c0a546e1-ebd7-4d99-b201-65469ff2aa88"/>
    <rdfs:label>Gemfibrozil-atorvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/b6f46949-c064-445e-87bb-0aaed8c39a7c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/43a7e376-6190-4294-bf96-4154390b1619">
    <rdf:type rdf:resource="obo:RxNorm_1546356"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/f4f706d8-3668-4ffd-b671-d900bf6cde17">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/0c41273e-4334-41fc-a074-4c44b9980704"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/6e543694-79ac-4659-8216-715e6bff2432">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/aa6eeb14-41f0-45ab-a74a-eb4802045de0">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/399de078-131b-4b75-bb1b-5308ec7226ca"/>
    <rdfs:label>82 Percent </rdfs:label>
    <obo:OBI_0001937>82</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/bb2cfddb-3a56-4048-8293-8e6424d7801f">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/48b5cba3-3f01-43a3-8551-f323c722b803"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/172b4026-595c-499d-823a-e472d0da9242"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/9d66c943-4d94-4223-a91f-b03e24578fca">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/4e4defbb-7565-4e44-ac7d-13274936b6d8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/961f2876-0033-475e-be18-ef6c1073abc2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/f71f9d08-f89b-4ad9-bbea-f098db5ad78e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/00f63835-7018-43aa-b540-4a27aef63ea4">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/1497a33f-b3a3-4b50-b0f7-9163e6cbeb22"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/798b6f83-7a4d-441e-bf55-578a17a70b6e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/96f5e0d1-1c6e-4d49-bf28-8e2046052158">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/294aeee2-65b8-40d3-890a-be54fe8e8a76"/>
    <rdfs:label>itraconazole-zolpidem drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/54d61baa-a36a-43f6-ba97-24e1e24398d3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/ffaea816-796f-473d-b0c9-074e69c636eb">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/e5f78a37-03a2-4543-9fd2-29bb4da529be"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/cc2d469c-d98b-470d-b6ae-0894cdb533cd"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/5a311420-2781-464f-95ba-8b3a6513a780">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/022d3c12-3ada-4ab9-b40a-6c8a723e110e">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/6ca7438c-84b6-4cf0-9bbb-fb660b5cf04e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/7b24db8c-32c2-4c85-86a1-63521501fa5d"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/f48e84b8-243c-48f9-8fe1-b19b2899a811"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/630c7748-9cd3-46ac-8375-257c0bdc9c8e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/36ac76dd-795f-4ec5-bbda-3a3e3d42bc26">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/ef4d07e6-2c8d-4421-916a-d9f2e9083df5">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/65438dc6-7f29-4e47-b80b-dc0b86ac283a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/2e886ca7-6a29-442d-a81f-d06d850d42fb"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/b660c117-4022-4dfd-858f-18cdeec789ba">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/9f4fdd98-06b1-4747-9e1f-87f3e61b25b5">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/d24ac86b-1f94-4fa3-b9a3-c37f304e6d5e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/98fb63b1-5efc-4e92-b3f3-de246ab5ce5e"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/e97b39da-be53-473c-a33f-017c805ba6db"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/a949469e-fcbc-4284-a02e-821cbcb00fea">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/1e3e3679-30b8-4bcb-a9c5-e349677153cc"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/40e82b2c-a7d8-462d-86c6-3a91dfff047c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/439d8bf5-fd4f-4bc4-a073-0dafe1ec246b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/e181e6ab-8027-4ff9-adec-959e088efa8e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/a281cfd8-527e-43ea-92b7-a53cc15426ca"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/b26b391f-644d-4a5b-aba1-2f4e5447251d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/197eef3b-ca47-496d-957a-2617d46f257b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/989afbdc-1e03-4b76-899d-b0ce3076363b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/6780bad0-4805-4d74-9c29-79bed14af240">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/a8d8a858-6a6d-4bfd-b770-ffbc7f662191">
    <rdfs:label>nefazodone-triazolam DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/127c1bc6-b8e7-4365-a12d-528506abbd01">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/3b5edb47-8198-4663-baf1-c94a7c4ed0e5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/75d90925-62b2-4e47-a438-5e22a27f1ed0"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/4b709d41-84ca-4242-b48a-be4be103ae98"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/6741e979-a6af-4b2c-982e-40ff02a13f06">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/f4f20d81-6a98-4789-8a10-beb97e55012f"/>
    <rdfs:label>17 Percent </rdfs:label>
    <obo:OBI_0001937>17</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/d21085fb-c2d5-422f-acce-e8aa4d95c8b0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/2c4562eb-ef60-4230-9141-0c1e09f577b6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/3b9f3296-9db3-470d-b376-332def47ca4e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/1f5a7d51-69c4-482d-8c5a-a1c7dc4e0f88">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/14046930-f72e-48db-b375-e91ce6786037">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/be2e2e5a-a1c7-4946-882d-c3a6068072e7">
    <rdf:type rdf:resource="obo:RxNorm_1827"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/8857bb70-df4d-46b1-a1f0-c423a4182898">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/93e825df-1edb-4a4e-8de3-f6d9092d1ecf"/>
    <rdfs:label>40 Percent </rdfs:label>
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e9ffe408-2346-424c-b35c-a578d923fff4">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/c18c5122-5e48-4ed2-86f9-cff2e3ce5262"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/2d59d852-758b-47c2-9f51-8122730e828c">
    <rdf:type rdf:resource="obo:MeSH_C580748"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/a220e1e7-31dc-44c0-ad00-a60655ff81d4">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/e2b5b5cf-f355-41ca-b6c1-7f25744dd946"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/871350e7-7d58-4a7c-b705-6f0d32e34386"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/184532f0-e082-4952-8ba9-962f74893705"/>
    <rdfs:label>buspirone-hydroxynefazodone interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/651987db-e0d3-4cc2-bd76-3d4dbf263b13">
    <rdfs:label>midazolam-rivaroxaban DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/84239b40-c8c2-4231-917c-2284cb3bafd0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/7d9b3858-75ec-4d0a-b941-2072c7960477">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/72aa99f2-af8b-495c-a964-a943a132ecf8"/>
    <rdfs:label>simvastatin-bosentan drug package auc  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/8f39a909-4822-4607-bf10-f0d5de7dbfb2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/5d3eeda4-eb47-4ee8-9cdc-311443509b6c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/c8bc9dc7-44de-448f-92c8-19e6d9913de6">
    <rdf:type rdf:resource="obo:RxNorm_17767"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/7cd4a1ab-fa64-407e-ac7a-a70925ee16eb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/c8d1983a-a46e-4ce1-b810-df1d1d195b4e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/d974a5bd-7efe-4de7-a306-ec1a86213db7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/30e1cdd8-e4a5-4507-b1c0-4359beb4ee61">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/27c26c3d-1030-443a-8991-0c66ab606b07"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/7b769764-f1a6-4f1d-b490-3711056110c3"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/87e9d207-eb69-4a8c-af75-6f9452a3816c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/72d8428e-972b-4164-9ea4-9ee663d4316d">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/a089022a-516d-4a10-92ad-1df94c643310"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/ff267ce5-1ea2-4815-ba23-49db89a277ac"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/f4c48b4d-665e-4da8-995b-b6b69d943e58"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/714cbaa5-8bad-42ba-8a68-a7c9f46e178b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/f940e0a5-7dde-41e2-a0cc-95ffbe2ff567"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/1d60c51a-d7a8-4db8-9d80-633f4ed776c9"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/321e6c43-84f4-4736-a961-f269e51e4d1a">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/442692ee-152d-465e-ab7b-827ab5e0269c"/>
    <rdfs:label>3.9 Fold </rdfs:label>
    <obo:OBI_0001937>3.9</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/ce6261f9-05dc-44c3-8972-8bcf34672119">
    <rdfs:label>paroxetine-tramadol DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/dbb3f754-826e-4299-a381-e639ec5d16b5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/aff2e9f8-8c35-4652-b9bb-11675e8e5524">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/4290820f-b8dd-46f6-aaa0-54c4155ee93d">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/8e0b4d4a-98a9-407b-82a6-c1b87bee7d18"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/e09ae99c-8279-44a0-8fa5-b37a2a405a7c">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/869b8faf-d1e1-4c47-958d-181a921f8bc6"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/d0f993fd-7152-4ca8-8454-d6421ca06e98"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/13688c99-42b8-4dbf-b06f-f50943e4b04d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/485e06fe-834e-40ed-b0fd-58e42ccc4f6d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/c4112905-32d3-4118-a940-521d6aeff56d">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/a4fae80b-26de-41ad-b75d-b69fc1ea110b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/285fa0f7-2efc-4f0f-bcf1-bd846f129e5e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/b3b58875-b85d-4fe8-9464-ade166f90a7e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/81d05dd5-cf36-459b-8094-72edfe796882">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/c722056a-96ee-4aa2-9f7b-8d989d50a768">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/0d4a382e-8cb5-4e9f-b217-9fa13b205074"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/1d58ff75-0542-4e87-9ad3-0558103c37fa"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/3e20b592-d7e9-4588-aee9-35e922a937a1">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/67935f9b-055a-47ca-ab06-c45b6a38eb6a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/394de1df-b74f-4aa2-94f0-6590561fb9b6"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/bce0592e-f130-4aa4-b46a-310abd552130">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/46650607-a701-4fff-8a81-5fa6cea0ab4f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/d96c0b0c-0b3b-4cd0-b312-d4981bebb661"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/d189977b-b0fc-4d44-abf3-35450f52d402">
    <rdf:type rdf:resource="obo:RxNorm_39993"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/a358650b-1691-43b7-b701-c08c4d5852c6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/cd9cceb4-5c0c-49cb-a334-ba0f4ab4af8a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/1452f363-d4e7-41f5-827e-cb578267ce0e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/7ff35ab8-edf1-4984-81ae-4b5585211a8d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/68514770-bbc3-4cc5-9ee1-ab2982cf0b4c"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/5eafc98b-0877-4794-bd8a-5d922d47ce50">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/a30ab55b-e098-4e32-a389-f2b9db2aaca9">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/db05004c-0081-44da-b29f-25ebd01aea89"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/46ef398d-0df6-4352-a048-4fc9797a2fe3"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/2582808b-8e1f-4b3d-91bc-689b396fa90b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/9bd6b36a-2e0a-4653-9b56-1b6e5283df8a">
    <rdf:type rdf:resource="obo:MeSH_C060062"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/53593099-ab43-4179-8f55-263769966c77">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/7a357f95-cdd0-4dda-9216-d6f4dc2f416d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/7942c237-30a7-4c1f-a7a4-f9e2eacfc9b7">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/98c7df8f-9b12-463a-8e27-1ff39ec7d734"/>
    <rdfs:label>telaprevir-atorvastatin drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/0972f2c2-e2bf-4f0c-ba22-092e2788d0c5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/008a599d-7ca9-482c-9da5-ef8cd237d4eb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/812278b9-01a4-4c5e-8422-3ed7635ce0b0">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/996a2b42-2b6d-4d47-b84e-ebf93f166801"/>
    <rdfs:label>23 Percent </rdfs:label>
    <obo:OBI_0001937>23</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/e99587cf-ec54-40ae-b814-abcaa514d263">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/ce976564-b1dd-4e87-a05d-f611c137d271">
    <rdfs:label>fluvoxamine-thioridazine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/687f27c7-5734-4901-8a5e-11315e106f41">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/e969dd5f-777b-44c2-9af4-344c9b3ad628"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/2566a661-f546-4e4b-863e-b72195665b22">
    <rdf:type rdf:resource="obo:RxNorm_3498"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/d69e39bb-0692-4bd6-8033-641dbaabddf2">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/a60b79fe-9c5e-4fa0-b638-8076a6481a96"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/9b1c8184-b166-426a-b640-a67389acb65f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/f66fa062-0439-45e3-b02e-cbf94dddcdb3">
    <rdfs:label>atorvastatin-Nelfinavir DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/4c3ebba1-7789-449d-9be9-85f8b267e171">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/a71ea2c5-3b32-497d-8ab3-c51325a4d034"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/ad0ea5a9-1bcd-4813-897b-3d20e0be2e72"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/0bd8f242-e076-495e-a49d-a1139b1c5e21"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/6c6cf656-5756-4fe2-9bb6-1eb8f710ad7d"/>
    <rdfs:label>clopidogrel-fluvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/96edffaa-7216-4510-90c6-bdf8c5af5fa9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/667ea753-77e6-4ba8-9556-714b08afea51">
    <rdfs:label>ketoconazole-rosuvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/c3d14fc5-b661-410f-af50-71e6ff717265">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/ac8c5b9c-9a16-451d-bf8b-891d30b5d0ca">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/831d4641-3340-4dbc-a7f2-a086c9e5d2a4"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/9c769ff0-fc3f-4d07-83dc-4d6265c1a715"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/97432c05-8274-448d-a980-8b9e98de2761">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/1011ac46-c9a3-448e-9d29-f1da7996c517"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/4fe97566-2dba-4931-87da-6a6057274c9d">
    <rdf:type rdf:resource="obo:RxNorm_32937"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/e521b36b-5ba5-4be6-980c-04cfcc6bb210">
    <rdf:type rdf:resource="obo:RxNorm_2002"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/a49f2fa1-2136-47f3-88d6-b9db2e87dc05">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/667ea753-77e6-4ba8-9556-714b08afea51"/>
    <rdfs:label>ketoconazole-rosuvastatin drug package auc None information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/f61eb508-6c3c-459e-bb0f-a75328ab64be"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/595a34f2-cabe-4be9-8587-8d5ac978d026">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/af0dffbc-28a5-497d-8285-96b48894fa07">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/07be1f54-45f3-4749-82a6-945e9a2143e2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/9ee01733-584c-41c8-8e7a-d50c2eaf9250"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/48993144-02bb-4a75-8677-1c732f36ae90">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/2a6896cf-54b3-4404-b278-55e7bb9a49ca">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/5872ecea-6410-4fed-b0dc-c6d45ef4cff8">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/70c517ae-a5c9-4074-98ac-dbaba9ad70a0"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/597452f9-f464-4993-8ea5-bc8afd8d577a"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/e79d58e1-b5fa-4e63-92b0-4da1359f5350"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/ce13ed45-93b5-4204-be83-cfbe0a7c52e1">
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/4ed6effe-cf51-4b6c-8bba-a8587d517441"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/a4d81889-cb2a-495a-a259-e0711e293ff9">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/6d181ba6-fd18-412f-a716-ba3a16006700"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/8916f4e1-81e7-4033-a3c2-953d96de68f8"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/f1b0006b-4d21-42cc-b814-0b3ea2950833">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/4e277530-91f4-4bb9-bb2d-b0a43debf718">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/0e31cdc9-2132-47cd-8f64-f480d3e1ab4d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/bc05b1fa-7531-4448-a367-d556f4e66b69"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/39186783-a458-4371-ac08-4f095949193c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/f0388cfa-1e1b-4263-9d94-a8d5828c61a6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/ec204882-2fde-4363-ae7f-d8b5af9eb5f2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/2cb12470-64a6-4e56-8dea-d0909c3b858c">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/af5ae57f-878e-425f-ac00-67f983dc5eea"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/f2e4df98-04a3-4574-b660-019b97f4e528"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/19059ebd-9bbc-4e9d-8c16-1222b9539763">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/d99ad2e4-ecad-4b10-b96e-1bbd2d056f5c"/>
    <rdfs:label>6 Fold </rdfs:label>
    <obo:OBI_0001937>6</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/70dfd389-de67-4987-93f8-8688fa996dc7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/9f087d8e-3f6e-454b-86df-98225083278a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/bc6274e3-045a-47d5-8a8c-27d5f4670e67"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/bc0012a7-4978-4f87-aaa0-bc40ca31a902"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/e990e29b-eb9a-43cd-8d34-8bb97a63321a"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/c5394cca-4f22-4a80-ad8d-8197d34cd36b"/>
    <rdfs:label>phenytoin-mirtazapine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/880fb2e6-2ee4-41ea-a3a9-8092d23d4e93">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/4bb66ad0-003e-46ee-949d-500fb4508f8e">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/08bb3415-6d15-4cae-8ef6-b13bd75bb559"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/724ae9a9-964a-4b30-bbae-a65c85929f26">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/6ef07bb8-1585-42ae-a79d-0b3d66442c0a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/ab869beb-3488-4c21-a943-84fdddd1bc27">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/89a5b9bc-87c0-4b5d-88c3-5bad463f5d92"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/cdf8cf1f-fd1c-4ef5-bc50-cc0358c5b8d5"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/ec25384e-2ea8-4331-865a-faf0af23d5cd"/>
    <rdfs:label>sertraline-tolbutamide interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/43f1a5cb-96cf-4583-a425-5a35a9d98bac">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/511b0deb-4dc2-438c-8317-494add0e0112"/>
    <rdfs:label>37 Percent </rdfs:label>
    <obo:OBI_0001937>37</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/a7e013db-7372-4c53-bf5b-bc211b0bb560">
    <obo:OBI_0001937>60</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/f51c57fa-3a39-4d26-b384-fcb2d5a32db1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/97fa9e06-0e44-4c0b-9d4d-a1a27f50338a">
    <rdfs:label>carbamazepine-ziprasidone DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/b6fccad8-e8aa-458d-9393-c27563c6440d">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/8077a3e8-011d-4fe8-b066-f02cbc79508e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/8d686f84-b1ef-423e-b95a-97e844842cd7">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/c961c7c3-9d17-44c0-b7d0-81cc8363ff06"/>
    <rdfs:label>31 Percent </rdfs:label>
    <obo:OBI_0001937>31</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/975a41d5-aed9-4c37-bd13-3e867c140230">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/84c3b674-450e-4cf1-9588-c6fd3f0a361f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/b13cd345-72af-4e3f-b1c9-7153a2de610f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/35df2109-b68f-4ec9-b9c4-f3da6a54dff3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/fa17fa1d-cd1a-4aa6-b5a1-d467c573399f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/a49f2fa1-2136-47f3-88d6-b9db2e87dc05"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/d0520217-ca29-4c3e-9139-65790075b016"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/0b4f9c23-7df2-4f67-a6b4-1d8ed95d8003"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/63c486ad-0fcb-4242-b0e2-1498d4f1ab5e"/>
    <rdfs:label>ketoconazole-rosuvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/77d11329-092a-4c63-b5bd-64f73b8305a3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/800b91f7-9880-47f2-9c70-da84234d50b3">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/5add7fbc-8e56-4541-9040-c99fc1f8b07b"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/9a567300-9e9a-4528-84e4-e9112beed4d6"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/8571a965-aeb3-4c4c-ada6-8292e1a4b81a"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/7d5df45b-5b45-4d63-a0c2-d1883f740944"/>
    <rdfs:label>ticlopidine-bupropion interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/8971deb2-bfbc-4a77-b71a-3cffd4c171fd">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/6fd28098-2530-45dd-b208-22ef809b2ea7"/>
    <rdfs:label>rosuvastatin-warfarin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/21259c63-1866-4c7d-9ffb-4945f0568249"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/c2b0ff2e-638c-4288-9d01-4e0e74d0006a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/1ee84c6d-e501-4915-b73b-81b53cd85083"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/9488b72f-4410-4b2d-a3fa-f651fdfb59f1"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/74b1d6b6-5a14-4362-9b99-28e303ce7409">
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/73719073-ce35-445f-a82f-6637b305d0bf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/205e73ed-491d-402d-9ca4-74add746d62e">
    <rdfs:label>simvastatin-Nelfinavir DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e1c2c083-81f3-429d-be4a-27ff4155b877">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/7edd2f2e-8946-4272-b109-98970aa73259"/>
    <rdfs:label>paroxetine-desipramine drug package halflife Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/29e437d9-fbae-4b98-999d-219b1197b126"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/b050a5fa-f724-4c90-a9c5-6f4282ebee62">
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/8cae1583-54e7-46b6-a956-247c1b37fb25"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/46767742-8013-41a6-ab74-8b9304bd6a29">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/36f94859-1b45-4b41-981e-dcaacc57741c">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/56695ad2-274d-479d-a076-2fc185dda448"/>
    <rdfs:label>49.1 Percent </rdfs:label>
    <obo:OBI_0001937>49.1</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/f313c919-f8c5-419f-8a46-e1fa07fb1122">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/5eeb3fe7-0f7f-4b4b-a7d2-e89bf45ec9fb"/>
    <rdfs:label>2.2 Fold </rdfs:label>
    <obo:OBI_0001937>2.2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/08f1588a-9e46-47c9-9173-bcfdd5e44a37">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/aff2e9f8-8c35-4652-b9bb-11675e8e5524"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/db9f4281-a1f0-4289-996b-8268d5d851d8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/52f27f96-f88d-460c-a93c-a7eb4e5dcf37">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/46c59b66-3890-4075-982b-4ca1b83db1e7"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/8bf19883-ad97-4b5f-9c21-db1665b81a3a"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/c0ee00d0-5b23-4287-bb02-b6541b0c9313">
    <obo:OBI_0001937>25</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/88f03733-38f2-4ada-be2d-2001e6aa469c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/13307d16-21b3-4163-93fb-c0ded3703222">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/f313c919-f8c5-419f-8a46-e1fa07fb1122"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/633ab979-f5b2-415c-a750-8d24fbf9128f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/1d58ff75-0542-4e87-9ad3-0558103c37fa">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/ec2d09c6-5074-48f0-8b23-4871df83bd74">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/78a30733-6461-4693-a735-6c1adb9e27ac"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/df9c7d5e-e9f6-4731-a5d2-def36ea1db64"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/d9128ca0-2513-419c-8c90-c12d57a99f37">
    <rdfs:label>Fluvoxamine-sulforidazine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/b3be2e16-232a-4518-9a7d-77ae3140659c">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/06c93136-804c-455d-b317-9b9848ffd6fa"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/0585933f-669e-41bd-a0c5-2088975c6ce3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/efb5d586-2d18-4da9-8cf7-3464c17b75cb">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/e9d7b591-6e5d-4503-ae8a-a29a919a6e4e"/>
    <rdfs:label>paroxetine-duloxetine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/94fc11fc-c87d-4206-99e6-e57c6884a71c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/f843a8b6-579e-4b84-8a46-6c8a2add6d2a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/c3f77843-c2ec-4838-89e8-8851ec2c9c44">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/e731e181-5c4e-4ef3-b276-9fc5ccac175f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/e6d4b86b-0c11-4844-9156-67e16a9bab6b"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/d091e71e-62e1-4ab2-9329-13047e9ffaf4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/73cf1119-fe66-43ab-8609-2987a8788292">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/2f55fb51-7ef5-499b-a775-0ef08704c193">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/93a29126-48fb-4c73-b9eb-8deef03394c9"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/5cb92563-882c-46cf-b652-118db63786bb"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/64cb92c6-20b1-462c-bc13-6542a7f1c5de"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/097a4419-3945-4cf8-b624-dfed5e63d471"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/9f043cb4-c580-4e2e-981f-227f2a091579"/>
    <rdfs:label>cimetidine-sertraline interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/24b1d2f2-b77f-436e-890b-29db2ea11ce3">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/fc3423e7-d85b-491b-93f7-f998c6f0162f"/>
    <rdfs:label>low-dose ASA-Edoxaban drug package cmax UNK information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/734740a5-ec39-4890-bc90-3d47a1c4327f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/21f0f2f0-581d-4b5e-8ac1-ff41b7a8c4e9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/93e825df-1edb-4a4e-8de3-f6d9092d1ecf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/cfb7888f-eb29-440f-bb44-8ac39bb5fa7a">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/93ee3e39-3493-44bb-9b25-d4f5f667e12a"/>
    <rdfs:label>2 Fold </rdfs:label>
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/31b5765c-8d3d-45e3-8ca1-8ceb3ee4b514">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/7ba34334-8067-4a9c-845d-1a56f192df74"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/e2c8c184-692b-4648-9bf0-ed146e57260c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/cc08dc2c-76c6-4c49-b96b-4c625dea8983"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/7d0efc3c-e36e-4aa2-b03e-2b2cdd6ed942"/>
    <rdfs:label>cimetidine-threohydrobupropion and erythrohydrobupropion interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/aeefbb2a-96d0-45cd-8c91-968f26591888">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/15056856-9e15-4b30-b311-c4868f99d82f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/a190a000-5c11-4acd-80cd-4a29584fdcb7">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/c4a9740f-fb33-4dc0-8f84-ffd15cb27d8f"/>
    <rdfs:label>paroxetine-P95 drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/c24668f2-a5e9-45eb-a498-ffb5c92c3983"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/7a06c6ff-b37a-4c6b-bd66-121e96767118">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/78219942-de64-4cfa-8ef5-e51c7c9479af">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/0f127c7d-0c3f-4558-86c2-3afad1678ecf">
    <rdf:type rdf:resource="obo:RxNorm_1116632"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/36568555-8488-432d-8348-1f15ee60328f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/0dd4a8cb-6943-4b88-afb6-759d5064cd7c">
    <obo:OBI_0001937>80</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/65a42e6b-1c22-48a9-a3db-a7403c4fbfcb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/700ddc09-fcfa-49b0-abe3-d973c96f9951">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/9f5a9e6b-dac5-4371-b3a1-248b5307badb">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/103979b1-58f4-4817-8118-29eaf64a5cac"/>
    <rdfs:label>efavirenz-bupropion drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/75e621c0-9b6d-45da-abe6-3dd041fcdcc8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/b4c14f40-65be-4dcf-94bf-c97ea7f443fd">
    <rdf:type rdf:resource="obo:MeSH_C016904"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/c47c2107-45b4-4fdb-bb30-141ae5f15898">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/6baf685f-2901-4390-9334-f4acc549dcf3"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/f2d4d48c-2116-40fa-9d7a-907dac17dd2f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/4daf426e-9a97-4706-bb4a-a022877869ff">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/616a0c09-67ef-4fe4-8292-06a4c451c711"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/76259c41-9d74-463f-b1d8-7390ad7e10f5"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/3ffc8035-3082-49d8-b01e-49380e6f3e4e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/92e5c277-f3e5-49e6-a9d6-e5be44ae2607">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/3ba2d4c1-a973-4f3e-9171-4869f83faa1a"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/149c1152-4060-4e4a-a249-d2911921d5d0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/6dded392-e6de-473a-a210-b62dc3ab5837">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/1309be4d-5e94-4048-abd4-257a251e457d"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/c8ff1f0d-b8c2-450d-a8fa-6dca55ac239b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/cc2d469c-d98b-470d-b6ae-0894cdb533cd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/fb2dfbbd-112d-471b-bf4a-e2e994d51120">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/2acebdbf-bdf9-4593-828d-22375ec99080">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/c277a47c-b2d5-4cfb-ba27-b47b62f25e35"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/ccc92cfd-c7a1-4dca-a1f8-ead5e6f3248d"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/6d71c852-6b4a-423f-94d5-f132ec56cf93"/>
    <rdfs:label>carbamazepine-L-amphetamine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/ed069197-00b3-4286-b27c-21df8ed9ae04">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/f278aa4e-81c9-4d93-9199-bb52a0ff147e">
    <rdfs:label>aspirin-rivaroxaban DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/d572a828-3f0c-4bf8-8fdc-644cb0f9aa21">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/b74ce237-83f9-414b-8091-2cf673c6c8f1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/e47d2a35-0a18-445a-b789-52d638d96b5e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/8a5a347e-d12f-44c8-bb8a-e77eb9afbd09">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/827d694f-081d-4a73-80a6-0c3e989b5667"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/55ef2e8f-1ee7-47f6-a6a2-0dbad052fed7"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/8013dd26-f65c-4422-a48e-7a45e07d8294"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/93411e20-d87b-463d-ba0a-ec93eb8bae27"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/75b5289d-b929-4b28-b466-724553bbf770"/>
    <rdfs:label>atorvastatin-aliskiren interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/8ba14766-0846-4bb7-8e24-99ad22371436">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/81ec373d-5173-4334-a3c9-a6389188af37"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/520f0002-d3ef-4011-a01e-8b3d38594558"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/e171cb85-302f-4398-90d9-e21f405ba6bb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/7b769764-f1a6-4f1d-b490-3711056110c3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/c6a14a4f-7dbe-4e2a-addb-a1eee10c7424">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/553b21f1-6c1b-4109-8f24-43061721b1f6"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/bf2080f1-f33c-43ac-a335-9613185d1256"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/6566ec9d-cbb0-4acf-aab6-3da989f3811a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/f0f513b0-d5d0-4adf-8bc7-5e1b913f3922">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/9f8c9d46-7649-40d8-9a93-b7cab3545bba"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/a2eeda0a-de38-4c56-b8d3-c5488cda95d6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/3d62ea64-561e-4542-a1df-3612a747a3da">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/02cacadf-5bc8-41e4-a70d-8005b48f4c54"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/429186cf-9cda-4de2-be7b-927f505e6ffb"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/2f89817d-e7f0-47db-85bb-3b8672deb189">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/22554bf5-83c4-49ea-b77b-8c4942c74d0b"/>
    <rdfs:label>fluvoxamine-ramelteon drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/bb3ea027-6ceb-496f-9f40-981c88d988c3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/3fd0a316-f9e5-43b8-95f8-279d0f151eef">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/dc7d8d55-56cd-4f6d-b9dd-c5ec28a73385">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/a4b45d76-4d3c-43ac-9d77-7bfd1b131259">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/26cdc2a9-c8a8-494b-ba75-c6d8b41e70db">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/a1c82d8a-f6ab-414f-8e05-27b1b1c5dbff">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/f9e554dc-3858-4dc2-8d22-620112857fad">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/8e8da59b-3864-4198-9385-dfa98314131c">
    <rdfs:label>ABILIFY-fluoxetine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/573b87c9-3b49-40aa-b767-7d5b5a4a6e1b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/6566ec9d-cbb0-4acf-aab6-3da989f3811a">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/b3ceb397-b06b-4950-9556-daefec1e67c3"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/761fb1af-da5f-4923-8484-4c84c2122eb2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/a5d5861d-75cf-43fc-b714-a38b52a2a527">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/3973ee25-1c99-483e-a7d1-ca2538be5d95"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/14be4227-b744-463c-8d34-d1363798c49b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/bbd2fe67-b8fa-4e07-9a66-0b54c0b382e2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/ded08eee-9d61-4c8c-83d9-adec365c362e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/a1f3f027-b078-48b9-b20d-c7962aa8f9fb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/19673d55-90dd-4e1b-a0af-3b4b2ff69c68">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/76b62124-ef7e-498e-bdf7-b11c9e3f7cdd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/ff5468dc-a574-4392-9307-4a477723cbee">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/3df2643c-edc1-4f34-819d-d224bee28a64"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/47930a2f-4cd1-4f22-a6d2-535b4796fc5b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/b6b48d02-a581-468f-ac20-afd93766789c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/b08479e1-f45b-4bbe-9f86-e6148a3088bf">
    <rdf:type rdf:resource="obo:RxNorm_81864"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/33e224a5-9091-469a-a520-f9a54ce0c6cc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/b5215188-458f-490e-9442-4c1265046629">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/2b302498-1d00-42df-84d1-7d1bffd9c535">
    <rdf:type rdf:resource="obo:RxNorm_352393"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/72ca1791-eec8-4859-aac3-cdf2e045239c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/6b854cb4-d30b-4537-a25e-023612f158d5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/5bb18349-74ad-4eae-8941-7c61680f8006">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/49a5d08a-f74e-400b-b7a1-03ae8c566074">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/5f28a13a-10bc-47a0-a026-33b343a241ed">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/617856b3-fa0d-4775-b3a4-a3825b54e014"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/134c5d95-d687-4844-992d-e776e0099ab5">
    <rdf:type rdf:resource="obo:RxNorm_72625"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/b9f9aa63-bc7c-4462-ad7b-e5cb3d4ea384">
    <rdf:type rdf:resource="obo:RxNorm_1116632"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/b7abd340-6898-4c65-89fc-4f0b8fae3a47">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/ff8487f5-7b22-40c6-9c4a-ff16ccad9883">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/d61498a6-c8f9-4400-bcaa-adb7548b35f1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/eea83382-3551-4cc8-b056-41f9ff7e9b13">
    <obo:OBI_0001937>500</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/a154d897-b623-451d-8824-ddfe0a6926dd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/8fc68d43-fc00-4ba2-9752-8ba01cd9226b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/7be48a91-cedf-4498-9547-ee74dcfd0069">
    <rdf:type rdf:resource="obo:RxNorm_1546356"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/74d8a3f2-376d-4b84-99ba-026bea1fdfc6">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/990b9143-ca90-4a9e-894d-4cee1b20cb05"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/4ef2ac2e-65a4-4b3b-9fc4-f01414da8341"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/a46a1b02-efbb-4638-9e59-7f2dc3c325f8"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/91086d0c-b72d-458f-86fa-f7e6675e796a"/>
    <rdfs:label>desvenlafaxine-midazolam interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/98c7df8f-9b12-463a-8e27-1ff39ec7d734">
    <rdfs:label>telaprevir-atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/349ec9ad-81b6-4a17-8b25-9a7b07217bda">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/bc158d31-081e-4984-9256-197c41197199">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/4ccbc8d7-7ea5-48f0-8f93-bd725e268235">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/c9975040-1fa7-49f5-8cfd-07033ef1cadd"/>
    <rdfs:label>61 Percent </rdfs:label>
    <obo:OBI_0001937>61</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/7ad1306c-3042-4b1c-bfd4-c1867cf5c4a9">
    <rdf:type rdf:resource="obo:MeSH_D014859"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/55f27fdb-242d-4d58-b166-f617cd25545c">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/651987db-e0d3-4cc2-bd76-3d4dbf263b13"/>
    <rdfs:label>midazolam-rivaroxaban drug package cmax  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/2a1a26a6-d9eb-42be-b50d-b86173836b3c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/7aaf133b-1ada-4274-94da-398120b4c952">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/de228c64-2732-4654-a2f8-a56adbf24548"/>
    <rdfs:label>4.04 Fold </rdfs:label>
    <obo:OBI_0001937>4.04</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/cd5a634f-525e-459b-9361-aa5061079c52">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/f95710cc-4894-40be-9fa3-38973ab85768">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/d8277ea8-5fee-46a5-a038-1e519c1c07cd"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/6a66f734-d361-45b0-b9df-8c06422800d1"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/ddbb80f5-25b8-47d1-898b-607512facc51">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/d3c9e6f7-2192-47c3-932e-011d0ca4cbe8"/>
    <rdfs:label>cimetidine-citalopram drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/6bf4fbfa-5df5-460a-9c8c-1c8fdd2b2b5f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/df5e6072-4bb9-42d5-a364-f3366bce3092">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/c8b659bf-2f1e-4f27-ba08-7d4deec5b827">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/c8a22d60-ecd0-4ccc-b07d-9010a8e91557"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/785dc40a-33f0-4444-9e9d-c1e1702b0a20"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/49391e53-d600-4fed-ac1b-ca734a6476ac">
    <rdf:type rdf:resource="obo:RxNorm_35636"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/1e8a89e2-45e9-46b0-8366-89348eef619a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/616a1055-62ef-4f9a-9276-a5d43a63c40e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/48fd4ea7-05fe-4f1c-836c-a74755717e8d">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/77d84957-c3ea-434d-afc5-74591e3a61e3"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/a58c8305-10b0-47f2-b576-778b94c8f1c8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/ce1d511a-b3fd-4111-91d8-f8167a71cfa5">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/83120a86-f104-4f7e-b1b2-80da0333af94"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/6723d9ab-8b9b-4482-86a9-1d464fda10e4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/263a10ec-8bc0-449e-8d82-c1ab5180e006">
    <rdfs:label>ketoconazole-rivaroxaban DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/0f7f9329-37bf-4485-aad4-b7b8216ccfba">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/bf3da30b-65c6-4a20-9171-7e32a40474d6"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/7a8815de-4b99-43e2-8371-ddca97ed888b"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/43f52100-f1db-4f6e-9fbd-77df2a331959">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/399b084a-e224-4265-be6b-60b4d913f3fa"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/17c3a02c-2a9d-4786-a7ce-1cea9d3e7609">
    <rdfs:label>ritonavir-rivaroxaban DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/e78ae4a7-67e9-4bb0-a649-a15bd88d1441">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/c6ed7dbd-75dc-4e8c-a03d-c71bd305fe0a"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/cac7654a-9afb-4452-bdfd-319d6b9d409d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/c483f249-c7dd-4ba8-a7df-90f8ee0ecbea">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/11c4ca65-8e56-45d0-9d10-010124f2d48d"/>
    <rdfs:label>fluoxetine-mCPP drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/bfbf3409-cab9-4dfc-a37c-2f44af7fe154"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/fdbf173a-fde9-43a1-aba7-56eedc5cdea0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/4094acc2-47ec-465f-8904-0c7bf59298b8">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/dc865617-4b48-492f-9eae-1f3f1b5bf963"/>
    <rdfs:label>40 Percent </rdfs:label>
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/09232a67-3ae4-42a4-bf4b-c42b1fac944d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/4b82b1d5-b5cc-48d7-809b-7a293dcac340"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/c9c078be-2d2d-49b1-bf9f-2b70d9a4abe1"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/e3c57300-d161-44f2-af9b-75ae688751c7"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/32823fc3-3217-47bd-a04b-6f780ad810d6"/>
    <rdfs:label>iloperidone-dextromethorphan interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/33020182-af32-4584-8325-8ba7d6e38137">
    <obo:OBI_0001937>20-40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/be8580e5-f7ae-4066-bda2-b8f2828acf3b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/3bd56f51-841c-424c-a36c-8e9098f200b7">
    <rdf:type rdf:resource="obo:RxNorm_32937"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/90409af5-88a0-47ae-85eb-2dec313f1176">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/9971e06c-bf8e-4d04-ba56-3ccc755b6931">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/7940a489-499d-4c21-98bd-33878d3df18a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/da812a39-3a64-42ca-a806-dde8b40fa052">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/54ecf68d-d6c3-420b-9f1f-628ae14ba332"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/ed7ea8dd-1af7-45bc-9332-b544528667f4"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/15f9024a-1f87-41f6-82de-5adc641f838c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/f501b000-faf1-4f61-8fc8-095a48561253"/>
    <rdfs:label>atorvastatin-norverapamil interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/53701682-3525-4d21-87cf-27d0a9583e97">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/b0d985b6-c200-4692-a8ec-11224800629b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/0e31cdc9-2132-47cd-8f64-f480d3e1ab4d">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/55e2850a-09e2-49a7-a378-a2a07b676b06">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/33db0845-e01b-4a01-a52c-e8badf3de6ec"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/fb09c3b2-5f03-4eb8-af6d-bd5f7f93fd1f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/60f2f059-f822-4b96-b837-2f62a1d1005f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/ad949246-4dc9-45d5-af0e-62e28f391f5d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/6022ef34-8655-4940-bd28-746d1200ccb7">
    <obo:OBI_0001937>9</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/a6d40270-3797-42e0-97f5-3acb4738da58"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/5c8721c7-4471-4992-b810-4995df39401b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/7ab4f82e-ee7c-4dca-8945-0ed4c9d9623b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/9fc25a10-9f8a-4e78-93f6-f910639205c8"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/f1e92e4b-55a7-4a2e-9c9b-b8314f88a31a"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/1cda617b-80d5-4dcf-af2e-8f8ac347d2b4">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/c3124f1e-bb4d-438b-a5bd-5c8d33b5a8e3"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/91da2e85-59fd-4664-b60f-e795dffff1b2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/6da09620-7056-4f1a-8fa7-877dde14f89a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/73944167-b4ed-4b78-a738-d0d7491a6f49"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/42d2a863-fdba-428a-a298-fb3196506be2"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/33daf9ff-39f1-43ad-9127-0e8886ec0962">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/c300eaf3-9d0f-40fa-ab98-238a79415c69"/>
    <rdfs:label>2.3 Fold </rdfs:label>
    <obo:OBI_0001937>2.3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/b23c5332-cdff-40e9-bab5-7555db5693ad">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/ac8ad362-2e9a-480a-b7ff-94d59e9096e6">
    <rdf:type rdf:resource="obo:RxNorm_42347"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/92f0ad7a-5fcd-42b6-9a1c-99e10cd05bc7">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/7c7d61f6-3965-465d-af57-fe33af67fb48"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/98ee829e-4095-427f-b6ba-73a86cfe95b3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/be33f0df-0edb-42cd-a35a-1da5fa05a553">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/7a5dc9aa-f259-4afe-b89f-ab91b524a881"/>
    <rdfs:label>90 Percent </rdfs:label>
    <obo:OBI_0001937>90</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/03fa77bc-0b22-43e7-bc54-73b157cde3e9">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/b7e0e936-69d8-447c-9d9b-10b4fca14158"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/d6546534-a508-456b-bf34-b87e35df82ce">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/e4d60825-68c7-4e74-a483-742dfb6f99e5">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/6119db24-f3fb-4e77-9d06-ecfa4c18ea16"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/e43664c5-afae-458e-8387-413633e5d39a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/2e4de43f-8ab0-42b0-b867-8f824b0afa6c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/3fbcf814-240e-41bb-9f07-8b0ff34d6139">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/85d4abef-58a1-4776-902e-5ff037fdf8cc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/168b497c-b4df-4001-a8f9-cde9a500ce03">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/28ace315-0f32-46ea-9e91-3aab192b0f41"/>
    <rdfs:label>paroxetine-atomoxetine drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/e691149c-3680-4fc5-909d-11f777755fb6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/3a023c19-fe29-45e3-8806-1b4c4ea159fa">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/93ccd46a-4e27-44c3-836e-0f344c224ed5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/9832ecd8-e87d-4468-ab70-03dd5f46e500">
    <obo:OBI_0001937>8 or 12</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/9c1bc141-ad8f-44d8-9a72-e395b7e3a1f7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/4b09cfda-aa68-465f-a97e-26eaaf11118d">
    <rdf:type rdf:resource="obo:RxNorm_21212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/7481fb5b-63b7-4600-a751-c8379503d8a1">
    <rdf:type rdf:resource="obo:RxNorm_203143"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/35e45394-cbe9-4233-89a1-aa38ecd98fb0">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/04c45189-9ad7-4de6-8588-ca7ceb3ef235"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/087b09f7-42f7-4efd-a176-0883e7b9438b">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/32572292-6454-42b0-8acf-fcca84714fec"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/39f4c61a-93e4-4792-ac91-7085f6d36400"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/ab1b874f-a6d0-44fc-808d-85216f2dd905">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/77479ba9-9c40-4f01-8d8c-dd3e1a6ab435"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/313e85a6-1dd4-4872-bb89-f0605914b0f0"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/ef14a46f-4d3d-44c4-b59e-547e55b7fa27"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/51e10f91-c045-4d75-8ef1-7184f838a050"/>
    <rdfs:label>duloxetine-warfarin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/ab8b54e7-930c-4a5d-84a3-72b70405b864">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/5e167b0c-6cec-4d72-bd4e-c18cdd5dd354">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/7d1893a1-cf7d-4069-877b-b3d497d1b7ea">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/99a24833-b0f4-4304-a047-ad4445162fd1"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/4b7c73c5-b132-419d-910c-333f153cce9f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/6a944ffc-da13-4c5a-b0dc-fdf090f3aed9">
    <rdf:type rdf:resource="obo:RxNorm_36437"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/b8e7516a-c755-470b-a966-40b75be71496">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/e34366be-d6c5-4950-9c08-2f5df38415c5">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/3760585d-8f14-42ee-9fbf-26d05dee2a30"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/798b3b9d-1c77-4eb6-906d-3b3cd7ad449b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/6b50f426-bd3b-4dc0-9cf7-088e4a1c0f0c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/5e2ce4d8-f344-454c-98d5-2beb1c0432e0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/9615174c-619d-4d66-aa7c-2285722edc94">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/0baf1d85-75bd-42c1-b78c-20233eb7f5b4">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/3de4ac56-19ee-4c41-b95e-9377b9e11a28"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/77f39ddb-8786-4a7b-98c3-6073b025913b"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/bd286ea6-f3fa-480e-b696-c5d26ea66cf1"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/759f148c-96bd-4af8-816f-6bb675a50000"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/03eece02-7a29-4c44-877b-0a4266df8df1"/>
    <rdfs:label>ketoconazole-eszopiclone interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/920ef1fb-77ea-423a-88d4-13680b7ee542">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/000de972-c34c-4823-8ca0-8f13e4ff499c">
    <obo:OBI_0001937>1400</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/2f5377a0-6130-4e43-9dd6-f6536c4b357a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/082d2c29-520e-4e3d-95c2-2ee9f85f4aa7">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/8b59156a-d529-4add-9891-67335a1904fb"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/f119537b-0b92-4bbb-aa79-6216c780943c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/2246d402-1b6d-4116-8dc3-2de6d10cea8c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/f0528822-71c9-4ea7-9043-2badfa91f57b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/27a13ac5-8607-4471-a190-47c65df36706">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/9b416a71-f025-469e-a2b0-6c2c6e68ff23"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/4dc0f815-4744-4c52-acd7-d65c12af765b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/72238c7b-2939-4a68-b8d0-dda46a043df9">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/fc702945-bb3a-4995-83b7-8017210cc3b8"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/92b61796-9d5e-484c-8d69-4fc1f4e9ee1b"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/b6b48d02-a581-468f-ac20-afd93766789c">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/fa4793ee-e5ff-4bee-9a50-15f5e9af7444"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/fd94e014-96bf-40a5-904c-bd849da17be5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/a6139b81-6ff6-4875-8173-7584daa8bf32">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/1d32ce87-2fe6-463d-841e-392537ac6d40"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/40797bb9-eb9b-4bd5-bf2b-7ab484316d34"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/234da9d5-285c-4b04-847e-4b859056a6d0"/>
    <rdfs:label>fluvoxamine maleate-propranolol interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/f4f20d81-6a98-4789-8a10-beb97e55012f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/08d0cb81-a4e6-4e3c-93d8-6ccfdc55d368">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/2bf270ec-3922-4567-8977-d54c80ca1e7f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/355ef50f-7ffb-47af-a6b5-f2ad5e5063d8"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/f5c0bc60-6800-4ecf-bb54-4c76416d2e42">
    <rdf:type rdf:resource="obo:RxNorm_1116632"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/9a02ebc0-7b90-4ff8-bef9-f274076e16e9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/08e6214b-4c97-4242-a5d5-a47d14707582">
    <obo:OBI_0001937>Unk</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/2c801662-2fa1-4005-8dbf-376fa295cf9d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/1d023d3b-1116-4aba-8108-abb3b698333f">
    <rdf:type rdf:resource="obo:RxNorm_85762"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/8b1567d7-b075-4ef5-9b5d-0eb644b857f1">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/17cb0e1d-93c0-4c21-9a68-9bd8f4031cbb"/>
    <rdfs:label>ABILIFY-norfluoxetine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/18a7b3d6-f1cd-4f7b-a911-74470e988007"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/f66c5b9d-0b1e-49c4-9daf-08829e896209">
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/bdd3a716-58c9-4372-a743-236eaac44fd9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/c5394cca-4f22-4a80-ad8d-8197d34cd36b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/d20e2563-7225-424c-b873-bbde7abffc0c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/a61ba82e-2b8c-4c3c-9ec9-57942b5182a1"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/13649698-2973-429b-b1cc-7f597bffe459">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/acf5cfea-5108-4aeb-b7a6-fc5edefa7329">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/5647ac42-2cef-4e6f-8f39-29da8116c027">
    <obo:OBI_0001937>.25</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/cc8d8b62-1ead-4b69-9d49-ea71e71f2b8f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/91f6f870-11c8-4276-a7ca-cf95838564de">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/7d1fb71b-2f5f-49c5-a607-4ad31ca65f02">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/f45df5e8-2cc9-46e5-8003-fd44a0da5ec0"/>
    <rdfs:label>103 Percent </rdfs:label>
    <obo:OBI_0001937>103</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/ba3fc743-9d8d-4996-8d86-8ea1be0433f3">
    <rdf:type rdf:resource="obo:RxNorm_2556"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/97ca2854-0af1-4458-aa94-85e2cb4f6139">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/44ee0cde-c997-4921-b904-ae1eb597c333">
    <rdfs:label>desvenlafaxine succinate-desipramine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/c9acb12c-8f8f-4e26-86fa-0b10463ea944">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/eb39af9f-d7d5-4295-930c-778bda946a10">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/d5899a2e-f211-4ded-b56b-a2446cadf624">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/24e8a9a6-bedb-435d-92cc-f4294314f795"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/8e512325-cb52-4164-a90e-082aadf002bb"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/4ec2da87-f6c5-4ddd-8cbe-43056a80884b">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/ef3d7e7b-bc67-4685-953f-a48ac8708709"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/7e5d84da-6448-47b0-91d2-4c5b7af98aeb"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/8d045d3e-44d2-44ee-91cc-24e644704173"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/7fd66b2e-1b75-493b-8da1-994be36cd8e2">
    <rdfs:label>ticagrelor-simvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/7b9985df-f391-46b3-a4a0-8a249b6055f7">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/52fbb5b1-02c1-4afc-8613-ebfc4aa0f729"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/2cf65b13-1ff6-45d8-a4dc-d926a01fb959"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/82cee4f0-f4ff-4f33-b57b-df057289dcd5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/3e7a500b-e32a-4590-adf8-926693446d89">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/45c223e6-29b5-4d23-9431-718561ef41db"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/1063e8f0-4b8b-4c65-bb34-9e6e4c992334">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/11100d07-f6e8-4cc3-bc5e-7be0024706ad"/>
    <rdfs:label>clopidogrel-dabigatran drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/056ee090-7c9d-438d-9172-f3ce5bfa8a39"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/39cb7ecf-7417-4a5d-abe0-4b2b8791dfa5">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/4aadc266-d4ce-44e7-b2d5-858098215b0b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/49935cfa-0f53-461a-b934-1ad2d63b8e99"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/adf8e6cb-8603-4dbf-a14c-b3c5479e6e4e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/c7ff2f5c-93ae-415a-919f-3b4bd8b57e49">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/0af2c45e-086e-462f-ba90-52ff224036ee">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/f3110f78-0c49-43ee-9b08-15fd45f39b2a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/6898592d-7245-4f92-b206-2424e8cee982"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/a0c62957-4f6a-4318-ad80-11cd4f924962">
    <rdf:type rdf:resource="obo:RxNorm_35296"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/10803817-e092-4270-a8a4-131d6929a611">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/3004a18c-9210-489e-9c7d-86c0e9531dfa">
    <rdf:type rdf:resource="obo:RxNorm_4493"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/38ae4997-2cae-42a8-9fad-7602100426e4">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/d1b1dd1e-cb2e-4bc1-adf7-6420069533fa"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/740fbda2-fdf2-4e9b-bc00-fc0c013360ee"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/36dd98eb-92c6-42b1-a792-fc44f2803ea2"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/3a25dcf5-b693-4046-b80e-0897a2bcfdbe"/>
    <rdfs:label>naproxen-Edoxaban interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/a05c87c0-a249-4400-94f8-24098920938e">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/5eff9a88-4385-4ae5-8438-095996d27f2d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/b9f94214-1fc5-44d4-9b69-f51e408cab27">
    <rdf:type rdf:resource="obo:RxNorm_703"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/6a10b163-c450-4712-b98a-d29d996e2266">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/ce1f58cf-96b0-4719-b69b-23ea2de82cd4"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/514fcee1-356d-4e29-9193-dc45cc7c7f1d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/e43664c5-afae-458e-8387-413633e5d39a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/3a91f925-c95e-4b8f-bf52-37b6939cba84">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/60097dc8-9e08-4abc-92c7-57fef5079dae">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/577d375a-5736-4677-878c-0f434264126e">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/5937f337-0bf8-4e82-ad4f-422f22302fa9"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/29dda91d-17ab-47fe-8eea-d7e2dd7f6a53"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/0ee8874f-3196-4ae2-8574-6c1dc907aa0d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/2e24d004-7c77-450a-9125-994ab2b30d4b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/c476459c-2d62-402a-bfc8-f1207426de23"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/fc9a4f37-6aa9-4336-858f-731982eab70a"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/05b7ba67-3d95-4d5c-9d11-60719822ee23">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/50dd69b8-0a08-451e-9dff-026ed96a5188"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/8d3b360d-b72d-4a83-90bc-6330cfeb9a5b"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/ce9635f3-d426-4e38-98a1-e2c91789e455"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/5a2898ee-9127-484b-a2fb-691563834955">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/5bdd7350-4782-4bc5-90a6-03055a729b49"/>
    <rdfs:label>24 Percent </rdfs:label>
    <obo:OBI_0001937>24</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/4c748bf9-9af3-40b0-8f8c-ae057ddcb244">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/950a3d01-9ef3-45f6-befc-20447011e396"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/2113fc35-b4ba-450e-9a77-3b5fd1072257">
    <rdf:type rdf:resource="obo:RxNorm_215928"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/d7e25a9d-4815-41dc-926b-871b9c79fd97">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/20084216-aaa1-4bca-a918-41b6ec8d71b7"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/9fdf684e-da6e-4ae3-9ed8-6c9a3c8a4eff"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/73bc2e5a-8e90-421c-9414-68d2fe7bea83">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/cfd74b05-c0a2-4a0a-bb0c-af5665be0f6a">
    <rdf:type rdf:resource="obo:RxNorm_703"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/4ed6effe-cf51-4b6c-8bba-a8587d517441">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/93f23edc-d71b-46c8-b090-885d5b3f30e5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/0fc2384f-5b30-41c5-8d9c-4f8a8c6d9463">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/90c4240c-d825-4d72-8d83-a7668612e5dd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/1ec930e8-63b9-4a8a-a5dd-c2550e62bc26">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/c2f3ed95-bdc2-489f-ab04-7eff395c4fc5"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/d1eddf96-e154-4eed-92a1-37be0d4e9b66"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/31ad6045-877b-4edf-9324-885b40e1ad0e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/56175687-1411-4261-af4a-99f6bb248492"/>
    <rdfs:label>lopinavir/ritonavir-hydroxybupropion interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/6996d490-fb94-4477-b703-1528f241f31e">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/4e78f5e4-3020-40a5-9705-b232ec4e70e0"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/7b54b553-bb3d-455c-ac25-0f13f8af0e09"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/75e621c0-9b6d-45da-abe6-3dd041fcdcc8">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/5e7e4382-9706-4365-8443-b9032d023d0a"/>
    <rdfs:label>55 Percent </rdfs:label>
    <obo:OBI_0001937>55</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/6e935df7-52d2-4c30-92e6-d2d4da1b8b97">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/1410b0af-e3e2-4b6d-be6b-177068a9d2da">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/ac352281-b1f1-4985-af9a-aa3982c93c10">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/4487c6ab-26aa-4ff0-bb80-4472c4b97c8a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/8c2700f5-bd63-428d-99ed-a6e9aceb2dec"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/24a6c92a-be31-40ce-a84d-88a0714e1059">
    <obo:OBI_0001937>5</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/b83fee2b-ac65-4e28-afb0-af6788ba7f69"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/0e744c64-3a2f-4096-8e9d-044a2db24412">
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/7f7c73cb-5632-4c2e-a70a-9ebce9cfd44c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/184b8ddf-5469-4b49-8018-3294a681f765">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/1794b3c5-3e14-4f85-8663-bfc07db5a3d8">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/79ab6144-660d-4d57-b88e-9540076edf45"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/a53a311d-d9ea-4c19-9fd2-39066b4d7a01"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/a24c4e07-41af-43bc-89b4-1cb905e62619">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/fe0d8a04-192d-477c-a030-4d16fb11684a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/335900a2-ab34-4b87-8d34-235f6407b36c">
    <obo:OBI_0001937>80</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/e6287c42-2efc-4ee9-b5b5-ecdc60e95547"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/23960e4d-ce88-4dbb-8f8a-d37d3da98aa6">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/e19dd817-b615-474e-bfbf-c39b94555051"/>
    <rdfs:label>28 Percent </rdfs:label>
    <obo:OBI_0001937>28</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/7be9f38b-d3b1-42eb-a7e7-0ce21cf1acd5">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/fa90b7d0-7fc5-4085-8958-4f9ef9987592"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/dbbab9d8-545a-4aa0-ab51-01bdcd7b182b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/15da2910-c45a-4616-8af7-5333dd1081f1">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/c0a546e1-ebd7-4d99-b201-65469ff2aa88"/>
    <rdfs:label>Gemfibrozil-atorvastatin drug package cmax  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/32c89a5e-c054-46d3-a8ff-863db621cf02"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/e0ecb2c2-1e8d-4bf2-b87f-07a9be700e87">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/22391947-af1d-4d37-adc0-9859946312c7"/>
    <rdfs:label>1.7 Fold </rdfs:label>
    <obo:OBI_0001937>1.7</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/97430b16-efc1-4d47-99a6-0df237b35cce">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/2aaaa38b-1972-404c-bba8-13fa8f527b62"/>
    <rdfs:label>99.9 UNK </rdfs:label>
    <obo:OBI_0001937>99.9</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/6a6ab9bc-7520-4911-ab7c-93c94594984c">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/96e2b14a-b87d-47ef-9864-735b66f2fd55"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/ae299303-afe5-4213-9556-067e8310cf5e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/2b59d38f-adeb-40ee-b443-1e7d93b2b773"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/6c6cf656-5756-4fe2-9bb6-1eb8f710ad7d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/c678d252-7ef0-437a-b274-8206d2d49b6e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/85abe0cf-6bab-4e6f-8f07-b1f8f641d213"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/d823ce24-1938-4ddb-bb16-374ac14ac25b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/470018cc-ec13-4f6f-9ab1-c43774a30004">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/831d4641-3340-4dbc-a7f2-a086c9e5d2a4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/96d838e6-a5cc-4a1f-8b88-7ecd96bd974a">
    <obo:OBI_0001937>4</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/77730288-1438-4244-b0a4-78d1f30e7259"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/0d780060-e040-4550-bae3-e16cfc88c4a4">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/f0bed6b6-2ab7-4a99-9c22-493c4dcd2dbb"/>
    <rdfs:label>106.3 UNK </rdfs:label>
    <obo:OBI_0001937>106.3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/0217df3e-f83d-4542-ac5a-c05a76e276f0">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/14f8e731-6f4e-41ac-8eac-1341107df947"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/5d3d53da-74c6-4402-8ef5-fed7c3b6d069">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/dcaff725-600c-477b-97e4-388ab2477f2e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/0cc11c42-0804-472c-95ca-71c17e1fbdad">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/e969dd5f-777b-44c2-9af4-344c9b3ad628">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/785b11d8-418d-4960-9a31-5f1526d8ba03">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/a01c5351-aa69-4d21-9ebe-8e7342729a72">
    <obo:OBI_0001937>30</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/d3394f37-b444-4f83-9f9d-3cd9a93a821b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/9d982cf4-4a6a-4dc2-80de-cfb60e476aa4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/e9f3a4f9-0ca2-4b5b-bda4-80909b34c032">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/c8d37d70-2709-43d1-881f-ceddbc80ab89"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/d4bb8d45-a9f4-4a33-add5-53516e560fd6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/174475f7-9f02-4a7c-bf39-61824235615b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/1adddcb4-f325-4324-a54c-a3830df292ed">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/51284e24-6e5c-4ab3-bacd-e1638fa60fcf"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/cd483bf8-072b-4902-a27b-0e02e0985cea"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/d75a2eef-6460-49db-aa1f-ae3aa4b246c3">
    <rdfs:label>Efavirenz-Atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/cc08dc2c-76c6-4c49-b96b-4c625dea8983">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/e34366be-d6c5-4950-9c08-2f5df38415c5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/0a529ed4-a10e-4e01-8a0e-969e420a6d61"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/73baba05-f02e-4b82-8cd1-5407e890f0f4">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/08931962-d4dd-48d0-9fa5-9031b953a518"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/dffca59e-c845-4296-96a8-81d3e0dce75a"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/b5390b58-701c-4c4a-93bc-b7ec9c1cd18d">
    <rdf:type rdf:resource="obo:RxNorm_3247"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/8018d4ba-5664-4245-88bb-02b42aaba797">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/340930c0-c31c-4a36-a62e-c371bbb464bd">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/78219942-de64-4cfa-8ef5-e51c7c9479af"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/c09811ed-c8fd-4bc5-8667-4de8053d1887">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/f1972c13-3bf0-4ee5-84f2-d9ea40a83396"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/49a5d08a-f74e-400b-b7a1-03ae8c566074"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/00cffb6b-770a-451d-9c99-e07793426559">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/b3b72143-5fed-411b-b2ce-2061c6271493">
    <rdfs:label>buspirone-nefazodone DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/95bf839e-eea4-49a1-9031-3f455fd94d94">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/6056cbd7-ed61-42d5-9f76-7573e0253cc9"/>
    <rdfs:label>ritonavir-erythrohydrobupropion drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/33489577-ab9c-49c5-889c-252d8a5bf5d5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/85e355d1-3997-4453-a814-31e0cd7684fe">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/9b0bfbd6-1323-4080-bd5a-c1f6d0e7f6f1"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/671a3560-5be9-48d7-a4c8-af703bef99c4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/535ab92f-f6f8-41b2-9ea1-ddd476104caa">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/857d4f43-cbeb-45ef-b77f-3831b8a76c63"/>
    <rdfs:label>28.5 Percent </rdfs:label>
    <obo:OBI_0001937>28.5</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/feb84155-c229-423d-a2a2-dfb3d8c8ce64">
    <obo:OBI_0001937>7.5</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/805e1568-5149-4ea4-aef1-bf431c96d1d8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/6c4393d2-f376-416d-9f73-17ceb9098dfd">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/c5b27cfb-65e7-488f-9522-2c4eed5a77d1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/728fbaf7-13b5-4c76-a41a-384cc78cf2ee">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/a1f7c223-0ec0-4787-b054-612dfe0e99d2"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/335900a2-ab34-4b87-8d34-235f6407b36c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/c777f075-b01f-4549-9401-3408c1b72c56">
    <rdfs:label>carbamazepine-mirtazapine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/7f696970-eaa8-4db3-a0b8-20cb46c7958e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/bd54bfba-bfda-4284-961c-a110a62c9906"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/29b5c39b-bf0f-41a1-84bb-e0415ae58b55"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/e34bd760-a83c-4943-b311-86a00604280a">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/d6c58986-cdcd-43da-a215-2c407fecccf9"/>
    <rdfs:label>34 Percent </rdfs:label>
    <obo:OBI_0001937>34</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/c78a4062-068a-4a31-9e4f-55b2f117c40b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/552a9669-1670-4977-8209-b2464af9c0a5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/f8db30b0-6618-4c8b-a383-1914b2e7755e"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/93515551-171f-4404-a34d-6aa382d52910">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/fec710de-dc3d-415a-b141-2b9761e5adbc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/f0b94c38-5717-4aa6-be94-5c51177738f7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/e8b72d05-3cf2-4ea7-b3f4-ec27d12312e1">
    <rdfs:label>mesoridazine-Fluvoxamine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/2bbef0b8-9870-4b1c-959d-37c4cbb017c4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/f4c48b4d-665e-4da8-995b-b6b69d943e58">
    <rdf:type rdf:resource="obo:RxNorm_2002"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/e3e62e3b-37f5-4815-b994-438125d65081">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/26f78317-7f73-4f5c-a085-0eb618ac47f9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/155d34e5-26ab-474f-82b5-2997c3f998be">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/42b17a93-ac90-4985-a8ba-0ae900b64ab4">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/d584a94a-928b-4ef0-be27-9a6cd2fe1f79"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/17fbb2b4-b845-465b-86ba-40150a7cb2fe"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/6ae03c25-fa97-4c4f-bf1c-d433de093bbe"/>
    <rdfs:label>nefazodone-atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/95641b25-3045-405f-a38b-25be9ca3690d">
    <rdf:type rdf:resource="obo:RxNorm_11289"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/b9b02e07-1e96-4235-a0f0-7e199036fc67">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/6391431a-744d-4c45-98ba-b051b297661b">
    <rdfs:label>fluoxetine-triazole-dione DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/3245171f-1209-4552-b0de-540569250607">
    <rdf:type rdf:resource="obo:RxNorm_42355"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/6d7bbf31-6da4-4746-b09c-44d7b7c26eeb">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/c16f2b63-8658-4661-b365-31e09d96ddd7"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/e7a0ae23-d8b5-4c65-9e31-86158579c062"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/a1ec5061-c7be-4e05-be75-05aa56c0e654"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/146369ec-f893-4994-8499-426b72aa76bd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/698a103b-8afb-4f29-8bda-01013ed68cd1">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/cc333f09-f894-45fc-b4fe-03ad4171a118"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/97a6b13d-dc02-4dd8-9dc2-705fa82bf2dd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/bb466dfe-75fa-4da4-9c8d-33597f848e29">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/b6e279f7-4b4f-4b1f-8e04-30ad81234978"/>
    <rdfs:label>35 Percent </rdfs:label>
    <obo:OBI_0001937>35</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/1768354f-9f64-47b6-a3d3-38d700f7cdb2">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/3355dfb4-584f-4310-b633-aa5843593e15"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/04af1970-74aa-442f-8340-7d3d149224f7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/98e12c7f-dd8e-4ef2-aa2d-f4c685274a46">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/c1c0f3d0-9d98-4c2e-bb16-34588062e209">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/848135c2-14bd-4fde-b095-35bc7acc18c4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/75528a85-0f6f-4000-8b86-08f1f451ff6e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/9eb6a173-b7de-4213-96b5-b96e403f18f9">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/ad63189d-9162-450e-87e2-1e8a45fbb7f5"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/a0224689-8a37-4b02-9743-357a71bf0460"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/9fc01af8-44dd-48b2-b8cf-7826cb7bd6f6">
    <obo:OBI_0001937>300</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/2545229d-d76d-48e4-8404-99588e691d9b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/707513ce-65d4-442e-acb9-7407350a7f1b">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/8d4c44a2-3ca3-4738-827d-71e46d198c86"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/02155cf6-1ebf-45e5-9b3d-b037fd11fa1b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/90f131a7-0c8c-4262-a1ce-4eeab22110ee"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/74760104-f1ae-45fb-994f-6a3c25e36e05">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/bcef736a-6db3-456f-bb64-2802a5312be0"/>
    <rdfs:label>1.7 Fold </rdfs:label>
    <obo:OBI_0001937>1.7</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/e7f9838d-c462-478f-8ba6-3f0dcab36e16">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/96c4ff2a-c83a-43ab-936b-ffa3b066a034"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/6a66f734-d361-45b0-b9df-8c06422800d1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/bc4462f0-97d3-415d-a27f-9a3f627b1aaa">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/d9a74ca3-6173-4306-84fa-fe02ba5a98f4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/9296e921-ee6c-4bf4-867c-105be402a5b0">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/d3c9e6f7-2192-47c3-932e-011d0ca4cbe8"/>
    <rdfs:label>cimetidine-citalopram drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/ae54c5fb-1ddf-4d55-82e4-a52cd23bd2f0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/f8db30b0-6618-4c8b-a383-1914b2e7755e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/d5de5293-a465-44e3-bf4d-28da463aa23b">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/c898936a-fa7c-4803-965b-7ed01f14cf21"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/3eb85019-932b-43b1-90b3-ead196924c5b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/f2a23299-1e90-45ff-be40-d7196df8f60f">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/63ab02a5-866b-400f-a1a2-0f68e0b4ca26"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/0b4f9c23-7df2-4f67-a6b4-1d8ed95d8003">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/6394df3c-01fe-46a0-9f48-487b3ec292a5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/fd47793e-05e1-4d9c-9b33-c5c917884815"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/41178956-af6e-4b39-b31c-ccf70136caa4">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/8d86e3f9-3dfa-460b-b43c-6304ae4623f5"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/1ef6b7af-2387-4f26-b733-016e68117831"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/d01f98d2-81d6-4944-93b1-bfa1342c262a"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/8bebb332-666d-4d75-933d-df73a010ed46"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/655f9cbf-e8de-4863-9b7f-708213f630be"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/66c48ed8-5f96-41eb-af7f-8d71a57fbd55"/>
    <rdfs:label>clarithromycin-rivaroxaban interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/9f448668-c117-4166-969c-6e3298c0aaa8">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/0045ecd9-0a56-45d3-851b-3d17c2052107"/>
    <rdfs:label>pitavastatin-R-warfarin drug package cmax  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/e7f9838d-c462-478f-8ba6-3f0dcab36e16"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/ff0768a8-d22e-49d4-9042-1419d439e19e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/8507aa62-a365-4849-929b-0635e7969524">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/d99c1c2d-5444-42c4-8e04-c05fd5333fb9">
    <rdf:type rdf:resource="obo:RxNorm_301542"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/fd8bafd0-4be0-41a9-b00c-8f7c36c34858">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/0da7a9a1-d51b-45df-bbf8-8139607cb644">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/6fcd2524-755d-4624-9ab1-9b59473bccf1"/>
    <rdfs:label>53 Percent </rdfs:label>
    <obo:OBI_0001937>53</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/f604e706-9e80-46a9-b49a-3cae6d03c596">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/013a73be-b191-42e6-819d-d9354f40218a">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/e2cd6ac3-3bc4-485a-b7eb-8f2b17e23e37"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/b0c7adca-1cd5-4cff-9521-7cb291ff2275">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/b2b02f72-a34a-488f-91de-973ef1e04329"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/4cbcefea-be79-4b15-a4fb-b2754138df59"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/21adf8b9-6611-47f8-a482-51e719614385"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/5bdd7350-4782-4bc5-90a6-03055a729b49">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/05be3b12-8437-40a3-9144-63d418a681c1">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/a2ee078f-dcf9-49da-a0c1-16bdb512ecf8"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/147baa82-ca69-46fc-b011-6b8468c07d78"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/65ca1a94-8af5-4d8c-8a20-693b62c38690">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/6429daf4-bb65-4c2a-b839-a81272d10a2f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/f935914f-7c10-40c1-8ac0-d725156f4ded">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/fda549af-5de6-4366-950c-256a62bd1ba1">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/bef218ac-082d-4616-aba2-2a11bba3f74e"/>
    <rdfs:label>6-8 Fold </rdfs:label>
    <obo:OBI_0001937>6-8</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/76f0090e-ee69-4c68-86ec-58ec8c480736">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/4fe0d47f-0d93-4859-8830-93c2e8dc20bc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/7fa1eda5-206b-460b-a22f-2026a2202e3e">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/0a7bb624-c1da-4541-a6ee-6286ae7f7331"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/73ca1515-579d-46b3-b9dc-0debf49f9fad">
    <rdf:type rdf:resource="obo:RxNorm_6135"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/e8d0262f-6f55-4b37-b60c-c6d07f235285">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/2753ce7b-0761-4a57-a585-76abc3a46c5e">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/e970391a-9376-4807-a1b3-888a8eea85ef"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/83b4e819-dab9-4f8f-9753-448cccc3b610"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/48f2cc6f-47a7-4701-99a7-1882bf2b66dc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/5e5cfd6f-1d8c-4eb6-b468-5866f9f8917a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/bbacb8df-4fe7-444b-aa0f-c1e410bbbea4">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/882db40f-c7c9-4395-8583-2f74c6cf1160"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/91d480e3-0594-42be-b654-9063ee759598"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/79b7039c-c2e5-489e-8117-a711d683c81b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/82db4252-7744-4b63-a5c5-a778a68cec18">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/486cc66d-6ea9-457b-8690-a7b11bc627aa"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/df3ee1f7-df24-4ad8-94e0-2694ec113340"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/af7c795a-35c4-42e6-a763-d46c68009681">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/879e2f7d-fea3-41b5-9059-20b9c0771b48">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/9abe7684-1e0c-4052-a6cb-599cdba47d42"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/17c6096f-b955-4d9d-bb9b-229277de0c59"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/b8804298-de45-4e22-bdce-e3f5ce605eff">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/5b9cac7a-68c2-4f71-a826-0992d17a405b"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/7074aaf2-33dd-4ddb-b346-687ad6f52adc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/72d3f91e-970f-4f52-b3ab-331130b301ca">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/1f7bc11a-ffdf-4658-b3f1-d6184ea0c5b5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/4a7847bd-4880-438f-9fba-14dd8b2c6a51">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/97f71682-261b-441f-aa72-426fe9d61bda"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/55e59a6f-bd13-4f77-9186-f8f10e678233"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/c1993858-47e5-4439-ac39-b4a312f2ea77">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/f8629a60-a215-4864-9e37-cd64d7fd0128">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/bfe444e0-c474-42d0-b21f-906bd060b7e5">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/5e4afa21-2edd-409f-bfe0-19247a7e7efe"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/22edf95a-913b-4d7d-b8ad-c2bf0723a931"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/787f053a-01ea-4c53-8f21-d75e0a71c060">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/0c2d810d-52da-4d7c-aa33-897fd9e6d8a7">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/a773840a-2196-49a0-a206-51f320219e15"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/a6d939b3-7c3e-4bf5-b731-338ae0c28092"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/83c91d29-10e6-4583-9a7c-844fc42a1713">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/180e05a9-d649-422d-bb16-30d0bd403b89"/>
    <rdfs:label>5 Fold </rdfs:label>
    <obo:OBI_0001937>5</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/87e9d207-eb69-4a8c-af75-6f9452a3816c">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/7ce292b6-c5d7-4ff8-9de8-15704189cfb4"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/19f1ef43-ea91-488f-af03-657dfcc69228"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/eca41873-3cb8-40d8-9802-339cb03ceab7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/84d32dd0-1bbc-47e6-b10f-3c4c59389aa4">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/fab43874-2dfb-4f76-8c0f-e733b4d016ae"/>
    <rdfs:label>51 Percent </rdfs:label>
    <obo:OBI_0001937>51</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/6bf4fbfa-5df5-460a-9c8c-1c8fdd2b2b5f">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/4239bb4c-8a6b-4ad0-9ba5-e942a5ea3a23"/>
    <rdfs:label>43 Percent </rdfs:label>
    <obo:OBI_0001937>43</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/b7e0e936-69d8-447c-9d9b-10b4fca14158">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/0a8ce5d1-4d58-4322-aa17-10e83acea3e7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/16995f94-a6ec-4260-959c-88998e8f93fb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/ee60718d-3aed-4b86-bd41-56e19e5bae97">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/07b7d5e6-79cb-4c3b-9b76-f61ab57dfe63">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/a184a587-2b6c-49db-bce9-16b20493fb6a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/73944167-b4ed-4b78-a738-d0d7491a6f49">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/5b3f699e-9f66-4c62-b03c-4cac4bfd6279"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/1da19976-5fb4-4928-a73d-96daef8de91f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/fafa496c-c716-40c4-9805-8ceacd3153ba"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/0751ba48-1fbc-400d-bc55-3706062602ee">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/97f71682-261b-441f-aa72-426fe9d61bda">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/9eb6a173-b7de-4213-96b5-b96e403f18f9"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/b17b70ea-4cf2-48e3-9f3b-793672fe5346"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/cfc0c374-7c9d-4d69-833c-43df67fc10ce"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/271912f5-08c7-4a04-a321-ad4f99d82bf7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/44475c3e-09ef-4af9-9b95-9141e71216c2">
    <rdf:type rdf:resource="obo:RxNorm_31565"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/02f8850f-eb82-4751-8eb3-436d7a24cfc0">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/cd94697b-3f56-45b9-9109-80ba92a9338e"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/a61a14b4-1c96-4e4f-8876-22318e2c76c8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/ca5ddb4b-67c0-492a-bda6-987ece52b0a7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/087814de-7282-4a54-93de-18031d1774ae">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/96fdef7c-50f4-47d7-a421-d30059e28206">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/d0577924-3821-4988-94ba-846173793448"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/d81d66f2-2c6b-4d03-a217-71a421c6268d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/9b0bfbd6-1323-4080-bd5a-c1f6d0e7f6f1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/4b7c73c5-b132-419d-910c-333f153cce9f">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/85dc697a-4e31-4c37-8406-0edc85e81e19"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/b40bd332-9507-4580-a476-d160729a41d1">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/aa158a95-bd4b-4121-b6b7-e43e54851e66"/>
    <rdfs:label>8.61 Fold </rdfs:label>
    <obo:OBI_0001937>8.61</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/81e8a385-2345-4578-9a92-52d97e47c548">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/acdbef4a-410f-4182-bf54-600d2e744966"/>
    <rdfs:label>54 Percent </rdfs:label>
    <obo:OBI_0001937>54</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/3875ce51-b81b-42f6-9fb1-2b126566178f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/39f438f8-ab6e-45e9-8047-f830cc9b82b9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/cf3506b0-957a-47ff-aa14-5933ab4cde3a">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/da710fb7-261e-404a-ae86-645715fcb494"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/af0dffbc-28a5-497d-8285-96b48894fa07"/>
    <rdfs:label>Rifampin-atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/5e43298f-3782-495e-8060-901e918ba0ef">
    <rdf:type rdf:resource="obo:RxNorm_85762"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/9b845e43-3417-4136-94eb-717901cce753">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/038a5429-abd1-4fea-80df-584e9f47db6a">
    <obo:OBI_0001937>400</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/5c8721c7-4471-4992-b810-4995df39401b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/13f284f7-7467-4868-ad33-b8c252e2a007">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/45a19674-6a80-460b-b476-9813db82cc2d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/056ee090-7c9d-438d-9172-f3ce5bfa8a39">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/2c281ea3-2f51-4a1e-aafd-606a6083e594"/>
    <rdfs:label>40 Percent </rdfs:label>
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/77077830-8316-4281-9af4-d4551b2104f5">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/b4d1ba75-8585-4db4-b611-17c91e106d95"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/e2d6432a-7975-431f-8536-a40e3f22ce25">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/4f6d2c05-a43d-41b6-ac8f-6a6346f27fac"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/65dcea3a-58e2-4c00-b2f9-a790c6d03529"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/9e66a0f3-a412-46a6-9eb2-16c35c2d8296"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/7a84ec7e-ed11-47f6-a591-602e64ee8cf8">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/5028529a-0603-428a-ad6a-4553561a95b6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/df83fc8e-ebac-46fa-9f5c-059264c1accf">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/acde9e91-a7e2-4898-a5f7-161b75888c09"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/2b903934-ffb9-4b81-9ced-b1614ad87e9c"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/1975d1c9-8290-42a8-9bc6-4fa6efaaa9df"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/b55d0190-14a2-48d5-b8a6-8ea3f0df30e8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/163b0300-6eb2-4ccc-b3e4-cdd41230524e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/c4a03653-d88d-4e57-b9ad-1001cfbb086c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/da5d5f55-dc4b-4d10-b1a8-c55ed606aac8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/81f0c68b-d241-410a-8506-2d4a899f5dc1">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/990d1df7-abb3-49c7-aba9-7adc7260fe50"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/6c75506a-df3c-4530-aab1-7edd8b38ea3f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/580666c8-003c-45c4-a98e-1b77c11329af">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/c231e45d-41fb-4b78-a7f7-c525d0eda437"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/0a52e8b7-c95f-4ebf-8a3d-a821842da3a8"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/49f64353-07a3-4825-8de6-addcc2307168">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/4642b6fb-8fff-4903-afc8-7b1e5cf964dc"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/6f5cd7de-0964-481f-94d4-f2bc2459cf1d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/1fccae04-8561-4ff7-be3d-d59a63c581bc">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/46f593db-078c-4430-bdef-665e2c2a576c"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/bbdee56f-61f9-486d-9eac-c3b6e72ff2e8"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/0c2d810d-52da-4d7c-aa33-897fd9e6d8a7"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/3cd2f113-55f7-4765-b265-d300161e5fb5"/>
    <rdfs:label>Amlodipine-Atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/bac55995-6067-4d83-ad6b-7b491b9e6a7d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/478a0ebf-c55e-4d39-88a0-34900a20321d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/a7cdd65f-2172-4e45-b511-37b8eaa165ae"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/494ea7f1-a08b-4e1f-b13e-820892695191"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/25ce9788-b665-4970-9afb-e293277ad597">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/8f24578a-513f-473f-8e4f-07a35eea3e2c">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/7f0f4a57-a277-45b1-9beb-ed47f02f543b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/5194c8e8-3652-4f30-a965-f536bd3b3a7d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/c03d0811-6922-4761-ba4f-9391269bcaf2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/2e8d25e8-6db7-452a-a727-cf9f282eb730">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/79916777-eace-437d-a08f-89b025e5d5f3">
    <rdfs:label>alitretinoin-simvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/b1aa0cb6-c6af-42d7-b6df-584fdcb3535a">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/62c2da88-bb5e-4571-8401-1f8a6d0ffd72"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/b234e775-b204-485f-9366-1760e963955a">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/895bf3dd-f294-40e9-a7ad-a30ba69f241b"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/0a706bfe-1975-44ad-9849-efe2e9b2865b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/21259c63-1866-4c7d-9ffb-4945f0568249">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/260bc181-902d-4961-afb3-1e2b0a846493"/>
    <rdfs:label>1.1 UNK </rdfs:label>
    <obo:OBI_0001937>1.1</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/1bb2206a-219d-4f31-96db-0427edbdcd60">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/0c154f28-ebef-48fb-ae9f-4e9b0dd60a7b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/5011f2fd-a282-43cf-8f86-d5e92139481b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/c1e34f2c-02af-4352-98a5-cf2cdece702b"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/c272e1e3-d41c-407b-8160-abe9b5a1d85b"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/49f64353-07a3-4825-8de6-addcc2307168"/>
    <rdfs:label>ritonavir-threohydrobupropion interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/e84357fa-047a-4129-87fb-73e46fa018c3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/a66fdec3-3cb6-438a-87b2-8d80d7654839">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/fa4793ee-e5ff-4bee-9a50-15f5e9af7444">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/8d3b994f-c60f-4dbc-8517-dd62e0f27ec7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/3355d417-a1a6-428f-8567-a2e02281e6a6">
    <rdfs:label>simvastatin-alitretinoin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/380d275a-6ee5-432d-a116-71bcc88cdd3e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/d503b825-a085-40a1-8b80-bc39babd8367"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/8aa5e40f-8c93-4d62-8e22-4a3c7ce26d47"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/aebcb020-17f0-451b-a269-d11ba6b3f272"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/677fdae4-1eca-48e3-8f6f-8307d534dba8"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/e67ef293-ca46-46cf-87ae-a1b5737c5943"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/d5899a2e-f211-4ded-b56b-a2446cadf624"/>
    <rdfs:label>ketoconazole-rivaroxaban interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/3c80cb4f-6641-424f-8322-cf9b3414f315">
    <rdf:type rdf:resource="obo:RxNorm_10502"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/e7ffaef4-6681-4f66-8d1b-f317b6d319c7">
    <rdfs:label>atorvastatin-aliskiren DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/09ba7174-d130-4a6e-a66b-10e54132819a">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/dcd6aba0-fd41-45f5-b883-275f6ae7ebfa"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/b3c97f65-4943-4f0d-a5ab-a4a8095632f1"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/642411a9-3057-4923-8ed6-8d80102ee140"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/d1359f6b-1153-49ac-9a6c-7f08e0aefc6b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/6056cbd7-ed61-42d5-9f76-7573e0253cc9">
    <rdfs:label>ritonavir-erythrohydrobupropion DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/d3b5dfa7-49bd-4193-a92b-d9cce04f86cb">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/c75fdf72-eda8-48aa-8538-334900bc2ef2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/12b68fef-00a3-4269-a043-5ef7ff1d998c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/20ee39ad-f218-498c-b09f-865917016c91"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/149a4c10-94a6-4283-9c05-6f64be17e07e">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/12ac85d6-b3fd-4aa0-ad58-5cc0fc073ee8"/>
    <rdfs:label>fluvoxamine maleate-alprazolam drug package halflife Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/a82b4031-95ca-4a33-84d5-d9b9b20e2087"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/f962a578-7f62-4e1a-8948-878da276ec16">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/ba224f8c-f660-4d42-bd92-293317307f0e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/2cddd678-10af-431a-bf62-a55912e53cf4"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/a82495b0-9046-478a-b7b8-8bf6ad4de940">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/5695979c-3041-4281-99a0-db65afe3fa13"/>
    <rdfs:label>carbamazepine-selegiline drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/a4406cad-1b8e-44c1-9eb7-0f05c3a43193"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/ca120c0d-c922-4498-9a45-19c53bf020e2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/1beb2d48-fdf2-42b1-884e-c0cafc6f0e69">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/c678f33e-107d-4a00-a42f-f8d51487cff2"/>
    <rdfs:label>Clarithromycin-Atorvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/f2ecd61a-e6f9-41fd-a41d-7b9028a4f51c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/06d92933-c89e-4913-9d90-d8657dee447b">
    <rdf:type rdf:resource="obo:RxNorm_734064"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/344dc4f7-a479-448f-8dcd-2df073bb7a3e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/f650336a-588d-45fb-bdd6-a4f171b11d2a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/cc451833-a491-4ee8-9739-d2500fa00b43"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/76216ce0-0fb6-49f6-a1b3-0c330c45e90b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/a3723644-6f9d-473c-b3fa-d2af1056fb30">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/4bd0a2cc-a0f0-4377-9be0-001bd16702c6">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/705fb482-27e9-486e-a980-d6c4658f081b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/8992027c-9fe2-45bd-b246-98376a68e1d5">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/3e41ec4f-53e9-4283-b606-a52e94c78dbc"/>
    <rdfs:label>16 Percent </rdfs:label>
    <obo:OBI_0001937>16</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/bbab154b-2d68-49c1-beb4-51fe9e0c9aa1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/67371079-c78e-4d32-8f45-c6790fd921ba">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/18c20748-0c5a-44a0-86f8-c6684e9425ae"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/f9f9a59c-be30-42a8-9fe8-246a6c5d4a9c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/1657efd6-5352-43f1-be37-7d5a94f0b4f7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/b4615096-f2f3-4c02-a00a-280c9f98764c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/d840dac4-8589-4260-b9a2-e2135bb72361">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/8b6fdafa-3c5c-4135-a0c7-42521cce9dbd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/f0fdcc4b-232b-44d5-81ef-f66e97f17b54">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/724ae9a9-964a-4b30-bbae-a65c85929f26"/>
    <rdfs:label>2 Fold </rdfs:label>
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/930a5200-aed7-4233-9fd1-f9358046b6be">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/cbcd02c6-57a9-4067-a9de-a05389b231ea">
    <obo:OBI_0001937>1000</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/2a97a190-46f5-4650-8ff0-5bd6b81ba6df"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/040ce903-1f18-479a-9ded-2e978c838a55">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/a29cbaf4-e17e-4179-b667-abdf4c756fcf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/0d457fbb-931f-4852-86c3-e2df5aafa767">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/5013b215-25e0-4f16-a7af-b6c9261e4bb2"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/52ef3b4b-e49a-4b01-bd76-7d73f758f2a6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/1aeac76c-bccd-4c0b-bdb0-b49e3decdebe">
    <obo:OBI_0001937>5</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/c79edf8b-b4df-42d2-9e0c-14f888c00003"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/3ab742b1-1540-4dfc-beea-fb9b2a80d76b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/aaf39b24-92b3-4d79-90e8-3ba9771cd543">
    <rdf:type rdf:resource="obo:RxNorm_3407"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/1fb011a0-0c07-4fba-afbc-d9e08d409fc2">
    <rdf:type rdf:resource="obo:RxNorm_6960"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/e4bfac7c-738a-40d0-87c5-e753a094e2bd">
    <obo:OBI_0001937>25</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/6d63c48e-e5bf-4665-90e0-47d824af733d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/9d21feaf-0681-4928-9b58-694ecd822b1d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/e4b1f812-4de5-42d5-a085-b868ff78a619">
    <rdf:type rdf:resource="obo:RxNorm_17767"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/208f6e4c-b5fa-4634-abfe-95671ec076bf">
    <rdf:type rdf:resource="obo:RxNorm_57258"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/99d1d274-9c68-4037-aeb5-aa240e14fbe3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/f3a005db-c99c-4838-8fac-117f48f0817c">
    <rdf:type rdf:resource="obo:RxNorm_31565"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/326376d3-d36e-4ad7-8bed-8981ff605361">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/37cf1913-871b-4290-9e6f-ee366d0caf50"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/8632a552-a5c7-4ca6-9a2a-5bd214b6f669"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/b610a7aa-16d1-4364-9eb0-f3546155e28b">
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/9ce93f3e-2260-4d30-9b59-75cd51103b13"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/4d056ea3-9e42-4243-afee-6ed8f5a32f11">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/9b06a2ec-189f-4e61-b2fa-9a508cb67980"/>
    <rdfs:label>22 Percent </rdfs:label>
    <obo:OBI_0001937>22</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/6a1ecc81-f7c6-4d9f-84ce-44782d86d065">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/0eae54d0-6cb8-4001-95cc-e24a17ed32a6"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/c083781c-9d1c-4742-8157-02040667ab4c"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/0b38ef78-3235-47f7-ae77-c8ef7246baff"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/bb49ac84-907d-4bf1-b108-d6aa3f5e66b3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/debc5f26-934f-4501-bd78-a8f8915adf20">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/f6887c24-ab52-433b-a681-cb071919679f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/214796ee-bde6-4366-b0ee-10bffe7dd87e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/8e30a8c3-c5e8-4876-8ba9-90c3944803ce"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/ed58a880-1ce6-4848-bbbb-86fe52bf7547"/>
    <rdfs:label>desipramine-HO-NEF interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/173f8382-b077-4ef8-9a45-014718917b78">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/88bf54ca-01d0-46e2-89a9-91b7b0cbec0c">
    <rdfs:label>bupropion-desipramine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/923daaae-6534-4d12-8b84-d647d51a2bf1">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/6567c74f-094b-45b3-86d1-4d9c500e55db"/>
    <rdfs:label>mCPP-desipramine drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/804d5f7e-ea7b-4300-9b69-bae9f19d35a8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/e691149c-3680-4fc5-909d-11f777755fb6">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/45e61dbd-8001-47d7-bee8-ada284e8101f"/>
    <rdfs:label>3-4 Fold </rdfs:label>
    <obo:OBI_0001937>3-4</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/93c91bda-858e-4313-a8a5-ce7e5866e093">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/d745b5d4-a6b6-4e3d-a700-1884acdcc43b">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/fd8bafd0-4be0-41a9-b00c-8f7c36c34858"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/a3edf21e-cca7-4974-8c29-1265bb7d5576"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/8d950745-3b12-42c5-b6ff-5349aafbd4cc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/a300fb0b-4520-4444-9227-623d971b9e31">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/1c510296-c7a5-4bf3-9460-9907a943632c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/cff7d254-37ef-4e46-9270-1adefac89854"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/244e9fa4-0973-404d-95e6-d64b4ffcfb37"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/7610fd77-8c1f-43c5-b3fb-779ef671605f">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/99bb77b7-7b53-4594-8c9f-8244741c0a22"/>
    <rdfs:label>Erythromycin-Atorvastatin drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/f8ab7364-be20-42a9-875b-a2bdd7671966"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/33c21f97-1263-4162-84b0-721b152279b3">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/e2222a53-6fb0-4dd5-a8e1-82c8d79ba05b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/0a303011-a7a3-4478-926f-6026a8e5f015"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/1863c50d-2770-4656-9d23-2a58ec36abd0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/298ae06f-c3ad-41fc-a951-7b4ac5314a38">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/7b6cc899-bef9-4c0c-87ec-79ac610b8106">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/dd26dd70-b571-4bc6-a66e-139475d0da09"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/c5580250-3e25-45bc-af96-b96e0851ffe8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/55818644-be8f-42f9-908f-04e98be538bc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/d96c0b0c-0b3b-4cd0-b312-d4981bebb661">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/439fdd56-e651-4676-a778-bcb4c88be18b">
    <rdf:type rdf:resource="obo:RxNorm_1114195"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/7bffc644-01a7-49d9-993c-af3f75b19668">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/a8bbb47a-c2ec-4e34-aa7c-1ca290e1f4e0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/79d76a33-7c00-48dd-95f6-be566f957722">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/9053bcc0-a290-4dea-9b8f-73236cab08c2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/bf414177-1a40-4350-b172-986d162105b6">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/58c3784f-bf51-4a7d-a208-b734773f1748"/>
    <rdfs:label>3 Fold </rdfs:label>
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/ff5b5e10-25c5-48f6-87de-d19214739d82">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/8948bad2-7149-45f6-9976-acae43d2618c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/1b539799-3e06-41ea-a643-dbf87c11d25e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/72ca1791-eec8-4859-aac3-cdf2e045239c"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/713933a4-ff0c-4b5a-9305-446516cfd679">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/ea6f7bf0-8b93-41f2-9463-6f74e1138fc0"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/d4f87263-d245-41db-8d57-1bb81909ec6d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/18190d4b-b8f5-454c-9d8a-0f16c90f0b8b">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/17c3a02c-2a9d-4786-a7ce-1cea9d3e7609"/>
    <rdfs:label>ritonavir-rivaroxaban drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/2116ee10-f24c-49e7-b369-f1ba79e80b65"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/51284e24-6e5c-4ab3-bacd-e1638fa60fcf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/ce6c28d8-7fa9-451b-af7f-ac18362f6df1">
    <rdfs:label>ketoconazole-desvenlafaxine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/f1134523-5ac7-41ca-ba72-248a9853b605">
    <rdf:type rdf:resource="obo:RxNorm_9384"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/76bf1d24-d57d-45e0-b66d-2203ef273ebf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/d6060f0f-6f46-49b0-aa3e-3091efa889a3">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/84574d5d-8b17-4f6b-abf4-9a8da2ee8f78"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/da81728e-6aed-4f60-9487-8078f6a23101"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/8c72fbc8-7dd7-4e67-a451-6eb444d5b71f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/cee6b0e4-0f4b-4d0b-bc28-37ba1a240a3b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/4cab9fe3-6e57-45da-a16f-75657211f065">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/0f6f8c59-f7a1-45da-a1bd-0b614bfb029c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/4e8bb059-5742-44d6-bc52-0fd89f5e18df"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/2aff703d-0502-4be7-8299-70adc337321c">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/99e3f280-66ea-477a-92ad-2201e0b96275"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/72299084-bfd7-41aa-816e-479aa12f6d6b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/23900ecb-9aa5-4012-af45-3df876bc947b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a85ccb01-ef28-40a9-9538-6afbeb7db401">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/cbedd838-fe16-4cdf-9a37-db00dd499ab7"/>
    <rdfs:label>85 Percent </rdfs:label>
    <obo:OBI_0001937>85</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/2a8c1ec6-39dc-4668-94e6-97b2afb1654a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/a5aaffb2-92b8-4c5a-870a-baed3f459c4d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/ea34d3b1-1d3f-4c3c-a569-f50d99382c12"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/9bd7cd8d-446d-4e9a-8759-eb20c5301444">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/57d4eb15-308e-4401-a8c3-2e932c64ae1d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/4d6f7730-d74f-45e6-a531-6647ffcd825d">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/d202878b-390d-43dd-8c82-c9af480199a8"/>
    <rdfs:label>28.9% Percent </rdfs:label>
    <obo:OBI_0001937>28.9%</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/c00dd9fb-8a2c-49fb-aea9-c78c57a40b21">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/875f33bd-f4d8-4b47-88b5-d3e7d1c5a486"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/2747c108-23e2-4978-a311-072df189d470"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/08f38622-51cd-4e83-84aa-68e6f988b4cc">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/62fbee30-a001-438f-8d28-32eceab148fb"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/d68a113e-3336-497c-8748-06a839ca8fa8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/b06ea772-28ca-4254-a1f2-62a97d39a970">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/be5409e5-3117-4b1d-822f-0d3bf4eee267">
    <rdf:type rdf:resource="obo:RxNorm_4493"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/550b89a6-c0b8-42b8-bb35-9439bf387518">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/4186af21-30f1-45ad-aec3-c9a7ee8599ac"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/eea83382-3551-4cc8-b056-41f9ff7e9b13"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/3338a9ec-af3c-49f1-9cd7-531438bc93a7">
    <rdfs:label>nefazodone-simvastatin acid DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/1a9ff2ea-2a68-45ff-b998-ad49daee1709">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/27c5f5f0-70c0-4b6a-beae-f2d553b5fbf1"/>
    <rdfs:label>fluvoxamine-duloxetine drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/77f0c3a8-e0a2-4b7f-9eac-58c1f4b415c7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/8da394da-9ac8-4345-aae1-eb3dbc1cdf9b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/a01ca0e0-81bf-4ddd-8214-9c5dbe616c51">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/f2688c54-d970-4137-b948-b2aad92964e2">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/a39553e4-7607-499f-8be0-05acafa68b6b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/cd4353b1-1ba4-48e4-a4e6-c0a7ede57c53">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/a2e643b6-feaa-4db2-bb2a-d70090ab6d02">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/efc66e1d-a1fb-4d4d-afc5-a5c5390c3a14">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/933a978c-59f6-4151-877e-a34698252c34">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/1a419594-124d-4645-94d0-a9e1b00d2ee0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/fe86b2c7-23ad-48fa-ae3c-e1af8481de90">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/3e4e9021-ce25-4456-8687-c6b27eba52b9"/>
    <rdfs:label>ticagrelor-dabigatran drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/d277d365-ff99-4e89-b24c-554ab412b714"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/bc1b0371-9b15-4c49-883f-68c85ccdf710">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/34375e93-914b-4b13-b754-8293293bd544"/>
    <rdfs:label>Fluoxetine-olanzapine drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/5b70e761-8fc9-4308-a0ed-847e0f7cc202"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/da2bae09-9e29-4564-8aed-5a9fc72f1288">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/fd9c9289-9aa2-42a7-9343-6744b28f426f"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/c00dd9fb-8a2c-49fb-aea9-c78c57a40b21"/>
    <rdfs:label>fimasartan-atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000187">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/f6f973a7-5811-4acf-a953-a0192cd8c70e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/a2f60781-9be9-4111-aaac-a2916bac73be">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/ce6261f9-05dc-44c3-8972-8bcf34672119"/>
    <rdfs:label>paroxetine-tramadol drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/6754a2a1-7721-4ef3-99fe-8db73a7308b6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000039">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/e116fc6c-0371-4afd-8674-d56a019dc631">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/6fe9f8c6-cc81-43d7-b7f1-52a89dabba5c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/a523f874-c264-479f-81bf-478248dfeba5">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/bf98b7e4-1e61-44da-989b-ca53b4ba6120"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/c9eb8eb2-578c-40bb-8bec-c6baf058d99a"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/46585113-595b-4d08-899a-924a07d35712">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/0c9c1d32-a833-4363-ae44-c3d5963c85c1"/>
    <rdfs:label>65 Percent </rdfs:label>
    <obo:OBI_0001937>65</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/7793cc05-d221-4c4b-b270-0d0040542990">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/464c67db-9360-4927-b74d-9b6149ad56ab">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/a6d3b0d8-685d-4f0e-a4c1-1116450712ee">
    <rdf:type rdf:resource="obo:RxNorm_6135"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/080b7243-5227-4c15-8c1f-a5c98620a87a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/f71de8b1-7e5e-4299-b4dc-e29309891e38">
    <rdfs:label>cimetidine-zaleplon DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/9e695a25-a1d0-42d7-8bee-d4f6865c926b">
    <rdf:type rdf:resource="obo:RxNorm_42355"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/01733842-7c6a-4ebc-b3ab-a58589961529">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/93f23edc-d71b-46c8-b090-885d5b3f30e5"/>
    <rdfs:label>53 Percent </rdfs:label>
    <obo:OBI_0001937>53</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/aaab8314-8f7e-4fec-8214-ba0ff5d2bec7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/157f583d-bb68-40ec-9de4-5adffbf4703b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/7e8bbc59-8caa-4267-9bc6-8076f5892457">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/976b640b-934c-48e6-b539-b6fcb392ab9f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/275d2534-e3fc-468c-bc0d-30a2123f3518"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/69972595-36ee-40c4-892b-865dba28dbff"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/3c1ee6d9-1592-4495-97af-8b92018ce30d"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/bc2ef585-6235-44fc-b5e1-e115a59cf080"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/cc32200e-422d-454d-af57-d867712b8b7c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/bbe97c43-abca-4f9c-a7a0-b43131727656"/>
    <rdfs:label>erythromycin-rivaroxaban interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/4e304e90-4fc6-4afa-8743-920556cc216d">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/14386102-1f23-43c7-9c40-567d1f188a5e"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/f1f1358e-cbf9-49a9-8411-b69a8d842510"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/1f4ab884-ca02-4330-8b7f-3c2233fd57a0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/0081d8c4-c64e-4169-b466-fca11e993ae1">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/0b8e4f72-aed1-4659-9568-439d2c57950d"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/038a5429-abd1-4fea-80df-584e9f47db6a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/ba7f8265-175c-4c37-bf57-a7cdf39957ac">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/fe31ccec-2a15-4f75-b769-af51e53e4bba">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/54f909bf-7858-44cc-8b28-3684aef1b944">
    <rdfs:label>Boceprevir-Atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/6b50f426-bd3b-4dc0-9cf7-088e4a1c0f0c">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/ded08eee-9d61-4c8c-83d9-adec365c362e"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/aa21c512-f206-4090-8db0-2649f569242f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/28bb9eb2-9743-4d8b-9d46-51371b06c0da">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/41c91477-f8af-4f5a-adfe-1f0b28ef7936"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/123c0a6e-c17d-4075-a9f7-3e1f18969299"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/44558514-c4dc-4ecb-a3ce-9cb50c19b1ba">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/d4a40131-7a3e-4748-8bd0-04a5fb3e8788">
    <rdf:type rdf:resource="obo:RxNorm_31565"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/9f8b1556-3cd1-4e8f-87ee-dfed8d0b7d44">
    <obo:OBI_0001937>1250</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/9f3e83da-1502-4415-b475-095bbe350b8e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/285fa0f7-2efc-4f0f-bcf1-bd846f129e5e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/cda036ab-12f2-4003-89d5-888b2214cac4">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/ba7f5e0b-2d59-44a0-863d-8ab6d531f7e3"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/500d4252-5079-4941-bd1c-300043d1a894"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/4f4177e1-0d57-452d-aa9f-7c5922cf4b1b">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/191fa5b1-c97f-4b07-8e29-d9eaa987e911"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/0316bfa9-e1dd-4b71-ab14-13ae2548ee97"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/d63f022e-b7b9-4029-b02c-c388d459ad7e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/655f9cbf-e8de-4863-9b7f-708213f630be">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/43bc6e3d-cb43-40de-92ca-d1ea8670b915"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/3a91f925-c95e-4b8f-bf52-37b6939cba84"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/aa10836e-63da-4c34-8571-3014e7176c65">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/ba3fc743-9d8d-4996-8d86-8ea1be0433f3"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/88b64ce9-4d54-48c2-b8f3-fe2bfd530135"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/beb1f0c4-2d06-419f-a508-d669e9492dca"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/66c563f1-1be8-4d8a-97a9-7f343bc07f9c">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/092fc3f4-c3b2-446b-b74a-2c80344edc4b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/3a0df5a3-1600-4260-b990-511d30f310ed">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/197a5440-2e7f-432f-912b-16e6579c7817"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/c77482ca-adb6-4e4c-9f12-b73bf0fde70e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/4daf426e-9a97-4706-bb4a-a022877869ff"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/52f27f96-f88d-460c-a93c-a7eb4e5dcf37"/>
    <rdfs:label>nefazodone-alprazolam interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/a8e81847-6a20-4f8e-bb96-dd40ed2cebc0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/c446da8c-9b73-43e9-8477-6d841e200717">
    <obo:OBI_0001937>400</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/641ebe87-76e6-497a-9a02-b3328399eaa6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/63d967aa-77a6-47df-91a5-d5fa8dd77cb2">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/025e8e7a-15de-483e-9f28-e7cf12aa4116"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/3ceb54fa-2d9c-4170-8927-a2e6e1b783b4"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/a7e2b6ec-7e83-4f50-aa17-05ab1be3a49b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/b725b331-2c43-429e-9241-521f47b50e1f">
    <obo:OBI_0001937>75</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/130246bd-fe7d-451d-bf2d-f93297c8e8d5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/d34a04fa-c0bf-4d16-95bc-eb96c2205d8b">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/995697f8-4c18-4aa9-964d-397e960b5a49"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/3b15c481-c907-463d-816a-94ec5fe876dc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/08895af8-5ead-48ef-b08d-e9630550ac2c">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/9729d871-0133-410d-8b74-996817a30a3e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/83fb437f-b12e-4f00-b95c-a4611baa7535"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/28bb9eb2-9743-4d8b-9d46-51371b06c0da"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/6a75fbfa-2fe0-4f1e-8dc7-85dcb87819a2">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/2753ce7b-0761-4a57-a585-76abc3a46c5e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/f1f01378-ef6f-4e95-8f57-985cb50c147b"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/01cd61ef-d8e5-4aac-9c5d-f07171a0e18a">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/99607a14-c67a-4bd4-8ed5-acf16ce6225e"/>
    <rdfs:label>rifampin-pitavastatin drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/d429a6f1-8276-4549-bfc5-f7e0eeeb30d8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/c203ae74-329d-4e3d-924c-9dbd8f6be14b">
    <rdf:type rdf:resource="obo:RxNorm_1114195"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/fae604c6-e0b2-40dd-8443-4c022977e198">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/197eef3b-ca47-496d-957a-2617d46f257b"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/0177e925-1630-4695-9fd8-1b291713a8d6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/520f0002-d3ef-4011-a01e-8b3d38594558">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/82cee4f0-f4ff-4f33-b57b-df057289dcd5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/45048fe0-5098-4801-b884-caa857b4ecf1">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/8cdd95a2-4d63-4eca-889d-1fbd9c90ad04"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/9f32d9ec-c521-40bd-91ec-b446c6e62631"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/d503b825-a085-40a1-8b80-bc39babd8367">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/82433ba6-2e85-475c-bc7b-486f7e178689"/>
    <rdfs:label>ketoconazole-rivaroxaban drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/a26f5b3a-855c-4077-b0a6-774a6eac7509"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/509f21f4-5b59-42e6-bd11-0fb1e42351a8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/7229c0df-b821-4fce-a615-698f0ed48983">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/a99dea58-3b5d-4ed2-8eb7-ab3f8f97c44b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/6df2c03d-4c2f-4da9-b134-b2721f162a4f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/73eab58b-7cbb-4b83-9729-87cdf34ea623">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/b8804298-de45-4e22-bdce-e3f5ce605eff"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/d85b9ffd-b2a9-4128-a3e9-f08634ae70f0"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/b19ad30f-97ff-461c-ac4b-566afa4454e6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/d8f79f24-a60f-4870-97fe-f98e0b8e5c09">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/a2a233b5-b4cd-4941-a654-1833b7f990b5">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/3ba648ff-8715-4528-bc70-86d667b9af3a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/2c1d5d67-4bdf-4f4c-aab3-26c56ee50460"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/6fae3fe1-abcd-4a64-a31b-b97bdaa5c33e">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/0d87d07f-560d-44b6-b0da-524a1612d71d"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/f2ed956f-9b98-49b7-a5c7-2f335aa8f2e4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/f68cb0d0-a09d-4458-a885-6ad387f9048d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/3a53a65e-0a71-438b-a066-590cf3304cdb">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/0b1922bc-00b9-4884-9f9a-ac76f943f50a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/1faa111c-e1fc-454e-89f8-2586f0214dd6"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/160ec5e8-e297-44e8-8ca8-2a40232a0cc4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/1633d79e-bee5-4542-bb7d-4cbecf35be16">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/411661a7-26a2-4bcf-bf14-2391e69237f4">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/63430a32-29ec-4719-8110-be464c210cb7"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/aabcdadd-e894-4c0c-ac9f-29b8c4fff520"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a88b43bb-beef-4975-87d6-03c27607ae8f">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/eddeeb79-8c5d-429e-af51-8ebbdd1dfbd1"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/4391fccb-d723-49cf-9db3-5030bd7b946b">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/3b24a793-e6a6-4dd3-80d4-180bf2099f0e"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/e1aff51d-10bf-4727-9915-4c465a1f1f23"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/36dbd033-3ee6-43ea-878c-aa2f71566238">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/edb0583b-3ffd-4c90-aafc-0f7374fb821d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/6c944f19-31bc-4922-877d-e7055d932d7c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/c92ace6b-2425-4874-96e5-35f59e50df2b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/e75a5aa3-3da9-4871-addf-3b5715b1e089">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/773c26a0-66b3-4b24-9bfc-1481550c2d0a"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/35eec514-dbbd-429f-8d00-60aff3e75d31"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/692782c7-c826-4fd2-8d16-be1b1eca8a4e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/455a83ec-2e0b-4e22-b6a2-71141a3f5fb2">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/27c5f5f0-70c0-4b6a-beae-f2d553b5fbf1"/>
    <rdfs:label>fluvoxamine-duloxetine drug package halflife Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/8c12c56c-cfc7-4ea4-a95f-251dadcd9c83"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/3ab9a8ae-a07c-4634-a728-b616fd65c358">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/e734ec77-8e69-4a46-8f69-e3746adef5e4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/8fc4618e-f45e-4180-8a3c-9d9f30868f02">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/3f08f184-2103-4052-bd39-e259174e171d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/ff5d640a-cb90-420d-bba5-7d478e9014fd"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/788572ed-f807-49a8-8c9a-eefacc3f3ed9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/ea34d3b1-1d3f-4c3c-a569-f50d99382c12">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/6e56ab53-a34f-4dce-9853-36aea5453446">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/0485e34d-1464-4597-aebb-0cac5abd0850">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/a69a85a5-32d1-46ea-b6df-9ffcdbedd873">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/e57c0faa-541a-4361-bd4b-f753d33e499d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/f32ba152-f6a5-49a5-b0f7-cbfe16c92ba5">
    <obo:OBI_0001937>37.5-50</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/79f4ca34-9edf-4b7a-8688-a8e8cb5ffde5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/7a1909af-2cdd-4296-89b5-135ce00cde78">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/15483d5b-743e-4e06-ab98-b7c4e00fb57c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/2ec774da-4a22-4d3a-b900-1c9445253600"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/9b0b3d1f-7936-4aea-b1c4-f45f229ce9f2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/13d96535-47d4-4cf4-af38-76d3d48d7a0f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/ab6b0689-691b-4a62-bca5-eae2231f893c">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/8c380678-4ae1-4d6c-a238-3f7f887e1489"/>
    <rdfs:label>rifampin-zolpidem drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/cfd67d78-46e4-4874-bba3-bec5c5be2eb9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/fd9978b1-6095-4e58-9cdb-2448a53aafc4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/905adce1-eb92-4953-b0c2-af671cb7e22a">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/7a39e538-d6e8-422f-b833-ee14584e444a"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/19f05f1b-1881-4a75-8dba-4675c872b53a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/8f111372-0408-4d53-a99c-60cd82b17ad3">
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/b7a3cfac-c349-4758-a108-a8866664b75c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/d7c22e48-6b49-4cad-9275-d4e86c3872e0">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/0fc387d3-6922-47aa-8fb6-234fa5a50418"/>
    <rdfs:label>carbamazepine-hydroxynefazodone drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/25eab861-4108-4823-9b9e-5d8890dac2d7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/817f2ed2-ffea-4021-a88e-2d04f93685ba">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/a121eff1-6e9a-4239-86b5-f0e9d4488a75"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/a8767a60-af8e-4bf4-9d8c-574aa9019edd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/af5ae57f-878e-425f-ac00-67f983dc5eea">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/9abacc5d-7a29-4dcf-b6c4-8405c74c60ea">
    <rdfs:label>duloxetine-theophylline DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/fd9af4d2-2af3-421b-8017-f6fdcd7a2c7d">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/9bd6b36a-2e0a-4653-9b56-1b6e5283df8a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/a78d6e2a-57ac-4b4f-a588-98c60feac49b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/700bd9ce-52b3-467a-a7b5-6e9fcd33e108"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/dafc7775-03ca-4b26-83af-8b5be3b18bde">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/815051aa-bdca-4cf0-818d-251e746b9672">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/87f233aa-7d16-40c3-b658-1a7868de81c8">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/47f76ef8-1d82-476f-afdc-a1ea0814ae55"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/32807cbd-4541-4be9-8c56-7c5112a804fa"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/b2ba8743-7727-45c4-9591-5ac7ad469f93"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/009d9ae9-ff25-40e9-af29-a8d1e94c7b62"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/a6e7e6b9-cbb8-4725-95d9-512bed26e45e"/>
    <rdfs:label>nefazodone-triazolam interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/8f7e7ef4-da6f-4930-a53b-0a309ac7b788">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/2fe8559c-76f7-41e9-95ff-3f85830f3ce7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/129ab74f-ac62-4241-9fee-99cf5df92455">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/dd172577-9fb3-4585-9243-2894ae7fe7e5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/918bf850-49a9-4343-9ae6-ea2e2ca7fd85">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/01889bc4-2897-42c0-87ca-7d2674af6cd3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/205ec66b-2948-4065-88ef-56e8dd9a99b6">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/f98ab704-77aa-4769-b533-f5656d473887"/>
    <rdfs:label>517 Percent </rdfs:label>
    <obo:OBI_0001937>517</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/fe350716-6358-4cf2-9dfa-bad0dc32adf4">
    <rdfs:label>amiodarone-dabigatran DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/26cba1b6-cb6c-4064-b11f-6378789b219e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/61ec80b4-38d7-49fe-b83a-80b2c33aea00">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/bd18272c-6dbe-4fe3-b6f8-e41eae6a5c49"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/cc4c74db-8ace-4289-90ad-6dc06200b700"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/b30f2cef-b1d4-42f8-a0fd-234b1b57efa7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/ccdf8ee7-df5e-4843-ba75-50fe8565c8a9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/3b4b87b1-0bb9-4536-a362-2940178343fb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/b1d2b75c-af30-4fa6-bfb6-d9ec296b9b30">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/16c9d402-8809-4f68-a4dd-839309e00834">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/69082dae-173f-458e-b79d-478cfd4bbd18"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/7c6919c6-83b1-448b-8744-548a484ac743"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/3933a456-de5f-46bb-8cf8-88a2e3db98f9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/3ef70a61-fd95-431a-b854-91e15485f658">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/47cb7427-1758-4629-9b17-76e7d3a9bd93"/>
    <rdfs:label>desvenlafaxine succinate-desipramine drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/3613135f-7bc0-456e-95c1-7206ca7554cd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/b44a4a98-19c4-4042-9961-d0d110407c04">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/8b5a312c-6fab-4855-949f-adfc9263f9ff"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/3bc6bd04-6de5-4441-b6ab-d9f711bc3055"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/582ae973-cdba-43fb-a0e4-9f0ad6975d58">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/98c7df8f-9b12-463a-8e27-1ff39ec7d734"/>
    <rdfs:label>telaprevir-atorvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/067e8f19-b78b-4c5f-b554-23770339c645"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/bdfebc48-3a02-422d-8a29-673fb457d7d1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/34e28bc1-ff41-4b44-8e2d-55168cc5e336">
    <rdf:type rdf:resource="obo:RxNorm_72625"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/97cdbebc-ae92-4de3-8084-60c0ba65efcb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/7871f471-e568-4c7b-9194-1c9014518bfd">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/afb0c7a5-7170-4eba-9608-7e9b005a6ffa"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/cc79ada6-9133-45e9-9929-df7d12351132">
    <rdf:type rdf:resource="obo:RxNorm_42355"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/825c0634-cf1a-4f94-9786-787d02d36e1c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/4f0bf5a0-e635-47eb-9646-a5ff472cb708">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/55a15853-d287-46b3-9b4c-8a8e178cedb6"/>
    <rdfs:label>telaprevir-amlodipine drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/594613f9-6a26-41ad-854a-27f0847ac3dc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/d032e642-6434-4e6a-842f-a6464eaa68b2">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/c44db32f-3d7c-474a-be2f-55324a43919d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/ccdf8ee7-df5e-4843-ba75-50fe8565c8a9"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/005cfa8b-8d3e-49a1-93bf-ed114ff624d2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/c05b3f88-c118-45b9-86b6-b215a9ec270b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/cc333f09-f894-45fc-b4fe-03ad4171a118">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/8e79f7e3-3c12-4b5c-ac32-107ca1251fd7">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/8e5666e8-c66d-4863-8603-13b504ca2355"/>
    <rdfs:label>34 Percent </rdfs:label>
    <obo:OBI_0001937>34</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/a5ed884f-4337-45fb-92a0-1c54d9b3cd01">
    <rdf:type rdf:resource="obo:RxNorm_134527"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/5a5b63b4-2d33-4be6-88b3-74964d9a6620">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/1471f962-696c-4fd8-bbca-fee8feabb2f6"/>
    <rdfs:label>Ticagrelor-atorvastatin drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/9aca7b3e-7cad-441f-8318-c364f98d1681"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/a221ee14-38c0-4e3b-99a2-4edf51a06d3c">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/5695979c-3041-4281-99a0-db65afe3fa13"/>
    <rdfs:label>carbamazepine-selegiline drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/36f50023-7865-4ca2-9c4a-4c0f41a6f6c9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/6437b3b6-a463-4674-9777-06792dcf2114">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/06afc643-f7d1-43e0-811f-737d05f07856"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/212d5bc1-9a38-4573-b4c1-b94fd6d98f90"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/290edcc6-4afe-4d2c-9a2a-9dd15d9318a7">
    <rdfs:label>rivaroxaban-midazolam DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/96995f7b-ea34-439e-a1c1-827eb52d2fdc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/b6c71f6f-cf99-436e-a8a7-37352fc73bdb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/8a61b321-cff7-4613-b535-644f768d4af9">
    <rdfs:label>nefazodone-simvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/56e1f074-4231-4404-a86f-8bd6f64c6294">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/c89fe522-ac60-47db-935d-bbdc70cb5ed7"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/5e5cfd6f-1d8c-4eb6-b468-5866f9f8917a"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/9a988496-a458-4429-82e5-7c03af839171">
    <obo:OBI_0001937>Unk</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/ca5ddb4b-67c0-492a-bda6-987ece52b0a7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/3142c845-34e3-42ca-acb1-6450a790d2a2">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/01e1617c-818a-4b2f-842a-89b73886b5c4"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/554cc2d1-6a3c-4395-b0fa-f9aca4a02f3a"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/ec025003-a062-4ae6-8e20-44e8a36af2c9">
    <rdf:type rdf:resource="obo:RxNorm_36567"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/ebcac4f6-1794-497e-86bd-709d321d92ac">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/b2191d98-f9bb-4d36-bfd1-d849d705dd0a"/>
    <rdfs:label>Fluvoxamine-tizanidine drug package halflife Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/238370d8-a897-4e55-872b-93472f8365e4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/98fb63b1-5efc-4e92-b3f3-de246ab5ce5e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/1f87579b-e60d-49d6-a2ce-ff09b95acc2f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/62c8d43b-7c35-47d7-a61e-0f8a431403cf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/487adc9c-abea-4ede-b867-6da817184949">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/b3be2e16-232a-4518-9a7d-77ae3140659c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/ad949246-4dc9-45d5-af0e-62e28f391f5d"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/f803dc0c-4d33-49a2-a53b-dcdf6d6ca8e2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/ca8bdf27-95f2-44e4-9749-f1eaee4aa774">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/cea35177-bb36-4c4d-8f2e-1c8907b7fb42">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/163b0300-6eb2-4ccc-b3e4-cdd41230524e"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/aff37e07-1698-4c63-9a70-33e06550e183"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/e5f78a37-03a2-4543-9fd2-29bb4da529be">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/4529e51e-dfe1-4344-b396-bdeacc904d34"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/477a17d7-72df-4bb9-8cee-ae1a812e89a5"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/f5f5790c-d998-463d-a7a6-b195b730c5bc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/a04f74ff-ad17-4a46-bd27-19cd93105ed7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/b54c20c8-b496-4de2-b49d-8752f30ec8e8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/5cce782d-bdd6-4310-bd22-5bb613dda860">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/022d3c12-3ada-4ab9-b40a-6c8a723e110e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/b153c1de-ad0c-4442-a867-b58164f12ca3"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/db69cbf7-3221-43a4-948d-0c87e8667ccf">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/2c4562eb-ef60-4230-9141-0c1e09f577b6"/>
    <rdfs:label>UNKUNUNK UNK </rdfs:label>
    <obo:OBI_0001937>UNKUNUNK</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/54d61baa-a36a-43f6-ba97-24e1e24398d3">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/30145897-e26c-4d24-b592-1dc5b30fd996"/>
    <rdfs:label>34 Percent </rdfs:label>
    <obo:OBI_0001937>34</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/e8903c9f-c00a-4fb3-822b-3fb1a5938a03">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/d69cb994-5328-4696-a534-d19a7cec3dd1"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/97e58806-350f-4b32-8e11-77abc38fb9bc"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/a24e396e-a6f2-49ee-ac81-f01caf236dc3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/042ef0dc-5559-472a-b890-2f7b1eb13a69">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/117bdb8d-2261-4a6c-bec7-e29eaa2cf1fb"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/21b3824b-0599-4a64-8109-8a02cbf124f8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/cf4a126c-8d23-4dec-ac0f-74010544fe37">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/7e46af40-863f-4b85-8055-1dbd22a926e7"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/706973af-4c47-4d59-b6e2-d735a7135e21"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/5e4c8cbd-1d12-4ca2-b75f-aadaa7174b6f"/>
    <rdfs:label>paroxetine-iloperidone interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/4399a64a-71a0-4d47-8a9f-fdfb69604523">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/df5e6072-4bb9-42d5-a364-f3366bce3092"/>
    <rdfs:label>20 Percent </rdfs:label>
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/66441956-aa14-411f-a236-d21ed771e302">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/4f1fd5ae-27b1-4a61-98d5-f7e85c06881a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/28ace315-0f32-46ea-9e91-3aab192b0f41">
    <rdfs:label>paroxetine-atomoxetine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/1f8c920c-5332-4b74-9eb5-696cdec88dc3">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/91f6f870-11c8-4276-a7ca-cf95838564de"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/7cd5e418-0578-4fed-9712-308e9a1e587f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/701ba154-f2e5-41de-8ab0-cd4a5bc52d49">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/14d1fb29-08c7-4d63-81cc-859799c74dd4">
    <rdf:type rdf:resource="obo:MeSH_C580748"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/9851855f-90d6-4fed-a24e-6d579861f534">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/ddb91906-316a-41ee-8a4c-23ca51f28855"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/4eca74aa-d7b2-46bc-a1ac-80b45ecedcb0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/01867df7-52fd-4ea6-872d-9439d8e22e92">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/59bf85bd-bc82-43a5-94cd-0fe9a40de203"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/483fff0b-ae05-4d01-853e-c87af91c9ee4">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/4ff41aa7-659c-4ef7-896d-93f536028099"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/0bf9f570-78b6-49fd-9e66-b23f031ee28c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/24aff558-ce43-4896-a549-daaa4bd07099">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/9e3edc75-3db4-4858-b975-cb4ebba15751">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/4cf8bb1b-4b58-4c79-b9e5-e75a639ae453">
    <rdf:type rdf:resource="obo:RxNorm_8718"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/0d09815c-1700-486b-b523-7c8b6f2f60b6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/4a3f3b54-903a-414f-883e-b8004ce590a7">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/fd2025ab-eabe-4df3-b953-d726aebe254d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/b3d658c2-0a07-4fd6-b28b-582470d53b12"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/20f31585-c6f5-4c05-9316-12f0a41dce78">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/54652f31-1f44-4ed7-8264-f49292111dec">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/1b8b9d34-5ac3-49f3-8949-b81fe86ce238"/>
    <rdfs:label>sertraline-pimozide drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/8857bb70-df4d-46b1-a1f0-c423a4182898"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/c9b9a5c3-d3f9-4c91-9a3c-f2677df1209e">
    <obo:OBI_0001937>1250</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/222ef4c0-df60-4aff-b57c-d830d526fb8d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/229ad34e-8290-41de-9c5e-e872c1172f6a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/58554a44-f79d-4a56-a157-51bed2373194">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/22dbac2d-1116-4588-bf71-25a7408ed71c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/cf940502-ef7c-4f06-882b-024efc0f9ed0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/6fa4b854-1a8a-4f0e-8019-a1fdb3a9f98a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/8e59fde3-b888-468f-8bb6-42148dee71ab">
    <rdfs:label>carbamazepine-methamphetamine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/f6e3871f-3fd0-42c0-8795-bd9d8ad8e260">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/ed69e047-b569-4f20-86a9-a230f8c724d9">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/e76f5f84-027b-4bff-801b-e84ff59f653a"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/db8ba1d0-4749-4e30-bb61-8808d83881f9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/0081ef3a-ea35-466c-b353-77030ab76db9">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/a79bd1a1-2429-444f-a2ff-339d49e8fc67"/>
    <rdfs:label>21 Percent </rdfs:label>
    <obo:OBI_0001937>21</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/d8609b25-aba3-42a5-aef6-7c88d95bd77c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/bb8a4787-1f29-4b5e-a19e-a91333a35d55">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/2cc76a93-a20c-4acb-a161-536e309c09ca"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/fc3f7a6f-998c-49e6-a1db-2be28f9c4aad"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/45545b80-5de4-4f89-a5c2-e838342c95f9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/fa90b7d0-7fc5-4085-8958-4f9ef9987592">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/450e7606-bb84-47d9-ae1c-75dc89bd8df9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/ff267ce5-1ea2-4815-ba23-49db89a277ac">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/e5ffd950-0a34-4ecb-aff0-9aafa3b20817">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/983d9e2a-5e7e-4dff-a6b1-317f1c4ea423">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/511e9506-b3e5-4d5d-90b1-5fd7c383825a"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/1d042c23-6abc-465a-bfc2-bae36b311e58"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/9ff59ad5-2644-426c-9f64-fbf7baa4b584"/>
    <rdfs:label>cimetidine-mirtazapine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/47b1416c-dc9d-4d09-9c12-29c6089d1e47">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/71112a9e-1980-40d3-b459-231556eee660">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/349ec9ad-81b6-4a17-8b25-9a7b07217bda"/>
    <rdfs:label>45 Percent </rdfs:label>
    <obo:OBI_0001937>45</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/4a345bbe-9e36-408b-9db6-d60c2918fc54">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/fbfeb74e-cc4a-44fe-9f3e-2b68a901ce67">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/e92982f3-ebf9-4550-b62c-ec9effd642dd"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/6eef1003-1f51-4bb5-932e-2f2768344198"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/bdd196b5-34e4-40c4-a4a8-d712ac0e4d2e">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/ebe7bec8-645b-49d3-a131-b520b3c440c4"/>
    <rdfs:label>Telaprevir-atorvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/ce25df40-3d29-458d-bb70-020e1d85815d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/c3911cb0-19f3-4f26-8c34-7cdd0cb72575">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/01c9c24a-e3cb-4328-9996-4660004fc888"/>
    <rdfs:label>paroxetine-procyclidine drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/de801071-97a2-4936-9858-e67c88a1de8e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/2c801662-2fa1-4005-8dbf-376fa295cf9d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/ccf07320-4601-42fc-b343-588e1c76445a">
    <obo:OBI_0001937>400</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/f90c655c-3a0e-4c47-97a5-511c705d5eda"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/9f3e83da-1502-4415-b475-095bbe350b8e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/b2b02f72-a34a-488f-91de-973ef1e04329">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/172416fd-75c4-409c-bef3-63d937330595"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/cbcd02c6-57a9-4067-a9de-a05389b231ea"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/bff728b1-d221-4c60-9a48-7355aa7359a9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/399de078-131b-4b75-bb1b-5308ec7226ca">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/20eb0136-4f3d-41b0-b39f-1c5a6c26d894">
    <rdfs:label>propranolol-m-chlorophenylpiperazine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/75426047-3140-4a82-b88c-e2d76a45c6b4">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/a12e0f2a-48ad-437b-ade6-a031260de01a"/>
    <rdfs:label>36 Percent </rdfs:label>
    <obo:OBI_0001937>36</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/e58584be-78df-4505-a5a0-063cf2e52448">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/72a5d286-5f5f-4a4f-8f1f-8ebbfd774796"/>
    <rdfs:label>7-20 Percent </rdfs:label>
    <obo:OBI_0001937>7-20</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/11c19a0c-4117-4908-bcb8-bd35a3b20bff">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/63b0c545-68e5-44ff-8908-1f1f4a00c548">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/d62d3e78-e1b3-4ca5-8302-409fff5fe759"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/cd9cceb4-5c0c-49cb-a334-ba0f4ab4af8a"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/7bd0c0a7-8604-4acf-a505-44d46b6319b3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/97c4f8e2-1dee-4ba5-b8ed-56356b5f146a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/62610ab0-0914-4594-aeb1-10d51de89366"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/9d41c35e-b1cd-4af2-bba3-a5cc4af87e34"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/608f16bb-ecee-4a14-91d9-850bdc2beb77">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/4d77cb2b-7e81-42e2-9904-34c1ace5fe84">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/76522839-892e-4cfc-9f5e-c4bc036c0ef3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/22c90d82-9985-424b-86d7-3ffb81a29c37">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/70c517ae-a5c9-4074-98ac-dbaba9ad70a0">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/a936f15a-0d3c-4354-b4d0-dfd6521d4f21"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/d4c85aca-b62c-4f7f-82ff-d908c2fb984a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/55ea1951-2970-415e-b27a-5f2ea1109bbd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/b6f46949-c064-445e-87bb-0aaed8c39a7c">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/4ffa88c5-80bc-4505-ad67-382fa424fb85"/>
    <rdfs:label>135 Percent </rdfs:label>
    <obo:OBI_0001937>135</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/b4ddf33c-c37d-4b15-abdc-aec96fe55a1b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/21a33916-2cea-4423-84e1-b7690ed93bf7">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/c3f77843-c2ec-4838-89e8-8851ec2c9c44"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/ea55747f-40a5-455f-b740-7959bf3c22f0"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/721e29c7-32fc-4979-9576-1782c789d218">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/0a16b88b-02b6-4fa1-b721-28bd41378d17"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/d66ed95d-d5ec-4887-8197-31fdb659435a"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/009d9ae9-ff25-40e9-af29-a8d1e94c7b62">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/de78fed4-180b-4af3-be57-2e2c0159c414"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/506f137e-e01f-44a7-b61b-899d32aab1d4"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/d66ed95d-d5ec-4887-8197-31fdb659435a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/eb81aaa0-5376-4cba-abe5-2ea8b3af1fa7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/5fa7297d-9ba9-4c44-9d4a-fa99504fb5da">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/dcfe8541-7b6e-4f8c-98f7-efb9c55838a1"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/dbf704eb-46d3-4073-aa67-5ebf4b7a1d22"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/1452f363-d4e7-41f5-827e-cb578267ce0e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/d803d58e-b9e7-4784-8961-bfe866a60345"/>
    <rdfs:label>fluvoxamine-duloxetine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/95998749-941f-47b7-86a0-83b5ebc4ad75">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/04b9cc00-a362-4b2f-a1e8-6099c4b04c59"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/78b57279-326e-4b64-989a-f062a5f036cf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/c272e1e3-d41c-407b-8160-abe9b5a1d85b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/2309fe6f-1ae2-4dfe-aa29-581b0b77d59b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/4d77cb2b-7e81-42e2-9904-34c1ace5fe84"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/75eb76bb-5604-4ac0-aa9d-db35fdccd8e2">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/37d5462e-3f8f-40ff-be03-84b9ee194ab5">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/cebead08-4750-4ad6-a0b5-f86b8eb5df36"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/d9ac85ee-0f34-43fa-8c8f-2dca2e6df57d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/707513ce-65d4-442e-acb9-7407350a7f1b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/54749b2d-8a8b-48be-ac19-a3435ccde343"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/e9d7b591-6e5d-4503-ae8a-a29a919a6e4e">
    <rdfs:label>paroxetine-duloxetine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/59bab93c-79b3-482d-b5e3-200e0a0d13be">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/c8522f74-0c5b-4ae5-af40-9f8dab5d1aa7">
    <rdfs:label>ritonavir-bupropion DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/0a4ff77a-f1e3-43de-b104-166d660268fe">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/9f445c68-59ae-41fe-9f0a-1aa7493b2819"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/869cbee7-65b8-4f78-be51-233d6b146dcf"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/c5bd63de-c90d-426d-a1a1-ef09f1425ae3">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/85d0f105-a76d-4804-9c0c-29e32e05de48"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/92f266c3-c283-415f-a78e-eb1d3d21c6a9">
    <obo:OBI_0001937>30</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/4359bb8b-0c09-487a-bf9a-7b5c24a6fc79"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/889a3446-bd5e-4239-ba05-e249f0a0ebc3">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/3358fd7c-02dc-4608-9c75-85b415cdd565"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/0f736132-bbcc-4ecd-88b5-cb53a8f4dc6e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/6526f915-b403-408b-bdc1-41411ad71ec5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/31ba1037-831b-46e1-9eaf-8cc10c75be6f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/746ea678-305c-466a-a791-6b6b73ded7e0"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/acb0c86e-e4cb-43ba-9180-3a590451de6e"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/140813c0-f7c3-4c15-b466-53ae7dcc8927">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/d39966fd-dc40-4daa-bbda-19e3fb7e8b01">
    <rdf:type rdf:resource="obo:RxNorm_74667"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/7b7f8a6c-5ebf-4bf8-8abc-789fafcf2f33">
    <rdf:type rdf:resource="obo:RxNorm_15996"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/c4a9740f-fb33-4dc0-8f84-ffd15cb27d8f">
    <rdfs:label>paroxetine-P95 DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/533beb5e-811d-4134-bb14-dfee33da2739">
    <rdfs:label>LPV/r-Midazolam DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/cd4f220f-004f-4191-8135-ee312b8081bd">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/827b07ed-f768-41b8-97be-a8390023a545"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/334c266a-37dc-4c4e-b974-a4d00784e86b"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/6320dc49-dcbf-4b6e-aade-bd1d137c42f0"/>
    <rdfs:label>buspirone-mCPP interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/73371035-838f-4e33-8e9f-a17c4dff5b3a">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/191762fd-3767-44c3-a0d0-f4bae4eb82b0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/030d2075-b132-4f5a-a8d7-fdc93e36f7a7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/6e51dd3f-b260-4b8d-99f7-e7b0f5512836">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/319df08d-419d-4905-810e-39748b128047"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/f910c5da-1583-4186-abd6-1a581c73d3e3"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/1900f851-7cd1-4fb5-8d15-85bbaa0f5618"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/2947d4d5-11f1-4f4b-a30d-1d2f249a4c62">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/fc3bbacd-c3c7-44e5-83cf-b4af74e93f05"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/b49f0bf9-e73c-465e-9c59-98d4bb8fdef5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/88071883-a246-4873-aa02-5e0748181500">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/bdd196b5-34e4-40c4-a4a8-d712ac0e4d2e"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/1dbb2858-d0d0-494b-abb8-96b5e9a5fb95"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/79166b9a-3716-4e77-bcd4-126a7bd0597b"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/03a59941-f2ca-494d-98f2-edc6e4ac1453"/>
    <rdfs:label>Telaprevir-atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/377a176b-529a-484c-9c25-42ae427d8fed">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/dd131d51-4f5f-4ea8-a590-83d6a331c3aa"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/7be36750-340b-48e0-ab24-8fbf6bf936f1">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/fe31ccec-2a15-4f75-b769-af51e53e4bba"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/7d1a1627-03d3-4995-8ea6-be7591ba981e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/172b4026-595c-499d-823a-e472d0da9242">
    <obo:OBI_0001937>400</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/b578a8ee-2d25-490e-a9f5-8aecf46d6f40"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/1daa8ac7-b374-4f80-83ae-85c248ef21d0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/abc66e39-2ff5-4cf6-92a1-db7b894ee868">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/698d379e-8894-46df-83a6-2e46a7ca4053">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/e619c50d-8cfd-4f8b-8ba4-641923290a29"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/25eab861-4108-4823-9b9e-5d8890dac2d7">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/2630c414-003d-493f-a65e-a722f92ad884"/>
    <rdfs:label>95 Percent </rdfs:label>
    <obo:OBI_0001937>95</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/17cb0e1d-93c0-4c21-9a68-9bd8f4031cbb">
    <rdfs:label>ABILIFY-norfluoxetine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/bbdee56f-61f9-486d-9eac-c3b6e72ff2e8">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/1bfea671-896a-4987-9155-6a29cfb646e0"/>
    <rdfs:label>Amlodipine-Atorvastatin drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/c631837b-a385-4c59-bbee-82f04d32d7eb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/20f02162-ae8e-437e-bbe7-c16532d0323a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/5afd6b9b-b94b-4607-b8d0-5396c0c4fad8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/c914ecde-273a-41c3-8ec7-c9af345e2d86">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/0c0b1a9e-3799-4a2f-b030-32af17400e52">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/ccf3f0f0-140e-4105-b09c-0ab9e14efc23"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/e8a4d093-ed17-47db-a80e-15d36520a275"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/f27b9271-2079-4b2b-bed1-a5bafbc56e07">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/68fd75ec-3d6a-42a8-985e-8ac5922a7389"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/ba832875-ba1b-42fe-aecf-626624052c29"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/3dcade90-00c8-4712-8693-aa5de10dacd8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/81a902e7-1ba2-48ec-a880-84f5e96df5bd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/b863a93a-3081-4119-896d-ecacae0f6c9e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/c5a5aadd-ce49-491e-9b6f-ea00db8818cf">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/ea5c0987-7186-4228-adc6-9fe29be5227b"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/8701e0f6-63da-4ac0-95b5-c88a1b613c0d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/16e1c976-8f3b-4933-8978-1a1db04ffb46">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/d74b1fba-f048-4513-a915-7c99fe37e5d9"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/ec204882-2fde-4363-ae7f-d8b5af9eb5f2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/65afed72-2397-4a88-a150-e4489eb99419"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/7f23cef6-d7f1-4648-8c51-470c840112d6">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/22c90d82-9985-424b-86d7-3ffb81a29c37"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/46ca7b6e-2619-4cd1-ab39-fa8740a9c510">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/5f4c967b-ef7a-44c7-9c6f-5822a8d9e36a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/4dd19258-288a-46a0-b4ae-6e1706d28e2f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/a4bbacd2-66c9-4b75-8648-d0e75b25a236">
    <rdf:type rdf:resource="obo:RxNorm_8331"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/34e8b2e1-e67a-4721-b5c0-9511c6a01834">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/1aa6659e-0ac9-45cf-be9e-e339dde8c5bd"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/8213fd46-b4d2-4475-8685-e7a5111c7aef"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/acfc5e90-5bea-438d-b15c-95f9fa3b8538">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/c42ef09e-b6c1-482d-a6d1-370fab8ec880">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/ac2c2381-8719-4f1b-8dea-a992d7d165de">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/45170352-85d3-404b-a98c-b170bce6f4f1"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/e798ebcd-bb24-4bfb-baa0-8624dab9a81c"/>
    <rdfs:label>fimasartan-atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/fe2a58ee-1dce-4679-8d8b-81f8f68c4dd4">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/0b045096-4312-42ee-b0ba-c5113456b9a3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/01a1ff41-b12e-4530-a985-f2c3e4abe1a0">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/02623eb3-325a-4448-a3b9-23074fdeafc3"/>
    <rdfs:label>escitalopram-desipramine drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/4094acc2-47ec-465f-8904-0c7bf59298b8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/eb94032b-7dbe-4b76-b508-5fa9b59f9224">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/4c78791a-0ccd-4762-9c3e-1234cfcf06d6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/847d0593-eb6b-4f13-ad27-e0e7319c9dea">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/e4307dab-04a6-4421-9d18-2f813ca78a39"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/dd90d421-3b64-463b-92ef-bc7a0353f68e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/abda9fe3-3ec3-4e77-bed7-f66b989ba770">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/99bb77b7-7b53-4594-8c9f-8244741c0a22"/>
    <rdfs:label>Erythromycin-Atorvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/ebe741d3-e4af-409e-8eb4-05f2d820ad15"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/19ff9f75-dde9-4a37-a355-5faa1874b3ae">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/d552e71f-4844-4153-b796-a3cd0a4c6345"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/1a9ff2ea-2a68-45ff-b998-ad49daee1709"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/455a83ec-2e0b-4e22-b6a2-71141a3f5fb2"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/605b9863-0b23-42ff-85a3-09bd113088f6"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/ac352281-b1f1-4985-af9a-aa3982c93c10"/>
    <rdfs:label>fluvoxamine-duloxetine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/417bca06-f461-4cd1-932b-d576b0dd1c99">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/bcc8063e-583a-4b27-ae14-2fd3dbbf5a63"/>
    <rdfs:label>ticagrelor-dabigatran drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/579793eb-5b25-475f-acec-2f6d58d5a474"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/12522873-3ec8-4208-a61e-66ff511acf52">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/3f1b2f51-47f5-42c6-8d57-411822ad0d3f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/2c49b9ea-c68d-4290-ba66-a2440ae47a5a">
    <obo:OBI_0001937>Unk</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/130ffa5e-1577-4f89-9622-c193f8d9e8fb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/0447b9dc-6ea6-4f19-a4b9-fb04aae2535f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/09a528dc-653d-4c4a-9fe8-2174e30c474d">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/d97fa22e-8ecf-4b5f-9898-ee5aa33a570d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/2897fe2a-5981-4219-95b6-05b3dc2a88cb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/5423b2e8-b957-4067-b004-7225e3ce3166">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/f3976ab0-27fc-4d88-81f4-ee63085c559d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/afccb4fe-990c-43a7-8e6a-1850941ff070">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/4995098d-62a7-4688-b4d4-eda9ad607532">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/b75b4f63-a8dd-43bf-93f3-48755eaa124d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/d59e4976-cae5-4135-ba72-80fdf7359425"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/89445cde-7aeb-4943-8730-f26980cd376d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/7276125c-d6d9-4a48-9665-997357695418">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/ce757ab7-2e5f-40fd-9aba-197025b810f2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/9406109c-13cb-44f0-841c-1507309cf0c9"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/26efcdff-3d0c-4345-a89b-94522271b4cb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/dd3ac1d4-80f9-4dba-8460-5d1b644f1a39">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/36228cc3-b98c-4d8e-ab9e-ea1c2fdaae31">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/b18727b3-22e8-456d-b84d-1a653f9121f8">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/cb5a0e46-896f-47a2-8d78-b04d1e85d55e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/1704fb0b-ef04-4ca0-a056-f9bd2cde9eba"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/3d8602d3-514b-4026-bdd3-1452bd6f33dc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/add76ccd-5890-43bf-8e9e-34e5e18ad557">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/a48d83d3-b6a1-48ef-8d46-3078982ed13f"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/a0b63470-1c02-4d81-89b3-1be392a004d3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/96fba297-0d01-46bd-b7b8-79c560fe5324">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/a026d260-e887-496f-8c1d-b6e3024cc381"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/ee035928-8bc4-4a52-88b1-886b10010d27"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/66571f08-4c0f-41bc-99fa-ed7c06842e76">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/c5cb4c08-ccb4-47e8-9516-74dc89453f60"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/b90f69f1-4682-4695-8527-138d9d8d5931"/>
    <rdfs:label>ciclosporin-alitretinoin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/e2bc8818-d621-4b1c-b39e-7ca52e0d3306">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/33f9778b-c9f1-4258-8578-b87c8893f666"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/02836239-35c6-435f-ac6e-4cc26b49d1d6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/4cbcefea-be79-4b15-a4fb-b2754138df59">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/fb575cf9-08ac-4a41-868f-be2a62b5f05a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/011b5810-9ddb-44f5-bded-e1c509c67b6d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/114564e6-180c-42f9-9a67-773dbdb90d4f"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/fcdfc4e6-3131-4ca5-a7c5-58587da97652"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/a1549f0f-0cdc-4573-87a2-ff958570bbef"/>
    <rdfs:label>fluvoxamine-mexiletine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/b0a12521-1b2d-4b63-a851-4ad9290fafd9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/e31efd3f-ea4f-4082-a2e3-a9f59fc20255">
    <rdfs:label>Lovastatin-verapamil DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/025e8e7a-15de-483e-9f28-e7cf12aa4116">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/c709a01e-017e-4754-98f6-aa58a1f86925"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/772320d7-b759-424f-837c-29ca2671fadd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/63ab02a5-866b-400f-a1a2-0f68e0b4ca26">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/bb83af92-8e8e-4770-ba7b-284f255cca85">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/ff5d640a-cb90-420d-bba5-7d478e9014fd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/4ba49e51-edb6-485c-9cda-25be25307816">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/fb78a1c1-c51d-4d1f-bcd4-e5a4cc3e4616"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/e4da6686-88b7-400b-b7a3-97e2dbaead54"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/13838d4c-6cc6-4bf7-b673-69809c45fa6b">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/ff8487f5-7b22-40c6-9c4a-ff16ccad9883"/>
    <rdfs:label>2.1 Fold </rdfs:label>
    <obo:OBI_0001937>2.1</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/869cbee7-65b8-4f78-be51-233d6b146dcf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/5cba0dab-757a-4a83-8ca1-85c89db971a6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/2ad58ec1-f9a6-427b-8a68-fe772b2cfcab">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/7b144301-0538-45e6-b2e8-63915374cfbc"/>
    <rdfs:label>16 Percent </rdfs:label>
    <obo:OBI_0001937>16</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/7b1e1995-dc2e-4792-a43a-5df9f8dc1e22">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/2175e104-b48a-4547-9933-a56f8247ae23"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/ec260ab9-1876-48c5-b44f-43c0d2573cb5"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/83c31f4e-f1c2-40b3-aad7-510be12b8fe7">
    <rdf:type rdf:resource="obo:RxNorm_42355"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/7db7c99a-a774-4b6d-8eb8-20dd037d636e">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/49602561-e0ff-45c4-923e-1aea269ef1c1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/798683e2-5efe-4069-ab03-1eba9c660bfa">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/77446eaf-81e8-4953-85ac-72378c9cd2b3">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/f568e1ad-a4fb-4a04-a90c-41bcc623bdb6"/>
    <rdfs:label>1 Percent </rdfs:label>
    <obo:OBI_0001937>1</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/e798ebcd-bb24-4bfb-baa0-8624dab9a81c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/9d3fbe02-7e60-42e6-b6c0-56134f474792"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/9b3e533a-b388-4552-9e95-75b352617c01"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/ef3d7e7b-bc67-4685-953f-a48ac8708709">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/b0f48d47-d081-4509-8c7e-3d220a819ffe"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/fff50b05-231d-457c-81be-8a2104bba01a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/9cb3e1df-85fb-424c-a38d-73b2aa027564">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/ee60718d-3aed-4b86-bd41-56e19e5bae97"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/14ba3217-9e86-46cc-9394-4a2afe2bd1ec">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/f803dc0c-4d33-49a2-a53b-dcdf6d6ca8e2">
    <rdf:type rdf:resource="obo:RxNorm_36567"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/48c93ad6-97b7-4f47-bdba-3dd4e8c9919e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/00d9fb93-2119-4496-89d1-97925bb2d3b5">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/4b49aab8-b60d-49ee-8998-d3ab2820c715"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/ba6c83df-14a1-46ce-9f70-2208e8b51765"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/e481bdef-a256-42f2-b045-92903111c818">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/8632a552-a5c7-4ca6-9a2a-5bd214b6f669">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/de78bdc7-3d23-4933-bd6b-4d1d972a24fe"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/26efcdff-3d0c-4345-a89b-94522271b4cb">
    <rdf:type rdf:resource="obo:RxNorm_4493"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/8d72f15a-7644-48ac-abcf-8e1a302a063e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/2398b37b-04f8-4fae-a865-be50faf45e65">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/4db0ef58-57f9-43f3-ae7f-2cf4c048a946"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/d162fb65-d43a-4eba-b588-9f2ecc4a2715"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/76647eff-849a-4966-bffe-35bbea065c0b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/95d197e9-c907-4ae7-ab14-5a414a7dd9c0">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/b2277bd0-e2bb-46bd-9ffd-d0cb1cab4e2b"/>
    <rdfs:label>32 Percent </rdfs:label>
    <obo:OBI_0001937>32</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/c7ef8258-2459-4577-992c-b4de90921d47">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/909df765-16ae-4e11-b000-9348a0146a2a"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/15da2910-c45a-4616-8af7-5333dd1081f1"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/146b3176-b123-4e26-9abb-70dfd55c154f"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/9aa5d131-7ef9-4ef6-a3af-75dff0799df7"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/c750da45-20fe-4cd7-9b06-f030886cbb4a"/>
    <rdfs:label>Gemfibrozil-atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/b71d8f60-c43a-4505-88b1-2c8ca18e29e0">
    <rdf:type rdf:resource="obo:RxNorm_1114195"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/e806ccc2-cd43-4ddb-a40f-be2cc44a21e5">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/4391fccb-d723-49cf-9db3-5030bd7b946b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/62c8d43b-7c35-47d7-a61e-0f8a431403cf"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/9a36d0d8-237e-49e9-ac91-3ca4b7eb67d5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/17fbb2b4-b845-465b-86ba-40150a7cb2fe">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/7ca38953-76a2-4c26-b930-013d9538a206"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/4130df86-0991-49fa-be01-81cdf2a993a8"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/0c5cf354-a855-469f-9b79-c147d09ef90b">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/98720410-2cb3-4b34-930e-847a25d5a836"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/85af2864-c95b-4c7e-9847-19474c4e53c8">
    <rdf:type rdf:resource="obo:RxNorm_114289"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/cc8d8b62-1ead-4b69-9d49-ea71e71f2b8f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/c8636f34-740b-4aa6-9bd2-0544c8f8392f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/5da0b401-5fea-4428-b027-dd4f488421e5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/8ef626ce-e1fa-4f04-918a-09ab65310905">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/86eb13b1-7c37-4aeb-b083-8df996dac6d8">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/e10237fe-bc99-4e77-935e-548e1be8d35e"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/2f89817d-e7f0-47db-85bb-3b8672deb189"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/177d9c20-ca61-447d-8a7b-fc0188b26d59"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/66a87868-5e11-4c51-b903-241c5b9863ea"/>
    <rdfs:label>fluvoxamine-ramelteon interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/092fc3f4-c3b2-446b-b74a-2c80344edc4b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/2aaaa38b-1972-404c-bba8-13fa8f527b62">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/d61a9e29-8468-40f5-a234-e9c9f9f84381">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/f086a17c-d8f5-4a38-823d-858043081877">
    <rdf:type rdf:resource="obo:RxNorm_115698"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/b1ff57dd-323b-4e0f-8193-6603d711b6d3">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/8ba14766-0846-4bb7-8e24-99ad22371436"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/1e8a89e2-45e9-46b0-8366-89348eef619a"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/9ddced42-d13d-4ad6-bb4f-364e93608328"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/61d34d41-a36d-49fd-a654-a262e6ddd7d5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/c5254f16-86bf-4b98-8a29-970b7fb34afb">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/00f63835-7018-43aa-b540-4a27aef63ea4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/0badbc2e-7590-46f3-9613-79e722331ad8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/b7021151-dde6-4c57-be86-5f3d3badb23a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/0aeef77f-baca-4ed4-8736-ba04dbd18400">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/326cc1a1-731a-476d-81a9-27a2fa4045fe"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/65ca00a8-5bf6-4fbc-a62e-a8ae86603053">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/26f78317-7f73-4f5c-a085-0eb618ac47f9"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/16b4811b-55b7-40f2-89a7-b4bdd4a5a7d9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/27977aff-b023-4137-a531-08bc6b98ac54">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/dc331968-98ec-469f-a0d2-045422142157"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/fe2a58ee-1dce-4679-8d8b-81f8f68c4dd4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/b102910f-e7ec-437c-b726-2f5a39a9e2fb">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/d5c42dfc-d6c5-4637-aefc-8bc8c4c8f488"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/eb987b81-4609-4422-926e-dc6eddab6e64"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/0f77b7c9-9ff0-48e3-b7ab-4b21299d01a8">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/8f2d9564-97b2-4624-bc43-d2535b8e533c"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/a1de9c7d-3504-4090-9511-b2592024d542"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/e1120b05-ddbb-4e1d-865c-583da3d39286">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/ff062a23-49c6-4a59-9f2e-a3f7074ab68d"/>
    <rdfs:label>27 Percent </rdfs:label>
    <obo:OBI_0001937>27</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/2e4de43f-8ab0-42b0-b867-8f824b0afa6c">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/351e58ea-da80-421f-a439-2a6f0bdf6137"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/a9a1ca53-c8ba-4430-8ac6-b64b528da916"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/22949a6e-bb3e-4a50-8959-280c8b36c2eb">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/651987db-e0d3-4cc2-bd76-3d4dbf263b13"/>
    <rdfs:label>midazolam-rivaroxaban drug package auc  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/1d522d5c-b60b-4f0e-aadf-be2a5108e118"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/201160c2-1488-455c-b5f0-27d99d0a9ca0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/be36a2c7-33dc-4a6e-97f4-ede414041b58">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/a54c0a71-85ea-41d4-b161-9722d37523a0"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/3c48bb63-2eb9-4b90-aeed-c7456d502284"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/a5ed884f-4337-45fb-92a0-1c54d9b3cd01"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/2adda992-9712-4bd8-83c2-2910c5b8e484">
    <obo:OBI_0001937>5.2mg/kg/day</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/03c6b76c-13f0-4040-9eb4-4d1e7fbac5f5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/756fad09-36af-47ae-af6c-626753ae74bc">
    <rdf:type rdf:resource="obo:RxNorm_683693"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/e655fa8b-8503-46ae-9d5d-babff688cb51">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/928af2c3-7965-45e4-86e6-55463e56ef9b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/a0560c5d-a4b8-4173-bad7-a3b363789fd2"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/15335d5e-963e-4a90-a0a6-5e77e354f10e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/97e58806-350f-4b32-8e11-77abc38fb9bc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/92c536f3-cb9f-436e-9280-c42318524f5c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/0bd1bf17-56b4-4a00-b263-f29333e3ad60"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/8c999da2-8089-4851-b4c0-6cc49b1bf816"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/4e8bb059-5742-44d6-bc52-0fd89f5e18df">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/6a34b7a1-c9a7-4b68-81f3-df3b76f4e77d">
    <rdf:type rdf:resource="obo:RxNorm_10767"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/2a7c0a3c-4531-4436-83ec-aa5a266c8860">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/82efb2cc-00e8-4104-b709-177c65f4cb1d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/332822bb-af22-4675-ae63-c57be5b00133"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/977170d1-74f5-46f7-90d7-87244f6e2011">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/552238a5-5cdb-4ea4-85f4-da12e1af11a8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/00f00a7b-996e-4809-b087-63e06d0e65dc">
    <obo:OBI_0001937>750</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/f9bab027-4c76-4bd2-aced-4cbdf15d6554"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/1af81fd5-92ce-444a-9429-e3b892650d7e">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/d100ec55-897e-4b57-854d-b62e53003035"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/ad03202d-2546-4002-9537-578e1108fd58"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/c074039b-1b7b-4cad-90d9-d177fc0d9500">
    <rdf:type rdf:resource="obo:RxNorm_10502"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/797bd6dc-9240-48b0-ad9d-3fb184074020">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/9abacc5d-7a29-4dcf-b6c4-8405c74c60ea"/>
    <rdfs:label>duloxetine-theophylline drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/e58584be-78df-4505-a5a0-063cf2e52448"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/2cf65b13-1ff6-45d8-a4dc-d926a01fb959">
    <obo:OBI_0001937>400/100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/972bf20e-1e87-4bfd-af68-f492cba21d18"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/d09a48fd-0a8d-43c5-880d-089d259e7c4f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/8fdfb1b5-7651-4602-aabc-fd960a0b29bf"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/9ecaf000-68fa-4b7a-942b-e8b320eb6bb1"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/7f696970-eaa8-4db3-a0b8-20cb46c7958e"/>
    <rdfs:label>nefazodone-haloperidol interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/8dee4a97-d2be-46e0-a7fa-d91ac25de307">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/40d5f9ed-f8e2-4a59-91ea-0645e3a6b25b"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/feb84155-c229-423d-a2a2-dfb3d8c8ce64"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/f568e1ad-a4fb-4a04-a90c-41bcc623bdb6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/1422b470-b21a-4708-9fdc-f33b89cebb63">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/a5923664-afda-43db-9d14-d79725e147c1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/91de1ecb-9c78-43c0-b8a1-c19628998b0f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/e2cd6ac3-3bc4-485a-b7eb-8f2b17e23e37">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/31fbfcdd-7972-4d89-9966-4fdca026ec87">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/cb7fc37b-a028-4a9b-b3be-10ec9e1880a7">
    <rdf:type rdf:resource="obo:RxNorm_36437"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/770a13e8-95a9-440b-9033-68784306e99e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/659ff95f-c8b5-412a-9ac2-1df5bd9faf5c">
    <rdfs:label>rifampin-zaleplon DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/dc61e4aa-d60e-4a88-ba86-f45f1f7a6077">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/ca1888fa-ef95-4d79-8ce2-d205107e828d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/4a41ac09-3ebb-4482-9f8d-f45cf47315c8">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/3f9ecca2-3692-4540-8489-df0eb66040b3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/0972f2c2-e2bf-4f0c-ba22-092e2788d0c5">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/2f4a3939-e4cc-44c2-8f9d-47f7764498c8"/>
    <rdfs:label>10.6 Fold </rdfs:label>
    <obo:OBI_0001937>10.6</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/4e89237f-93dc-421e-8e7f-b1d2172870ea">
    <obo:OBI_0001937>1</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/99a1d7a4-f49f-4a87-8dfc-8752cf1ac791"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/ca94f194-4446-4e7d-a097-9e1d0b0b65ea">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/f6447974-109c-4d0f-b346-9c5f65bbb134"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/0eae54d0-6cb8-4001-95cc-e24a17ed32a6">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/cc441086-6129-4202-9d91-7f33afe23aab"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/8ac530f9-f76c-4c2a-8747-600e99f2e22c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/c81c1a11-cefd-4aa3-84f0-397ac2ff8b17">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/12de81a6-3648-4a56-bf6c-8cea9e7ffb1c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/97a4b625-2ca2-4433-93df-cd9bba4f7387">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/abb2662b-2d82-4071-97f0-d158bbe13055"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/f961b9a3-f001-4c4e-9de6-7db44591e0c6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/597c005b-6f01-425e-af97-dc3ca830ff94">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/3ced53e9-137e-48d5-bb34-6858aa551448"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/8a0d2674-f8e9-4dbf-949d-10dbf3e97d65"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/00166dda-4151-4e12-909c-be76141f4d40">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/a9cef03a-7e7b-4316-9aa2-a8d11d939151">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/64b9abf7-624c-4c20-a287-fc7173df7ed9">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/8c380678-4ae1-4d6c-a238-3f7f887e1489"/>
    <rdfs:label>rifampin-zolpidem drug package halflife Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/75426047-3140-4a82-b88c-e2d76a45c6b4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/0d8af8e1-620a-4104-99cc-5bddb9c27e85">
    <obo:OBI_0001937>150</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/9282f6fb-ebfe-4592-839c-a980cf42b533"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/2c29fa61-5ee3-4965-a977-5cce8d877312">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/101f253a-b29f-4b52-b29e-48e9ed553b23">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/3521ff69-177e-45de-8fa5-daf5b4b93799">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/a91d9641-1dce-4a46-a36b-74bb3901c1e1">
    <rdf:type rdf:resource="obo:RxNorm_6960"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/0b1922bc-00b9-4884-9f9a-ac76f943f50a">
    <rdf:type rdf:resource="obo:RxNorm_31565"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/9ee01733-584c-41c8-8e7a-d50c2eaf9250">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/8f39a909-4822-4607-bf10-f0d5de7dbfb2">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/9aebe8f0-2567-4994-bd35-8c86095f445b"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/d5e259a5-dbd3-4007-b168-aee7d4e798bb">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/6d65d0df-1472-4804-bee3-57653f99ec44"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/815051aa-bdca-4cf0-818d-251e746b9672"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/29b947fb-4b5b-4489-9071-f8b58c0e1af0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/29c638ec-b536-492f-b855-13cdaffb894c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/4186af21-30f1-45ad-aec3-c9a7ee8599ac">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/68e4d3c9-8e81-41cd-8410-7b838eddf3ce">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/d4fe804b-e53a-435a-a606-6725234d45bb"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/a2adcb74-dedb-45c5-bbb2-0092926eeae1">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/1fb011a0-0c07-4fba-afbc-d9e08d409fc2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/09bb1d01-36e6-4b91-8310-830c8f83c434"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/8dee4a97-d2be-46e0-a7fa-d91ac25de307"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/d048690f-33ba-4dd0-aa8c-e1863115c57e">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/321e6c43-84f4-4736-a961-f269e51e4d1a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/5f4c4ec9-765d-4a88-b712-ffe9022fca79">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/2c39010b-43cb-4591-86d0-cb2c4debfff2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/39e6c0f6-40f1-4369-9a22-b5fc80f2f75e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/1d9f8cdd-f40c-4be0-9987-84fda409521e">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/90fa1e19-0be0-4720-9f1f-d8be2b379a4d"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/4bb66ad0-003e-46ee-949d-500fb4508f8e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/77521af4-36ba-4da5-9672-43651476923f">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/1218f00f-8dbf-449f-b8d9-762696d58c00"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/b86b9b2f-b24f-4789-8179-0591705dc02b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/532c9f7b-0445-4300-99a5-67c05131f64e">
    <obo:OBI_0001937>800</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/33f4f726-af0f-4e96-8b5e-cc8a27ff6242"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/bb0d51a7-77c0-4497-a281-5a9db0f40378">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/880d81c3-7492-4295-8f19-4a8b73c26bd5"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/7d786cbf-17c7-4839-b1cf-53d37cf6d828"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/7db12fd6-7c0b-4ce5-82b7-2ceb45290a25">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/6c75506a-df3c-4530-aab1-7edd8b38ea3f">
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/1e6f23e4-430c-4be7-8038-4f29930fbdae"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/7e5d84da-6448-47b0-91d2-4c5b7af98aeb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/51e10f91-c045-4d75-8ef1-7184f838a050">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/2af00c66-e022-402e-9166-8905364065f6"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/c7844e9f-da43-4cba-9c17-0ef6c30c729c"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/101d19c1-e97a-4257-a6d3-329d797fb221">
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/82416dce-ec44-4723-8ade-6da03a746b3e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/514fcee1-356d-4e29-9193-dc45cc7c7f1d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/UO_0000022">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/4027ba9c-d80a-4930-a036-329e4679944d">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/cee3fe92-d08b-4a5a-ace7-8a85bbd18cf5"/>
    <rdfs:label>3 Fold </rdfs:label>
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/870e5b3d-b047-4e04-8160-bcc1987fa059">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/a1549f0f-0cdc-4573-87a2-ff958570bbef">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/20ddaf8b-6ebc-47d2-a261-27109382872e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/60f2f059-f822-4b96-b837-2f62a1d1005f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/99ef20cc-4d1b-4b08-9c39-15ab0f508f29">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/3f2b89be-5fb3-4e2d-9a34-287f0fb6af5f">
    <obo:OBI_0001937>150</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/ca1888fa-ef95-4d79-8ce2-d205107e828d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/f904f503-2c21-4094-a135-a556f61a92f8">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/90b2ddae-60f5-4333-8167-e03a4eb29053"/>
    <rdfs:label>efavirenz-hydroxybupropion drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/4a2944e1-a53e-4122-ab0c-cc05af2a727d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/218824a0-3a64-403c-8282-ec7f37620ea3">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/6196140a-b5d4-46e8-a47b-7ce4006bbd90"/>
    <rdfs:label>0.97 Fold </rdfs:label>
    <obo:OBI_0001937>0.97</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/fc5faece-cc65-4a3b-8e8b-a5639ee2deb8">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/99607a14-c67a-4bd4-8ed5-acf16ce6225e"/>
    <rdfs:label>rifampin-pitavastatin drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/36280d77-29a8-44bd-9b7a-54ca1f68e463"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/cfc95d77-c974-4bef-8a7f-465cabb4563d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/8f5c0072-f802-4b84-8fcb-46ee8b9a268a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/c083781c-9d1c-4742-8157-02040667ab4c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/30a6ffa5-e89a-4c8b-8f13-52d57b5b5adb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/65438dc6-7f29-4e47-b80b-dc0b86ac283a">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/de47395b-117e-4a19-ab97-81e7098191ca"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/9a1cfc29-d7b0-47ab-9b33-d771f9571776"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/84dbfcbe-75b5-47dd-92fb-53beaca1d3ea"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/72fe86d6-9edf-4bf9-ad43-011a64330122">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/c46e05af-0867-4450-b08e-9ea65e3cba1b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/e0d5774a-0705-4385-82e7-3ffc78ff2d7d">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/879f5557-95f0-466a-9610-420b461a3275"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/f29a1755-b99a-4807-9e10-a743b501fca4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/96754039-e998-4309-b66e-e06b85400184">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/8f7e7ef4-da6f-4930-a53b-0a309ac7b788"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/2bd0239b-08f5-4532-97e1-ed40d0570808"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/08f38622-51cd-4e83-84aa-68e6f988b4cc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/afd6deb7-88b8-4cce-b85a-65daa401619f">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/2663f552-9701-4cb9-9b80-b521c3791da4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/35c344f0-8b90-4391-b049-275019162be5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/a07fe148-9839-4ba4-9437-bec4b3732ae3">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/972ac059-27e3-4550-9494-9ac354989ea0"/>
    <rdfs:label>duloxetine-desipramine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/c4e024d9-4747-41ab-a16d-ade4a5679e1f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/10b847c3-3be7-4e2d-96c4-122715f11788">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/86a6fc05-80d1-4d50-83dc-1589ce0f1f30"/>
    <rdfs:label>23 Percent </rdfs:label>
    <obo:OBI_0001937>23</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/06cbe583-f05c-432e-a990-3a3cc98896b5">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/87b7c311-f99f-4f6d-ae12-3d9b545f1b3c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/5218cea2-f3b9-4f2e-b5f5-9cfb7a7f5b9f">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/3aa49352-b191-468f-870d-32098dbf3c93"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/b1fb60fb-97d8-4b3f-b753-f593f3b90e20"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/52f5a1ab-1a30-446f-bcca-d8cbf01850ac"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/9636317a-a948-482c-abd1-df0ff71b1cf2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/7238ab7e-5392-46a5-9cc5-f7beb95e6867">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/7c304aae-0ee9-428b-87f6-7185c6260b1f"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/4439e66b-5451-41f0-9b41-81a355d9f870"/>
    <rdfs:label>simvastatin-vildagliptin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/8e86050f-baaa-4c85-b908-55752a16cbf9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/39186783-a458-4371-ac08-4f095949193c">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/412ab478-4069-4443-bcb3-4218a1d3c172"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/4c748bf9-9af3-40b0-8f8c-ae057ddcb244"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/326cc1a1-731a-476d-81a9-27a2fa4045fe">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/4a5297e5-960f-4315-b4b0-8d002c457085">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/2bbef0b8-9870-4b1c-959d-37c4cbb017c4"/>
    <rdfs:label>153 Percent </rdfs:label>
    <obo:OBI_0001937>153</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/8dd7304f-5711-479e-b31f-0d0c44623b84">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/d34a04fa-c0bf-4d16-95bc-eb96c2205d8b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/068760bc-8920-45fe-b206-823b05bb7480"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/d7a00de6-1e3a-4dbd-93aa-d59b961a0b69"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/4b333a2d-ca39-47eb-b9a6-1514b2694e31">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/0cb4c3d6-2616-4f0c-a459-85351ea1a868"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/9b4ca571-e4a3-4e7a-8754-a16428599f2d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/1c0bdcea-eb5d-4ac8-9b1c-bb744dc5c187">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/8d4c44a2-3ca3-4738-827d-71e46d198c86">
    <rdf:type rdf:resource="obo:MeSH_C580748"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/0176b286-4b70-4602-9967-70aecbaa861f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/ae844e39-e2c6-437a-8368-e0166ecbd7c8">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/7b911eb3-e667-423e-9d2a-a5e3d09ecf1e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/2820c58f-2f69-41ba-9053-3ab0bf40e2e4"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/eb1e7239-dfb4-4e2d-ba3f-caad8d38b3a5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/f1e92e4b-55a7-4a2e-9c9b-b8314f88a31a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/5bc2b090-dfad-44dd-9ba0-3ab1b4072b18">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/cbbfc020-fb83-4ac0-a287-11e0a9880810"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/764f6a78-23fd-4233-9bda-37de4aed0e07"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/29c4a2de-1aef-4c28-ae1a-def5f85ec284">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/827b07ed-f768-41b8-97be-a8390023a545">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/6c05fefe-205a-4014-a1a6-eb8ba4b19805"/>
    <rdfs:label>buspirone-mCPP drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/61024bc3-c098-4ec3-871f-0baa06be8728"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/15d9bdfa-24ea-446a-9b07-8a3f20594e80">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/f7b97372-8ccc-44b0-b727-1fc59b55a86e"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/3a988c1c-c663-4db4-91b3-5cc0548f568f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/60004ffb-12ca-4924-800d-f8803f3bd77c">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/a2a25eba-f1df-4a10-9b79-50b86807e99f"/>
    <rdfs:label>68 Percent </rdfs:label>
    <obo:OBI_0001937>68</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/18bfca3f-1b16-41da-b579-b7d1fd32e99a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/d9819726-b799-4ad6-b32b-eab360fc3de8">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/29094c90-af7c-4ed2-9c69-5b54a01efc00"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/f99e8909-c457-421b-8beb-6535e8592cf0"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/bb94fc2b-d6b9-47f8-bc0b-74146dc7403a"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/34eaec1c-f5b3-4cf4-84f4-d8abf4ff043d"/>
    <rdfs:label>ritonavir-bupropion interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/31ad6045-877b-4edf-9324-885b40e1ad0e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/8b005648-c1d8-46f8-bbd5-735e5d18f98b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/153c1a03-2c0e-4598-8a3a-5cd55a0fbe5d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/4dad48ea-6dda-4b54-b233-7065465cf305">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/bceda6a2-510a-4845-9f71-4be9aef3091e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/700e0dec-ac31-4a02-99e0-6265490279e0"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/2a8c1ec6-39dc-4668-94e6-97b2afb1654a"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/6437b3b6-a463-4674-9777-06792dcf2114"/>
    <rdfs:label>paroxetine-risperidone interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/e0027834-8336-4cc2-af03-93d1ce4eca7e">
    <obo:OBI_0001937>80</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/ca6fc921-2153-48c0-a405-cae85a2914c2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/29e437d9-fbae-4b98-999d-219b1197b126">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/438bc012-dd31-496e-ba96-909b9879d4d9"/>
    <rdfs:label>3 Fold </rdfs:label>
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/67289b2d-23ef-44eb-989e-2d1553c9cc1d">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/2d59d852-758b-47c2-9f51-8122730e828c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/acf5cfea-5108-4aeb-b7a6-fc5edefa7329"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/2f7d1c1d-50c4-4a3e-8a22-707acc0b34a9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/be4859ac-84dd-43bc-b6ea-10ab75ec3366">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/c9421994-8946-4d2f-acad-563f6ecda205"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/b656ed9c-83f0-434f-b0ff-fa461f160d29"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/b220aeb3-a2b6-4f6b-b36c-4acd4a06af35"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/5e1d0b27-72b0-409e-a6c1-e39d72643592">
    <rdf:type rdf:resource="obo:RxNorm_72625"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/651cc3bb-9bd8-4d31-94ba-fbb36a8caa6f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/d22c3047-5330-44f3-b09b-d64a655f0dfe"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/f604e706-9e80-46a9-b49a-3cae6d03c596"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/7994c412-dd9f-49eb-adab-39a30940d786">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/7be48a91-cedf-4498-9547-ee74dcfd0069"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/b74ce237-83f9-414b-8091-2cf673c6c8f1"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/0ac35503-cb4e-406b-980e-62b68500bf90"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/15f9024a-1f87-41f6-82de-5adc641f838c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/0143fa48-8d5c-4e24-9c17-32723972189a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/d1be21b3-bffc-4f9b-be90-d8d4bd5fd530"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/8213fd46-b4d2-4475-8685-e7a5111c7aef">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/394de1df-b74f-4aa2-94f0-6590561fb9b6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/0030e5d8-8caf-4d81-9440-5ae8dccfa50d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/b25a7889-bbfb-4bee-b996-39a82508d30e"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/4ae8f50f-7506-4e00-a812-a17ee115169a"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/3142c845-34e3-42ca-acb1-6450a790d2a2"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/aba77994-c01e-44a3-82cf-e81637d4c10e"/>
    <rdfs:label>rifampin-dabigatran interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/28b94737-ead6-4bfc-8d2c-159ef615b623">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/5a4da57d-76ff-4178-800e-da2e9233f276">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/7a1909af-2cdd-4296-89b5-135ce00cde78"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/dc61e4aa-d60e-4a88-ba86-f45f1f7a6077"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/8a59e8df-ab68-41b6-9a76-7ebcce30b30a">
    <rdfs:label>desvenlafaxine-midazolam DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/c9975040-1fa7-49f5-8cfd-07033ef1cadd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/30143a1d-864f-4c58-801d-774486f88114">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/3973ee25-1c99-483e-a7d1-ca2538be5d95">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/4db0ef58-57f9-43f3-ae7f-2cf4c048a946">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/60097dc8-9e08-4abc-92c7-57fef5079dae"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/7871f471-e568-4c7b-9194-1c9014518bfd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/2285042b-89e4-4373-bda2-628fbb85a4cc">
    <rdfs:label>erythromycin-rivaroxaban DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/6fec0f2b-00c9-4943-b75d-748524793db0">
    <rdf:type rdf:resource="obo:RxNorm_6135"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/1cd1e638-7481-4e54-9321-70d06e2eeb58">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/9a93f1f9-c14b-4884-bee1-95da39ac9f99">
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/78c31c8c-2769-417b-a691-bf837a8663dd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/a9043a72-70fd-4ecf-8263-903117b53991">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/df3f2949-bc35-4983-a620-593bf434f103">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/6703524f-6159-4068-8e3e-3c2811c344a2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/00cffb6b-770a-451d-9c99-e07793426559"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/4f863644-5569-4864-bcbf-69abd8014b4d">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/c5b10008-2210-417f-8d80-bf40ad20bc6d"/>
    <rdfs:label>Nelfinavir-Atorvastatin drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/62cef6a3-a179-45f7-9bd5-be7ea5c731f0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/63d3289d-5f15-4c3a-9664-26fd1bea94d4">
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/f4b10917-af2a-4091-b812-407497686f78"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/21e65450-56c9-4f10-9d1c-40815c06e919">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/69a24c57-859f-4bda-9980-752ecd057a93">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/25103cd3-235d-44fc-9adb-67f806200e94">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/6723d9ab-8b9b-4482-86a9-1d464fda10e4">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/692782c7-c826-4fd2-8d16-be1b1eca8a4e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/89a5b9bc-87c0-4b5d-88c3-5bad463f5d92">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/d0de8477-806b-4cf6-a18b-c31971212737"/>
    <rdfs:label>sertraline-tolbutamide drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/71824001-e91e-4e35-8cf9-478acaae36c0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/8715e437-7824-4c3a-abd0-8a71169bbc32">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/4d6c448d-37db-4f36-bf67-523bfb2e0169">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/d78307ad-886c-47de-a394-d88fe61ab0d5"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/6c4393d2-f376-416d-9f73-17ceb9098dfd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/3f08f184-2103-4052-bd39-e259174e171d">
    <rdf:type rdf:resource="obo:RxNorm_1599538"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/2ef587da-1206-43fb-82a5-9ac38f2641ed">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/d7380c24-8abc-4bfd-9402-a6d41a6b5878">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/4a874f01-65ba-44a9-8217-90aae5a1ccc9">
    <rdf:type rdf:resource="obo:RxNorm_686438"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/fafae931-9e33-4b06-8a77-2c7f53ea9d8c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/71780f4a-3100-4466-81ce-14d0612d8d76">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/e18d7087-a837-41c6-812b-37febf0bd463"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/2de54422-e8a6-4185-9959-ab33b1413f5a"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/ad5c7ac9-20dc-4568-9d92-1985f681373f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/513b35a8-e91c-40c1-b4f1-46c02d79a0e3">
    <obo:OBI_0001937>160</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/4b2a573f-f989-4ad2-b305-9fd247ebe52a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/f48e84b8-243c-48f9-8fe1-b19b2899a811">
    <rdf:type rdf:resource="obo:RxNorm_85762"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/191762fd-3767-44c3-a0d0-f4bae4eb82b0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/5e7ab9b1-0f77-45ae-92fb-a3faf9381723">
    <rdf:type rdf:resource="obo:RxNorm_31565"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/89f34c37-8308-4c5f-9711-c91eca0aef5d">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/11c0efb9-ee63-4fbd-bf28-494ffaaca0e5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/40eda329-bbb9-4224-850e-7d0fe235013a">
    <rdf:type rdf:resource="obo:RxNorm_6918"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/a0d01676-d55c-42a7-a7f5-c555de44755e">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/3f1b2ca0-847f-47b6-851d-bc5060ab2052"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/f8344db0-073b-41ba-99f0-1f3e836b2c01">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/fdb1bf5f-7fd3-401b-b45b-337d3d63048f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/ae34130a-b8e3-49e0-9754-6a9d2859d5fc"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/e3cb1cba-d2ee-4543-a418-f5eb7acf401c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/907cacaf-2218-4d63-a1bc-160d332ee44a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/e43000a8-ece9-4472-80d8-4de929ca71bb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/3b693c9c-bb8f-48f6-a828-1db73d46b074">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/0d3044a3-5aee-44a4-90e3-c300fa476561"/>
    <rdfs:label>10 UNK </rdfs:label>
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/a60b79fe-9c5e-4fa0-b638-8076a6481a96">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/d001096b-2186-4d61-b5a4-bac4597647d4"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/af55714e-9b07-422b-991a-10b72baae465"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/4ccfdb8d-17fb-43ac-8d26-2f03375fd45b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/23f82fa4-84cb-4ba9-b29c-44d0bda93739">
    <rdf:type rdf:resource="obo:MeSH_D014859"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/875f33bd-f4d8-4b47-88b5-d3e7d1c5a486">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/1d6460be-8c00-49dc-ae05-7636245f69c2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/1fb07ca6-36eb-45d6-9506-02a72243528b"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/ec869fac-142e-4848-a664-76ab20f77018"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/3532dfe6-7c74-47bb-aa4a-05c3d0b9bc05">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/bff728b1-d221-4c60-9a48-7355aa7359a9"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/f20b0c58-29fc-4668-ad7c-8db94b2b262a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/1d7b28c9-6654-4bf0-bb34-2cfa148cad1e">
    <obo:OBI_0001937>8 or 12</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/3494bb9f-ee9f-4997-87c7-ba308ce103c8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/2126ed31-ff0c-4414-864e-f2af52f7e208">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/61cb3d1d-4279-407e-9765-cf43666309cc">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/163a186d-8c98-4c39-9fd8-5be2e83e974a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/95ff4a13-885d-424b-b8b0-12c2eef7f339"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/8689187e-cbec-45f0-a2c3-86a9ce3758d0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/d9fe130c-b21e-407c-aac6-13e8cf22a399">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/b708f5f0-323e-4fa8-9703-33807d450a9a"/>
    <rdfs:label>ketoconazole-dabigatran drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/67492b9a-f7e9-4173-9bdb-080fd6f125d9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/4d04bc88-ea1c-48f0-bb0c-0fbe14f88072">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/adc3f895-cc57-4eb0-8b43-cb6cadb5c7a4"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/524e0f37-b517-4035-bef5-fbfc5d50265d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/fac13d70-45b5-4d08-aad5-07a7695ecaa3">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/6fa7d4c8-3490-484e-842b-f4f25f5fbafa"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/1f39eceb-2fa6-469a-bd39-9bef12100fd3"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/d11d0bc1-5f9c-4c16-86ab-bdfc7e6767b8"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/7b6d2d57-8a9b-4157-bd69-c966c25681d8"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/11210c64-305c-4224-adf5-c5fef82f55dc"/>
    <rdfs:label>bupropion-desipramine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/719d406c-9f90-4769-842d-9b9d0e9d9c12">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/de5ada8a-7352-4306-aa68-473446f8ad64"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/66c563f1-1be8-4d8a-97a9-7f343bc07f9c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/79494117-45f9-4038-980f-69dec115c99b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/9f6a0827-6d86-495b-b804-79c40b3c23c4"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/ede9c238-dc39-489e-8865-11a1583a2ec6"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/546e11ad-96bd-4ddb-983e-8815c9d495a2">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/2897fe2a-5981-4219-95b6-05b3dc2a88cb"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/9d42a203-def7-469d-88ef-206ab22ff820"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/5fe9098a-345f-4811-a692-19f7c32c25fe">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/d8609b25-aba3-42a5-aef6-7c88d95bd77c"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/e2222a53-6fb0-4dd5-a8e1-82c8d79ba05b">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/f7cc140d-2af8-42fa-a72d-a1be4de99f08"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/f331b6a6-04dc-4396-bb73-64e454a700f0"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/48f52c47-8bd6-4c7a-8aec-3d49e97d4cf3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/b375eab7-3d57-4a28-8355-25dc5c7d2c96">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/58fe946e-8569-4b82-aa1a-1f464102f3c1"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/6894a873-f752-477c-b37b-348630f4b96d"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/06d92933-c89e-4913-9d90-d8657dee447b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/46875afb-e481-4507-b89a-515120984aee">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/ea85b13d-6f03-4c41-b2a6-1d5e4243d2a9">
    <obo:OBI_0001937>Unk</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/23a0b54a-bbe5-479a-8cb9-61021f75f06f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/6894a873-f752-477c-b37b-348630f4b96d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/66cb148d-780a-485a-9c4e-2ccb9c282474">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/bfd719c6-7c9d-455a-9749-e16fafe423d5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/c8fb783c-ee4b-41cb-8b99-610bff2caa59"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/17aa437b-fc8e-4a6e-9733-d16959c01a87"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/b64f3e7a-4db1-493f-906c-cd9749ec87c7">
    <rdfs:label>carbamazepine-nefazodone DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/c89f54c0-cfa0-4222-b2c0-7d735744b4a7">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/e26faf29-4408-46c3-8f96-c12d00d764b9"/>
    <rdfs:label>4.13 Fold </rdfs:label>
    <obo:OBI_0001937>4.13</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/17275df8-2754-4fd6-a28a-6e7241e9b3db">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/ce2ee3a0-2693-421b-9c14-9e38af13f479"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/a6e7e6b9-cbb8-4725-95d9-512bed26e45e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/3b2b80eb-f63c-499f-85b9-4a21ee0c166a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/75528a85-0f6f-4000-8b86-08f1f451ff6e"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/1593ca34-d9a6-4115-b824-69c1ea5c3a18">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/99f97de2-2181-4d7a-b0ce-66121fb56d8e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/f6b19bb0-6ef9-4bf5-b773-a2f12d7e294d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/e735fda8-0d46-4c78-af15-6aac5add695f">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/2f8081ae-60a4-4102-8038-e5f350cd47aa"/>
    <rdfs:label>8 Percent </rdfs:label>
    <obo:OBI_0001937>8</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/6e02a7f3-ec96-455a-afac-065c83ffa368">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/9ade9383-85a5-473d-95c9-46110281f417">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/5add7fbc-8e56-4541-9040-c99fc1f8b07b">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/bab45b7c-a3c5-40ad-b2c7-1ef50f79d9d7"/>
    <rdfs:label>ticlopidine-bupropion drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/5d557a83-fd92-481f-b51f-651fae8f72bd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/dfb6b7a9-5570-486b-a0f0-227b8522ebf3">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/6a1ecc81-f7c6-4d9f-84ce-44782d86d065"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/485e06fe-834e-40ed-b0fd-58e42ccc4f6d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/41db61d1-d8b4-46b0-abe2-ef5d911ceae7">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/5daf7795-1f11-4ec1-a2f4-8c6dfb37ea25"/>
    <rdfs:label>82 Percent </rdfs:label>
    <obo:OBI_0001937>82</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/fd54c615-29b4-4749-b868-dbff408e15b1">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/92a58b4f-6595-4035-9330-8b9c64b1b9e1"/>
    <rdfs:label>nefazodone-haloperidol drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/22fa8d1b-3540-43c9-81d6-50f4e88518de"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/656fbb2b-ff70-4dcb-8e1d-021f2ca8947b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/722b605d-e786-4a37-8825-75fe503e75ed">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/33f9778b-c9f1-4258-8578-b87c8893f666">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/de26cf50-b600-4bbe-b8c5-1b1c91e10b0d">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/993a7c8e-dd6a-4114-b885-4d7699bf6bcc"/>
    <rdfs:label>505 Percent </rdfs:label>
    <obo:OBI_0001937>505</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/e4307dab-04a6-4421-9d18-2f813ca78a39">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/b578a8ee-2d25-490e-a9f5-8aecf46d6f40">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/310f46c6-56b9-4d91-b012-802df1d43844">
    <rdfs:label>paroxetine-9-hydroxyrisperidone DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/99a24833-b0f4-4304-a047-ad4445162fd1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/3eba5c6e-385d-4675-ad1a-268f9ec9b18b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/dc3b9a20-99e8-4101-80f6-aa8121a7cd5c">
    <rdf:type rdf:resource="obo:MeSH_C062257"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/69b45a59-641c-404f-b0ab-c0c50b3ed6df">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/0b9f7319-1dc8-48ba-97ff-cdb7da972ad1"/>
    <rdfs:label>BRINTELLIX-salicylic acid drug package clearance UNK information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/91755911-b834-4386-b2fd-19bf7ae54ab0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/b3cab413-9289-4a46-9199-1bc8391f5f45">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/ae15ad16-50d4-4daa-8555-18578afaa5c5">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/488eea45-377b-41ab-8b8b-ba17a329f085"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/d9ac85ee-0f34-43fa-8c8f-2dca2e6df57d"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/3ecf7a04-47aa-40e9-800c-8848ffa379c2"/>
    <rdfs:label>ritonavir-hydroxybupropion interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/04d6cc30-49b2-4c72-a8fe-7a910f55fcce">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/79491dfe-48cc-4436-9d6d-9a4a47e0d1a5">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/e132fbd8-106e-463d-a406-0cfeb9d4cb9a"/>
    <rdfs:label>Diltiazem-Atorvastatin drug package cmax  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/11df427c-7461-466d-8f56-9fab9df72cf2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/bec9cb7a-940a-460e-a63e-341c303ca62c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/93a29126-48fb-4c73-b9eb-8deef03394c9">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/d74dd2e4-ad20-432c-aced-e83ceaf32057"/>
    <rdfs:label>cimetidine-sertraline drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/1ec28b9b-8fbc-4290-b4ff-9493839dea70"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/aef01f47-a39c-45f4-8cc5-fb034d66d505">
    <rdf:type rdf:resource="obo:RxNorm_1191"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/552238a5-5cdb-4ea4-85f4-da12e1af11a8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/6316a863-5ce2-4e2f-8b32-16bd4056cb91">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/2795daf5-a8d0-4f20-b6d4-9156e07b6ac3"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/8e086d7d-38b3-4a34-aa67-5a784097ab3e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/a8bf8b89-adb0-46fa-a507-39717840c7ce">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/56bd65a5-97c7-4a08-b9c0-2b3d1a789424"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/798683e2-5efe-4069-ab03-1eba9c660bfa"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/d203533d-8325-4562-b75d-fb54ab454bde"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/fd1dd8d2-1b83-498f-9b4c-7f64726fe02a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/2b903934-ffb9-4b81-9ced-b1614ad87e9c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/1b539799-3e06-41ea-a643-dbf87c11d25e">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/613dce09-f2f2-46a7-adab-904c7deb16c5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/442649e4-43d2-4b0c-9e32-db188632d420"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/11f2b32f-43fd-4d86-8166-528954c58f8f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/8c341043-7456-49c9-8dc0-70c0d9026c44">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/533ac14a-9668-4db6-adf3-b5163878e6fd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/64cb92c6-20b1-462c-bc13-6542a7f1c5de">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/d74dd2e4-ad20-432c-aced-e83ceaf32057"/>
    <rdfs:label>cimetidine-sertraline drug package halflife Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/12002992-8db9-4be8-92dc-ffa0c8930fb3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/0da7d2be-e89b-471d-85de-a8563fb69c61">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/52f5a1ab-1a30-446f-bcca-d8cbf01850ac">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/5afd6b9b-b94b-4607-b8d0-5396c0c4fad8"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/c37980cd-f191-4da3-90e9-1e6f7d402b6d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/13168418-7c73-4e4d-b611-582272fcf7cb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/cbedd838-fe16-4cdf-9a37-db00dd499ab7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/14386102-1f23-43c7-9c40-567d1f188a5e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/a7e2b6ec-7e83-4f50-aa17-05ab1be3a49b">
    <rdf:type rdf:resource="obo:RxNorm_352393"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/52a33c45-107c-444b-a9d1-2f36ea58f403">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/56782f79-ab84-44d8-8619-4e34d8713e06"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/cd0df484-aa57-4a5f-8073-c88b67420d9d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/72299084-bfd7-41aa-816e-479aa12f6d6b">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/b98641e4-94ec-4c2e-a952-e6edc9d85654"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/f99e8909-c457-421b-8beb-6535e8592cf0">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/c8522f74-0c5b-4ae5-af40-9f8dab5d1aa7"/>
    <rdfs:label>ritonavir-bupropion drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/cf7b80df-812a-4ad4-86a8-03542624e5b9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/8b005648-c1d8-46f8-bbd5-735e5d18f98b">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/b80330bb-79ed-4bda-8a3d-fbe6c6c7b867"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/2f4a871d-6390-413c-a643-e7e49962aeff"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/1d66eccb-71e9-438e-abcf-3201aaa0b629"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/ebf884e4-c320-4f8f-a2b6-e7f77b3e418a">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/f376a7a3-3ef9-47a7-a062-a5c4f3db9e3a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/d34f92be-4842-426b-9ced-9e5d22e57876"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/9ab403ed-52bc-4095-bb92-4c76b7de9df6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/9642cd96-b443-49d0-82da-5a677be89eef">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/a2adcb74-dedb-45c5-bbb2-0092926eeae1"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/fb207e6a-27b4-4f0b-b6a8-99ecfacab28e"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/ce44968f-f048-413f-899a-961eb5cd4e36">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/46606d24-bca1-4915-b007-c492ad0b7d98"/>
    <rdfs:label>ketoconazole-citalopram drug package cmax UNK information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/6ae3035d-e8b1-437f-aa23-6f179be3de55"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/27b27d82-68ea-4c44-a29c-dde896fc9dbe">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/34b20987-ea0c-47d2-a79e-7c2e085e8c9e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/18e9b134-ad96-40f1-99ad-b5435814f6bd">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/a52bc730-5c7f-4d6c-9e7d-7fd4afc9b27b"/>
    <rdfs:label>37 Percent </rdfs:label>
    <obo:OBI_0001937>37</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a71f3a39-4d2a-4679-9748-2e4b6369a87e">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/670c55e2-076e-47df-8f37-3a02e67c588c"/>
    <rdfs:label>12 Percent </rdfs:label>
    <obo:OBI_0001937>12</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/bfbf3409-cab9-4dfc-a37c-2f44af7fe154">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/ff94d62b-b49b-4899-94dc-413bb33ee7f2"/>
    <rdfs:label>3 to 6 Percent </rdfs:label>
    <obo:OBI_0001937>3 to 6</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/889b8f08-bc58-4039-884c-b827df403122">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/1f388a55-28e1-4976-a8f7-e56189395393"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/e3bce6f8-0ead-4f80-99a0-0c4c28ad2713"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/5f7c0c20-923f-4645-8526-7c1e26750602"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/114306dc-a958-4cbe-911f-85af446e4fba">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/81e36b6a-b9e5-423d-885b-f0ad568f6de3"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/e81fd1f8-c6ce-43d9-8f7e-fc22e2dbf214"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/a5d1894b-9c63-46e8-a37d-83b54b54bf6f">
    <rdf:type rdf:resource="obo:MeSH_C496216"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/57a535bd-4ecb-4efe-b8de-6c1f7fd37729">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/af2fa785-127d-49ce-bfb6-d69ee45350b5"/>
    <rdfs:label>25 Percent </rdfs:label>
    <obo:OBI_0001937>25</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/8a0d2674-f8e9-4dbf-949d-10dbf3e97d65">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/34eaec1c-f5b3-4cf4-84f4-d8abf4ff043d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/0b7d55a3-0397-4d76-b35d-672b5ee8ab0e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/7faaf42e-e110-4fec-9a26-317cdf6367cc"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/5b7e81ba-f139-461e-b940-e885d655965a">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/1b8b9d34-5ac3-49f3-8949-b81fe86ce238"/>
    <rdfs:label>sertraline-pimozide drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/9912a715-8c1e-48bd-a81b-0fb89a0d4c19"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/a936f15a-0d3c-4354-b4d0-dfd6521d4f21">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/5f97bd57-7ffe-4d24-985e-f0f91a227f14">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/785dc40a-33f0-4444-9e9d-c1e1702b0a20">
    <obo:OBI_0001937>160</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/cfcb1ed0-2705-46ab-96ae-c92e253dea01"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/78fdad0c-e5e5-4e1f-9aad-12790a6bb39e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/21f3e5a1-48ec-45a3-ad79-a6939b86930f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/918bf850-49a9-4343-9ae6-ea2e2ca7fd85"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/5cb92563-882c-46cf-b652-118db63786bb">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/d74dd2e4-ad20-432c-aced-e83ceaf32057"/>
    <rdfs:label>cimetidine-sertraline drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/5a2898ee-9127-484b-a2fb-691563834955"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/e07d6b8f-5d02-4825-9a45-cb76ebcc6cc7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/5eeb3fe7-0f7f-4b4b-a7d2-e89bf45ec9fb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/c44db32f-3d7c-474a-be2f-55324a43919d">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/b4d1ba75-8585-4db4-b611-17c91e106d95">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/e21722a7-fa58-49a6-b634-28d8eb990025">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/a38e8fd6-1fb9-492d-a6fb-1136168477f9"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/1d8488fe-1f07-4c31-92ab-8b62d39748a4"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/f722b8c9-e130-48ca-be55-cf53e9a47461"/>
    <rdfs:label>fluvoxamine-N-desmethyldiazepam interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/af2aa48e-c48c-41d1-a769-9f7615c13a79">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/5ff916ae-243b-4b17-abbd-0fa40b85b9eb"/>
    <rdfs:label>20 Fold </rdfs:label>
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/2ea6c1c1-8dd5-4008-9ade-6a30d1827f94">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/b0146b1b-3f06-463d-b070-33fafd229d05"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/c2439d71-5952-40bb-bcc8-65f5f075944d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/83659194-27fe-4a6d-8333-0d0d81eb0a61">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/42db92e4-07e1-4acc-9fa1-152aab7124a6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/a78d6e2a-57ac-4b4f-a588-98c60feac49b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/9d4fa60e-2ae9-4bd0-a9d5-2632cf275866">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/22ef8be7-9c0c-41b6-bc02-658956788824"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/a3edf21e-cca7-4974-8c29-1265bb7d5576">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/da5d5f55-dc4b-4d10-b1a8-c55ed606aac8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/4e7e5f57-71ac-48f0-9ce3-10d46760c93a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/d31f8c16-b603-49a8-ac23-7bb29676c5b9">
    <rdfs:label>Fosamprenavir-Atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/b6bf2338-0535-4fe0-b4e2-63b62f4e0a73">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/ab6b0689-691b-4a62-bca5-eae2231f893c"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/a38d5e49-149f-4dfd-8b49-29e23e6e54f0"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/64b9abf7-624c-4c20-a287-fc7173df7ed9"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/a19e1177-29f6-4ca5-a21d-6fad5a4eb29a"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/37fe0ee8-681b-459b-aae9-b436963beb1c"/>
    <rdfs:label>rifampin-zolpidem interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/38fcebb5-22cf-4b3b-bb30-209328517d43">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/02bc03d5-ce43-4100-8d9b-809050d9f558"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/83b4e819-dab9-4f8f-9753-448cccc3b610">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/7d1af480-c87e-4ae2-8eea-bc358380290e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/4be94b4d-3da8-454b-a717-061b01f324bc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/08931962-d4dd-48d0-9fa5-9031b953a518">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/6d24902d-9ca0-4d09-ae7d-2561051f3e93"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/d8959914-e132-49d5-ac30-fd60ed434b21"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/79070d86-bbc2-4c5c-8f02-cf5db59af543"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/dbcd143b-5e13-4273-a973-c9d5b300eac9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/fe076fd0-bc62-4391-918d-9fc8bca710f8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/950f2a28-301b-4764-a520-dd93a009bbc7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/8c6eb072-59d0-4c4d-8b2b-9cfe749091cb">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/b6059a6f-eca0-40da-883c-9d79135285a4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/5df55dfc-3c51-4920-b1ab-3c0449fe199f">
    <rdfs:label>lopinavir/ritonavir-bupropion DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/98134212-7003-405b-b096-84bc2bb889eb">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/c4554bda-2a56-4e32-b6cd-fe016f204c4a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/34b695eb-e97a-4488-8a5d-33117fcbd3c2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/b220aeb3-a2b6-4f6b-b36c-4acd4a06af35">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/7ac79a22-9bd2-4fc0-bf9f-f268cadac770"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/e15f2375-f288-4a73-a870-5747fc6634ea"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/51076e81-8813-49ee-bac3-dfcb6cb3d8c8">
    <rdfs:label>naproxen-Edoxaban DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d1aa67fb-27e2-4197-b0b9-1425430a15c4">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/c50aa9e7-cf81-4c43-9077-23d5cbdd6851"/>
    <rdfs:label>36 Percent </rdfs:label>
    <obo:OBI_0001937>36</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/de927940-8244-46bf-887b-38b7cb340be7">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/fc3423e7-d85b-491b-93f7-f998c6f0162f"/>
    <rdfs:label>low-dose ASA-Edoxaban drug package auc UNK information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/97430b16-efc1-4d47-99a6-0df237b35cce"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/83b13b2f-3eaa-472a-bb45-94c4415df8ea">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/a4ad6c3b-84e6-41ff-9c24-a13f55d96303"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/6f8e9269-738b-4b60-81d7-2563139f5297">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/d31f8c16-b603-49a8-ac23-7bb29676c5b9"/>
    <rdfs:label>Fosamprenavir-Atorvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/5087b625-c0a3-4fa2-9891-6db276d43709"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/466a1d9b-ee2b-4905-9a00-50bafa3a4960">
    <rdf:type rdf:resource="obo:RxNorm_32937"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/bdb4663e-07e3-4cf9-bcc8-e2c7182cf0aa">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/e9819012-4061-4086-b210-e3d6dee24f33">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/5f8d2384-72c8-4e26-93bc-c80ec8e6e586"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/d3049c2f-e5e8-4ac5-b97d-bd33cba05150"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/e1c2c083-81f3-429d-be4a-27ff4155b877"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/33c21f97-1263-4162-84b0-721b152279b3"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/eeed3ae7-2f8b-4c2f-9fed-e835e63e05ca"/>
    <rdfs:label>paroxetine-desipramine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/827d694f-081d-4a73-80a6-0c3e989b5667">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/e7ffaef4-6681-4f66-8d1b-f317b6d319c7"/>
    <rdfs:label>atorvastatin-aliskiren drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/42e107ef-657e-464e-9806-863baed71bda"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/950a3d01-9ef3-45f6-befc-20447011e396">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/60a65c24-959e-4f47-a986-1ba89021c0ba">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/d1d4eaac-deba-497b-a767-64791543efec"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/fdac9405-ba83-4de0-8614-4d29198b2c21"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/8e328195-ed44-4839-a3d3-82a45d3c3567">
    <rdf:type rdf:resource="obo:RxNorm_39993"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/4172e3ec-4960-4090-b2fd-a07214e1caed">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/7e9dc98d-7dd1-4d0d-a418-b75b375b00e6">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/d3438578-c159-4c0c-beec-2b2fe6d477be"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/477a17d7-72df-4bb9-8cee-ae1a812e89a5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/0da5b0fe-8775-4389-9445-2df5999d5035">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/e411677d-c087-4762-987b-c24b9dccb381"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/a48e47c8-18fe-4650-a4a2-267008ecf62a"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/fe297c4d-eecd-4247-8910-cd1ae890d00a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/48b43afe-383a-4ae4-8744-310596ee792a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/bb80e3e1-8849-4154-bbd9-95ccbf434ac4"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/a5d5738c-f344-4863-b092-0267c050b5aa"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/b17244e2-bbae-45f8-86c9-5a53b8c442ee">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/b96c5c5e-8359-4ca9-bfcd-b4ad42045999"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/ac3f7ece-093b-4259-8d05-e5b74a0edec3"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/81f0c68b-d241-410a-8506-2d4a899f5dc1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/581321d1-cf19-434d-8b70-6f5f0e46cde2">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/1beb2d48-fdf2-42b1-884e-c0cafc6f0e69"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/f5ddcc77-2079-4819-af2d-9998ea844151"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/476f9ce2-1126-48e0-8951-9b6a497e8694"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/3e20b592-d7e9-4588-aee9-35e922a937a1"/>
    <rdfs:label>Clarithromycin-Atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/80fe17a3-4115-46cc-886a-826f20892fbe">
    <rdf:type rdf:resource="obo:RxNorm_74667"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/1db1bd42-db18-4bd7-953b-c6ba1b23d32f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/DRON_00000028">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/7684da70-8d42-4f40-a4cb-5596c33e022f">
    <rdf:type rdf:resource="obo:RxNorm_40254"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/967c6f5e-ba2e-406a-aa21-b1f59d001c0f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/5ecdabe6-1956-43c1-807f-3f6375c7a948">
    <rdf:type rdf:resource="obo:RxNorm_32937"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/0cb4c3d6-2616-4f0c-a459-85351ea1a868">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/4af096ad-c555-411c-b374-9909877087ec">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/f8f4d62c-d272-4452-adb0-482deae40929">
    <obo:OBI_0001937>300</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/484bf8f1-5f83-4c2d-8c16-32926342944c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/059af977-c56e-40c6-8a75-b4ffb6f769d4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/5daf7795-1f11-4ec1-a2f4-8c6dfb37ea25">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/b0146b1b-3f06-463d-b070-33fafd229d05">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/5208bcec-e0aa-4afb-9c92-3a8b4fc33b99"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/0a80ff0a-39d4-490c-aa21-c582223f91e2"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/503ba1f1-a00e-4acb-9e52-879a7fee25c5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/0bbb830c-90fd-4f81-87f1-da71c9987631">
    <rdf:type rdf:resource="obo:RxNorm_6135"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/37431714-6d8f-4517-b768-edecb24b8fa1">
    <rdf:type rdf:resource="obo:RxNorm_36567"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/791a7ddf-a07e-4fb1-9080-25fb16406064">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/6df2c03d-4c2f-4da9-b134-b2721f162a4f"/>
    <rdfs:label>unchanged UNK </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/f63959fa-ad25-40fc-b6d9-e51ab1fb14bc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/4ee5c1e2-d380-447c-82ae-bbceca1382f5">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/0dd4cb13-ec6c-4d91-91a9-8ca73ec6d2a0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/570e8606-21db-47f6-96f4-085845ca97fe">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/55fbd304-49a6-41b2-acc6-34cfed9e682f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/f82b6a1f-e430-4093-bed1-2fd03e84e12f"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/315f6443-4fad-4366-b40a-7a361c5188d9"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/9d0a932d-4e0c-4f8c-aea2-854f223be6aa"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/1c2f2b1a-dd59-4ffc-b1a5-15932a31c1f6"/>
    <rdfs:label>erythromycin-zaleplon interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/21adf8b9-6611-47f8-a482-51e719614385">
    <rdf:type rdf:resource="obo:MeSH_D014635"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/d344bbca-7feb-439a-b26a-65501f3c0cee">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/aeb7c1ef-5bd4-4870-8308-12da31cf1d56">
    <rdfs:label>high-dose ASA-Edoxaban DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/f7369b3a-4c35-4c13-a491-ddff47e17b9f">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/11100d07-f6e8-4cc3-bc5e-7be0024706ad"/>
    <rdfs:label>clopidogrel-dabigatran drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/77f50bc2-407c-45e7-b420-3f4afb6effa5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/cfe2a962-47eb-4000-8281-e2e3295d61b5">
    <rdf:type rdf:resource="obo:RxNorm_6135"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/e208d4a3-4dda-4b79-ae8b-c5818ab96677">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/420a6539-46df-4975-9a5c-778dfe7cce61"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/72d3f91e-970f-4f52-b3ab-331130b301ca"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/5a67f03b-8dee-4fec-a3f0-a096248cfa76"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/8e2471ef-0999-4bbb-95c4-1171f503d5c8">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/6b667423-cb4a-4a78-a552-05d42077565e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/a36569a9-b7ec-426d-929a-f40b50ef7e25"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/29b00e14-9f9e-4170-84d6-0884bb94d91b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/2f25d616-97a2-4b02-b824-8c95bf1359e4">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/577d375a-5736-4677-878c-0f434264126e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/7bffc644-01a7-49d9-993c-af3f75b19668"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/5937f337-0bf8-4e82-ad4f-422f22302fa9">
    <rdf:type rdf:resource="obo:RxNorm_301542"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/6bdf01df-0929-4e51-8742-cf0953d91692">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/fb575cf9-08ac-4a41-868f-be2a62b5f05a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/449e918b-2b9b-4dd3-aa22-aa52ca3aec8f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/f70144fc-5747-46c1-bd3f-8ce19ee89bea">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/57542bcf-c8af-46a2-9b08-f5702d3b270e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/2d1729f6-8fb1-48be-b15c-e41a10083b8c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/3b76ed99-9534-4471-960d-474edde68553">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/a8fbf5ee-d594-4ace-a9ac-f80eefb41ae1"/>
    <rdfs:label>warfarin-ambrisentan drug package cmax  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/0a1b38b6-76be-4466-83c2-1855011a1f77"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/c709a01e-017e-4754-98f6-aa58a1f86925">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/ddfbc3ba-30aa-4d3a-984f-069531b61dff">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/dfaf40c9-5451-470b-9e4a-393094607a8b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/f03d1fe1-9bd1-408d-8ace-f8a1e6b6bc95">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/41c91477-f8af-4f5a-adfe-1f0b28ef7936">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/58faf509-8e93-46e2-a4e6-4dfef33af9f4">
    <obo:OBI_0001937>Unk</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/fcd421bd-d04f-4a30-b060-6c73b2a3a004"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/a22560cc-5f51-4417-9115-f39b404c3461">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/bb222152-e862-41c0-94c1-cd150cb41930"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/f8f4d62c-d272-4452-adb0-482deae40929"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/39bfc487-6568-488b-979c-18707d390c6c">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/7960214e-16c0-4fe3-83f9-fd96f85c9b78"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/1422b470-b21a-4708-9fdc-f33b89cebb63"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/cb5b3432-a363-4d6e-806b-fa47d2762fb2">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/290edcc6-4afe-4d2c-9a2a-9dd15d9318a7"/>
    <rdfs:label>rivaroxaban-midazolam drug package cmax None information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/93e7a327-6af8-4ec8-a8c8-b6de5a9eb70c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/d0520217-ca29-4c3e-9139-65790075b016">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/667ea753-77e6-4ba8-9556-714b08afea51"/>
    <rdfs:label>ketoconazole-rosuvastatin drug package cmax None information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/7aca3f85-6698-4fbd-a4c6-91600e679d44"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/469b6af7-daab-4eb8-9518-01be9dcd4255">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/9353f29d-6e84-4f88-99d4-188d95f5ec27"/>
    <rdfs:label>warfarin-Rosuvastatin drug package auc  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/68e4d3c9-8e81-41cd-8410-7b838eddf3ce"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/177d9c20-ca61-447d-8a7b-fc0188b26d59">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/a8bf8b89-adb0-46fa-a507-39717840c7ce"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/0c9e3560-38cb-4857-a824-e026927bf736"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/bf7f7b54-55d9-415e-b7b2-98f4060b6e53">
    <rdf:type rdf:resource="obo:RxNorm_8183"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/28c9647a-a75f-49e9-9801-a8f7cfb7b8e0">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/4a95af59-515f-4e34-8318-556ebb2fba9c"/>
    <rdfs:label>44 Percent </rdfs:label>
    <obo:OBI_0001937>44</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/06afc643-f7d1-43e0-811f-737d05f07856">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/7d1893a1-cf7d-4069-877b-b3d497d1b7ea"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/2d97efc6-b2c5-4307-bec4-69a0c3ad354d"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/828c1c95-f4a9-4ad9-bfc6-77c063616ca5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/5b69dbaa-dd3c-431f-81cb-5ec34e5034ba">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/ef414ee6-782d-4371-bd44-7c43aa1c05a6"/>
    <rdfs:label>25.6 Percent </rdfs:label>
    <obo:OBI_0001937>25.6</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/d99be735-59f1-42f7-8428-1244e9fa782c">
    <rdfs:label>fluvoxamine maleate-propranolol DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/761fb1af-da5f-4923-8484-4c84c2122eb2">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/85e2046c-0ead-45b3-a023-6ade3184e504"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/58e0f062-9050-420d-a6c0-3085b27cbf39">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/e4e9869f-9cfd-4b1c-a3fc-35e8c040324e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/95524fbb-9415-4a3f-b8da-9b2ca2531e6f"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/8c4f9c5c-5e8e-4a29-9dec-3da30240a7c1"/>
    <rdfs:label>paroxetine-phenytoin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/a847c5fd-d2ea-4232-9905-f67d65bffe88">
    <rdf:type rdf:resource="obo:RxNorm_31565"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/f641494e-8f29-4eb0-9ffc-05bc930ad018">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/6e52b175-6328-4d25-ba7d-940169197d58"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/65ca1a94-8af5-4d8c-8a20-693b62c38690"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/88b64ce9-4d54-48c2-b8f3-fe2bfd530135">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/1747c8b7-253e-4b7e-9951-d17f7a5f3c56">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/55a15853-d287-46b3-9b4c-8a8e178cedb6"/>
    <rdfs:label>telaprevir-amlodipine drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/6b668cc2-fad5-4a7c-95fa-00c89821edc2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/af4c7a74-b57d-48e2-973b-ae624185a923">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/9afbcb88-dccf-4f12-974b-7c5da65b1c2c">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/f68cb0d0-a09d-4458-a885-6ad387f9048d"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/0e993b40-c341-4e29-ad1f-631c4eb6893d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/24191573-e612-4164-b768-9d79230e4fbe">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/b12698bc-b720-4be7-8cc9-7699dd41d5c4"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/98e12c7f-dd8e-4ef2-aa2d-f4c685274a46"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/a9a6873b-b808-47ac-b0ad-0d5037a7461c">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/b40bd332-9507-4580-a476-d160729a41d1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/80791f82-4818-4c45-9308-7adb4a9c9004">
    <rdfs:label>zaleplon-diphenhydramine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/f4858acd-7770-456f-a8e7-2d0d829ab7db">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/e806ccc2-cd43-4ddb-a40f-be2cc44a21e5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/33d940fd-9078-4032-9016-0b49729158a2"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/7579e1a0-cd91-47bf-86e1-ec8cfb10a7dc">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/5dd688d5-a8c3-47bf-90ee-272d9ae5fb92"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/31880e33-a1ce-405a-b3ca-72fa443f2592"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/7ee66d0c-5c37-4201-bcc7-f753d30eb109">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/db05004c-0081-44da-b29f-25ebd01aea89">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/e934d825-a06a-4a34-bb6e-081278a1e3c2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/4b554f71-6b4f-4278-ad62-18506d2db5b7"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/2cb12470-64a6-4e56-8dea-d0909c3b858c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/65900665-d70c-4695-9e4a-69e3a5ce2388">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/a401bb34-85fd-4e24-b3f9-16421bdf2b5d">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/1bf845fb-0bdf-46ec-922b-aa1509d4b944"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/aaf8fcea-7132-4cd5-8f85-6c12f9219481"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/92b61796-9d5e-484c-8d69-4fc1f4e9ee1b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/eafbf0eb-e815-453c-864c-69c23cf1f582">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/1ef2f06a-6fef-4af8-abc9-0f6ab22d0a93">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/d8f16922-7f5e-42cd-bfc7-42058cd32fa0"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/1f7bc11a-ffdf-4658-b3f1-d6184ea0c5b5"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/2117b077-40a1-4c4a-abb2-72fe4af7578e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/890cb348-a50d-4f2d-83f5-cf4def540cad">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/24adceec-a284-4beb-b696-057028436ed6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/1e3e3679-30b8-4bcb-a9c5-e349677153cc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/95954686-f4cf-47ee-bc70-9d2c3fc1d29c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/c0dc15ea-fef2-4a2d-b868-bace191fca2c">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/c53eb13d-426a-46f1-aafb-d759dd6e0ec0"/>
    <rdfs:label>3 to 4 Fold </rdfs:label>
    <obo:OBI_0001937>3 to 4</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/53d610ac-9d1a-4fbb-8034-efcd7c74f898">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/891033f3-133b-4802-88e6-a392f0f2cbda">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/81ec373d-5173-4334-a3c9-a6389188af37">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/2747c108-23e2-4978-a311-072df189d470">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/35b229b2-a632-4186-9336-1cc5d67a6686">
    <rdf:type rdf:resource="obo:RxNorm_301542"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/bab3e17e-35ed-461c-87a0-4be28925e224">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/15f026e1-1e0d-41e9-926b-6c775b347d97"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/0d2839b7-bd61-45ae-bd9a-79d3194a3dd8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/498e0dba-c8ba-4d10-8755-a6a54f638d7b">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/11c6f2c7-ed48-4069-840c-8da242b14a9b"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/37d5462e-3f8f-40ff-be03-84b9ee194ab5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/25a0d840-e062-4963-8828-ed6be40e308a">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/6fae3fe1-abcd-4a64-a31b-b97bdaa5c33e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/ca49b711-a5d1-4993-b14d-2cfb0844276c"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/28f3177c-2b25-49bd-81d2-21f6909b791c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/990d1df7-abb3-49c7-aba9-7adc7260fe50">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/3769c272-ec33-4e9a-9dbf-4fcc7796dde8">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/701a3551-a6f8-4253-a730-96c7463215ea"/>
    <rdfs:label>UNKUNK UNK </rdfs:label>
    <obo:OBI_0001937>UNKUNK</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/3cd2f113-55f7-4765-b265-d300161e5fb5">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/04c021a5-1c43-4d79-a7a4-f4b883c6fd3e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/983c71f1-1c29-47d2-8d5c-693c3c075b91"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/0eea905a-f94d-4cb4-853b-eede4e1d5cde">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/4a904053-5703-4a10-9be2-3580ad7397c0"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/e47d2a35-0a18-445a-b789-52d638d96b5e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/c2989691-4f6a-4852-9c0a-0f3276ab26e7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/18f4d6c1-a5e5-41a4-9b31-acf5c23e3dca">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/08a421c4-a0e3-4fc9-98d9-66d67c9bca65">
    <rdf:type rdf:resource="obo:RxNorm_32937"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/beadba51-5d12-490e-b8a4-d9745a18e385">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/81a56c49-e8be-4e0a-a6cf-27d89365ee5e"/>
    <rdfs:label>18 Percent </rdfs:label>
    <obo:OBI_0001937>18</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/83447270-fa82-4838-9595-28f2fbdb71a3">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/587102ac-1ccd-46d8-b09b-014512e6b8d4"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/ae331a6d-6b38-498b-9f8a-8b68feed1705"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/ffaea816-796f-473d-b0c9-074e69c636eb"/>
    <rdfs:label>carbamazepine-ziprasidone interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/cb5a0e46-896f-47a2-8d78-b04d1e85d55e">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/7229c0df-b821-4fce-a615-698f0ed48983"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/12522873-3ec8-4208-a61e-66ff511acf52"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/1d75a33d-6fa8-4c5d-9820-83f9922186ad">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/95641b25-3045-405f-a38b-25be9ca3690d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/791a4769-7ed7-4453-a298-04cdcc5b549b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/711446fd-0d93-4826-8f26-d089994ecc40"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/d5943b97-7a5b-48b2-a5c0-5b5afae7ed1f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/52bbbca0-97a7-4c7b-a371-c0d811e71f24">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/f78f61ba-0309-4f86-a1e4-b3a0b709233a">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/d6546534-a508-456b-bf34-b87e35df82ce"/>
    <rdfs:label>unchanged UNK </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/c9659c9e-0642-4a4e-bd47-69e245786615">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/52fd3542-48ab-4e8f-90ff-7ca842c805c5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/c0422ba0-efa8-4ea2-9252-1e4ab1a95fc1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/e67ef293-ca46-46cf-87ae-a1b5737c5943">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/3e0d2947-5bf2-47a8-b1d7-28fe79f83d7d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/0ce58183-692d-4b27-aa23-66b28cbb3dc2"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/a19189b6-26f0-448a-b650-e2708897ba39">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/cd17989b-c5d5-43de-8d6e-091da50e819e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/26c94cc6-095d-4be5-86a0-dc2b3d2896ff">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/6ccdc6a1-5c87-4ae4-8711-5b3f2e86e76c">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/d8266dce-63ee-4385-8190-8e7186180be9"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/eebc18ff-2bbd-4ed9-b5b4-fcf0fe82171c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/d745b5d4-a6b6-4e3d-a700-1884acdcc43b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/d35de974-f232-476a-8114-a2424fcffece">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/e2d791d3-e53c-474d-8399-03de06b6c9f2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/6c2f12ee-b7c3-453c-a16c-592091d68966"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/a8a390ee-d5e5-4d9a-8777-3c3cce81bf6a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/eaab3030-4e33-4491-a27b-fb77ad21499b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/8b9f2f3e-210c-4e10-8114-d42bf94540d8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/c25167bb-667c-4426-aa0a-7f6e742c87a7">
    <rdfs:label>simvastatin-digoxin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/cbc036b6-2942-44d2-8b76-8b56a9a72b63">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/7786db3b-71c9-4ca8-a399-d13e2c148f41"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/42e0afec-f4a2-4b2e-945a-153c232fb613"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/2116ee10-f24c-49e7-b369-f1ba79e80b65">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/5b424ecb-756a-4ac4-bb26-c69a7e8374bc"/>
    <rdfs:label>55 Percent </rdfs:label>
    <obo:OBI_0001937>55</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/ce1f58cf-96b0-4719-b69b-23ea2de82cd4">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/3004a18c-9210-489e-9c7d-86c0e9531dfa"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/bd800384-0f57-44da-afaa-027856b99b9e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/ec818b55-6e5a-4837-87d1-dc498156fe58"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/4f6d2c05-a43d-41b6-ac8f-6a6346f27fac">
    <rdf:type rdf:resource="obo:RxNorm_41127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000051">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/49935cfa-0f53-461a-b934-1ad2d63b8e99">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/96929a95-b61d-48bc-8f1b-c38d1c8050e4">
    <rdf:type rdf:resource="obo:MeSH_C102211"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/15132a20-40aa-4c93-a6a7-a0ec80b721dc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/56782f79-ab84-44d8-8619-4e34d8713e06">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/470d2cf9-fa65-4248-9a91-ab101f57bb13">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/467afb1d-6a1c-40a0-b34a-703309087772"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/61a1c694-2fd1-41c1-bdc2-925ccc57c6b6"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/fa8e1185-00d7-4466-9687-53cac22e02cb">
    <obo:OBI_0001937>150</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/0ee61c67-a4c4-40bc-b0df-34cb15d8d110"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/ab81ebf4-e645-4143-88cf-250a46e5eaa3">
    <rdfs:label>clarithromycin-dabigatran DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/6db386d8-7579-4146-99b0-8d9a4d1a490c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/e3bce6f8-0ead-4f80-99a0-0c4c28ad2713">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/4b554f71-6b4f-4278-ad62-18506d2db5b7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/6b793b44-7c84-4fb7-83af-62769a9eb347">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/c2c198f5-9f82-4fe2-a4dd-146f6a9c0555">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/3203be8d-b6a7-4c43-a102-f4a397d96850"/>
    <rdfs:label>10 Percent </rdfs:label>
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/9b06a2ec-189f-4e61-b2fa-9a508cb67980">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/d63a7d7b-f942-40cd-84a5-a32388036b4c">
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/7e8bbc59-8caa-4267-9bc6-8076f5892457"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/5a1d51f5-70c6-4635-b4d3-d2c367e8370b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/1309b19a-b086-435e-acd9-477057234b0f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/45812e88-6679-4f8e-a8e5-787efb7e77ae"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/4a6beb0a-a4e3-49a3-ac10-0713aa3b9ff2"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/58f6ca23-6164-435a-9b58-eb8b1a95f132"/>
    <rdfs:label>carbamazepine-methamphetamine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/0483e58b-01b9-4de2-b38c-efd025cf7269">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/1f33026a-3118-4fe4-b428-23c41a2be19c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/c4e024d9-4747-41ab-a16d-ade4a5679e1f">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/f1fa682a-857b-4f54-9caf-5e0140367c06"/>
    <rdfs:label>3 Fold </rdfs:label>
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/02623eb3-325a-4448-a3b9-23074fdeafc3">
    <rdfs:label>escitalopram-desipramine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/8c9e9787-af12-48c8-aa9e-fe6901147b8e">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/68fb9765-ab5d-499f-8bed-18187d99079f"/>
    <rdfs:label>4 Fold </rdfs:label>
    <obo:OBI_0001937>4</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/438bc012-dd31-496e-ba96-909b9879d4d9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/01f60e1b-0538-42d3-af2d-b927ebbf76e8">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/66748015-50d3-4d7d-9b34-f90413ef9302"/>
    <rdfs:label>21 Percent </rdfs:label>
    <obo:OBI_0001937>21</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/2e886ca7-6a29-442d-a81f-d06d850d42fb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/fdd163f9-98e3-4481-8949-24b899f25b38">
    <obo:OBI_0001937>30</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/4cddcaf6-c8e4-4f51-9960-03638e0b9b88"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/56bda280-fd78-4001-a9d1-8253d23d4cd7">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/259f316d-fb65-4922-8b3a-fb5b33c49c79"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/2e9ea029-7b3f-40fe-9510-47809ea4c138"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/cf82fc41-6da3-480d-ba7c-aba771954937"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/6fe0d2ff-0379-4630-913a-adefebc1dd2c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/a279136c-dcd1-450c-b720-5bc435929542">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/9cdbc204-f85a-4593-91e8-496520ecd937"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/d2a08818-407a-47c6-8937-efef370b58c6"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/6e4e19ce-a58c-4f82-a75a-6b71155d2f97">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/8cd68f8a-c551-4364-ac20-babc66e33ea9"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/8d3b994f-c60f-4dbc-8517-dd62e0f27ec7"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/47d6de10-0363-482a-9264-1fb098ffc6ff"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/87b56d35-bba7-463c-9f7a-93478d5ea5ad">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/76ea5873-28f2-463e-82c5-89b3d112ca58"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/76b62124-ef7e-498e-bdf7-b11c9e3f7cdd"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/863be2da-a80b-46c3-83fa-6981a692a2ef"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/f4906d33-1b15-4dd4-a8a2-5edfa128d5f0">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/cea35177-bb36-4c4d-8f2e-1c8907b7fb42"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/028c727f-0b80-4acb-a908-f84359cbdc09"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/3d370ef3-12c0-4b2f-abf3-c154423a0362"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/b4b7f531-58b2-409f-93df-df787f5b6e71">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/e05d9dc3-b337-43db-b9ba-e7d51aaaf3ed"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/4ea6fb3c-2c24-4806-9e1d-73e38d8cce16"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/739802b8-a323-43de-bd77-b555546cb273">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/5d2dc596-c282-45a8-825d-f327b7c3fe28">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/1cd1e638-7481-4e54-9321-70d06e2eeb58"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/0483e58b-01b9-4de2-b38c-efd025cf7269"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/528ef2c9-37e3-437d-a23e-b6351d1cfdd9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/b87499f7-a4b9-4d57-837a-529544320888">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/6277853e-2197-444a-876a-383311dfeb5b">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/d75a2eef-6460-49db-aa1f-ae3aa4b246c3"/>
    <rdfs:label>Efavirenz-Atorvastatin drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/77446eaf-81e8-4953-85ac-72378c9cd2b3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/5a915a49-832a-4240-afd4-0e8abf228601">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/5e949848-d351-459d-a9a7-518312c56897"/>
    <rdfs:label>up to 20 Fold </rdfs:label>
    <obo:OBI_0001937>up to 20</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/0ce58183-692d-4b27-aa23-66b28cbb3dc2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/8c1c8e32-0969-426c-bc2b-eb15598a51ba">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/a01ca0e0-81bf-4ddd-8214-9c5dbe616c51"/>
    <rdfs:label>16 Percent </rdfs:label>
    <obo:OBI_0001937>16</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/e411677d-c087-4762-987b-c24b9dccb381">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/c8b6d955-1b6d-4533-a5fd-6dcd186aaf3b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/7e729c4c-1134-4885-b489-2d85fbe5ab54"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/2085ea37-c14a-4847-a977-b06fa13d4ed5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/eae5ec03-7b64-4dd3-a791-edd8f57d14ae">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/9b1c8184-b166-426a-b640-a67389acb65f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/e07fadbc-e6ae-48f0-b9ea-01af0877c53f">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/1792fa33-987d-424f-8699-f0c8f52d058c"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/1fe2fe8e-f72b-4521-90e6-7cc44cf82ba3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/8701e0f6-63da-4ac0-95b5-c88a1b613c0d">
    <obo:OBI_0001937>1</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/ca8bdf27-95f2-44e4-9749-f1eaee4aa774"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/1823fc66-8687-4b5c-aa84-52dd6aa94c9d">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/0eac833a-1121-4791-b7b0-fdf0d19718e7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/0074cf65-c82a-4916-8a92-d4a76981c5d0">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/bdfebc48-3a02-422d-8a29-673fb457d7d1"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/2adda992-9712-4bd8-83c2-2910c5b8e484"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/48bd1b4a-a58d-46f0-b546-b15ccc692bab">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/ec190041-112a-48a3-baf4-968806293eb5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/706ffae7-4087-4d3f-ba6a-662b203271f6"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/97a4b625-2ca2-4433-93df-cd9bba4f7387"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/12002992-8db9-4be8-92dc-ffa0c8930fb3">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/7dee104a-535e-4800-9a11-f4a413a8cdb8"/>
    <rdfs:label>26 Percent </rdfs:label>
    <obo:OBI_0001937>26</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/4355cfcb-771a-4464-934e-cb6c6bedad4b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/68fc1554-27bb-4ee3-a9d4-e858a24709b3">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/abc66e39-2ff5-4cf6-92a1-db7b894ee868"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/24a6c92a-be31-40ce-a84d-88a0714e1059"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/40d4ba40-5db6-48ec-a6b2-51356487845e">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/ad3daf4e-869f-44b6-9bd4-709b8053c469"/>
    <rdfs:label>0.23 UNK </rdfs:label>
    <obo:OBI_0001937>0.23</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e4e9869f-9cfd-4b1c-a3fc-35e8c040324e">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/47405f55-e4a8-4ae7-86d3-f84ba80290b7"/>
    <rdfs:label>paroxetine-phenytoin drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/a71f3a39-4d2a-4679-9748-2e4b6369a87e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/ad292deb-7f2f-48cc-bf12-735b606fa864">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/f3c59397-9da2-4070-85d7-dd4edd3f36e2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/0cdc40b9-15b7-4c15-943b-c7f6e9668d68"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/9a187cc7-0272-4efd-bb12-1b84f537a113">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/54a8fd21-6e21-41f1-93fe-ff61f1118617"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/ee2f23c4-43dd-4922-8bb9-510434014f3f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/89445cde-7aeb-4943-8730-f26980cd376d">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/8bd48d77-4afa-48dc-a0b9-5157727c2eb1"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/b2937023-a66d-40c0-bb6c-9e4bb0908e91"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/1cdfc948-0bcd-4932-b3a8-e3ff4e7a86dd">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/c53675ba-189c-4331-a16b-842b6fd780b6"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/a1a59908-0351-4bfe-a5f8-3fadc350ea8c"/>
    <rdfs:label>ketoconazole-alitretinoin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/d74dd2e4-ad20-432c-aced-e83ceaf32057">
    <rdfs:label>cimetidine-sertraline DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/7c5f27f0-1f37-4eb3-aec1-e7f76a63fedf">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/6cc14793-98b6-4cd6-8c3e-f6837add1350"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/73cf1119-fe66-43ab-8609-2987a8788292"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/022fd1d6-4ce3-4936-a777-956dc2c50924"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/cd180e2f-ec2f-4968-ad14-b4b418458ff7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/44159068-1cbf-43c8-a2e5-4a4ca4bec988">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/7efb4dbd-b013-4769-9b46-a6ccea5387a8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/1a0e71f5-5946-4afb-a252-3c289656e036">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/e6907fab-619c-42bf-8575-da6e82fa9f99">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/5c1c5946-692c-4c27-a318-8f7ae8956cff">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/91086d0c-b72d-458f-86fa-f7e6675e796a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/b375eab7-3d57-4a28-8355-25dc5c7d2c96"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/f65aa933-b157-4448-8a5d-4ffacc8fd857"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/1c8e3eb6-0732-4f6a-a5b0-d220e3f975ba">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/84239b40-c8c2-4231-917c-2284cb3bafd0"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/1ba7862e-4f50-4fd2-8aa1-ddd229d0d55b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/33489577-ab9c-49c5-889c-252d8a5bf5d5">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/13168418-7c73-4e4d-b611-582272fcf7cb"/>
    <rdfs:label>48 Percent </rdfs:label>
    <obo:OBI_0001937>48</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/89708702-8056-49cf-9206-3d2b903a515d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/0eb46b5d-e4a1-457c-9ee4-fe248b96afe9"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/6f087f1b-6313-49c6-a635-54503d6112c4"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/c7d0f603-02b5-42bf-9615-a17cc4a87398">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/ba7f8265-175c-4c37-bf57-a7cdf39957ac"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/fbe4d0c5-0f01-4851-913c-85fd30e5717e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/f9b280b7-2300-467f-a8a3-aea9bb29a6d7">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/053ee1f4-9113-449e-8d1c-a92cb9cd17bd"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/ccd6f7ae-643b-4ca8-88da-ebaa111980f3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/9f445c68-59ae-41fe-9f0a-1aa7493b2819">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/b30b8614-4475-4539-a06a-7802adf00bde"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/eb90b8b4-6b46-432c-ae91-8db3f5956868"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/22efe479-cd25-4a96-8490-1673199d96ac"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/8efc59a4-7531-418f-a960-f5ef76e6445a">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/c362fc08-c7dd-4d83-b10b-b8935d17fb2c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/ea11edaa-9e93-46e0-80f7-fee46ea43d5f"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/8accfe57-aa6b-443d-9707-41a54270167e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/4c167fd3-114e-4bb2-840d-41a5b0f95227">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/fe9dbeb7-8273-420d-98f5-2c66ba9de10e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/a3077495-f8aa-4baf-90b9-507e307d70d9"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/35c344f0-8b90-4391-b049-275019162be5"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/aacd6fb3-0ec9-4d73-b383-e154be9df0d7">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/2df0b141-99aa-4e67-a821-e5baf6dc54b7"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/ee9c3247-be0c-464b-905c-229704754c71">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/96c2f2fd-9689-47b8-904f-b193fdf4c1dc"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/d7a63d92-ac1e-426d-a65f-395929a07392"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/77695f48-618c-4205-bbcf-af9cb47df977"/>
    <rdfs:label>fluoxetine-P88 interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/00431608-6cf1-4abf-aa08-9a286d5b091f">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/79693930-58b4-4aa6-af23-dd83c7a484f3"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/c743aaea-5fcd-44c7-87da-539e6a5dcfad"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/1523feee-8ecf-4948-9ef3-34676b78bf83"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/00a30d18-e55d-4e0c-bee5-13b2aa9dfd3a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/17214b82-e28e-4e7f-b096-2ea34c400acc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/ad63189d-9162-450e-87e2-1e8a45fbb7f5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/4359f93e-5f61-4b16-a2c9-f5a09b56b744">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/36dbd033-3ee6-43ea-878c-aa2f71566238"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/420329eb-a909-4874-be63-6b338de66846"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/2820c58f-2f69-41ba-9053-3ab0bf40e2e4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/82efb2cc-00e8-4104-b709-177c65f4cb1d">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/a9b84e1c-fba8-40ea-9a73-f44aa035b11e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/38a95834-5638-455b-a522-285cf859d580"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/db5a8930-c417-4c36-836f-827eb41207de"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/a39d349e-8472-49c9-b8da-493445c6cd49">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/9d3fbe02-7e60-42e6-b6c0-56134f474792">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/eb07e71b-afee-4a2b-9f6c-44b7bcf78920"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/9d66c943-4d94-4223-a91f-b03e24578fca"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/88281874-ecc4-43d1-83c5-7cc9a6ab5c06"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/bad13316-d674-4da3-8064-45db77b6249e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/889b8f08-bc58-4039-884c-b827df403122"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/79567f6e-833c-418b-b235-d2cc63d6e5d2"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/d359fb46-dfd2-4117-9dd8-749cb2814006">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/d01c2476-11af-4ae7-b90d-4dda86dbcfe2"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/3f2b89be-5fb3-4e2d-9a34-287f0fb6af5f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/892db7c3-a534-4376-8441-4643c374175d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/61024bc3-c098-4ec3-871f-0baa06be8728">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/fd914744-5d0b-452b-8105-3db77360ce4e"/>
    <rdfs:label>9 Percent </rdfs:label>
    <obo:OBI_0001937>9</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/d8034f2a-c5e8-46e4-9670-bc215da8e1f2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/734740a5-ec39-4890-bc90-3d47a1c4327f">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/26b2a1c7-71ae-4166-bda8-518b684f6f4e"/>
    <rdfs:label>103.2 UNK </rdfs:label>
    <obo:OBI_0001937>103.2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/83d23fe9-8f85-477d-83e4-8f1b3d60f03b">
    <rdf:type rdf:resource="obo:RxNorm_3289"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/eb683760-abf0-4062-8282-9cce2e363b21">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/253d0bc2-58d6-4a80-bd09-61594dc0e202"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/eee4a522-39a1-4089-addd-1a9051abd820"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/a80c2655-6471-426a-907a-9d3b787a75cd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/a262bd5d-2a9a-4ae7-a5ec-9cf624c05481">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/59f03eb0-f2b3-4a6a-9996-97136a529c72"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/20ad6d5d-7344-4270-a170-b9a6e95038dc"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/b7c7ab66-1419-4024-b9ad-62c09493ef6a"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/639e6c58-b348-4e69-bd95-f0950829c23c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/007b32d3-f195-46b2-b679-6fa2079a9bd6"/>
    <rdfs:label>carbamazepine-INVEGA interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/8b59156a-d529-4add-9891-67335a1904fb">
    <rdf:type rdf:resource="obo:RxNorm_1599538"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/bef81c0b-8b84-4107-ad7c-77a630a6d4d5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/0440d82d-cca1-4644-afa4-06292a24f36a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/dc3676b0-38f1-4e7e-b06b-c13a65458d82">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/0cad4e1b-2781-472a-bfe4-c34e44e3d792"/>
    <rdfs:label>0.84 Fold </rdfs:label>
    <obo:OBI_0001937>0.84</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/c75abdc0-4cb0-4aa3-8e59-1320c04dc868">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/d8277ea8-5fee-46a5-a038-1e519c1c07cd">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/1ef85e30-6de4-4d53-ab5a-0ce2c9f1f5df"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/97c362f9-0331-47b0-9b2b-fc4fd515960d"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/a478b997-c731-4781-a5fb-4ee6787e3263"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/6429daf4-bb65-4c2a-b839-a81272d10a2f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/a4612b0f-198b-45f2-b4ee-7fc419dba481">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/c16557b8-9f4c-485b-aa61-5f5928efc487"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/a47e081e-4dfc-4ca0-8db3-ec9f63c76e9e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/4ffacb43-49a8-43e2-aca2-eba175c99c05">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/83b13b2f-3eaa-472a-bb45-94c4415df8ea"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/47e8bb28-4884-443e-baf1-8178b739da00">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/1633d79e-bee5-4542-bb7d-4cbecf35be16"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/91145ef3-8bfa-4eb5-922d-3cdc9fc49584"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/7fadea2e-fc4a-477b-8ff2-0bd74b800d4e">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/20eb0136-4f3d-41b0-b39f-1c5a6c26d894"/>
    <rdfs:label>propranolol-m-chlorophenylpiperazine drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/10b847c3-3be7-4e2d-96c4-122715f11788"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/9efcb20a-4ae9-49a8-8481-6bdbfb885448">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/5a67f03b-8dee-4fec-a3f0-a096248cfa76">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/268c8482-1e2f-4055-b2bf-2a4fc4ae0f0c"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/e5c1c9b7-06a3-4e8e-aaed-e2e4834cf8d9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/BFO_0000051">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/8b7c9bdf-9e0d-413e-a082-7aa582b2ddf2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/f7b97372-8ccc-44b0-b727-1fc59b55a86e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/cc451833-a491-4ee8-9739-d2500fa00b43">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/66a87868-5e11-4c51-b903-241c5b9863ea">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/9ac8b686-64d7-46ea-b1d8-270a915d44c1"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/77be3aa2-cf73-4b0a-8a30-3f5c7df2b754"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/613dce09-f2f2-46a7-adab-904c7deb16c5">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/bfd53510-e800-41f8-96ba-6deafb85224c"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/546960f4-a34d-4fd1-a0a4-8d61cbf469f3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/7c123247-0366-49ba-8142-35e395c8a4ff">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/f4197b18-cdeb-442b-8d5d-1676039a91db"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/67d3be46-ee98-40f5-9a75-652ff1e4af61">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/dfec51bf-334b-45c9-b877-2fd2ace807bd"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/483fff0b-ae05-4d01-853e-c87af91c9ee4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/966df4c0-f013-42c9-b3c9-42571597ac1a">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/af83fec6-0294-4cc0-a84d-808943626925"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/0ef1cf94-2dd5-4c2f-9dfa-67311391aa2c">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/d5f1155d-1815-4ab4-81ca-956ba0cb1eb7"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/3011fa81-72ff-43e9-ab85-9d1721f81fe2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/8423c249-0b13-4d65-bb45-4e91cf9fa025">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/d8d932d7-f7f3-4c03-aedb-9e73cff34f5b"/>
    <rdfs:label>60 Percent </rdfs:label>
    <obo:OBI_0001937>60</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/90e80a68-ebd6-43a7-b435-d2c766aaf100">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/d30da78e-23b2-4506-9366-f68c6d1b6c10"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/a4521e64-b5ce-4e73-a464-064bc300a4f2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/2efb9cd3-dce2-422f-bae8-e9d33ebe7e4b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/a8c4aa51-3c5a-4a14-8bb1-b0699672d93b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/225b0e97-33f1-4152-bcc3-44aea204ba14">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/900bbbdb-5d9c-41fd-b874-6ee49506fafd">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/3fbcf814-240e-41bb-9f07-8b0ff34d6139"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/77730288-1438-4244-b0a4-78d1f30e7259">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/3b24a793-e6a6-4dd3-80d4-180bf2099f0e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/6bc12412-ea51-4fe1-ac50-16e227d6e9ce">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/0f41aae1-3e8a-4db0-88e6-e4b112e51cea"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/6e7ccb03-a767-4102-b818-a518ca147901"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/f5c0bc60-6800-4ecf-bb54-4c76416d2e42"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/b766072c-683b-49d7-8cc4-cd47a286cf43">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/7b9985df-f391-46b3-a4a0-8a249b6055f7"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/4330643f-5513-40aa-8424-51f67ca33ad7"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/0e987114-1788-449e-8cf2-49b1b0819ac0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/0325654d-4663-4916-a9c9-0cdf67aae098">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/885c4a62-c30a-495c-8bda-88e6ad0caa23"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/02e738d2-5d13-4a8b-a83b-a085a0f9cbf0"/>
    <rdfs:label>alitretinoin-simvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/f80d81e6-42e5-4407-ac7c-6ee94d9654dd">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/a2f60781-9be9-4111-aaac-a2916bac73be"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/33ebb8d5-a52d-4462-8431-00f1ab6b52c4"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/a9176c7d-5b0a-4943-bf42-cd582e1f6eb5"/>
    <rdfs:label>paroxetine-tramadol interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/1f5a6764-fb71-4880-b286-20c43f7c196c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/513e46b0-9942-41a5-93cc-44960fb8ef6e">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/bda25dd0-4f39-45ba-9cca-e79c173996af"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/6ca7438c-84b6-4cf0-9bbb-fb660b5cf04e">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/017e929d-6e3e-4db7-a148-c1f6d942cd94"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/84012eed-b2d5-44a2-911a-d0a2f1084858"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/524a035a-0f37-4f4b-b2f4-73ffa9be6c4f">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/d1e63bdf-563e-4694-8383-29722fa99cdd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/b6539e89-d74d-4873-9d08-773f6fcf5f98">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/0f57727e-513e-44ef-a38e-98ebb431d749">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/a4521e64-b5ce-4e73-a464-064bc300a4f2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/ce2ee12d-ce95-468c-8c24-82786031ea37">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/c678861e-62c9-42ee-b1de-d73805614bf4"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/e44d4ef5-0e89-46c5-b928-78d58333eaff"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/b605946a-dd08-4bf1-a545-f578c7d37d57">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/3c13db7e-c88a-4300-b1c2-077552f8d5cc"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/ad292deb-7f2f-48cc-bf12-735b606fa864"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/a78e6943-62b1-419d-8bc8-385eb551d95d"/>
    <rdfs:label>nefazodone-4-hydroxypropranolol interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/d6d1a27c-7d6e-41bd-8d3a-8fa50f26714c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/7c555b48-ae7a-4745-bba6-3cc822e32bf7">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/594afc6a-8cf8-4c4c-b2d9-23503950f1c7"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/967c6f5e-ba2e-406a-aa21-b1f59d001c0f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/42d18baa-831f-4bc3-afa1-fdf42823d159"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/fa2f2593-afce-49b2-b681-6d9cf8c19d59">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/1523b4cb-bda4-4972-9d63-cca0639121b3"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/62f4c577-1f44-4f68-bd5f-254b0dbd9fa2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/a59aa33c-7d2c-462e-99ae-6cda6582bfba">
    <rdf:type rdf:resource="obo:RxNorm_6779"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a82b4031-95ca-4a33-84d5-d9b9b20e2087">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/dcdd5dc6-fa91-4440-b64f-648651d82d73"/>
    <rdfs:label>2 Fold </rdfs:label>
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/cc441086-6129-4202-9d91-7f33afe23aab">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/c3124f1e-bb4d-438b-a5bd-5c8d33b5a8e3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/eaa30375-bc2e-4652-84a7-aa0d71d942c2">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/ec2d09c6-5074-48f0-8b23-4871df83bd74"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/e5ffd950-0a34-4ecb-aff0-9aafa3b20817"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/5e43298f-3782-495e-8060-901e918ba0ef"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/2e9ea029-7b3f-40fe-9510-47809ea4c138">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/9406109c-13cb-44f0-841c-1507309cf0c9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/85dca8d2-f4b2-4625-bf28-0260c8bf4b10">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/a331bc7f-b047-4038-9371-a10403e5b071"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/cf07805e-6fee-4fef-80c2-23d35e05998f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/1218b922-a077-4f0d-a194-5a6b7fbe8978">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/d48bdef6-9308-4c65-abda-36e20779086c"/>
    <rdfs:label>lopinavir/ritonavir-Rosuvastatin drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/c4839cbc-083c-42a1-9ad0-54f7ce98e481"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/360dbd20-f9ae-4369-85bd-b80ea26c315c">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/85445820-d61c-4cac-8d3b-1a0ae17ed723"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/3346ba72-2757-4f27-8204-9870003e96b1"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/864bc945-c466-480a-9634-727d14ac2b7a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/8c302989-6717-4f23-a3ec-ca7beda339ad">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e314c038-e1ca-4d25-859e-d2a3635d03f1">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/28352f55-ab77-4b4c-996c-8422ca30a72a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/85445820-d61c-4cac-8d3b-1a0ae17ed723">
    <rdf:type rdf:resource="obo:RxNorm_1546356"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/f5ddcc77-2079-4819-af2d-9998ea844151">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/c678f33e-107d-4a00-a42f-f8d51487cff2"/>
    <rdfs:label>Clarithromycin-Atorvastatin drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/dcded61e-9b7c-4534-90e8-ad6558776e28"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/f7bec3ae-627b-46df-85c5-fdfe3ff781ec">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/ce25df40-3d29-458d-bb70-020e1d85815d">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/2897cc0b-3d58-4594-b6ac-d38ec6598361"/>
    <rdfs:label>7.88 Fold </rdfs:label>
    <obo:OBI_0001937>7.88</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/28352f55-ab77-4b4c-996c-8422ca30a72a">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/b0213ea7-af6a-422c-b3b1-c1d8356080ec"/>
    <rdfs:label>2.84 Fold </rdfs:label>
    <obo:OBI_0001937>2.84</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/b96c5c5e-8359-4ca9-bfcd-b4ad42045999">
    <rdf:type rdf:resource="obo:MeSH_C102211"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/6d24902d-9ca0-4d09-ae7d-2561051f3e93">
    <rdf:type rdf:resource="obo:RxNorm_3322"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/ad2720c7-fcef-40ae-b354-69e93f63a353">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/338fa4e0-e3b3-48fa-a52d-ea02c5ec326f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/d7c22e48-6b49-4cad-9275-d4e86c3872e0"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/f429fc91-6815-4d52-957e-0cbe042966b7"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/f95710cc-4894-40be-9fa3-38973ab85768"/>
    <rdfs:label>carbamazepine-hydroxynefazodone interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/14c2f614-79aa-4de1-ab4b-995b92795159">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/aac8aba8-2f01-4538-92b2-86e199a9c4ff"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/65f177e5-0140-4e18-92cf-0a0d172cc2b9"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/20ee39ad-f218-498c-b09f-865917016c91">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/e43f10e7-ee70-4390-8166-4cbb76685b83"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/ef4f3c2e-c6a3-4555-98eb-7449579fdbbf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/6e80ac3e-6fa9-4d2b-9fef-2c7cd87c1eba">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/aafd3dd1-482e-4904-82f5-ab7f22c52866"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/2732f81b-f551-4425-b6bc-73b69b002100"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/853ccda9-4cf6-4112-be68-79629b2ccdb8"/>
    <rdfs:label>citalopram-desipramine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/37ca87dc-f980-4253-9495-5d15c1afde9b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/503ba1f1-a00e-4acb-9e52-879a7fee25c5">
    <rdf:type rdf:resource="obo:RxNorm_11289"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/885c4a62-c30a-495c-8bda-88e6ad0caa23">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/d30be50d-f196-4067-995a-53ff00911219"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/72a5f568-a931-49e3-8b67-e8f1a1ec2d46"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/29b76738-c893-4c22-b639-6db15fd48d45">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/90bec411-5700-40a3-911a-05e5f054d191">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/7b8b8d61-5ca5-464f-88c6-92fcd68afbe3"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/39e6c0f6-40f1-4369-9a22-b5fc80f2f75e"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/ad508dc1-1d02-4cec-a75d-6e73637c895a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/7d4a5d7d-b15d-4b5d-bcff-aed8ce4e24ee">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/b0505456-03ea-44b6-98b5-b57073610efc">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/0f6c8b6e-929e-47e7-af73-7a05ab1749fb"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/b5e94e40-4cac-4545-8605-588f161cc12f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/d0653ec4-a878-44fe-b3a3-2e681b6550cc">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/756edf21-5c3f-43fc-9469-a043de541d31"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/8e5dea4d-0d02-4f33-96dd-a52b7e54d0d0"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/3b41adbb-b3af-4669-aa99-ea3cb0e02870"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/824fa15b-37a1-4407-a8d4-78900cf85696"/>
    <rdfs:label>ketoconazole-desvenlafaxine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/ac0ef354-d6bb-47ab-9f9e-15b65955edf2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/aa158a95-bd4b-4121-b6b7-e43e54851e66">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/a4d93b4b-0399-47c4-9749-6fe44ecb119b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/e8578ddb-3a49-45c9-b7b9-3668f866ac17"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/921a3700-bdcb-4de0-afe5-e57917d64c55"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/eada4354-9861-4343-8975-ff30d4e5e448"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/174feef9-0392-418d-97ff-d1732f3d2f9f"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/7ab4f82e-ee7c-4dca-8945-0ed4c9d9623b"/>
    <rdfs:label>amiodarone-dabigatran interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/74f05ef9-07dc-43fb-8f95-38eb157e4a33">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/bb222152-e862-41c0-94c1-cd150cb41930">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/e6626689-c232-41d1-aecd-3e4bffb4a516">
    <rdfs:label>quinidine-dabigatran DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/0f6046e6-84fb-4a9a-82a1-5ecd0743e2c7">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/27ebd1ba-5550-40d7-9ded-d32603810246"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/6d336556-3e70-4a18-a5c5-b2a20e49ef80">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/f18d5eff-c610-418c-8128-2acb7eed4edb">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/330f45d4-372a-4082-928a-6dbd31355fc6"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/fb1295b2-bf45-4703-a39d-b54fd8add79f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/20329a78-5464-4e9d-808e-7b8425cdc4b6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/79c18850-d5f4-4ecd-a519-c02b3a7eb63c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/fe0afe68-76b0-4e92-aeb6-1127ab028ff2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/7ca38953-76a2-4c26-b930-013d9538a206">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/0a1319b8-de06-46fc-ad76-0f0183f943c6"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/570e8606-21db-47f6-96f4-085845ca97fe"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/5a6a65a2-f950-40db-b8fc-3f7157f4334b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/49e87e01-6033-4e1b-8e61-5103af70f0bb">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/de927940-8244-46bf-887b-38b7cb340be7"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/24b1d2f2-b77f-436e-890b-29db2ea11ce3"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/4035cdf4-08a4-4e59-b747-4708a82cb438"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/14c2f614-79aa-4de1-ab4b-995b92795159"/>
    <rdfs:label>low-dose ASA-Edoxaban interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/c8a22d60-ecd0-4ccc-b07d-9010a8e91557">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/97ca23d9-3e48-48b1-80a6-3b1fb4f5c76d">
    <rdfs:label>Nelfinavir-atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/d52d3976-8d9c-4754-8740-8e1abd99853d">
    <rdfs:label>amiodarone-warfarin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/573b1a8b-73a4-4387-a2ae-6ef08c9edc57">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/c468d6c2-51cd-404d-bc61-d073b3983d36">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/c3025b88-6300-4dfa-9c53-5cde79d08ead"/>
    <rdfs:label>atorvastatin-verapamil drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/722c6fef-526c-4d6b-9817-43697c7f651f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/f3164e93-d18d-4db6-a2e4-1c282a7e7990">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/ad181b03-5ea5-4e84-8f66-6ee1112a3df5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/36cae759-aa95-403b-ade1-1aaf55360dc4"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/8d84876b-2928-4ea6-a74b-53318afd2fa6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/0176e2fc-d112-4116-8b65-102551b8c751">
    <rdf:type rdf:resource="obo:RxNorm_36437"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/042704c3-e134-4090-a6b4-2a7b59e6a4b0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/167cb479-1715-4c29-ac25-4debb21bb00d">
    <rdf:type rdf:resource="obo:RxNorm_2541"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/2f8081ae-60a4-4102-8038-e5f350cd47aa">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/9533c96c-0e80-4a8e-b223-814d3f01106c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/602ecdf5-7410-468e-8acb-c98c109a3a27">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/9cdc88aa-96e4-42db-a560-c0a9cc2d05c8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/3eea0896-2df8-451b-af35-4eba416c7a2e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/e1aff51d-10bf-4727-9915-4c465a1f1f23">
    <obo:OBI_0001937>240</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/4a345bbe-9e36-408b-9db6-d60c2918fc54"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/f7a15e3f-efa0-4915-bb6e-b640f2151ec3">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/9a44bc58-077f-4374-808e-b74da25a8699"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/baa843b0-b27d-4789-8d6a-44d6108225b4"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/18de3096-6120-4dac-878b-f4da33354e4a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/05c726cd-4689-4e1b-b54c-9468d0576ca2">
    <rdf:type rdf:resource="obo:MeSH_C060062"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/3a25dcf5-b693-4046-b80e-0897a2bcfdbe">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/63b0c545-68e5-44ff-8908-1f1f4a00c548"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/37eb3be2-ecbd-499a-b0d1-f04336bb6d9a"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/f866085b-1792-42cc-8a3b-260b24053bfd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/f8d5a379-db47-49d0-8a02-5cf30e9341e8">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/3ad371cb-f8ad-4beb-b78b-83b2cad8271a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/b17cec29-c53e-4161-b1b8-aca8cdc14d37">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/46ef398d-0df6-4352-a048-4fc9797a2fe3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/e57c0faa-541a-4361-bd4b-f753d33e499d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/02a85d6a-8754-435d-b47f-a8e03a3293f4">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/99607a14-c67a-4bd4-8ed5-acf16ce6225e"/>
    <rdfs:label>rifampin-pitavastatin drug package halflife Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/0c090e7c-7008-480d-968c-bb78a3257159"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/8005161c-2a0d-40d3-ab9d-9cb1bb22cb4c">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/b704b560-6959-427b-8261-1b44624c8e80"/>
    <rdfs:label>79 Percent </rdfs:label>
    <obo:OBI_0001937>79</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/a71ea2c5-3b32-497d-8ab3-c51325a4d034">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/35ab1ca8-7a82-45b0-aca8-18348863d5d9"/>
    <rdfs:label>clopidogrel-fluvastatin drug package auc  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/9cb3e1df-85fb-424c-a38d-73b2aa027564"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/1b5dfa54-7843-4ba1-b7ec-2621c07c9b9e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/202e77d9-a637-4303-beaa-f75cf91520da">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/51785bef-ce62-49b6-b985-a3442dffc942">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/dbcd143b-5e13-4273-a973-c9d5b300eac9"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/a8fbf5ee-d594-4ace-a9ac-f80eefb41ae1">
    <rdfs:label>warfarin-ambrisentan DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/8c2700f5-bd63-428d-99ed-a6e9aceb2dec">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/8a3e0dde-f9d6-4000-ad60-2c362b029ca7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/eb8c84ed-c78e-42bb-ae1d-5ef3a67d288c">
    <rdfs:label>Fluoxetine-olanzapine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e8578ddb-3a49-45c9-b7b9-3668f866ac17">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/fe350716-6358-4cf2-9dfa-bad0dc32adf4"/>
    <rdfs:label>amiodarone-dabigatran drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/2ac03c48-43a2-4b85-b2d3-c411b0c706dd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/336069cb-bc92-434a-bfb0-c91c0db454c6">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/8904d496-de25-4252-89f9-0800915f8a68"/>
    <rdfs:label>duloxetine-warfarin drug package cmax  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/0441c6ab-e32d-40b9-8699-69448ffe94b5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/ca294ba3-d163-49e3-9de4-692313d76778">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/2758d427-dccf-4c70-8b88-d2c116e045b2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/18e2982e-278d-4cb7-bb2f-ab7f72bee177"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/9694a299-e990-477a-be18-383aeb22de07">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/1218f00f-8dbf-449f-b8d9-762696d58c00">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/9334aa74-0a7c-4361-9877-61e5657d74d6">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/b111beed-733d-49f7-8cf9-4d3297e21b1a"/>
    <rdfs:label>clopidogrel-bupropion drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/8423c249-0b13-4d65-bb45-4e91cf9fa025"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/0a774898-ac14-4a4b-a23b-69e9f0b6a50b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/5aa96ea2-7357-4f33-987b-6905430e5bf2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/2f7ec1d6-5c3c-4bf7-b9e1-5b9d1bf10c89">
    <rdf:type rdf:resource="obo:RxNorm_8183"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/6d43ebe7-a9cf-4520-bba2-53084b6e1de7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/16e93a92-6b10-4c89-9506-1f2403b79188">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/a5d1894b-9c63-46e8-a37d-83b54b54bf6f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/7d4a6357-ddcd-4e40-8f63-b6631bd85c2d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/c233c4d3-b241-4377-9602-e48ae066d4ee"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/02b0d811-5298-43c7-a84b-bcc9e4e4e6c3">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/c4d1ed52-b419-42f0-a0e9-1a7b1bf5e95d"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/7babaa74-9fb4-4c91-bdb5-8fdf368d502d"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/ca6db112-2f61-4098-b4e8-469b3377e3d9"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/f18d5eff-c610-418c-8128-2acb7eed4edb"/>
    <rdfs:label>ketoconazole-dabigatran interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/ba22d944-54e2-4045-b858-2a3acce78462">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/e34b77a3-3c34-49bf-8029-f291144d6cf1"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/a523f874-c264-479f-81bf-478248dfeba5"/>
    <rdfs:label>rosuvastatin-Lopinavir/Ritonavir interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/9ff59ad5-2644-426c-9f64-fbf7baa4b584">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/9795a09a-da43-44cd-af85-a87779c1f0ae"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/86b86765-406f-4c8f-9502-fb5145b8bc57"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/7cccd4ff-381e-4f9c-ab6b-c9f05e8d8354">
    <obo:OBI_0001937>8 or 12</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/1c7ecdbe-21ee-4e1f-9d3e-f8b3a193f8a4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/23cba13d-aa24-45d6-b8f6-91331540ef76">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/e21211c0-2c5e-4500-bede-83f6c3e71160"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/51d5b655-8c8b-4d03-89e6-8287f9e92573"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/45391281-2f37-4e1d-9a31-06cee17dcaac">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/bb26b5bf-ab90-4757-9e59-921b9150dc4f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/5e167b0c-6cec-4d72-bd4e-c18cdd5dd354"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/d8e06f01-e114-4c6b-a345-f6a7a694b95a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/8d0d79c7-575d-4a29-942e-f7855c149d8d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/be74934e-9774-4d86-b908-50a9c6f1f600"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/4cd5526e-2bc5-4b37-9407-919ccb74ac4a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/5b050d52-1896-482e-b5f2-2b699d010955"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/14ae3f86-3a0e-4311-bd22-2891e69b9e71"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/a4078a76-671b-4d40-9978-18b2c95b9fbd"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/c7a4b74a-0ab8-4698-8502-9b88239a50aa"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/939cb2f6-f27a-4356-9947-42cfdba910a7"/>
    <rdfs:label>ketoconazole-zolpidem interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/d0f993fd-7152-4ca8-8454-d6421ca06e98">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/4c782f39-2859-4119-92fd-613cc7fa2608">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/08d5ca11-4626-4a94-be86-22250a8a4191">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/c2670224-95b5-4b94-830a-83575dfca4fd">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/bec9cb7a-940a-460e-a63e-341c303ca62c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/26d03100-1d46-453c-86df-c2110eebfa6c">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/fee3b57f-b55f-4561-b33c-2429aa45e8bf"/>
    <rdfs:label>3 Fold </rdfs:label>
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/be95d368-7265-4758-9ff6-5c2019dcafed">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/8bf19883-ad97-4b5f-9c21-db1665b81a3a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/5559a0a9-0b02-4691-b290-d575dc727282">
    <obo:OBI_0001937>180</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/8517598b-91a3-4902-ae4a-59d59f40e312"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/658cdf1c-a230-407d-8987-e4740be9507f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/a61ba82e-2b8c-4c3c-9ec9-57942b5182a1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/544d9e1a-1d4d-4f85-8e04-e16fdaa8b1b0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/939cb2f6-f27a-4356-9947-42cfdba910a7">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/56bda280-fd78-4001-a9d1-8253d23d4cd7"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/1d510844-aa81-4699-8550-c68fe5d1871e"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/1c510296-c7a5-4bf3-9460-9907a943632c">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/fad57d67-7e47-49f1-9625-b9791c5cbfb7"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/d854b108-5bb4-4cee-8d72-a9e7754f172d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/edc22c4b-897e-4716-8b7d-74de659ce0c0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/3a233df9-a625-47e1-98b4-a4013a5861eb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/9640a21b-30e1-40f9-906f-7227a58d9bd1">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/1b5dfa54-7843-4ba1-b7ec-2621c07c9b9e"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/c62e9ce4-7afa-48c1-8fe3-da9e7f0429a6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/b64c164c-de2e-42af-b125-400771cc00df">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/d6bb39ee-db83-48a6-831a-6e102392d3ad"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/da710fb7-261e-404a-ae86-645715fcb494">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/0eea905a-f94d-4cb4-853b-eede4e1d5cde"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/b1ae0124-bdef-4e2d-ba67-18c68ded23eb"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/8c999da2-8089-4851-b4c0-6cc49b1bf816">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/68098df0-9e1d-4a7a-b133-a7179cfd29dd">
    <rdfs:label>fluvoxamine-mexiletine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e2c8c184-692b-4648-9bf0-ed146e57260c">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/b7684c18-1cda-4ac4-be85-0841c5fd3247"/>
    <rdfs:label>cimetidine-threohydrobupropion and erythrohydrobupropion drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/a8785fa3-f7bb-488a-9302-d78e984e1fd7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/0ee61c67-a4c4-40bc-b0df-34cb15d8d110">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/bd073076-d31d-4cdd-ad7e-263f7c6eb786">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/2544327c-be45-4573-92f4-169b1be031ab"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/65739527-7807-4759-a6be-7d01fa60e3c5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/1eb07266-2e3d-4f6b-9d5a-0107bffa6f4f">
    <obo:OBI_0001937>400</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/229ad34e-8290-41de-9c5e-e872c1172f6a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/35501f67-3a74-4b1c-8dd2-12a19b1d1e7a">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/0905571e-1f7b-4310-ab8a-ca050c2b7fdc"/>
    <rdfs:label>57 Percent </rdfs:label>
    <obo:OBI_0001937>57</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/604b3cdb-5673-46c8-8bfa-8bdf2a0ea976">
    <obo:OBI_0001937>Unk</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/8b9f2f3e-210c-4e10-8114-d42bf94540d8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/7901d590-9a10-49af-ab5c-69e722f5ff4a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/13c121b5-a0bf-46fc-a071-a43674cdfeac"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/a02462e1-a867-431b-bb63-6f25d26d7ebb"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/8dd226d2-d85b-466d-9172-ca6a0948d8b0">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/8005161c-2a0d-40d3-ab9d-9cb1bb22cb4c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/c8ca70b4-24d8-4ef3-aabf-a6f4493fdaf7">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/be4859ac-84dd-43bc-b6ea-10ab75ec3366"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/aeefbb2a-96d0-45cd-8c91-968f26591888"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/5eb4337a-3c60-460b-b01e-d0d00df9ab24">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/3a233df9-a625-47e1-98b4-a4013a5861eb"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/0e744c64-3a2f-4096-8e9d-044a2db24412"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/d290eb13-972e-4abc-ac5b-c2a84b7ef7bb">
    <rdf:type rdf:resource="obo:RxNorm_31565"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/c89fe522-ac60-47db-935d-bbdc70cb5ed7">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/fbfeb74e-cc4a-44fe-9f3e-2b68a901ce67"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/6ef07bb8-1585-42ae-a79d-0b3d66442c0a"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/5e1d0b27-72b0-409e-a6c1-e39d72643592"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/97a6b13d-dc02-4dd8-9dc2-705fa82bf2dd">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/930a5200-aed7-4233-9fd1-f9358046b6be"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/09c0d609-57b9-4e15-8f26-0be7b7be867d">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/5dfafccf-f4ab-4db7-8a4d-59ef81fc1ca7"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/adc6117b-11b8-4892-9588-bad0b66ba3b4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/f5f5790c-d998-463d-a7a6-b195b730c5bc">
    <rdf:type rdf:resource="obo:RxNorm_2002"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/3025f317-4038-4f2b-9140-f1671886e934">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/7276125c-d6d9-4a48-9665-997357695418"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/b0523029-38c3-4ce2-9f29-6739a8a520a6"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/017511fc-37ca-4446-a42d-749ee048c36b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/91110d6d-1612-458b-ac69-3d6cdd2847ab">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/587102ac-1ccd-46d8-b09b-014512e6b8d4">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/97fa9e06-0e44-4c0b-9d4d-a1a27f50338a"/>
    <rdfs:label>carbamazepine-ziprasidone drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/b0f6ca3b-7220-4023-9742-35348852e9f7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/fd4f127b-ea26-4ad2-a02a-2299b814b4ca">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/fb15ea75-54bb-41aa-a833-b8f08ad962de"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/fa2f0c05-2720-4279-9468-b5ee02848c76"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/f0e74d9e-0dd9-4c82-9bfe-629517cd1aab">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e2b5b5cf-f355-41ca-b6c1-7f25744dd946">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/f3048158-6c30-48bf-b971-11636561db77"/>
    <rdfs:label>buspirone-hydroxynefazodone drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/6741e979-a6af-4b2c-982e-40ff02a13f06"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e943ea84-2fd4-4126-881a-5c69de573583">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/47cb7427-1758-4629-9b17-76e7d3a9bd93"/>
    <rdfs:label>desvenlafaxine succinate-desipramine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/be33f0df-0edb-42cd-a35a-1da5fa05a553"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/1be5692e-4757-4c32-b14f-abfe0d7adf50">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/854253cd-dbc4-428d-bd8f-e1e3575476d3"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/4bc3a64d-d44a-4a1d-872b-66df899f79ec"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/1ec28b9b-8fbc-4290-b4ff-9493839dea70">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/2b644ada-9385-4b20-8ed8-d85908b0f2d2"/>
    <rdfs:label>50 Percent </rdfs:label>
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/bc1d8e71-5864-49f6-a962-4887f16dc0d6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/200e1563-0715-49f2-9577-f70882f10fb5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/29b00e14-9f9e-4170-84d6-0884bb94d91b">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/8d7bb40f-3885-482d-84eb-50bcf187e862"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/0d8af8e1-620a-4104-99cc-5bddb9c27e85"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/bdd3a716-58c9-4372-a743-236eaac44fd9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/0c9c1d32-a833-4363-ae44-c3d5963c85c1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/878651d7-2e91-4634-a64d-08044826cf94">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/57115106-ce29-43d5-b901-aceb0d810d9c"/>
    <rdfs:label>21 Percent </rdfs:label>
    <obo:OBI_0001937>21</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/9f567384-fe50-4526-9f75-22f6911add37">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/ed8a0ac2-a43a-45e4-8de6-451b6694d97c">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/473e1b48-3b5e-4996-a21d-258463e407ac"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/f8d5a379-db47-49d0-8a02-5cf30e9341e8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/8e7bbc75-628d-46ed-93e3-e0b52288f260">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/d9b9e831-91ea-4501-b9ce-1357e7ff4066">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/83bdee5a-3fec-4f4c-9e20-ba30faf41531"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/33a31ae8-f643-4fcf-9517-099ac6db568a"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/b2c838c8-8829-4f28-8660-bf2377375ad5">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/46d79dcc-55c5-444b-9102-cd286eaa7e57">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/be4c11cc-e631-4f46-aca0-4f34d7843733">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/1e406a6e-d235-4e13-8239-7c018b8d2258"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/a7e013db-7372-4c53-bf5b-bc211b0bb560"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/30d5dd09-806e-482f-922d-19c4d97b625a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/ffd573a5-1110-4c08-80d9-8f5a62768fef">
    <rdfs:label>citalopram-desipramine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/9a0a954e-87d3-4f68-a7c9-36e913ea8e0d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/d9197cd5-2e4a-4d0e-ad01-007f4a225206">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/dbc89e7b-bec0-4606-a1d2-8936f3de5753">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/90fa1e19-0be0-4720-9f1f-d8be2b379a4d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/cb51099b-2fed-48b4-a347-12415fc6e151">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/137de959-16fe-4621-a642-0b25f48cb821">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/408d69b7-dd09-4a14-ade2-a6bb3e847032"/>
    <rdfs:label>2 Fold </rdfs:label>
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/144f5512-c040-498f-bf2e-ba272ef19612">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/7f7c73cb-5632-4c2e-a70a-9ebce9cfd44c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/9c87c790-05e1-4a80-aa46-1b65d32d0338">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/c21c5a2c-2ce1-49ec-8928-a2748c492164">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/a8e81847-6a20-4f8e-bb96-dd40ed2cebc0"/>
    <rdfs:label>up to 50 Fold </rdfs:label>
    <obo:OBI_0001937>up to 50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/dcfe8541-7b6e-4f8c-98f7-efb9c55838a1">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/6594818b-54fd-4ce1-bde0-90ef48b9ac0d"/>
    <rdfs:label>fluvoxamine-duloxetine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/60ab044b-3ebf-45ef-8fea-764bde00b9a4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/46a768b1-ed99-4606-9a40-59f360ab10f8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/1ec11a6b-89f1-4e78-8057-d283b5b0d15f">
    <rdfs:label>fluvoxamine-N-desmethyldiazepam DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/e79a50cd-318e-4a8a-a066-646576b0d205">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/6e3a162b-4627-40d1-b16b-baa2da0f0cc1"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/e4bfac7c-738a-40d0-87c5-e753a094e2bd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/c4d1ed52-b419-42f0-a0e9-1a7b1bf5e95d">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/c96c1471-5d72-40b6-80fa-a0dcd1242165"/>
    <rdfs:label>ketoconazole-dabigatran drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/7411c814-b9c3-4a19-910f-5abe128e8cc9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/22f84f5d-a792-4848-9789-3ff932ff2885">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/df56a825-20fd-4114-b998-97f914bc04d8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/e0cb3b7a-1318-4f98-be43-0af295e57aef">
    <rdfs:label>ritonavir-hydroxybupropion DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/095ab47f-e8af-4340-a2d7-fba3e9874660">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/4027ba9c-d80a-4930-a036-329e4679944d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/6a3ac0e2-6256-4164-a4cb-ab00405d5b55">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/ce2c6129-8cd4-4946-939a-12db4629aa73"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/3e7a500b-e32a-4590-adf8-926693446d89"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/a8c847d9-1698-4cd3-9fc2-1ef52b18919e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/93b97569-86ad-4225-b733-f1e1387b2390">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/25fda15b-6c98-4a33-91eb-5a3767ab0ac2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/2e107fd7-e86f-44d3-82c3-5990022276a8">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/817842a7-f723-4bf1-bf7a-4842b7807da7"/>
    <rdfs:label>1.4 Fold </rdfs:label>
    <obo:OBI_0001937>1.4</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/7c1dcd1d-2245-479b-ae4b-843db5b5d86c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/218cd32c-e68d-4160-b64d-4388673d9834">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/6200d069-7b62-43fc-97b4-686fcd5b2b39">
    <rdfs:label>low-dose ASA-Edoxaban DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/f98ab704-77aa-4769-b533-f5656d473887">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/6879f54a-b0f4-46dd-9fc5-4fc496a787b9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/3e41ec4f-53e9-4283-b606-a52e94c78dbc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/9c21da82-74df-48c7-a0ff-42a08b0ed4ed">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/0751ba48-1fbc-400d-bc55-3706062602ee"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/e984aa27-a228-4be0-9a11-15faeaba58de">
    <rdfs:label>iloperidone-dextromethorphan DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/8a6ab728-a99e-4d75-b6dd-c0e81d852f06">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/0c9e3560-38cb-4857-a824-e026927bf736">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/0231108c-2c3e-4042-987b-e52829215041">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/a8d8a858-6a6d-4bfd-b770-ffbc7f662191"/>
    <rdfs:label>nefazodone-triazolam drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/e0ecb2c2-1e8d-4bf2-b87f-07a9be700e87"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/7516c72e-a845-4745-8a25-1689fdd0af2f">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/3cae1f29-e68b-42e8-a89f-d3bd95b53360"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/3e2df0a6-357f-4816-8620-bb0fedca8d13">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/9df656a6-0faf-4ac1-859c-08b18fdc0280"/>
    <rdfs:label>phenobarbital-paroxetine drug package halflife Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/18c8dec9-c898-4d19-98c0-304e1b1c2141"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/c62e9ce4-7afa-48c1-8fe3-da9e7f0429a6">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/00248bf6-8dff-4be4-a6f3-5ec6cd1f1262"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/3d17f648-6e39-42fa-864e-ac5eaaf2240f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/8b9c5810-f260-4f05-b8c6-59ad5c13c6e6">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/91638688-c922-4d23-b4dd-73dad92fe8f2"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/7d5ebb7f-4d70-43c7-9fbe-f3d691a72032"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/3d5b0921-84bc-4814-bdd8-565203e2705f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/e0457f0c-4b84-4374-b7c2-c3ff54b8c295"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/b1145f59-67ce-4314-a3e0-7869f2dd8ad8"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/81e36b6a-b9e5-423d-885b-f0ad568f6de3">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/e75a5aa3-3da9-4871-addf-3b5715b1e089"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/b4d689fd-7585-4c05-880d-298c00f2c31b"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/e37cdc44-b273-4368-bf33-3b58d682a035"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/b17b70ea-4cf2-48e3-9f3b-793672fe5346">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/a1de9c7d-3504-4090-9511-b2592024d542">
    <obo:OBI_0001937>125</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/144f5512-c040-498f-bf2e-ba272ef19612"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/0d3044a3-5aee-44a4-90e3-c300fa476561">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/e85f3b06-c5f9-49f3-a74b-031c408531b4">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/090561ce-228b-4e1b-aaa4-37446e72bde6"/>
    <rdfs:label>30 Percent </rdfs:label>
    <obo:OBI_0001937>30</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/4a2944e1-a53e-4122-ab0c-cc05af2a727d">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/b0a12521-1b2d-4b63-a851-4ad9290fafd9"/>
    <rdfs:label>50 Percent </rdfs:label>
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/bb4f87ee-1def-4170-a620-79e1a0e21552">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/111280b1-d2e4-4a63-b1eb-7f4447c02781"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/75e654c4-ac4a-49c8-b92f-2794692ac713"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/add76ccd-5890-43bf-8e9e-34e5e18ad557"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/62556358-6897-4eab-8fbb-61a28deeb8ea">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/8368c026-baa1-4d69-9689-090bd32f6bc1"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/a8c4aa51-3c5a-4a14-8bb1-b0699672d93b"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/cfb4c4cb-cc04-4b78-b24d-de3372162973">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/9f8de545-d571-48a1-9546-79419eb2629b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/3a51365f-4950-4465-a723-cf7c0c2857f5"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/852aa65e-64d0-4d7d-b5ff-7b7da1b15b56"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/a21a427a-2541-45f0-93bc-121fc64c9721">
    <rdf:type rdf:resource="obo:RxNorm_195085"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/0c02ecc2-850f-4e8e-8933-b6f3e9b3bba7">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/fd2c394d-ad9d-40f7-bb71-6b515844d588"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/5aa96ea2-7357-4f33-987b-6905430e5bf2"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/8fa8220e-ecec-4da9-b9fb-ef21b34e6a87"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/7960214e-16c0-4fe3-83f9-fd96f85c9b78">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/c4a04170-d295-4f58-8774-7a3ddd66601b">
    <rdfs:label>sitagliptin-simvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/c85f3ee3-88a0-4c09-8bbf-8ccd33e9dcac">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/c8ff1f0d-b8c2-450d-a8fa-6dca55ac239b"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/d3d9547f-b091-46d1-a5e6-72cdd7c9e243">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/af4447e2-9092-4e50-8c5e-3d82748bc289"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/6d76ccf5-3da9-449e-8db1-76abca7df33e"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/b40021cf-f149-4775-8c33-bb0ac496e60a">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/c1e76235-6878-4a73-ace3-3d95acaec566"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/94d9a8a8-05ec-410c-aecd-ba7a9fd6a25b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/0f77b7c9-9ff0-48e3-b7ab-4b21299d01a8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/3d658302-0e51-4acf-a61a-9068eb6360ed">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/66517f6c-e558-458a-88b8-fe7fc846f94d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e619b7eb-54bb-4ba3-972a-61647c133e40">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/43f1a5cb-96cf-4583-a425-5a35a9d98bac"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/72aa99f2-af8b-495c-a964-a943a132ecf8">
    <rdfs:label>simvastatin-bosentan DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/af24be4b-0ce0-4475-ad78-bc834f8dfbb0">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/58ede1b6-a502-439b-9a5b-30423cb7cfd4"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/190d739f-dcb9-4411-bba6-e29e81fd9a88"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/f65aa933-b157-4448-8a5d-4ffacc8fd857">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/063e30d5-b81f-4cde-8aef-90f767437e51">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/81c064d6-f518-424a-8555-4921237e3458">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/c6162111-0a50-4e0c-979b-5db2f60ba885">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/0eb46b5d-e4a1-457c-9ee4-fe248b96afe9">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/a0c62957-4f6a-4318-ad80-11cd4f924962"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/b66908c9-8bfd-4ef4-8fa0-346ec9aba775"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/ad4fd5ec-519d-4b22-8969-51a80c8a05b4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/e6f3582d-ef92-47f3-99b4-3291d14341a3">
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/7b69f5a7-7572-4dfd-87fd-acb90f0e8314"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/74eda6f0-1e94-4ab5-a59d-269dc9c656e6">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/9989754c-665e-478a-aa24-3f0fee2ee5b9"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/1571a5e1-0ee2-479b-831e-50176ac03800"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/a4f6bb3e-f0ae-4829-99de-3cfd5fc1e28a">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/7b7f8a6c-5ebf-4bf8-8abc-789fafcf2f33"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/2d1729f6-8fb1-48be-b15c-e41a10083b8c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/817f2ed2-ffea-4021-a88e-2d04f93685ba"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/187274e6-142f-44ea-8f37-f8a84b32584b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/c64da2f4-7239-4737-8a3c-490d8745e83c"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/b0b53472-ffe2-4956-a670-d2cc1518e527"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/798cbd23-0b08-4903-8d02-303d064d7b57"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/d23ad2ee-f4b1-4cd3-af54-2f2918825600"/>
    <rdfs:label>rifampicin-rivaroxaban interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/e9ca2a3c-2d99-4285-aa57-08dd4433d043">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/ca120c0d-c922-4498-9a45-19c53bf020e2"/>
    <rdfs:label>6 Fold </rdfs:label>
    <obo:OBI_0001937>6</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/01166835-db80-4bfb-b302-3afc8dde324f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/83bdee5a-3fec-4f4c-9e20-ba30faf41531">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/14d1fb29-08c7-4d63-81cc-859799c74dd4"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/5f72a7bc-3fb1-444d-8b49-fd934b8d5160"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/786c5cd2-5905-40c8-9397-742a14e7f618"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/72a5d286-5f5f-4a4f-8f1f-8ebbfd774796">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/ea43a98d-1537-4389-99f9-7111c5b4fc5a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/3ba2d4c1-a973-4f3e-9171-4869f83faa1a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/77725804-26c7-4419-895a-f5bc438f52fe">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/651987db-e0d3-4cc2-bd76-3d4dbf263b13"/>
    <rdfs:label>midazolam-rivaroxaban drug package halflife  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/f6352586-931b-4c3b-9987-db16b828d2ea"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/a450c92d-1ea9-46a5-b838-6e593d24466b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/62237e73-c6ab-4cc1-b727-f47099b63adc"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/37d4a1a0-b8e6-4630-a8b6-3d3de71bbcbb"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/a00cab87-c88b-4656-aba7-2e12a59dabf6">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/55a15853-d287-46b3-9b4c-8a8e178cedb6"/>
    <rdfs:label>telaprevir-amlodipine drug package halflife Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/33daf9ff-39f1-43ad-9127-0e8886ec0962"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/59bf85bd-bc82-43a5-94cd-0fe9a40de203">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/31880e33-a1ce-405a-b3ca-72fa443f2592">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/8fc68d43-fc00-4ba2-9752-8ba01cd9226b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/bfbd741c-1244-468d-a7d8-5e5c870a11fd">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/fad5a90f-12c8-4e31-865f-823304c82281"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/e285160d-bc5f-4acf-a17e-993aeaf43cb7"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/72efc4cc-0765-4c5d-9278-606d518ab61b"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/597c005b-6f01-425e-af97-dc3ca830ff94"/>
    <rdfs:label>low-dose ASA-Edoxaban interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/95a811f2-2e8b-4ab4-a456-d30df4809795">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/5b5b8280-eba1-47ec-b6c5-71c9d7980bae">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/5c1c5946-692c-4c27-a318-8f7ae8956cff"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/a69a85a5-32d1-46ea-b6df-9ffcdbedd873"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/999825fe-6123-4620-aca6-e0624993a377">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/6f3d6540-852a-41d5-8d2b-853d76ef20ee"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/56daee46-5d71-4653-bce4-8e2d1cbf0f22">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/ed5c9c3a-7203-4326-96c4-957dabb3dcd4"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/17275df8-2754-4fd6-a28a-6e7241e9b3db"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/e2798e3f-249f-4aee-b052-dad131d7fec9">
    <rdf:type rdf:resource="obo:MeSH_C558899"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/4529e51e-dfe1-4344-b396-bdeacc904d34">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/f6f973a7-5811-4acf-a953-a0192cd8c70e"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/302db8dc-0fa1-4239-973a-cf7f09329194"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/c2c1f694-2fb4-458a-9460-34c8623524a1">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/825c0634-cf1a-4f94-9786-787d02d36e1c"/>
    <rdfs:label>4 Fold </rdfs:label>
    <obo:OBI_0001937>4</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/e413056b-b953-42f2-b7ff-99e697548145">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/c11489c4-3075-4975-8788-77b27f940664"/>
    <rdfs:label>15 Percent </rdfs:label>
    <obo:OBI_0001937>15</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/0216e4ce-fa7b-48fe-8218-73a6929a7e48">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/167b2513-2400-408e-a8cc-d7eeaea310f4">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/be36a2c7-33dc-4a6e-97f4-ede414041b58"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/b3df0c1e-46c1-4350-8c13-10c04e4cb7de"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/d803d58e-b9e7-4784-8961-bfe866a60345">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/24710782-a92f-474c-854e-4e85a80b7a58"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/5d9c9499-8cbf-4c6c-bc6e-130d982d1df6"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/c3458a2b-f554-4907-b0c1-f7ce9a2737ed">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/8715e437-7824-4c3a-abd0-8a71169bbc32"/>
    <rdfs:label>50 Percent </rdfs:label>
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/3b2b80eb-f63c-499f-85b9-4a21ee0c166a">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/cbc036b6-2942-44d2-8b76-8b56a9a72b63"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/870e5b3d-b047-4e04-8160-bcc1987fa059"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/d4a40131-7a3e-4748-8bd0-04a5fb3e8788"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/f1a2dc42-7d0d-497e-8141-37517dd1f9e2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/a21edd74-7534-48bf-b170-227bc4a29fef">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/879ca4e8-ebba-4e01-ae6b-dbfa993c04cd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/5f621b12-01cc-4feb-8889-fab8b0b8d5fd">
    <obo:OBI_0001937>60</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/2a5887a5-296e-4f2b-9787-48e49f963af6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/5afef711-c957-42a8-9e5a-0085b10fc03a">
    <rdf:type rdf:resource="obo:RxNorm_358274"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/62708a1e-a91b-4791-9725-bb7d2fbba3cf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/80232d33-e33b-42bd-bde2-88bfc6a9ccda">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/39c98f6a-b8d4-4c74-b970-5a47b1194438"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/fd93da0e-90b1-4f6a-ba34-f5942cafc310"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/d32ceabe-374c-4895-a327-9b149c60dd3e">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/1471f962-696c-4fd8-bbca-fee8feabb2f6"/>
    <rdfs:label>Ticagrelor-atorvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/d1aa67fb-27e2-4197-b0b9-1425430a15c4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/d35fd02a-7f25-4b1e-bc54-08a7bb275b26">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/10d83d25-cd15-4749-9579-ff5a5116cd2a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/cdf8cf1f-fd1c-4ef5-bc50-cc0358c5b8d5">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/cd364de2-cebf-4282-bca8-ea68721cc6f5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/3ab9a8ae-a07c-4634-a728-b616fd65c358"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/700e0dec-ac31-4a02-99e0-6265490279e0">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/678e6755-7c4b-478a-871f-30ed56d5a3d0"/>
    <rdfs:label>paroxetine-risperidone drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/8c9e9787-af12-48c8-aa9e-fe6901147b8e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/f21a6d80-9ae0-4230-8142-9740ea30d493">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/fd934894-bfb3-4183-9cbd-9f02669bde72"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/cd80be7c-7ca3-4b6d-8f4d-1844133ff208"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/bd073076-d31d-4cdd-ad7e-263f7c6eb786"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/500d4252-5079-4941-bd1c-300043d1a894">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/a2395009-44f7-4578-9f07-79704b00ee0b">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/80791f82-4818-4c45-9308-7adb4a9c9004"/>
    <rdfs:label>zaleplon-diphenhydramine drug package clearance UNK information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/db69cbf7-3221-43a4-948d-0c87e8667ccf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/0be431e8-ddf5-4159-abb6-27cf04136be2">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/17c3a02c-2a9d-4786-a7ce-1cea9d3e7609"/>
    <rdfs:label>ritonavir-rivaroxaban drug package halflife  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/aeaeb7d0-d918-4562-b4d1-ed4486a4dced"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/3bdcc4ff-a041-407c-ab09-e331cc6af627">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/8650e9fe-d517-42a7-a12e-975322816f4b"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/efd83a49-7487-4032-b23f-9101b9f8fc96"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/580666c8-003c-45c4-a98e-1b77c11329af"/>
    <rdfs:label>mesoridazine-Fluvoxamine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/f04482ae-5783-4ad4-9a46-9d2ec7b5b9ff">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/a2032d7d-9044-4c94-bf13-a2c94c5747f5">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/ac0ef354-d6bb-47ab-9f9e-15b65955edf2"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/6bdf01df-0929-4e51-8742-cf0953d91692"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/ec1ac74d-07b4-4f5c-bdef-fdb8c5065aea">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/c5e44452-f6dd-4649-b731-5e6d2338d845">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/906fdd27-8373-4bf1-952d-643bd66fc241">
    <rdf:type rdf:resource="obo:RxNorm_1546356"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/4439e66b-5451-41f0-9b41-81a355d9f870">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/2d5a3b2d-3c00-4847-9091-5d88e3baa1a1"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/c7219f73-b04b-43f5-af31-03eb24dc241a"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/eeb87e57-4c8d-40f4-9ffc-342c5779866e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/0bd6f4a0-4e31-4a89-af8d-64e2bfb92249">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/659ff95f-c8b5-412a-9ac2-1df5bd9faf5c"/>
    <rdfs:label>rifampin-zaleplon drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/b699ab1e-5490-4741-9b5b-49d9b602ef36"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/11130902-38e9-4efc-9c1c-6ee5d7c7a5af">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/dae873bc-157b-4876-8229-2cde37a4f6a1">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/8aa2f21b-d302-4143-a7b9-db99b3826086"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/933a978c-59f6-4151-877e-a34698252c34"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/bea8ba18-711e-45a3-83ec-02cb57e0e546">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/2a786adb-d9ab-4b7e-a708-23b6671f5ae2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/590a59d3-8aaa-4cd8-8b16-3f6228830239">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/2bf270ec-3922-4567-8977-d54c80ca1e7f">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/c8111cd0-fcb4-40b6-82d6-524ed141b533"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/080db6ee-b1aa-4ef0-a0c3-a776de69657b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/f18e2c9c-f836-430c-9363-1125301c2015"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/2270e7e9-8f7d-4c50-80ae-4d579a8973d6">
    <rdf:type rdf:resource="obo:RxNorm_81864"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/27b256da-535c-40e6-bba4-72fc39fdf650">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/d652bb4c-feed-4923-8285-666af12cfb01"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/6b3ad920-2434-43c1-a6d4-c0c2dea7dd5a"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/d2131273-0e57-45d9-9cb0-7469ff493d0d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/069f3ffa-28dc-409b-bd24-063116dfbd8d">
    <rdf:type rdf:resource="obo:RxNorm_195085"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/3a140cff-3c63-4bf7-b222-7d32d3849ad0">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/c505b620-07eb-49cb-ab26-085b5e41120d"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/1a7c564a-75d0-47a3-8461-f8ed3212915b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/77f50bc2-407c-45e7-b420-3f4afb6effa5">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/6e0b2484-73a6-4dac-ae85-8f223f3ddd16"/>
    <rdfs:label>30 Percent </rdfs:label>
    <obo:OBI_0001937>30</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/30912982-9334-4b77-a196-9a0943ae4bb0">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/372348d2-4398-4a72-ba2a-039f8c4f5c47"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/0440d82d-cca1-4644-afa4-06292a24f36a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/638194f6-c60d-4a3e-88f7-06ed8812214a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/870b0aba-00ab-4778-bde3-bef8c2f7254f">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/1c0eecf7-1c24-463a-a0ac-b5c38f67428b"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/03fa77bc-0b22-43e7-bc54-73b157cde3e9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/30145897-e26c-4d24-b592-1dc5b30fd996">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/8bd48d77-4afa-48dc-a0b9-5157727c2eb1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/db1b9d6d-d075-4200-9041-1dd9618c8fad">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/85cb8f1b-9167-4755-b2c6-f097714ede15"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/79c18850-d5f4-4ecd-a519-c02b3a7eb63c"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/7481fb5b-63b7-4600-a751-c8379503d8a1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/0a56aa3f-47a4-4665-a0fc-be503e563e50">
    <rdf:type rdf:resource="obo:RxNorm_352741"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/a61a14b4-1c96-4e4f-8876-22318e2c76c8">
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/dbe8dd00-963c-4b52-9d65-c2fcddcdf296"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/864bc945-c466-480a-9634-727d14ac2b7a">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/9a7071e5-bb4c-4538-a35a-f127cdd2b2cd"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/8c896e89-6bf5-40dd-a6e8-ed9dcbcf0b7c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/3de33ff5-c126-4626-8015-55ac6110b3a8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/e01f19d4-66d9-4b9d-8f79-4d2cf415f93c">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/5eafc98b-0877-4794-bd8a-5d922d47ce50"/>
    <rdfs:label>50 Percent </rdfs:label>
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/a003e1f5-c550-46f3-90a9-1a7e853955f3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/d162fb65-d43a-4eba-b588-9f2ecc4a2715">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/b3b58875-b85d-4fe8-9464-ade166f90a7e">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/4c78791a-0ccd-4762-9c3e-1234cfcf06d6"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/900bbbdb-5d9c-41fd-b874-6ee49506fafd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/04f121d3-ba6f-4ae9-9dae-557fa76cb772">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/502fac57-6e57-4026-a4ca-7cbd848a1183"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/6f2112e7-412e-4441-9f11-91786e86c52c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/1bf56cc4-6d0b-40f1-830f-ef420bb67180">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/e758f5d9-9f7b-4b1d-bb98-bc84ba6159a5"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/0a78fea2-5afc-4f6d-9cd1-f21d646a0942">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/a88b43bb-beef-4975-87d6-03c27607ae8f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/711446fd-0d93-4826-8f26-d089994ecc40">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/00d55913-3e01-4111-9945-6daad7a53fa7"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/5b4f98af-5cc9-418b-8286-b4a0435d3598"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/be925372-06b9-4952-bbfe-cb3fa3505827">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/94cbcee7-c422-4626-afa9-5aebfeefa20b">
    <rdf:type rdf:resource="obo:RxNorm_8787"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/0f487bd0-15ea-49ba-8a76-941235a2b4a6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/84c3b674-450e-4cf1-9588-c6fd3f0a361f">
    <rdf:type rdf:resource="obo:RxNorm_3247"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/1ba7862e-4f50-4fd2-8aa1-ddd229d0d55b">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/72af9dfa-a7b6-4667-93e0-f457a170dfe2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/1c2f2b1a-dd59-4ffc-b1a5-15932a31c1f6">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/1ef2f06a-6fef-4af8-abc9-0f6ab22d0a93"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/c2fe8971-efaf-4e52-ae61-f2d97fa1555a"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/4cc941bb-b973-4a26-9456-1f16b8e57836">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/82570a4f-45b5-4f41-b456-4caa04d4479b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/090561ce-228b-4e1b-aaa4-37446e72bde6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/35199bc3-766f-4d50-8847-09d9adfadcd9">
    <rdf:type rdf:resource="obo:RxNorm_1546356"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/a4e2953e-9baa-4d3e-87aa-f7bf247123f5">
    <obo:OBI_0001937>400</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/d20b8a80-dd03-4d29-804f-17e6cd286049"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/f4b1f2d0-9184-4135-9cb8-eb5c9169cb7d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/8689187e-cbec-45f0-a2c3-86a9ce3758d0">
    <rdf:type rdf:resource="obo:RxNorm_42355"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/2213d8cb-2980-4188-8371-b86775f17b07">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/53892299-d937-4328-9c5b-531f3ab369b7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/84574d5d-8b17-4f6b-abf4-9a8da2ee8f78">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/39bfc487-6568-488b-979c-18707d390c6c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/fe0d8a04-192d-477c-a030-4d16fb11684a"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/6d0ba148-3595-4413-badb-6560400288d5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/c46e05af-0867-4450-b08e-9ea65e3cba1b">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/3fe1f91c-e110-4ccc-b047-65b61656a705"/>
    <rdfs:label>2 Fold </rdfs:label>
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/85d55114-d5a4-4de9-bac1-3fecac5ac1c7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/f03673c5-ede9-4c8e-9c2e-d079635428f1">
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/d9ce6a6a-a8ef-4fc3-8e14-158e87d49289"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/c4989981-8c99-42c9-ad2e-6aa941ad9e81">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/26234cc5-f402-45db-988b-17b3864fb882">
    <rdfs:label>fenofibrate-atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/f651f870-6352-4dae-8b14-2d130f58f778">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/238f44ea-c0a3-45f0-8b89-76c62606ae88"/>
    <rdfs:label>16 Percent </rdfs:label>
    <obo:OBI_0001937>16</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/91d480e3-0594-42be-b654-9063ee759598">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/75f609a3-55e4-49bc-a64a-4c2edbadc5e7">
    <rdf:type rdf:resource="obo:RxNorm_72625"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/DIDEO_00000050">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/c0e5549a-0ee2-40aa-95b4-96608c00e5bf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/5d25950c-6602-4004-ad8b-69463e46867a">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/4bb48206-8883-4b81-8add-bac70a00b391"/>
    <rdfs:label>2 Fold </rdfs:label>
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a26f5b3a-855c-4077-b0a6-774a6eac7509">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/4352090d-5d9b-41a4-9b7c-b316ea00f0d7"/>
    <rdfs:label>158 Percent </rdfs:label>
    <obo:OBI_0001937>158</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/2ee7dba3-926a-4433-85a1-997d3eb1dc59">
    <rdfs:label>ciclosporin-alitretinoin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/f1fa682a-857b-4f54-9caf-5e0140367c06">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/29b5c39b-bf0f-41a1-84bb-e0415ae58b55">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/71cc008a-d691-4d38-944e-0f045b4cb637">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/0045ecd9-0a56-45d3-851b-3d17c2052107"/>
    <rdfs:label>pitavastatin-R-warfarin drug package auc  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/5845324b-7696-4378-85ea-0276eac780fc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/c79edf8b-b4df-42d2-9e0c-14f888c00003">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/85cf648b-adbe-48c9-b42c-d377ae5c68ca">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/f3862e77-2559-4a74-b1de-d4a42e4ac3a2">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/fb9beb3f-8f97-4559-8926-5227acb49094"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/58626754-ee03-4b67-8325-9d58e7cbe497">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/45745013-cfee-4098-a092-92631188d0b2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/0d457dcc-4ee9-445a-bc99-8cbd020768d9"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/b90e18a3-b525-4cc9-8ee3-411821f01ddc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/96e2b14a-b87d-47ef-9864-735b66f2fd55">
    <rdf:type rdf:resource="obo:RxNorm_8331"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/dbf47488-ab48-419d-a94e-f5f87d2e3bcd">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/0216e4ce-fa7b-48fe-8218-73a6929a7e48"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/e0d5774a-0705-4385-82e7-3ffc78ff2d7d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/f8270c98-059d-4fc9-af22-64b05687f349">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/0fed6fb1-5a2d-4a7c-8ba1-ddb693e21203"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/bc2ef585-6235-44fc-b5e1-e115a59cf080">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/2285042b-89e4-4373-bda2-628fbb85a4cc"/>
    <rdfs:label>erythromycin-rivaroxaban drug package halflife  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/5688d59c-5803-4ed9-85d8-1bd7740513fb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://www.w3.org/2000/01/rdf-schema#label">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/130c217c-611d-4e37-ac3a-dc5d9b291be5">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/23f2471f-fd1a-4d63-9ee7-9412237d0da5"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/f4f706d8-3668-4ffd-b671-d900bf6cde17"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/9aca7b3e-7cad-441f-8318-c364f98d1681">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/a2e643b6-feaa-4db2-bb2a-d70090ab6d02"/>
    <rdfs:label>23 Percent </rdfs:label>
    <obo:OBI_0001937>23</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/44b93f15-eea2-4be3-a614-d243f43a20e1">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/bb667948-5060-4fe9-acb9-13e8c708267e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/ff6735ad-63e1-4bf9-97f0-553569780e43"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/b77cef71-cdb1-47a7-8104-e573bd902ba2"/>
    <rdfs:label>LPV/r-Midazolam interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/94fc11fc-c87d-4206-99e6-e57c6884a71c">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/1f5a7d51-69c4-482d-8c5a-a1c7dc4e0f88"/>
    <rdfs:label>60 Percent </rdfs:label>
    <obo:OBI_0001937>60</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/7d66ae14-c3ce-426d-be71-97953f1988fd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/60b2e4af-b97b-4327-b836-52e31b1f4493">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/cc32200e-422d-454d-af57-d867712b8b7c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/c7fdac2d-5b7c-46fb-8f60-f06e10a2853d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/6f9133b0-9d94-4a3b-8eb4-4058aa2b3d71"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/fb9beb3f-8f97-4559-8926-5227acb49094">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/55a15853-d287-46b3-9b4c-8a8e178cedb6">
    <rdfs:label>telaprevir-amlodipine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/e9888929-84fa-4259-bf67-2f369dce23a5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/33d5fb4e-eaac-4d11-92d3-e5c8e6a4b882">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/8face4e2-7c10-4c93-bcd4-9157b7f9f650"/>
    <rdfs:label>57 Percent </rdfs:label>
    <obo:OBI_0001937>57</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/27c26c3d-1030-443a-8991-0c66ab606b07">
    <rdf:type rdf:resource="obo:RxNorm_6816"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/f6e5046c-f103-4c41-b712-f855bf4a5896">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/c92ace6b-2425-4874-96e5-35f59e50df2b">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/5b6a1880-2326-48da-9fcd-7c250b1b0140"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/cdd8aeed-d963-4e25-aa84-6cd989b57f9f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/fec8a8c1-4f9d-47aa-834e-bbbbba7810e2">
    <rdf:type rdf:resource="obo:RxNorm_8183"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/53906f94-023c-4c72-939d-684496fb1ee2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/bb80e3e1-8849-4154-bbd9-95ccbf434ac4">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/c8b659bf-2f1e-4f27-ba08-7d4deec5b827"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/c5e44452-f6dd-4649-b731-5e6d2338d845"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/b8cb6719-ea33-4546-804f-e3dde8f203d7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/3bc15e2f-448b-4ab4-956f-ede674a5a559">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/5e093727-8b93-49b2-b2b1-4e244ce3b9ca"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/e3cb1cba-d2ee-4543-a418-f5eb7acf401c"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/7c5646cf-164a-4848-8c2f-b893a8b3038a">
    <obo:OBI_0001937>5</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/84656a11-cd61-4bfb-8045-a652b298c7a3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/29dda91d-17ab-47fe-8eea-d7e2dd7f6a53">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/5401a9be-33f3-455f-a25f-a78113445300">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/f278aa4e-81c9-4d93-9199-bb52a0ff147e"/>
    <rdfs:label>aspirin-rivaroxaban drug package cmax  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/65ca00a8-5bf6-4fbc-a62e-a8ae86603053"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e285160d-bc5f-4acf-a17e-993aeaf43cb7">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/6200d069-7b62-43fc-97b4-686fcd5b2b39"/>
    <rdfs:label>low-dose ASA-Edoxaban drug package cmax UNK information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/0d780060-e040-4550-bae3-e16cfc88c4a4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/09eeb01c-cf5e-4023-a3f7-61ad958f8770">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/14ce319b-b4a6-4d8d-8589-c975a912b703">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/8e39656d-01cf-425b-988e-8a2481f35de8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/9488b72f-4410-4b2d-a3fa-f651fdfb59f1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/70358b58-bb7f-4e79-bea3-6438efc9fed4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/09072007-f93f-4117-88a6-3c8aecd7c0ee">
    <rdfs:label>nefazodone-atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/94b7a846-10a7-4a59-8a03-3ff572c857de">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/ff3db9ff-35a0-4d2e-82fe-3de3abcb5c10">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/3cae1f29-e68b-42e8-a89f-d3bd95b53360">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/08beee4d-0650-43c3-89c7-a4a05fddebf8"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/58426bae-b1fa-4330-9acb-18b3c6a57ee0">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/a39d349e-8472-49c9-b8da-493445c6cd49"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/f853df85-cb07-4d17-9fb5-38db641a5d73">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/8d5894e7-8877-4e33-b37b-cf31944afe96"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/700bd9ce-52b3-467a-a7b5-6e9fcd33e108">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/a003e1f5-c550-46f3-90a9-1a7e853955f3"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/5f28a13a-10bc-47a0-a026-33b343a241ed"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/d3c9e6f7-2192-47c3-932e-011d0ca4cbe8">
    <rdfs:label>cimetidine-citalopram DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/cec9a630-d1dc-4096-96f8-d057397cbbf9">
    <obo:OBI_0001937>5</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/5da0b401-5fea-4428-b027-dd4f488421e5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/ffb4fd64-dac6-4237-99b5-a449b6528d00">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/6391431a-744d-4c45-98ba-b051b297661b"/>
    <rdfs:label>fluoxetine-triazole-dione drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/b8edf3d8-ca76-49ae-9a0b-8c3878c771cc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/9f092c57-b48a-4dc4-bc28-33eed91a77ad">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/993a7c8e-dd6a-4114-b885-4d7699bf6bcc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/23dcc326-10dc-4f45-839e-5b4fa4c528fb">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/030d2075-b132-4f5a-a8d7-fdc93e36f7a7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/cdd8aeed-d963-4e25-aa84-6cd989b57f9f">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/21f0f2f0-581d-4b5e-8ac1-ff41b7a8c4e9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/dab0c71d-5147-4398-ba68-42c405a9fd81">
    <rdfs:label>risperidone-valproate DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/a38d5e49-149f-4dfd-8b49-29e23e6e54f0">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/8c380678-4ae1-4d6c-a238-3f7f887e1489"/>
    <rdfs:label>rifampin-zolpidem drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/51298d74-3aae-4cb9-bdaa-dd79973ec7c3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/9795a09a-da43-44cd-af85-a87779c1f0ae">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/b3f0677b-af76-41f6-a0d6-670015153e3e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/eb81aaa0-5376-4cba-abe5-2ea8b3af1fa7"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/a2a8e4c7-4b05-47bb-af96-7dbfc7eb54ae"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/f1aad1ab-575e-4f73-919e-e323c9562bcd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/77be3aa2-cf73-4b0a-8a30-3f5c7df2b754">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/3fa5d052-e1d0-4f73-ba3b-48415f15700d">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/21886568-6211-4adf-bc17-cbc43aa7e63c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/49a42e82-2ae1-4bde-a375-4fb55a9e9024">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/225e7035-ce56-4b1f-859d-4a2a06242327"/>
    <rdfs:label>UNKUNUNK UNK </rdfs:label>
    <obo:OBI_0001937>UNKUNUNK</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/f5e6b8b1-1580-4975-a594-57de738774f3">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/7e53bf3e-d7b6-4de7-b252-e9c2ceb39315"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/a01c5351-aa69-4d21-9ebe-8e7342729a72"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/69cacca7-8701-4f16-b2d4-a1d24ececfe7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/848ed393-bcbf-4575-8a23-47695878d749">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/0bf9f570-78b6-49fd-9e66-b23f031ee28c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/d23ad2ee-f4b1-4cd3-af54-2f2918825600">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/87b56d35-bba7-463c-9f7a-93478d5ea5ad"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/db0e3b16-406c-4015-bc9e-352ee6ebb5f0"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/9ad4a3bd-3b90-4762-bb9f-3cd4d96946c4">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/27f25646-9f9e-4420-9596-94d5154631c6"/>
    <rdfs:label>ritonavir-bupropion drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/29ea69c0-242a-45bc-bef7-9aef1a687979"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/2a5887a5-296e-4f2b-9787-48e49f963af6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/639e6c58-b348-4e69-bd95-f0950829c23c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/210bee54-3174-43d2-89f4-14bfcf855f98"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/b32c0f2f-7961-42a9-8e77-a42ea8a121fd"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/f76dbf1d-c822-450f-83e0-043593aa6b34">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/863be2da-a80b-46c3-83fa-6981a692a2ef">
    <rdf:type rdf:resource="obo:MeSH_D012293"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/16c40c3c-837c-438e-aab0-a9b8374b51c6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/6567c74f-094b-45b3-86d1-4d9c500e55db">
    <rdfs:label>mCPP-desipramine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/284a28ec-b957-4fa3-b8cb-d12beecd6eef">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/7f85467a-bec1-4a90-8b84-df6192754c47"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/e7cdae4a-77bc-47b9-82f6-411f4e22a3b8"/>
    <rdfs:label>alitretinoin-ciclosporin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/e750dcf2-09a4-44ea-979a-4634821aa7af">
    <obo:OBI_0001937>1000</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/5c654bdc-ce44-4dce-bfe9-ced2404adbc0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/23aa7ad5-824f-49da-8800-e6838c9a3ed1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/af9deee3-9bd7-4820-b357-8c9a77549f9b">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/1432f67f-76fe-47ed-a656-181f9868c48c"/>
    <rdfs:label>nefazodone-propranolol drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/81a1b9cb-a5bd-4b2d-a231-e684e01cefa2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/05b4054b-4e2b-4d68-8e4c-2ea27c593808">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/ad211dfd-b7a0-4e04-a960-87afead31c40"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/7f456144-f23d-49af-8d70-1ead3caba906"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/9b3236ab-6576-4d00-ae40-316c6e6921de">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/fb8c93da-b086-47c7-b9c9-9773cfb84e12">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/48993144-02bb-4a75-8677-1c732f36ae90"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/29094c90-af7c-4ed2-9c69-5b54a01efc00">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/c8522f74-0c5b-4ae5-af40-9f8dab5d1aa7"/>
    <rdfs:label>ritonavir-bupropion drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/7d9237cb-b5fc-4ce7-8378-b7941424eef7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/6556c582-9f8e-4023-afba-c9047b8dca23">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/120d1d98-cee9-49e5-8e1e-b7ce879bcce0">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/aa10836e-63da-4c34-8571-3014e7176c65"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/2a11d3c4-507f-4889-b265-340641dffdd3"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/fd9c9289-9aa2-42a7-9343-6744b28f426f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/d2076eca-6017-4d67-b961-a4299d9c8282"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/eb94032b-7dbe-4b76-b508-5fa9b59f9224"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/65f177e5-0140-4e18-92cf-0a0d172cc2b9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/54db5af2-b545-49b2-ad78-113b8a5ddc6a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/38c6da15-0685-48a7-b631-dc64d0173cf5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/33bc5526-aedf-4bd9-a963-b2892e42e152">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/9f7a207a-5821-4cf0-a482-fa79b43e84ae"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/7d1a1627-03d3-4995-8ea6-be7591ba981e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/713933a4-ff0c-4b5a-9305-446516cfd679"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/07ff0906-8589-465c-be91-2efadf4a6345">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/12459a5e-23a8-4509-b2c4-ce0672c07c9b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/b0c7adca-1cd5-4cff-9521-7cb291ff2275"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/edc22c4b-897e-4716-8b7d-74de659ce0c0"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/c21641ff-b200-4cd8-8a6e-42b9eb1f1f89">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/d3d7a0ed-5227-458c-8d6e-86d2d6cc3ba2"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/2926519f-a7a7-47cb-aa4a-8ab21ade5a4d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/f753fca9-79af-43f3-bcb7-734390916cec">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/408d69b7-dd09-4a14-ade2-a6bb3e847032">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/a117ab8a-a3ab-4dd2-bd43-430e2d1dacdb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/11ae4554-44d3-4bbe-acf3-af7f88818c29">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/b18727b3-22e8-456d-b84d-1a653f9121f8"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/555985a0-f88f-4353-a03f-47912ff0b148"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/f5f5897d-97b6-43d5-91f0-0c6e8af981cc">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/67d3be46-ee98-40f5-9a75-652ff1e4af61"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/059af977-c56e-40c6-8a75-b4ffb6f769d4"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/cec71460-f428-4715-a273-8943bf45e4f3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/a9b84e1c-fba8-40ea-9a73-f44aa035b11e">
    <rdf:type rdf:resource="obo:RxNorm_1827"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/bef218ac-082d-4616-aba2-2a11bba3f74e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/1299d741-8793-431d-8ff3-c09e1a412e36">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/bab45b7c-a3c5-40ad-b2c7-1ef50f79d9d7">
    <rdfs:label>ticlopidine-bupropion DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/2c58c49e-2689-4669-8270-8a5ece1147ca">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/9dc0c2c1-4026-4909-a058-7333e37d8a97"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/bc686958-bfbd-4a06-a9e2-ce44684919a5">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/b1624e1c-92e5-4197-aca3-b8228473126f"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/48c257e9-c5dd-43ff-b6e6-4005153d3ade"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/0b47fa33-ac95-4f39-89d9-adf521ea7907"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/fea1f1fe-5a8e-4db5-b27c-77f6397b17a9"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/41f08544-7eb7-4929-a43d-7c96006ec044"/>
    <rdfs:label>quinidine-dabigatran interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/29beb17c-fb9b-4bec-ab0e-a27c19e2dcce">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/53a02392-cc8f-4f2b-97d4-a20036470300"/>
    <rdfs:label>Gemfibrozil-Atorvastatin drug package cmax  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/3f52e93e-3755-444e-9131-feace19343ff"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/9282f6fb-ebfe-4592-839c-a980cf42b533">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/3ad371cb-f8ad-4beb-b78b-83b2cad8271a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/238370d8-a897-4e55-872b-93472f8365e4">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/beae3aad-a88f-49cd-aa1b-478158b9f10b"/>
    <rdfs:label>3 Fold </rdfs:label>
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/30dc5e43-9617-4ba5-8d6b-32a65c23c20e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/9ff5c29a-4589-4e28-b5b5-01b2d3cc7d48"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/16b4811b-55b7-40f2-89a7-b4bdd4a5a7d9"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/f73e10f1-679c-4fe1-8599-c903ddb9a9f3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/f32c4ad5-8b69-413e-b600-9074ce878f61">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/89979cb4-0ae1-462a-aee2-0341c46dfd97"/>
    <rdfs:label>35 Percent </rdfs:label>
    <obo:OBI_0001937>35</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/05890b93-fc3f-42a9-b291-7aef1d1dd81a">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/c25167bb-667c-4426-aa0a-7f6e742c87a7"/>
    <rdfs:label>simvastatin-digoxin drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/c2523cd1-a77d-4ebe-9b73-135fa8d1801f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/7f17f72f-e468-44b5-86ee-fe11e79bd167">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/fb09c3b2-5f03-4eb8-af6d-bd5f7f93fd1f">
    <obo:OBI_0001937>50-200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/00e1a507-b4ce-4f66-92d1-b4809058cfb9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/84ff9c43-3d9c-4606-b5a7-17a564aa1787">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/8d652514-559f-4da7-a39a-d9e11fbfc995">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/c7f00660-5d72-4fe6-8a44-a2486784b13c"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/9a93f1f9-c14b-4884-bee1-95da39ac9f99"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/fdac9405-ba83-4de0-8614-4d29198b2c21">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/c8c3e464-5e01-403e-8ce4-6d15a0ed818c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/2e0248ef-6e86-423a-9b73-e3559e90bd52">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/97c362f9-0331-47b0-9b2b-fc4fd515960d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/9729d871-0133-410d-8b74-996817a30a3e">
    <rdf:type rdf:resource="obo:MeSH_C558899"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/227ddd43-46ab-4418-9e5c-934dc5540080">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/28ace315-0f32-46ea-9e91-3aab192b0f41"/>
    <rdfs:label>paroxetine-atomoxetine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/fda549af-5de6-4366-950c-256a62bd1ba1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/6ae3035d-e8b1-437f-aa23-6f179be3de55">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/13649698-2973-429b-b1cc-7f597bffe459"/>
    <rdfs:label>21 UNK </rdfs:label>
    <obo:OBI_0001937>21</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/4ae8f50f-7506-4e00-a812-a17ee115169a">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/51c5bfa0-8d04-488d-8640-f67a93427672"/>
    <rdfs:label>rifampin-dabigatran drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/7b7e324a-b880-42e0-9891-0bea3b35b248"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/26085036-e046-49d5-89ce-a0967dbb8623">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/87d4a18b-6ad0-47dc-937d-8da2e6b3941c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/8a3e0dde-f9d6-4000-ad60-2c362b029ca7"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/b4584828-c988-4d5f-b7bf-230ae7c02a94">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/0e7ca6b9-66c9-41cb-88a7-631828220e66">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/a718e4a8-2066-4e67-b854-4872382d1c8b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/25fa121d-0cff-41cc-a66d-3cef8c47cf7c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/82036479-4a2b-44f3-a831-35bff551a4e0">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/05105507-3b67-4518-a06c-c942ceaee838"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/770e7489-a04e-4e2e-9e37-88034197111a"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/55b45150-0747-48da-a308-5244624024ab"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/21a33916-2cea-4423-84e1-b7690ed93bf7"/>
    <rdfs:label>ketoconazole-mirtazapine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/3c1ee6d9-1592-4495-97af-8b92018ce30d">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/2285042b-89e4-4373-bda2-628fbb85a4cc"/>
    <rdfs:label>erythromycin-rivaroxaban drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/9a26c401-cbe9-471e-9081-ea7be3edf840"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/48b5cba3-3f01-43a3-8551-f323c722b803">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/9f6d162d-8525-421e-b5ac-4b78096bee38">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/f900a3d9-ee3e-4e15-ac6c-f6db029d42be">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/630b15ad-df4d-48f0-b0a6-8ca1632a42d6"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/d1adf36c-1863-4204-81a3-06af220eaca4"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/8dbbcebc-84c7-4128-8591-3018b9972bef"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/78fdad0c-e5e5-4e1f-9aad-12790a6bb39e"/>
    <rdfs:label>paroxetine-pimozide interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/96c2f2fd-9689-47b8-904f-b193fdf4c1dc">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/9a9b1240-c091-4c2c-9d42-565624502f59"/>
    <rdfs:label>fluoxetine-P88 drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/a38e8943-09f6-464f-9c29-66d0e12cd4f5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/4b01302f-eb4d-49bc-a9f0-afa76953bcd7">
    <rdf:type rdf:resource="obo:MeSH_C040634"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/7520123b-aab9-42c9-8a36-e6df9dec0f32">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/b2e22f69-1ca2-445c-b25b-d11bff6ade5b">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/5df55dfc-3c51-4920-b1ab-3c0449fe199f"/>
    <rdfs:label>lopinavir/ritonavir-bupropion drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/9548d7eb-0a71-4c96-ab33-9da9bb19d8bb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/e2638114-e3b1-4f23-8d6b-6efdb6041d84">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/906e7177-6775-4cff-aa47-468e25bf142d"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/d940bbe5-bba0-4c58-8ae2-43e58348d9e9"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/053eec63-135d-4622-988b-b934f72b370f"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/714cbaa5-8bad-42ba-8a68-a7c9f46e178b"/>
    <rdfs:label>Boceprevir-Atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/83de4e4c-28c6-4ab9-acce-2834dfad159d">
    <rdfs:label>ketoconazole-alitretinoin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/850bc41e-a77c-4d85-9abc-08cfef5311a9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/87d4a18b-6ad0-47dc-937d-8da2e6b3941c">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/aca61305-a187-40d7-8c07-7a348815c9a1"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/5049c0a9-cbf0-4e11-a05f-182154fb2b28"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/b311a97f-f306-4bca-b114-749586362810"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/08bb3415-6d15-4cae-8ef6-b13bd75bb559">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/d091e71e-62e1-4ab2-9329-13047e9ffaf4">
    <rdf:type rdf:resource="obo:RxNorm_6135"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/b32c0f2f-7961-42a9-8e77-a42ea8a121fd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/f1f01378-ef6f-4e95-8f57-985cb50c147b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/57115106-ce29-43d5-b901-aceb0d810d9c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/454e5020-a1a6-4133-9372-07c7544e1785">
    <rdf:type rdf:resource="obo:RxNorm_73178"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/ff62e542-1305-4634-8b9d-76434734e9bd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/db74e31f-2ee6-4470-91a2-edafc5f862ff">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/8d045d3e-44d2-44ee-91cc-24e644704173">
    <rdf:type rdf:resource="obo:RxNorm_42463"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/0528a723-a957-48d2-a622-e742d2080d6b">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/3dc69caa-756b-40c2-beb8-1c3ca466121a"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/340930c0-c31c-4a36-a62e-c371bbb464bd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/0952e092-b4f6-41e7-99aa-c17830d07f9f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/be74934e-9774-4d86-b908-50a9c6f1f600">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/c4fcc44a-1d38-4d7f-83bb-ca660fa2683a">
    <obo:OBI_0001937>2.5 or 5</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/e21849e1-6122-4e79-9f3e-1d9739a59c18"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/41f08544-7eb7-4929-a43d-7c96006ec044">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/91336f33-6931-4c43-a388-560d7f74b721"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/046e0996-4a7b-49c1-9ac1-fcf2c618b0a2"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/9b5b87d5-1d15-4e0b-8902-d775638272d6">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/cd585645-48d1-4552-9769-87c2ab899692"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/8f111372-0408-4d53-a99c-60cd82b17ad3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/ae331a6d-6b38-498b-9f8a-8b68feed1705">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/d8467101-26bf-4ad9-826b-43d6fefbd23e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/4cc941bb-b973-4a26-9456-1f16b8e57836"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/3760585d-8f14-42ee-9fbf-26d05dee2a30">
    <rdf:type rdf:resource="obo:MeSH_C496216"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/2a1a26a6-d9eb-42be-b50d-b86173836b3c">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/16995f94-a6ec-4260-959c-88998e8f93fb"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/7b54b553-bb3d-455c-ac25-0f13f8af0e09">
    <obo:OBI_0001937>15</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/3b4f547a-1b3a-40f1-af66-dafce7a2c0b7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/2d2fec1c-65fc-4311-9647-763bd960ea0d">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/77521af4-36ba-4da5-9672-43651476923f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/a2b2eb18-d931-4486-a8b5-c99f0a6c5d33">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/d9c1382b-e7b9-4619-9c04-169f1fdf2ff4"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/342614af-5152-4805-8004-9770602ee3c4"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/7901d590-9a10-49af-ab5c-69e722f5ff4a"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/52914206-73c0-4cc1-a50f-98b2672c868a"/>
    <rdfs:label>citalopram-pimozide interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/352f3fdb-bbff-4ab5-b294-92dfb6cb0b63">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/c43a25ca-ff1a-40af-b20f-ba5006921167">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/0f6c8b6e-929e-47e7-af73-7a05ab1749fb">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/02e42480-3101-4044-a0c4-bb16c9f41502"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/5036c562-542f-4745-bd5a-595845ef8ff5"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/0f127c7d-0c3f-4558-86c2-3afad1678ecf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/d4fe804b-e53a-435a-a606-6725234d45bb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/34bb6a33-416a-40a0-82bc-1519d1da62ee">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/80a86b5f-a39e-4480-8e18-97c5e4ff04d6">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/c1872ae8-5e77-4e17-aac9-d61461f2e9a7"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/3535d478-5f43-4792-9380-05573a9b589d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/308b24a5-7eda-4669-b6b5-7adac382995c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/440788bd-1c1d-4f7e-84ee-7fffaf8304d3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/711fa98e-14bb-44f8-b946-62f7a48d4caa">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/5e7b9aeb-9808-496f-b770-c313c7091b00">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/114acfed-c984-4ce7-9a5c-e3edfb761953"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/a1f3f027-b078-48b9-b20d-c7962aa8f9fb"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/af584092-d757-4e1f-b8af-b99b8495c7a1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/9548d7eb-0a71-4c96-ab33-9da9bb19d8bb">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/debc5f26-934f-4501-bd78-a8f8915adf20"/>
    <rdfs:label>57 Percent </rdfs:label>
    <obo:OBI_0001937>57</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/d69d1116-282d-4e15-a0fb-71bdc4a6df27">
    <rdf:type rdf:resource="obo:RxNorm_36567"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/6a82f4d3-a9a3-40a9-87bf-660bbd832bc8">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/81c064d6-f518-424a-8555-4921237e3458"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/4ef2ac2e-65a4-4b3b-9fc4-f01414da8341">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/8a59e8df-ab68-41b6-9a76-7ebcce30b30a"/>
    <rdfs:label>desvenlafaxine-midazolam drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/8c1c8e32-0969-426c-bc2b-eb15598a51ba"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/77175608-77a7-4e12-bd33-01af965a98c6">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/ddea4679-d17f-4d4d-adf4-f9f2fbb75259"/>
    <rdfs:label>4.3 Fold </rdfs:label>
    <obo:OBI_0001937>4.3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/7411c814-b9c3-4a19-910f-5abe128e8cc9">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/30a6ffa5-e89a-4c8b-8f13-52d57b5b5adb"/>
    <rdfs:label>153 Percent </rdfs:label>
    <obo:OBI_0001937>153</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/c394e982-4805-4e8d-bdfe-c6cd9b017fa6">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/ae844e39-e2c6-437a-8368-e0166ecbd7c8"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/6d336556-3e70-4a18-a5c5-b2a20e49ef80"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/285df13e-0a15-49d2-820e-933cf20cb971">
    <rdf:type rdf:resource="obo:RxNorm_42355"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/adc6117b-11b8-4892-9588-bad0b66ba3b4">
    <obo:OBI_0001937>1000</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/9efcb20a-4ae9-49a8-8481-6bdbfb885448"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/613ac937-fc8e-42e9-aa0a-091c95fe6cc3">
    <rdfs:label>sertraline-cisapride DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/3e4e9021-ce25-4456-8687-c6b27eba52b9">
    <rdfs:label>ticagrelor-dabigatran DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/0948f0fc-2f80-446e-a439-9c3781b32d49">
    <rdfs:label>nefazodone-alprazolam DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/8d24b300-19ad-40bd-8bac-8f59d0438c46">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/b2e126a7-ab0a-4d1d-8e55-e50099b4e321">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/e0cb3b7a-1318-4f98-be43-0af295e57aef"/>
    <rdfs:label>ritonavir-hydroxybupropion drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/74666a98-2fcf-4902-a679-18a68a41a414"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/45745013-cfee-4098-a092-92631188d0b2">
    <rdf:type rdf:resource="obo:RxNorm_596"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/7cdc7191-710b-4295-8e12-f194800ea8b5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/d81d66f2-2c6b-4d03-a217-71a421c6268d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/e093bd0d-978a-4ee4-8943-e54079be78fb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/d0348fe2-4421-4ae1-8bb4-913311f7d0d3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/3776117d-e4ff-4429-8993-282b211d4f38">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/9711045a-796a-4fab-b4dc-69eda62ebc6a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/fa570a61-ac20-4538-9f0b-cb87dcc39b51"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/e9d1bb34-987a-48a5-9090-00c21bfecfd6">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/67c2cb82-c454-4d7a-9983-5d0dbc8dd183"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/b2154be1-843c-45fc-af12-8fd14b6c99e5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/23f16a51-63b4-444b-95f4-9316169c8065">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/5a1d51f5-70c6-4635-b4d3-d2c367e8370b"/>
    <rdfs:label>5 Fold </rdfs:label>
    <obo:OBI_0001937>5</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/cd94697b-3f56-45b9-9109-80ba92a9338e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/80c5e020-ccb0-40b3-b822-53254fbe6e4d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/8368c026-baa1-4d69-9689-090bd32f6bc1">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/89c54d53-25f3-4e4b-b9f0-fbd6e5b4140a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/e580a8cd-76d7-4420-b486-e7fb51519e5d"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/3cc35099-cae6-457c-82b5-b82e40fefdf2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/cf0720d2-bffd-4328-8ac2-f7555a3ae0ac">
    <obo:OBI_0001937>25</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/1d30878d-a95f-42d5-96c6-0cf7a927b24e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/a478b997-c731-4781-a5fb-4ee6787e3263">
    <rdf:type rdf:resource="obo:RxNorm_2002"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/3ad40ee9-b187-48f7-8d6f-374dd2b2172c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/9d2b401d-1210-4aa8-9fc8-1581a8273bc2"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/080ec9d3-02f6-4555-b905-262a69eec5db"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/786a98fe-951e-4d3d-9415-b7bfca21163e"/>
    <rdfs:label>sertraline-zolpidem interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/d59d3e59-fe26-4e81-8bd2-5167ee520359">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/88f7a5bc-5aee-43cf-9e75-31526de7fbf0"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/75b96428-5f42-4a60-9ffe-e0164f1d431a"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/0f692ec9-94a8-47aa-b134-53d87ccf0805"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/1facdbdf-706d-47f8-ac7e-d9e4c08998f3"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/80232d33-e33b-42bd-bde2-88bfc6a9ccda"/>
    <rdfs:label>nefazodone-alprazolam interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/2ddf7266-c0e1-4751-aa08-352763b3e293">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/e6bcb9db-c67c-4495-bfd5-f13d5bc13932">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/48546cfc-a603-4914-986f-281daeca7de3"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/ec190041-112a-48a3-baf4-968806293eb5">
    <rdf:type rdf:resource="obo:MeSH_C496216"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/afda377e-0cea-429f-9464-3b589bd963e3">
    <rdf:type rdf:resource="obo:RxNorm_10767"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/1bd5bcff-096e-44a4-af93-c76c2c3c8728">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/22949a6e-bb3e-4a50-8959-280c8b36c2eb"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/55f27fdb-242d-4d58-b166-f617cd25545c"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/77725804-26c7-4419-895a-f5bc438f52fe"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/d5be3051-e047-4ca6-813e-2dd083881bce"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/fb282331-5b12-4fd1-a1fc-edd5c370f3a7"/>
    <rdfs:label>midazolam-rivaroxaban interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/fd93da0e-90b1-4f6a-ba34-f5942cafc310">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/78b57279-326e-4b64-989a-f062a5f036cf">
    <obo:OBI_0001937>60</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/f0388cfa-1e1b-4263-9d94-a8d5828c61a6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/1e56f38a-0ff3-4a45-b2ae-cfc2ede15cb3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/4a5ba02f-ef9a-4374-ae2e-69fe7661da93">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/5423b2e8-b957-4067-b004-7225e3ce3166"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/9832ecd8-e87d-4468-ab70-03dd5f46e500"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/cfcb1ed0-2705-46ab-96ae-c92e253dea01">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/3968c791-0f3b-493c-8865-2916449e634d">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/425e41d5-b508-40a3-a23c-e0dfd3929814"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/249a4f67-b18e-4974-9123-8e906471c8d2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/ba0531e0-0516-4252-9cd4-0a506a96daaf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/1aa6659e-0ac9-45cf-be9e-e339dde8c5bd">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/9afbcb88-dccf-4f12-974b-7c5da65b1c2c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/b70fe901-fa2a-482b-b134-b67012b66d32"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/75f609a3-55e4-49bc-a64a-4c2edbadc5e7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/c476459c-2d62-402a-bfc8-f1207426de23">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/44475c3e-09ef-4af9-9b95-9141e71216c2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/cf92f792-1d2b-4ef9-bcee-f35b6d8a1cc9"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/dbf47488-ab48-419d-a94e-f5f87d2e3bcd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/36aae63e-7ab5-44d3-b749-490f6087bc5d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/fad57d67-7e47-49f1-9625-b9791c5cbfb7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/aacfb119-8876-4a7b-8a6b-a2475833610d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/dfec51bf-334b-45c9-b877-2fd2ace807bd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/fa2f0c05-2720-4279-9468-b5ee02848c76">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/fb207e6a-27b4-4f0b-b6a8-99ecfacab28e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/c3c3fa9c-0995-4c2f-822f-710cae51b004">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/de801071-97a2-4936-9858-e67c88a1de8e">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/eca41873-3cb8-40d8-9802-339cb03ceab7"/>
    <rdfs:label>37 Percent </rdfs:label>
    <obo:OBI_0001937>37</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/bb667948-5060-4fe9-acb9-13e8c708267e">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/533beb5e-811d-4134-bb14-dfee33da2739"/>
    <rdfs:label>LPV/r-Midazolam drug package clearance UNK information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/40d4ba40-5db6-48ec-a6b2-51356487845e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/04faf930-7aef-41e7-b858-3272f87b34bd">
    <rdf:type rdf:resource="obo:RxNorm_3247"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/f11656af-5e62-48d0-85db-2cc7ba94b920">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/af9deee3-9bd7-4820-b357-8c9a77549f9b"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/110efbe9-342e-4c41-a40c-e421f6d7c905"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/79494117-45f9-4038-980f-69dec115c99b"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/1c66b199-ef69-4cb2-b78d-4d0482838757"/>
    <rdfs:label>nefazodone-propranolol interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/4e12f1e2-8a70-443c-9826-81c82695a4eb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/b850f103-b9cf-4752-a720-ae63b4082e6f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/71856a4c-908f-4374-8c59-745d1890d575">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/0d2839b7-bd61-45ae-bd9a-79d3194a3dd8">
    <obo:OBI_0001937>.25</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/2d64273b-3956-4760-ad06-8b2ebc3b3733"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/38085ce6-04ed-4f4b-a8e8-ffe5f3c7ac4b">
    <rdf:type rdf:resource="obo:RxNorm_36567"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/442649e4-43d2-4b0c-9e32-db188632d420">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/a302b46a-0f79-4fe2-b33d-31a615609297">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/cf940502-ef7c-4f06-882b-024efc0f9ed0"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/77b48ef9-4af3-46f1-965e-0c5606e649ee"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/cd64e586-ceee-4023-bb85-c84fca7d8e07">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/469851c4-4c04-47f2-b33f-16413a28ed9d"/>
    <rdfs:label>ketoconazole-P88 drug package clearance UNK information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/49a42e82-2ae1-4bde-a375-4fb55a9e9024"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/1f6139c9-0307-4548-b5b6-dab968a21d9f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/9c99533f-a098-48d2-835c-17e4af8ce9f3">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/add480ad-feb3-4d10-844b-785f4d7e2a3e"/>
    <rdfs:label>fluconazole-rivaroxaban drug package halflife  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/6dded392-e6de-473a-a210-b62dc3ab5837"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/3ced53e9-137e-48d5-bb34-6858aa551448">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/5254b8d6-6516-4927-b0d8-ab47fddb4616"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/6ec094dc-1d96-40be-8f48-007b92c4ec9b"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/04dace1b-3773-404b-b140-a02313ec2a35"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/594613f9-6a26-41ad-854a-27f0847ac3dc">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/1593ca34-d9a6-4115-b824-69c1ea5c3a18"/>
    <rdfs:label>67.6 Percent </rdfs:label>
    <obo:OBI_0001937>67.6</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/bd800384-0f57-44da-afaa-027856b99b9e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/e758f5d9-9f7b-4b1d-bb98-bc84ba6159a5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/1f8d671a-83df-4fcb-a8bb-2174b80e996b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/4348978f-8015-4d10-8776-c9f40592731a"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/18190d4b-b8f5-454c-9d8a-0f16c90f0b8b"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/4fbb857a-065c-4c14-a950-60a4e2137534"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/0be431e8-ddf5-4159-abb6-27cf04136be2"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/0af2c45e-086e-462f-ba90-52ff224036ee"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/5cce782d-bdd6-4310-bd22-5bb613dda860"/>
    <rdfs:label>ritonavir-rivaroxaban interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/ea7e7e3f-cbe4-4790-8dbb-395c642ba341">
    <obo:OBI_0001937>800</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/81a902e7-1ba2-48ec-a880-84f5e96df5bd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/74e02629-4a4b-4f66-85b2-106130dea312">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/86062765-787b-4a53-9553-8c34f46cbcaa"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/97cdbebc-ae92-4de3-8084-60c0ba65efcb"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/3532dfe6-7c74-47bb-aa4a-05c3d0b9bc05"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/e306c212-4a72-4536-9fea-a7c02392e579">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/dded8bdc-f354-415c-b41d-332169d7e0ae">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/964e974a-80cb-4016-9a6f-b5989cfa18fc">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/74e02629-4a4b-4f66-85b2-106130dea312"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/128e7747-19db-46a0-bf59-116d5d455bf8"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/ff570212-a07b-4888-9ac8-13f0f46d5a13">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/dbc89e7b-bec0-4606-a1d2-8936f3de5753"/>
    <rdfs:label>50 Percent </rdfs:label>
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/9ef96ed2-d431-4f2f-a857-d7723c823878">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/94d70ee4-82b5-4bfd-828a-7a339adecf1b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/45ead715-9daa-4da9-ae20-7fed6d66b1fd">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/e1605e2e-93e3-46b6-be00-ee5cea7808d3"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/1f4ab884-ca02-4330-8b7f-3c2233fd57a0"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/5943fdfa-480e-40ff-b186-11e07fb5e827">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/0287694b-e428-4943-804a-024b6e10ddb9"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/a650d9bf-5cb7-4a6e-bd9b-7c086154f9f3"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/5ea6c7a4-cb32-42fe-82a2-19ccf96d69da">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/158c1250-7da3-47d0-9982-be4d968a79dd">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/9e08fce2-dd1b-42d9-82c8-dd28c1787d75"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/a4e2953e-9baa-4d3e-87aa-f7bf247123f5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/0143fa48-8d5c-4e24-9c17-32723972189a">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/b4c14f40-65be-4dcf-94bf-c97ea7f443fd"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/9091803e-3e0d-492e-ad48-d42d1d62abb7"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/e4a8c1b0-1a47-4bd2-8876-807df0516c3f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/6fdbc474-fa88-4ad5-a2cc-caf369e78526">
    <rdf:type rdf:resource="obo:RxNorm_4493"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/a0224689-8a37-4b02-9743-357a71bf0460">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/d3696276-6989-468f-a32a-68c2ce0d71bc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/92ba0c52-3a4c-4833-937b-e2137a93a3f8">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/9b7ca5cd-3a2c-4978-b0a0-9104f6c253fc"/>
    <rdfs:label>digoxin-aliskiren drug package auc  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/d766c4f7-5f2e-4414-84e2-e8ab48b5a0ed"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/54c23983-43cf-4bee-bd4d-90795c1e135b">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/613ac937-fc8e-42e9-aa0a-091c95fe6cc3"/>
    <rdfs:label>sertraline-cisapride drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/75929d97-5e42-4505-b9fe-7dc6b8d7f8ff"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/6baf685f-2901-4390-9334-f4acc549dcf3">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/7684da70-8d42-4f40-a4cb-5596c33e022f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/1f6139c9-0307-4548-b5b6-dab968a21d9f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/d4cc4322-a357-4847-a53d-395c1423e3d1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/7b6d2d57-8a9b-4157-bd69-c966c25681d8">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/58cb6697-97d2-4b88-a5a8-e8bc6ff76f8a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/4e4defbb-7565-4e44-ac7d-13274936b6d8"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/8571a965-aeb3-4c4c-ada6-8292e1a4b81a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/4995098d-62a7-4688-b4d4-eda9ad607532"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/59b9d8aa-ebab-440c-bbc0-a7be460de61f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/a4fae80b-26de-41ad-b75d-b69fc1ea110b">
    <rdf:type rdf:resource="obo:RxNorm_11289"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/080ec9d3-02f6-4555-b905-262a69eec5db">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/6eb03266-ea4c-4034-9c76-a34b678f8370"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/52b52560-7d25-45d4-8f26-210516f060f8"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/7a39e538-d6e8-422f-b833-ee14584e444a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/cb43a263-33f1-4bbe-9792-759ada841787">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/71cc008a-d691-4d38-944e-0f045b4cb637"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/9f448668-c117-4166-969c-6e3298c0aaa8"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/651cc3bb-9bd8-4d31-94ba-fbb36a8caa6f"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/32cb48bd-7532-4e52-a3b3-b2388d6025ea"/>
    <rdfs:label>pitavastatin-R-warfarin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/bfa5bb68-006f-4780-84cc-5873097264b6">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/25c92b9c-6bcc-4c5c-a65f-e20ac5dbc553"/>
    <rdfs:label>15 Percent </rdfs:label>
    <obo:OBI_0001937>15</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/76714e7c-bd04-4052-a625-b46a389d2dd5">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/4325d443-a47d-4725-8698-f880a3c4565c"/>
    <rdfs:label>66 Percent </rdfs:label>
    <obo:OBI_0001937>66</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/313e85a6-1dd4-4872-bb89-f0605914b0f0">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/ff2dd303-f3b5-455a-8919-bedcf51b7d9d"/>
    <rdfs:label>duloxetine-warfarin drug package cmax UNK information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/2df84982-5672-4f59-9d72-b3af73878881"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/8e0b4d4a-98a9-407b-82a6-c1b87bee7d18">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/5dbfd6c7-07c0-499a-8ed6-24b9d036c8c3">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/0301e6d4-6fbe-43b5-9464-b122778216b1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/9aed607c-7062-4b67-b5f5-f8df8cac7556">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/89708702-8056-49cf-9206-3d2b903a515d"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/b48dc0b1-bb0e-4ee4-8427-d0c01a00089b"/>
    <rdfs:label>simvastatin-ramipril interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/7dee104a-535e-4800-9a11-f4a413a8cdb8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/8b2c205b-1efc-4e49-b4a1-0f8b1546211e">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/73bc2e5a-8e90-421c-9414-68d2fe7bea83"/>
    <rdfs:label>50 Percent </rdfs:label>
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/bef2d228-b9cf-4065-a6ab-57f061c8f70e">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/f76dbf1d-c822-450f-83e0-043593aa6b34"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/c4d5d258-cd93-4909-8a71-515ff3aa3130"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/4b49aab8-b60d-49ee-8998-d3ab2820c715">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/05be3b12-8437-40a3-9144-63d418a681c1"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/f32831d4-da9a-48a7-ae67-199437504ffd"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/f72ff939-887f-4eeb-b1c9-5f75df9fc16a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/9b3e533a-b388-4552-9e95-75b352617c01">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/06dffb90-7f48-4241-97d7-caa842212a69">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/a488c8ac-933e-4593-81ff-cde81a282b57">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/852aa65e-64d0-4d7d-b5ff-7b7da1b15b56">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/3612db29-6cae-4373-9817-75f008ee0216">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/4fd00911-5727-4e5f-bcf7-eddf1cd8ddc7">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/e31962f9-3df3-448e-b248-9169244872d9"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/6312cc91-6070-4deb-942e-0becbaca8e63"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/94cbcee7-c422-4626-afa9-5aebfeefa20b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/26693c1f-cba0-4359-acc0-8cd583f8c249">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/0c5b60d1-a222-4653-a868-cf4dec1c5163">
    <rdfs:label>Fluvastatin-indinavir DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/1432f67f-76fe-47ed-a656-181f9868c48c">
    <rdfs:label>nefazodone-propranolol DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/2da7488a-9d54-4b2f-9372-35a29823b1d2">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/94c5f522-8b5d-4809-8a0e-1922fac422d0"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/badd7a88-df3e-4b56-b840-8f3efacc5745"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/689200b1-4e5a-4efe-9cd4-46f5483cd15c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/0a4ff77a-f1e3-43de-b104-166d660268fe"/>
    <rdfs:label>ticagrelor-dabigatran interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/a281cfd8-527e-43ea-92b7-a53cc15426ca">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/55aeb4df-915e-4ffe-ba3b-8a7ef2085968"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/633ab979-f5b2-415c-a750-8d24fbf9128f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/ebbacc2f-0b22-4a76-8283-1e1c691904c5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/64a7a9f0-14ce-47a9-b065-fab2163dbab9">
    <rdf:type rdf:resource="obo:RxNorm_703"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/0689fd6e-fd4b-40f5-8915-0c9eb6e0145c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/9ebb6359-fdd5-4585-8c4f-70a2fa2c173f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/b3c97f65-4943-4f0d-a5ab-a4a8095632f1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/9730b373-3d49-4be9-9124-def65ef5b6ed">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/bd286ea6-f3fa-480e-b696-c5d26ea66cf1">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/9f7943fd-9bec-4db7-a7c3-7e86d2e8d05b"/>
    <rdfs:label>ketoconazole-eszopiclone drug package halflife Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/a0e5d419-bd45-4e66-ba5f-a8a32736dcc2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/77c05e46-1c30-40db-b727-7bc910686892">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/a8c847d9-1698-4cd3-9fc2-1ef52b18919e"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/bb52518a-521e-4986-9bda-ae995cb9a686"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/db5a8930-c417-4c36-836f-827eb41207de">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/17135685-e33c-4129-8400-c238308ad29a"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/c4fcc44a-1d38-4d7f-83bb-ca660fa2683a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/7f7f519d-b0d4-4cd7-9f38-61d0d33dd4a3">
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/d9197cd5-2e4a-4d0e-ad01-007f4a225206"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/e77c1296-4aeb-4913-9f58-a554f70ce2ac">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/c483ed5b-ddfb-4d37-ac10-fdc90be272a7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/59f39ab2-5ca9-4468-a7c2-5aa321a1354e">
    <obo:OBI_0001937>250</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/e4e0e17c-d05a-4617-804a-cd056e099084"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/e6287c42-2efc-4ee9-b5b5-ecdc60e95547">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/399b084a-e224-4265-be6b-60b4d913f3fa">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/8463441d-5ca3-4100-85e9-0ababf77cbcb"/>
    <rdfs:label>0.7 Fold </rdfs:label>
    <obo:OBI_0001937>0.7</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/5b6f6d75-7166-4aa6-8acd-36edd075d266">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/59bab93c-79b3-482d-b5e3-200e0a0d13be"/>
    <rdfs:label>2 Fold </rdfs:label>
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/52123f87-ce53-4c74-92d9-199f8d0a9d4c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/4e277530-91f4-4bb9-bb2d-b0a43debf718"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/7940a489-499d-4c21-98bd-33878d3df18a"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/706973af-4c47-4d59-b6e2-d735a7135e21">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/299bf320-be50-48c4-ad4c-905e0b427110"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/892db7c3-a534-4376-8441-4643c374175d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/552a9669-1670-4977-8209-b2464af9c0a5">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/d5de5293-a465-44e3-bf4d-28da463aa23b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/d83bdcc4-8264-4b14-84e7-7656e5a0234b"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/73450238-0e7f-4ad5-9c39-6686d5083b66"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/4d9ed476-d0f0-43b5-a557-51423309a890">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/2926519f-a7a7-47cb-aa4a-8ab21ade5a4d">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/3be5c7ef-2c3d-4b7d-b76b-c548bb89e58f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/84098bd5-4604-4c1d-bc4e-82157d52c5c4">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/c42ef09e-b6c1-482d-a6d1-370fab8ec880"/>
    <rdfs:label>2 Fold </rdfs:label>
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/e06ae21c-45a9-48f5-b8db-0a835c935a4f">
    <rdf:type rdf:resource="obo:RxNorm_6472"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/b3d658c2-0a07-4fd6-b28b-582470d53b12">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/b8ef45bf-be19-446d-8997-300ae423b3a7">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/31a412ca-848e-4982-96e1-81c52c798013"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/fe0afe68-76b0-4e92-aeb6-1127ab028ff2"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/c18e2947-611b-476b-94a8-f84e22d89795"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/8d899cf4-47ac-4b60-9c8f-604fa449de11">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/f7a15e3f-efa0-4915-bb6e-b640f2151ec3"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/fe6f66cc-735d-4a35-bb1a-1d08ef736f2e"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/c208137f-3b71-4ea8-b018-155e43755d2c">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/0da5b0fe-8775-4389-9445-2df5999d5035"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/e944f0fa-1479-43e8-b6e5-199fd63ad0c5"/>
    <rdfs:label>Fluvastatin-indinavir interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/0633a538-0476-42ec-ad0d-0023f85af11e">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/c3d14fc5-b661-410f-af50-71e6ff717265"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/ba5504ab-c5cd-47ec-96d2-c1830d31974f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/040dc447-220c-44a6-9f12-4b2124b27e04">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/53593099-ab43-4179-8f55-263769966c77"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/8de8a1e8-a23f-4e86-b5e5-137226fdd4b1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/16e323f2-3a2a-4dfc-ab1e-29783758b17d">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/97ca23d9-3e48-48b1-80a6-3b1fb4f5c76d"/>
    <rdfs:label>Nelfinavir-atorvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/598447eb-fd4a-464b-901e-8e61cf37e9f0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/9ac9fa53-1948-4337-9512-622901670841">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/c03d0811-6922-4761-ba4f-9391269bcaf2"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/b050a5fa-f724-4c90-a9c5-6f4282ebee62"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/d9c1382b-e7b9-4619-9c04-169f1fdf2ff4">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/1ebe46f0-634d-4953-aee1-5949489aa244"/>
    <rdfs:label>citalopram-pimozide drug package auc UNK information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/2fd4d117-cbff-4441-878d-ba39e939756a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/33a31ae8-f643-4fcf-9517-099ac6db568a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/cc3982e2-4ca6-47a9-8afb-f236fdbea641">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/dabdf84a-391b-4784-9a0a-dd67cbf5fe8c">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/fb2dfbbd-112d-471b-bf4a-e2e994d51120"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/f0918d8b-686f-4800-ac9d-817ba340bcbc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/78ba1119-98ef-41d2-a271-f90cdf6b825d">
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/5e51202d-9314-4110-a4f4-4f213c0209cb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/373adb27-2827-4094-a7fd-7069748dd970">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/c77ddce9-7dec-48db-a414-92cf192dffee"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/13f284f7-7467-4868-ad33-b8c252e2a007"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/fae604c6-e0b2-40dd-8443-4c022977e198"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/dcd6aba0-fd41-45f5-b883-275f6ae7ebfa">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/c8d1983a-a46e-4ce1-b810-df1d1d195b4e"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/532c9f7b-0445-4300-99a5-67c05131f64e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/1e406a6e-d235-4e13-8239-7c018b8d2258">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/142cc809-bd6c-4dd5-8d26-45441b620b51">
    <obo:OBI_0001937>180</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/19446387-5cfa-436f-a986-8044e1a10f10"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/aac8aba8-2f01-4538-92b2-86e199a9c4ff">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/e78ae4a7-67e9-4bb0-a649-a15bd88d1441"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/d8e1ce2b-3c98-40db-9727-a9d85e991ea6"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/aef01f47-a39c-45f4-8cc5-fb034d66d505"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/d06475de-85a1-416e-b172-3e2fe2dfc2e2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/3baf6ac8-9bf3-439e-bbe7-25cd745dd3d9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/01d05631-4987-4de7-98b8-5c8f1d36804b">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/747f05dc-9d54-47bd-b422-2be5e0a7342c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/b0921bce-7323-45a9-83e9-9df086bf8a10"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/c198554e-3682-4386-82ea-e1fc8bd2e75c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/ae04149e-b8d7-4cc2-9aec-6dd01073c73d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/81a1b9cb-a5bd-4b2d-a231-e684e01cefa2">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/e77c1296-4aeb-4913-9f58-a554f70ce2ac"/>
    <rdfs:label>14 Percent </rdfs:label>
    <obo:OBI_0001937>14</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/857d4f43-cbeb-45ef-b77f-3831b8a76c63">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/0fbfd928-ad94-478b-bd6b-8df9226f9902">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/3a14f622-678e-43e6-8248-e97581f9a8ec"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/74b1d6b6-5a14-4362-9b99-28e303ce7409"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/9d1261be-ebb6-4805-800a-6917000d9ce0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/0ed4a684-acf2-43ed-829f-bd5457ee3390">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/25103cd3-235d-44fc-9adb-67f806200e94"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/fdd163f9-98e3-4481-8949-24b899f25b38"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/01fc502f-d615-4c9b-89f2-adaae0c53ee0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/ed4ce86d-da05-4f22-94e3-dae2854f0522">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/492b3f8a-662c-4c3f-9953-278f89773ff6">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/8b1f7f2f-050e-4813-8935-2f20c2a3bce4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/0a303011-a7a3-4478-926f-6026a8e5f015">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0002351">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/22391947-af1d-4d37-adc0-9859946312c7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/e3c57300-d161-44f2-af9b-75ae688751c7">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/f32764a7-e89d-4c0b-bbf0-15c940c8a7f1"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/21f86d48-9b38-4451-88b0-b5d2dd5c0b0e"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/d0cad0fc-4b08-400b-915e-647331825756">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/04824e71-2c1d-4056-afd6-dc6a36dc7da7"/>
    <rdfs:label>Carbamazepine-olanzapine drug package clearance Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/b6e658cb-6167-4c10-b38d-551d70ac3168"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a6e90158-0233-43fe-bdeb-beecccceecd3">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/bbd2fe67-b8fa-4e07-9a66-0b54c0b382e2"/>
    <rdfs:label>3.4 Fold </rdfs:label>
    <obo:OBI_0001937>3.4</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/6746ec19-65f6-45e9-a13e-c6433864b6b8">
    <obo:OBI_0001937>0.25</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/7d1fd459-7b4e-4fde-ac52-99d0960f304e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/eb1e7239-dfb4-4e2d-ba3f-caad8d38b3a5">
    <rdf:type rdf:resource="obo:RxNorm_8703"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/deaf8d0d-9616-432b-b4b7-0c720530b247">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/4352090d-5d9b-41a4-9b7c-b316ea00f0d7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/ad70a91f-a65e-44a4-af63-e873a038a11a">
    <rdf:type rdf:resource="obo:RxNorm_1599538"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/c1878f69-ae28-4241-b4cb-d4695cd77769">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/75b96428-5f42-4a60-9ffe-e0164f1d431a">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/0948f0fc-2f80-446e-a439-9c3781b32d49"/>
    <rdfs:label>nefazodone-alprazolam drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/95cd014e-d63f-4fc2-a5b2-76dd5f77bc80"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/d5bc1ce8-945e-4790-927f-3a8837a43295">
    <rdf:type rdf:resource="obo:MeSH_C062257"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/9f8c9d46-7649-40d8-9a93-b7cab3545bba">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/21c5f36d-2a12-45f7-87ac-3229b278b4f5">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/a37c03ac-eada-4432-bb68-0da629eeba9f"/>
    <rdfs:label>Nelfinavir-simvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/de26cf50-b600-4bbe-b8c5-1b1c91e10b0d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/130229eb-fa04-4277-a5cc-9e97a548b7ab">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/55818644-be8f-42f9-908f-04e98be538bc"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/f1c58b18-c2f0-434e-992d-dd05eae2f23d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/2d5a3b2d-3c00-4847-9091-5d88e3baa1a1">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/48f63eb8-dd02-4e48-9cff-04dabc87b7c2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/590a59d3-8aaa-4cd8-8b16-3f6228830239"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/8c7df13c-9277-4fa7-a3fe-0d20cc7d0064"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/3613135f-7bc0-456e-95c1-7206ca7554cd">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/61e22507-2b75-4539-af20-2c0233350538"/>
    <rdfs:label>50 Percent </rdfs:label>
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/ea11edaa-9e93-46e0-80f7-fee46ea43d5f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/407db4f9-b8f8-4f39-9425-c013d23f38a6">
    <rdfs:label>phenytoin-paroxetine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/51ad759d-529e-46b3-ba5b-79af8805c641">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/d359fb46-dfd2-4117-9dd8-749cb2814006"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/fdbf173a-fde9-43a1-aba7-56eedc5cdea0"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/61176be5-6202-408f-a3bf-6c045dc0f9f9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/2f4a3939-e4cc-44c2-8f9d-47f7764498c8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/2c97e529-1329-40cf-9041-53bfde026d00">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/2270e7e9-8f7d-4c50-80ae-4d579a8973d6"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/07b7d5e6-79cb-4c3b-9b76-f61ab57dfe63"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/c9ce42e4-af36-4960-bc90-396d8cead16f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/5b4a77a3-ddd3-4127-b717-6dc83e23ccf7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/527aa277-e479-43ba-a26b-920ab40f676a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/2fb50fb2-bc8a-4648-a01d-2439e4537b10">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/bea8ba18-711e-45a3-83ec-02cb57e0e546"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/0dc95245-9240-4dea-a196-01a59be8c11a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/d0877156-15f0-4654-9dad-6e5aefae7ed8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/6cc14793-98b6-4cd6-8c3e-f6837add1350">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/6bd8ea0b-860f-487f-a78d-6071b921d683"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/999825fe-6123-4620-aca6-e0624993a377"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/4ea6fb3c-2c24-4806-9e1d-73e38d8cce16">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/0615c5b1-a131-4988-a815-c07e422bfca3">
    <rdf:type rdf:resource="obo:RxNorm_3247"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/8d34b6c5-ead7-4250-8d6e-ba5a775f771f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/6594818b-54fd-4ce1-bde0-90ef48b9ac0d">
    <rdfs:label>fluvoxamine-duloxetine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/2ec774da-4a22-4d3a-b900-1c9445253600">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/dbbab9d8-545a-4aa0-ab51-01bdcd7b182b">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/8f5c0072-f802-4b84-8fcb-46ee8b9a268a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/2bfc5fbd-8976-447b-99b3-441618f42277">
    <rdf:type rdf:resource="obo:RxNorm_42355"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/256ddb84-1075-464c-b5ef-1b7e93ecc381">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/9b416a71-f025-469e-a2b0-6c2c6e68ff23">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/e68d0baf-ec08-4f7f-a270-95d0fcebfb56">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/cebc2819-3df5-41de-91d7-bc6379151a18"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/edaf54e5-330d-413e-9999-d517398d3c49"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/58fc8aee-754d-4f75-bdb6-badd88f89b1d"/>
    <rdfs:label>Celexa-metoprolol interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/f6876967-5c80-430e-a7e8-ebffea3ac8af">
    <rdf:type rdf:resource="obo:RxNorm_1546356"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/dd943484-20d8-4dc5-9695-b9294a1a9150">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/a86698c6-4dfb-40f8-9909-c0bb2067b84b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/5036c562-542f-4745-bd5a-595845ef8ff5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/03d3468a-547e-4d9d-a517-cd219a9ebc39">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/9f092c57-b48a-4dc4-bc28-33eed91a77ad"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/c446da8c-9b73-43e9-8477-6d841e200717"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/e1c20e98-1ce8-4713-a626-bc4cf9c8ca01">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/527aa277-e479-43ba-a26b-920ab40f676a"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/ce13ed45-93b5-4204-be83-cfbe0a7c52e1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/db2a525b-f45d-440f-b68e-db8703b8b856">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/69082dae-173f-458e-b79d-478cfd4bbd18">
    <rdf:type rdf:resource="obo:MeSH_D000068882"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/e27fe75e-e85f-4cd4-9c4b-9da01aaa8e43">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/18c20748-0c5a-44a0-86f8-c6684e9425ae">
    <rdf:type rdf:resource="obo:MeSH_C496216"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/5a677cf9-f949-4bef-9f36-d131f71aa956">
    <obo:OBI_0001937>60</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/ee9bbf64-6924-4f1c-900f-af0c31b3e4f6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/18e2982e-278d-4cb7-bb2f-ab7f72bee177">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/c5580250-3e25-45bc-af96-b96e0851ffe8">
    <obo:OBI_0001937>5</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/7a357f95-cdd0-4dda-9216-d6f4dc2f416d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/5d557a83-fd92-481f-b51f-651fae8f72bd">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/e4ec4659-d3f3-4f49-a56c-08cc381c8a6a"/>
    <rdfs:label>85 Percent </rdfs:label>
    <obo:OBI_0001937>85</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/9c2b47cb-22c2-49b8-957d-16f5f1d5fc29">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/8826b977-fac7-48cc-8e63-e036f5f34299">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/a66fdec3-3cb6-438a-87b2-8d80d7654839"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/26935a44-5a59-4d56-a125-eb9dd68bf988"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/cca30d28-a27b-42b7-8771-fcb725ad49a6">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/2514ad54-827d-4a00-b3d1-f5d6cfeb7671"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/01a1ff41-b12e-4530-a985-f2c3e4abe1a0"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/62d32251-6ce7-44f2-84d0-76b18b900f19"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/85c39e35-6015-41f1-9273-dbba222272e6"/>
    <rdfs:label>escitalopram-desipramine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/1a419594-124d-4645-94d0-a9e1b00d2ee0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/5013b215-25e0-4f16-a7af-b6c9261e4bb2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/9d502667-20bc-4dd4-8221-52121871085f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/f644552f-298e-436c-90f8-0c6f339074b2"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/7e8e4de7-59ed-42a6-a660-6abd03b6fa05"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/7de8ee04-a7c6-457c-8fb9-97b6ae02e100"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/8f203be0-6969-4fdc-8376-b333c3858837"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/8d899cf4-47ac-4b60-9c8f-604fa449de11"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/22ed78e9-01ea-4151-87d3-fb8814ab8491"/>
    <rdfs:label>ketoconazole-rivaroxaban interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/df4acb21-a55d-4a23-a514-98fae04ddaf3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/5c252e97-feec-4d02-84ec-96d3a557dcd9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/c23105c5-dde2-454a-b903-5de079e4a01a">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/f2f3c9d2-3a86-456f-9655-38957d12ede2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/22ef8be7-9c0c-41b6-bc02-658956788824">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/46875afb-e481-4507-b89a-515120984aee"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/3f9c86d9-66ac-4b39-aa7d-7a34af3abb9e">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/60c07b91-e14e-47cb-b09d-44df9459c5ce"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/197a5440-2e7f-432f-912b-16e6579c7817">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/ba0da8da-d1ca-4ed7-b344-2b860c3cf08a"/>
    <rdfs:label>nefazodone-alprazolam drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/f0fdcc4b-232b-44d5-81ef-f66e97f17b54"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/a5923664-afda-43db-9d14-d79725e147c1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/701a3551-a6f8-4253-a730-96c7463215ea">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/c1872d07-26c9-451a-a9e1-55ea917c46db">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/464e9e87-51b4-4498-8e76-184b54add140"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/d1be21b3-bffc-4f9b-be90-d8d4bd5fd530">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/6c944f19-31bc-4922-877d-e7055d932d7c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/e9a9333d-76ab-45d3-a0b6-4bcb41bcf5bd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/1d077357-97ac-4efe-a583-3baa98841f81">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/3a988c1c-c663-4db4-91b3-5cc0548f568f">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/950f2a28-301b-4764-a520-dd93a009bbc7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/352ae1ec-5406-40a6-a972-9ec9be32ddb7">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/f8a7281b-d4b3-40de-97dc-9294cc7fe396"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/0498b349-4580-4912-9985-1bf9369e1f48"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/af2fa785-127d-49ce-bfb6-d69ee45350b5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/895bf3dd-f294-40e9-a7ad-a30ba69f241b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/e88418bf-c9ae-44b9-9d2a-f039123a1886">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/227ddd43-46ab-4418-9e5c-934dc5540080"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/168b497c-b4df-4001-a8f9-cde9a500ce03"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/4359f93e-5f61-4b16-a2c9-f5a09b56b744"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/0f7f9329-37bf-4485-aad4-b7b8216ccfba"/>
    <rdfs:label>paroxetine-atomoxetine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/df033e82-ed43-4cf0-adcc-3caf6fb5690a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/5f1cb41b-0853-4fc7-ad6c-b3079c3cba25">
    <rdf:type rdf:resource="obo:MeSH_C060062"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/ead49966-66a9-4608-a69e-d619d3689f90">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/76647eff-849a-4966-bffe-35bbea065c0b">
    <rdf:type rdf:resource="obo:RxNorm_85762"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/689200b1-4e5a-4efe-9cd4-46f5483cd15c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/360dbd20-f9ae-4369-85bd-b80ea26c315c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/309c852d-d0d8-4aef-be9d-2dd67166879e"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/af9a7256-469a-476e-ae7e-74abb993bde1">
    <rdfs:label>paroxetine-iloperidone DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/c560e842-45a6-459c-bd9c-ab7d25c28bb1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/983c71f1-1c29-47d2-8d5c-693c3c075b91">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/db028535-0735-4acd-badc-15b31433aaa8">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/1471f962-696c-4fd8-bbca-fee8feabb2f6"/>
    <rdfs:label>Ticagrelor-atorvastatin drug package halflife  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/59f6f1e2-3518-4668-8cca-5e0bab3dd0e0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/9ddf6cd2-706b-4259-b876-1a6b5238ae5c">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/92a58b4f-6595-4035-9330-8b9c64b1b9e1"/>
    <rdfs:label>nefazodone-haloperidol drug package cmax UNK information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/43615e5d-38c6-4bc6-ad4c-1db94c1388b3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/9f8de545-d571-48a1-9546-79419eb2629b">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/6d45d608-b460-4472-accf-5bad07cc8115"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/3d59640b-f901-4089-86d8-e77473b6e4dc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/b1ae0124-bdef-4e2d-ba67-18c68ded23eb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/6ec094dc-1d96-40be-8f48-007b92c4ec9b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/fea1f1fe-5a8e-4db5-b27c-77f6397b17a9">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/86627efd-0e10-4506-9fe9-dadc55ccb789"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/e04174d3-de8f-445f-833c-6b66f04e5611"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/e4ec4659-d3f3-4f49-a56c-08cc381c8a6a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/09d1b62b-43da-48e6-8cc3-caf9bb92e1f3">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/8528e0a2-8d0e-4fb2-b6d5-271fb54cd533"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/d6428c27-d4c7-48d3-a7fb-09443deb6339"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/2f01b7a3-0d1e-45a1-a9f0-6ba6783b937c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/f1b1a344-064e-4a4b-9245-43c01726898e">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/218824a0-3a64-403c-8282-ec7f37620ea3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/82416dce-ec44-4723-8ade-6da03a746b3e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/c387e9b3-c906-49a6-ab86-f6a1f6ea9a89">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/6e2a2740-deb4-416f-b173-1c11a7bcfacf">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/8507aa62-a365-4849-929b-0635e7969524"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/1df6eec0-e1e9-4627-8e41-45135fb569b1">
    <rdf:type rdf:resource="obo:RxNorm_5093"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/65a42e6b-1c22-48a9-a3db-a7403c4fbfcb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/325a641e-1e3a-47b0-a160-1fdf0492cffb">
    <rdf:type rdf:resource="obo:RxNorm_31565"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/c847de80-ac13-4c9d-a49e-858fb8bd8dbc">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/f3164e93-d18d-4db6-a2e4-1c282a7e7990"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/cd31190f-d480-4063-af73-09e7d52329a8"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/61785908-12c8-4c03-a2c1-ebaad62a044f">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/99607a14-c67a-4bd4-8ed5-acf16ce6225e"/>
    <rdfs:label>rifampin-pitavastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/065321e2-fee3-40af-8329-c80fa839b15b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/c9421994-8946-4d2f-acad-563f6ecda205">
    <rdf:type rdf:resource="obo:RxNorm_686438"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/502fac57-6e57-4026-a4ca-7cbd848a1183">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/1a7ae1fb-fb01-44d7-b36a-9e7c6d9264b1">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/8bae553a-662d-418c-94e1-1b93dcef24d7"/>
    <rdfs:label>67 Percent </rdfs:label>
    <obo:OBI_0001937>67</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/98ec9d7c-4fe6-4306-9f0b-53a3bb6e849d">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/788ce902-496a-4b27-b54b-a6fd41512b9c"/>
    <rdfs:label>100 Percent </rdfs:label>
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/7a5dc9aa-f259-4afe-b89f-ab91b524a881">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/4b2a573f-f989-4ad2-b305-9fd247ebe52a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/792ab9f0-cf9a-4a24-81da-7a7a08d34a4d">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/64994016-e2c7-44ef-b3a4-e6797a3cb7a1"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/00f00a7b-996e-4809-b087-63e06d0e65dc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/1dd883c9-3ce4-4896-a516-920c0a2094e6">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/c51e9820-e9eb-4999-9838-9f78c571f231"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/377a176b-529a-484c-9c25-42ae427d8fed"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/623174c8-9047-46aa-821b-6c8ef6464160">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/dba94a8f-3e3c-4a14-8cfc-8a662eeed03e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/3e0ed9da-8645-4ce6-95f7-0b17331cac0e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/598f6881-b997-40a0-b728-4663d98b9bfd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/97f1df42-bcc7-4c04-8880-523f2eb06134">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/f71de8b1-7e5e-4299-b4dc-e29309891e38"/>
    <rdfs:label>cimetidine-zaleplon drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/a85ccb01-ef28-40a9-9538-6afbeb7db401"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/7366b6e2-e0f1-4855-ab55-d36d34fe94cd">
    <rdf:type rdf:resource="obo:RxNorm_8787"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/5208bcec-e0aa-4afb-9c92-3a8b4fc33b99">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/6daf43df-62c6-458e-bfce-bc56a3cdd7ab"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/3095e519-1866-4a17-95f6-f1c54038835a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/2dc8b5c5-060c-4b11-a20b-1edb8307e65d">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/c3987ec3-1c5c-4b8d-b4e4-919f732d5312"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/8bb88c58-50c8-4995-bc2c-41b0778d6fc6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/0c7a9872-1e6f-43c2-9b5e-2476151adf56">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/a401bb34-85fd-4e24-b3f9-16421bdf2b5d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/9730b373-3d49-4be9-9124-def65ef5b6ed"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/4cace9a6-74ee-494e-ae17-d499ccd468cf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/75c95f87-3ec1-4323-b20a-409ef0aa8898">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/da9300ef-f92a-4c27-8981-354654a103aa">
    <rdf:type rdf:resource="obo:RxNorm_2002"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/22efe479-cd25-4a96-8490-1673199d96ac">
    <rdf:type rdf:resource="obo:RxNorm_1116632"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/bb88e224-4fa6-4f0f-890e-2bbafaae13d7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/3b4f547a-1b3a-40f1-af66-dafce7a2c0b7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/67c412dd-5bf3-4ad1-a433-8564110f2963">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/469851c4-4c04-47f2-b33f-16413a28ed9d"/>
    <rdfs:label>ketoconazole-P88 drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/3b6bde50-a2bf-4960-b4cf-f3531adb45a9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/4dd19258-288a-46a0-b4ae-6e1706d28e2f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/acc4ce17-265f-473e-9ac0-828793525165">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/046353b9-b220-4251-9784-c2b7fbad6439">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/fe653393-6292-40be-a65d-1dbd1e143ca9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/d854b108-5bb4-4cee-8d72-a9e7754f172d">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/bbab154b-2d68-49c1-beb4-51fe9e0c9aa1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/cec71460-f428-4715-a273-8943bf45e4f3">
    <rdf:type rdf:resource="obo:RxNorm_6135"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/dd170d8f-5316-48b4-98c9-e067181473a0">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/81d05dd5-cf36-459b-8094-72edfe796882"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/35e45394-cbe9-4233-89a1-aa38ecd98fb0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/991da71c-4e59-407b-acbc-0bdcc4891771">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/8bd57248-84ad-42d8-8b37-df0dc994096b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/e6a9198c-2e8d-4e4d-bfd9-d321ae326a6d">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/15132a20-40aa-4c93-a6a7-a0ec80b721dc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/b1145f59-67ce-4314-a3e0-7869f2dd8ad8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/028646ad-ab96-4b4b-a368-3921c211f585">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/3ee69d0e-5017-4d89-a462-4e061b1c5ed2"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/ccf07320-4601-42fc-b343-588e1c76445a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/c198554e-3682-4386-82ea-e1fc8bd2e75c">
    <rdf:type rdf:resource="obo:RxNorm_4719"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/de78bdc7-3d23-4933-bd6b-4d1d972a24fe">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/f287e62e-e985-46c5-8935-e1a6f152d482">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/0811f084-7442-4d85-9025-565999ec48c8"/>
    <rdfs:label>72 Percent </rdfs:label>
    <obo:OBI_0001937>72</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/d0e7cf71-c3dd-42e1-955d-eb9f918e074e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/cdb4f475-bdb5-4f2b-a8b3-59bd5e324139">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/407db4f9-b8f8-4f39-9425-c013d23f38a6"/>
    <rdfs:label>phenytoin-paroxetine drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/8b2c205b-1efc-4e49-b4a1-0f8b1546211e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/2778a627-0bb8-4012-9cea-7fc5d8939e2b">
    <rdf:type rdf:resource="obo:MeSH_C001422"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/f82b6a1f-e430-4093-bed1-2fd03e84e12f">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/d19e1416-757f-46a5-b98f-ca24480f63a8"/>
    <rdfs:label>erythromycin-zaleplon drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/4399a64a-71a0-4d47-8a9f-fdfb69604523"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/d940bbe5-bba0-4c58-8ae2-43e58348d9e9">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/54f909bf-7858-44cc-8b28-3684aef1b944"/>
    <rdfs:label>Boceprevir-Atorvastatin drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/a951e6e4-3156-427f-8ae4-ffbae7fbdd5f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/b13cd345-72af-4e3f-b1c9-7153a2de610f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/31cd569e-32da-4bde-b1fc-366852b73202">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/f346cbb5-45da-4a47-bdff-ccf99d0c7791">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/f8d7fdf3-cde6-4b31-908d-6df33cc33f30"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/b9eab827-c3ac-4af1-ab33-1589b2ab5b28"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/120d1d98-cee9-49e5-8e1e-b7ce879bcce0"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/45048fe0-5098-4801-b884-caa857b4ecf1"/>
    <rdfs:label>cimetidine-citalopram interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/33081cea-ffe1-4a93-8e52-4ae2920e933a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/7890b2ea-bd63-4377-92b5-ee390f2b8fc1">
    <rdf:type rdf:resource="obo:RxNorm_6135"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/3011fa81-72ff-43e9-ab85-9d1721f81fe2">
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/dc1faed7-5f05-4eb2-a422-c2904450a657"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/8516d388-df26-483b-8407-2e5978101026">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/2d5dc1d6-65a2-4d69-b7a8-70ce65bd6b0d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/660f023a-b1d1-41c8-bf45-527e2bc2ac3b">
    <rdf:type rdf:resource="obo:RxNorm_21212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/e19dd817-b615-474e-bfbf-c39b94555051">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/e773ec51-ef93-4bf3-b252-448283db1cb1">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/ee72f70b-7219-401f-a867-17d6d1151fe7"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/a4539ab1-9367-4a1b-a4a6-46bcb1c285b5"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d3438578-c159-4c0c-beec-2b2fe6d477be">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/dd34b9e0-50fd-4a76-8cd2-dacebbbe6ba8"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/3c48bb63-2eb9-4b90-aeed-c7456d502284">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/bb52518a-521e-4986-9bda-ae995cb9a686">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/373dc5c0-32f1-42db-8966-f193d3a64661"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/1c6a5ba8-0e7a-4297-b9a6-157634746fc6">
    <rdf:type rdf:resource="obo:MeSH_D016572"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/95524fbb-9415-4a3f-b8da-9b2ca2531e6f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/a3518c1e-a9d4-4f8c-b956-cefe55b0d0d4"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/8e4570d5-1470-404a-a6cb-7f2c3301c557"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/e0603c30-a1a5-4f76-9334-5c5618166daa">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/707b10b9-f6d2-4fd8-b61d-8e2a661b627f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/9c1bc141-ad8f-44d8-9a72-e395b7e3a1f7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/f7f3233c-36e1-40b0-a8a7-5bc3be7aecd4">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/7e5f0dcb-fd18-49bb-9f99-d50215e98b75"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/848ed393-bcbf-4575-8a23-47695878d749"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/79ed4eb9-bc12-497b-95e6-eb8c6e81e782">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/84dbfcbe-75b5-47dd-92fb-53beaca1d3ea">
    <rdf:type rdf:resource="obo:RxNorm_195085"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/386eae0c-d3d3-4e8a-b455-c69b188baeeb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/66748015-50d3-4d7d-9b34-f90413ef9302">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/71164f19-e5ed-4c50-a626-c77be5acafaf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/ea55747f-40a5-455f-b740-7959bf3c22f0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/54a8fd21-6e21-41f1-93fe-ff61f1118617">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/570a75e8-141d-4500-84f1-ade1e0577960"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/873e5cfa-54cf-465f-bde9-1eb6e96d40ff"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/130c217c-611d-4e37-ac3a-dc5d9b291be5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/b12698bc-b720-4be7-8cc9-7699dd41d5c4">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/eefad98e-7796-4c53-b67b-1a73bdb22738"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/e43000a8-ece9-4472-80d8-4de929ca71bb"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/9c052a37-284c-4ca9-97eb-2f82641dd657"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/757b4db9-c172-41cf-b3e2-db8bdfe6894a">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/d4d4f7a4-46b1-49c9-bc9d-ee5e4cfb5608"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/a38f4268-9bb0-42be-a5a6-e14de42e0700"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/560185bd-3ebb-43e5-b83f-14a683a4c995"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/78d5a1db-4f5e-4e0a-b45c-88416313eb67">
    <obo:OBI_0001937>.2</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/d35fd02a-7f25-4b1e-bc54-08a7bb275b26"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/99607a14-c67a-4bd4-8ed5-acf16ce6225e">
    <rdfs:label>rifampin-pitavastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/b63f6e3c-33f2-4146-bfdb-4c7101d0c539">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/8d90738a-368a-47c0-8a79-9e2abdfac076">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/d032e642-6434-4e6a-842f-a6464eaa68b2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/f2c1a857-d11f-4ca6-bfe2-103053d84a38"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/c919fd0e-d4b2-451c-8ffd-3eb6291139f6">
    <obo:OBI_0001937>400/100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/749e3c27-506a-4e1b-9f15-81c2ce9e2b8e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/6b9e4807-6050-43d6-874f-0574bcade8c1">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/c483ed5b-ddfb-4d37-ac10-fdc90be272a7"/>
    <rdfs:label>2 Fold </rdfs:label>
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/77b48ef9-4af3-46f1-965e-0c5606e649ee">
    <obo:OBI_0001937>Unk</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/60f5ef77-b857-4d96-8bd7-a3b37471097b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/f7c500b8-7f4d-41a8-9efc-0fa5ee96c07a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/5bf4cd3f-1583-4669-b219-5994a076ea1f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/16e323f2-3a2a-4dfc-ab1e-29783758b17d"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/93bbce2a-e782-4664-aaff-a8a7b85c12b8"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/52123f87-ce53-4c74-92d9-199f8d0a9d4c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/c580df41-0f90-4862-b1a9-2e763112fd0e"/>
    <rdfs:label>Nelfinavir-atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/72f390bd-f783-4a65-b67d-0537905c58c3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/7dc23193-fc55-431b-9809-3cc097c7f730">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/4dad48ea-6dda-4b54-b233-7065465cf305"/>
    <rdfs:label>66 Percent </rdfs:label>
    <obo:OBI_0001937>66</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/fbfba40e-abab-40e1-b738-27736d139eb9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/01e1617c-818a-4b2f-842a-89b73886b5c4">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/dea1f07e-f0e7-442a-920d-1948c56f1d07"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/8bd36961-14a5-4f18-97dc-f72dce3e761b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/c526c66a-1a3d-4a61-a5b9-a3b77a42fdfc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/31a412ca-848e-4982-96e1-81c52c798013">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/bd05db0b-010b-44a1-a3bf-ba0dc3e1ec4b"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/46729a21-1c2f-4834-b0f3-5302d033eaaa"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/7ff35ab8-edf1-4984-81ae-4b5585211a8d">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/8f1fa790-0c5c-4b26-91ab-1cb3344dc937"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/7213521b-e129-41c7-bb69-0c42a4d90486"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/08f1588a-9e46-47c9-9173-bcfdd5e44a37"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/7194a584-3bd1-4cfc-8b11-48d4f4a9ae26">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/d0cad0fc-4b08-400b-915e-647331825756"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/9a187cc7-0272-4efd-bb12-1b84f537a113"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/60a65c24-959e-4f47-a986-1ba89021c0ba"/>
    <rdfs:label>Carbamazepine-olanzapine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/972bf20e-1e87-4bfd-af68-f492cba21d18">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/2a6b1cc5-48a4-44e4-bba0-f6ae4b342650">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/565dfdb0-bb37-457a-8a65-c93e60aa6227"/>
    <rdfs:label>3 Fold </rdfs:label>
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/56c15ce6-9b04-40d5-8dfc-a1794b2853ad">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/1242864d-5fd8-4108-a289-9b29e10163e6"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/d0877156-15f0-4654-9dad-6e5aefae7ed8"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/6352d45d-c037-4abf-86b9-9cd22740ef34"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/d74b2149-223e-4aa8-9e88-69bf3a1dbe92">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/5e949848-d351-459d-a9a7-518312c56897">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/b8a1b370-a4cf-410d-8ff2-0a708f03cdd4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/234fc4d6-1721-4009-99fe-feb5bf7c4eea">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/42190fd6-b918-4059-8f08-b0fa379f2a79"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/e734ec77-8e69-4a46-8f69-e3746adef5e4"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/8624df18-0b92-4da6-a07e-81ee73121fb3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/560185bd-3ebb-43e5-b83f-14a683a4c995">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/811ce48a-6062-4923-b233-e96ace6cc267"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/b5beaad6-5f68-4103-bd82-283c1453a06f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/85c39e35-6015-41f1-9273-dbba222272e6">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/b73cd0cc-41a0-4f21-82fd-b984ee0a76cf"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/dab87e2b-0a96-4c08-8d10-e02e3c04d739"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/524e0f37-b517-4035-bef5-fbfc5d50265d">
    <obo:OBI_0001937>400</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/27617c2c-679a-4314-b6ff-109e020faca5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/053ee1f4-9113-449e-8d1c-a92cb9cd17bd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/b0f48d47-d081-4509-8c7e-3d220a819ffe">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/8e32e90e-2e90-4123-9b8e-b8351baa6926">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/78c55b77-16e1-4f21-95e4-7c453a6a2ca9">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/a5d5861d-75cf-43fc-b714-a38b52a2a527"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/d13db1d2-bb45-4699-b592-34f7c0cc54b3"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/be5409e5-3117-4b1d-822f-0d3bf4eee267"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/4f56aec1-f7aa-4efb-8a4b-eb595d3a0616">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/ac19582f-5eab-4e5a-8007-031175bba4ce"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/4663ee44-d9c8-46d8-9df8-4c57966b7657"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/0c0b1a9e-3799-4a2f-b030-32af17400e52"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/c394e982-4805-4e8d-bdfe-c6cd9b017fa6"/>
    <rdfs:label>Fenofibrate-Atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/987c38ae-b11e-4455-9368-bf8d673e3f45">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/b4a77126-0011-431e-8403-8e2f380e0d36">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/35199bc3-766f-4d50-8847-09d9adfadcd9"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/30143a1d-864f-4c58-801d-774486f88114"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/748d823f-af5b-4178-ae2b-5efece07f0aa"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/395b2952-695d-41de-a8f1-5f318ffee469">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/8fe0ea44-26ff-461d-9b14-4575b2496683"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/336069cb-bc92-434a-bfb0-c91c0db454c6"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/08d0cb81-a4e6-4e3c-93d8-6ccfdc55d368"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/34e8b2e1-e67a-4721-b5c0-9511c6a01834"/>
    <rdfs:label>duloxetine-warfarin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/d69cb994-5328-4696-a534-d19a7cec3dd1">
    <rdf:type rdf:resource="obo:RxNorm_61381"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/184532f0-e082-4952-8ba9-962f74893705">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/8590bb29-d893-45a5-9d33-75322649f05d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/759dff6f-8a05-4c4e-8635-3ad47d228073"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/c7a4b74a-0ab8-4698-8502-9b88239a50aa">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/6a3b0de3-adfc-44d2-ba7e-a55b4f501d13"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/dcaff725-600c-477b-97e4-388ab2477f2e"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/4172ec86-5a71-40aa-9084-83871ec429d0">
    <obo:OBI_0001937>30</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/352f3fdb-bbff-4ab5-b294-92dfb6cb0b63"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/3786e0f4-a9fc-438c-967d-c9eb6a5dcd4a">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/1c9decb4-1181-42c6-b6a0-ed4b2582499c"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/6c26a1b3-b3a4-495e-ae89-6ec6187aa83e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/8a64c6d4-a915-4ea9-bb0c-26c3937af218">
    <obo:OBI_0001937>150</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/33e224a5-9091-469a-a520-f9a54ce0c6cc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/6526f915-b403-408b-bdc1-41411ad71ec5">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/c1c0f3d0-9d98-4c2e-bb16-34588062e209"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/492b3f8a-662c-4c3f-9953-278f89773ff6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/f3c59397-9da2-4070-85d7-dd4edd3f36e2">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/2778a627-0bb8-4012-9cea-7fc5d8939e2b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/a3b62934-82e2-4451-bbd1-0f248f5f5d61"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/9182a029-3e4b-4385-a0f1-1a5cf75351b3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/eb031b2a-9110-4539-8bc9-da3eef7bc45e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/1b1bff70-284f-48c8-a200-a88f65e787d4">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/917d3cc2-adf0-4a02-9429-ede9d90841e3"/>
    <rdfs:label>theophylline-nefazodone drug package clearance UNK information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/3769c272-ec33-4e9a-9dbf-4fcc7796dde8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/5087b625-c0a3-4fa2-9891-6db276d43709">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/b3cab413-9289-4a46-9199-1bc8391f5f45"/>
    <rdfs:label>2.3 Fold </rdfs:label>
    <obo:OBI_0001937>2.3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/3b35bd15-7665-4f8f-b57e-7b2f047bcf92">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/60c07b91-e14e-47cb-b09d-44df9459c5ce">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/f88f06da-5aad-4179-8ffc-5e7536b9bfa7"/>
    <rdfs:label>2.4 Fold </rdfs:label>
    <obo:OBI_0001937>2.4</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/253d0bc2-58d6-4a80-bd09-61594dc0e202">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/2d50a42c-bf9d-4739-9afc-abedf35c5a6d"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/64bf5b1c-2a3d-4d1d-b3da-071201032a53"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/f2ed956f-9b98-49b7-a5c7-2f335aa8f2e4">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/9d982cf4-4a6a-4dc2-80de-cfb60e476aa4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/4f29de76-ab25-4b2e-a423-0cfebb04c45f">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/ec9175d7-2bf6-4f9d-b321-e2b933bb52b7"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/99d1d274-9c68-4037-aeb5-aa240e14fbe3"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/42440d8f-18dc-4edb-a212-708f962600f9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/7e5244e5-4a8c-4a8c-966d-14f5ade95bbe">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a2622d70-07f5-4b33-a6e8-413970182302">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/70358b58-bb7f-4e79-bea3-6438efc9fed4"/>
    <rdfs:label>41 Percent </rdfs:label>
    <obo:OBI_0001937>41</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/5ed4533d-484c-4540-85a1-170f0d98994f">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/5b088fc6-0488-4126-8e32-29286ad69c92"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/aebb348d-e348-42e4-b693-41e6e9472345"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/cc79ada6-9133-45e9-9929-df7d12351132"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/af584092-d757-4e1f-b8af-b99b8495c7a1">
    <rdf:type rdf:resource="obo:RxNorm_31565"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/fce2e6e7-4080-4dfa-8ad1-eeff66411960">
    <obo:OBI_0001937>6</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/f52bd8f9-1a86-4812-b8fc-fc13bb77b04c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/00e1a507-b4ce-4f66-92d1-b4809058cfb9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/3346ba72-2757-4f27-8204-9870003e96b1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/528d867a-5710-4ad7-a12c-0474f1712968">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/07ff0906-8589-465c-be91-2efadf4a6345"/>
    <rdfs:label>12 Fold </rdfs:label>
    <obo:OBI_0001937>12</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/249a4f67-b18e-4974-9123-8e906471c8d2">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/e0a915ef-1e63-4cf7-a1a5-4c1a8f0c6543"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/6d466061-10d5-4f3f-9685-d9a487428915">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/d72140fc-abe9-4f6e-b4df-f9668fb1da81">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/acfc5e90-5bea-438d-b15c-95f9fa3b8538"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/ca58c5c5-adea-4fe5-9840-8874c7a830bf">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/4331d516-1286-4c4f-bdcd-0eaf315aefc8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/92933fbb-4d73-4d72-8729-107bc91324c2">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/e544bbde-d8f7-4075-9f0d-d50924795420"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/f0528822-71c9-4ea7-9043-2badfa91f57b"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/da9300ef-f92a-4c27-8981-354654a103aa"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/23df0c48-7c1c-4209-b457-6dcd20e888a6">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/5b4a77a3-ddd3-4127-b717-6dc83e23ccf7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/f910c5da-1583-4186-abd6-1a581c73d3e3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/c0154d8b-deba-4ee0-b3f9-f2b0de2c1460">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/5e4afa21-2edd-409f-bfe0-19247a7e7efe">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/f641494e-8f29-4eb0-9ffc-05bc930ad018"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/743c1c2a-d6fd-4b5d-844b-81a5efef621c"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/a6d3b0d8-685d-4f0e-a4c1-1116450712ee"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/7c304aae-0ee9-428b-87f6-7185c6260b1f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/8be631ad-8542-47ea-92b6-3c74dca46eda"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/6acba756-c07a-47eb-afa4-08becb81bea5"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/18e9547c-6d53-4764-ac66-21495ebec9d4">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/75c95f87-3ec1-4323-b20a-409ef0aa8898"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/76f0090e-ee69-4c68-86ec-58ec8c480736"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/69c86525-6950-4964-a40c-41cd2d51047f">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/851688ef-4b50-4415-9b6a-155bdbdee8e4"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/1410b0af-e3e2-4b6d-be6b-177068a9d2da"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/4015c3f1-479b-4f66-a478-fa55386637e2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/71545a6e-8433-4748-8f6e-38fa833cc708">
    <rdf:type rdf:resource="obo:RxNorm_32937"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/d99ad2e4-ecad-4b10-b96e-1bbd2d056f5c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/2bd5a9ba-28ca-4fc3-91b7-add899cf20eb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/0a7bb624-c1da-4541-a6ee-6286ae7f7331">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/e3c5fe17-8793-417c-942a-8314233ac584">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/cd483bf8-072b-4902-a27b-0e02e0985cea">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/4942d2cf-5b1c-4eee-8b10-d925c7fbcb22"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/d94e093e-db46-45ee-8e49-79fa4ae09598">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/80836706-e198-4a6b-9b25-00f01aeff53e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/1a8d0782-4c88-47c2-ab55-d5e79293bed7">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/1db7a024-c446-4935-a888-bc77b01c3a1a"/>
    <rdfs:label>134.6 UNK </rdfs:label>
    <obo:OBI_0001937>134.6</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/1f7faf89-29a0-4350-b0a1-93bfa8a67385">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/2a570d86-e41a-4339-8ac2-d3ed0336b33b">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/357bf344-cc0a-43b7-a76e-285e5716688f"/>
    <rdfs:label>2 to 3 Fold </rdfs:label>
    <obo:OBI_0001937>2 to 3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/fa44464e-95d1-44ac-be3f-8af3f93b0932">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/e75d5661-46f6-4478-b6f4-1fa37b331532">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/5cc9d774-38b6-44bb-bf5d-0f88aa5c7c57"/>
    <rdfs:label>33 Fold </rdfs:label>
    <obo:OBI_0001937>33</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/aaf8fcea-7132-4cd5-8f85-6c12f9219481">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/cf80c5a5-7c87-42b4-a481-496929555c9e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/cf7b80df-812a-4ad4-86a8-03542624e5b9">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/880fb2e6-2ee4-41ea-a3a9-8092d23d4e93"/>
    <rdfs:label>62 Percent </rdfs:label>
    <obo:OBI_0001937>62</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/0b8f5f7e-39fd-4106-836d-c628d85ce834">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/3b9f3296-9db3-470d-b376-332def47ca4e"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/cb5ea945-2eb0-43df-b5c4-334118f2a30d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/c4839cbc-083c-42a1-9ad0-54f7ce98e481">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/7cdc7191-710b-4295-8e12-f194800ea8b5"/>
    <rdfs:label>4.7 Fold </rdfs:label>
    <obo:OBI_0001937>4.7</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/d4b9b9d6-6472-40f4-a221-30bbe1c6d5d4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/40f6792b-7a5f-4563-bbd5-7ad7bbafe8f2">
    <rdf:type rdf:resource="obo:RxNorm_9384"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/6a7668f9-cf4c-415f-92b5-f5f8b18e7aed">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/b4e83a7d-1240-4cab-9a73-3e6273754af1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/439bc0fc-ec7e-4651-a1ac-685347b576a6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/7b24db8c-32c2-4c85-86a1-63521501fa5d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/d3d46496-6f8e-4c57-857b-d35632fc468f">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/dc3676b0-38f1-4e7e-b06b-c13a65458d82"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/1975d1c9-8290-42a8-9bc6-4fa6efaaa9df">
    <rdf:type rdf:resource="obo:RxNorm_31565"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/b034b3c6-4d27-42ba-9d04-c053eaf4a8c7">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/ab81ebf4-e645-4143-88cf-250a46e5eaa3"/>
    <rdfs:label>clarithromycin-dabigatran drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/36f94859-1b45-4b41-981e-dcaacc57741c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/4d1b3631-8c21-474c-8b42-f2ea6fb2b0df">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/5b5b8280-eba1-47ec-b6c5-71c9d7980bae"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/dafc7775-03ca-4b26-83af-8b5be3b18bde"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/64a7a9f0-14ce-47a9-b065-fab2163dbab9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/21886568-6211-4adf-bc17-cbc43aa7e63c">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/0fc2384f-5b30-41c5-8d9c-4f8a8c6d9463"/>
    <rdfs:label>1.7 Fold </rdfs:label>
    <obo:OBI_0001937>1.7</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/e5c1c9b7-06a3-4e8e-aaed-e2e4834cf8d9">
    <obo:OBI_0001937>160</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/98196f24-d42d-4ce2-b5a4-8db4e1981a31"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/53295cc5-be99-4c47-8e4c-92ce1cf81c63">
    <rdf:type rdf:resource="obo:RxNorm_32968"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/8f203be0-6969-4fdc-8376-b333c3858837">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/263a10ec-8bc0-449e-8d82-c1ab5180e006"/>
    <rdfs:label>ketoconazole-rivaroxaban drug package halflife  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/aacd6fb3-0ec9-4d73-b383-e154be9df0d7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/6cd03f47-6106-46d2-ade4-96d4de6075f4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/6b667423-cb4a-4a78-a552-05d42077565e">
    <rdf:type rdf:resource="obo:RxNorm_10689"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/610c1601-4536-4b37-97dd-283f24f8fb5f">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/4a7f478e-3a9e-4a76-b489-fdda6e8759d0"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/013a73be-b191-42e6-819d-d9354f40218a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/14f8e731-6f4e-41ac-8eac-1341107df947">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/f29a1755-b99a-4807-9e10-a743b501fca4"/>
    <rdfs:label>0.92 Fold </rdfs:label>
    <obo:OBI_0001937>0.92</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/d8b6a02d-5b0e-4991-8830-52d8118374bb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/6c46b1e5-da6b-4c94-94e6-da5fce9af08b">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/39e12ccc-0366-4979-813b-fb906ef626bf"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/5f44f009-c3ec-4b0a-bb69-09aed8c326b1"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/caf641dd-15e7-4eba-9a64-2667ce41d3d7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/18f8aba8-3cbb-44b7-a8c3-88a8afa9bc6f">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/6fa4b854-1a8a-4f0e-8019-a1fdb3a9f98a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/66c48ed8-5f96-41eb-af7f-8d71a57fbd55">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/dece938d-3071-4ff7-9c87-3f112244a3a4"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/b166fc5e-f056-45ca-acb9-4c07c20921e4"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/9e445a12-f8cc-422e-9d54-c2f1df251328">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/e2737159-575d-49c4-9f01-5ff66fd4bfb3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/0cdc40b9-15b7-4c15-943b-c7f6e9668d68">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/26b158b7-82c5-4bec-949e-85bc0b8dd5cc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/2c352a88-4cda-45db-bc5f-8b712a2de52c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/fdd2641a-70e3-4f6a-b96d-1c446012f548">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/eb8c84ed-c78e-42bb-ae1d-5ef3a67d288c"/>
    <rdfs:label>Fluoxetine-olanzapine drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/2ad58ec1-f9a6-427b-8a68-fe772b2cfcab"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/db0e3b16-406c-4015-bc9e-352ee6ebb5f0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/4cd94f1e-6744-4770-9c52-437bbb7260d1">
    <rdf:type rdf:resource="obo:MeSH_D000661"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/559db6c7-c46c-4139-a459-33e46799a479">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/0510a415-19aa-456d-b4a1-e933e2d3847c">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/70df8e7f-e7fe-4195-b2e6-49b889126ab5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/1d5d3de5-8aea-4fb9-92fa-ca6d900831ab"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/0bbb830c-90fd-4f81-87f1-da71c9987631"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/3a14f622-678e-43e6-8248-e97581f9a8ec">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/c9c1adf8-9ce3-41d7-b23a-229ac7f95022">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/4b7f119c-9bf7-4be5-a923-eee30c8cf26a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/481ea044-0492-4d67-8be5-a56b01c84028"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/202e77d9-a637-4303-beaa-f75cf91520da"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/8c31895e-7fe6-45bb-bddf-6e9aeb4237dd">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/97ca2854-0af1-4458-aa94-85e2cb4f6139"/>
    <rdfs:label>3 Fold </rdfs:label>
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/c18c5122-5e48-4ed2-86f9-cff2e3ce5262">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/0689fd6e-fd4b-40f5-8915-0c9eb6e0145c"/>
    <rdfs:label>44.2 Percent </rdfs:label>
    <obo:OBI_0001937>44.2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/f2ecd61a-e6f9-41fd-a41d-7b9028a4f51c">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/fc25d94f-c102-4ec9-9a97-1234333b531c"/>
    <rdfs:label>4.4 Fold </rdfs:label>
    <obo:OBI_0001937>4.4</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/9dc0c2c1-4026-4909-a058-7333e37d8a97">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/f8a7281b-d4b3-40de-97dc-9294cc7fe396">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/2494402c-54b3-4b8f-a2de-89903d5d299e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/3fd62a44-c8c0-4582-a6f0-5c16e493d2c4"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/05c726cd-4689-4e1b-b54c-9468d0576ca2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/65739527-7807-4759-a6be-7d01fa60e3c5">
    <obo:OBI_0001937>Unk</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/6fe9f8c6-cc81-43d7-b7f1-52a89dabba5c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/b13313d4-bde4-41d2-94b7-1fbfef243c9c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/a0b63470-1c02-4d81-89b3-1be392a004d3">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/80c5e020-ccb0-40b3-b822-53254fbe6e4d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/fd47793e-05e1-4d9c-9b33-c5c917884815">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/e9a71991-4e12-4d80-9382-4ad9154efea0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/923a0c09-002e-4758-9391-ed0e86815867">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/07afc13b-fe73-4aba-8cf5-f55bb8d14bbf"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/ca58c5c5-adea-4fe5-9840-8874c7a830bf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/8e5666e8-c66d-4863-8603-13b504ca2355">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/ae34130a-b8e3-49e0-9754-6a9d2859d5fc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/fbe4d0c5-0f01-4851-913c-85fd30e5717e">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/18bfca3f-1b16-41da-b579-b7d1fd32e99a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/c4573061-3704-4b35-aad7-324543e101a9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/22ed78e9-01ea-4151-87d3-fb8814ab8491">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/d84e69e4-7d89-4cf7-b1f6-32f6beae2cb0"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/b63f6e3c-33f2-4146-bfdb-4c7101d0c539"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/a0833035-ee87-4846-9df9-9d48f75ee6c9">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/0bd6f4a0-4e31-4a89-af8d-64e2bfb92249"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/e40bfe72-3250-4e3c-846b-2766fde73252"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/c847de80-ac13-4c9d-a49e-858fb8bd8dbc"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/cda036ab-12f2-4003-89d5-888b2214cac4"/>
    <rdfs:label>rifampin-zaleplon interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/69bc90d4-7b2f-4239-9182-c2ddd28fe58b">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/f1aad1ab-575e-4f73-919e-e323c9562bcd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/c16f2b63-8658-4661-b365-31e09d96ddd7">
    <rdf:type rdf:resource="obo:RxNorm_5093"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/ad5c7ac9-20dc-4568-9d92-1985f681373f">
    <rdf:type rdf:resource="obo:RxNorm_2556"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/c23ff75e-8e0a-4b79-b15b-b41de736c6f1">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/8c72fbc8-7dd7-4e67-a451-6eb444d5b71f"/>
    <rdfs:label>50 Percent </rdfs:label>
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/ee48db5b-69ec-49ed-8e33-a68fc1ed99b2">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/47a3a6f7-a66a-49ce-a912-7b877a18b70d"/>
    <rdfs:label>26 Percent </rdfs:label>
    <obo:OBI_0001937>26</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/2630c414-003d-493f-a65e-a722f92ad884">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/294aeee2-65b8-40d3-890a-be54fe8e8a76">
    <rdfs:label>itraconazole-zolpidem DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/63430a32-29ec-4719-8110-be464c210cb7">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/08a421c4-a0e3-4fc9-98d9-66d67c9bca65"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/4e12f1e2-8a70-443c-9826-81c82695a4eb"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/92e5c277-f3e5-49e6-a9d6-e5be44ae2607"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/19b3911b-7a6a-469c-ac7d-7b862722df8f">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/e1b96dc2-b11e-4614-9edb-65b56e758c65"/>
    <rdfs:label>rifampin-dabigatran drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/1a7ae1fb-fb01-44d7-b36a-9e7c6d9264b1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/3bc6bd04-6de5-4441-b6ab-d9f711bc3055">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/1e56f38a-0ff3-4a45-b2ae-cfc2ede15cb3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/c678861e-62c9-42ee-b1de-d73805614bf4">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/9f2690ee-3966-4ce2-89e0-26f92923be9a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/89080a0c-19e5-44af-8b6b-ae22d485264b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/41cee1b4-80a0-4c4b-972f-6e01f8e11440"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/4726d705-307c-4831-83d5-ccdb38ff1021">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/aabcdadd-e894-4c0c-ac9f-29b8c4fff520">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/90f131a7-0c8c-4262-a1ce-4eeab22110ee">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/ef81afcb-4c23-4ec5-b9b3-2e94a49b2095"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/9e445a12-f8cc-422e-9d54-c2f1df251328"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/616831c4-235f-4a4d-bdd5-2f154e6f6b34">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/3b6bde50-a2bf-4960-b4cf-f3531adb45a9">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/eb91b7d2-719c-4dff-8377-ab7c5e61d148"/>
    <rdfs:label>55 Percent </rdfs:label>
    <obo:OBI_0001937>55</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/24e58185-9a94-44fd-a9bf-4e0615df1227">
    <obo:OBI_0001937>400</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/b415938a-f9e4-498f-8844-818a6378c9dd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/f1972c13-3bf0-4ee5-84f2-d9ea40a83396">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/3786e0f4-a9fc-438c-967d-c9eb6a5dcd4a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/dd3ac1d4-80f9-4dba-8460-5d1b644f1a39"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/f7597418-0859-4848-8818-a767f4adf788"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/b6059a6f-eca0-40da-883c-9d79135285a4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/e2d791d3-e53c-474d-8399-03de06b6c9f2">
    <rdf:type rdf:resource="obo:RxNorm_11170"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/42028dd6-e6e7-4c0d-870a-a67afb3d5923">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/ed58a880-1ce6-4848-bbbb-86fe52bf7547">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/27b256da-535c-40e6-bba4-72fc39fdf650"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/39fb518c-77d2-4ae9-86e2-c5e455ab295c"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/0d7a1c50-fc14-4536-933b-46ec527aa71e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/1031187b-5b06-428c-9340-75cde25a18f3">
    <rdfs:label>amiodarone-warfarin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/c8228bbf-50d2-4792-8145-cf5a9156c783">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/6fa7d4c8-3490-484e-842b-f4f25f5fbafa">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/88bf54ca-01d0-46e2-89a9-91b7b0cbec0c"/>
    <rdfs:label>bupropion-desipramine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/83c91d29-10e6-4583-9a7c-844fc42a1713"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/20ac46c1-da8c-4e4c-ac57-5d0bfa14d271">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/50f15fc9-3e18-4371-ad57-2144743b6732"/>
    <rdfs:label>citalopram-ketoconazole drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/8494b975-90a5-4545-8c6b-b1581d9803c7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/1a7996a7-02c5-47dd-8468-1af4adb6bc7e">
    <rdf:type rdf:resource="obo:RxNorm_31565"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/779ff667-b6eb-42fb-b4ed-127dda099c99">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/d8b68ba1-b7f9-4c7a-8c8c-ad5ad67c2294"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/ac0e1a27-dc27-4f94-9cd8-9fe7c735b34c"/>
    <rdfs:label>simvastatin-alitretinoin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/1d2595f5-8184-45d7-a146-20f6ad6fe85d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/d1eddf96-e154-4eed-92a1-37be0d4e9b66">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/2f79021f-0222-4066-ad22-590ce4cce624"/>
    <rdfs:label>lopinavir/ritonavir-hydroxybupropion drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/8d686f84-b1ef-423e-b95a-97e844842cd7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/facf01a3-fd53-4473-a516-cf3b57eb55b4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/f650f0e0-2c32-4344-90dc-3dc2b6778f28">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/12ac85d6-b3fd-4aa0-ad58-5cc0fc073ee8"/>
    <rdfs:label>fluvoxamine maleate-alprazolam drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/85b901a6-24c5-46fa-9f8c-98ee311820dc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/930a2646-f3bf-43a1-bab0-38e017497df2">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/bb2cfddb-3a56-4048-8293-8e6424d7801f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/62d82b63-f404-4210-96ab-b4b25c5bd7b2"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/c15ee107-3771-46fb-8e79-91aeb72a59eb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/65d8cf15-db9c-4cad-af24-171a16e9c346">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/129ab74f-ac62-4241-9fee-99cf5df92455"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/020f61b4-c54b-467d-bf49-d832e62fd306"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/f9f9a59c-be30-42a8-9fe8-246a6c5d4a9c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/e2ffea60-47e0-49a2-95df-362f009bdf63">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/61cb3d1d-4279-407e-9765-cf43666309cc"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/b1d2b75c-af30-4fa6-bfb6-d9ec296b9b30"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/602cfa3b-0080-4a24-9234-bb413eeb01e8">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/504c99c0-096c-4a61-9268-bcfb17e5b3f1"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/2bd5a9ba-28ca-4fc3-91b7-add899cf20eb"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/102c6784-0900-4be9-8b1f-ad2b61d1dd0e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/504c99c0-096c-4a61-9268-bcfb17e5b3f1">
    <rdf:type rdf:resource="obo:MeSH_C092333"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/6b59f784-edee-4fb2-ac4d-42b6c532915e">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/16177e48-c49c-424d-a0bc-8201e2004e41"/>
    <rdfs:label>Cimetidine-Atorvastatin drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/d08020ce-6ec7-4ee8-89f2-251d7bb9e688"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/a58aee93-e4db-499e-9f8e-ea8912a72617">
    <rdfs:label>ritonavir-threohydrobupropion DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/ee2f23c4-43dd-4922-8bb9-510434014f3f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/1497a33f-b3a3-4b50-b0f7-9163e6cbeb22">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/7b144301-0538-45e6-b2e8-63915374cfbc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/b48dc0b1-bb0e-4ee4-8427-d0c01a00089b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/487adc9c-abea-4ede-b867-6da817184949"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/626261b6-c095-4094-a67e-c9b3c47b2c34"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/3b15c481-c907-463d-816a-94ec5fe876dc">
    <obo:OBI_0001937>400</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/9ebb6359-fdd5-4585-8c4f-70a2fa2c173f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/4b4d5cb2-9225-4cb5-934f-24cf150e6733">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/e57b1a9f-389a-411c-9372-75d3caab9ce9">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/ad1ac383-d969-4ad6-9db6-a2ab079b9600"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/60660d83-5aa0-4d73-96f5-b3d06bb28cba"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/22379ecb-3c72-4cf2-9699-7247357e73a4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/0316bfa9-e1dd-4b71-ab14-13ae2548ee97">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/2e83afdc-2ff0-4b17-b2c1-51f6fe3709bf">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/610c1601-4536-4b37-97dd-283f24f8fb5f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/d9af69c1-91e4-4712-a880-94528ed1ec9f"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/0a56aa3f-47a4-4665-a0fc-be503e563e50"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/4db18d44-3871-44d1-9b88-a312d260e1d9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/e4db57c3-b310-46c0-aff6-9063e74956cb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/93411e20-d87b-463d-ba0a-ec93eb8bae27">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/82c17bab-d79f-436d-9abb-5fe8c51a6574"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/6e56ab53-a34f-4dce-9853-36aea5453446"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/c2fe8971-efaf-4e52-ae61-f2d97fa1555a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/6b039447-d2d5-4ee6-97c0-4f5493d2b51d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/93658087-eb59-4277-acf2-5c182a508179">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/1145b078-7549-4be1-8e00-2a33691b3050"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/440788bd-1c1d-4f7e-84ee-7fffaf8304d3"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/1d9f8cdd-f40c-4be0-9987-84fda409521e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/b90e18a3-b525-4cc9-8ee3-411821f01ddc">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/79f7d6e3-eba3-4ad3-9883-bc15a5356cd0"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/263bd40b-2f1d-4832-8664-abf50baf8865"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/1b0f3f41-8182-4a4b-9512-823bfa584ed4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/e77f6178-e104-4e0e-b005-64fff3e90488">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/3414c94c-371c-4c3b-b6fb-ac2a31ca7e90">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/040ce903-1f18-479a-9ded-2e978c838a55"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/99c59547-9568-4cdd-9edc-35731012508a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/a7f27b0a-9a28-4d9d-8088-6668769cbfa2">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/9c058910-9286-4ac4-a869-2acf23cff73d"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/cf5e9a63-6723-4c88-9660-c78cbe9bbb07"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/3e8bf1e8-9e07-4525-8773-deb8a0557d15">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/b600c33d-a3d6-4348-9e40-dc677384ac5f"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/3776117d-e4ff-4429-8993-282b211d4f38"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/0b0f22bc-252e-451e-b22a-72c3a315f00e"/>
    <rdfs:label>nefazodone-simvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/00165819-b4af-4138-a516-267cc6235711">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/2efb9cd3-dce2-422f-bae8-e9d33ebe7e4b">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/8d4ac256-224a-478a-88b7-5e2dbe79d4d0"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/2b2cc0d7-a437-47b7-a068-8b9088be38dc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/51c5bfa0-8d04-488d-8640-f67a93427672">
    <rdfs:label>rifampin-dabigatran DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/d6c58986-cdcd-43da-a215-2c407fecccf9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/0dc95245-9240-4dea-a196-01a59be8c11a">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/4a8b6267-1dbe-43c8-8cc5-6e6433500205"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/c82d3a51-dcc6-4eca-8238-73a81b604071">
    <rdf:type rdf:resource="obo:RxNorm_4719"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/77af39d8-344b-43ab-8ba0-4b88fddc4943">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/68ae3bd3-4416-4c60-96d5-ba755feefe79">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/d9306a5c-2fab-407a-be75-840c7bfcf529"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/35f05f47-8cd2-471c-94f1-de08041439a9">
    <rdf:type rdf:resource="obo:RxNorm_2556"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/3b5e8446-e2be-4458-b69c-eb2ac89b30dc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/b78f0f72-e018-4cbb-8452-3fd75535caa9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/4c04814e-ed02-4cf1-af70-4fc27790454c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/c0a546e1-ebd7-4d99-b201-65469ff2aa88">
    <rdfs:label>Gemfibrozil-atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/9495d346-c911-4f60-b208-b038130449a7">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/30f8d8da-c422-426e-aa4f-442a9b36e06f"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/cdb51c3b-f07d-49c1-86b8-5c500cb56c60"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/a4db88ef-51c3-4113-8cea-c3dd0a38a15d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/79430ff7-8af7-4413-9a4e-19a004df17d8"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/c7383815-a2b6-45f8-a59c-f4ed99e76e27"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/17d83e56-f285-4b57-9f0d-59ac07abdcee">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/4b2c6219-9312-46dd-b6ad-2d06c167961d">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/8516d388-df26-483b-8407-2e5978101026"/>
    <rdfs:label>15.7 Percent </rdfs:label>
    <obo:OBI_0001937>15.7</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/eee4a522-39a1-4089-addd-1a9051abd820">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/f50f54e0-c220-4c05-aa8f-e5bd5315df5c">
    <rdf:type rdf:resource="obo:MeSH_D003708"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/fd934894-bfb3-4183-9cbd-9f02669bde72">
    <rdf:type rdf:resource="obo:RxNorm_42347"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/62d32251-6ce7-44f2-84d0-76b18b900f19">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/975a41d5-aed9-4c37-bd13-3e867c140230"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/470018cc-ec13-4f6f-9ab1-c43774a30004"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/ce161a28-79a1-49dc-91ce-bea91cf00133">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/719d406c-9f90-4769-842d-9b9d0e9d9c12"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/2fe8559c-76f7-41e9-95ff-3f85830f3ce7"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/ec5fbcca-97b3-48e1-8622-f544473f147f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/44d54615-b7fe-40f2-8528-367d60cfec81">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/0ec7e2db-799a-4960-a2ab-286efbb56174">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/5d565f3a-e35c-4bfa-abfc-abe8079b7124">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/e57b1a9f-389a-411c-9372-75d3caab9ce9"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/c365edbc-a649-40bd-8c95-647b1db0b1b2"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e10237fe-bc99-4e77-935e-548e1be8d35e">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/22554bf5-83c4-49ea-b77b-8c4942c74d0b"/>
    <rdfs:label>fluvoxamine-ramelteon drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/fa05f93f-0d8c-4985-bf43-063d42edb52d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/351e58ea-da80-421f-a439-2a6f0bdf6137">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/1523feee-8ecf-4948-9ef3-34676b78bf83">
    <rdf:type rdf:resource="obo:RxNorm_2541"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/c7f00660-5d72-4fe6-8a44-a2486784b13c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/eada4354-9861-4343-8975-ff30d4e5e448">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/fe350716-6358-4cf2-9dfa-bad0dc32adf4"/>
    <rdfs:label>amiodarone-dabigatran drug package clearance Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/46585113-595b-4d08-899a-924a07d35712"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/d3049c2f-e5e8-4ac5-b97d-bd33cba05150">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/7edd2f2e-8946-4272-b109-98970aa73259"/>
    <rdfs:label>paroxetine-desipramine drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/e3a209b5-5356-4b0b-94fc-a02f14f050f1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/f1e1e9b0-f0de-4e07-b695-c8d2604a5221">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/1f423d7c-33a4-4585-8e65-e716ab393e34"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/f1a2dc42-7d0d-497e-8141-37517dd1f9e2"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/cb7fc37b-a028-4a9b-b3be-10ec9e1880a7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/58ede1b6-a502-439b-9a5b-30423cb7cfd4">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/837d1196-a840-4bcc-8eff-6d91882f9882"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/464c67db-9360-4927-b74d-9b6149ad56ab"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/2947d4d5-11f1-4f4b-a30d-1d2f249a4c62"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/39e12ccc-0366-4979-813b-fb906ef626bf">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/7415f0ef-885d-4606-ba53-4f5554751588"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/270f2145-4213-42c3-aef3-75d9d40320b3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/9ab403ed-52bc-4095-bb92-4c76b7de9df6">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/509f21f4-5b59-42e6-bd11-0fb1e42351a8"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/3e9d4769-f473-4b1e-99bd-f3c748754f86"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/7cef3183-1e1e-45e0-971e-d6e0374069c2">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/9636317a-a948-482c-abd1-df0ff71b1cf2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/0b47fa33-ac95-4f39-89d9-adf521ea7907">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/e6626689-c232-41d1-aecd-3e4bffb4a516"/>
    <rdfs:label>quinidine-dabigatran drug package clearance UNK information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/5cc4cbdc-d8ce-4edc-94e1-de564bd905d3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/4d3ca238-ccd7-41a0-bc8b-658537dcb086">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/770a13e8-95a9-440b-9033-68784306e99e"/>
    <rdfs:label>1.5 Fold </rdfs:label>
    <obo:OBI_0001937>1.5</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/b73cd0cc-41a0-4f21-82fd-b984ee0a76cf">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/30757edc-c217-4660-af38-5aa0956a7f0d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/8e86050f-baaa-4c85-b908-55752a16cbf9"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/eca1b5fc-3021-47e5-bb72-51a74b80b582"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/badd7a88-df3e-4b56-b840-8f3efacc5745">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/edd2d142-238c-4f6c-a213-1fc3906d4481"/>
    <rdfs:label>ticagrelor-dabigatran drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/53f64e0b-896f-4e29-9f70-f56e1b7167f8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/5df41d2b-b81f-42a9-a5bf-5a2bb7efba72">
    <rdf:type rdf:resource="obo:RxNorm_4450"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/9c769ff0-fc3f-4d07-83dc-4d6265c1a715">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/dcb5441c-1ca6-40d9-abf6-6eef755d8eaa"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/996a2b42-2b6d-4d47-b84e-ebf93f166801">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/a38e8fd6-1fb9-492d-a6fb-1136168477f9">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/1ec11a6b-89f1-4e78-8057-d283b5b0d15f"/>
    <rdfs:label>fluvoxamine-N-desmethyldiazepam drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/b0d97414-65b2-4abf-ac08-1da028c66039"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/27990eb5-e630-4d77-bc3d-e3238a7382a3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/fb1974ac-a15d-4621-80d8-c32b18533a8b">
    <rdfs:label>ritonavir-hydroxybupropion DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/5fed0dcb-5ffa-406a-917d-66e14e23dac4">
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/71fcb9f3-8559-4eb8-bd81-e5fbba204c6e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/5545cfcf-b5a5-4ada-a6d4-4e29a0b7ee85">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/3a4498c6-3ed9-45b1-9de5-bc786a9d190c"/>
    <rdfs:label>fluvoxamine-theophylline drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/20149fe3-56dd-4658-9381-ec62ddf26f67"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/6a3b0de3-adfc-44d2-ba7e-a55b4f501d13">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/42bdb7d8-7eb4-45f6-b88a-d51becd55089"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/08a6694c-bfa6-45bd-98d8-71778f6feeed"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/ab708708-833f-4958-8821-2c1d1d2ebbc1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/b0a4475e-c19a-45d7-bce0-40dd088aa5df">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/3701078b-4fbe-4669-8b2c-448f142e63fe">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/0485e34d-1464-4597-aebb-0cac5abd0850"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/101959b1-c3d7-461e-b265-645fa287993f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/0b0d7dbf-8118-4185-9673-1e7ef9400c94">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/99e3f280-66ea-477a-92ad-2201e0b96275">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/df62d687-3128-4b2b-b737-0eb26032fa3f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/30fcaee2-2340-4dae-83fa-e73129f0347d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/d572a828-3f0c-4bf8-8fdc-644cb0f9aa21"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/be351be8-0f14-44fe-b8aa-6ba8a455e27c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/b1a44c3a-3998-4467-9ffe-755e551d89b0"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/77af39d8-344b-43ab-8ba0-4b88fddc4943"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/172416fd-75c4-409c-bef3-63d937330595">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/99b1ec0c-3c7c-4005-8da9-913d50ba9a36">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/f650336a-588d-45fb-bdd6-a4f171b11d2a">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/ee4653e4-43ff-4f7b-8116-2cac14ae0405"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/01889bc4-2897-42c0-87ca-7d2674af6cd3"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/a847c5fd-d2ea-4232-9905-f67d65bffe88"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/23f92952-9547-41c2-9394-f9761d25836b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/b2e126a7-ab0a-4d1d-8e55-e50099b4e321"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/ecd7b1d2-5a3d-46fd-8dba-dc0f2fcb839b"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/4a7847bd-4880-438f-9fba-14dd8b2c6a51"/>
    <rdfs:label>ritonavir-hydroxybupropion interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/546960f4-a34d-4fd1-a0a4-8d61cbf469f3">
    <obo:OBI_0001937>600 to 1200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/c75abdc0-4cb0-4aa3-8e59-1320c04dc868"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/b153b37c-d59e-4680-8a80-3ee7c6307623">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/208f6e4c-b5fa-4634-abfe-95671ec076bf"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/fbfba40e-abab-40e1-b738-27736d139eb9"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/0b8f5f7e-39fd-4106-836d-c628d85ce834"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/213050e3-435e-4248-9b37-32a5a94101ba">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/ee387f78-b635-45b0-9d81-91c77206bae1"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/bcabacc6-b90a-4feb-b82f-3959c39b1039"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/8bae553a-662d-418c-94e1-1b93dcef24d7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/93d06dc4-311b-47b5-8761-e7e649186346">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/0d457fbb-931f-4852-86c3-e2df5aafa767"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/dded8bdc-f354-415c-b41d-332169d7e0ae"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/2113fc35-b4ba-450e-9a77-3b5fd1072257"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/1d522d5c-b60b-4f0e-aadf-be2a5108e118">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/f82db67c-1e51-4548-8528-b1abaf28f43f"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/35df2109-b68f-4ec9-b9c4-f3da6a54dff3">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/eaab3030-4e33-4491-a27b-fb77ad21499b"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/78ba1119-98ef-41d2-a271-f90cdf6b825d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/3075ede2-739f-4a1e-a30e-865fd3f323b7">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/9f4fdd98-06b1-4747-9e1f-87f3e61b25b5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/8b7c9bdf-9e0d-413e-a082-7aa582b2ddf2"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/1f548017-1fe5-4fbc-930d-a165deaacd25">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/68ae3bd3-4416-4c60-96d5-ba755feefe79"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/9df656a6-0faf-4ac1-859c-08b18fdc0280">
    <rdfs:label>phenobarbital-paroxetine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/0cad4e1b-2781-472a-bfe4-c34e44e3d792">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/4ff85aa6-adf5-43c5-a2cc-c092d8d5ac91">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/ba7f5e0b-2d59-44a0-863d-8ab6d531f7e3">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/9ac9fa53-1948-4337-9512-622901670841"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/3b35bd15-7665-4f8f-b57e-7b2f047bcf92"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/ccaa23bf-f7bb-4348-81f6-4b2f829f62fc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/47e49e63-5dce-49ca-8f1a-9ead1233b2fa">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/e07d6b8f-5d02-4825-9a45-cb76ebcc6cc7"/>
    <rdfs:label>26 Percent </rdfs:label>
    <obo:OBI_0001937>26</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/b2aba457-ef34-4432-abe8-658c23e3af7c">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/3eba5c6e-385d-4675-ad1a-268f9ec9b18b"/>
    <rdfs:label>78 Percent </rdfs:label>
    <obo:OBI_0001937>78</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/46606d24-bca1-4915-b007-c492ad0b7d98">
    <rdfs:label>ketoconazole-citalopram DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/19fd0c28-96a5-4e66-933f-c44b56b6cf50">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/bd89eae3-ebc8-4771-88c9-3fb361223cff">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/35ac071d-c487-472b-a362-323aefe24db1">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/b0603ebc-2c2a-46be-864b-4eeff93ddc58"/>
    <rdfs:label>nefazodone-buspirone drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/c21c5a2c-2ce1-49ec-8928-a2748c492164"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/d9b4e08d-7bca-4259-b2a7-f1b2c5fe2843">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/5f1cb41b-0853-4fc7-ad6c-b3079c3cba25"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/60c4a5e0-3095-4bee-a67e-6cd35af2e980"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/1d2fc0b5-cb1c-4f78-aa97-181fb5e190e3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/f09e9023-e677-4223-84db-6bb61a4463fa">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/f67df7e0-912a-4ba7-9664-eb59cfdb9890">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/2582808b-8e1f-4b3d-91bc-689b396fa90b"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/c919fd0e-d4b2-451c-8ffd-3eb6291139f6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/20255f2f-0fcf-4849-a415-864a574496f8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/7d5df45b-5b45-4d63-a0c2-d1883f740944">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/25f6b1b0-8a02-4424-888b-ab074f512afd"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/1299d741-8793-431d-8ff3-c09e1a412e36"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/044f71a5-cc6f-473d-94a3-bd76168c7f72">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/9c058910-9286-4ac4-a869-2acf23cff73d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/0d7c3bb0-7055-4a99-8375-11589ad9b277">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/d0348fe2-4421-4ae1-8bb4-913311f7d0d3"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/7c123247-0366-49ba-8142-35e395c8a4ff"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/e21211c0-2c5e-4500-bede-83f6c3e71160">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/914c4423-95de-4503-9f24-e26204710956"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/c914ecde-273a-41c3-8ec7-c9af345e2d86"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/00efe31b-3ad9-4bde-8404-ee5fd21eb2ab"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/092654a1-4374-4dac-a50a-85621ffa94a8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/9274e001-1492-4fb6-b185-4a1537ba6e06">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/7b8b8d61-5ca5-464f-88c6-92fcd68afbe3">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/325a641e-1e3a-47b0-a160-1fdf0492cffb"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/9c87c790-05e1-4a80-aa46-1b65d32d0338"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/a0457665-fef5-4dfd-b028-cb4894c2ac71"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/7b40367c-f468-4a55-9531-d7e02baf1460">
    <obo:OBI_0001937>1250</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/69cacca7-8701-4f16-b2d4-a1d24ececfe7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/c2d27cd8-7067-43b9-93f8-d9092660afa7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/0177e925-1630-4695-9fd8-1b291713a8d6">
    <obo:OBI_0001937>300</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/f95d4f65-80dd-4f0f-a0f3-7335257c09bb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/dc334269-1317-4905-b636-9d4e116b8aca">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/2398b37b-04f8-4fae-a865-be50faf45e65"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/ac50d2ee-5a05-4b80-8611-8922dc2d96fe"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/85dc697a-4e31-4c37-8406-0edc85e81e19">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/e7a0ae23-d8b5-4c65-9e31-86158579c062">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/9fdf684e-da6e-4ae3-9ed8-6c9a3c8a4eff">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/d4cc4322-a357-4847-a53d-395c1423e3d1">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/c1878f69-ae28-4241-b4cb-d4695cd77769"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/e750dcf2-09a4-44ea-979a-4634821aa7af"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/62610ab0-0914-4594-aeb1-10d51de89366">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/060e7300-1890-4086-9607-07b622e27a7b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/1b0f3f41-8182-4a4b-9512-823bfa584ed4"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/9b5b87d5-1d15-4e0b-8902-d775638272d6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/f8ab7364-be20-42a9-875b-a2bdd7671966">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/616831c4-235f-4a4d-bdd5-2f154e6f6b34"/>
    <rdfs:label>38 Percent </rdfs:label>
    <obo:OBI_0001937>38</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/a6aa2746-e547-4556-af2a-addb0a1fa033">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/3a86ad2c-9736-48ee-9ae7-69d6886c947a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/f1148e59-8b6b-431b-8860-236c81d57c80">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/98c7df8f-9b12-463a-8e27-1ff39ec7d734"/>
    <rdfs:label>telaprevir-atorvastatin drug package halflife Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/535ab92f-f6f8-41b2-9ea1-ddd476104caa"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/e731e181-5c4e-4ef3-b276-9fc5ccac175f">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/8d33f7e1-e427-44ad-b087-fcb125207078"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/0aeef77f-baca-4ed4-8736-ba04dbd18400"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/44bf2d3f-6ecf-47ac-96a1-44e7faaef9ff">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/fb1295b2-bf45-4703-a39d-b54fd8add79f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/0c5faaff-40d1-4e2d-ad85-618db15c691f">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/add480ad-feb3-4d10-844b-785f4d7e2a3e"/>
    <rdfs:label>fluconazole-rivaroxaban drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/23960e4d-ce88-4dbb-8f8a-d37d3da98aa6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/3a9734bc-9cb2-4225-a38d-37ca60bb5a4b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/84a3ec1c-f917-4ca8-ac94-c7a6c1977089"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/598f6881-b997-40a0-b728-4663d98b9bfd"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/f85a7451-8800-479f-9b42-7b2e907e00ec">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/b4d689fd-7585-4c05-880d-298c00f2c31b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/34cfcc3c-db99-4dc5-bcc2-6c0aacef43d2">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/22c7a7a5-3a49-4bf8-9565-d476fa8a7a57"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/70b334ac-16a1-4850-9c98-52189df0ced2"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/05b4054b-4e2b-4d68-8e4c-2ea27c593808"/>
    <rdfs:label>ketoconazole-iloperidone interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/705fb482-27e9-486e-a980-d6c4658f081b">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/6a960aa0-baef-48c7-bbc9-fd33b07e8014"/>
    <rdfs:label>1.8 Fold </rdfs:label>
    <obo:OBI_0001937>1.8</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/55e87634-d6b1-4e17-8bd9-c75c13b93fdf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/0db2e311-4d97-4272-bc2c-48b99ccbcfb9">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/c8bc9dc7-44de-448f-92c8-19e6d9913de6"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/f0b94c38-5717-4aa6-be94-5c51177738f7"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/879e2f7d-fea3-41b5-9059-20b9c0771b48"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/93beaec7-60f6-425c-847e-b965b136aca4">
    <rdf:type rdf:resource="obo:RxNorm_85762"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/e50743cc-5e63-4753-baba-03abf2da6523">
    <rdf:type rdf:resource="obo:RxNorm_2556"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/ea66ac68-a44c-485e-9768-95575e2294ce">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/0952e092-b4f6-41e7-99aa-c17830d07f9f"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/101d19c1-e97a-4257-a6d3-329d797fb221"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/fa570a61-ac20-4538-9f0b-cb87dcc39b51">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/0e987114-1788-449e-8cf2-49b1b0819ac0">
    <rdf:type rdf:resource="obo:MeSH_C558899"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/85b901a6-24c5-46fa-9f8c-98ee311820dc">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/ee916793-4530-417c-a8b5-7ce6a4c0af29"/>
    <rdfs:label>2 Fold </rdfs:label>
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/192a7c1e-580f-4b26-915f-dd9b8330e237">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/70165823-c400-4224-a9e8-59f6f34c806a"/>
    <rdfs:label>3.08 Fold </rdfs:label>
    <obo:OBI_0001937>3.08</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/5ff916ae-243b-4b17-abbd-0fa40b85b9eb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/c277a47c-b2d5-4cfb-ba27-b47b62f25e35">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/963264f6-118b-4575-bded-493f7dc60108"/>
    <rdfs:label>carbamazepine-L-amphetamine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/cfb7888f-eb29-440f-bb44-8ac39bb5fa7a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/72efc4cc-0765-4c5d-9278-606d518ab61b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/495f805a-d7fb-4981-bb2f-0f4075cbe982"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/e90c61fb-ee36-44c3-ae2b-3c7071217e3c"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/b5e5eeab-f83d-4f7f-9ac7-c917e8378fc5">
    <rdf:type rdf:resource="obo:RxNorm_21212"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/72af9dfa-a7b6-4667-93e0-f457a170dfe2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/f2ab1653-f180-4c9b-8d4d-f60de27a767f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/f7f3f380-d387-419d-9cdc-bf9bf41204a7"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/d92be064-f5f8-4641-a861-bbef2efb9f85"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/a450c92d-1ea9-46a5-b838-6e593d24466b"/>
    <rdfs:label>paroxetine-P88 interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/56c95373-9391-4f95-966d-784d3432dc7b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/ebe741d3-e4af-409e-8eb4-05f2d820ad15">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/faef1e19-9f89-4f9e-914d-bfefda6902b8"/>
    <rdfs:label>33 Percent </rdfs:label>
    <obo:OBI_0001937>33</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/d4b11581-1d21-4c6f-a06b-9efb99b9afea">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/94b7a846-10a7-4a59-8a03-3ff572c857de"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/ca98e8f4-841e-40e2-80cd-ceb5535b3d81"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/fa8b9af6-583d-42bf-9ccc-f2ec53cc2be6">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/d1288121-43dd-45e3-83f4-7fa2955197d6"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/aa4365f7-a90c-47b5-bf7f-98176b45d37d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/7d786cbf-17c7-4839-b1cf-53d37cf6d828">
    <obo:OBI_0001937>750</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/a2e3232a-6e47-4552-b4dc-3ac01b819e35"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/a32e50b7-c9ae-459a-80b0-ae952c29d49c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/b6e279f7-4b4f-4b1f-8e04-30ad81234978">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/84012eed-b2d5-44a2-911a-d0a2f1084858">
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/b5eff669-b4bb-4b9d-8d16-f5e79e8cc832"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/5f4c967b-ef7a-44c7-9c6f-5822a8d9e36a">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/34e28bc1-ff41-4b44-8e2d-55168cc5e336"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/a32e50b7-c9ae-459a-80b0-ae952c29d49c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/56daee46-5d71-4653-bce4-8e2d1cbf0f22"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/308d364f-423a-4034-bedb-1aea38bf31fc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/fb1b40f0-d778-480c-9c4a-d31c4cf26c45">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/8dd8fc49-8aa4-4218-aad6-0da1b008f3bf"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/ea845f73-7262-4892-a2eb-604568b9ad59">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/706ffae7-4087-4d3f-ba6a-662b203271f6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/787afdb3-a6ae-4836-aacc-70e0ba8f79e0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/c8b6d955-1b6d-4533-a5fd-6dcd186aaf3b">
    <rdf:type rdf:resource="obo:RxNorm_114289"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/cfd67d78-46e4-4874-bba3-bec5c5be2eb9">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/a686a8c8-4eb9-4307-9e48-3b1e53d5989a"/>
    <rdfs:label>73 Percent </rdfs:label>
    <obo:OBI_0001937>73</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/a78e6943-62b1-419d-8bc8-385eb551d95d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/74d388e2-f0ab-45ed-b7f2-0d49bf67eeb3"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/00166dda-4151-4e12-909c-be76141f4d40"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/88467e9d-800a-4589-9dd6-946f382b3d53">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/46e19aba-13f4-4d6d-9cda-ed034671eecc">
    <rdf:type rdf:resource="obo:RxNorm_32937"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/6320dc49-dcbf-4b6e-aade-bd1d137c42f0">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/37a369a6-db98-48c9-8eda-ade97c15d6fc"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/62d7d57e-2bce-4306-853c-8c3d5e9cef47"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/eca1b5fc-3021-47e5-bb72-51a74b80b582">
    <rdf:type rdf:resource="obo:RxNorm_321988"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/1f796382-9b66-4e80-8e05-3cdb40d1cff9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/e3e069d2-a163-4914-9356-77488b537d0c">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/a9043a72-70fd-4ecf-8263-903117b53991"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/2e3253db-8cb1-4aa5-8ee5-977585b07a89">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/a520e82e-bcb9-48a4-ad2a-e73642ff25bf"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/eb8d95b9-fcbe-412d-8d72-f37238f21887"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/a686a8c8-4eb9-4307-9e48-3b1e53d5989a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/32807cbd-4541-4be9-8c56-7c5112a804fa">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/2b37e856-11a3-4e79-9a61-ba0aee0266f3"/>
    <rdfs:label>nefazodone-triazolam drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/74760104-f1ae-45fb-994f-6a3c25e36e05"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/1d8488fe-1f07-4c31-92ab-8b62d39748a4">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/2e67d9df-4be0-438d-b4aa-cabeaa636568"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/b8e7516a-c755-470b-a966-40b75be71496"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000136">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/58957e1e-e288-4e47-80b8-7db7d74566d0">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/e132fbd8-106e-463d-a406-0cfeb9d4cb9a"/>
    <rdfs:label>Diltiazem-Atorvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/d2646a47-3ef0-4ab2-a4be-7a2301bb8d0b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/b15b010a-6a99-4b3c-8729-f0e1560b0ac5">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/c3025b88-6300-4dfa-9c53-5cde79d08ead"/>
    <rdfs:label>atorvastatin-verapamil drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/85ba64df-ab00-42bb-b777-94d092e12c36"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/3a4498c6-3ed9-45b1-9de5-bc786a9d190c">
    <rdfs:label>fluvoxamine-theophylline DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/8746f622-1b8c-4048-8689-55966d12e63c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/0d457dcc-4ee9-445a-bc99-8cbd020768d9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/420a6539-46df-4975-9a5c-778dfe7cce61">
    <rdf:type rdf:resource="obo:RxNorm_8787"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/b5beaad6-5f68-4103-bd82-283c1453a06f">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/d1d3b409-f1b3-4f92-b685-909d4b70c015"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/82c17bab-d79f-436d-9abb-5fe8c51a6574">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/223c5083-0dc1-47e1-994c-97c1d5fe0b1b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/00165819-b4af-4138-a516-267cc6235711"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/48fd4ea7-05fe-4f1c-836c-a74755717e8d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/58cb6697-97d2-4b88-a5a8-e8bc6ff76f8a">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/04faf930-7aef-41e7-b858-3272f87b34bd"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/52e9fb5c-1d8f-4773-ba45-ef7044e12791"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/02f8850f-eb82-4751-8eb3-436d7a24cfc0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/36015d36-7b70-4453-8522-9f678a7c4b54">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0001933">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/4af0cdc5-e3c6-4cbc-a25b-f8e3c598126f">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/aaf39b24-92b3-4d79-90e8-3ba9771cd543"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/559db6c7-c46c-4139-a459-33e46799a479"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/e2ab6c51-7f31-4687-80b8-8a0cf8ad8aff"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/baa843b0-b27d-4789-8d6a-44d6108225b4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/07be1f54-45f3-4749-82a6-945e9a2143e2">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/1adddcb4-f325-4324-a54c-a3830df292ed"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/3e0ed9da-8645-4ce6-95f7-0b17331cac0e"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/31ab8765-b24f-4dea-ba21-2a6ac20ce1b8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/0095e808-c1de-4e93-873e-beb28ace5e86">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/147baa82-ca69-46fc-b011-6b8468c07d78">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/b6c71f6f-cf99-436e-a8a7-37352fc73bdb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/b00063f4-f979-4815-8896-7d8bd20498a0">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/897fd39b-bfd5-47da-815c-9d0ab069e030"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/e4e0e17c-d05a-4617-804a-cd056e099084">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/9e31091e-8c7a-4374-afac-3089c84d0490">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/dffca59e-c845-4296-96a8-81d3e0dce75a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/63c486ad-0fcb-4242-b0e2-1498d4f1ab5e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/02f04371-1479-4c7a-8efd-df7f3ab4785a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/36568555-8488-432d-8348-1f15ee60328f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/2a689777-31b6-403d-a83a-bb0fae06c8cb">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/5194c8e8-3652-4f30-a965-f536bd3b3a7d"/>
    <rdfs:label>4 Fold </rdfs:label>
    <obo:OBI_0001937>4</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/97188515-3e76-493c-a563-6d31febbed82">
    <rdf:type rdf:resource="obo:RxNorm_6135"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/c53eb13d-426a-46f1-aafb-d759dd6e0ec0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/b9eab827-c3ac-4af1-ab33-1589b2ab5b28">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/c13b1752-a306-42cf-aa32-941ef11cd373"/>
    <rdfs:label>cimetidine-citalopram drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/6d3021a3-191d-4ee0-a26c-8a91724fd604"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/0e6485b5-dfbb-4be6-9e81-8dfe1026d478">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/c75fdf72-eda8-48aa-8538-334900bc2ef2">
    <rdf:type rdf:resource="obo:RxNorm_3407"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/f9bab027-4c76-4bd2-aced-4cbdf15d6554">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/96f36d6e-b1b1-483f-b36d-7832a03bd918">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/82433fac-bcb3-438c-b6c7-6b26b0c5941e">
    <obo:OBI_0001937>Unk</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/7e5244e5-4a8c-4a8c-966d-14f5ade95bbe"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/d5332f52-dee0-4c82-ab47-970bcf106748">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/984d3725-1c5c-4ce6-a3a8-18b5f6c46198">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/aa370437-5862-4189-8ce3-49a449c10d9e">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/7fd66b2e-1b75-493b-8da1-994be36cd8e2"/>
    <rdfs:label>ticagrelor-simvastatin drug package halflife  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/54e3507a-3a45-4c01-91b9-a4bface99622"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/360d84f8-b853-4539-8a3c-e9968a95907d">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/74a08199-1248-49cc-a96e-8d20bd385de5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/49f9884a-9e7c-40f2-863a-cb17ef57a7b3"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/ed69e047-b569-4f20-86a9-a230f8c724d9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/804d5f7e-ea7b-4300-9b69-bae9f19d35a8">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/8af1da73-0487-4986-8a9d-ed7c815386ce"/>
    <rdfs:label>48 Percent </rdfs:label>
    <obo:OBI_0001937>48</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/9f38db52-3169-46ef-a79f-68f878750c96">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/4b01302f-eb4d-49bc-a9f0-afa76953bcd7"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/c51cf992-b9c2-4566-b82e-978f5ebd32c9"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/c21641ff-b200-4cd8-8a6e-42b9eb1f1f89"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/616a0c09-67ef-4fe4-8292-06a4c451c711">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/b8ee3e72-49c2-495e-8bba-2a84b9949fb6"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/c6aba840-ac0e-4ee4-ac4b-0edf23fc17cf"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/83eebaa0-14bf-4783-9f88-5b491fbace73"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/324fced3-f6a0-4328-bfaa-797077112bfb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/2c837e51-d6ad-4009-a9c4-f39a350143c2">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/3de33ff5-c126-4626-8015-55ac6110b3a8"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/e51cf647-25af-4a1a-8e25-1ff8f271dd42"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/b553c597-bd5f-478c-8448-9efa69b073b6">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/ca592355-0cb4-4621-aad2-be7499b8abd4"/>
    <rdfs:label>fluvoxamine-tacrine drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/20f07e55-e622-433d-a2ef-18284f47ead3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/03f4dd92-4314-492d-b618-5c688ba04957">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/93c30e8d-76ef-4d80-a18b-2d13b4638334">
    <rdfs:label>ritonavir-erythrohydrobupropion DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/ee387f78-b635-45b0-9d81-91c77206bae1">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/d39966fd-dc40-4daa-bbda-19e3fb7e8b01"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/d97bb25e-51bb-4d19-b354-336f576f9d9c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/73da4ae2-6148-4007-94b4-24637b3a09a9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/aca61305-a187-40d7-8c07-7a348815c9a1">
    <rdf:type rdf:resource="obo:RxNorm_42347"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/fafa496c-c716-40c4-9805-8ceacd3153ba">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/6556c582-9f8e-4023-afba-c9047b8dca23"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/4feafa0b-62e1-473a-b086-bf0ed9077837"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/2cc76a93-a20c-4acb-a161-536e309c09ca">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/be0027f2-96d5-4b0a-b73f-5c6212fbc8ea"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/ddfbc3ba-30aa-4d3a-984f-069531b61dff"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0001937">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/4363030c-945a-460b-9a27-f2af8846c128">
    <obo:OBI_0001937>1250</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/44d54615-b7fe-40f2-8528-367d60cfec81"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/51d5b655-8c8b-4d03-89e6-8287f9e92573">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/756edf21-5c3f-43fc-9469-a043de541d31">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/ce6c28d8-7fa9-451b-af7f-ac18362f6df1"/>
    <rdfs:label>ketoconazole-desvenlafaxine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/fef04293-29d0-4c33-8100-dfe36832f914"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/50cfaa12-f1f0-4fee-a985-dbb57ee78f41">
    <rdfs:label>carbamazepine-INVEGA DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/b794b8b4-8fa2-48d5-8a5e-366e7715dfd6">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/34ceccf9-2916-43a9-8985-071eccf6eacb"/>
    <rdfs:label>fluoxetine-P95 drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/56519862-f9b8-4f7c-af7e-eaffe79e7975"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/bb94fc2b-d6b9-47f8-bc0b-74146dc7403a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/ef43cd07-2e7f-4b2e-ae7a-3b376dd7b043"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/afccb4fe-990c-43a7-8e6a-1850941ff070"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/130ffa5e-1577-4f89-9622-c193f8d9e8fb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/0af0c008-34c3-4ec4-b5ef-694d559afec8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/9ddced42-d13d-4ad6-bb4f-364e93608328">
    <rdf:type rdf:resource="obo:RxNorm_32937"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/e2737159-575d-49c4-9f01-5ff66fd4bfb3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/ff93bc91-ed5c-4dbf-a077-56ec26818eb9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/c2523cd1-a77d-4ebe-9b73-135fa8d1801f">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/ff0768a8-d22e-49d4-9042-1419d439e19e"/>
    <rdfs:label>.3ng//mL UNK </rdfs:label>
    <obo:OBI_0001937>.3ng//mL</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/d7a00de6-1e3a-4dbd-93aa-d59b961a0b69">
    <rdf:type rdf:resource="obo:RxNorm_6135"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/c678f33e-107d-4a00-a42f-f8d51487cff2">
    <rdfs:label>Clarithromycin-Atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/22edf95a-913b-4d7d-b8ad-c2bf0723a931">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/f1e25bae-69dd-42d1-9147-205276794730">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/249c754e-636e-4632-95de-aa921a0e1dd2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/83eae040-7d22-49e8-97c0-2e3d90167e72"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/8a335765-fbe8-42a1-bcb0-e61691025082"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/5d9c9499-8cbf-4c6c-bc6e-130d982d1df6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/411268c8-416e-4fc9-b822-56ad27f246f1">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/7d1af480-c87e-4ae2-8eea-bc358380290e"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/f2a23299-1e90-45ff-be40-d7196df8f60f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/345aec20-ac24-41e0-a1b5-da8d7503c568">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/2a11d3c4-507f-4889-b265-340641dffdd3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/89cfb125-78bc-4212-ad77-cb984481ef8a">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/e0c322c3-ab25-4d92-90ae-89db0a5184aa"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/4487c6ab-26aa-4ff0-bb80-4472c4b97c8a">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/a257d43f-6ea6-47c5-9055-29b062573a77"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/eb39af9f-d7d5-4295-930c-778bda946a10"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/2bfc5fbd-8976-447b-99b3-441618f42277"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/b66908c9-8bfd-4ef4-8fa0-346ec9aba775">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/355ef50f-7ffb-47af-a6b5-f2ad5e5063d8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/30f8d8da-c422-426e-aa4f-442a9b36e06f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/9f7a207a-5821-4cf0-a482-fa79b43e84ae">
    <rdf:type rdf:resource="obo:RxNorm_11170"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/3f1b2f51-47f5-42c6-8d57-411822ad0d3f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/00e22028-d2f1-4986-a2aa-d54ce36fa954">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/a58c8305-10b0-47f2-b576-778b94c8f1c8">
    <obo:OBI_0001937>300</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/c387e9b3-c906-49a6-ab86-f6a1f6ea9a89"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/6cb4d5d4-65df-47fc-b83e-e12a3ddaebf6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/fbcf1fd2-fa50-492e-852b-2b7dc036ada8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/e2ab6c51-7f31-4687-80b8-8a0cf8ad8aff">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/c76e7734-3cdf-456e-8631-2b4e6a5554e0"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/78d5a1db-4f5e-4e0a-b45c-88416313eb67"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/0b7d55a3-0397-4d76-b35d-672b5ee8ab0e">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/78230948-70ad-4776-9cb1-f16e7b6a1d08"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/a168c0fa-7d1f-4f4f-859b-747403203a4d"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/cc1b0db9-b532-4e57-9353-55697c474d5a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/DIDEO_00000124">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/f76f49a0-cdca-464a-b2b3-54681b16ab55">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/2ef587da-1206-43fb-82a5-9ac38f2641ed"/>
    <rdfs:label>23 Percent </rdfs:label>
    <obo:OBI_0001937>23</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/788ce902-496a-4b27-b54b-a6fd41512b9c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/3f1b2ca0-847f-47b6-851d-bc5060ab2052">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/9027908b-8bf9-4b4b-a176-981077b89412">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/45812e88-6679-4f8e-a8e5-787efb7e77ae">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/8e59fde3-b888-468f-8bb6-42148dee71ab"/>
    <rdfs:label>carbamazepine-methamphetamine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/137de959-16fe-4621-a642-0b25f48cb821"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/8d33f7e1-e427-44ad-b087-fcb125207078">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/2246d402-1b6d-4116-8dc3-2de6d10cea8c">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/54b2409d-d4ff-4817-a2df-4f9d00e246c1"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/5f621b12-01cc-4feb-8889-fab8b0b8d5fd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/f519b5d0-7b62-4a8e-9a03-b17ee27ab486">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/6f8e9269-738b-4b60-81d7-2563139f5297"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/24d4f079-02c5-41cf-911f-3fbb56dc1d71"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/8d90738a-368a-47c0-8a79-9e2abdfac076"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/8efb58fb-7133-4877-9ee5-571723dec16b"/>
    <rdfs:label>Fosamprenavir-Atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/e6ac79f0-499d-4aaf-82f5-29d5e5c9decb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/e7cdae4a-77bc-47b9-82f6-411f4e22a3b8">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/7bf8a52e-75ff-4b92-9365-41fb6abd58c3"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/6154f1be-96a8-4913-927d-807d0c79314a"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/cb5ea945-2eb0-43df-b5c4-334118f2a30d">
    <obo:OBI_0001937>4</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/cd17989b-c5d5-43de-8d6e-091da50e819e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/6d3021a3-191d-4ee0-a26c-8a91724fd604">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/00cd532e-79d6-4fcc-93be-68ea61ea1e8d"/>
    <rdfs:label>39 Percent </rdfs:label>
    <obo:OBI_0001937>39</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/2544327c-be45-4573-92f4-169b1be031ab">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/373dc5c0-32f1-42db-8966-f193d3a64661">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/1af6c515-c7e3-4e64-b289-12a2aaa41425">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/53c1c675-548c-44f0-844e-846e1749fb2c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/f6e5046c-f103-4c41-b712-f855bf4a5896"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/871350e7-7d58-4a7c-b705-6f0d32e34386">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/4eabbd18-a305-47bb-96a9-1b1538e4687f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/689f7117-fa29-4c8a-a93e-5f49db0521ae"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/56bd65a5-97c7-4a08-b9c0-2b3d1a789424">
    <rdf:type rdf:resource="obo:RxNorm_596205"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/372df799-5d5f-4e3d-abfb-e637d9c25aac">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/ff3db9ff-35a0-4d2e-82fe-3de3abcb5c10"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/bc6a9d7a-d1b7-40ce-98ce-f8c15cf3ded1">
    <rdf:type rdf:resource="obo:RxNorm_9068"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/35ea7019-b383-4c2a-b7d3-4ef15e8138bd">
    <rdf:type rdf:resource="obo:MeSH_C092333"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/d8467101-26bf-4ad9-826b-43d6fefbd23e">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/f086a17c-d8f5-4a38-823d-858043081877"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/84ce9344-bd35-4c52-b22f-629af58678b3"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/7666be26-986b-4cb0-b3e2-0f02470fc887"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/47d7e59c-fb10-479e-82bf-abc63c1892c3">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/f63959fa-ad25-40fc-b6d9-e51ab1fb14bc"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/eb253660-650e-4c2e-87c1-5be56be258a5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/d01c2476-11af-4ae7-b90d-4dda86dbcfe2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/594afc6a-8cf8-4c4c-b2d9-23503950f1c7">
    <rdf:type rdf:resource="obo:RxNorm_6926"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/ae54c5fb-1ddf-4d55-82e4-a52cd23bd2f0">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/1db1bd42-db18-4bd7-953b-c6ba1b23d32f"/>
    <rdfs:label>39 Percent </rdfs:label>
    <obo:OBI_0001937>39</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/09bb1d01-36e6-4b91-8310-830c8f83c434">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/1cde2fe1-1d39-40aa-bbd3-4cd7fe69bb0d">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/722b605d-e786-4a37-8825-75fe503e75ed"/>
    <rdfs:label>24 Percent </rdfs:label>
    <obo:OBI_0001937>24</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/d54df87a-53b0-4dca-be07-299d6d941a32">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/bc39b31a-3576-4ec4-9b78-4db9eee860f4"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/040fbf53-b3af-4764-aed0-356c90587369"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/39ab9bac-f667-4600-8ed3-6f17dc32749d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/469b6af7-daab-4eb8-9518-01be9dcd4255"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/956c9954-fad1-459d-8cf1-1cb4639390f1"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/2ea6c1c1-8dd5-4008-9ade-6a30d1827f94"/>
    <rdfs:label>warfarin-Rosuvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/3b41adbb-b3af-4669-aa99-ea3cb0e02870">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/ebf884e4-c320-4f8f-a2b6-e7f77b3e418a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/1f796382-9b66-4e80-8e05-3cdb40d1cff9"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/ff55bd03-f218-4970-bfe1-1d14c3575317">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/432fc7a6-3093-460f-8cfa-564ea8b62eec"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/271912f5-08c7-4a04-a321-ad4f99d82bf7"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/336cd96f-08a9-40d1-9176-75634268f039"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/bc2082c7-06e6-432b-88bf-a76f9c047ed1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/cc1b0db9-b532-4e57-9353-55697c474d5a">
    <rdf:type rdf:resource="obo:RxNorm_85762"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/20e90f80-ee34-41d0-bcbc-255b6a21531a">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/cae517aa-a907-443d-9b3f-ffaa86af78a6"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/1eb07266-2e3d-4f6b-9d5a-0107bffa6f4f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/7e959055-9ce1-4edb-8757-32b1e9c05199">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/f28c8849-3754-45a7-888f-e951cc2b877d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/544d9e1a-1d4d-4f85-8e04-e16fdaa8b1b0"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/77c05e46-1c30-40db-b727-7bc910686892"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/068760bc-8920-45fe-b206-823b05bb7480">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/20084216-aaa1-4bca-a918-41b6ec8d71b7">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/bb458de8-21d1-4709-bc97-55fcd5bf8894"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/be925372-06b9-4952-bbfe-cb3fa3505827"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/dab381ce-8278-4e62-b1a5-16a85f23eecc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/9cdc88aa-96e4-42db-a560-c0a9cc2d05c8">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/2e0248ef-6e86-423a-9b73-e3559e90bd52"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/020f61b4-c54b-467d-bf49-d832e62fd306">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/27b27d82-68ea-4c44-a29c-dde896fc9dbe"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/6d63c48e-e5bf-4665-90e0-47d824af733d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/6abe4b81-d32f-48e6-8360-d8818ec55dae">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/cd3f1af6-dbe7-4b07-ba97-4ff57a400f1f"/>
    <rdfs:label>85 Percent </rdfs:label>
    <obo:OBI_0001937>85</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/8a016732-d67a-4dfc-9a2b-4f37cc1c2301">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/08d5ca11-4626-4a94-be86-22250a8a4191"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/3425ea46-6356-4eb1-8cfc-8d97b3fb2a62">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/11851848-4943-477c-bac6-b54af16e52f1">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/5a415c0d-4926-4c4d-a276-80529937e678"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/332822bb-af22-4675-ae63-c57be5b00133">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/28831a36-b8f6-43cf-b99a-80f9a1719d3e">
    <rdf:type rdf:resource="obo:MeSH_C406672"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/9b5fe557-e4ee-44d1-bfe5-ea0a125b4f33">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/257b9d19-0353-4a4b-9871-653968575dfa"/>
    <rdfs:label>95 Percent </rdfs:label>
    <obo:OBI_0001937>95</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/e95ef55e-f4b3-47f4-b9a8-45bd4b3af112">
    <rdfs:label>fimasartan-atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/8face4e2-7c10-4c93-bcd4-9157b7f9f650">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/1903c307-b673-433c-862d-4a8614a90bdd">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/a8bbb47a-c2ec-4e34-aa7c-1ca290e1f4e0"/>
    <rdfs:label>12 Percent </rdfs:label>
    <obo:OBI_0001937>12</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/a64ab815-d3eb-4df4-9770-27df8a36eca3">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/fd622ee8-e0ca-46bd-8a84-efa1e6919ec3"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/6277853e-2197-444a-876a-383311dfeb5b"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/3520f80f-6031-4e88-adfa-b9bfdc9ca415"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/1172907f-762f-4fc5-a186-d18e5cc9216a"/>
    <rdfs:label>Efavirenz-Atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/b90f69f1-4682-4695-8527-138d9d8d5931">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/df20f340-7b29-4459-bd85-72cbb5496c67"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/47b1416c-dc9d-4d09-9c12-29c6089d1e47"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/9ccf4bdf-2859-46ff-9156-da4d954d6c26">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/5afef711-c957-42a8-9e5a-0085b10fc03a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/b5215188-458f-490e-9442-4c1265046629"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/3635ba35-8ea2-45fd-9559-258b0549d735"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/46f593db-078c-4430-bdef-665e2c2a576c">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/1bfea671-896a-4987-9155-6a29cfb646e0"/>
    <rdfs:label>Amlodipine-Atorvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/bfa5bb68-006f-4780-84cc-5873097264b6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/64994016-e2c7-44ef-b3a4-e6797a3cb7a1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/4f5f2055-9db4-4755-ac47-e2d1f4643bcd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/59415bf0-3ed5-4465-9a91-97581eab3708">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/cf3eabac-1fab-4d07-b5f3-21e9033bea69"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/d023dbd0-854f-462d-8511-92834e6db0ff"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/3edff2ce-e236-4bad-ba3b-76334db7a0bf">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/ee4a42ca-5cea-4cd3-a9b9-a3fe2fd9296b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/beb1f0c4-2d06-419f-a508-d669e9492dca">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/6b854cb4-d30b-4537-a25e-023612f158d5"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/513e46b0-9942-41a5-93cc-44960fb8ef6e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/3fee5692-95e0-4120-8993-184e8cc2ff3e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/399d9499-3e80-4ca5-87a6-b7918a00acad">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/05890b93-fc3f-42a9-b291-7aef1d1dd81a"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/1b1457ac-1009-4b16-820a-1b9aedb3dd2d"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/85dca8d2-f4b2-4625-bf28-0260c8bf4b10"/>
    <rdfs:label>simvastatin-digoxin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/9908c967-5a17-4c3f-beae-e3478c28d9c8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/fd4f0fcf-b5a9-4cf4-8fa9-8369305c7db6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/174feef9-0392-418d-97ff-d1732f3d2f9f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/501a9168-83db-4ee2-afd2-a7888b178e57"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/7e2ca55c-508d-46f0-845c-a2ee6da782a4"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/9ce93f3e-2260-4d30-9b59-75cd51103b13">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/d8266dce-63ee-4385-8190-8e7186180be9">
    <rdf:type rdf:resource="obo:MeSH_C063287"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/8eba358c-b599-47c5-b58f-ccb63771bc58">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/4f49420b-adb8-4856-9cf5-3bc4320cfe8a">
    <rdf:type rdf:resource="obo:RxNorm_32968"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/10082824-10c6-417e-9235-d223362045c2">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/f67df7e0-912a-4ba7-9664-eb59cfdb9890"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/9eab51f6-a8e9-4e5a-be9d-cdee2b884526"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/e2798e3f-249f-4aee-b052-dad131d7fec9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/0a3efc59-73b8-47f1-b409-fb69f232e407">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/ff8f021e-ab18-46a1-b28e-d8c153dd083f"/>
    <rdfs:label>fluoxetine-estazolam drug package cmax UNK information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/791a7ddf-a07e-4fb1-9080-25fb16406064"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/8077a3e8-011d-4fe8-b066-f02cbc79508e">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/45b39f73-e0f0-4461-a8d3-41ad2aaebb85"/>
    <rdfs:label>4.23 UNK </rdfs:label>
    <obo:OBI_0001937>4.23</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/b311a97f-f306-4bca-b114-749586362810">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/256ddb84-1075-464c-b5ef-1b7e93ecc381"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/bf5c406d-a1a3-4b77-bbca-c18ee3c46c7a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/ccf3f0f0-140e-4105-b09c-0ab9e14efc23">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/568e786d-21c0-42f4-8904-f85d8b9cfa49"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/3b7853a3-f9f4-4f43-8bfc-a6b58182492a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/1af81fd5-92ce-444a-9429-e3b892650d7e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/2b59d38f-adeb-40ee-b443-1e7d93b2b773">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/8165b135-1240-4917-be06-248788da0b9b"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/d22a482f-6120-4fb5-86af-d9301a7a32a2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/906e7177-6775-4cff-aa47-468e25bf142d">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/54f909bf-7858-44cc-8b28-3684aef1b944"/>
    <rdfs:label>Boceprevir-Atorvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/050bf134-98a9-4f83-ad71-9d9f78faaba0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/59f6f1e2-3518-4668-8cca-5e0bab3dd0e0">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/0f57727e-513e-44ef-a38e-98ebb431d749"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/547ef569-4f1c-4513-a79b-167eb128998f">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/0095e808-c1de-4e93-873e-beb28ace5e86"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/a05c87c0-a249-4400-94f8-24098920938e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/828c1c95-f4a9-4ad9-bfc6-77c063616ca5">
    <rdf:type rdf:resource="obo:RxNorm_32937"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/fd9b5c48-8148-47aa-9a70-64579497cae8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/9c052a37-284c-4ca9-97eb-2f82641dd657">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/e5e98bdb-955d-42ff-b34e-f44494a9f585"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/a5743f56-844a-4e22-a7e4-a7b287fe60f2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/417ef117-bea5-47f7-9491-0649ae76a388">
    <rdfs:label>ritonavir-threohydrobupropion DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/c3c3b034-84f2-478e-85ce-4fdde5b2111f">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/24b42e29-e2a1-43f8-b63c-debe444e3ccd"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/59f39ab2-5ca9-4468-a7c2-5aa321a1354e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/4daf9589-601b-477b-90bf-e06ee4d3e216">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/c317f10b-f7d2-42f7-bfd2-6c4d13fad164"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/26cdc2a9-c8a8-494b-ba75-c6d8b41e70db"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/50651583-9277-4439-a9b8-0bfcf72582e8">
    <rdf:type rdf:resource="obo:RxNorm_4053"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/5efea4e9-38df-41b0-aac3-81d38660e0b8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/68fd75ec-3d6a-42a8-985e-8ac5922a7389">
    <rdf:type rdf:resource="obo:RxNorm_32937"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/bfff0e59-2f66-45df-83e2-5ccf00d98579">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/bb8a4787-1f29-4b5e-a19e-a91333a35d55"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/bc2082c7-06e6-432b-88bf-a76f9c047ed1"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/77f39ddb-8786-4a7b-98c3-6073b025913b">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/9f7943fd-9bec-4db7-a7c3-7e86d2e8d05b"/>
    <rdfs:label>ketoconazole-eszopiclone drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/2e107fd7-e86f-44d3-82c3-5990022276a8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/6a373630-1866-44e0-b2b7-240617230707">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/f8304ef9-4900-4055-b2b8-828b8206436e">
    <rdf:type rdf:resource="obo:RxNorm_11289"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/49f9884a-9e7c-40f2-863a-cb17ef57a7b3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/ec818b55-6e5a-4837-87d1-dc498156fe58">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/8ef626ce-e1fa-4f04-918a-09ab65310905"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/33020182-af32-4584-8325-8ba7d6e38137"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/d6bb39ee-db83-48a6-831a-6e102392d3ad">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/1d5d3de5-8aea-4fb9-92fa-ca6d900831ab">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/00efe31b-3ad9-4bde-8404-ee5fd21eb2ab">
    <rdf:type rdf:resource="obo:RxNorm_42355"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/495f805a-d7fb-4981-bb2f-0f4075cbe982">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/ad70a91f-a65e-44a4-af63-e873a038a11a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/fafae931-9e33-4b06-8a77-2c7f53ea9d8c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/b234e775-b204-485f-9366-1760e963955a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/42f6b8bf-ffa6-4627-bfc2-7b1170653234">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/175b1ef6-502d-497f-890b-1cbce4abafab"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/7e5f0dcb-fd18-49bb-9f99-d50215e98b75">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/d30be50d-f196-4067-995a-53ff00911219">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/d69d1116-282d-4e15-a0fb-71bdc4a6df27"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/218cd32c-e68d-4160-b64d-4388673d9834"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/b6c8dbbb-1a59-4eea-a3b2-c5f3c6d20868"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/8a335765-fbe8-42a1-bcb0-e61691025082">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/159d0b2e-3b5e-4eeb-acc7-296e8fa692d3"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/3d9a29ed-f976-4d53-a4a8-5fdbfd1796a6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/f722b8c9-e130-48ca-be55-cf53e9a47461">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/aa3301ef-bde0-4dfa-b50f-dc5b7346a328"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/bc158d31-081e-4984-9256-197c41197199"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/c64da2f4-7239-4737-8a3c-490d8745e83c">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/86b5a345-da6b-423e-bf25-2cc6be5219f8"/>
    <rdfs:label>rifampicin-rivaroxaban drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/c3458a2b-f554-4907-b0c1-f7ce9a2737ed"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/cff7d254-37ef-4e46-9270-1adefac89854">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/b8cb6719-ea33-4546-804f-e3dde8f203d7">
    <rdf:type rdf:resource="obo:RxNorm_8703"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/058cbf24-b6ff-40b6-ba99-896c14d7621f">
    <rdfs:label>ketoconazole-P95 DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/a7dc7ad1-5c1f-488e-a22b-698102726e5b">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/f3df4026-67cd-44f4-8669-0c61116b66cd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/a751c791-97d3-4923-8eff-5c2020beb794">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/40d5f9ed-f8e2-4a59-91ea-0645e3a6b25b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/23a0b54a-bbe5-479a-8cb9-61021f75f06f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/7391b61e-5279-4f40-a857-209b419d7fe0">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/e3a2e0da-4360-4933-a2ed-c239b8c7659b"/>
    <rdfs:label>Fluvoxamine-alosetron drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/059977a5-3c71-4b61-9df5-083607f96ba9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/24b42e29-e2a1-43f8-b63c-debe444e3ccd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/9dc74b12-6e53-43cb-826b-d02b881f8880">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/4663ee44-d9c8-46d8-9df8-4c57966b7657">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/7a42afe2-886a-4b8c-a4ba-52bb388f62e2"/>
    <rdfs:label>Fenofibrate-Atorvastatin drug package cmax  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/687f27c7-5734-4901-8a5e-11315e106f41"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/24d4f079-02c5-41cf-911f-3fbb56dc1d71">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/d31f8c16-b603-49a8-ac23-7bb29676c5b9"/>
    <rdfs:label>Fosamprenavir-Atorvastatin drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/7aaf133b-1ada-4274-94da-398120b4c952"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/32572292-6454-42b0-8acf-fcca84714fec">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/9182a029-3e4b-4385-a0f1-1a5cf75351b3">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/4db18d44-3871-44d1-9b88-a312d260e1d9"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/8f24578a-513f-473f-8e4f-07a35eea3e2c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/c57e1551-7196-46b6-a691-49311d175349">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/546e11ad-96bd-4ddb-983e-8815c9d495a2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/d2dc99b8-9739-4590-93bc-368f34f52b1f"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/6a944ffc-da13-4c5a-b0dc-fdf090f3aed9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/a61de54d-d548-4274-bd11-6f370cd02832">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/39bb8f91-cb3d-4974-9658-ce3fc04e7396">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/02926ff6-f7d8-4a06-82f8-89be986d7102">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/c79f3d16-73be-42d3-89b5-2df2a829b1de"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/71e0ba36-fc7d-4358-bf12-238cb26d28e3"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/5dd24465-c3b4-4ac4-9940-f84cd1cb77fe">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/5e9aedf7-2683-47a0-86d3-ed8b69bdae31"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/4a14476f-5f3b-41ea-b6fd-e2fbd7edacf4"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/c7d0f603-02b5-42bf-9615-a17cc4a87398"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/b1fb60fb-97d8-4b3f-b753-f593f3b90e20">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/ce2c6129-8cd4-4946-939a-12db4629aa73">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/d90e39e5-5b31-4f69-9419-cb55b83f0a13">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/38c8e837-b349-4157-a12c-9363813bb2f3"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/a4b4c96d-7570-4fc6-ae43-d73835a3c5f8"/>
    <rdfs:label>amiodarone-warfarin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/00ca5e92-05b9-4e5d-97c7-b5e7f903c4a0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/b13a04ce-e818-40b8-b43d-2f5e99871f10">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/8c896e89-6bf5-40dd-a6e8-ed9dcbcf0b7c">
    <obo:OBI_0001937>110</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/a6aa2746-e547-4556-af2a-addb0a1fa033"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/00731e97-2cf4-4ef4-a9df-c314863175ba">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/d13db1d2-bb45-4699-b592-34f7c0cc54b3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/ee72f70b-7219-401f-a867-17d6d1151fe7">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/4d6c448d-37db-4f36-bf67-523bfb2e0169"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/8d950745-3b12-42c5-b6ff-5349aafbd4cc"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/4fe97566-2dba-4931-87da-6a6057274c9d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/ef43cd07-2e7f-4b2e-ae7a-3b376dd7b043">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/f68b9d78-6589-4523-b314-7d43b01e550e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/1dd7923c-1ea2-4e81-b254-faf3cb119fc3"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/6619d24a-5543-4f4b-a352-d4c5e942fbd4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/4a5a4f85-2628-4e07-9e33-0947bd061d3e">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/3d6a0b7c-e119-44fc-8e2c-a4fd005ef7ff"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/897ee1ea-45a3-4484-ada2-4723a19bed4e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/282b5f68-74cf-4953-9d40-7c5b4e6f36f3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/447425e8-f4d2-40c3-8438-045c19e3d45e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/28f3177c-2b25-49bd-81d2-21f6909b791c">
    <rdf:type rdf:resource="obo:RxNorm_352393"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/0bd1bf17-56b4-4a00-b263-f29333e3ad60">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/b5390b58-701c-4c4a-93bc-b7ec9c1cd18d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/3b63c437-b838-45b8-afa6-a998ba91a486"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/2dcb4d24-f284-4380-9cf1-ba557cfbe155"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/9ba223fe-322c-4378-8a01-ef05705e1042">
    <obo:OBI_0001937>500</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/7793cc05-d221-4c4b-b270-0d0040542990"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/053eec63-135d-4622-988b-b934f72b370f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/fd3fe293-ad04-46e2-8931-19c2e7786b1f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/3b2293ac-cc9d-4625-9118-4017ea2505a7"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/cf82fc41-6da3-480d-ba7c-aba771954937">
    <rdf:type rdf:resource="obo:RxNorm_6135"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/dd4f1029-be00-43ea-a26a-0a4d5ebc2316">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/5b088fc6-0488-4126-8e32-29286ad69c92">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/58554a44-f79d-4a56-a157-51bed2373194"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/8345eeea-6206-446b-bce5-e57d84a30065"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/ff062a23-49c6-4a59-9f2e-a3f7074ab68d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/192f5599-d1ff-4c07-adae-e1a1188a851f">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/46606d24-bca1-4915-b007-c492ad0b7d98"/>
    <rdfs:label>ketoconazole-citalopram drug package auc UNK information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/3b693c9c-bb8f-48f6-a828-1db73d46b074"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/5b4f98af-5cc9-418b-8286-b4a0435d3598">
    <obo:OBI_0001937>25</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/e9ac6386-ff65-4950-b290-abae7c5fa988"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/cf80c5a5-7c87-42b4-a481-496929555c9e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/d59e070a-83e1-4215-bc90-3dca99c03b8a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/f7cc140d-2af8-42fa-a72d-a1be4de99f08">
    <rdf:type rdf:resource="obo:RxNorm_3247"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/2e071571-4cca-4534-bb6a-1b7d0a7d025c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/757b4db9-c172-41cf-b3e2-db8bdfe6894a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/c7ff2f5c-93ae-415a-919f-3b4bd8b57e49"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/a1ffbd57-44fe-4db2-a212-69c49fbd8d3d">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/c0422ba0-efa8-4ea2-9252-1e4ab1a95fc1"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/4363030c-945a-460b-9a27-f2af8846c128"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/4e78f5e4-3020-40a5-9705-b232ec4e70e0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/10e6f848-f35e-4db6-8c91-41f433d13fbb">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/26234cc5-f402-45db-988b-17b3864fb882"/>
    <rdfs:label>fenofibrate-atorvastatin drug package auc  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/3a140cff-3c63-4bf7-b222-7d32d3849ad0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/9ac8b686-64d7-46ea-b1d8-270a915d44c1">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/ec41f693-6930-4a4e-b63f-357ff7ca895e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/d8405d00-9b23-4d0f-a30b-924433f34622"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/285df13e-0a15-49d2-820e-933cf20cb971"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/b0e9bfff-4910-4ce9-92af-e3d3140f42a5">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/0a063172-ae83-418e-8cce-d41fb12bb47b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/040f5192-a3e7-405e-9802-b23c4235b80e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/85e2046c-0ead-45b3-a023-6ade3184e504">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/dd34b9e0-50fd-4a76-8cd2-dacebbbe6ba8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/2aaeb02c-b8e3-4e6e-9021-2ad4657fcc13">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/6f2112e7-412e-4441-9f11-91786e86c52c">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/b1dfc512-0400-4684-bead-3df47ebd5110"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/2248ca3e-c7dc-40ca-a11c-e35b0ededf4c">
    <rdf:type rdf:resource="obo:RxNorm_1102261"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/9d564005-6b89-4227-93b0-1aa0c739e3eb">
    <obo:OBI_0001937>500</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/848135c2-14bd-4fde-b095-35bc7acc18c4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/1309be4d-5e94-4048-abd4-257a251e457d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/6f3d6540-852a-41d5-8d2b-853d76ef20ee">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/f30e5914-bd21-45cb-a475-f56f1297475e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/53a02392-cc8f-4f2b-97d4-a20036470300">
    <rdfs:label>Gemfibrozil-Atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/62d7d57e-2bce-4306-853c-8c3d5e9cef47">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/43615e5d-38c6-4bc6-ad4c-1db94c1388b3">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/b8a1b370-a4cf-410d-8ff2-0a708f03cdd4"/>
    <rdfs:label>unchanged UNK </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/a331bc7f-b047-4038-9371-a10403e5b071">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/dae873bc-157b-4876-8229-2cde37a4f6a1"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/4d47ff08-0bd0-46e1-8b40-4e7329b7a458"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/6725154e-d1ea-4d79-905f-eff9336b2365"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/e18d7087-a837-41c6-812b-37febf0bd463">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/9694a299-e990-477a-be18-383aeb22de07"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/5a0b4809-66d7-480d-bfd5-88ce111891d8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/174d94e0-f41d-4299-8c3e-e595f6edf1d7">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/3741d3e5-8765-41f9-8973-07839007de3d"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/6a10b163-c450-4712-b98a-d29d996e2266"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/b4b7f531-58b2-409f-93df-df787f5b6e71"/>
    <rdfs:label>ABILIFY-fluoxetine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/27f25646-9f9e-4420-9596-94d5154631c6">
    <rdfs:label>ritonavir-bupropion DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/ab6a2ec8-16ac-415b-a9bd-9e8b5312db11">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/9a1cfc29-d7b0-47ab-9b33-d771f9571776">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/1b05351e-f965-409b-bbe7-5cae22684297">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/a51f655c-a24c-4f7f-8c24-e302e69e7d99">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/046e0996-4a7b-49c1-9ac1-fcf2c618b0a2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/27a8761b-9ae5-42f0-b00e-bbd25f4429d5">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/6f7e4855-78b7-4e68-8f5c-4bba344fd053"/>
    <rdfs:label>sertraline-diazepam drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/95d197e9-c907-4ae7-ab14-5a414a7dd9c0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/a224f2fc-6240-402e-ad5a-0c786257a408">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/01c9c24a-e3cb-4328-9996-4660004fc888"/>
    <rdfs:label>paroxetine-procyclidine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/e3fa16ba-61cf-4e99-b257-b3d53ebab9c1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/7e8e4de7-59ed-42a6-a660-6abd03b6fa05">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/263a10ec-8bc0-449e-8d82-c1ab5180e006"/>
    <rdfs:label>ketoconazole-rivaroxaban drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/0da7a9a1-d51b-45df-bbf8-8139607cb644"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/b8ee3e72-49c2-495e-8bba-2a84b9949fb6">
    <rdf:type rdf:resource="obo:RxNorm_596"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/02e42480-3101-4044-a0c4-bb16c9f41502">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/2ddf7266-c0e1-4751-aa08-352763b3e293"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/5559a0a9-0b02-4691-b290-d575dc727282"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/79070d86-bbc2-4c5c-8f02-cf5db59af543">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/991da71c-4e59-407b-acbc-0bdcc4891771"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/604b3cdb-5673-46c8-8bfa-8bdf2a0ea976"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/fa05f93f-0d8c-4985-bf43-063d42edb52d">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/5d3d53da-74c6-4402-8ef5-fed7c3b6d069"/>
    <rdfs:label>190 Fold </rdfs:label>
    <obo:OBI_0001937>190</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/f385e405-41d7-4286-951f-0adc8b33970e">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/46d79dcc-55c5-444b-9102-cd286eaa7e57"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/c6e4cc23-5b90-41d4-a291-8dce8366d2c7">
    <rdf:type rdf:resource="obo:RxNorm_36567"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/df3ee1f7-df24-4ad8-94e0-2694ec113340">
    <obo:OBI_0001937>15</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/b4584828-c988-4d5f-b7bf-230ae7c02a94"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/ce757ab7-2e5f-40fd-9aba-197025b810f2">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/71856a4c-908f-4374-8c59-745d1890d575"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/b2a852e8-9624-46c1-ae46-68a9163dd08e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/07909617-4026-41c8-a309-c495deddfdaa">
    <obo:OBI_0001937>60  or 120</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/a117ab8a-a3ab-4dd2-bd43-430e2d1dacdb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/aa0c6ef8-13ab-40a6-8be7-4291fee1606a">
    <rdfs:label>fluoxetine-iloperidone DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/d001096b-2186-4d61-b5a4-bac4597647d4">
    <rdf:type rdf:resource="obo:RxNorm_861634"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/575cdf45-6333-4f16-887a-746845427654">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/553b21f1-6c1b-4109-8f24-43061721b1f6">
    <rdf:type rdf:resource="obo:RxNorm_6135"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/f331d3a8-faae-4099-ac06-9b5d285aed9a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/f650f0e0-2c32-4344-90dc-3dc2b6778f28"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/8e712cef-7420-4f74-87fa-ef71d183ea1b"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/0c9e0b0d-29de-481b-bee6-3bf542837922"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/149a4c10-94a6-4283-9c05-6f64be17e07e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/478a0ebf-c55e-4d39-88a0-34900a20321d"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/80851d33-e352-474b-8c56-8c86adc6160c"/>
    <rdfs:label>fluvoxamine maleate-alprazolam interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/4a904053-5703-4a10-9be2-3580ad7397c0">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/5582eafd-9293-40d6-9d2c-c0bce0d9335c">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/25ce9788-b665-4970-9afb-e293277ad597"/>
    <rdfs:label>0.87 Fold </rdfs:label>
    <obo:OBI_0001937>0.87</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/de78fed4-180b-4af3-be57-2e2c0159c414">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/afda377e-0cea-429f-9464-3b589bd963e3"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/1e543e08-011e-4611-9a50-991fa45da9f8"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/bab3e17e-35ed-461c-87a0-4be28925e224"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/49602561-e0ff-45c4-923e-1aea269ef1c1">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/3fee5692-95e0-4120-8993-184e8cc2ff3e"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/389b0365-b00e-48b1-8b81-29790973edea">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/9f567384-fe50-4526-9f75-22f6911add37"/>
    <rdfs:label>14 Percent </rdfs:label>
    <obo:OBI_0001937>14</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/ad0ea5a9-1bcd-4813-897b-3d20e0be2e72">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/35ab1ca8-7a82-45b0-aca8-18348863d5d9"/>
    <rdfs:label>clopidogrel-fluvastatin drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/4b2c6219-9312-46dd-b6ad-2d06c167961d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/e37cdc44-b273-4368-bf33-3b58d682a035">
    <rdf:type rdf:resource="obo:RxNorm_4493"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/b189bccb-a673-457e-8ec5-9fc3cefb5d23">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/8efc59a4-7531-418f-a960-f5ef76e6445a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/c05b3f88-c118-45b9-86b6-b215a9ec270b"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/0de27741-ceb6-4ff0-b6f2-96528a1766ee">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/ac8ad362-2e9a-480a-b7ff-94d59e9096e6"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/cd180e2f-ec2f-4968-ad14-b4b418458ff7"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/042ef0dc-5559-472a-b890-2f7b1eb13a69"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/bd54bfba-bfda-4284-961c-a110a62c9906">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/087b09f7-42f7-4efd-a176-0883e7b9438b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/101f253a-b29f-4b52-b29e-48e9ed553b23"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/f3a005db-c99c-4838-8fac-117f48f0817c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/e5124ea0-40af-476d-8840-c2b2d4012d56">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/b7e8b71a-5bbe-4168-a384-87b7551a1500"/>
    <rdfs:label>35 Percent </rdfs:label>
    <obo:OBI_0001937>35</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/95538aba-43fb-4add-913a-fc1e23c7de53">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/6e865c68-0e92-48a9-8ea6-3f33ed5fa342">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/c4a03653-d88d-4e57-b9ad-1001cfbb086c"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/f9b868da-2497-4bb3-8070-458e735d9974"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/554cc2d1-6a3c-4395-b0fa-f9aca4a02f3a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/1792fa33-987d-424f-8699-f0c8f52d058c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/973027f2-891d-4775-8abf-0d6ef2bf8ad4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/f7a9e64a-1ceb-4bae-81e5-fdaa3afc3446">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/bcf9167b-e524-4862-97b3-3a23c9eb3590"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/e67c7cdb-709f-4f4b-b394-e1448b757ea7"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/b5e5eeab-f83d-4f7f-9ac7-c917e8378fc5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/268be147-6319-4707-ba61-c716f359880f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e2d2ac97-83b1-48e7-9332-6d6f0d7b096c">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/34375e93-914b-4b13-b754-8293293bd544"/>
    <rdfs:label>Fluoxetine-olanzapine drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/f651f870-6352-4dae-8b14-2d130f58f778"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/94db65e9-7e71-45ce-9950-f84d543bac80">
    <obo:OBI_0001937>6</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/728e60ee-e8c7-4884-8503-a1c4ab661184"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/9f32d9ec-c521-40bd-91ec-b446c6e62631">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/370dfee4-d744-4395-89ee-4206ba0d8edb">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/79a21351-9400-4250-a996-c521396f8360"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/7f23cef6-d7f1-4648-8c51-470c840112d6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/9ef8f14f-d419-4824-b9af-faa49f7e91b2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/42440d8f-18dc-4edb-a212-708f962600f9">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/34bb6a33-416a-40a0-82bc-1519d1da62ee"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/4b3a6894-d348-47fb-9ce5-88a8a2b81372"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e40bfe72-3250-4e3c-846b-2766fde73252">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/659ff95f-c8b5-412a-9ac2-1df5bd9faf5c"/>
    <rdfs:label>rifampin-zaleplon drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/c6807e8a-0b7d-4cb3-bf70-4b7c07536b33"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/2defa171-ded4-4e2b-a125-c68cc22d8cb6">
    <rdf:type rdf:resource="obo:RxNorm_134527"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/289b1b11-6004-46c4-b635-d0de8cdce0a5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/967b295b-cd1e-4980-a912-79ba39a16550">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/f5e6b8b1-1580-4975-a594-57de738774f3"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/787f053a-01ea-4c53-8f21-d75e0a71c060"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/71545a6e-8433-4748-8f6e-38fa833cc708"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/880d81c3-7492-4295-8f19-4a8b73c26bd5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/1dbb2858-d0d0-494b-abb8-96b5e9a5fb95">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/ebe7bec8-645b-49d3-a131-b520b3c440c4"/>
    <rdfs:label>Telaprevir-atorvastatin drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/5d4cf547-4b33-4da6-86e5-ff4cddc48c01"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/6cd8201c-42e2-4412-8be6-bfe1c45b4aa5">
    <rdf:type rdf:resource="obo:RxNorm_42355"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/429186cf-9cda-4de2-be7b-927f505e6ffb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/72595144-8239-4442-9b24-dea71120f589">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/96f5e0d1-1c6e-4d49-bf28-8e2046052158"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/964e974a-80cb-4016-9a6f-b5989cfa18fc"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/bfff0e59-2f66-45df-83e2-5ccf00d98579"/>
    <rdfs:label>itraconazole-zolpidem interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/59e2fa68-28bc-486d-8ed3-1bb3f6600296">
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/528ef2c9-37e3-437d-a23e-b6351d1cfdd9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/0cf1a816-7fbd-49ef-bce3-0ab2c6994bb7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/e9b06338-0cc3-48a2-91b7-4663b80a334b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/eb07e71b-afee-4a2b-9f6c-44b7bcf78920">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/d94e093e-db46-45ee-8e49-79fa4ae09598"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/69bc90d4-7b2f-4239-9182-c2ddd28fe58b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/f2e4df98-04a3-4574-b660-019b97f4e528">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/fe076fd0-bc62-4391-918d-9fc8bca710f8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/27009cec-3e1e-4e79-869c-12287a053f36">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/028646ad-ab96-4b4b-a368-3921c211f585"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/69a24c57-859f-4bda-9980-752ecd057a93"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/649af4bc-8a84-4712-8010-51ff4151bcce"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/58806e43-aa51-4197-b0cb-c335bc0aefa5">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/bc1b0371-9b15-4c49-883f-68c85ccdf710"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/e2d2ac97-83b1-48e7-9332-6d6f0d7b096c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/45c947d9-0095-4343-a021-7cb1c37337fb"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/3025f317-4038-4f2b-9140-f1671886e934"/>
    <rdfs:label>Fluoxetine-olanzapine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/0caa5548-cbac-4a7e-9fb6-041381d1b7df">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/b2191d98-f9bb-4d36-bfd1-d849d705dd0a"/>
    <rdfs:label>Fluvoxamine-tizanidine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/e75d5661-46f6-4478-b6f4-1fa37b331532"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/0f3ed284-327b-4607-93c3-36189d368c57">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/3dcade90-00c8-4712-8693-aa5de10dacd8">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/851897c1-96a7-42e0-9201-3dd66ca232b1"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/f32ba152-f6a5-49a5-b0f7-cbfe16c92ba5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/f150aec2-5763-484d-aa34-c23b353ed2d7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a39553e4-7607-499f-8be0-05acafa68b6b">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/a9924e77-5b80-4b14-9844-3af86f98491a"/>
    <rdfs:label>2.27 Fold </rdfs:label>
    <obo:OBI_0001937>2.27</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/d4b6fce5-1469-4fed-a0cb-bcf8f2615f7d">
    <obo:OBI_0001937>6</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/b1d35907-8d18-4a80-baed-a95bab92abfb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/7bda248e-db72-4205-8af7-5b3f10a2150c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/96de6b1a-2e1b-4bef-87f6-8c6e7b9152db">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/cd80be7c-7ca3-4b6d-8f4d-1844133ff208">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/c580df41-0f90-4862-b1a9-2e763112fd0e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/ad146fb3-f07c-4462-a576-ff2a61df26b4"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/70dfd389-de67-4987-93f8-8688fa996dc7"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/bb3ea027-6ceb-496f-9f40-981c88d988c3">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/b78f0f72-e018-4cbb-8452-3fd75535caa9"/>
    <rdfs:label>70 Fold </rdfs:label>
    <obo:OBI_0001937>70</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/9f2115df-47bb-4d72-b937-ed8aef272f3e">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/0074cf65-c82a-4916-8a92-d4a76981c5d0"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/1f7faf89-29a0-4350-b0a1-93bfa8a67385"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/94327e3c-e65a-435e-bc03-5748a1491fdb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/b05f4dc5-dd6a-4310-b969-3616588b0df4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/447ae81f-1725-45f8-aafa-5dae55a89679">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/efb5d586-2d18-4da9-8cf7-3464c17b75cb"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/46ca7b6e-2619-4cd1-ab39-fa8740a9c510"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/e773ec51-ef93-4bf3-b252-448283db1cb1"/>
    <rdfs:label>paroxetine-duloxetine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/1dd7923c-1ea2-4e81-b254-faf3cb119fc3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/828c6845-b048-4bc6-b720-a6c1a1c030fc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/9595725f-0a1d-4544-aa37-a0a3f3be943f">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/616a1055-62ef-4f9a-9276-a5d43a63c40e"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/5fc56cfa-df91-428a-8993-5f9809fdeb21"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/b5a1f229-c3ea-4475-8fc5-9b0bf196f5fe">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/39d969f6-d89f-438b-84bf-ffb70af7ff9f">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/9df656a6-0faf-4ac1-859c-08b18fdc0280"/>
    <rdfs:label>phenobarbital-paroxetine drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/c8ed0c39-b7a5-477a-a9dc-1c21bd88718a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/8aa5e40f-8c93-4d62-8e22-4a3c7ce26d47">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/82433ba6-2e85-475c-bc7b-486f7e178689"/>
    <rdfs:label>ketoconazole-rivaroxaban drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/f287e62e-e985-46c5-8935-e1a6f152d482"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/9a91ed2f-424b-464e-b30f-14ef270c80e5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/88b0f06c-e65d-4aaf-95ec-199f05d9796d">
    <rdf:type rdf:resource="obo:RxNorm_134527"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/8f9e5217-8e15-4513-828f-760fe66a7f05">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/6a3923d0-c85a-4f2c-ba13-51e3e8fcd031"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/65dcea3a-58e2-4c00-b2f9-a790c6d03529">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/5f7c0c20-923f-4645-8526-7c1e26750602">
    <rdf:type rdf:resource="obo:MeSH_C558899"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/579e1abc-caca-4bf8-9b9a-20a2973398df">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/48bd1b4a-a58d-46f0-b546-b15ccc692bab"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/0ec7e2db-799a-4960-a2ab-286efbb56174"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/21b3824b-0599-4a64-8109-8a02cbf124f8">
    <obo:OBI_0001937>Unk</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/75dde4a3-74d9-474c-b559-a5724ca311fb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/655c00a3-69a5-46b0-8db4-08c14bd9049d">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/94b891cf-2f7a-45a9-87bf-2841a0166ae6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/9287be4a-5085-4a13-8ce1-94fad5c3b3f8">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/4290bd71-2157-4344-9ba5-5a917ea9bd5b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/5e7e4382-9706-4365-8443-b9032d023d0a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/99775fed-1350-4897-a8a0-ace9bbdf5938">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/f00ab04d-d9c3-463f-9fff-82d5a8355594">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/45e3af83-5d0a-4aba-a948-e5c05abfce04">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/98c7df8f-9b12-463a-8e27-1ff39ec7d734"/>
    <rdfs:label>telaprevir-atorvastatin drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/1b8e98a3-ae3a-4f40-9aba-9e10fcafb8c4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/2fd4ba5d-134c-46d8-b9b2-0f3d01430868">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/62fccb55-7c7a-4d9c-939d-a43eedff8205">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/6a34b7a1-c9a7-4b68-81f3-df3b76f4e77d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/d58da7f6-a16f-4cf2-835a-3bba723dba42"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/57121487-4a7b-4e9b-9477-3ea7c93a2a67"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/a5260e05-89c6-4fda-b230-784e26b652fc">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/bb0397f7-2e7b-4f73-8076-29e8272cb4cd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/b2a852e8-9624-46c1-ae46-68a9163dd08e">
    <obo:OBI_0001937>60</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/466edf4d-0823-417f-9229-5198e0562090"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/8ebf25cb-a56f-4733-b3fb-0eb15b75068b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/9800532a-be4b-4e00-83c2-50139875fbef"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/c3bbd85e-f826-44f0-aaba-b40080827bf3"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/c8ca70b4-24d8-4ef3-aabf-a6f4493fdaf7"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/12459a5e-23a8-4509-b2c4-ce0672c07c9b"/>
    <rdfs:label>divalproex sodium-INVEGA interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/4c5694f9-1eb3-44a5-ba80-5807d3cec188">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/b0f6ca3b-7220-4023-9742-35348852e9f7">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/6d466061-10d5-4f3f-9685-d9a487428915"/>
    <rdfs:label>35 Percent </rdfs:label>
    <obo:OBI_0001937>35</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/2d2d92bd-90e2-422e-b8ec-2550d673d972">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/dd26dd70-b571-4bc6-a66e-139475d0da09">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/5c654bdc-ce44-4dce-bfe9-ced2404adbc0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/d68a113e-3336-497c-8748-06a839ca8fa8">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/a16daec8-a8ed-4f27-9a80-42e858621d58"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/21f86d48-9b38-4451-88b0-b5d2dd5c0b0e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/e97b39da-be53-473c-a33f-017c805ba6db">
    <rdf:type rdf:resource="obo:RxNorm_2541"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/8c07520e-9625-45e6-a902-df38a1983238">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/9aebe8f0-2567-4994-bd35-8c86095f445b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/097a4419-3945-4cf8-b624-dfed5e63d471">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/66cb148d-780a-485a-9c4e-2ccb9c282474"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/ccd6f7ae-643b-4ca8-88da-ebaa111980f3"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/c4d5d258-cd93-4909-8a71-515ff3aa3130">
    <obo:OBI_0001937>60</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/5e2ce4d8-f344-454c-98d5-2beb1c0432e0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/e0fd6afe-f3d1-4f43-bab6-e0379681a411">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/d85b9ffd-b2a9-4128-a3e9-f08634ae70f0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/afd71fa7-25f6-42a7-a566-2f4097144030">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/883e66a1-9725-4fa1-a67c-3f6989a4f3fd"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/a184a587-2b6c-49db-bce9-16b20493fb6a"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/0bd8f242-e076-495e-a49d-a1139b1c5e21">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/e2d6432a-7975-431f-8536-a40e3f22ce25"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/c2651de3-ee6c-46d4-9d44-967a8e6c5671"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/a9a84f98-e3f0-4738-9bb6-b32d13ec9a2e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/304b0f28-d8fd-46fa-a522-741b1f9d8fb0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/c6aba840-ac0e-4ee4-ac4b-0edf23fc17cf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/ec869fac-142e-4848-a664-76ab20f77018">
    <rdf:type rdf:resource="obo:MeSH_C558933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/5e30758c-1ee9-413f-8c7c-7210a2281e59">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/21a851b1-5607-46ee-b32f-d11d072e261f"/>
    <rdfs:label>129.9 UNK </rdfs:label>
    <obo:OBI_0001937>129.9</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/4035cdf4-08a4-4e59-b747-4708a82cb438">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/082d2c29-520e-4e3d-95c2-2ee9f85f4aa7"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/e933c049-1bd4-488f-b08e-1f3449441dc5"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/73e45b91-7295-4bfa-98ab-7dbfb6abddc0">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/ed4ce86d-da05-4f22-94e3-dae2854f0522"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/b1aa0cb6-c6af-42d7-b6df-584fdcb3535a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/62c2da88-bb5e-4571-8401-1f8a6d0ffd72">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/7d0efc3c-e36e-4aa2-b03e-2b2cdd6ed942">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/7c32dd9b-5bb1-4e1c-9c3b-c77073f84f69"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/5f816856-220e-4beb-ae2f-38893c663138"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/5abe56ba-e7e4-47a0-95a1-80847600c096">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/554ca650-dde0-4400-a9cd-219c5d6f6746">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/6de7c537-719b-46ea-9fd1-f0f9a0ba4362">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/a4612b0f-198b-45f2-b4ee-7fc419dba481"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/0d09815c-1700-486b-b523-7c8b6f2f60b6"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/46e19aba-13f4-4d6d-9cda-ed034671eecc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/8ecd9dab-db56-477d-b103-c7b0e4541c66">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/37431714-6d8f-4517-b768-edecb24b8fa1"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/9908c967-5a17-4c3f-beae-e3478c28d9c8"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/981dec8b-5984-4903-8013-69d3fbb110e4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/1a02eb7f-600d-4d95-9ebe-c428a31febe6">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/85d55114-d5a4-4de9-bac1-3fecac5ac1c7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/7219953e-e321-4249-b83d-90bc87543a63">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/1f5a6764-fb71-4880-b286-20c43f7c196c"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/ff0e5b04-6b55-47e7-9f16-3928f3e24238"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/59c029c2-a630-4e0b-889c-19d8a0da53d2">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/f71f9d08-f89b-4ad9-bbea-f098db5ad78e"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/000de972-c34c-4823-8ca0-8f13e4ff499c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/9e08fce2-dd1b-42d9-82c8-dd28c1787d75">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/cddc8db3-36e5-4778-a7e8-f76249b5fa5e">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/fd4f0fcf-b5a9-4cf4-8fa9-8369305c7db6"/>
    <rdfs:label>45 Percent </rdfs:label>
    <obo:OBI_0001937>45</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/ccf270cd-7c21-4a9e-8b39-75b6e83bcd1b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/192f5599-d1ff-4c07-adae-e1a1188a851f"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/ce44968f-f048-413f-899a-961eb5cd4e36"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/5d565f3a-e35c-4bfa-abfc-abe8079b7124"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/ce4d5031-7761-4059-a741-4be6501176b9"/>
    <rdfs:label>ketoconazole-citalopram interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/0827d11a-d692-48ca-9f6f-25455f8f753f">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/b524dc25-eedf-4531-80b8-5b0c4949745d"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/3bc15e2f-448b-4ab4-956f-ede674a5a559"/>
    <rdfs:label>Lovastatin-verapamil interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/cfc0c374-7c9d-4d69-833c-43df67fc10ce">
    <rdf:type rdf:resource="obo:RxNorm_85762"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/b704b560-6959-427b-8261-1b44624c8e80">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/5e093727-8b93-49b2-b2b1-4e244ce3b9ca">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/6316a863-5ce2-4e2f-8b32-16bd4056cb91"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/55ea1951-2970-415e-b27a-5f2ea1109bbd"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/e06ae21c-45a9-48f5-b8db-0a835c935a4f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/4cddcaf6-c8e4-4f51-9960-03638e0b9b88">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/dc17a3e3-570d-455a-91af-b8ad3767faf0">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/8971deb2-bfbc-4a77-b71a-3cffd4c171fd"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/44fb585a-9d52-4d24-89f4-ab0afde230ed"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/1af6c515-c7e3-4e64-b289-12a2aaa41425"/>
    <rdfs:label>rosuvastatin-warfarin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/372348d2-4398-4a72-ba2a-039f8c4f5c47">
    <rdf:type rdf:resource="obo:RxNorm_42463"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/de350af9-75b1-4db0-b90f-940d8af2b078">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/6703524f-6159-4068-8e3e-3c2811c344a2">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/3070748d-29ce-4ebd-a94a-a06a798e5d6c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/df033e82-ed43-4cf0-adcc-3caf6fb5690a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/4d04bc88-ea1c-48f0-bb0c-0fbe14f88072"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/33d940fd-9078-4032-9016-0b49729158a2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/060e7300-1890-4086-9607-07b622e27a7b">
    <rdf:type rdf:resource="obo:RxNorm_4077"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/98352329-58e7-4000-919f-6d5514214a2a">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/44ee0cde-c997-4921-b904-ae1eb597c333"/>
    <rdfs:label>desvenlafaxine succinate-desipramine drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/57a535bd-4ecb-4efe-b8de-6c1f7fd37729"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/f961b9a3-f001-4c4e-9de6-7db44591e0c6">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/11130902-38e9-4efc-9c1c-6ee5d7c7a5af"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/33c6447e-4445-4839-8930-e20c9563b93d">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/fa3acf58-35f1-4245-bba3-1b27de4e4b33"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/d1adf36c-1863-4204-81a3-06af220eaca4">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/018d414c-c2e6-4bbf-a02e-111adccc320c"/>
    <rdfs:label>paroxetine-pimozide drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/30267eef-25b7-4e66-892e-5f33b8ff2184"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/8ed6b213-c5b4-4177-9dc2-a1abd0221f3b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/f21a6d80-9ae0-4230-8142-9740ea30d493"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/008a599d-7ca9-482c-9da5-ef8cd237d4eb"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/7ea5ff84-5ce8-4007-acf5-6c8bbf081703">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/26f1ef73-c96e-4a8b-969f-555f2e6ddb0f"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/d35579f5-5556-4811-9f4c-8b74561bc263"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/08a6694c-bfa6-45bd-98d8-71778f6feeed">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/1daaa386-1a0e-4da0-a42f-a00dfe746ba8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/3b4614f4-12fd-4a1d-b5a7-3149cec5cef4">
    <rdf:type rdf:resource="obo:RxNorm_85248"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/302db8dc-0fa1-4239-973a-cf7f09329194">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/984d3725-1c5c-4ce6-a3a8-18b5f6c46198"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/20f07e55-e622-433d-a2ef-18284f47ead3">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/43ba5cff-eb07-4855-8f13-4c6aa27fdee0"/>
    <rdfs:label>5 Fold </rdfs:label>
    <obo:OBI_0001937>5</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/76259c41-9d74-463f-b1d8-7390ad7e10f5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/35b0e1c1-9b28-482c-b31d-1116c9227ec4">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/0af0c008-34c3-4ec4-b5ef-694d559afec8"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/1d7b28c9-6654-4bf0-bb34-2cfa148cad1e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/dab90f05-4897-4852-85d9-2c159ecbf7fa">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/e4d60825-68c7-4e74-a483-742dfb6f99e5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/91de1ecb-9c78-43c0-b8a1-c19628998b0f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/c25d7594-76a5-4512-9633-7ee9e0b6f508">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/65018a0f-f876-466c-80af-2179d1747519">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/fefd0cbe-e8bc-4e18-85ab-e76380679c41"/>
    <rdfs:label>38 Percent </rdfs:label>
    <obo:OBI_0001937>38</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/47f76ef8-1d82-476f-afdc-a1ea0814ae55">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/2b37e856-11a3-4e79-9a61-ba0aee0266f3"/>
    <rdfs:label>nefazodone-triazolam drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/61c039d3-2bdc-4401-84eb-d5cb91008a49"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/2f01b7a3-0d1e-45a1-a9f0-6ba6783b937c">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/db2a525b-f45d-440f-b68e-db8703b8b856"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/c9b9a5c3-d3f9-4c91-9a3c-f2677df1209e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/259f316d-fb65-4922-8b3a-fb5b33c49c79">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/7f17f72f-e468-44b5-86ee-fe11e79bd167"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/e6a9198c-2e8d-4e4d-bfd9-d321ae326a6d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/35a63f3b-d8b7-4a0b-bb01-279f82d4828f">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/62b92f22-a725-4bb1-8f77-d641f6fc263c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/9819f23a-eb82-4cf3-86e2-4a618bb263c1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/85a24681-7181-4b5e-810f-569a072e666f">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/baa81b04-6858-4c2d-8054-140b10d7c17a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/be0027f2-96d5-4b0a-b73f-5c6212fbc8ea">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/9a44bc58-077f-4374-808e-b74da25a8699">
    <rdf:type rdf:resource="obo:RxNorm_1114195"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/da81728e-6aed-4f60-9487-8078f6a23101">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/94327e3c-e65a-435e-bc03-5748a1491fdb">
    <rdf:type rdf:resource="obo:RxNorm_3008"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/d6c5ace0-2d23-430c-94bb-033ec2922a54">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/5bc2b090-dfad-44dd-9ba0-3ab1b4072b18"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/7fd7d8a2-4b4b-4f6f-ae11-488aee9a822a"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/756fad09-36af-47ae-af6c-626753ae74bc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/75929d97-5e42-4505-b9fe-7dc6b8d7f8ff">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/a488c8ac-933e-4593-81ff-cde81a282b57"/>
    <rdfs:label>35 Percent </rdfs:label>
    <obo:OBI_0001937>35</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/936e2235-53bf-4a62-b302-834465faea0f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/27f93966-02d0-4eb4-b50e-8d6739735f10">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/671a3560-5be9-48d7-a4c8-af703bef99c4">
    <obo:OBI_0001937>800</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/809c1fe1-7b4f-4ecc-8b67-afeff628460b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/1d2fc0b5-cb1c-4f78-aa97-181fb5e190e3">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/33081cea-ffe1-4a93-8e52-4ae2920e933a"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/a8949445-76b8-4401-bf65-c31dcae71b07"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/39f4c61a-93e4-4792-ac91-7085f6d36400">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/71f548ba-6022-4234-b2cf-4ceec39f69d0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/12b68fef-00a3-4269-a043-5ef7ff1d998c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/5b05d79a-0a1f-4ce4-b466-01e85fd7ec1a">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/447425e8-f4d2-40c3-8438-045c19e3d45e"/>
    <rdfs:label>60 Percent </rdfs:label>
    <obo:OBI_0001937>60</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/5e51202d-9314-4110-a4f4-4f213c0209cb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/748d823f-af5b-4178-ae2b-5efece07f0aa">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/aacfb119-8876-4a7b-8a6b-a2475833610d"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/6a82f4d3-a9a3-40a9-87bf-660bbd832bc8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/c505b620-07eb-49cb-ab26-085b5e41120d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/98e42349-c67b-49ed-981a-d2d5a3a71e25">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/cb51099b-2fed-48b4-a347-12415fc6e151"/>
    <rdfs:label>55 Percent </rdfs:label>
    <obo:OBI_0001937>55</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/37cf1913-871b-4290-9e6f-ee366d0caf50">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/ae51aad8-33d2-41c0-8ea4-ff132a3ebadc">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/01f60e1b-0538-42d3-af2d-b927ebbf76e8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/de46afa3-df8d-4683-9239-076a563c1b6c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/e1646697-1fc9-4911-80e5-e93e828d9102">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/4c782f39-2859-4119-92fd-613cc7fa2608"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/966df4c0-f013-42c9-b3c9-42571597ac1a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/ee7963d6-b0bc-4dc2-9b5f-c05da245f4c1">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/ce976564-b1dd-4e87-a05d-f611c137d271"/>
    <rdfs:label>fluvoxamine-thioridazine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/bf414177-1a40-4350-b172-986d162105b6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/5189dfce-4bdb-425e-9076-b77f6c9c7899">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/0f4fc334-33e8-49dc-914e-90acc5b69799">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/25af63a8-3e3e-45b7-9c8d-1c11c20a4155">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/9fac4825-9550-4d77-8545-5c4135688c7b">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/b111beed-733d-49f7-8cf9-4d3297e21b1a"/>
    <rdfs:label>clopidogrel-bupropion drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/5d81ef11-f452-40bd-ac6e-feaf279beb22"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/f47038f7-2b0c-44c6-af5c-e2b9b9122d54">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/399b384a-a23d-4e46-8275-5751449f6bbc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/6c26a1b3-b3a4-495e-ae89-6ec6187aa83e">
    <obo:OBI_0001937>750</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/b86b9b2f-b24f-4789-8179-0591705dc02b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/8fbb45af-e1ac-4f2c-857d-6bd16403be0e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a8785fa3-f7bb-488a-9302-d78e984e1fd7">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/345aec20-ac24-41e0-a1b5-da8d7503c568"/>
    <rdfs:label>32 Percent </rdfs:label>
    <obo:OBI_0001937>32</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/0919832a-bc32-46eb-afb7-c0509e4c41ab">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/9f38db52-3169-46ef-a79f-68f878750c96"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/36aae63e-7ab5-44d3-b749-490f6087bc5d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/55c93cba-90e3-4e47-896e-d6753504b989">
    <rdfs:label>pravastatin-NFV DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/9b65cc83-886c-40dc-9b3c-9cd1fd267eb7">
    <rdfs:label>Lexapro-metoprolol DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/ad1ac383-d969-4ad6-9db6-a2ab079b9600">
    <rdf:type rdf:resource="obo:RxNorm_2556"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/88281874-ecc4-43d1-83c5-7cc9a6ab5c06">
    <rdf:type rdf:resource="obo:MeSH_C558933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/1523b4cb-bda4-4972-9d63-cca0639121b3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/873844a6-e980-45ac-a94e-5f82e9b6b4ac">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/a91d9641-1dce-4a46-a36b-74bb3901c1e1"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/d1359f6b-1153-49ac-9a6c-7f08e0aefc6b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/e9f3a4f9-0ca2-4b5b-bda4-80909b34c032"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/694aaa5f-bb11-42fb-bbb6-09c2e0877dbd">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/6b2b16ec-a127-41db-b55e-4d79fd2ede54"/>
    <rdfs:label>2 Fold </rdfs:label>
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/c5cb4c08-ccb4-47e8-9516-74dc89453f60">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/80a86b5f-a39e-4480-8e18-97c5e4ff04d6"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/564583cf-ca77-4a20-a701-96cf8cfebc79"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/474837a9-0942-4bea-8d5e-fa2ace2b4e7a">
    <obo:OBI_0001937>800</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/f09e9023-e677-4223-84db-6bb61a4463fa"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/6019fc85-e344-426c-bb22-239c8edc99b9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/6c73aa9b-9e2e-4431-b9a3-941df6382767">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/cd585645-48d1-4552-9769-87c2ab899692">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://www.w3.org/1999/02/22-rdf-syntax-ns#type">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/e4a8c1b0-1a47-4bd2-8876-807df0516c3f">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/ae04149e-b8d7-4cc2-9aec-6dd01073c73d"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/b64c164c-de2e-42af-b125-400771cc00df"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a951e6e4-3156-427f-8ae4-ffbae7fbdd5f">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/f8629a60-a215-4864-9e37-cd64d7fd0128"/>
    <rdfs:label>2.66 Fold </rdfs:label>
    <obo:OBI_0001937>2.66</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/6217b60d-ed2c-4a44-882b-34aeadad24d5">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/b64f3e7a-4db1-493f-906c-cd9749ec87c7"/>
    <rdfs:label>carbamazepine-nefazodone drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/9b5fe557-e4ee-44d1-bfe5-ea0a125b4f33"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/cd6d8968-b342-49a1-b0f5-81834d3d821a">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/af92d88e-a592-4b15-94b6-0348e3791eea"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/92f266c3-c283-415f-a78e-eb1d3d21c6a9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/114564e6-180c-42f9-9a67-773dbdb90d4f">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/68098df0-9e1d-4a7a-b133-a7179cfd29dd"/>
    <rdfs:label>fluvoxamine-mexiletine drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/f462058c-3718-4b8f-9756-990c768f2314"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/b7b7c3c0-4bdf-4dd0-8e7e-09cd438bc2bf">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/d32ceabe-374c-4895-a327-9b149c60dd3e"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/5a5b63b4-2d33-4be6-88b3-74964d9a6620"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/db028535-0735-4acd-badc-15b31433aaa8"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/f65f8e4f-2e6f-4bd9-bcf8-31d0edfb8b32"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/0808ea61-b317-4eb9-9b26-6638c1a83667"/>
    <rdfs:label>Ticagrelor-atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/087f42bf-d885-41fe-bf78-225734221b21">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/2311bc9c-b805-4761-8927-60141a65cc77">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/6f5cd7de-0964-481f-94d4-f2bc2459cf1d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/77f0c3a8-e0a2-4b7f-9eac-58c1f4b415c7">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/20f02162-ae8e-437e-bbe7-c16532d0323a"/>
    <rdfs:label>2.5 Fold </rdfs:label>
    <obo:OBI_0001937>2.5</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/31327462-5f94-4765-b014-362807e05802">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/ff62e542-1305-4634-8b9d-76434734e9bd"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/c9659c9e-0642-4a4e-bd47-69e245786615"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/cee3fe92-d08b-4a5a-ace7-8a85bbd18cf5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/7d4a6357-ddcd-4e40-8f63-b6631bd85c2d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/464e9e87-51b4-4498-8e76-184b54add140">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/aa047d90-0882-497a-8297-86c62cc11497"/>
    <rdfs:label>65.1 Percent </rdfs:label>
    <obo:OBI_0001937>65.1</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/98ee829e-4095-427f-b6ba-73a86cfe95b3">
    <obo:OBI_0001937>800</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/84ff9c43-3d9c-4606-b5a7-17a564aa1787"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/58f6ca23-6164-435a-9b58-eb8b1a95f132">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/72d8428e-972b-4164-9ea4-9ee663d4316d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/deaf8d0d-9616-432b-b4b7-0c720530b247"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/4025d067-1ed1-4c72-b840-713c8cd94ab3">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/1e525708-641e-4dc2-8da5-7be555f17c62"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/87216a9e-309d-40b1-9af5-d7ed7ae10e43">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/1d7dbae1-761a-4f1f-9e9a-feaa1c715221">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/68f8c743-62e0-4df3-a142-cd3976beab70"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/ba5504ab-c5cd-47ec-96d2-c1830d31974f"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/069f3ffa-28dc-409b-bd24-063116dfbd8d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/efd83a49-7487-4032-b23f-9101b9f8fc96">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/469df909-f8f0-49af-8965-b3bf4eba3e54"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/d5943b97-7a5b-48b2-a5c0-5b5afae7ed1f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/ca6db112-2f61-4098-b4e8-469b3377e3d9">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/4a3f7520-3afb-472c-8bd1-ff80c8cc1318"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/a4b45d76-4d3c-43ac-9d77-7bfd1b131259"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/080db6ee-b1aa-4ef0-a0c3-a776de69657b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/9212c94b-5e5d-4706-bcd3-664123552b29">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/bcc8063e-583a-4b27-ae14-2fd3dbbf5a63"/>
    <rdfs:label>ticagrelor-dabigatran drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/42f51c29-e32d-46eb-8753-777878e1d0bd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/16663ac5-2c3d-4b2d-8068-beda0b6d4920">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/bc1d8e71-5864-49f6-a962-4887f16dc0d6"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/96d838e6-a5cc-4a1f-8b88-7ecd96bd974a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/61176be5-6202-408f-a3bf-6c045dc0f9f9">
    <rdf:type rdf:resource="obo:RxNorm_42347"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/a8949445-76b8-4401-bf65-c31dcae71b07">
    <obo:OBI_0001937>250</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/edfd2129-f912-489a-8981-f58a56d3fd0f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/41cee1b4-80a0-4c4b-972f-6e01f8e11440">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/4fd9524e-284f-4d1e-86fe-6463058ade52"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/94db65e9-7e71-45ce-9950-f84d543bac80"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/b83fee2b-ac65-4e28-afb0-af6788ba7f69">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/c7f84d8c-3210-4e26-ac0a-b0d2eb423085">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/6d6077c1-430e-4413-ab39-7e7b6d8772f6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/58c3784f-bf51-4a7d-a208-b734773f1748">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/9abe7684-1e0c-4052-a6cb-599cdba47d42">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/190d739f-dcb9-4411-bba6-e29e81fd9a88">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/9bb262a5-8b4c-4aa3-a774-7102a38fac57">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/7ea5ff84-5ce8-4007-acf5-6c8bbf081703"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/4af096ad-c555-411c-b374-9909877087ec"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/e50743cc-5e63-4753-baba-03abf2da6523"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/4d47ff08-0bd0-46e1-8b40-4e7329b7a458">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/e115504f-2df5-445f-92ca-25a0d4e9bf9d">
    <rdfs:label>Gemfibrozil-atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/56695ad2-274d-479d-a076-2fc185dda448">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/506fa6de-353b-42b0-9dec-658110639e4d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/37a369a6-db98-48c9-8eda-ade97c15d6fc">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/68fc1554-27bb-4ee3-a9d4-e858a24709b3"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/d4fcef1f-e611-4fb6-a1b8-0e945f6f428c"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/f635b324-33c3-4480-9e3f-ef14a05413f5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/16821c2b-d31f-4f90-a670-e4db86642426">
    <rdf:type rdf:resource="obo:RxNorm_81864"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/890d6a50-7be1-42ec-af00-59a916ba8695">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d8c4e675-efbf-4f88-ab0c-cabe0589a7f4">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/cfa85a92-7d01-498f-974c-edb0c1a90da6"/>
    <rdfs:label>21 Percent </rdfs:label>
    <obo:OBI_0001937>21</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/a4539ab1-9367-4a1b-a4a6-46bcb1c285b5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/f9ee1cba-7490-41bc-9f67-98c254998c3f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/a1ec5061-c7be-4e05-be75-05aa56c0e654">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/6cd03f47-6106-46d2-ade4-96d4de6075f4"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/9fe6a987-27c5-4df4-8752-3d14e76f1dc1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/54749b2d-8a8b-48be-ac19-a3435ccde343">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/c2fc47bc-3db1-455d-ac99-d14fb7ff9078">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/2f79021f-0222-4066-ad22-590ce4cce624">
    <rdfs:label>lopinavir/ritonavir-hydroxybupropion DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/0d4a382e-8cb5-4e9f-b217-9fa13b205074">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/bfbb3ccf-76ce-45eb-9fc9-7c0450e5be8d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/2311bc9c-b805-4761-8927-60141a65cc77"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/b9f94214-1fc5-44d4-9b69-f51e408cab27"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/38d02878-ea92-4768-9bd5-dc644940acd9">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/6567c74f-094b-45b3-86d1-4d9c500e55db"/>
    <rdfs:label>mCPP-desipramine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/28c9647a-a75f-49e9-9801-a8f7cfb7b8e0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/081cf9c9-fbaa-4284-90db-68597630b562">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/de228c64-2732-4654-a2f8-a56adbf24548">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/0585933f-669e-41bd-a0c5-2088975c6ce3">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/31fbfcdd-7972-4d89-9966-4fdca026ec87"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/e81fd1f8-c6ce-43d9-8f7e-fc22e2dbf214">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/89c54d53-25f3-4e4b-b9f0-fbd6e5b4140a">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/9a0c64ad-ccf8-4b90-b26d-ffd0c279347c"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/9f8b1556-3cd1-4e8f-87ee-dfed8d0b7d44"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/882f2e52-1cbc-483e-b66f-7da9b8a61227">
    <obo:OBI_0001937>90</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/90c4240c-d825-4d72-8d83-a7668612e5dd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/6c2f12ee-b7c3-453c-a16c-592091d68966">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/9800532a-be4b-4e00-83c2-50139875fbef">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/b26732a1-7d13-4013-bad2-da84143048cc"/>
    <rdfs:label>divalproex sodium-INVEGA drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/466ffca7-5b37-4da8-b824-2a1b9eb425e6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/017e929d-6e3e-4db7-a148-c1f6d942cd94">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/5fc56cfa-df91-428a-8993-5f9809fdeb21">
    <obo:OBI_0001937>80</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/c26d7b91-5deb-4fe0-b664-cab953c4903a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/d9bbd2d8-2146-405a-b2c0-e0b9db5af319">
    <rdfs:label>ambrisentan-warfarin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/d897baf9-a07f-4600-91f8-2c28a27c85dd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/ff0e5b04-6b55-47e7-9f16-3928f3e24238">
    <obo:OBI_0001937>6</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/46767742-8013-41a6-ab74-8b9304bd6a29"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/482a63f6-f38e-42c0-b0b8-ff4fdce605cb">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/40f52669-6887-4d4e-8954-2c1c270d5ac9"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/f76bc1d8-37c1-46ae-b1f7-1524ec158bae"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/93beaec7-60f6-425c-847e-b965b136aca4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/1c3bfc0e-0847-4b41-9301-ece72ce83105">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/6e543694-79ac-4659-8216-715e6bff2432"/>
    <rdfs:label>3 Fold </rdfs:label>
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/ecd7b1d2-5a3d-46fd-8dba-dc0f2fcb839b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/67289b2d-23ef-44eb-989e-2d1553c9cc1d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/ba0531e0-0516-4252-9cd4-0a506a96daaf"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/b3f0677b-af76-41f6-a0d6-670015153e3e">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/a61de54d-d548-4274-bd11-6f370cd02832"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/ea7e7e3f-cbe4-4790-8dbb-395c642ba341"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/a4aafa01-a7f6-4a5a-834c-8188f41c86b2">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/55e2850a-09e2-49a7-a378-a2a07b676b06"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/f49f62d0-95bf-409b-9772-76b7229fb8fb"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/0176e2fc-d112-4116-8b65-102551b8c751"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/87b7c311-f99f-4f6d-ae12-3d9b545f1b3c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/a154d897-b623-451d-8824-ddfe0a6926dd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/25c92b9c-6bcc-4c5c-a65f-e20ac5dbc553">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/76f42c8a-afdc-457e-8366-0d2438848d03">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/4aeb2a7c-9d32-481c-8461-e31b2295df44">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/a868c204-b602-467b-b619-dbeebe6d3ac5"/>
    <rdfs:label>98.6 UNK </rdfs:label>
    <obo:OBI_0001937>98.6</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/bbe97c43-abca-4f9c-a7a0-b43131727656">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/56c15ce6-9b04-40d5-8dfc-a1794b2853ad"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/b59e84c6-645e-4cf1-b43d-744bb5822d29"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/45c947d9-0095-4343-a021-7cb1c37337fb">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/e8903c9f-c00a-4fb3-822b-3fb1a5938a03"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/850bc41e-a77c-4d85-9abc-08cfef5311a9"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/ce733c48-aaba-4603-a0cb-c86f196b04cf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/4dc0f815-4744-4c52-acd7-d65c12af765b">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/b13a04ce-e818-40b8-b43d-2f5e99871f10"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/123c0a6e-c17d-4075-a9f7-3e1f18969299">
    <obo:OBI_0001937>400/100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/3827715f-52fc-4e45-a2bf-7d921c42596a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/d5be3051-e047-4ca6-813e-2dd083881bce">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/1208a483-56b4-427e-b56d-d4b3e14f262e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/7efb4dbd-b013-4769-9b46-a6ccea5387a8"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/f036136c-3f75-4ed9-9154-050743a5dd0c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/3a53a65e-0a71-438b-a066-590cf3304cdb"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/775a0f75-1f0d-4d91-9bff-7759063b082c"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/5a998069-5731-4cff-b435-0a2bc56b4ed0">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/a190a000-5c11-4acd-80cd-4a29584fdcb7"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/de729eba-ae1c-4a6e-91fa-961c4eb9558e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/499da48d-b36d-422f-9844-82ff27d99bd6"/>
    <rdfs:label>paroxetine-P95 interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/7af0ccdc-1054-4c26-aaf5-043f0258daf4">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/02b01aaa-305a-4887-a8f5-f58365578cdf"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/4610a90b-2b8f-4425-ba55-4b48d82b5751"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/0ceab1d2-e1d3-4ba5-abbb-f3149b2ad065"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/8463441d-5ca3-4100-85e9-0ababf77cbcb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/9f81cb1b-9829-4613-9266-b5b26094630f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/2545229d-d76d-48e4-8404-99588e691d9b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/24e48836-2b88-437f-9fe4-0d31bb0ec699">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/d189977b-b0fc-4d44-abf3-35450f52d402"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/c560e842-45a6-459c-bd9c-ab7d25c28bb1"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/c0e8847e-e2c1-4c94-afeb-fce29c3bf5e0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/b49f0bf9-e73c-465e-9c59-98d4bb8fdef5">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/6830a237-dd88-4da8-a7a1-7b3092d528f2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/e89e2092-7489-40e4-964e-c59412e7f371">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/33bc5526-aedf-4bd9-a963-b2892e42e152"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/33268528-8050-406a-8dfc-c8556db232a1"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/393cc7e3-44ce-4de5-8e85-3a9b367eb92b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/fd3fe293-ad04-46e2-8931-19c2e7786b1f">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/5bdefe20-28a2-4fb1-9e46-9624388d4079"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/93c91bda-858e-4313-a8a5-ce7e5866e093"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/d0ae8eb9-cc0a-4f9b-a88d-209ca34dbf93"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/2eb1c247-137b-4f7a-ae30-da648c49ff0c">
    <rdf:type rdf:resource="obo:RxNorm_15996"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/ca98e8f4-841e-40e2-80cd-ceb5535b3d81">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/450e7606-bb84-47d9-ae1c-75dc89bd8df9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/3f9ecca2-3692-4540-8489-df0eb66040b3">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/93b97569-86ad-4225-b733-f1e1387b2390"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/a0b3d085-5dbf-48ed-9fe6-231cc956b918">
    <rdf:type rdf:resource="obo:RxNorm_10635"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/5d49d9d1-94d7-4ef8-be67-554882caab26">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/9aabd109-2266-4aea-a825-fb383c3d076e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/05105507-3b67-4518-a06c-c942ceaee838">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/4b101cf9-7efe-456a-ab4e-3143507b300d"/>
    <rdfs:label>ketoconazole-mirtazapine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/ff570212-a07b-4888-9ac8-13f0f46d5a13"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/3520f80f-6031-4e88-adfa-b9bfdc9ca415">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/daa53e55-5122-43ce-a11e-5ec7d0949584"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/0b282eab-d966-4bfb-99d3-a47b3abbd27f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/e5b979ad-ec81-4681-ac08-a4076c29bc34">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/282b5f68-74cf-4953-9d40-7c5b4e6f36f3"/>
    <rdfs:label>2 Fold </rdfs:label>
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/2732f81b-f551-4425-b6bc-73b69b002100">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/b31d30cf-e251-43b7-a75e-c44c15d5e043"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/ec1ac74d-07b4-4f5c-bdef-fdb8c5065aea"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/55495589-b729-4986-bd8e-337db5a7194d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/f4906d33-1b15-4dd4-a8a2-5edfa128d5f0"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/a2eeda0a-de38-4c56-b8d3-c5488cda95d6"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/e934d825-a06a-4a34-bb6e-081278a1e3c2">
    <rdf:type rdf:resource="obo:RxNorm_31565"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/b6c8dbbb-1a59-4eea-a3b2-c5f3c6d20868">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/d61a9e29-8468-40f5-a234-e9c9f9f84381"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/b77e7aba-bfa2-4d6e-8aa5-7f3aad2248ae"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/882db40f-c7c9-4395-8583-2f74c6cf1160">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/53d610ac-9d1a-4fbb-8034-efcd7c74f898"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/d72140fc-abe9-4f6e-b4df-f9668fb1da81"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/e3a209b5-5356-4b0b-94fc-a02f14f050f1">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/506fa6de-353b-42b0-9dec-658110639e4d"/>
    <rdfs:label>2 Fold </rdfs:label>
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/488eea45-377b-41ab-8b8b-ba17a329f085">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/fb1974ac-a15d-4621-80d8-c32b18533a8b"/>
    <rdfs:label>ritonavir-hydroxybupropion drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/b2aba457-ef34-4432-abe8-658c23e3af7c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/127dd3e1-c17d-46a3-a560-1ea42557bff2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/6f7e4855-78b7-4e68-8f5c-4bba344fd053">
    <rdfs:label>sertraline-diazepam DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/12f52971-f22a-4d63-bd82-74688290dff3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/8e512325-cb52-4164-a90e-082aadf002bb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/acde9e91-a7e2-4898-a5f7-161b75888c09">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/cd17e2cf-a636-4eb5-9368-f89377cfb243"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/436938b3-04d0-41cc-b31c-964a6a1db87e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/c37980cd-f191-4da3-90e9-1e6f7d402b6d">
    <obo:OBI_0001937>Unk</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/f9a4e952-8d3f-49e9-8b1c-ea0d096655d6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/c6c7f2f2-a29e-419d-89d3-c45b91119213">
    <rdfs:label>nefazodone-haloperidol DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/53997ea5-2c49-4e28-b3c8-dd67eb8d3104">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/41db61d1-d8b4-46b0-abe2-ef5d911ceae7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/71fcb9f3-8559-4eb8-bd81-e5fbba204c6e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/1ef3ca94-922d-404d-be5e-82be8d69df4b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/d652bb4c-feed-4923-8285-666af12cfb01">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/a19a462e-7bcd-4fd2-ae3c-f0ecf488d69e"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/2ee7e184-265e-47da-ba06-72237884def7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/96568288-6e88-455a-8aa6-4fb5a100f418">
    <rdf:type rdf:resource="obo:RxNorm_4493"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/20239d74-9a9c-4b5a-bfab-5096fb159037">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/98e42349-c67b-49ed-981a-d2d5a3a71e25"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/6c06765d-5425-4227-b77c-ee4b8a574503">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/b75b4f63-a8dd-43bf-93f3-48755eaa124d">
    <rdf:type rdf:resource="obo:RxNorm_42347"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/7cc86f3b-ac27-44b1-8c27-5842e7edcde3">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/11b92c69-6361-4e3c-97c4-06a39f0026d2">
    <rdf:type rdf:resource="obo:RxNorm_1546356"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/1f4e29f0-d09e-4059-a644-323545877472">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/632a688c-748c-4941-92a0-ee6ad9e3cb12">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/61e39b89-5749-4313-8eab-646a275b509f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/5f816856-220e-4beb-ae2f-38893c663138">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/7e59f4e9-e1a9-46fb-8b8e-f4f6093bd59c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/58957e1e-e288-4e47-80b8-7db7d74566d0"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/79491dfe-48cc-4436-9d6d-9a4a47e0d1a5"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/fe9dbeb7-8273-420d-98f5-2c66ba9de10e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/f4858acd-7770-456f-a8e7-2d0d829ab7db"/>
    <rdfs:label>Diltiazem-Atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/8c09547b-d974-4e0a-950f-c2c9840846e3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/08beee4d-0650-43c3-89c7-a4a05fddebf8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/ba0da8da-d1ca-4ed7-b344-2b860c3cf08a">
    <rdfs:label>nefazodone-alprazolam DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/5028529a-0603-428a-ad6a-4553561a95b6">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/f62920b4-9d53-4cf6-8af4-0be0b2286ba8"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/3df7cdb6-7a5c-4cf8-ac8b-2be23374b811">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/f150aec2-5763-484d-aa34-c23b353ed2d7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/c79f3d16-73be-42d3-89b5-2df2a829b1de">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/2566a661-f546-4e4b-863e-b72195665b22"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/e9888929-84fa-4259-bf67-2f369dce23a5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/2dc8b5c5-060c-4b11-a20b-1edb8307e65d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/0e201bf8-6150-4641-8f9f-c4d1ff5f418d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/bb91182c-f82b-4216-b9f8-96d029a75c7c"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/5a7a4ac4-0499-467d-ba29-98783fb3d753"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/cf4c3134-d423-441b-a9b9-edbdb69fa149"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/aa728252-ba41-4d76-8dc8-7d2dbaa6b224"/>
    <rdfs:label>citalopram-ketoconazole interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/63e1d459-e9c2-40a7-9a00-579960f74151">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/46650607-a701-4fff-8a81-5fa6cea0ab4f">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/96929a95-b61d-48bc-8f1b-c38d1c8050e4"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/424206b1-6ed8-400e-8f5f-3ae638925f22"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/0fbfd928-ad94-478b-bd6b-8df9226f9902"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/641578df-a70b-47b8-b704-de230e7c36a1">
    <rdf:type rdf:resource="obo:RxNorm_32937"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/0b8e4f72-aed1-4659-9568-439d2c57950d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/f68b9d78-6589-4523-b314-7d43b01e550e">
    <rdf:type rdf:resource="obo:RxNorm_42347"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/d99d4abc-b3aa-407c-b55b-ffca4b24e5c9">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/ff8f021e-ab18-46a1-b28e-d8c153dd083f"/>
    <rdfs:label>fluoxetine-estazolam drug package auc UNK information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/f78f61ba-0309-4f86-a1e4-b3a0b709233a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/96c4ff2a-c83a-43ab-936b-ffa3b066a034">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/19f05f1b-1881-4a75-8dba-4675c872b53a">
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/9d21feaf-0681-4928-9b58-694ecd822b1d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/4aafec4a-2a27-4855-a8e8-636353b9cb1b">
    <rdf:type rdf:resource="obo:RxNorm_134527"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/1f863d91-bf08-4205-99ae-5bf1a0dd9699">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/7fd66b2e-1b75-493b-8da1-994be36cd8e2"/>
    <rdfs:label>ticagrelor-simvastatin drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/f2f64751-a670-4d08-8a74-2fc032a6e547"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/809c1fe1-7b4f-4ecc-8b67-afeff628460b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/82426f79-0e19-481e-8628-f30c1560bb2b">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/5582eafd-9293-40d6-9d2c-c0bce0d9335c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/43bc6e3d-cb43-40de-92ca-d1ea8670b915">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/f30e3ec1-c172-4a11-ab35-d473c56b6471"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/52bbbca0-97a7-4c7b-a371-c0d811e71f24"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/4ba49e51-edb6-485c-9cda-25be25307816"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/72669bde-8996-4be6-97ac-93266630fdbb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/3933a456-de5f-46bb-8cf8-88a2e3db98f9">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/42772df2-c4b8-4b01-9e63-1c2e07b3c726"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/ea85b13d-6f03-4c41-b2a6-1d5e4243d2a9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/4b709d41-84ca-4242-b48a-be4be103ae98">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/4d43ee61-4e96-404c-84f5-10a05afd855c"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/4172ec86-5a71-40aa-9084-83871ec429d0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/7fc82fbb-6ad6-45a8-b3f5-b7d6cee08141">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/4fe0d47f-0d93-4859-8830-93c2e8dc20bc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/73719073-ce35-445f-a82f-6637b305d0bf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/386166c7-8094-44dd-a9d7-ac3c41bc508d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/1d66eccb-71e9-438e-abcf-3201aaa0b629">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/a5bd7c37-c9d9-498e-a13f-ea2e9c8ea006"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/08e6214b-4c97-4242-a5d5-a47d14707582"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/e1ae0d89-203f-4660-8f3a-1fcc33f85cf1">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/d61498a6-c8f9-4400-bcaa-adb7548b35f1"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/ebaffbb0-b44d-4287-b284-4d70863c9a50"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/c1872ae8-5e77-4e17-aac9-d61461f2e9a7">
    <rdf:type rdf:resource="obo:RxNorm_81864"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/c7ecb19b-3dba-4852-a54f-e346a1eeef9b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/0d1d0c0a-0404-41a0-8d0c-541e3210a498">
    <rdf:type rdf:resource="obo:RxNorm_1114195"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/b6e658cb-6167-4c10-b38d-551d70ac3168">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/1286638c-8cdc-4230-91da-203c54c40e27"/>
    <rdfs:label>50 Percent </rdfs:label>
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/d2131273-0e57-45d9-9cb0-7469ff493d0d">
    <rdf:type rdf:resource="obo:RxNorm_3247"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/a520e82e-bcb9-48a4-ad2a-e73642ff25bf">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/39995613-1717-4bc1-bbc0-58f99da7f847"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/f03d1fe1-9bd1-408d-8ace-f8a1e6b6bc95"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/6996d490-fb94-4477-b703-1528f241f31e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/2d64273b-3956-4760-ad06-8b2ebc3b3733">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/fdd79c6b-0924-41b4-b6c0-b327f782e41e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/990b9143-ca90-4a9e-894d-4cee1b20cb05">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/8a59e8df-ab68-41b6-9a76-7ebcce30b30a"/>
    <rdfs:label>desvenlafaxine-midazolam drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/2d780e1e-9435-4586-9155-a462f9bd0d66"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/6f96c216-e7ca-4b75-9427-e463efcb15c1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/914c4423-95de-4503-9f24-e26204710956">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/34b695eb-e97a-4488-8a5d-33117fcbd3c2"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/8b54f6c4-3f3c-40e3-a9e4-2ffe6c428bb4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/204dee60-f8ca-4974-ac5a-2a7b6fce5dde">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/4bc3a64d-d44a-4a1d-872b-66df899f79ec">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/676d343f-384e-4682-a6bc-02e71159b01a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/bfe81354-cf8c-4076-bce6-ffa956952ee7">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/a751c791-97d3-4923-8eff-5c2020beb794"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/18f8aba8-3cbb-44b7-a8c3-88a8afa9bc6f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/1f39eceb-2fa6-469a-bd39-9bef12100fd3">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/88bf54ca-01d0-46e2-89a9-91b7b0cbec0c"/>
    <rdfs:label>bupropion-desipramine drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/db6e765e-8fbe-4ca4-948d-53f402c215e1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/1242864d-5fd8-4108-a289-9b29e10163e6">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/a8bcd855-c65a-4423-aa00-00d2c120bc19"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/8538b0f0-1759-4907-8bf0-5acade6609b2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/f9456007-fd8c-4eca-8e6d-7c5bcfed9093">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/ddea4679-d17f-4d4d-adf4-f9f2fbb75259">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/1036ae58-cfd1-4fad-b91f-0538b1257995">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/c5b10008-2210-417f-8d80-bf40ad20bc6d"/>
    <rdfs:label>Nelfinavir-Atorvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/5a681b1a-9009-449b-b717-b1994d52ded2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/c51cf992-b9c2-4566-b82e-978f5ebd32c9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/b7a3cfac-c349-4758-a108-a8866664b75c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/f7597418-0859-4848-8818-a767f4adf788">
    <rdf:type rdf:resource="obo:RxNorm_1102261"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/8e525b54-833d-46e9-bc23-82798ff5f740">
    <rdf:type rdf:resource="obo:RxNorm_42355"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/d1d3b409-f1b3-4f92-b685-909d4b70c015">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/b5ba9564-d1ad-47c2-b387-80a61f0934c5">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/ff55bd03-f218-4970-bfe1-1d14c3575317"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/bac55995-6067-4d83-ad6b-7b491b9e6a7d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/e6792e02-6ec8-4c4a-9326-773814f18163">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/824fa15b-37a1-4407-a8d4-78900cf85696">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/ff8f464b-d1db-49ae-af0e-b5ff3a8b22ee"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/cb5fa557-73d3-4c79-a9fd-239b34c04914"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/fcfec356-682f-4589-a984-946b1365a568">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/faba0fea-0ce8-4603-9cdb-134790f89c6e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/1863c50d-2770-4656-9d23-2a58ec36abd0"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/60ab044b-3ebf-45ef-8fea-764bde00b9a4">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/5d3eeda4-eb47-4ee8-9cdc-311443509b6c"/>
    <rdfs:label>6 Fold </rdfs:label>
    <obo:OBI_0001937>6</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/477b09c2-3f3d-40e3-8f3d-ca7b28279d0e">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/192a7c1e-580f-4b26-915f-dd9b8330e237"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/3f52e93e-3755-444e-9131-feace19343ff">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/c8228bbf-50d2-4792-8145-cf5a9156c783"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/bf2080f1-f33c-43ac-a335-9613185d1256">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/917d3cc2-adf0-4a02-9429-ede9d90841e3">
    <rdfs:label>theophylline-nefazodone DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/bb458de8-21d1-4709-bc97-55fcd5bf8894">
    <rdf:type rdf:resource="obo:RxNorm_9525"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/d552e71f-4844-4153-b796-a3cd0a4c6345">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/27c5f5f0-70c0-4b6a-beae-f2d553b5fbf1"/>
    <rdfs:label>fluvoxamine-duloxetine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/e9ca2a3c-2d99-4285-aa57-08dd4433d043"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/5ee2cac4-7ab3-42cc-89b4-4c414a3290f9">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/a8d8a858-6a6d-4bfd-b770-ffbc7f662191"/>
    <rdfs:label>nefazodone-triazolam drug package halflife Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/2a689777-31b6-403d-a83a-bb0fae06c8cb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/c960bc5a-563b-4513-a8c7-b59abf686dfc">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/76f42c8a-afdc-457e-8366-0d2438848d03"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/00d55913-3e01-4111-9945-6daad7a53fa7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/b77cef71-cdb1-47a7-8104-e573bd902ba2">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/34726716-d7d5-484f-ab87-9c70c385ca13"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/0997424e-9600-49c9-a529-cd1b4a541851"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/d9af69c1-91e4-4712-a880-94528ed1ec9f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/36dd98eb-92c6-42b1-a792-fc44f2803ea2">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/8fc4618e-f45e-4180-8a3c-9d9f30868f02"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/06983e95-f1d7-43e5-89cb-453c88ba2386"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/e7869174-c596-4c4b-bccb-daafb88e5b28">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/a2acead3-27c0-4e0e-9f45-967c38ebe80b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/e2971bb0-ae0f-4c29-a7a7-ca2fac8f1363">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/f1aeb7ca-f994-4ba2-b8ec-0109ef379510"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/550647d6-c147-4ab3-8ace-ad5bd96ebbf9"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/a55921ab-2181-45e3-bbf7-03e82ec233bf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/30feb6d7-9cdc-4182-971d-e7f1353e99b4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/837d1196-a840-4bcc-8eff-6d91882f9882">
    <rdf:type rdf:resource="obo:RxNorm_42347"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/617fac7b-d888-4280-8d62-6ff9c7a85bee">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/4348978f-8015-4d10-8776-c9f40592731a">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/17c3a02c-2a9d-4786-a7ce-1cea9d3e7609"/>
    <rdfs:label>ritonavir-rivaroxaban drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/4a5297e5-960f-4315-b4b0-8d002c457085"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/fcdfc4e6-3131-4ca5-a7c5-58587da97652">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/7c555b48-ae7a-4745-bba6-3cc822e32bf7"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/eb706807-491f-4659-b647-c0cc20bdb07c"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/b2277bd0-e2bb-46bd-9ffd-d0cb1cab4e2b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/6fd28098-2530-45dd-b208-22ef809b2ea7">
    <rdfs:label>rosuvastatin-warfarin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/b708f5f0-323e-4fa8-9703-33807d450a9a">
    <rdfs:label>ketoconazole-dabigatran DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/79693930-58b4-4aa6-af23-dd83c7a484f3">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/575cdf45-6333-4f16-887a-746845427654"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/d3803493-32ab-408b-9bd8-6ac47752cb70"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/bef96ea3-bd18-4243-9959-336568b1403f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/85ba64df-ab00-42bb-b777-94d092e12c36">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/69402641-e418-43c2-a7b1-b039937ab870"/>
    <rdfs:label>42.8 Percent </rdfs:label>
    <obo:OBI_0001937>42.8</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/5798f821-cb7f-4665-b67d-8346ab2cb101">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/f2c30be2-dbab-416e-8811-e2bfea0d5f02"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/31ba1037-831b-46e1-9eaf-8cc10c75be6f"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/23cba13d-aa24-45d6-b8f6-91331540ef76"/>
    <rdfs:label>Fluvoxamine-thioridazine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/6725154e-d1ea-4d79-905f-eff9336b2365">
    <rdf:type rdf:resource="obo:RxNorm_36567"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/1471f962-696c-4fd8-bbca-fee8feabb2f6">
    <rdfs:label>Ticagrelor-atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/91336f33-6931-4c43-a388-560d7f74b721">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/451df329-c6c5-4c04-be53-da90bbbc91c1"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/a99dea58-3b5d-4ed2-8eb7-ab3f8f97c44b"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/bc6a9d7a-d1b7-40ce-98ce-f8c15cf3ded1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/75e654c4-ac4a-49c8-b92f-2794692ac713">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/963264f6-118b-4575-bded-493f7dc60108">
    <rdfs:label>carbamazepine-L-amphetamine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/4a6beb0a-a4e3-49a3-ac10-0713aa3b9ff2">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/30e1cdd8-e4a5-4507-b1c0-4359beb4ee61"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/1ead40d3-fdb7-4a28-8d28-eebe8656de67"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/2007378c-8b3d-47bf-a288-a6bc1c712757">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/3ee0ea9f-7a93-4c6d-8e52-b2fffb9273d2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/8e7bbc75-628d-46ed-93e3-e0b52288f260"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/16821c2b-d31f-4f90-a670-e4db86642426"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/f55544ee-210d-4698-899a-79b866f69039">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/1a7c564a-75d0-47a3-8461-f8ed3212915b"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/7c5646cf-164a-4848-8c2f-b893a8b3038a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/0c9e0b0d-29de-481b-bee6-3bf542837922">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/12ac85d6-b3fd-4aa0-ad58-5cc0fc073ee8"/>
    <rdfs:label>fluvoxamine maleate-alprazolam drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/e6c2a36e-89b6-440d-82dd-1388b7c36c94"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/677fdae4-1eca-48e3-8f6f-8307d534dba8">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/82433ba6-2e85-475c-bc7b-486f7e178689"/>
    <rdfs:label>ketoconazole-rivaroxaban drug package halflife  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/bee79898-ebb3-439c-8282-3985609e405d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/9f2690ee-3966-4ce2-89e0-26f92923be9a">
    <rdf:type rdf:resource="obo:RxNorm_9639"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d766c4f7-5f2e-4414-84e2-e8ab48b5a0ed">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/063e30d5-b81f-4cde-8aef-90f767437e51"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/511a2571-85b4-4540-b894-7f838017c580">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/bb26b5bf-ab90-4757-9e59-921b9150dc4f">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/5eb4337a-3c60-460b-b01e-d0d00df9ab24"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/cd4353b1-1ba4-48e4-a4e6-c0a7ede57c53"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/3245171f-1209-4552-b0de-540569250607"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/12ac85d6-b3fd-4aa0-ad58-5cc0fc073ee8">
    <rdfs:label>fluvoxamine maleate-alprazolam DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/f88f06da-5aad-4179-8ffc-5e7536b9bfa7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/4a255375-62be-4afd-b0ba-03a27914937a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/99ee5243-a016-40df-b7ba-907c15c382ae"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/0cf1a816-7fbd-49ef-bce3-0ab2c6994bb7"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/f6447974-109c-4d0f-b346-9c5f65bbb134">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/9af069c9-27bf-4018-86c0-d36dc9212b70">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/c3c6cf5f-cb30-409e-99a8-ac870af540ae">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/103979b1-58f4-4817-8118-29eaf64a5cac"/>
    <rdfs:label>efavirenz-bupropion drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/8e79f7e3-3c12-4b5c-ac32-107ca1251fd7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/ca420835-89a9-4cdd-8a88-6d62dbc09621">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/081b0047-9743-4b4e-9fb9-9a7a165ef0f4">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/417ef117-bea5-47f7-9491-0649ae76a388"/>
    <rdfs:label>ritonavir-threohydrobupropion drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/72610fbb-dc1d-42d4-8ce2-cfd82b0517df"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/af83fec6-0294-4cc0-a84d-808943626925">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/6619d24a-5543-4f4b-a352-d4c5e942fbd4">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/eafbf0eb-e815-453c-864c-69c23cf1f582"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/2c49b9ea-c68d-4290-ba66-a2440ae47a5a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/cebc2819-3df5-41de-91d7-bc6379151a18">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/1d63cec9-d46a-417d-9d56-3aaae49b552e"/>
    <rdfs:label>Celexa-metoprolol drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/5b6f6d75-7166-4aa6-8acd-36edd075d266"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/47d6de10-0363-482a-9264-1fb098ffc6ff">
    <rdf:type rdf:resource="obo:RxNorm_6135"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/0a063172-ae83-418e-8cce-d41fb12bb47b">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/d6c57296-1965-4313-9436-8a618b7249f1"/>
    <rdfs:label>3059 Percent </rdfs:label>
    <obo:OBI_0001937>3059</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/9682cd16-6a36-4018-82dd-c0330e98d893">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/26b2a1c7-71ae-4166-bda8-518b684f6f4e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/fc25d94f-c102-4ec9-9a97-1234333b531c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/1a7ae759-c67f-4b1d-907f-f04aa3eb1501">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/512191b6-62c4-4fb9-b67c-be3ccd63de83"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/f4a83757-51fc-439e-99e6-b22a6235dcf2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/88f03733-38f2-4ada-be2d-2001e6aa469c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/adb8bfa1-4a51-4564-9950-4f76cca70804">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/40eda329-bbb9-4224-850e-7d0fe235013a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/d595a596-cda4-4644-aebd-c7efb3cbefd6"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/dabdf84a-391b-4784-9a0a-dd67cbf5fe8c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/9d0715a1-d4b0-4e98-a772-2e6b75dc7200">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/d24ac86b-1f94-4fa3-b9a3-c37f304e6d5e">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/928ccefa-94b8-4933-9abe-b4372c501aa0"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/474837a9-0942-4bea-8d5e-fa2ace2b4e7a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/a326c4df-d80e-4e7e-95e7-9a84a7223380">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/18a7b3d6-f1cd-4f7b-a911-74470e988007">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/fe653393-6292-40be-a65d-1dbd1e143ca9"/>
    <rdfs:label>36 Percent </rdfs:label>
    <obo:OBI_0001937>36</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/1db7a024-c446-4935-a888-bc77b01c3a1a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/71e0ba36-fc7d-4358-bf12-238cb26d28e3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/7786db3b-71c9-4ca8-a399-d13e2c148f41">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/f77470cc-f5fe-4c7a-85f3-29b9f3c1197c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/c53675ba-189c-4331-a16b-842b6fd780b6">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/2c97e529-1329-40cf-9041-53bfde026d00"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/017511fc-37ca-4446-a42d-749ee048c36b"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/649af4bc-8a84-4712-8010-51ff4151bcce">
    <rdf:type rdf:resource="obo:RxNorm_2002"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/5ca683a0-893c-489d-bae1-83a14bfbfed7">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/6e282309-9224-4d59-9b90-f1ff8a8f85fa"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/166bc93c-e80c-481f-8d33-0316f605eaeb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/05261182-2bd1-46eb-ad25-2ce3aa60a826">
    <rdfs:label>citalopram-ketoconazole DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/20ad6d5d-7344-4270-a170-b9a6e95038dc">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/50cfaa12-f1f0-4fee-a985-dbb57ee78f41"/>
    <rdfs:label>carbamazepine-INVEGA drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/9e1e4f71-437a-4764-9044-24d353da9754"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/49f0ba04-9fbd-477c-84e5-65ff132d26ec">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/67c412dd-5bf3-4ad1-a433-8564110f2963"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/cd64e586-ceee-4023-bb85-c84fca7d8e07"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/bce0592e-f130-4aa4-b46a-310abd552130"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/bfe444e0-c474-42d0-b21f-906bd060b7e5"/>
    <rdfs:label>ketoconazole-P88 interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/e990e29b-eb9a-43cd-8d34-8bb97a63321a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/859eefd4-495a-44f8-af5f-2a7668865fbf"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/5b31006f-cfbb-48fe-b921-e381637db04b"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/f72ff939-887f-4eeb-b1c9-5f75df9fc16a">
    <rdf:type rdf:resource="obo:RxNorm_31565"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/40e82b2c-a7d8-462d-86c6-3a91dfff047c">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/20f31585-c6f5-4c05-9316-12f0a41dce78"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/e79d58e1-b5fa-4e63-92b0-4da1359f5350">
    <rdf:type rdf:resource="obo:RxNorm_32937"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/db6e765e-8fbe-4ca4-948d-53f402c215e1">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/7db12fd6-7c0b-4ce5-82b7-2ceb45290a25"/>
    <rdfs:label>2 Fold </rdfs:label>
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/180e05a9-d649-422d-bb16-30d0bd403b89">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/d161518d-c5f6-434c-b25e-38c4947e1d87">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/6bc12412-ea51-4fe1-ac50-16e227d6e9ce"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/37ca87dc-f980-4253-9495-5d15c1afde9b"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/b4db4dc1-53d6-475c-a020-c1f127592272">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/24aff558-ce43-4896-a549-daaa4bd07099"/>
    <rdfs:label>50 Percent </rdfs:label>
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/f28c8849-3754-45a7-888f-e951cc2b877d">
    <rdf:type rdf:resource="obo:RxNorm_61381"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/1c9decb4-1181-42c6-b6a0-ed4b2582499c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/cb6e931b-a6a3-402b-8508-c2b59240a51f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/582ae973-cdba-43fb-a0e4-9f0ad6975d58"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/7942c237-30a7-4c1f-a7a4-f9e2eacfc9b7"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/45e3af83-5d0a-4aba-a948-e5c05abfce04"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/f1148e59-8b6b-431b-8860-236c81d57c80"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/b102910f-e7ec-437c-b726-2f5a39a9e2fb"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/39506e3e-afff-4c14-9615-2f2fe80a101e"/>
    <rdfs:label>telaprevir-atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/69402641-e418-43c2-a7b1-b039937ab870">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/d1288121-43dd-45e3-83f4-7fa2955197d6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/dab381ce-8278-4e62-b1a5-16a85f23eecc">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/656fbb2b-ff70-4dcb-8e1d-021f2ca8947b"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/97c04695-abb5-48d6-bd49-b3659700993d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/210bee54-3174-43d2-89f4-14bfcf855f98">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/4a874f01-65ba-44a9-8217-90aae5a1ccc9"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/e481bdef-a256-42f2-b045-92903111c818"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/7219953e-e321-4249-b83d-90bc87543a63"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/4602a5e3-9d77-48dc-8850-3ec541cd6c6e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/25a0d840-e062-4963-8828-ed6be40e308a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/d8b6a02d-5b0e-4991-8830-52d8118374bb"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/476f9ce2-1126-48e0-8951-9b6a497e8694">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/da424c76-bef7-4b40-809c-f1b7fc893282"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/081b51ba-46d5-4c56-b7ef-9f419f2826e2"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/a54c0a71-85ea-41d4-b161-9722d37523a0">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/ab6a2ec8-16ac-415b-a9bd-9e8b5312db11"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/7b40367c-f468-4a55-9531-d7e02baf1460"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/d210e26e-2b32-4c79-a1a3-49bf621ca9d7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/4c9544cb-4250-4a39-9e33-874009ff86b5">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/44159068-1cbf-43c8-a2e5-4a4ca4bec988"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/b61aa132-a910-491d-8dba-2c3999109bce"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/72a5f568-a931-49e3-8b67-e8f1a1ec2d46">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/06983e95-f1d7-43e5-89cb-453c88ba2386">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/20149fe3-56dd-4658-9381-ec62ddf26f67">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/16c40c3c-837c-438e-aab0-a9b8374b51c6"/>
    <rdfs:label>3 Fold </rdfs:label>
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/7b7e324a-b880-42e0-9891-0bea3b35b248">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/71164f19-e5ed-4c50-a626-c77be5acafaf"/>
    <rdfs:label>67 Percent </rdfs:label>
    <obo:OBI_0001937>67</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/8e086d7d-38b3-4a34-aa67-5a784097ab3e">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/b30f2cef-b1d4-42f8-a0fd-234b1b57efa7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/a24e396e-a6f2-49ee-ac81-f01caf236dc3">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/498934ef-f426-4388-ae69-7f3f9bb0bae5"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/9a988496-a458-4429-82e5-7c03af839171"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/2d97efc6-b2c5-4307-bec4-69a0c3ad354d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/fca1bc35-2373-4c00-a771-133a1164be0b">
    <obo:OBI_0001937>4</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/289b1b11-6004-46c4-b635-d0de8cdce0a5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/aa7b6a2f-e1f1-4d8a-9a2f-3ef151a4fa44">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/90e80a68-ebd6-43a7-b435-d2c766aaf100"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/a5d8cfb8-305a-46e6-a1df-73ac80b932b9"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/50223abc-5bee-42e8-ac57-d9fb927988ae">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/2299d19f-473e-4ca6-a7c0-d35fdcb12c55">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/747f05dc-9d54-47bd-b422-2be5e0a7342c">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/82570a4f-45b5-4f41-b456-4caa04d4479b"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/d51598b1-192f-4787-9e24-30ecc3afa510"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/3dbfa64c-833d-4bdc-85a4-1b17a2932311">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/7c93ab1c-7cf8-4638-a410-4194870589e7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/d0e130a9-aeef-41f7-827a-54201bc11b5a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/972ac059-27e3-4550-9494-9ac354989ea0">
    <rdfs:label>duloxetine-desipramine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/c8affee0-8fb6-4e88-a6a3-8eede8345983">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/afa426a6-d6a9-4c4d-8832-b006050458d2"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/d9fe130c-b21e-407c-aac6-13e8cf22a399"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/673852e7-eace-4074-8f9a-7a25c2e3f6c1"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/4cab9fe3-6e57-45da-a16f-75657211f065"/>
    <rdfs:label>ketoconazole-dabigatran interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/83fb437f-b12e-4f00-b95c-a4611baa7535">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/b2154be1-843c-45fc-af12-8fd14b6c99e5">
    <obo:OBI_0001937>25</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/e3eb9a93-0be0-44a4-aaa9-e4af0dedfdff"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/550647d6-c147-4ab3-8ace-ad5bd96ebbf9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/638f4910-f821-4bfc-b3aa-39e9d9c0c0ed">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/def01050-53e9-4942-893a-7000f94d6646"/>
    <rdfs:label>60 Percent </rdfs:label>
    <obo:OBI_0001937>60</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/5173bf71-9c51-47af-833a-d707168374f1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/4757df67-4c15-4bb6-9109-3f2d7a7624e8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/a2c11060-e1e4-4653-8584-7b290c595883">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/a8d8a858-6a6d-4bfd-b770-ffbc7f662191"/>
    <rdfs:label>nefazodone-triazolam drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/c2c1f694-2fb4-458a-9460-34c8623524a1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/6d381aca-f82c-437c-b497-b41ab56dc813">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/2b37a95b-f72e-4db0-89bc-3e35255b0a11"/>
    <rdfs:label>10.7 Fold </rdfs:label>
    <obo:OBI_0001937>10.7</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/0ba8f51d-c4ed-4562-972a-c5967aea046a">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/2299d19f-473e-4ca6-a7c0-d35fdcb12c55"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/fb3a8e4d-6d03-4e06-ba89-50a6c9f17a55">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e8a376d3-7c8a-40df-ad7c-b3fcad0259b3">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/93c30e8d-76ef-4d80-a18b-2d13b4638334"/>
    <rdfs:label>ritonavir-erythrohydrobupropion drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/60004ffb-12ca-4924-800d-f8803f3bd77c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/2117b077-40a1-4c4a-abb2-72fe4af7578e">
    <rdf:type rdf:resource="obo:RxNorm_4053"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/13e98390-323c-459b-9511-3b1f5e2bec9e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/7d917cf5-40d9-44f1-a2f0-a771787708db">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/0ceab1d2-e1d3-4ba5-abbb-f3149b2ad065">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/d5332f52-dee0-4c82-ab47-970bcf106748"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/699dc9cd-1667-4f15-9813-6e24aef64385"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/b5c589db-d8fe-41d5-8e28-a173fa944fab">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/8b1567d7-b075-4ef5-9b5d-0eb644b857f1"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/e181e6ab-8027-4ff9-adec-959e088efa8e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/54a16bb3-7a4d-4b9f-9ebe-fce4a374b535"/>
    <rdfs:label>ABILIFY-norfluoxetine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/cdb51c3b-f07d-49c1-86b8-5c500cb56c60">
    <obo:OBI_0001937>4-8</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/d4b9b9d6-6472-40f4-a221-30bbe1c6d5d4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/57121487-4a7b-4e9b-9477-3ea7c93a2a67">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/961f2876-0033-475e-be18-ef6c1073abc2"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/6746ec19-65f6-45e9-a13e-c6433864b6b8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/811ce48a-6062-4923-b233-e96ace6cc267">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/cbd2b7a4-432d-449b-b728-44b404c010bb">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/6217b60d-ed2c-4a44-882b-34aeadad24d5"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/f036136c-3f75-4ed9-9154-050743a5dd0c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/462184a6-1d23-408d-9aea-e097bd8f701c"/>
    <rdfs:label>carbamazepine-nefazodone interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/faba0fea-0ce8-4603-9cdb-134790f89c6e">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/a339d72a-8be6-4c31-8be3-ab6147b3b298"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/f70144fc-5747-46c1-bd3f-8ce19ee89bea"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/94600aa1-a6d3-458f-b707-0fa18d45f444"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/326a8dc4-9b52-4b02-bf0f-661d46456f1d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/03a32a52-d49e-4ebc-9bd6-a77ddbe62d9f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/6e9fa35d-4674-449c-b06e-b4a06c7aacc7"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/c7f84d8c-3210-4e26-ac0a-b0d2eb423085"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/56701547-ac8e-451b-887f-c6b0d5426577">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/f9e9552c-dba2-422f-ab68-78f5aa85c7ba"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/6cb4d5d4-65df-47fc-b83e-e12a3ddaebf6"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/5a29d70e-49a9-4659-99c9-5043cd317932"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/300c92a6-29e6-40dd-933a-cb13f79d03ac">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/d1694e74-ee8b-4fd5-956c-7ee262c815c4">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/d8c8ce49-5d9e-4d6e-b635-eb4a11ab9b35"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/ef48e527-8a81-467c-bc7e-893e72bc306d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/6adbd84b-6d86-4cf9-a731-c6ab0ae05d87"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/c24668f2-a5e9-45eb-a498-ffb5c92c3983">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/feb7232d-ea9d-4146-9bc5-4c3529aaba73"/>
    <rdfs:label>50 Percent </rdfs:label>
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/570a75e8-141d-4500-84f1-ade1e0577960">
    <rdf:type rdf:resource="obo:RxNorm_61381"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d429a6f1-8276-4549-bfc5-f7e0eeeb30d8">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/5abe56ba-e7e4-47a0-95a1-80847600c096"/>
    <rdfs:label>81.4 Percent </rdfs:label>
    <obo:OBI_0001937>81.4</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/1b1457ac-1009-4b16-820a-1b9aedb3dd2d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/d3b5dfa7-49bd-4193-a92b-d9cce04f86cb"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/8c07520e-9625-45e6-a902-df38a1983238"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/b59e84c6-645e-4cf1-b43d-744bb5822d29">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/8ac530f9-f76c-4c2a-8747-600e99f2e22c">
    <obo:OBI_0001937>60</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/96f36d6e-b1b1-483f-b36d-7832a03bd918"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/58521e8d-d0dd-448b-b53b-4bc9b8b13174">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/11100d07-f6e8-4cc3-bc5e-7be0024706ad">
    <rdfs:label>clopidogrel-dabigatran DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/c300eaf3-9d0f-40fa-ab98-238a79415c69">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/759f148c-96bd-4af8-816f-6bb675a50000">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/a5c6df1c-7ef4-48fa-9e37-22ba3a28318c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/f7bec3ae-627b-46df-85c5-fdfe3ff781ec"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/2d68a3eb-4ba9-4832-b12c-b8eae863967e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/fc9a4f37-6aa9-4336-858f-731982eab70a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/f2f3c9d2-3a86-456f-9655-38957d12ede2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/424206b1-6ed8-400e-8f5f-3ae638925f22">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/0aa3011c-3fa1-48aa-8322-6f898642a99d">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/e6bcb9db-c67c-4495-bfd5-f13d5bc13932"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/9c7518ca-112e-4d53-a468-be97d434e01d">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/88467e9d-800a-4589-9dd6-946f382b3d53"/>
    <rdfs:label>10 Percent </rdfs:label>
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/48c2e6a3-7a30-4567-a369-0e4ee2bea81e">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/ac8c5b9c-9a16-451d-bf8b-891d30b5d0ca"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/200e1563-0715-49f2-9577-f70882f10fb5"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/96568288-6e88-455a-8aa6-4fb5a100f418"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/7886ee2c-39ff-4894-8115-213fcc17e516">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/46729a21-1c2f-4834-b0f3-5302d033eaaa">
    <obo:OBI_0001937>7.5</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/17214b82-e28e-4e7f-b096-2ea34c400acc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/b0d97414-65b2-4abf-ac08-1da028c66039">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/386166c7-8094-44dd-a9d7-ac3c41bc508d"/>
    <rdfs:label>unmeasurable UNK </rdfs:label>
    <obo:OBI_0001937>unmeasurable</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/a4b4c96d-7570-4fc6-ae43-d73835a3c5f8">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/4d1b3631-8c21-474c-8b42-f2ea6fb2b0df"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/b4abb220-e53a-4499-a3bd-0f3ebecb8101"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/fa876e01-170b-4976-a6a5-133b84a742b9">
    <obo:OBI_0001937>80</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/15335d5e-963e-4a90-a0a6-5e77e354f10e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/4c199232-3747-40e1-b48e-ecdba924b975">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/2eccee82-42f9-4f7b-9f74-712cdab87d24"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/4c5694f9-1eb3-44a5-ba80-5807d3cec188"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/3741d3e5-8765-41f9-8973-07839007de3d">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/8e8da59b-3864-4198-9385-dfa98314131c"/>
    <rdfs:label>ABILIFY-fluoxetine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/beadba51-5d12-490e-b8a4-d9745a18e385"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/95191168-c1aa-436b-b0a4-0e62667cdc12">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/8345eeea-6206-446b-bce5-e57d84a30065">
    <obo:OBI_0001937>25</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/9a52e84d-a5b0-427b-aa09-22c8a4122403"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/be8580e5-f7ae-4066-bda2-b8f2828acf3b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/3581157a-f82e-4a64-a40d-030f82a2e713">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/94d70ee4-82b5-4bfd-828a-7a339adecf1b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/73450238-0e7f-4ad5-9c39-6686d5083b66">
    <rdf:type rdf:resource="obo:RxNorm_85762"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/d1b1dd1e-cb2e-4bc1-adf7-6420069533fa">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/51076e81-8813-49ee-bac3-dfcb6cb3d8c8"/>
    <rdfs:label>naproxen-Edoxaban drug package auc UNK information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/4aeb2a7c-9d32-481c-8461-e31b2295df44"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/1900f851-7cd1-4fb5-8d15-85bbaa0f5618">
    <rdf:type rdf:resource="obo:RxNorm_32937"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/0a16b88b-02b6-4fa1-b721-28bd41378d17">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/c074039b-1b7b-4cad-90d9-d177fc0d9500"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/df56a825-20fd-4114-b998-97f914bc04d8"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/3e2e5543-7b0e-403c-9894-22d7cb9f8dad"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/3ceb54fa-2d9c-4170-8927-a2e6e1b783b4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/19dcc526-0b31-4692-8d48-c39a3c3a7143">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/973027f2-891d-4775-8abf-0d6ef2bf8ad4"/>
    <rdfs:label>2 Fold </rdfs:label>
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/2d50a42c-bf9d-4739-9afc-abedf35c5a6d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/5b424ecb-756a-4ac4-bb26-c69a7e8374bc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/5774fa1b-f5b1-4340-889d-a99b3708c6fe">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/4330643f-5513-40aa-8424-51f67ca33ad7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/95fc1218-52f6-409b-8ff0-2b303d49e8c1">
    <rdf:type rdf:resource="obo:RxNorm_1191"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/8650e9fe-d517-42a7-a12e-975322816f4b">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/e8b72d05-3cf2-4ea7-b3f4-ec27d12312e1"/>
    <rdfs:label>mesoridazine-Fluvoxamine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/26d03100-1d46-453c-86df-c2110eebfa6c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/b646bef2-73cd-41fd-a6ab-1a77af3f3e9b">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/b7d03af7-ba69-4d5b-8cce-c2dd22ece0f5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/20329a78-5464-4e9d-808e-7b8425cdc4b6"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/bfe81354-cf8c-4076-bce6-ffa956952ee7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/f2c1a857-d11f-4ca6-bfe2-103053d84a38">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/d5d5e1ca-a3fb-43b6-b854-69d1ade35e39">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/38d02878-ea92-4768-9bd5-dc644940acd9"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/923daaae-6534-4d12-8b84-d647d51a2bf1"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/92c536f3-cb9f-436e-9280-c42318524f5c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/352ae1ec-5406-40a6-a972-9ec9be32ddb7"/>
    <rdfs:label>mCPP-desipramine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/cd1416bc-1ef5-433d-8f01-61764f2c6e9c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/ac938868-75d4-48cd-8a82-3ec5045b96fd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/c8ed0c39-b7a5-477a-a9dc-1c21bd88718a">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/5ba36b39-d47a-4dbd-b697-f92dc05a2c05"/>
    <rdfs:label>25 Percent </rdfs:label>
    <obo:OBI_0001937>25</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/b0b53472-ffe2-4956-a670-d2cc1518e527">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/86b5a345-da6b-423e-bf25-2cc6be5219f8"/>
    <rdfs:label>rifampicin-rivaroxaban drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/4d056ea3-9e42-4243-afee-6ed8f5a32f11"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/f90c655c-3a0e-4c47-97a5-511c705d5eda">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/94600aa1-a6d3-458f-b707-0fa18d45f444">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/909aaee6-e282-4608-b5ad-4ade2fcf97c5"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/c0ee00d0-5b23-4287-bb02-b6541b0c9313"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/9235142e-db87-45c4-9b12-67b7d7f9424d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/fb15ea75-54bb-41aa-a833-b8f08ad962de">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/7cc86f3b-ac27-44b1-8c27-5842e7edcde3"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/785b11d8-418d-4960-9a31-5f1526d8ba03"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/1cda617b-80d5-4dcf-af2e-8f8ac347d2b4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/80a68cba-449f-4b3d-a3d3-b7cfeda81a0c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/20dccf97-75fa-4a35-90fa-2797f530a88e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/e306c212-4a72-4536-9fea-a7c02392e579"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/74d388e2-f0ab-45ed-b7f2-0d49bf67eeb3">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/1794b3c5-3e14-4f85-8663-bfc07db5a3d8"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/f1b0006b-4d21-42cc-b814-0b3ea2950833"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/e6d7857e-af3e-4cdb-8735-0fe2ce717905"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/8494b975-90a5-4545-8c6b-b1581d9803c7">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/bb0397f7-2e7b-4f73-8076-29e8272cb4cd"/>
    <rdfs:label>10 Percent </rdfs:label>
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/bad6ba6e-2139-4fe1-b42d-4c62cbf8e95e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/fc8f44f2-47ac-4390-90d8-b7067d5af45c">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/26234cc5-f402-45db-988b-17b3864fb882"/>
    <rdfs:label>fenofibrate-atorvastatin drug package halflife Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/4d6f7730-d74f-45e6-a531-6647ffcd825d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/b6520182-addd-4880-ab44-8f04bf7eb9a6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/2f7d1c1d-50c4-4a3e-8a22-707acc0b34a9">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/9cf09d8a-b63e-481d-b385-a0cdc1f3a444"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/1f8c920c-5332-4b74-9eb5-696cdec88dc3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/9b4ca571-e4a3-4e7a-8754-a16428599f2d">
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/76bf1d24-d57d-45e0-b66d-2203ef273ebf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/1445524f-1163-4c0c-b881-3704cdc7fd67">
    <rdf:type rdf:resource="obo:MeSH_C015068"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/be96a4ae-8e69-4945-a18f-ea9625b6e1f6">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/fb8c93da-b086-47c7-b9c9-9773cfb84e12"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/8af1da73-0487-4986-8a9d-ed7c815386ce">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/cb5fa557-73d3-4c79-a9fd-239b34c04914">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/b981e4a2-858e-4ea8-834a-75df8794e888">
    <rdf:type rdf:resource="obo:RxNorm_10594"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/a12e0f2a-48ad-437b-ade6-a031260de01a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/466edf4d-0823-417f-9229-5198e0562090">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/770e7489-a04e-4e2e-9e37-88034197111a">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/4b101cf9-7efe-456a-ab4e-3143507b300d"/>
    <rdfs:label>ketoconazole-mirtazapine drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/fea2121b-3522-4b10-8eaf-941db4cabf10"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/7a8815de-4b99-43e2-8371-ddca97ed888b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/a6d939b3-7c3e-4bf5-b731-338ae0c28092">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/97c02f11-a9bc-4984-b545-2bdefac3edf3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/5a415c0d-4926-4c4d-a276-80529937e678">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/7bfa13b9-c346-4748-97d3-5d61b1c2a179">
    <obo:OBI_0001937>250</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/cd0df484-aa57-4a5f-8073-c88b67420d9d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/74bcf0ea-fccb-4681-8d1f-d3f51af96f30">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/29662d41-20cf-4819-8c26-5583c1f3bc6e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/0919832a-bc32-46eb-afb7-c0509e4c41ab"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/7202cdce-4183-45c9-b562-d4b2c12604dc"/>
    <rdfs:label>Fluvoxamine-sulforidazine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/8e39656d-01cf-425b-988e-8a2481f35de8">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/0c154f28-ebef-48fb-ae9f-4e9b0dd60a7b"/>
    <rdfs:label>16 Percent </rdfs:label>
    <obo:OBI_0001937>16</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/3a7bc317-2443-442d-b980-b0de421c0471">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/f278aa4e-81c9-4d93-9199-bb52a0ff147e"/>
    <rdfs:label>aspirin-rivaroxaban drug package auc  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/5fe9098a-345f-4811-a692-19f7c32c25fe"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/cf3eabac-1fab-4d07-b5f3-21e9033bea69">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/974183e6-6a80-42ac-a9bf-b06a0dc24031">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/e3a2e0da-4360-4933-a2ed-c239b8c7659b"/>
    <rdfs:label>Fluvoxamine-alosetron drug package halflife Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/8c31895e-7fe6-45bb-bddf-6e9aeb4237dd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/8bb88c58-50c8-4995-bc2c-41b0778d6fc6">
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/90409af5-88a0-47ae-85eb-2dec313f1176"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/3be5c7ef-2c3d-4b7d-b76b-c548bb89e58f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/a48d83d3-b6a1-48ef-8d46-3078982ed13f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/71376e69-d445-41b6-8fbf-47289739ea1c">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/95954686-f4cf-47ee-bc70-9d2c3fc1d29c"/>
    <rdfs:label>5 Fold </rdfs:label>
    <obo:OBI_0001937>5</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/a74be8fb-a372-48a7-84b5-0448607009aa">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/4fd00911-5727-4e5f-bcf7-eddf1cd8ddc7"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/bb88e224-4fa6-4f0f-890e-2bbafaae13d7"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/aa728252-ba41-4d76-8dc8-7d2dbaa6b224">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/4bdcc8ab-8ede-4514-8277-2d3c31aacf79"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/0ae81712-8785-4a7c-be81-e8354163b284"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/ebaffbb0-b44d-4287-b284-4d70863c9a50">
    <obo:OBI_0001937>400</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/1cd5a4cf-e133-49ab-af1e-713a9dcc6b24"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/7e2ca55c-508d-46f0-845c-a2ee6da782a4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/79a21351-9400-4250-a996-c521396f8360">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/58fe946e-8569-4b82-aa1a-1f464102f3c1">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/533ac14a-9668-4db6-adf3-b5163878e6fd"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/24e58185-9a94-44fd-a9bf-4e0615df1227"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/aebcb020-17f0-451b-a269-d11ba6b3f272">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/82433ba6-2e85-475c-bc7b-486f7e178689"/>
    <rdfs:label>ketoconazole-rivaroxaban drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/4ccbc8d7-7ea5-48f0-8f93-bd725e268235"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/c154c56e-66ec-40c6-997b-114a0446f715">
    <rdf:type rdf:resource="obo:RxNorm_32937"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/7c7d61f6-3965-465d-af57-fe33af67fb48">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/f2f64751-a670-4d08-8a74-2fc032a6e547">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/fb3a8e4d-6d03-4e06-ba89-50a6c9f17a55"/>
    <rdfs:label>81 Percent </rdfs:label>
    <obo:OBI_0001937>81</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/c1e76235-6878-4a73-ace3-3d95acaec566">
    <rdf:type rdf:resource="obo:RxNorm_75207"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/45c223e6-29b5-4d23-9431-718561ef41db">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/275d2534-e3fc-468c-bc0d-30a2123f3518">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/2285042b-89e4-4373-bda2-628fbb85a4cc"/>
    <rdfs:label>erythromycin-rivaroxaban drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/99f0682f-6302-4a79-adab-244a837045a4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/8f90e14b-5ffc-4911-bf4d-1c491197ccee">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/573b87c9-3b49-40aa-b767-7d5b5a4a6e1b"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/e0027834-8336-4cc2-af03-93d1ce4eca7e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/b7c7ab66-1419-4024-b9ad-62c09493ef6a">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/50cfaa12-f1f0-4fee-a985-dbb57ee78f41"/>
    <rdfs:label>carbamazepine-INVEGA drug package clearance Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/186805e4-ac2f-48ab-ba95-58d8718634a3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/1208a483-56b4-427e-b56d-d4b3e14f262e">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/439fdd56-e651-4676-a778-bcb4c88be18b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/046353b9-b220-4251-9784-c2b7fbad6439"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/9dc48a7b-8ec7-4ffc-bbbb-92c6e32a0cde"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/722c6fef-526c-4d6b-9817-43697c7f651f">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/989afbdc-1e03-4b76-899d-b0ce3076363b"/>
    <rdfs:label>22.5 Percent </rdfs:label>
    <obo:OBI_0001937>22.5</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/d78307ad-886c-47de-a394-d88fe61ab0d5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/004208e3-78cf-4fc0-9a2d-8048c5a80009">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/e1b96dc2-b11e-4614-9edb-65b56e758c65"/>
    <rdfs:label>rifampin-dabigatran drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/76714e7c-bd04-4052-a625-b46a389d2dd5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/2b2cc0d7-a437-47b7-a068-8b9088be38dc">
    <obo:OBI_0001937>375</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/60b2e4af-b97b-4327-b836-52e31b1f4493"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/0fc0fa7f-e2b0-463a-875f-8bfcd6eba15e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/7b3a01cf-b133-43c3-8c81-6f8ce715eb40">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/06c93136-804c-455d-b317-9b9848ffd6fa">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/73328c6d-53fa-4791-a7d3-5da3e469ec83">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/88d6bf3c-7f6d-47d6-922e-e5927bc8fed9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/54ecf68d-d6c3-420b-9f1f-628ae14ba332">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/362b08a3-2e9e-4f75-8ac2-693917859877"/>
    <rdfs:label>atorvastatin-norverapamil drug package auc  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/1bf56cc4-6d0b-40f1-830f-ef420bb67180"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/e31962f9-3df3-448e-b248-9169244872d9">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/040f5192-a3e7-405e-9802-b23c4235b80e"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/23573fc9-62c7-4e47-95b7-6679ccb11bdc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/130246bd-fe7d-451d-bf2d-f93297c8e8d5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/2d2a8b97-8c33-4f7a-9024-4bb3bce6877b">
    <rdf:type rdf:resource="obo:RxNorm_8703"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/d4bb8d45-a9f4-4a33-add5-53516e560fd6">
    <obo:OBI_0001937>4</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/f219ce0e-1c8e-445a-b500-4038affa70ba"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/ede9c238-dc39-489e-8865-11a1583a2ec6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/7666be26-986b-4cb0-b3e2-0f02470fc887">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/b4e83a7d-1240-4cab-9a73-3e6273754af1"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/afd6deb7-88b8-4cce-b85a-65daa401619f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/5b6a1880-2326-48da-9fcd-7c250b1b0140">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/5688d59c-5803-4ed9-85d8-1bd7740513fb">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/34b20987-ea0c-47d2-a79e-7c2e085e8c9e"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/73da4ae2-6148-4007-94b4-24637b3a09a9">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/298ae06f-c3ad-41fc-a951-7b4ac5314a38"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/0ba8f51d-c4ed-4562-972a-c5967aea046a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/1c0eecf7-1c24-463a-a0ac-b5c38f67428b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/6b3ad920-2434-43c1-a6d4-c0c2dea7dd5a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/f119537b-0b92-4bbb-aa79-6216c780943c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/6ec3cf40-ba50-4047-b883-934aeb759ce0">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/c20456eb-5a1b-4fc4-ab10-616e65c84b02">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/57773bb5-20c9-4468-a41f-3d30520f4af4"/>
    <rdfs:label>4 Fold </rdfs:label>
    <obo:OBI_0001937>4</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/2d780e1e-9435-4586-9155-a462f9bd0d66">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/bc4462f0-97d3-415d-a27f-9a3f627b1aaa"/>
    <rdfs:label>31 Percent </rdfs:label>
    <obo:OBI_0001937>31</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/862db85c-a27a-45d8-9f9e-5f84ad7699d5">
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/3eea0896-2df8-451b-af35-4eba416c7a2e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/c5b27cfb-65e7-488f-9522-2c4eed5a77d1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/89306b85-c4f9-4627-9834-1c3ac4a64675">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/22fa8d1b-3540-43c9-81d6-50f4e88518de">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/f3a05efc-705c-4782-8d00-f51adee8abd9"/>
    <rdfs:label>35 Percent </rdfs:label>
    <obo:OBI_0001937>35</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/d63f022e-b7b9-4029-b02c-c388d459ad7e">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/66517f6c-e558-458a-88b8-fe7fc846f94d"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/7cccd4ff-381e-4f9c-ab6b-c9f05e8d8354"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/e8a4d093-ed17-47db-a80e-15d36520a275">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/de729eba-ae1c-4a6e-91fa-961c4eb9558e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/724345ec-b3f5-405d-a77d-cb7d35ae370d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/140813c0-f7c3-4c15-b466-53ae7dcc8927"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/633a7e2e-41e5-4a44-9709-0e6553d43795">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/b7aa27b4-66c5-45c4-998d-c54c87008d22"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/98352329-58e7-4000-919f-6d5514214a2a"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/fcde0f36-327d-40ab-a776-2970478e0932"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/65d1c036-def9-41ab-881a-4a7b7260efb3"/>
    <rdfs:label>desvenlafaxine succinate-desipramine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/270f2145-4213-42c3-aef3-75d9d40320b3">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/9dc8e7cc-10a4-47bf-aef8-4aaac0f39dd8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/854253cd-dbc4-428d-bd8f-e1e3575476d3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/772320d7-b759-424f-837c-29ca2671fadd">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/a5fe7cf0-355f-4226-a4e0-6b68e1050924"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/6a960aa0-baef-48c7-bbc9-fd33b07e8014">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/f1f1358e-cbf9-49a9-8411-b69a8d842510">
    <obo:OBI_0001937>3</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/f753fca9-79af-43f3-bcb7-734390916cec"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/432fc7a6-3093-460f-8cfa-564ea8b62eec">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/7ee66d0c-5c37-4201-bcc7-f753d30eb109"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/c856b01a-b2f9-454d-a366-7fce95da152a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/b00b0b55-4293-42d8-91d2-03fd1b5ba177">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/1bc8acac-ea83-4706-a0e7-756a768f9731">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/e2b8a536-898e-4615-868f-4fbeca0f96b7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/d2114b2a-957d-4baf-8ef1-76a2032c4c24">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/c019c96b-2af0-406f-a715-06206ddf3d15">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/f06cea21-94c4-4762-a153-25a7b5ec3511">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/721c7351-962f-4166-ac15-5a1699a7011b">
    <obo:OBI_0001937>16</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/85cf648b-adbe-48c9-b42c-d377ae5c68ca"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/cebead08-4750-4ad6-a0b5-f86b8eb5df36">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/a46a1b02-efbb-4638-9e59-7f2dc3c325f8">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/873844a6-e980-45ac-a94e-5f82e9b6b4ac"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/99ef20cc-4d1b-4b08-9c39-15ab0f508f29"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/d888607f-89de-4864-ad64-b96b5d0fd67b">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/24191573-e612-4164-b768-9d79230e4fbe"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/ca294ba3-d163-49e3-9de4-692313d76778"/>
    <rdfs:label>alitretinoin-ketoconazole interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/1facdbdf-706d-47f8-ac7e-d9e4c08998f3">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/58626754-ee03-4b67-8325-9d58e7cbe497"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/8d34b6c5-ead7-4250-8d6e-ba5a775f771f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/7feafb0a-82b5-417d-88c0-4acf2f18a13b">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/092654a1-4374-4dac-a50a-85621ffa94a8"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/3494bb9f-ee9f-4997-87c7-ba308ce103c8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/e580a8cd-76d7-4420-b486-e7fb51519e5d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/9a9b1240-c091-4c2c-9d42-565624502f59">
    <rdfs:label>fluoxetine-P88 DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/a3992698-0cb9-4342-aab4-c30f85cfcd07">
    <obo:OBI_0001937>75</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/0da7d2be-e89b-471d-85de-a8563fb69c61"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/7e9400ac-db65-419e-b3bf-3426c4e3143c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/39c98f6a-b8d4-4c74-b970-5a47b1194438">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/5d2dc596-c282-45a8-825d-f327b7c3fe28"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/482fe0d5-8918-4850-90e2-c0d93edf8478"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/d290eb13-972e-4abc-ac5b-c2a84b7ef7bb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/96469649-57f0-46dc-b735-86393ab337b8">
    <obo:OBI_0001937>400/100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/de46afa3-df8d-4683-9239-076a563c1b6c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/35f4870b-df9c-4a35-89cd-64e84f262e22">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/823c276d-fa6a-4241-ace6-0159e0e5ed00">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/c8111cd0-fcb4-40b6-82d6-524ed141b533">
    <rdf:type rdf:resource="obo:RxNorm_11289"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/1cd0e9d3-6c86-4f7b-aa07-9d356c0f18a5">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/3710fe50-dc59-4215-addd-ae32cee5f93b"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/2d307a50-c47c-4013-a2b0-3f7b64383509"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/c8f0614d-628a-45a9-a708-b80b73e1eb29">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/e6792e02-6ec8-4c4a-9326-773814f18163"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/6969667d-a55c-43fc-adfb-d8a8f6af2452">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/add480ad-feb3-4d10-844b-785f4d7e2a3e"/>
    <rdfs:label>fluconazole-rivaroxaban drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/59473203-2614-4a7b-a5ef-32e8034abade"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/149c1152-4060-4e4a-a249-d2911921d5d0">
    <obo:OBI_0001937>30</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/cd5a634f-525e-459b-9361-aa5061079c52"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/a52bc730-5c7f-4d6c-9e7d-7fd4afc9b27b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/737db6c6-fb45-4810-b0ef-67249554d4cc">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/4d9ed476-d0f0-43b5-a557-51423309a890"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/f4a83757-51fc-439e-99e6-b22a6235dcf2">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/920ef1fb-77ea-423a-88d4-13680b7ee542"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/c1e34f2c-02af-4352-98a5-cf2cdece702b">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/a58aee93-e4db-499e-9f8e-ea8912a72617"/>
    <rdfs:label>ritonavir-threohydrobupropion drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/1399622e-faa0-4fb8-a220-b42bbe6254ce"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/c7fdac2d-5b7c-46fb-8f60-f06e10a2853d">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/b71d8f60-c43a-4505-88b1-2c8ca18e29e0"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/5bb18349-74ad-4eae-8941-7c61680f8006"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/847d0593-eb6b-4f13-ad27-e0e7319c9dea"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/0997424e-9600-49c9-a529-cd1b4a541851">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/bf5c406d-a1a3-4b77-bbca-c18ee3c46c7a">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/c43a25ca-ff1a-40af-b20f-ba5006921167"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/c79e32a9-f60c-468d-995b-0c22eeef3a5c">
    <rdf:type rdf:resource="obo:RxNorm_73178"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/d0ae8eb9-cc0a-4f9b-a88d-209ca34dbf93">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/8baad700-1b1c-4234-8178-105554ee73d4"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/06cbe583-f05c-432e-a990-3a3cc98896b5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/fd2c394d-ad9d-40f7-bb71-6b515844d588">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/077c2826-5fab-4797-9249-4ff85a00faf7"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/3b695ee7-2167-4937-9dc3-7e9880f0d189"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/ecbc2d2d-cd27-4692-9719-01beb66c10f9">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/a5adad81-a2a9-4cd0-92b1-9cfa54ea209c"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/4e89237f-93dc-421e-8e7f-b1d2172870ea"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/11c0efb9-ee63-4fbd-bf28-494ffaaca0e5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/d4c85aca-b62c-4f7f-82ff-d908c2fb984a">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/ad508dc1-1d02-4cec-a75d-6e73637c895a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/e6c2a36e-89b6-440d-82dd-1388b7c36c94">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/5fe698a5-c07f-4e62-b217-0cec804fe81b"/>
    <rdfs:label>50 Percent </rdfs:label>
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/883e66a1-9725-4fa1-a67c-3f6989a4f3fd">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/ea3b6998-b013-4bf3-b13c-f660a97746ac"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/7d66ae14-c3ce-426d-be71-97953f1988fd"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/40f6792b-7a5f-4563-bbd5-7ad7bbafe8f2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/29662d41-20cf-4819-8c26-5583c1f3bc6e">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/d9128ca0-2513-419c-8c90-c12d57a99f37"/>
    <rdfs:label>Fluvoxamine-sulforidazine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/2a6b1cc5-48a4-44e4-bba0-f6ae4b342650"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/642411a9-3057-4923-8ed6-8d80102ee140">
    <rdf:type rdf:resource="obo:RxNorm_2541"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/330f45d4-372a-4082-928a-6dbd31355fc6">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/0081d8c4-c64e-4169-b466-fca11e993ae1"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/7886ee2c-39ff-4894-8115-213fcc17e516"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/e26de6e7-9387-41fc-bba0-5cdcd108df0d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/d58da7f6-a16f-4cf2-835a-3bba723dba42">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/d3b6afd0-432d-42a9-98ac-c32654852523">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/7317af06-0e8d-4422-91ca-3d8b06c4ff11">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/f62920b4-9d53-4cf6-8af4-0be0b2286ba8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/08f3b417-e877-43fa-83c6-83ee04d0ad55">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/890ba861-9d00-49e3-bbf0-daf36f0ab8e0"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/8438644b-2810-4b71-bd38-ed7e79294982"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/6394df3c-01fe-46a0-9f48-487b3ec292a5">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/0686b452-510e-44ed-9fb4-e88a1e9115ac"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/161fae7c-7b61-48f3-a086-da5919609a3d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/8f90e14b-5ffc-4911-bf4d-1c491197ccee"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/ec25384e-2ea8-4331-865a-faf0af23d5cd">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/f1e1e9b0-f0de-4e07-b695-c8d2604a5221"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/304b0f28-d8fd-46fa-a522-741b1f9d8fb0"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/8cd68f8a-c551-4364-ac20-babc66e33ea9">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/d344bbca-7feb-439a-b26a-65501f3c0cee"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/524a035a-0f37-4f4b-b2f4-73ffa9be6c4f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/eefad98e-7796-4c53-b67b-1a73bdb22738">
    <rdf:type rdf:resource="obo:RxNorm_6135"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/4ae7724a-2efe-4c3d-8646-96841ab72658">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/ddbb80f5-25b8-47d1-898b-607512facc51"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/9296e921-ee6c-4bf4-867c-105be402a5b0"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/3a60e3de-1bc4-430f-9a6a-ea0ec4ef192e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/2237d5e3-5f59-4cb1-843b-9ba79895a654"/>
    <rdfs:label>cimetidine-citalopram interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/187532af-d4a7-4ef6-8120-2496a9b38c28">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/100bb300-8560-486d-9d99-868c00b8447f"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/6a75fbfa-2fe0-4f1e-8dc7-85dcb87819a2"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/b7a6da50-54a9-4279-a597-d667791785a8"/>
    <rdfs:label>fluoxetine-iloperidone interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/59473203-2614-4a7b-a5ef-32e8034abade">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/2f73cf2e-05ff-4213-915b-ce69bc5a700e"/>
    <rdfs:label>29 Percent </rdfs:label>
    <obo:OBI_0001937>29</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/161878a3-355c-4b3f-a327-90370d3ad9ee">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/f76bc1d8-37c1-46ae-b1f7-1524ec158bae">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/2de54422-e8a6-4185-9959-ab33b1413f5a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/b3df0c1e-46c1-4350-8c13-10c04e4cb7de">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/60f5ef77-b857-4d96-8bd7-a3b37471097b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/10fa8ffb-5a53-47f4-aae2-113183a3a791">
    <rdfs:label>nefazodone-4-hydroxypropranolol DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/764f6a78-23fd-4233-9bda-37de4aed0e07">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/30e22f71-fb1e-40b1-a440-a6b24de45a60"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/d6242d5d-cf11-4949-a892-b5f85625ee42">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/8af4cac2-58b0-4765-a2e7-e8c2d86d53be">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/de5ada8a-7352-4306-aa68-473446f8ad64">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/018d414c-c2e6-4bbf-a02e-111adccc320c">
    <rdfs:label>paroxetine-pimozide DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/84ce9344-bd35-4c52-b22f-629af58678b3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/f97080f7-626c-4481-979d-4bd4e581d4b4">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/e9b06338-0cc3-48a2-91b7-4663b80a334b"/>
    <rdfs:label>28 Percent </rdfs:label>
    <obo:OBI_0001937>28</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/c38eb161-9ad8-41bb-9849-eb24bd03c1d2">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/f7c500b8-7f4d-41a8-9efc-0fa5ee96c07a"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/1aeac76c-bccd-4c0b-bdb0-b49e3decdebe"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/4a3f7520-3afb-472c-8bd1-ff80c8cc1318">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/43a7e376-6190-4294-bf96-4154390b1619"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/bc9be44f-57e4-454a-9dcc-602ea6fa2c37"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/870b0aba-00ab-4778-bde3-bef8c2f7254f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/06b96a01-5102-4d8e-9525-6798594fb53a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/de631e17-9ff4-4c41-b3e8-07d7519d04a1">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/614ba190-86a7-490d-b841-d2ec115481ae"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/74eda6f0-1e94-4ab5-a59d-269dc9c656e6"/>
    <rdfs:label>pravastatin-NFV interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/63781b43-45fc-4161-97cd-170c62650dc2">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/027b5f58-8de4-42c3-b325-a99a63209742"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/433cdcbc-b624-4085-b800-0d4851d0a37f"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/5ecdabe6-1956-43c1-807f-3f6375c7a948"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/1fb07ca6-36eb-45d6-9506-02a72243528b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/6754a2a1-7721-4ef3-99fe-8db73a7308b6">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/86220f3f-299d-45db-8ce3-ccf19c7f9536"/>
    <rdfs:label>32 Percent </rdfs:label>
    <obo:OBI_0001937>32</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/ac19582f-5eab-4e5a-8007-031175bba4ce">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/7a42afe2-886a-4b8c-a4ba-52bb388f62e2"/>
    <rdfs:label>Fenofibrate-Atorvastatin drug package auc  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/fb1b40f0-d778-480c-9c4a-d31c4cf26c45"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/be0680ae-c827-4ed5-98b5-dd1d310671cc">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/3ab742b1-1540-4dfc-beea-fb9b2a80d76b"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/ff8f021e-ab18-46a1-b28e-d8c153dd083f">
    <rdfs:label>fluoxetine-estazolam DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/7b69f5a7-7572-4dfd-87fd-acb90f0e8314">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/d448b315-32b4-40ae-886d-e83de69b9ef2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/b80330bb-79ed-4bda-8a3d-fbe6c6c7b867">
    <rdf:type rdf:resource="obo:MeSH_C580748"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/30cae3a2-bf2f-4bbe-af27-5f314bf1c837">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/df94628e-562a-4212-b9f1-6eb255031e82"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/f9456007-fd8c-4eca-8e6d-7c5bcfed9093"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/7c6919c6-83b1-448b-8744-548a484ac743">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/e1b0b2a0-9125-4a6c-b75e-ed094d2d8b4d">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/158c1250-7da3-47d0-9982-be4d968a79dd"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/588d39ed-4850-4434-92f7-fc51a6ebbb0d"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/5df41d2b-b81f-42a9-a5bf-5a2bb7efba72"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/b153c1de-ad0c-4442-a867-b58164f12ca3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/8a9ca2ba-7cfb-4741-8e61-4fefa62ffc28">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/5f44f009-c3ec-4b0a-bb69-09aed8c326b1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/9ebe342f-1aac-4c91-bf1b-1dcb41a1f418">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/8ecd9dab-db56-477d-b103-c7b0e4541c66"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/c7ecb19b-3dba-4852-a54f-e346a1eeef9b"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/1d63cec9-d46a-417d-9d56-3aaae49b552e">
    <rdfs:label>Celexa-metoprolol DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/fad5a90f-12c8-4e31-865f-823304c82281">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/6200d069-7b62-43fc-97b4-686fcd5b2b39"/>
    <rdfs:label>low-dose ASA-Edoxaban drug package auc UNK information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/1e86e93a-0e71-460c-8e4e-0cda6252029f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/dc331968-98ec-469f-a0d2-045422142157">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/d01f98d2-81d6-4944-93b1-bfa1342c262a">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/aad0be41-8592-476a-80bd-b58cbaa4b5ba"/>
    <rdfs:label>clarithromycin-rivaroxaban drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/1be70aee-16e2-441f-80e1-db10c517cda5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/2fe4907e-2b4f-41d1-a432-3541d9552909">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/25a6d787-c316-4e52-a9d8-a6715d14d27d"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/42f6b8bf-ffa6-4627-bfc2-7b1170653234"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/e9604b1e-3930-4183-8908-d473f6ce886e">
    <rdf:type rdf:resource="obo:RxNorm_325646"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/77d84957-c3ea-434d-afc5-74591e3a61e3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/9aabd109-2266-4aea-a825-fb383c3d076e">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/5774fa1b-f5b1-4340-889d-a99b3708c6fe"/>
    <rdfs:label>1.12 Fold </rdfs:label>
    <obo:OBI_0001937>1.12</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/8165b135-1240-4917-be06-248788da0b9b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/859eefd4-495a-44f8-af5f-2a7668865fbf">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/2eb1c247-137b-4f7a-ae30-da648c49ff0c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/61d34d41-a36d-49fd-a654-a262e6ddd7d5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/cd6d8968-b342-49a1-b0f5-81834d3d821a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/36f50023-7865-4ca2-9c4a-4c0f41a6f6c9">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/0f487bd0-15ea-49ba-8a76-941235a2b4a6"/>
    <rdfs:label>2 Fold </rdfs:label>
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/0fd472a6-2b25-4a4f-b2d1-c73faad3dd1c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/60b990a3-7509-47aa-b62c-88365eb4ac15">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/c2bf3e3c-7939-402f-8df1-2568fd6327a1">
    <rdf:type rdf:resource="obo:MeSH_C496216"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/f3a05efc-705c-4782-8d00-f51adee8abd9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/a9c4641e-ec93-4510-81d7-60f97085c3b3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/c233c4d3-b241-4377-9602-e48ae066d4ee">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/b17cec29-c53e-4161-b1b8-aca8cdc14d37"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/c5bd63de-c90d-426d-a1a1-ef09f1425ae3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/6352d45d-c037-4abf-86b9-9cd22740ef34">
    <rdf:type rdf:resource="obo:RxNorm_4053"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/9f6a0827-6d86-495b-b804-79c40b3c23c4">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/7366b6e2-e0f1-4855-ab55-d36d34fe94cd"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/8090e060-0e28-43c5-8f71-51d0a11962b2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/c91c3ec1-11fc-41e8-ada3-b93194c04338"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/837d21a7-15f3-4071-a74c-e61716abd7d9">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/d48bdef6-9308-4c65-abda-36e20779086c"/>
    <rdfs:label>lopinavir/ritonavir-Rosuvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/13838d4c-6cc6-4bf7-b673-69809c45fa6b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/f331b6a6-04dc-4396-bb73-64e454a700f0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/8f1beca4-31a5-45e5-b173-56aa3699d43e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/7c93ab1c-7cf8-4638-a410-4194870589e7">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/b7abd340-6898-4c65-89fc-4f0b8fae3a47"/>
    <rdfs:label>2.29 Fold </rdfs:label>
    <obo:OBI_0001937>2.29</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/a55921ab-2181-45e3-bbf7-03e82ec233bf">
    <rdf:type rdf:resource="obo:RxNorm_9384"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/ca1c8389-1815-4981-a9f4-51691638b157">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/d1535424-6ec7-4d70-8cee-c6063af793ae"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/f47038f7-2b0c-44c6-af5c-e2b9b9122d54"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/4290bd71-2157-4344-9ba5-5a917ea9bd5b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/853ccda9-4cf6-4112-be68-79629b2ccdb8">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/9bb262a5-8b4c-4aa3-a774-7102a38fac57"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/26c94cc6-095d-4be5-86a0-dc2b3d2896ff"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/3ecf7a04-47aa-40e9-800c-8848ffa379c2">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/482a63f6-f38e-42c0-b0b8-ff4fdce605cb"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/95fe3c4d-96a6-4ea8-8251-443bb5154a74"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/b4abb220-e53a-4499-a3bd-0f3ebecb8101">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/d202878b-390d-43dd-8c82-c9af480199a8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/0904b475-e502-4151-ad49-f155e518fab2">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/173b3c28-a2a0-4aa2-8917-a74642ed24ca"/>
    <rdfs:label>30 Percent </rdfs:label>
    <obo:OBI_0001937>30</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/ef387208-2ab5-420f-92be-ce77d4797647">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/bb0d51a7-77c0-4497-a281-5a9db0f40378"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/e6a90e13-e497-4154-b442-8ca100e7ef45"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/2248ca3e-c7dc-40ca-a11c-e35b0ededf4c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/759dff6f-8a05-4c4e-8635-3ad47d228073">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/117bdb8d-2261-4a6c-bec7-e29eaa2cf1fb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/bbf4c188-e3c9-4a22-a3f9-9ca967968d9b">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/087f42bf-d885-41fe-bf78-225734221b21"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/c70b26b6-6bb2-4b7b-b517-562929b87ac0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/b19ad30f-97ff-461c-ac4b-566afa4454e6">
    <rdf:type rdf:resource="obo:RxNorm_4493"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/25c96b69-9963-4d29-9334-bfb7692b055f">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/6fe0d2ff-0379-4630-913a-adefebc1dd2c"/>
    <rdfs:label>29 Percent </rdfs:label>
    <obo:OBI_0001937>29</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/52914206-73c0-4cc1-a50f-98b2672c868a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/f5d822d3-57af-47e5-9bda-2bb60467839e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/dbb3f754-826e-4299-a381-e639ec5d16b5"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/ed463ab3-c87a-4bca-bdd4-b4bcc6646220">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/d25837a5-5027-4603-a81e-60efe9e7ec22">
    <rdf:type rdf:resource="obo:MeSH_C558899"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/03577fbb-3f90-4a6b-9bad-c3e0f0ad8248">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/6f087f1b-6313-49c6-a635-54503d6112c4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/11c4ca65-8e56-45d0-9d10-010124f2d48d">
    <rdfs:label>fluoxetine-mCPP DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/4642b6fb-8fff-4903-afc8-7b1e5cf964dc">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/73e45b91-7295-4bfa-98ab-7dbfb6abddc0"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/3b4b87b1-0bb9-4536-a362-2940178343fb"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/1d023d3b-1116-4aba-8108-abb3b698333f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/8e5dea4d-0d02-4f33-96dd-a52b7e54d0d0">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/ce6c28d8-7fa9-451b-af7f-ac18362f6df1"/>
    <rdfs:label>ketoconazole-desvenlafaxine drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/e735fda8-0d46-4c78-af15-6aac5add695f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/2ea0e53b-84ab-4c22-bd08-aa3fa10b51fc">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/ad2720c7-fcef-40ae-b354-69e93f63a353"/>
    <rdfs:label>1.18 Fold </rdfs:label>
    <obo:OBI_0001937>1.18</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/a2a8e4c7-4b05-47bb-af96-7dbfc7eb54ae">
    <rdf:type rdf:resource="obo:RxNorm_2541"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/689f7117-fa29-4c8a-a93e-5f49db0521ae">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/91fffbaa-7f14-480e-a972-e5a12a65cad6">
    <rdf:type rdf:resource="obo:RxNorm_461016"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/64a08b0d-1bee-4a82-99c9-539b5e092223">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/1c544e89-ded3-4265-a8c3-846064b6cf05">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/72aa99f2-af8b-495c-a964-a943a132ecf8"/>
    <rdfs:label>simvastatin-bosentan drug package cmax  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/7feafb0a-82b5-417d-88c0-4acf2f18a13b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/065321e2-fee3-40af-8329-c80fa839b15b">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/2209ec3c-0040-4b9b-a456-7d3d3027890d"/>
    <rdfs:label>573.5 Percent </rdfs:label>
    <obo:OBI_0001937>573.5</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/f394e762-8da6-40ad-ab85-805917fcfc4e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/d6ed94f5-da8d-4c0a-8edf-7b0f9aae6dcd">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/be4c11cc-e631-4f46-aca0-4f34d7843733"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/97e880ca-c9be-4524-98aa-ec568cc6a56f"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/6fdbc474-fa88-4ad5-a2cc-caf369e78526"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/917f8878-b4d4-4191-ad97-d865fd202332">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/7d1fb71b-2f5f-49c5-a607-4ad31ca65f02"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/d3d7a0ed-5227-458c-8d6e-86d2d6cc3ba2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/6649b5d1-c6d9-487b-a010-203e4336a5a3">
    <rdf:type rdf:resource="obo:RxNorm_861634"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/42190fd6-b918-4059-8f08-b0fa379f2a79">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/ce733c48-aaba-4603-a0cb-c86f196b04cf"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/6e32deb2-f476-409c-a407-783bb6cfc581"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/a2a25eba-f1df-4a10-9b79-50b86807e99f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/a5bd7c37-c9d9-498e-a13f-ea2e9c8ea006">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/4a8b6267-1dbe-43c8-8cc5-6e6433500205">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/165561c4-dc8a-464e-b7d8-632ced2e298e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/8a83b44d-9757-4c42-95d2-480959276ed5">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/290edcc6-4afe-4d2c-9a2a-9dd15d9318a7"/>
    <rdfs:label>rivaroxaban-midazolam drug package auc None information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/23c4541f-71f1-42ac-b950-1fe114220c9b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/46be9fd4-a28a-4daa-96fa-4494ad009d9f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/906d28ef-c192-4d2c-8965-5d0f9f0395c2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/61b4f09d-3bac-4346-9293-764531352a75">
    <rdfs:label>nefazodone-digoxin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/25f6b1b0-8a02-4424-888b-ab074f512afd">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/e53c7a51-d624-4ca8-ab80-b9218a39b248"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/b7021151-dde6-4c57-be86-5f3d3badb23a"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/b981e4a2-858e-4ea8-834a-75df8794e888"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/146b3176-b123-4e26-9abb-70dfd55c154f">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/c0a546e1-ebd7-4d99-b201-65469ff2aa88"/>
    <rdfs:label>Gemfibrozil-atorvastatin drug package halflife Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/5b69dbaa-dd3c-431f-81cb-5ec34e5034ba"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/4927105a-da50-4d12-b016-7f6e99a2059b">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/e9604b1e-3930-4183-8908-d473f6ce886e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/8c7eae66-f099-4dc1-971a-352e924dad9b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/cd778fb2-08ab-4736-87bf-0fb92c7df096"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/909aaee6-e282-4608-b5ad-4ade2fcf97c5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/b70fe901-fa2a-482b-b134-b67012b66d32">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/0f6f8c59-f7a1-45da-a1bd-0b614bfb029c">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/20e90f80-ee34-41d0-bcbc-255b6a21531a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/99b1ec0c-3c7c-4005-8da9-913d50ba9a36"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/cfe2a962-47eb-4000-8281-e2e3295d61b5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/425e41d5-b508-40a3-a23c-e0dfd3929814">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/1286638c-8cdc-4230-91da-203c54c40e27">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/11d902d8-6a43-4b4a-a752-d04e03a946bf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/30757edc-c217-4660-af38-5aa0956a7f0d">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/326a8dc4-9b52-4b02-bf0f-661d46456f1d"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/7be36750-340b-48e0-ab24-8fbf6bf936f1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/42d18baa-831f-4bc3-afa1-fdf42823d159">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/fe1281dc-0616-44f3-b33e-7ed912a5629c"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/bcb101b8-f04c-4641-91f6-09d18e3acc2a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/5a0b4809-66d7-480d-bfd5-88ce111891d8">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/0387694c-fda8-4c99-936c-69445187c419"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/c26d7b91-5deb-4fe0-b664-cab953c4903a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/6149aba6-915a-4668-a2ee-d55fdf5ad4e7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/4810d3be-596d-4942-967e-7d72d08e1b2d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/8965be8e-40bf-4bf4-8912-c962da6f85bd"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/aaab8314-8f7e-4fec-8214-ba0ff5d2bec7"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/486cc66d-6ea9-457b-8690-a7b11bc627aa">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/85ad8856-e669-4ea7-b648-289087d35efc">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/fd9af4d2-2af3-421b-8017-f6fdcd7a2c7d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/9f6d162d-8525-421e-b5ac-4b78096bee38"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/451df329-c6c5-4c04-be53-da90bbbc91c1">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/375aa9e3-4992-46e1-9d5b-c4441aa534e6"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/32b23735-ce8d-4def-8d40-2e8e4ca3d997"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/a5743f56-844a-4e22-a7e4-a7b287fe60f2">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/17d83e56-f285-4b57-9f0d-59ac07abdcee"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/fef04293-29d0-4c33-8100-dfe36832f914">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/7fc82fbb-6ad6-45a8-b3f5-b7d6cee08141"/>
    <rdfs:label>43 Percent </rdfs:label>
    <obo:OBI_0001937>43</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/1ef6b7af-2387-4f26-b733-016e68117831">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/aad0be41-8592-476a-80bd-b58cbaa4b5ba"/>
    <rdfs:label>clarithromycin-rivaroxaban drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/10c0cb49-2ea3-43fd-a526-acd4f9c8d5b0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/404f38ed-b21a-4f32-8d02-48479c850b86">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/d4f87263-d245-41db-8d57-1bb81909ec6d">
    <obo:OBI_0001937>60</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/6149aba6-915a-4668-a2ee-d55fdf5ad4e7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/25e7329f-c8ae-4710-8d8b-c2be1a25b053">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/0240b3d9-a715-4551-8d3a-3d5ea2bfe23e">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/9819f23a-eb82-4cf3-86e2-4a618bb263c1"/>
    <rdfs:label>43 Percent </rdfs:label>
    <obo:OBI_0001937>43</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/c55b81d5-b896-41b7-b642-621127f5dee7">
    <rdf:type rdf:resource="obo:RxNorm_1114195"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/aa0c38b9-be15-4f44-9e69-3c98445f0287">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/44558514-c4dc-4ecb-a3ce-9cb50c19b1ba"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/96469649-57f0-46dc-b735-86393ab337b8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/88f7a5bc-5aee-43cf-9e75-31526de7fbf0">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/0948f0fc-2f80-446e-a439-9c3781b32d49"/>
    <rdfs:label>nefazodone-alprazolam drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/80fe5724-3837-452e-92d7-eace14c306be"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/fcd923f7-32c6-4297-8b0c-e673ec770ca4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/5d368d4a-e3ec-44b9-aa43-b22e48e63f0f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/a2395009-44f7-4578-9f07-79704b00ee0b"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/02926ff6-f7d8-4a06-82f8-89be986d7102"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/d5e259a5-dbd3-4007-b168-aee7d4e798bb"/>
    <rdfs:label>zaleplon-diphenhydramine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/41bf16f5-7314-40cd-916a-bc730e0bbbea">
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/b05f4dc5-dd6a-4310-b969-3616588b0df4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/41a78973-8ee8-4c2d-a566-aae16ed66d81">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/e76f5f84-027b-4bff-801b-e84ff59f653a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/e3eb9a93-0be0-44a4-aaa9-e4af0dedfdff">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/0686b452-510e-44ed-9fb4-e88a1e9115ac">
    <rdf:type rdf:resource="obo:RxNorm_301542"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/890ba861-9d00-49e3-bbf0-daf36f0ab8e0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/1172907f-762f-4fc5-a186-d18e5cc9216a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/1fd03551-ced5-4d3a-8d71-f0b2be66425d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/5f97bd57-7ffe-4d24-985e-f0f91a227f14"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/e301f83f-1d77-479e-89c9-b48b01901fdd">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/6a85ffce-cd7f-4d27-9e87-8631e3ed0165"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/3fb6bd24-2719-4322-b0f5-0030a32f2006"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/9ebe342f-1aac-4c91-bf1b-1dcb41a1f418"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/b5ba9564-d1ad-47c2-b387-80a61f0934c5"/>
    <rdfs:label>sitagliptin-simvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/c3987ec3-1c5c-4b8d-b4e4-919f732d5312">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/5e2eb378-f006-415d-8d4a-7cd81d16eef3">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/fd9606e9-0fb6-45b9-8207-8f0479374d43"/>
    <rdfs:label>2 Fold </rdfs:label>
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/eb706807-491f-4659-b647-c0cc20bdb07c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/88d6bf3c-7f6d-47d6-922e-e5927bc8fed9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/cd364de2-cebf-4282-bca8-ea68721cc6f5">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/a0b3d085-5dbf-48ed-9fe6-231cc956b918"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/d897baf9-a07f-4600-91f8-2c28a27c85dd"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/09c0d609-57b9-4e15-8f26-0be7b7be867d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/895b13b6-ff68-4ad8-ab15-8b2526982ada">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/6fe1b955-dfdb-4662-8d7c-75db77dcd707"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/b55d0190-14a2-48d5-b8a6-8ea3f0df30e8"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/53295cc5-be99-4c47-8e4c-92ce1cf81c63"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/791a4769-7ed7-4453-a298-04cdcc5b549b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/a8767a60-af8e-4bf4-9d8c-574aa9019edd">
    <obo:OBI_0001937>30</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/31cd569e-32da-4bde-b1fc-366852b73202"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/f462058c-3718-4b8f-9756-990c768f2314">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/b5a1f229-c3ea-4475-8fc5-9b0bf196f5fe"/>
    <rdfs:label>38 Percent </rdfs:label>
    <obo:OBI_0001937>38</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/e1e675d0-789d-4732-844e-e4761a918b01">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/9ccf4bdf-2859-46ff-9156-da4d954d6c26"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/7a06c6ff-b37a-4c6b-bd66-121e96767118"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/f5d604fc-4eab-400e-96e2-410f6374be4c">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/a949469e-fcbc-4284-a02e-821cbcb00fea"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/48c93ad6-97b7-4f47-bdba-3dd4e8c9919e"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/2d2a8b97-8c33-4f7a-9024-4bb3bce6877b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/3a51365f-4950-4465-a723-cf7c0c2857f5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/466ffca7-5b37-4da8-b824-2a1b9eb425e6">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/ed069197-00b3-4286-b27c-21df8ed9ae04"/>
    <rdfs:label>50 Percent </rdfs:label>
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/02bc03d5-ce43-4100-8d9b-809050d9f558">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/4355cfcb-771a-4464-934e-cb6c6bedad4b"/>
    <rdfs:label>2.25 Fold </rdfs:label>
    <obo:OBI_0001937>2.25</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/0e4d6ce9-8e56-45da-8167-e629bbb227a6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/a3b62934-82e2-4451-bbd1-0f248f5f5d61">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/3a60e3de-1bc4-430f-9a6a-ea0ec4ef192e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/7b276e0f-6c72-45cf-8b99-6c66596ede57"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/936e2235-53bf-4a62-b302-834465faea0f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/8bebb332-666d-4d75-933d-df73a010ed46">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/aad0be41-8592-476a-80bd-b58cbaa4b5ba"/>
    <rdfs:label>clarithromycin-rivaroxaban drug package halflife  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/c85f3ee3-88a0-4c09-8bbf-8ccd33e9dcac"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/deb61bec-ee2d-4759-982e-983fb9dc8877">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/9b7ca5cd-3a2c-4978-b0a0-9104f6c253fc"/>
    <rdfs:label>digoxin-aliskiren drug package clearance  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/9ccdb32d-5734-4e91-ab72-ad1e7b1874cc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/3b7853a3-f9f4-4f43-8bfc-a6b58182492a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/f940e0a5-7dde-41e2-a0cc-95ffbe2ff567">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/85e355d1-3997-4453-a814-31e0cd7684fe"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/8746f622-1b8c-4048-8689-55966d12e63c"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/e680097f-193d-4e23-8c35-411dd9cba022"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/249c754e-636e-4632-95de-aa921a0e1dd2">
    <rdf:type rdf:resource="obo:RxNorm_10318"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/190222e9-4a35-4eac-b74e-d6c07cfafeaf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/786c5cd2-5905-40c8-9397-742a14e7f618">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/13d96535-47d4-4cf4-af38-76d3d48d7a0f"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/c960bc5a-563b-4513-a8c7-b59abf686dfc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/a9176c7d-5b0a-4943-bf42-cd582e1f6eb5">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/63781b43-45fc-4161-97cd-170c62650dc2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/7b3a01cf-b133-43c3-8c81-6f8ce715eb40"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/2ac03c48-43a2-4b85-b2d3-c411b0c706dd">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/7439dc69-c5b4-4d4b-9f95-fd226d841a40"/>
    <rdfs:label>58 Percent </rdfs:label>
    <obo:OBI_0001937>58</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/507b3449-d956-4e47-93f8-301e1ea60e4c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/f635b324-33c3-4480-9e3f-ef14a05413f5">
    <rdf:type rdf:resource="obo:RxNorm_1827"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/4fcbde08-cb2f-4d77-acaf-85b906a8e3fe">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/b55d0693-c800-4409-9e78-3455ddd133c8"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/1dd32c3b-d6c1-4e24-8236-0bcbc7cf1034"/>
    <rdfs:label>fenofibrate-pravastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/bda25dd0-4f39-45ba-9cca-e79c173996af">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/3e0a529a-d040-4daf-9c52-60b3b1e5269d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/3d948339-524f-4e19-8704-7f98e6373716">
    <rdfs:label>Fluvoxamine-thioridazine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/57da8204-13f2-4343-a21c-08a838945168">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/7fd7d8a2-4b4b-4f6f-ae11-488aee9a822a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/22c7a7a5-3a49-4bf8-9565-d476fa8a7a57">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/0544fcf0-8f76-4b58-9899-a06e724a34e2"/>
    <rdfs:label>ketoconazole-iloperidone drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/33d5fb4e-eaac-4d11-92d3-e5c8e6a4b882"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/95ff4a13-885d-424b-b8b0-12c2eef7f339">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/e0a915ef-1e63-4cf7-a1a5-4c1a8f0c6543">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/90a04167-be1f-48ab-845f-ce14d054331e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/956aab5e-ce18-4aa0-8576-24433af4a058">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/737db6c6-fb45-4810-b0ef-67249554d4cc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/ce4d5031-7761-4059-a741-4be6501176b9">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/f5f5897d-97b6-43d5-91f0-0c6e8af981cc"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/890d6a50-7be1-42ec-af00-59a916ba8695"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/805e1568-5149-4ea4-aef1-bf431c96d1d8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/0387694c-fda8-4c99-936c-69445187c419">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/1657efd6-5352-43f1-be37-7d5a94f0b4f7">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/d06475de-85a1-416e-b172-3e2fe2dfc2e2"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/97432c05-8274-448d-a980-8b9e98de2761"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/6d181ba6-fd18-412f-a716-ba3a16006700">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/c3c3b034-84f2-478e-85ce-4fdde5b2111f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/157f583d-bb68-40ec-9de4-5adffbf4703b"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/1a7996a7-02c5-47dd-8468-1af4adb6bc7e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/5e9aedf7-2683-47a0-86d3-ed8b69bdae31">
    <rdf:type rdf:resource="obo:RxNorm_36567"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/d8959914-e132-49d5-ac30-fd60ed434b21">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/10c0cb49-2ea3-43fd-a526-acd4f9c8d5b0">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/7ab650ec-8847-4237-9f37-0ea6dc7e48b6"/>
    <rdfs:label>40 Percent </rdfs:label>
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/62ba0a58-5313-4539-8a97-badf204b7638">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/39d969f6-d89f-438b-84bf-ffb70af7ff9f"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/3e2df0a6-357f-4816-8620-bb0fedca8d13"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/5a4da57d-76ff-4178-800e-da2e9233f276"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/6faf09e2-fe8b-4761-9881-162df6d2e114"/>
    <rdfs:label>phenobarbital-paroxetine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/e51cf647-25af-4a1a-8e25-1ff8f271dd42">
    <obo:OBI_0001937>500</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/03577fbb-3f90-4a6b-9bad-c3e0f0ad8248"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/f95d4f65-80dd-4f0f-a0f3-7335257c09bb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/91da2e85-59fd-4664-b60f-e795dffff1b2">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/8778e029-943f-48f9-86d8-e89675d5b17d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/7adcff61-6138-4af3-aa77-890ea517d769">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/64f100ef-fbb7-46ff-b61c-87a2721890df"/>
    <rdfs:label>50 Percent </rdfs:label>
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/f4a6b84b-fa98-4b4d-b1b7-7cdc9ff9a9bd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/7d5ebb7f-4d70-43c7-9fbe-f3d691a72032">
    <obo:OBI_0001937>Unk</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/f2b0dc29-1739-44b4-96a8-05e9885e2f0d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/6739abec-9485-4cad-8ca8-822396183eb6">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/5282e30c-b7ad-4be5-b6e5-576fe58a624d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/a326c4df-d80e-4e7e-95e7-9a84a7223380"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/af55714e-9b07-422b-991a-10b72baae465">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/bc0012a7-4978-4f87-aaa0-bc40ca31a902">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/821815c3-d9d4-4d19-8e12-228ca3589f09"/>
    <rdfs:label>phenytoin-mirtazapine drug package clearance Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/84098bd5-4604-4c1d-bc4e-82157d52c5c4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/a5037073-5a08-4dc8-8ac6-1c96c90877de">
    <rdfs:label>fenofibrate-pravastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/feb7232d-ea9d-4146-9bc5-4c3529aaba73">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/55aeb4df-915e-4ffe-ba3b-8a7ef2085968">
    <rdf:type rdf:resource="obo:MeSH_C036139"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/66b74b4d-de6d-49ed-962c-d9422bf2a0c4">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/0caa5548-cbac-4a7e-9fb6-041381d1b7df"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/39423dc5-0832-4dfd-8858-3d51a485c2e9"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/ebcac4f6-1794-497e-86bd-709d321d92ac"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/5ce0de96-c4e4-4662-b8e3-c1faa4eabdde"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/c2b0ff2e-638c-4288-9d01-4e0e74d0006a"/>
    <rdfs:label>Fluvoxamine-tizanidine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/5eff9a88-4385-4ae5-8438-095996d27f2d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/996b48d6-c3c6-471f-baa3-abd2415730d2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/d3803493-32ab-408b-9bd8-6ac47752cb70">
    <obo:OBI_0001937>400</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/0f3ed284-327b-4607-93c3-36189d368c57"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/cf07805e-6fee-4fef-80c2-23d35e05998f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/6e282309-9224-4d59-9b90-f1ff8a8f85fa">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/d1e63bdf-563e-4694-8383-29722fa99cdd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/6ae04cc0-5c6a-40a7-b093-1d0e5520cc62">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/b53dc756-b4cb-4f36-820e-5cb52ac13b86"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/270bac97-e5c9-45ed-a335-bbb085494432"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/4b7f119c-9bf7-4be5-a923-eee30c8cf26a"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/e5cee616-a4b3-46fb-ae79-3395ce0ac427"/>
    <rdfs:label>carbamazepine-mirtazapine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/db6e0da8-5326-4aa9-a589-6aa605033021">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/7fd66b2e-1b75-493b-8da1-994be36cd8e2"/>
    <rdfs:label>ticagrelor-simvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/f78ec3ff-c64b-40f4-b982-23e287558f21"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/ed12a61e-b770-4bd3-b0c4-7c7becb862c9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/42e107ef-657e-464e-9806-863baed71bda">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/41a78973-8ee8-4c2d-a566-aae16ed66d81"/>
    <rdfs:label>1.46 Fold </rdfs:label>
    <obo:OBI_0001937>1.46</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/315f6443-4fad-4366-b40a-7a361c5188d9">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/d19e1416-757f-46a5-b98f-ca24480f63a8"/>
    <rdfs:label>erythromycin-zaleplon drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/e34bd760-a83c-4943-b311-86a00604280a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/1e3913fa-b716-4cf1-9ec9-1503bb1e97e4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/f61eb508-6c3c-459e-bb0f-a75328ab64be">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/c81c1a11-cefd-4aa3-84f0-397ac2ff8b17"/>
    <rdfs:label>unchanged None </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a4406cad-1b8e-44c1-9eb7-0f05c3a43193">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/6b793b44-7c84-4fb7-83af-62769a9eb347"/>
    <rdfs:label>2 Fold </rdfs:label>
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/568e786d-21c0-42f4-8904-f85d8b9cfa49">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/bcbdbcda-f3dc-41b2-85a9-5d629bdd19ac">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/9b56ebb1-23a3-4690-b880-79b8100f3eab"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/8803e72d-6af6-4667-9d15-8fec62add599"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/8803e72d-6af6-4667-9d15-8fec62add599">
    <obo:OBI_0001937>300</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/26693c1f-cba0-4359-acc0-8cd583f8c249"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/6d0ba148-3595-4413-badb-6560400288d5">
    <rdf:type rdf:resource="obo:RxNorm_1114195"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/86b86765-406f-4c8f-9502-fb5145b8bc57">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/2f73cf2e-05ff-4213-915b-ce69bc5a700e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/7202cdce-4183-45c9-b562-d4b2c12604dc">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/4281e1ed-2b26-4ace-bc9d-264e5a29beb6"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/acc4ce17-265f-473e-9ac0-828793525165"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/9b56ebb1-23a3-4690-b880-79b8100f3eab">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/4b31baaf-fa95-4973-843e-f0b3364d8a8b">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/3fba90d0-1201-4f95-b904-674ce6d00719"/>
    <rdfs:label>138 Percent </rdfs:label>
    <obo:OBI_0001937>138</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/4159cab6-5861-463c-906e-dce477f1d9ba">
    <rdf:type rdf:resource="obo:RxNorm_3247"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/9a36d0d8-237e-49e9-ac91-3ca4b7eb67d5">
    <rdf:type rdf:resource="obo:RxNorm_3443"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/9353f29d-6e84-4f88-99d4-188d95f5ec27">
    <rdfs:label>warfarin-Rosuvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/1644eb45-81e8-49ad-bf92-1fbe9dd0a2fa">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/0615c5b1-a131-4988-a815-c07e422bfca3"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/2e8d25e8-6db7-452a-a727-cf9f282eb730"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/8dd3974e-e262-45a4-bdd3-f9b9a66d21d8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/498934ef-f426-4388-ae69-7f3f9bb0bae5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/dbf704eb-46d3-4073-aa67-5ebf4b7a1d22">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/6594818b-54fd-4ce1-bde0-90ef48b9ac0d"/>
    <rdfs:label>fluvoxamine-duloxetine drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/19059ebd-9bbc-4e9d-8c16-1222b9539763"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/7b911eb3-e667-423e-9d2a-a5e3d09ecf1e">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/7bda248e-db72-4205-8af7-5b3f10a2150c"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/513b35a8-e91c-40c1-b4f1-46c02d79a0e3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/cebb49b9-c1ca-4521-bfba-cbb085f64249">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/11929973-f99a-4e26-a505-4be1b21741c2"/>
    <rdfs:label>600 Percent </rdfs:label>
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/8d86e3f9-3dfa-460b-b43c-6304ae4623f5">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/aad0be41-8592-476a-80bd-b58cbaa4b5ba"/>
    <rdfs:label>clarithromycin-rivaroxaban drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/81e8a385-2345-4578-9a92-52d97e47c548"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/4a7f478e-3a9e-4a76-b489-fdda6e8759d0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/ff6735ad-63e1-4bf9-97f0-553569780e43">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/4f29de76-ab25-4b2e-a423-0cfebb04c45f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/b87499f7-a4b9-4d57-837a-529544320888"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/5b70e761-8fc9-4308-a0ed-847e0f7cc202">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/c4989981-8c99-42c9-ad2e-6aa941ad9e81"/>
    <rdfs:label>16 Percent </rdfs:label>
    <obo:OBI_0001937>16</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/f0bed6b6-2ab7-4a99-9c22-493c4dcd2dbb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/f49f62d0-95bf-409b-9772-76b7229fb8fb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/5bcb52c4-7049-4a64-9d28-cb1976960cc7">
    <rdf:type rdf:resource="obo:RxNorm_2541"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/a13aabff-4c04-4df0-b7eb-8a338bc88366">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/69972595-36ee-40c4-892b-865dba28dbff">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/2285042b-89e4-4373-bda2-628fbb85a4cc"/>
    <rdfs:label>erythromycin-rivaroxaban drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/65018a0f-f876-466c-80af-2179d1747519"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/10d7272c-fcd5-434a-bfdb-8b3ead28f780">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/3fd0a316-f9e5-43b8-95f8-279d0f151eef"/>
    <rdfs:label>1.5 Fold </rdfs:label>
    <obo:OBI_0001937>1.5</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/6deffa57-5564-44de-9846-3b33fec40fa9">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/6ccdc6a1-5c87-4ae4-8711-5b3f2e86e76c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/c3c3fa9c-0995-4c2f-822f-710cae51b004"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/0eac833a-1121-4791-b7b0-fdf0d19718e7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/186805e4-ac2f-48ab-ba95-58d8718634a3">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/9615174c-619d-4d66-aa7c-2285722edc94"/>
    <rdfs:label>35 Percent </rdfs:label>
    <obo:OBI_0001937>35</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/f376a7a3-3ef9-47a7-a062-a5c4f3db9e3a">
    <rdf:type rdf:resource="obo:RxNorm_734064"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/60c4a5e0-3095-4bee-a67e-6cd35af2e980">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/e05d9dc3-b337-43db-b9ba-e7d51aaaf3ed">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/326376d3-d36e-4ad7-8bed-8981ff605361"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/204dee60-f8ca-4974-ac5a-2a7b6fce5dde"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/2b302498-1d00-42df-84d1-7d1bffd9c535"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/53c1c675-548c-44f0-844e-846e1749fb2c">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/ed8a0ac2-a43a-45e4-8de6-451b6694d97c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/1d2595f5-8184-45d7-a146-20f6ad6fe85d"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/35b229b2-a632-4186-9336-1cc5d67a6686"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/00cd532e-79d6-4fcc-93be-68ea61ea1e8d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/b0213ea7-af6a-422c-b3b1-c1d8356080ec">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/e5039e62-4916-46d5-83ab-0661455cbffb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/0a706bfe-1975-44ad-9849-efe2e9b2865b">
    <obo:OBI_0001937>60</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/ea845f73-7262-4892-a2eb-604568b9ad59"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/93ee3e39-3493-44bb-9b25-d4f5f667e12a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/a257d43f-6ea6-47c5-9055-29b062573a77">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/0e4d6ce9-8e56-45da-8167-e629bbb227a6"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/0b760834-6a1d-47c9-b8a6-10b2766e6275"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/27ebd1ba-5550-40d7-9ded-d32603810246">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/2126ed31-ff0c-4414-864e-f2af52f7e208"/>
    <rdfs:label>50 Percent </rdfs:label>
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/25a6d787-c316-4e52-a9d8-a6715d14d27d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/ba224f8c-f660-4d42-bd92-293317307f0e">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/c3486b8c-b7c2-4559-bdf3-3d0bff4ae3e3"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/ceb117fe-c444-4767-aa4c-e74999bcf546"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/3e2edbc9-cb17-4f5b-b423-7b6f9ea0eb91"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/56175687-1411-4261-af4a-99f6bb248492">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/10082824-10c6-417e-9235-d223362045c2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/77d11329-092a-4c63-b5bd-64f73b8305a3"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/7edd2f2e-8946-4272-b109-98970aa73259">
    <rdfs:label>paroxetine-desipramine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/1579d8d5-642b-457c-9829-dc5786846f1c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/20ac46c1-da8c-4e4c-ac57-5d0bfa14d271"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/ce86d8b7-1ae3-4c10-a6b0-2a22a999c07e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/dcb02c87-c884-43ee-b507-e868d9d11a74"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/0e3fb43e-d33b-42c4-90ea-81151dd049ce"/>
    <rdfs:label>citalopram-ketoconazole interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/6086c2e9-723c-4abf-b222-d902c07b295b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/d74b1fba-f048-4513-a915-7c99fe37e5d9">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/aa047d90-0882-497a-8297-86c62cc11497">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/f5d822d3-57af-47e5-9bda-2bb60467839e">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/27a13ac5-8607-4471-a190-47c65df36706"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/03f4dd92-4314-492d-b618-5c688ba04957"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/35f05f47-8cd2-471c-94f1-de08041439a9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/42772df2-c4b8-4b01-9e63-1c2e07b3c726">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/0c41273e-4334-41fc-a074-4c44b9980704">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/a48e47c8-18fe-4650-a4a2-267008ecf62a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/f735df1b-2002-4683-b5cd-f6b551eb4dfe">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/67c2cb82-c454-4d7a-9983-5d0dbc8dd183">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/9ef89d64-50a5-48bd-8c6a-284589a3cf83">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/1b1bff70-284f-48c8-a200-a88f65e787d4"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/a30ab55b-e098-4e32-a389-f2b9db2aaca9"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/8948bad2-7149-45f6-9976-acae43d2618c"/>
    <rdfs:label>theophylline-nefazodone interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/bee79898-ebb3-439c-8282-3985609e405d">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/0badbc2e-7590-46f3-9613-79e722331ad8"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/8fdfb1b5-7651-4602-aabc-fd960a0b29bf">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/c6c7f2f2-a29e-419d-89d3-c45b91119213"/>
    <rdfs:label>nefazodone-haloperidol drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/bb466dfe-75fa-4da4-9c8d-33597f848e29"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/abc519a0-b097-4c34-82fc-6bc00115502d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/670c55e2-076e-47df-8f37-3a02e67c588c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/1be70aee-16e2-441f-80e1-db10c517cda5">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/632a688c-748c-4941-92a0-ee6ad9e3cb12"/>
    <rdfs:label>35 Percent </rdfs:label>
    <obo:OBI_0001937>35</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/e3fa16ba-61cf-4e99-b257-b3d53ebab9c1">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/84cc089c-7171-40cf-9a90-ae32c6daefaa"/>
    <rdfs:label>35 Percent </rdfs:label>
    <obo:OBI_0001937>35</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/9f043cb4-c580-4e2e-981f-227f2a091579">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/09ba7174-d130-4a6e-a66b-10e54132819a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/27f21b42-bb85-475b-893c-214be68cd673"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/84656a11-cd61-4bfb-8045-a652b298c7a3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/420329eb-a909-4874-be63-6b338de66846">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/059977a5-3c71-4b61-9df5-083607f96ba9">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/14e9bde0-521d-49bf-b07d-6b2ac3c00ae5"/>
    <rdfs:label>6 Fold </rdfs:label>
    <obo:OBI_0001937>6</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/8fe0ea44-26ff-461d-9b14-4575b2496683">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/8904d496-de25-4252-89f9-0800915f8a68"/>
    <rdfs:label>duloxetine-warfarin drug package auc  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/f0f513b0-d5d0-4adf-8bc7-5e1b913f3922"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/0287694b-e428-4943-804a-024b6e10ddb9">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/f6876967-5c80-430e-a7e8-ebffea3ac8af"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/b6520182-addd-4880-ab44-8f04bf7eb9a6"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/8b9c5810-f260-4f05-b8c6-59ad5c13c6e6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/214796ee-bde6-4366-b0ee-10bffe7dd87e">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/e1ec432b-ef74-4ed0-adbb-effc36322ead"/>
    <rdfs:label>desipramine-HO-NEF drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/06f3ea65-daf3-464d-a6ef-9bae5d082873"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/eddeeb79-8c5d-429e-af51-8ebbdd1dfbd1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/1f33026a-3118-4fe4-b428-23c41a2be19c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/c47518ba-b1f9-491c-96fc-0f989280487f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/b75949d2-4103-48e7-88f3-a3484c738582">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/4d3ca238-ccd7-41a0-bc8b-658537dcb086"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/605b9863-0b23-42ff-85a3-09bd113088f6">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/b7f49d1f-7a04-454d-b630-9c4a1d5b0294"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/5a311420-2781-464f-95ba-8b3a6513a780"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/c15ee107-3771-46fb-8e79-91aeb72a59eb">
    <rdf:type rdf:resource="obo:RxNorm_2002"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/821815c3-d9d4-4d19-8e12-228ca3589f09">
    <rdfs:label>phenytoin-mirtazapine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/740fbda2-fdf2-4e9b-bc00-fc0c013360ee">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/51076e81-8813-49ee-bac3-dfcb6cb3d8c8"/>
    <rdfs:label>naproxen-Edoxaban drug package cmax UNK information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/cf8f2d10-bba5-47ea-b20d-0b1e1f492841"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/e92982f3-ebf9-4550-b62c-ec9effd642dd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/007b32d3-f195-46b2-b679-6fa2079a9bd6">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/a300fb0b-4520-4444-9227-623d971b9e31"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/95538aba-43fb-4add-913a-fc1e23c7de53"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/5d4b1ede-8d55-4ad5-9b8a-96b46ad6bfaa">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/e21849e1-6122-4e79-9f3e-1d9739a59c18">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/b30b8614-4475-4539-a06a-7802adf00bde">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/66441956-aa14-411f-a236-d21ed771e302"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/26b68121-a318-417e-92da-b589843163c2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/1aa25c2c-7538-42d3-929d-20fcedfce169">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/5d1b44c0-557e-474a-8fa1-b6c3e85898ff">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/16e93a92-6b10-4c89-9506-1f2403b79188"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/a3723644-6f9d-473c-b3fa-d2af1056fb30"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/0b282eab-d966-4bfb-99d3-a47b3abbd27f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/133553e1-a457-4678-93be-f77f6cf120c3">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/3521ff69-177e-45de-8fa5-daf5b4b93799"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/4290820f-b8dd-46f6-aaa0-54c4155ee93d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/42e0afec-f4a2-4b2e-945a-153c232fb613">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/80d27b3e-32e5-4f57-88bc-876307a49b89"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/9989754c-665e-478a-aa24-3f0fee2ee5b9">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/2bf2ec18-3d2c-48a9-8745-3f60a93d3037"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/4c04814e-ed02-4cf1-af70-4fc27790454c"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/43403e41-0d6e-4c6a-a8df-1984be0563d8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/4aadc266-d4ce-44e7-b2d5-858098215b0b">
    <rdf:type rdf:resource="obo:MeSH_D016572"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/8d84876b-2928-4ea6-a74b-53318afd2fa6">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/9a91ed2f-424b-464e-b30f-14ef270c80e5"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/977170d1-74f5-46f7-90d7-87244f6e2011"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/dcb5441c-1ca6-40d9-abf6-6eef755d8eaa">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/ec9175d7-2bf6-4f9d-b321-e2b933bb52b7">
    <rdf:type rdf:resource="obo:RxNorm_6960"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/43f9ac45-89d0-4948-ba23-6dc126158877">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/2309fe6f-1ae2-4dfe-aa29-581b0b77d59b">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/c2bf3e3c-7939-402f-8df1-2568fd6327a1"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/54db5af2-b545-49b2-ad78-113b8a5ddc6a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/4ff1a94b-fa6f-493e-a5e8-5f7d451f173f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/0a80ff0a-39d4-490c-aa21-c582223f91e2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/c7383815-a2b6-45f8-a59c-f4ed99e76e27">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/c51e9820-e9eb-4999-9838-9f78c571f231">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/ea5c0987-7186-4228-adc6-9fe29be5227b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/22eea34e-af36-4814-9905-58f071759ee7">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/2ea0e53b-84ab-4c22-bd08-aa3fa10b51fc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/f330b4b6-4c22-4010-a474-54a31aba6f66">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/e90c61fb-ee36-44c3-ae2b-3c7071217e3c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/6acba756-c07a-47eb-afa4-08becb81bea5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/4e99a836-2764-428c-b1ba-1c2862615073">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/e00d16a0-38a6-492e-84e4-2bc3b5077a60"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/511a2571-85b4-4540-b894-7f838017c580"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/c79e32a9-f60c-468d-995b-0c22eeef3a5c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/c961c7c3-9d17-44c0-b7d0-81cc8363ff06">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/ddf4a1b6-1edd-4470-8b32-37db5889ca41">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/ea02796b-bcd0-43de-8d4f-96f23e4c6acd"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/7fadea2e-fc4a-477b-8ff2-0bd74b800d4e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/d3d9547f-b091-46d1-a5e6-72cdd7c9e243"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/a74be8fb-a372-48a7-84b5-0448607009aa"/>
    <rdfs:label>propranolol-m-chlorophenylpiperazine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/72610fbb-dc1d-42d4-8ce2-cfd82b0517df">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/85706667-ed32-4783-b360-c9f23f0e9a00"/>
    <rdfs:label>50 Percent </rdfs:label>
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/fcd6f9eb-1fe6-4733-9052-bc017b3e84ab">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/0510a415-19aa-456d-b4a1-e933e2d3847c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/658cdf1c-a230-407d-8987-e4740be9507f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/f6a46dc4-f726-4371-a663-75972258df1e">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/f385e405-41d7-4286-951f-0adc8b33970e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/df40fd2f-5cf7-424d-ab6a-b0b32e2af925">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/db74e31f-2ee6-4470-91a2-edafc5f862ff"/>
    <rdfs:label>20 Fold </rdfs:label>
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/04c021a5-1c43-4d79-a7a4-f4b883c6fd3e">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/041a11ab-36ce-474e-8ef8-891b8cca2398"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/30d5dd09-806e-482f-922d-19c4d97b625a"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/e4b1f812-4de5-42d5-a085-b868ff78a619"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/f501b000-faf1-4f61-8fc8-095a48561253">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/6c46b1e5-da6b-4c94-94e6-da5fce9af08b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/c2fc47bc-3db1-455d-ac99-d14fb7ff9078"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/33db0845-e01b-4a01-a52c-e8badf3de6ec">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/f6352586-931b-4c3b-9987-db16b828d2ea">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/6c4d10e4-1cbb-495e-bda7-043d6f13afe5"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/d83d8854-1589-4da7-b689-20468e94d09f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/494ea7f1-a08b-4e1f-b13e-820892695191">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/482fe0d5-8918-4850-90e2-c0d93edf8478">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/c5beeb14-f455-4ec8-b52b-05efd592ae53">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/bb49ac84-907d-4bf1-b108-d6aa3f5e66b3"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/5fed0dcb-5ffa-406a-917d-66e14e23dac4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/36bc292f-a58c-45cf-96cc-2646c5145e0f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/f7369b3a-4c35-4c13-a491-ddff47e17b9f"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/1063e8f0-4b8b-4c65-bb34-9e6e4c992334"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/6da09620-7056-4f1a-8fa7-877dde14f89a"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/b189bccb-a673-457e-8ec5-9fc3cefb5d23"/>
    <rdfs:label>clopidogrel-dabigatran interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/641ebe87-76e6-497a-9a02-b3328399eaa6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/19d9012e-96f1-490b-8518-93215e8bcfeb">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/a6e90158-0233-43fe-bdeb-beecccceecd3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/b85966c4-f9bd-4cf9-9c51-9997c9fca414">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/9b65cc83-886c-40dc-9b3c-9cd1fd267eb7"/>
    <rdfs:label>Lexapro-metoprolol drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/914a9a72-527b-4727-8b51-eedf656b2485"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/0eab731a-f311-4e54-9a4f-b997a7f01c05">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/69b45a59-641c-404f-b0ab-c0c50b3ed6df"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/d7e25a9d-4815-41dc-926b-871b9c79fd97"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/03a32a52-d49e-4ebc-9bd6-a77ddbe62d9f"/>
    <rdfs:label>BRINTELLIX-salicylic acid interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/79430ff7-8af7-4413-9a4e-19a004df17d8">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/c6e4cc23-5b90-41d4-a291-8dce8366d2c7"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/711fa98e-14bb-44f8-b946-62f7a48d4caa"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/92744661-d838-4d02-8821-78554e46af8f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/128e7747-19db-46a0-bf59-116d5d455bf8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/0b38ef78-3235-47f7-ae77-c8ef7246baff">
    <rdf:type rdf:resource="obo:RxNorm_72625"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/4fd9524e-284f-4d1e-86fe-6463058ade52">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/b0a1fb8d-c539-4d07-9315-3d4685a1d475">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/aeb7c1ef-5bd4-4870-8308-12da31cf1d56"/>
    <rdfs:label>high-dose ASA-Edoxaban drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/5e30758c-1ee9-413f-8c7c-7210a2281e59"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/cd3f1af6-dbe7-4b07-ba97-4ff57a400f1f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/63b84061-5354-4f90-8148-897ecca9d481">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/d0e7cf71-c3dd-42e1-955d-eb9f918e074e"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/9fc01af8-44dd-48b2-b8cf-7826cb7bd6f6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/d100ec55-897e-4b57-854d-b62e53003035">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/dc865617-4b48-492f-9eae-1f3f1b5bf963">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/c22afad0-d23b-4221-9a9d-b111217d8ecc">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/11c19a0c-4117-4908-bcb8-bd35a3b20bff"/>
    <rdfs:label>34 Percent </rdfs:label>
    <obo:OBI_0001937>34</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/64bf5b1c-2a3d-4d1d-b3da-071201032a53">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/9e31091e-8c7a-4374-afac-3089c84d0490"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/c3486b8c-b7c2-4559-bdf3-3d0bff4ae3e3">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/044f71a5-cc6f-473d-94a3-bd76168c7f72"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/ca94f194-4446-4e7d-a097-9e1d0b0b65ea"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/17c6096f-b955-4d9d-bb9b-229277de0c59">
    <obo:OBI_0001937>5</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/554ca650-dde0-4400-a9cd-219c5d6f6746"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/99bb77b7-7b53-4594-8c9f-8244741c0a22">
    <rdfs:label>Erythromycin-Atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/47939dc7-de8b-4253-a50b-eb769c7ae475">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/6dffee0a-4a00-43ec-9c29-60bf7ba3f9a3">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/3a7bc317-2443-442d-b980-b0de421c0471"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/5401a9be-33f3-455f-a25f-a78113445300"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/2e3253db-8cb1-4aa5-8ee5-977585b07a89"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/420512f5-6d7a-4807-be7a-a9a6f2f192b2"/>
    <rdfs:label>aspirin-rivaroxaban interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/11929973-f99a-4e26-a505-4be1b21741c2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/76ea5873-28f2-463e-82c5-89b3d112ca58">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/5cba0dab-757a-4a83-8ca1-85c89db971a6"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/ee179152-6742-45bd-8eb3-261a841e6ae8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/adc3f895-cc57-4eb0-8b43-cb6cadb5c7a4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/66f3524a-786f-4b5c-9ca6-e4f87719b7eb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/f3df4026-67cd-44f4-8669-0c61116b66cd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/4281e1ed-2b26-4ace-bc9d-264e5a29beb6">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/e9d1bb34-987a-48a5-9090-00c21bfecfd6"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/e6ac79f0-499d-4aaf-82f5-29d5e5c9decb"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/6cd8201c-42e2-4412-8be6-bfe1c45b4aa5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/17135685-e33c-4129-8400-c238308ad29a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/42098895-729d-4139-ae9e-78ccf1eb9465">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/00ca5e92-05b9-4e5d-97c7-b5e7f903c4a0"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/e3e069d2-a163-4914-9356-77488b537d0c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/57509f39-7dc9-40e1-9ceb-453a772d9827">
    <rdfs:label>alitretinoin-ketoconazole DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/c3c6093c-e1b3-411e-bd83-22c94349c029">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/3d6a0b7c-e119-44fc-8e2c-a4fd005ef7ff">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/d20b8a80-dd03-4d29-804f-17e6cd286049">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/5f72a7bc-3fb1-444d-8b49-fd934b8d5160">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/de3e090b-c9ef-4652-b492-61a00d86e29a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/27a8761b-9ae5-42f0-b00e-bbd25f4429d5"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/73baba05-f02e-4b82-8cd1-5407e890f0f4"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/afc38902-b2c6-4f7b-ba41-cba09bfa78a8"/>
    <rdfs:label>sertraline-diazepam interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/087cd06a-b894-4af5-b49f-ad82574e8118">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/159d0b2e-3b5e-4eeb-acc7-296e8fa692d3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/3f649c35-1b1c-4a89-ae09-48e35ec03cb8">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/2c29fa61-5ee3-4965-a977-5cce8d877312"/>
    <rdfs:label>151 Percent </rdfs:label>
    <obo:OBI_0001937>151</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/59f03eb0-f2b3-4a6a-9996-97136a529c72">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/50cfaa12-f1f0-4fee-a985-dbb57ee78f41"/>
    <rdfs:label>carbamazepine-INVEGA drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/18e9b134-ad96-40f1-99ad-b5435814f6bd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/d7368420-5e12-498b-b90f-0fd808f8e1cf">
    <rdf:type rdf:resource="obo:RxNorm_36567"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/d203533d-8325-4562-b75d-fb54ab454bde">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/7520123b-aab9-42c9-8a36-e6df9dec0f32"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/721c7351-962f-4166-ac15-5a1699a7011b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/c7a0355f-15af-4dc0-a346-d748f8615310">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/63b84061-5354-4f90-8148-897ecca9d481"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/2d2c0b67-bba0-4c31-989c-919ced3e9609"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/167cb479-1715-4c29-ac25-4debb21bb00d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/77695f48-618c-4205-bbcf-af9cb47df977">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/73eab58b-7cbb-4b83-9729-87cdf34ea623"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/ec6a5111-19f5-437b-811a-38864bb5e658"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/101959b1-c3d7-461e-b265-645fa287993f">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/f941b014-9cd5-44af-9df1-e650890788c4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/ed7ea8dd-1af7-45bc-9332-b544528667f4">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/362b08a3-2e9e-4f75-8ac2-693917859877"/>
    <rdfs:label>atorvastatin-norverapamil drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/a2676f0b-c846-43f0-b299-f17240eb3bd2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/3070748d-29ce-4ebd-a94a-a06a798e5d6c">
    <rdf:type rdf:resource="obo:RxNorm_3247"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/a053129f-bef5-40ea-88cb-c2b33c0f12d1">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/b794b8b4-8fa2-48d5-8a5e-366e7715dfd6"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/96fdef7c-50f4-47d7-a421-d30059e28206"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/114306dc-a958-4cbe-911f-85af446e4fba"/>
    <rdfs:label>fluoxetine-P95 interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/c526c66a-1a3d-4a61-a5b9-a3b77a42fdfc">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/a37d4e27-2311-44d6-9d71-9b4ca787a9d4"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/8f9e5217-8e15-4513-828f-760fe66a7f05"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/5218940e-b47f-42ca-800b-fd43d6c69c2f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/e10396ce-4516-4371-a4c9-a6646fbf36ac"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/97f1df42-bcc7-4c04-8880-523f2eb06134"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/213050e3-435e-4248-9b37-32a5a94101ba"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/3075ede2-739f-4a1e-a30e-865fd3f323b7"/>
    <rdfs:label>cimetidine-zaleplon interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/6e2e8986-91d3-4d9a-ac30-76131c675ea3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/f04d51bb-cad2-470b-86e7-47903d4c6247">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/1d510844-aa81-4699-8550-c68fe5d1871e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/0b9f7319-1dc8-48ba-97ff-cdb7da972ad1">
    <rdfs:label>BRINTELLIX-salicylic acid DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/c7cb95ac-cc04-4fe7-8d17-d66d4bd3be65">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/53892299-d937-4328-9c5b-531f3ab369b7"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/3df7cdb6-7a5c-4cf8-ac8b-2be23374b811"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/775a0f75-1f0d-4d91-9bff-7759063b082c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/d23bbff2-02c2-4ead-94b1-cb4a148b05d1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/1b0bf04c-d8a7-4b80-adfd-b4aaa2bc2699">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/e943ea84-2fd4-4126-881a-5c69de573583"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/3ef70a61-fd95-431a-b854-91e15485f658"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/df3f2949-bc35-4983-a620-593bf434f103"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/02d6b207-1e5a-4f50-bb24-129b5b463987"/>
    <rdfs:label>desvenlafaxine succinate-desipramine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/655ce857-ed43-483c-9948-dcfc31177bbf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/678e6755-7c4b-478a-871f-30ed56d5a3d0">
    <rdfs:label>paroxetine-risperidone DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/513204ea-25f3-4f5b-8ff1-3f928d49112e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/6517d102-f318-481f-b635-5013531d1707">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/2cddd678-10af-431a-bf62-a55912e53cf4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/e1b96dc2-b11e-4614-9edb-65b56e758c65">
    <rdfs:label>rifampin-dabigatran DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/ffb85533-42b1-4bd9-8d12-ba219b4e9ba8">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/12de81a6-3648-4a56-bf6c-8cea9e7ffb1c"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/cda31cec-5859-40dd-b26b-bfde9922443c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/ac0e1a27-dc27-4f94-9cd8-9fe7c735b34c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/168b7250-35f6-44e6-9984-703725973f81"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/68410877-e6f6-4323-aac7-c246e523ccb9"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/9dfe6820-b2a7-4fba-b255-9bb0c21d1dfd">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/b9b02e07-1e96-4235-a0f0-7e199036fc67"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/b5d56245-884c-42b2-b8ed-763cdf888fca">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/f6cd580d-897b-48b8-b7af-789c8d48aac8">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/8f1beca4-31a5-45e5-b173-56aa3699d43e"/>
    <rdfs:label>1.6 Fold </rdfs:label>
    <obo:OBI_0001937>1.6</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/7e46af40-863f-4b85-8055-1dbd22a926e7">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/af9a7256-469a-476e-ae7e-74abb993bde1"/>
    <rdfs:label>paroxetine-iloperidone drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/333d0ec1-1b93-4957-a8df-758e2bdc491a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/1c8517df-a236-4bf9-a551-d09410f1a1a9">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/ee7963d6-b0bc-4dc2-9b5f-c05da245f4c1"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/721e29c7-32fc-4979-9576-1782c789d218"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/d70393db-c7f9-4be9-bd4f-8a14aea0096f"/>
    <rdfs:label>fluvoxamine-thioridazine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/2528b0d7-8da6-420c-8c2a-f40840252956">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/f85a7451-8800-479f-9b42-7b2e907e00ec"/>
    <rdfs:label>4.23 UNK </rdfs:label>
    <obo:OBI_0001937>4.23</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/ba9e6e63-96f2-4f04-bcc4-10ba67b52dea">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/1036ae58-cfd1-4fad-b91f-0538b1257995"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/4f863644-5569-4864-bcbf-69abd8014b4d"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/fd4f127b-ea26-4ad2-a02a-2299b814b4ca"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/62556358-6897-4eab-8fbb-61a28deeb8ea"/>
    <rdfs:label>Nelfinavir-Atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/8d7ba354-ceaf-4543-bb7e-a83fe6e22de1">
    <rdf:type rdf:resource="obo:RxNorm_1599538"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/e2914380-8fd5-4fe7-a6c1-b91157b4bc69">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/c9c1adf8-9ce3-41d7-b23a-229ac7f95022"/>
    <rdfs:label>35 Percent </rdfs:label>
    <obo:OBI_0001937>35</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/a0acc275-7299-4213-9648-65f062eb2734">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/df859daf-d6a0-4259-91b2-a8c38aa9b14a">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/613ac937-fc8e-42e9-aa0a-091c95fe6cc3"/>
    <rdfs:label>sertraline-cisapride drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/c6a9b70c-9d90-45b1-9ff4-f77161d0b6ee"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/a759e4d8-58f7-4af6-9822-09e8bac3bbdc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/7aca3f85-6698-4fbd-a4c6-91600e679d44">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/ff93bc91-ed5c-4dbf-a077-56ec26818eb9"/>
    <rdfs:label>unchanged None </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/6d45d608-b460-4472-accf-5bad07cc8115">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/2085ea37-c14a-4847-a977-b06fa13d4ed5">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/d840dac4-8589-4260-b9a2-e2135bb72361"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/23bbee10-9f1d-434f-bfbf-5b62dc3020f9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/ed5c9c3a-7203-4326-96c4-957dabb3dcd4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/c7844e9f-da43-4cba-9c17-0ef6c30c729c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/f9604974-9b2e-4595-a784-8b6ebf241b86">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/c03ec363-352d-4302-88d7-a03aa900aabf"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/93361e1f-8ccf-4b7f-ace3-036f14cc59ec"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/c830974e-f9a0-465e-a538-f1a866d26020"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/344dc4f7-a479-448f-8dcd-2df073bb7a3e"/>
    <rdfs:label>nefazodone-digoxin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/c3025b88-6300-4dfa-9c53-5cde79d08ead">
    <rdfs:label>atorvastatin-verapamil DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/1b942040-74a0-41d1-974d-a1142ef7e9a8">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/d1694e74-ee8b-4fd5-956c-7ee262c815c4"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/6348769e-adfc-418e-819f-1931dd9f7fb6"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/e83eee6f-042f-479b-bdb9-94306cafbe2e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/e1b0b2a0-9125-4a6c-b75e-ed094d2d8b4d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/439d8bf5-fd4f-4bc4-a073-0dafe1ec246b"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/5ba36b39-d47a-4dbd-b697-f92dc05a2c05">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/661b1d9c-55fd-4010-a86f-4e264fd047ce">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/df83fc8e-ebac-46fa-9f5c-059264c1accf"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/9ef8f14f-d419-4824-b9af-faa49f7e91b2"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/6ae03c25-fa97-4c4f-bf1c-d433de093bbe">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/234fc4d6-1721-4009-99fe-feb5bf7c4eea"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/15c53c18-cc2b-459c-a59c-8b4264af55da"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/1ee84c6d-e501-4915-b73b-81b53cd85083">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/7a4fad78-5603-402a-a18d-b5a31c9bd682"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/f330b4b6-4c22-4010-a474-54a31aba6f66"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/83c31f4e-f1c2-40b3-aad7-510be12b8fe7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/8ae7255b-d6d2-42d4-9c6e-3c8d8e70955a">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/290edcc6-4afe-4d2c-9a2a-9dd15d9318a7"/>
    <rdfs:label>rivaroxaban-midazolam drug package halflife None information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/5206a23c-f5a1-4c68-89e9-d41cb895bf01"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/9dc48a7b-8ec7-4ffc-bbbb-92c6e32a0cde">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/2fd4ba5d-134c-46d8-b9b2-0f3d01430868"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/7fa1eda5-206b-460b-a22f-2026a2202e3e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/95fe3c4d-96a6-4ea8-8251-443bb5154a74">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/89d90dd4-7e4e-4a02-b37e-86ba1740264b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/2e83afdc-2ff0-4b17-b2c1-51f6fe3709bf"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/dcfce6a8-674c-4f60-a544-6f5dcb2415ca"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/ee44cb6f-8af2-4d9c-89f2-34037b16ef1b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/d6ed94f5-da8d-4c0a-8edf-7b0f9aae6dcd"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/3d17f648-6e39-42fa-864e-ac5eaaf2240f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/80851d33-e352-474b-8c56-8c86adc6160c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/db1b9d6d-d075-4200-9041-1dd9618c8fad"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/e9a71991-4e12-4d80-9382-4ad9154efea0"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/ef4f3c2e-c6a3-4555-98eb-7449579fdbbf">
    <obo:OBI_0001937>.4</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/9bf97af0-2693-49c9-8edf-2a3e5277fca4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/b26b391f-644d-4a5b-aba1-2f4e5447251d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/7c29327c-a174-43b3-9e02-95b23d47c507">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/5173bf71-9c51-47af-833a-d707168374f1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/9cf09d8a-b63e-481d-b385-a0cdc1f3a444">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/77479ba9-9c40-4f01-8d8c-dd3e1a6ab435">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/ff2dd303-f3b5-455a-8919-bedcf51b7d9d"/>
    <rdfs:label>duloxetine-warfarin drug package auc UNK information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/c13e4027-7bb6-4d98-b3e1-11ca1227dd70"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/eb91b7d2-719c-4dff-8377-ab7c5e61d148">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/2209ec3c-0040-4b9b-a456-7d3d3027890d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/3d9f09f5-d9f6-4f86-9d48-c70cddaa71ea">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/add480ad-feb3-4d10-844b-785f4d7e2a3e"/>
    <rdfs:label>fluconazole-rivaroxaban drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/4d418939-633c-45e4-967a-01799a5fca90"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/270bac97-e5c9-45ed-a335-bbb085494432">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/c777f075-b01f-4549-9401-3408c1b72c56"/>
    <rdfs:label>carbamazepine-mirtazapine drug package clearance Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/e5b979ad-ec81-4681-ac08-a4076c29bc34"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/bcef736a-6db3-456f-bb64-2802a5312be0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/2e67d9df-4be0-438d-b4aa-cabeaa636568">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/f50f54e0-c220-4c05-aa8f-e5bd5315df5c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/a9a84f98-e3f0-4738-9bb6-b32d13ec9a2e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/1c8e3eb6-0732-4f6a-a5b0-d220e3f975ba"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/4feafa0b-62e1-473a-b086-bf0ed9077837">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/c8c3e464-5e01-403e-8ce4-6d15a0ed818c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/7bd0c0a7-8604-4acf-a505-44d46b6319b3">
    <rdf:type rdf:resource="obo:RxNorm_7258"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/6a85ffce-cd7f-4d27-9e87-8631e3ed0165">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/c4a04170-d295-4f58-8774-7a3ddd66601b"/>
    <rdfs:label>sitagliptin-simvastatin drug package auc  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/f9b280b7-2300-467f-a8a3-aea9bb29a6d7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/07afc13b-fe73-4aba-8cf5-f55bb8d14bbf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/cae517aa-a907-443d-9b3f-ffaa86af78a6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/c6ed7dbd-75dc-4e8c-a03d-c71bd305fe0a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/06f2eaa2-40b3-4200-9233-f1c58db81fc4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/b25a7889-bbfb-4bee-b996-39a82508d30e">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/51c5bfa0-8d04-488d-8640-f67a93427672"/>
    <rdfs:label>rifampin-dabigatran drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/7dc23193-fc55-431b-9809-3cc097c7f730"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/191fa5b1-c97f-4b07-8e29-d9eaa987e911">
    <rdf:type rdf:resource="obo:MeSH_C102211"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/afb8bee8-5c9e-46ea-bf25-35807b3216ac">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/386eae0c-d3d3-4e8a-b455-c69b188baeeb"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/fa57b449-ae30-47bd-b436-c19a4df25f6e">
    <rdf:type rdf:resource="obo:RxNorm_9384"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/3aa49352-b191-468f-870d-32098dbf3c93">
    <rdf:type rdf:resource="obo:RxNorm_10438"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/85d0f105-a76d-4804-9c0c-29e32e05de48">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/45a1147e-717c-418d-8df1-fbecf2b74b43">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/ca592355-0cb4-4621-aad2-be7499b8abd4"/>
    <rdfs:label>fluvoxamine-tacrine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/28acf257-965d-44c6-8739-7901df3a0b84"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/4a95af59-515f-4e34-8318-556ebb2fba9c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d08020ce-6ec7-4ee8-89f2-251d7bb9e688">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/513204ea-25f3-4f5b-8ff1-3f928d49112e"/>
    <rdfs:label>11 Percent </rdfs:label>
    <obo:OBI_0001937>11</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/cfa85a92-7d01-498f-974c-edb0c1a90da6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/def01050-53e9-4942-893a-7000f94d6646">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/fe682f32-6781-4964-9cd9-e792739c4913">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/0c090e7c-7008-480d-968c-bb78a3257159">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/8b6fdafa-3c5c-4135-a0c7-42521cce9dbd"/>
    <rdfs:label>38.8 Percent </rdfs:label>
    <obo:OBI_0001937>38.8</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/d84e0cb3-6531-4278-9591-4ac5e5973311">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/dd0bf265-597c-4675-bb5e-f3ac34f4745c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/00648e24-57a3-4683-9fc2-bd8991f3761c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/4602a5e3-9d77-48dc-8850-3ec541cd6c6e"/>
    <rdfs:label>ABILIFY-paroxetine CR interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/20ddaf8b-6ebc-47d2-a261-27109382872e">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/5ca683a0-893c-489d-bae1-83a14bfbfed7"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/fa44464e-95d1-44ac-be3f-8af3f93b0932"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/8e525b54-833d-46e9-bc23-82798ff5f740"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/8d5894e7-8877-4e33-b37b-cf31944afe96">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/2fc25f7f-65ee-45ca-a535-b099540ea968">
    <rdf:type rdf:resource="obo:RxNorm_85762"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/897ee1ea-45a3-4484-ada2-4723a19bed4e">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/573b1a8b-73a4-4387-a2ae-6ef08c9edc57"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/e944f0fa-1479-43e8-b6e5-199fd63ad0c5">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/eb683760-abf0-4062-8282-9cce2e363b21"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/399b384a-a23d-4e46-8275-5751449f6bbc"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/fab43874-2dfb-4f76-8c0f-e733b4d016ae">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/7455a829-e94d-4e77-87f2-b2ecddfa1d70">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/b0921bce-7323-45a9-83e9-9df086bf8a10">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/a4ad6c3b-84e6-41ff-9c24-a13f55d96303">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/e6a90e13-e497-4154-b442-8ca100e7ef45">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/173b3c28-a2a0-4aa2-8917-a74642ed24ca">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/ec41f693-6930-4a4e-b63f-357ff7ca895e">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/e91d4345-07cc-4e46-9885-ac9ec47caae5"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/33c6447e-4445-4839-8930-e20c9563b93d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/aa3301ef-bde0-4dfa-b50f-dc5b7346a328">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/bdf6ccb5-572d-4af6-a547-e853365b2d3d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/9971e06c-bf8e-4d04-ba56-3ccc755b6931"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/da3c6ef1-4997-4548-b947-3d29aefc3a0f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/d11d0bc1-5f9c-4c16-86ab-bdfc7e6767b8">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/88bf54ca-01d0-46e2-89a9-91b7b0cbec0c"/>
    <rdfs:label>bupropion-desipramine drug package halflife Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/6b9e4807-6050-43d6-874f-0574bcade8c1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/6348769e-adfc-418e-819f-1931dd9f7fb6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/028c727f-0b80-4acb-a908-f84359cbdc09">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d97fa22e-8ecf-4b5f-9898-ee5aa33a570d">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/04af1970-74aa-442f-8340-7d3d149224f7"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/2f4a871d-6390-413c-a643-e7e49962aeff">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/6d71c852-6b4a-423f-94d5-f132ec56cf93">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/56701547-ac8e-451b-887f-c6b0d5426577"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/93515551-171f-4404-a34d-6aa382d52910"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/3635ba35-8ea2-45fd-9559-258b0549d735">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/1e3913fa-b716-4cf1-9ec9-1503bb1e97e4"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/26bd67bf-f893-4755-be45-bafa7c057c5d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/63ed3831-96fd-47a4-a6f5-bba67f036745">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/f8304ef9-4900-4055-b2b8-828b8206436e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/300c92a6-29e6-40dd-933a-cb13f79d03ac"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/ce1d511a-b3fd-4111-91d8-f8167a71cfa5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/cf92f792-1d2b-4ef9-bcee-f35b6d8a1cc9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/8f2d9564-97b2-4624-bc43-d2535b8e533c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/79ab6144-660d-4d57-b88e-9540076edf45">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/22b88006-77b6-4366-9727-6edf507ccfe4">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/57d4eb15-308e-4401-a8c3-2e932c64ae1d"/>
    <rdfs:label>122 Percent </rdfs:label>
    <obo:OBI_0001937>122</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/f82db67c-1e51-4548-8528-b1abaf28f43f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/1b82f7c3-8cfd-4af4-9dd0-53c871ad07dd">
    <rdf:type rdf:resource="obo:RxNorm_1827"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/9711045a-796a-4fab-b4dc-69eda62ebc6a">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/ec025003-a062-4ae6-8e20-44e8a36af2c9"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/22f84f5d-a792-4848-9789-3ff932ff2885"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/f7f3233c-36e1-40b0-a8a7-5bc3be7aecd4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/48546cfc-a603-4914-986f-281daeca7de3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/b5eff669-b4bb-4b9d-8d16-f5e79e8cc832">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/7babaa74-9fb4-4c91-bdb5-8fdf368d502d">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/c96c1471-5d72-40b6-80fa-a0dcd1242165"/>
    <rdfs:label>ketoconazole-dabigatran drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/c3f92e10-48ec-41c3-90e1-8404f3359bf6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/18c8dec9-c898-4d19-98c0-304e1b1c2141">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/891033f3-133b-4802-88e6-a392f0f2cbda"/>
    <rdfs:label>38 Percent </rdfs:label>
    <obo:OBI_0001937>38</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/add480ad-feb3-4d10-844b-785f4d7e2a3e">
    <rdfs:label>fluconazole-rivaroxaban DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/4bb48206-8883-4b81-8add-bac70a00b391">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/b5e94e40-4cac-4545-8605-588f161cc12f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/f1c58b18-c2f0-434e-992d-dd05eae2f23d">
    <obo:OBI_0001937>50 to 200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/806408cd-7155-459e-9700-d656396620bf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/0ae81712-8785-4a7c-be81-e8354163b284">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/ad181b03-5ea5-4e84-8f66-6ee1112a3df5">
    <rdf:type rdf:resource="obo:RxNorm_74667"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/e6d7857e-af3e-4cdb-8735-0fe2ce717905">
    <rdf:type rdf:resource="obo:RxNorm_31565"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/3fee38bf-9e71-4d4c-a631-86876e0926bd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/38a95834-5638-455b-a522-285cf859d580">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/175b1ef6-502d-497f-890b-1cbce4abafab">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/83120a86-f104-4f7e-b1b2-80da0333af94">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/8e0d4c88-e34c-4117-9a67-3f3298d01e2f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/97716bd9-42a7-49fc-a844-9a65742ad766">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/b4db4dc1-53d6-475c-a020-c1f127592272"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/b3ffb6c2-66fc-4503-b679-239471391bf5">
    <rdf:type rdf:resource="obo:RxNorm_1102261"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/79166b9a-3716-4e77-bcd4-126a7bd0597b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/6650b385-5ad6-4ceb-8747-45f63756c46e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/30feb6d7-9cdc-4182-971d-e7f1353e99b4"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/4eca74aa-d7b2-46bc-a1ac-80b45ecedcb0">
    <obo:OBI_0001937>75</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/9b845e43-3417-4136-94eb-717901cce753"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/da676dbe-0739-4d01-84cf-3845051dcb64">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/a4563bcc-89f8-4e47-9ab0-6d633c282dbc"/>
    <rdfs:label>43 Percent </rdfs:label>
    <obo:OBI_0001937>43</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/ae299303-afe5-4213-9556-067e8310cf5e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/03eece02-7a29-4c44-877b-0a4266df8df1">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/8dd7304f-5711-479e-b31f-0d0c44623b84"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/4caa3355-3ea8-4ee6-a1dc-f866c5e341ca"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/0fed6fb1-5a2d-4a7c-8ba1-ddb693e21203">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/8ff96cc0-aa91-4a32-acea-b9b72a21d2a2">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/00a30d18-e55d-4e0c-bee5-13b2aa9dfd3a"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/58faf509-8e93-46e2-a4e6-4dfef33af9f4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/bbb3f8aa-21dc-41a0-a3e9-b0124c14ee6e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/36d00689-3842-4c60-904c-4e727fc9de73">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/05b7ba67-3d95-4d5c-9d11-60719822ee23"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/ac938868-75d4-48cd-8a82-3ec5045b96fd"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/f429fc91-6815-4d52-957e-0cbe042966b7">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/602cfa3b-0080-4a24-9234-bb413eeb01e8"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/b660c117-4022-4dfd-858f-18cdeec789ba"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/9a26c401-cbe9-471e-9081-ea7be3edf840">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/fec710de-dc3d-415a-b141-2b9761e5adbc"/>
    <rdfs:label>25 Percent </rdfs:label>
    <obo:OBI_0001937>25</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/a80c2655-6471-426a-907a-9d3b787a75cd">
    <rdf:type rdf:resource="obo:RxNorm_41127"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/a3518c1e-a9d4-4f8c-b956-cefe55b0d0d4">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/fec8a8c1-4f9d-47aa-834e-bbbbba7810e2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/5efea4e9-38df-41b0-aac3-81d38660e0b8"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/a22560cc-5f51-4417-9115-f39b404c3461"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/501a9168-83db-4ee2-afd2-a7888b178e57">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/906fdd27-8373-4bf1-952d-643bd66fc241"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/700ddc09-fcfa-49b0-abe3-d973c96f9951"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/31327462-5f94-4765-b014-362807e05802"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/fe6f66cc-735d-4a35-bb1a-1d08ef736f2e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/c96c1471-5d72-40b6-80fa-a0dcd1242165">
    <rdfs:label>ketoconazole-dabigatran DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/db6a5215-3f55-4da4-a28e-536e40a38509">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/91145ef3-8bfa-4eb5-922d-3cdc9fc49584">
    <obo:OBI_0001937>4</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/f4a6b84b-fa98-4b4d-b1b7-7cdc9ff9a9bd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/e00d16a0-38a6-492e-84e4-2bc3b5077a60">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/d448b315-32b4-40ae-886d-e83de69b9ef2"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/e6f3582d-ef92-47f3-99b4-3291d14341a3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/6fe1b955-dfdb-4662-8d7c-75db77dcd707">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/aed3ae9c-3292-4cb6-a219-1323b8540025"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/b725b331-2c43-429e-9241-521f47b50e1f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/879f5557-95f0-466a-9610-420b461a3275">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/aa63a3d9-4e44-4fad-9e84-3b4d3909da1e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/3fba90d0-1201-4f95-b904-674ce6d00719">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/8cdd95a2-4d63-4eca-889d-1fbd9c90ad04">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/03d3468a-547e-4d9d-a517-cd219a9ebc39"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/20255f2f-0fcf-4849-a415-864a574496f8"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/5bcb52c4-7049-4a64-9d28-cb1976960cc7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/92744661-d838-4d02-8821-78554e46af8f">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/d6d1a27c-7d6e-41bd-8d3a-8fa50f26714c"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/41421b34-3d33-4f60-a92f-fb82f7776088"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/b2191d98-f9bb-4d36-bfd1-d849d705dd0a">
    <rdfs:label>Fluvoxamine-tizanidine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/412ab478-4069-4443-bcb3-4218a1d3c172">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/9d0a932d-4e0c-4f8c-aea2-854f223be6aa">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/ba75c8b8-62ec-4208-a18f-8761c08feffa"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/2ca53930-b90e-44ae-bd73-442516c8ed7d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/9975ea37-11d6-4918-9d25-fe292bb69923">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/9af069c9-27bf-4018-86c0-d36dc9212b70"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/5647ac42-2cef-4e6f-8f39-29da8116c027"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/a198114d-f9c3-45c0-9fe4-1cab1b75b344">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/9e66a0f3-a412-46a6-9eb2-16c35c2d8296">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/6a373630-1866-44e0-b2b7-240617230707"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/fa876e01-170b-4976-a6a5-133b84a742b9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/420512f5-6d7a-4807-be7a-a9a6f2f192b2">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/e09ae99c-8279-44a0-8fa5-b37a2a405a7c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/3ffc8035-3082-49d8-b01e-49380e6f3e4e"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/1d30878d-a95f-42d5-96c6-0cf7a927b24e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/5586a5b6-f815-4c3d-9ebe-e200c87fdab9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/af4447e2-9092-4e50-8c5e-3d82748bc289">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/1445524f-1163-4c0c-b881-3704cdc7fd67"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/8116d608-1b1c-490e-90da-2d448838796c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/2fb50fb2-bc8a-4648-a01d-2439e4537b10"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/0739198f-d673-4154-b4aa-0765a3bb26dd">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/8a83b44d-9757-4c42-95d2-480959276ed5"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/cb5b3432-a363-4d6e-806b-fa47d2762fb2"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/8ae7255b-d6d2-42d4-9c6e-3c8d8e70955a"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/9642cd96-b443-49d0-82da-5a677be89eef"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/d6060f0f-6f46-49b0-aa3e-3091efa889a3"/>
    <rdfs:label>rivaroxaban-midazolam interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/2b37a95b-f72e-4db0-89bc-3e35255b0a11">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/fb78a1c1-c51d-4d1f-bcd4-e5a4cc3e4616">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/e680097f-193d-4e23-8c35-411dd9cba022">
    <rdf:type rdf:resource="obo:RxNorm_1102129"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/0f736132-bbcc-4ecd-88b5-cb53a8f4dc6e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/873e5cfa-54cf-465f-bde9-1eb6e96d40ff">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/7f85467a-bec1-4a90-8b84-df6192754c47">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/39cb7ecf-7417-4a5d-abe0-4b2b8791dfa5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/c58ad560-3e5e-4074-9a62-6442901b422b"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/DIDEO_00000013">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/0441c6ab-e32d-40b9-8699-69448ffe94b5">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/e5039e62-4916-46d5-83ab-0661455cbffb"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/97c04695-abb5-48d6-bd49-b3659700993d">
    <obo:OBI_0001937>150</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/6a7668f9-cf4c-415f-92b5-f5f8b18e7aed"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/c91c3ec1-11fc-41e8-ada3-b93194c04338">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/4289efbf-116b-4df3-85f9-2e1d3ee7c460"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/8c6eb072-59d0-4c4d-8b2b-9cfe749091cb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/48f63eb8-dd02-4e48-9cff-04dabc87b7c2">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/4f5f2055-9db4-4755-ac47-e2d1f4643bcd"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/136bbad5-3e91-4130-9b5b-3d2c136aeac6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/df9c7d5e-e9f6-4731-a5d2-def36ea1db64">
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/f3976ab0-27fc-4d88-81f4-ee63085c559d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/6830a237-dd88-4da8-a7a1-7b3092d528f2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/f52bd8f9-1a86-4812-b8fc-fc13bb77b04c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/2af00c66-e022-402e-9166-8905364065f6">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/3bb6b761-09de-42a7-ad35-5b52981b2ff9"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/b7e584c3-2827-4e91-9ceb-b767f487cdb2"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/74205c47-293a-4f68-8cf8-695563b4273e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/c50aa9e7-cf81-4c43-9077-23d5cbdd6851">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/e1605e2e-93e3-46b6-be00-ee5cea7808d3">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/75eb76bb-5604-4ac0-aa9d-db35fdccd8e2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/19e8acaf-76de-4329-905d-bbb9ebdde49d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/4a5a4f85-2628-4e07-9e33-0947bd061d3e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/7e729c4c-1134-4885-b489-2d85fbe5ab54">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/1fd03551-ced5-4d3a-8d71-f0b2be66425d">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/905adce1-eb92-4953-b0c2-af671cb7e22a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/50223abc-5bee-42e8-ac57-d9fb927988ae"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/a21a427a-2541-45f0-93bc-121fc64c9721"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/aa48c14a-8e25-491f-b1b1-fb70e633ba1b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/e15f2375-f288-4a73-a870-5747fc6634ea">
    <obo:OBI_0001937>12</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/e99587cf-ec54-40ae-b814-abcaa514d263"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/362b08a3-2e9e-4f75-8ac2-693917859877">
    <rdfs:label>atorvastatin-norverapamil DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/ef009048-0651-4570-811e-09130860a154">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/310f46c6-56b9-4d91-b012-802df1d43844"/>
    <rdfs:label>paroxetine-9-hydroxyrisperidone drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/c2c198f5-9f82-4fe2-a4dd-146f6a9c0555"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/d30da78e-23b2-4506-9366-f68c6d1b6c10">
    <rdf:type rdf:resource="obo:RxNorm_10438"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/faef1e19-9f89-4f9e-914d-bfefda6902b8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/97e880ca-c9be-4524-98aa-ec568cc6a56f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/0d87d07f-560d-44b6-b0da-524a1612d71d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/e544bbde-d8f7-4075-9f0d-d50924795420">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/a29cbaf4-e17e-4179-b667-abdf4c756fcf"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/23df0c48-7c1c-4209-b457-6dcd20e888a6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/68f1147c-8e3a-4483-bf29-e6d109480176">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/5545cfcf-b5a5-4ada-a6d4-4e29a0b7ee85"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/aa7b6a2f-e1f1-4d8a-9a2f-3ef151a4fa44"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/45391281-2f37-4e1d-9a31-06cee17dcaac"/>
    <rdfs:label>fluvoxamine-theophylline interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/d5c42dfc-d6c5-4637-aefc-8bc8c4c8f488">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/6ec3cf40-ba50-4047-b883-934aeb759ce0"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/339ad4d2-c8a0-4e04-b345-23af15a639ee"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/7579e1a0-cd91-47bf-86e1-ec8cfb10a7dc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/32b23735-ce8d-4def-8d40-2e8e4ca3d997">
    <obo:OBI_0001937>up to 1000</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/308d364f-423a-4034-bedb-1aea38bf31fc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/f8d7fdf3-cde6-4b31-908d-6df33cc33f30">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/c13b1752-a306-42cf-aa32-941ef11cd373"/>
    <rdfs:label>cimetidine-citalopram drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/da676dbe-0739-4d01-84cf-3845051dcb64"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/8e712cef-7420-4f74-87fa-ef71d183ea1b">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/12ac85d6-b3fd-4aa0-ad58-5cc0fc073ee8"/>
    <rdfs:label>fluvoxamine maleate-alprazolam drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/5d25950c-6602-4004-ad8b-69463e46867a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/04c45189-9ad7-4de6-8588-ca7ceb3ef235">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/d22c3047-5330-44f3-b09b-d64a655f0dfe">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/23f82fa4-84cb-4ba9-b29c-44d0bda93739"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/9235142e-db87-45c4-9b12-67b7d7f9424d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/f55544ee-210d-4698-899a-79b866f69039"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/2adb3d98-cce5-40df-a43f-42b38316daf1">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/ed032d5e-9d42-4214-b633-55de936fb27b"/>
    <rdfs:label>4 Fold </rdfs:label>
    <obo:OBI_0001937>4</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/0c22ad3f-e6bd-4655-ac4c-17ab94f3d996">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/3c00d3b4-d7f3-48b9-a480-901958819cbe"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/41421b34-3d33-4f60-a92f-fb82f7776088">
    <obo:OBI_0001937>80</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/723c0ed5-c7f2-4eb4-bb61-e37b52492c01"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/70165823-c400-4224-a9e8-59f6f34c806a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/dfaf40c9-5451-470b-9e4a-393094607a8b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/773c26a0-66b3-4b24-9bfc-1481550c2d0a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/5157cdbc-efa7-4f2f-ba88-dd4ce24c258c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/9ddf6cd2-706b-4259-b876-1a6b5238ae5c"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/fd54c615-29b4-4749-b868-dbff408e15b1"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/be351be8-0f14-44fe-b8aa-6ba8a455e27c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/661b1d9c-55fd-4010-a86f-4e264fd047ce"/>
    <rdfs:label>nefazodone-haloperidol interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/02cacadf-5bc8-41e4-a70d-8005b48f4c54">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/bbf4c188-e3c9-4a22-a3f9-9ca967968d9b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/9a35d398-c859-41c6-b687-ef9fef1ac3d0"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/09408d51-636d-40fc-bd84-91fe7fd9a2e9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/cac7654a-9afb-4452-bdfd-319d6b9d409d">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/10d83d25-cd15-4749-9579-ff5a5116cd2a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/fa3acf58-35f1-4245-bba3-1b27de4e4b33">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/8dd8fc49-8aa4-4218-aad6-0da1b008f3bf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/54a16bb3-7a4d-4b9f-9ebe-fce4a374b535">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/63d967aa-77a6-47df-91a5-d5fa8dd77cb2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/2a6896cf-54b3-4404-b278-55e7bb9a49ca"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/c76e7734-3cdf-456e-8631-2b4e6a5554e0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/1bffb90e-8475-4355-be41-607f956ffe3b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/aff37e07-1698-4c63-9a70-33e06550e183">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/b54c20c8-b496-4de2-b49d-8752f30ec8e8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/4bfd235a-5ec7-4200-8a46-a2cb533acd0e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/ac542df8-dbae-46a0-bf48-da59adffce38">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/d35ba66f-9416-40e3-a377-3b117a0a008d"/>
    <rdfs:label>6.73 UNK </rdfs:label>
    <obo:OBI_0001937>6.73</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/5206a23c-f5a1-4c68-89e9-d41cb895bf01">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/4f1fd5ae-27b1-4a61-98d5-f7e85c06881a"/>
    <rdfs:label>unchanged None </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/IAO_0000109">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/6abb3d8f-7c59-431b-8ea3-4a02aef0d384">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/d819ef6d-2fd6-451d-84f4-7d28f7c860bd">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/f76f49a0-cdca-464a-b2b3-54681b16ab55"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/db3c559c-6ec3-4d3c-b1e2-58c2b61b8ef6">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/e8a376d3-7c8a-40df-ad7c-b3fcad0259b3"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/579e1abc-caca-4bf8-9b9a-20a2973398df"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/c78a4062-068a-4a31-9e4f-55b2f117c40b"/>
    <rdfs:label>ritonavir-erythrohydrobupropion interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/eb253660-650e-4c2e-87c1-5be56be258a5">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/2d68a3eb-4ba9-4832-b12c-b8eae863967e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/71824001-e91e-4e35-8cf9-478acaae36c0">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/af7c795a-35c4-42e6-a763-d46c68009681"/>
    <rdfs:label>16 Percent </rdfs:label>
    <obo:OBI_0001937>16</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/42441020-1783-4e38-a036-561c516e8a64">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/e96c6008-cc2f-4d17-8e80-a53bdcf190e0"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/7d93551d-5399-48ae-bc2f-034298b1d19a"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/16b9c2a1-3f5c-46ff-b030-7ced14d1011f"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/44ae643a-3e0c-4f1e-8d9b-c0060de52b85"/>
    <rdfs:label>Cyclosporine-atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/4af0cf64-4a66-4ed0-87f0-7a5885db89ad">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/c7a0355f-15af-4dc0-a346-d748f8615310"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/e9a9333d-76ab-45d3-a0b6-4bcb41bcf5bd"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/93361e1f-8ccf-4b7f-ace3-036f14cc59ec">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/61b4f09d-3bac-4346-9293-764531352a75"/>
    <rdfs:label>nefazodone-digoxin drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/25c96b69-9963-4d29-9334-bfb7692b055f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/35c0591c-60ab-4fb3-a4e7-f5581b613cd7">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/a07fe148-9839-4ba4-9437-bec4b3732ae3"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/b3006dff-6339-47e7-a517-1b1cedb8eaf1"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/dfb6b7a9-5570-486b-a0f0-227b8522ebf3"/>
    <rdfs:label>duloxetine-desipramine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/edaf54e5-330d-413e-9999-d517398d3c49">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/adb8bfa1-4a51-4564-9950-4f76cca70804"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/bb83af92-8e8e-4770-ba7b-284f255cca85"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/45e61dbd-8001-47d7-bee8-ada284e8101f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/4c5b85fc-8da9-4cc5-84ff-14c6f5ff5003">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/2defa171-ded4-4e2b-a125-c68cc22d8cb6"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/4172e3ec-4960-4090-b2fd-a07214e1caed"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/3968c791-0f3b-493c-8865-2916449e634d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/86062765-787b-4a53-9553-8c34f46cbcaa">
    <rdf:type rdf:resource="obo:RxNorm_39993"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/19e8acaf-76de-4329-905d-bbb9ebdde49d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/9fc25a10-9f8a-4e78-93f6-f910639205c8">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/4b333a2d-ca39-47eb-b9a6-1514b2694e31"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/95a811f2-2e8b-4ab4-a456-d30df4809795"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/cfd74b05-c0a2-4a0a-bb0c-af5665be0f6a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/bc6274e3-045a-47d5-8a8c-27d5f4670e67">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/821815c3-d9d4-4d19-8e12-228ca3589f09"/>
    <rdfs:label>phenytoin-mirtazapine drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/cddc8db3-36e5-4778-a7e8-f76249b5fa5e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/b2937023-a66d-40c0-bb6c-9e4bb0908e91">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/6e02a7f3-ec96-455a-afac-065c83ffa368"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d2646a47-3ef0-4ab2-a4be-7a2301bb8d0b">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/e171cb85-302f-4398-90d9-e21f405ba6bb"/>
    <rdfs:label>51 Percent </rdfs:label>
    <obo:OBI_0001937>51</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/9ff5c29a-4589-4e28-b5b5-01b2d3cc7d48">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/9992ef3e-e126-426c-88f8-6433d49b7302"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/ed12a61e-b770-4bd3-b0c4-7c7becb862c9"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/bdb4663e-07e3-4cf9-bcc8-e2c7182cf0aa"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/34375e93-914b-4b13-b754-8293293bd544">
    <rdfs:label>Fluoxetine-olanzapine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/e7188977-cb46-4d8f-9afa-8fab41a57625">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/c3f92e10-48ec-41c3-90e1-8404f3359bf6">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/f735df1b-2002-4683-b5cd-f6b551eb4dfe"/>
    <rdfs:label>149 Percent </rdfs:label>
    <obo:OBI_0001937>149</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/8904d496-de25-4252-89f9-0800915f8a68">
    <rdfs:label>duloxetine-warfarin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/d97bb25e-51bb-4d19-b354-336f576f9d9c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/fd914744-5d0b-452b-8105-3db77360ce4e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/85abe0cf-6bab-4e6f-8f07-b1f8f641d213">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/238f44ea-c0a3-45f0-8b89-76c62606ae88">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/fd9606e9-0fb6-45b9-8207-8f0479374d43">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/bd05db0b-010b-44a1-a3bf-ba0dc3e1ec4b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/bfbcd0d6-19f6-410c-8045-77e473731863">
    <obo:OBI_0001937>250</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/9274e001-1492-4fb6-b185-4a1537ba6e06"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/fee3b57f-b55f-4561-b33c-2429aa45e8bf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/462184a6-1d23-408d-9aea-e097bd8f701c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/92933fbb-4d73-4d72-8729-107bc91324c2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/f37c5665-5aab-4504-a863-3b8cbe2b8794"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/70b334ac-16a1-4850-9c98-52189df0ced2">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/cccf8414-0b16-445a-bf75-7f2b6cb604b7"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/37d51499-d478-493a-8053-37e69d098e1b"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/3b2293ac-cc9d-4625-9118-4017ea2505a7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/40797bb9-eb9b-4bd5-bf2b-7ab484316d34">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/e208d4a3-4dda-4b79-ae8b-c5818ab96677"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/bd89eae3-ebc8-4771-88c9-3fb361223cff"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/897fd39b-bfd5-47da-815c-9d0ab069e030">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/47939dc7-de8b-4253-a50b-eb769c7ae475"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/30e22f71-fb1e-40b1-a440-a6b24de45a60">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/80fe5724-3837-452e-92d7-eace14c306be">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/477b7abf-6c3b-45c0-ad1d-7ca104c87c2c"/>
    <rdfs:label>2 Fold </rdfs:label>
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/65d1c036-def9-41ab-881a-4a7b7260efb3">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/d6c5ace0-2d23-430c-94bb-033ec2922a54"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/d8034f2a-c5e8-46e4-9670-bc215da8e1f2"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/91755911-b834-4386-b2fd-19bf7ae54ab0">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/18f4d6c1-a5e5-41a4-9b31-acf5c23e3dca"/>
    <rdfs:label>UNKUNUNK UNK </rdfs:label>
    <obo:OBI_0001937>UNKUNUNK</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/b3ceb397-b06b-4950-9556-daefec1e67c3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/cf5e9a63-6723-4c88-9660-c78cbe9bbb07">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/7317af06-0e8d-4422-91ca-3d8b06c4ff11"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/82433ba6-2e85-475c-bc7b-486f7e178689">
    <rdfs:label>ketoconazole-rivaroxaban DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/ab52caa7-41a1-47b7-b0bf-79354f55dadf">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/889a3446-bd5e-4239-ba05-e249f0a0ebc3"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/cfc95d77-c974-4bef-8a7f-465cabb4563d"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/d4fcef1f-e611-4fb6-a1b8-0e945f6f428c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/RO_0000053">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/168b7250-35f6-44e6-9984-703725973f81">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/c7cb95ac-cc04-4fe7-8d17-d66d4bd3be65"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/042704c3-e134-4090-a6b4-2a7b59e6a4b0"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/a90bb9e3-6931-4893-86b4-0a37ce41d991"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/cead34e8-6320-4a63-a041-228c411c4156">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/d5257dbc-082e-4fda-af4e-f64d6b2c5d5a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/786a98fe-951e-4d3d-9415-b7bfca21163e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/0c02ecc2-850f-4e8e-8933-b6f3e9b3bba7"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/cdba2ef0-7faa-4c37-b0e8-be0fe363bc93"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/88f23773-311d-48b3-8eb8-7db0a0aeb102">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/623174c8-9047-46aa-821b-6c8ef6464160"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/7cef3183-1e1e-45e0-971e-d6e0374069c2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/8624df18-0b92-4da6-a07e-81ee73121fb3">
    <rdf:type rdf:resource="obo:RxNorm_31565"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/3fd62a44-c8c0-4582-a6f0-5c16e493d2c4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/1d60c51a-d7a8-4db8-9d80-633f4ed776c9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/85706667-ed32-4783-b360-c9f23f0e9a00">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/4d98132d-a53c-46ae-8b3a-69c720b6498c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/fca95edd-70fb-4ec1-92d7-326c6c9d8433"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/b85966c4-f9bd-4cf9-9c51-9997c9fca414"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/dab90f05-4897-4852-85d9-2c159ecbf7fa"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/89d90dd4-7e4e-4a02-b37e-86ba1740264b"/>
    <rdfs:label>Lexapro-metoprolol interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/c75f164d-08e4-43fe-a9af-877c7f4893de">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/5411408e-041e-4983-bc6a-3bcefd230068">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/29b76738-c893-4c22-b639-6db15fd48d45"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e041fc24-51de-43e3-aafd-2104c1023d34">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/55a15853-d287-46b3-9b4c-8a8e178cedb6"/>
    <rdfs:label>telaprevir-amlodipine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/b17d593c-14db-431e-8ddb-6e5e37c3fbf1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/860be9c3-fe51-41ca-b90c-30bc7624cc5d">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/42098895-729d-4139-ae9e-78ccf1eb9465"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/3668d9ec-f3ff-408e-98fc-37e46fba4976"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/57b53531-30a6-46a9-8990-8156d06bf308"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d8a6aafe-d67f-45f1-ab17-48d3f7172e87">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/53701682-3525-4d21-87cf-27d0a9583e97"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/a19e1177-29f6-4ca5-a21d-6fad5a4eb29a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/24e48836-2b88-437f-9fe4-0d31bb0ec699"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/bfa5cb82-b74d-401d-a386-63ac83d70190"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/adf8e6cb-8603-4dbf-a14c-b3c5479e6e4e">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/255ae469-53f8-465c-ab48-c6aa3300d1cd"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/890cb348-a50d-4f2d-83f5-cf4def540cad"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/75dde4a3-74d9-474c-b559-a5724ca311fb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/37fe0ee8-681b-459b-aae9-b436963beb1c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/63a4857f-29ce-45bf-85c7-d5fd9687f95d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/165561c4-dc8a-464e-b7d8-632ced2e298e"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/93bbce2a-e782-4664-aaff-a8a7b85c12b8">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/97ca23d9-3e48-48b1-80a6-3b1fb4f5c76d"/>
    <rdfs:label>Nelfinavir-atorvastatin drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/22b88006-77b6-4366-9727-6edf507ccfe4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/1da19976-5fb4-4928-a73d-96daef8de91f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/ec6a5111-19f5-437b-811a-38864bb5e658">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/9ccdb32d-5734-4e91-ab72-ad1e7b1874cc">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/29b947fb-4b5b-4489-9071-f8b58c0e1af0"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/8778e029-943f-48f9-86d8-e89675d5b17d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/9b0b3d1f-7936-4aea-b1c4-f45f229ce9f2">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/a759e4d8-58f7-4af6-9822-09e8bac3bbdc"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/a9fb95dc-270f-4e13-a94b-5b7af6faf311"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/a121eff1-6e9a-4239-86b5-f0e9d4488a75">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/408319fc-03a9-4c02-b84f-4a8cb4834f91">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/b4a77126-0011-431e-8403-8e2f380e0d36"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/3875ce51-b81b-42f6-9fb1-2b126566178f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/b2ba8743-7727-45c4-9591-5ac7ad469f93">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/2b37e856-11a3-4e79-9a61-ba0aee0266f3"/>
    <rdfs:label>nefazodone-triazolam drug package halflife Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/2adb3d98-cce5-40df-a43f-42b38316daf1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/5282e30c-b7ad-4be5-b6e5-576fe58a624d">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/85af2864-c95b-4c7e-9847-19474c4e53c8"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/b850f103-b9cf-4752-a720-ae63b4082e6f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/923a0c09-002e-4758-9391-ed0e86815867"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/eb8d95b9-fcbe-412d-8d72-f37238f21887">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/798b3b9d-1c77-4eb6-906d-3b3cd7ad449b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/b55d0693-c800-4409-9e78-3455ddd133c8">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/30912982-9334-4b77-a196-9a0943ae4bb0"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/6517d102-f318-481f-b635-5013531d1707"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/484bf8f1-5f83-4c2d-8c16-32926342944c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/c13e4027-7bb6-4d98-b3e1-11ca1227dd70">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/21e65450-56c9-4f10-9d1c-40815c06e919"/>
    <rdfs:label>no change UNK </rdfs:label>
    <obo:OBI_0001937>no change</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/1f423d7c-33a4-4585-8e65-e716ab393e34">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/00e22028-d2f1-4986-a2aa-d54ce36fa954"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/372df799-5d5f-4e3d-abfb-e637d9c25aac"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/e866c84d-5844-40af-a56b-4d488a3163e2">
    <rdf:type rdf:resource="obo:RxNorm_1116632"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/23bbee10-9f1d-434f-bfbf-5b62dc3020f9">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/1d077357-97ac-4efe-a583-3baa98841f81"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/75b5289d-b929-4b28-b466-724553bbf770">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/cfb4c4cb-cc04-4b78-b24d-de3372162973"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/4425159b-77cc-4e30-9962-10f2b193f166"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/5888f2af-a802-4245-bf51-b5c5a4d3fa05">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/e041fc24-51de-43e3-aafd-2104c1023d34"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/1747c8b7-253e-4b7e-9951-d17f7a5f3c56"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/4f0bf5a0-e635-47eb-9646-a5ff472cb708"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/a00cab87-c88b-4656-aba7-2e12a59dabf6"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/ec049dbb-deca-47f2-a5af-978e712d8e8d"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/c09811ed-c8fd-4bc5-8667-4de8053d1887"/>
    <rdfs:label>telaprevir-amlodipine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/c8e12b9a-cf7f-484c-aef7-8a61358eda90">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/0811f084-7442-4d85-9025-565999ec48c8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/5843a2d0-089b-44ad-a4f9-ad7da5fec795">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/c0154d8b-deba-4ee0-b3f9-f2b0de2c1460"/>
    <rdfs:label>50 Percent </rdfs:label>
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/90b2ddae-60f5-4333-8167-e03a4eb29053">
    <rdfs:label>efavirenz-hydroxybupropion DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/2e94421f-24a5-4de2-a61e-9b8bfee57fbb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/7a42afe2-886a-4b8c-a4ba-52bb388f62e2">
    <rdfs:label>Fenofibrate-Atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/ba832875-ba1b-42fe-aecf-626624052c29">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/673852e7-eace-4074-8f9a-7a25c2e3f6c1">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/7994c412-dd9f-49eb-adab-39a30940d786"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/0a972fbd-c8c4-47a4-b682-818cb146455a"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/375aa9e3-4992-46e1-9d5b-c4441aa534e6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/10934541-adf0-4595-9d13-084163909db2">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/f866085b-1792-42cc-8a3b-260b24053bfd"/>
    <rdfs:label>30 Percent </rdfs:label>
    <obo:OBI_0001937>30</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/73de74ec-f776-42ed-8209-e83723dd1357">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/3ccbbc46-c879-4a7d-8c29-b8e2c4be68e9"/>
    <rdfs:label>70 UNK </rdfs:label>
    <obo:OBI_0001937>70</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/f78ec3ff-c64b-40f4-b982-23e287558f21">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/0a8ce5d1-4d58-4322-aa17-10e83acea3e7"/>
    <rdfs:label>56 Percent </rdfs:label>
    <obo:OBI_0001937>56</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/a3077495-f8aa-4baf-90b9-507e307d70d9">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/27f93966-02d0-4eb4-b50e-8d6739735f10"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/554d7c37-47d1-4b67-84ea-a38eeabb3854"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/040dc447-220c-44a6-9f12-4b2124b27e04"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/2237d5e3-5f59-4cb1-843b-9ba79895a654">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/00431608-6cf1-4abf-aa08-9a286d5b091f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/bef96ea3-bd18-4243-9959-336568b1403f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/cf4c3134-d423-441b-a9b9-edbdb69fa149">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/756c4569-7b31-4f49-8735-c271fe295084"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/173f8382-b077-4ef8-9a45-014718917b78"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/4ffa88c5-80bc-4505-ad67-382fa424fb85">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/ccc92cfd-c7a1-4dca-a1f8-ead5e6f3248d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/b06af83b-f3b1-49a6-8648-08d5d386a821"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/161878a3-355c-4b3f-a327-90370d3ad9ee"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/a5d5738c-f344-4863-b092-0267c050b5aa">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/35360b8f-d3c9-433f-bd7a-beb68bfaf9bd">
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/7d917cf5-40d9-44f1-a2f0-a771787708db"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/b1d35907-8d18-4a80-baed-a95bab92abfb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/51298d74-3aae-4cb9-bdaa-dd79973ec7c3">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/8a9ca2ba-7cfb-4741-8e61-4fefa62ffc28"/>
    <rdfs:label>58 Percent </rdfs:label>
    <obo:OBI_0001937>58</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/2b37e856-11a3-4e79-9a61-ba0aee0266f3">
    <rdfs:label>nefazodone-triazolam DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/c77ddce9-7dec-48db-a414-92cf192dffee">
    <rdf:type rdf:resource="obo:RxNorm_1546356"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/c3aa8619-8ec3-4e18-981b-3bf3a77e2024">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/308b24a5-7eda-4669-b6b5-7adac382995c">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/2c39010b-43cb-4591-86d0-cb2c4debfff2"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/7c29327c-a174-43b3-9e02-95b23d47c507"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/f7f3f380-d387-419d-9cdc-bf9bf41204a7">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/4804fd71-b5c2-4432-b585-b04af20a835f"/>
    <rdfs:label>paroxetine-P88 drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/f6cd580d-897b-48b8-b7af-789c8d48aac8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/3d8602d3-514b-4026-bdd3-1452bd6f33dc">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/b9dd8860-010a-46e2-afd9-33b6b7b2afa6">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/61785908-12c8-4c03-a2c1-ebaad62a044f"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/fc5faece-cc65-4a3b-8e8b-a5639ee2deb8"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/01cd61ef-d8e5-4aac-9c5d-f07171a0e18a"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/02a85d6a-8754-435d-b47f-a8e03a3293f4"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/d69e39bb-0692-4bd6-8033-641dbaabddf2"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/80a68cba-449f-4b3d-a3d3-b7cfeda81a0c"/>
    <rdfs:label>rifampin-pitavastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/c2989691-4f6a-4852-9c0a-0f3276ab26e7">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/115fa996-d20a-4821-a8ad-c63b05bbab1d"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/9c21da82-74df-48c7-a0ff-42a08b0ed4ed"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/dfe8b068-9eab-414b-bcfa-8cda9bc332b2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000312">
    <rdf:type rdf:resource="http://www.w3.org/1999/02/22-rdf-syntax-ns#Property"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/02d6b207-1e5a-4f50-bb24-129b5b463987">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/bbacb8df-4fe7-444b-aa0f-c1e410bbbea4"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/9bd7cd8d-446d-4e9a-8759-eb20c5301444"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/5eff0dc9-843d-4283-8753-70b7a110edf1">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/99775fed-1350-4897-a8a0-ace9bbdf5938"/>
    <rdfs:label>82 Percent </rdfs:label>
    <obo:OBI_0001937>82</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/79470e73-458f-4fe0-af9d-084dc7ea7b15">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/a0f7aa12-9f73-421d-b2cf-60fac651fa4f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/e15612f9-07b1-4c66-8b58-c52e62895d4c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/0ef1cf94-2dd5-4c2f-9dfa-67311391aa2c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/1fc53bf9-475f-498d-a48c-a62521eace41">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/e8d0262f-6f55-4b37-b60c-c6d07f235285"/>
    <rdfs:label>2.2 Fold </rdfs:label>
    <obo:OBI_0001937>2.2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/b7b638f7-3c5d-4135-a256-da9659815d31">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/b034b3c6-4d27-42ba-9d04-c053eaf4a8c7"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/de9052b3-7652-434f-9797-6e07ef654c8e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/683847df-46d2-4042-9d6c-eff4cd873562"/>
    <rdfs:label>clarithromycin-dabigatran interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/b0523029-38c3-4ce2-9f29-6739a8a520a6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/8bd36961-14a5-4f18-97dc-f72dce3e761b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/42bdb7d8-7eb4-45f6-b88a-d51becd55089">
    <rdf:type rdf:resource="obo:RxNorm_39993"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/b2740b75-d67b-4490-9fea-222f4e91973c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/78c55b77-16e1-4f21-95e4-7c453a6a2ca9"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/9027908b-8bf9-4b4b-a176-981077b89412"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/fecab007-5301-4365-aa8f-10834650f972">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/27617c2c-679a-4314-b6ff-109e020faca5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/e26de6e7-9387-41fc-bba0-5cdcd108df0d">
    <rdf:type rdf:resource="obo:RxNorm_6135"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/99ee5243-a016-40df-b7ba-907c15c382ae">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/a302b46a-0f79-4fe2-b33d-31a615609297"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/57a5a611-5c7f-46fc-ab07-db66a27e7617"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/7ad1306c-3042-4b1c-bfd4-c1867cf5c4a9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/c9eb8eb2-578c-40bb-8bec-c6baf058d99a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/ec260ab9-1876-48c5-b44f-43c0d2573cb5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/4b101cf9-7efe-456a-ab4e-3143507b300d">
    <rdfs:label>ketoconazole-mirtazapine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/729675ce-7029-4352-b1f7-87f9ebd18146">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/3534b536-af87-4f0f-8b3d-11d305614d36">
    <rdf:type rdf:resource="obo:RxNorm_42355"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/ad211dfd-b7a0-4e04-a960-87afead31c40">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/a2032d7d-9044-4c94-bf13-a2c94c5747f5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/dd943484-20d8-4dc5-9695-b9294a1a9150"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/31bf9436-f4dd-4a42-aac7-aae95f10a4d2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/c13b1752-a306-42cf-aa32-941ef11cd373">
    <rdfs:label>cimetidine-citalopram DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/1fbd7e5f-cb40-4b4c-b12d-bc30640fabbe">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/a4078a76-671b-4d40-9978-18b2c95b9fbd">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/56be8156-4cc5-4690-ab03-88ea23cc76f7"/>
    <rdfs:label>ketoconazole-zolpidem drug package halflife Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/e85f3b06-c5f9-49f3-a74b-031c408531b4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/27f21b42-bb85-475b-893c-214be68cd673">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/d9306a5c-2fab-407a-be75-840c7bfcf529">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/4af610d1-0fea-444b-9a23-28d48b8223cb">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/c89f54c0-cfa0-4222-b2c0-7d735744b4a7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/aebb348d-e348-42e4-b693-41e6e9472345">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/d5a93f89-e7cc-4671-a5e9-e697f11a9c64">
    <rdf:type rdf:resource="obo:RxNorm_81864"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/9eab51f6-a8e9-4e5a-be9d-cdee2b884526">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/767b5284-477c-4ee5-8b56-b3faedda6ac7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/f0918d8b-686f-4800-ac9d-817ba340bcbc">
    <obo:OBI_0001937>Unk</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/5fa17a03-8c2a-4d5f-be4e-3213af47fc93"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/2daadf57-d274-41e1-933b-61cc59b1aefb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/daa53e55-5122-43ce-a11e-5ec7d0949584">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/58521e8d-d0dd-448b-b53b-4bc9b8b13174"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/6c73aa9b-9e2e-4431-b9a3-941df6382767"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/e1646697-1fc9-4911-80e5-e93e828d9102"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/29acd8f3-bc25-4442-9695-96948b154247">
    <rdf:type rdf:resource="obo:RxNorm_358262"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/c5b10008-2210-417f-8d80-bf40ad20bc6d">
    <rdfs:label>Nelfinavir-Atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/ffe5f269-8271-4aa5-8264-394fba1f57b6">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/eed6e205-0141-401e-a1c1-e3a545dfc694"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/d8d932d7-f7f3-4c03-aedb-9e73cff34f5b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/39fb518c-77d2-4ae9-86e2-c5e455ab295c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/6e7ccb03-a767-4102-b818-a518ca147901">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/5e4c8cbd-1d12-4ca2-b75f-aadaa7174b6f">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/5872ecea-6410-4fed-b0dc-c6d45ef4cff8"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/c1993858-47e5-4439-ac39-b4a312f2ea77"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/7e52bdc7-d155-4ced-ba6f-c17a0bf7cacb">
    <obo:OBI_0001937>325</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/a9c4641e-ec93-4510-81d7-60f97085c3b3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/1b8e98a3-ae3a-4f40-9aba-9e10fcafb8c4">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/cee6b0e4-0f4b-4d0b-bc28-37ba1a240a3b"/>
    <rdfs:label>87.8 Percent </rdfs:label>
    <obo:OBI_0001937>87.8</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/edfd2129-f912-489a-8981-f58a56d3fd0f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/20f50b74-00f5-4206-bb49-fde769f1b5e1">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/792ab9f0-cf9a-4a24-81da-7a7a08d34a4d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/f6b19bb0-6ef9-4bf5-b773-a2f12d7e294d"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/b3ffb6c2-66fc-4503-b679-239471391bf5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/ad146fb3-f07c-4462-a576-ff2a61df26b4">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/a1ffbd57-44fe-4db2-a212-69c49fbd8d3d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/23aa7ad5-824f-49da-8800-e6838c9a3ed1"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/4aafec4a-2a27-4855-a8e8-636353b9cb1b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/47cb7427-1758-4629-9b17-76e7d3a9bd93">
    <rdfs:label>desvenlafaxine succinate-desipramine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/4331d516-1286-4c4f-bdcd-0eaf315aefc8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/b44d89c7-e780-407b-b9bc-59e3c47b35ac">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/c094d320-c94c-4055-a74b-17f08352fc8e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/de350af9-75b1-4db0-b90f-940d8af2b078"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/1cd0e9d3-6c86-4f7b-aa07-9d356c0f18a5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/fe1281dc-0616-44f3-b33e-7ed912a5629c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/25595753-b724-4d65-989b-f0090ac7490a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/4927105a-da50-4d12-b016-7f6e99a2059b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/225b0e97-33f1-4152-bcc3-44aea204ba14"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/7439dc69-c5b4-4d4b-9f95-fd226d841a40">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/2fd4d117-cbff-4441-878d-ba39e939756a">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/6d6077c1-430e-4413-ab39-7e7b6d8772f6"/>
    <rdfs:label>unchanged UNK </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/027b5f58-8de4-42c3-b325-a99a63209742">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/a95b657f-a844-4ad3-b902-c37a20eb16e9"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/3a023c19-fe29-45e3-8806-1b4c4ea159fa"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/2a60b81b-5f9c-467f-9397-e1ddeb2b99ef">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/69c86525-6950-4964-a40c-41cd2d51047f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/bad6ba6e-2139-4fe1-b42d-4c62cbf8e95e"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/f65f8e4f-2e6f-4bd9-bcf8-31d0edfb8b32">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/7af0ccdc-1054-4c26-aaf5-043f0258daf4"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/e0fd6afe-f3d1-4f43-bab6-e0379681a411"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/614ba190-86a7-490d-b841-d2ec115481ae">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/09d1b62b-43da-48e6-8cc3-caf9bb92e1f3"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/f04482ae-5783-4ad4-9a46-9d2ec7b5b9ff"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/ff94d62b-b49b-4899-94dc-413bb33ee7f2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/a4563bcc-89f8-4e47-9ab0-6d633c282dbc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/c8fb783c-ee4b-41cb-8b99-610bff2caa59">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/3e0d2947-5bf2-47a8-b1d7-28fe79f83d7d">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/0d1d0c0a-0404-41a0-8d0c-541e3210a498"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/999ba9a9-cb46-492b-a901-920c0b60c960"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/fa8b9af6-583d-42bf-9ccc-f2ec53cc2be6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/54e3507a-3a45-4c01-91b9-a4bface99622">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/a51f655c-a24c-4f7f-8c24-e302e69e7d99"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/b8edf3d8-ca76-49ae-9a0b-8c3878c771cc">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/1177a5ac-c1be-4977-a27c-c29909e971c6"/>
    <rdfs:label>1.3 Fold </rdfs:label>
    <obo:OBI_0001937>1.3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/a37c03ac-eada-4432-bb68-0da629eeba9f">
    <rdfs:label>Nelfinavir-simvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/a31c6553-9946-4775-bf95-8d921debe6f2">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/e68e84a6-14b7-4779-9425-127e0b57d9bd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/0498b349-4580-4912-9985-1bf9369e1f48">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/09e6a516-9766-4738-884b-659de2002ddf">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/a224f2fc-6240-402e-ad5a-0c786257a408"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/c3911cb0-19f3-4f26-8c34-7cdd0cb72575"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/4c199232-3747-40e1-b48e-ecdba924b975"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/e655fa8b-8503-46ae-9d5d-babff688cb51"/>
    <rdfs:label>paroxetine-procyclidine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/6409a91f-4b27-4897-94b3-20ca1951a877">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/eaa30375-bc2e-4652-84a7-aa0d71d942c2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/a19189b6-26f0-448a-b650-e2708897ba39"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/33ebb8d5-a52d-4462-8431-00f1ab6b52c4">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/8e2471ef-0999-4bbb-95c4-1171f503d5c8"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/5743131c-fc58-45fb-8c7d-29bc162ce9a0"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/34726716-d7d5-484f-ab87-9c70c385ca13">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/aa0c38b9-be15-4f44-9e69-3c98445f0287"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/06d24018-a5fd-4311-990e-952deafec586"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/d25837a5-5027-4603-a81e-60efe9e7ec22"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/0a1b38b6-76be-4466-83c2-1855011a1f77">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/bf354f90-d962-4546-9ed1-80a666ffdcc1"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/4eabbd18-a305-47bb-96a9-1b1538e4687f">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/35ea7019-b383-4c2a-b7d3-4ef15e8138bd"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/1099595d-5a8c-48f3-92e1-ac8e041f81ee"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/59415bf0-3ed5-4465-9a91-97581eab3708"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/da424c76-bef7-4b40-809c-f1b7fc893282">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/b2c838c8-8829-4f28-8660-bf2377375ad5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/b0d985b6-c200-4692-a8ec-11224800629b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/728fbaf7-13b5-4c76-a41a-384cc78cf2ee"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/c631837b-a385-4c59-bbee-82f04d32d7eb">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/79d76a33-7c00-48dd-95f6-be566f957722"/>
    <rdfs:label>12 Percent </rdfs:label>
    <obo:OBI_0001937>12</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/a5fe7cf0-355f-4226-a4e0-6b68e1050924">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/6a3923d0-c85a-4f2c-ba13-51e3e8fcd031">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/54263a1a-167c-4bd1-93b4-9215320ad1c6">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/96995f7b-ea34-439e-a1c1-827eb52d2fdc"/>
    <rdfs:label>3-4 Fold </rdfs:label>
    <obo:OBI_0001937>3-4</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/100bb300-8560-486d-9d99-868c00b8447f">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/aa0c6ef8-13ab-40a6-8be7-4291fee1606a"/>
    <rdfs:label>fluoxetine-iloperidone drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/2a570d86-e41a-4339-8ac2-d3ed0336b33b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/0045ecd9-0a56-45d3-851b-3d17c2052107">
    <rdfs:label>pitavastatin-R-warfarin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/94d9a8a8-05ec-410c-aecd-ba7a9fd6a25b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/fd622ee8-e0ca-46bd-8a84-efa1e6919ec3">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/d75a2eef-6460-49db-aa1f-ae3aa4b246c3"/>
    <rdfs:label>Efavirenz-Atorvastatin drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/a2622d70-07f5-4b33-a6e8-413970182302"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/00648e24-57a3-4683-9fc2-bd8991f3761c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/f27b9271-2079-4b2b-bed1-a5bafbc56e07"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/fdd79c6b-0924-41b4-b6c0-b327f782e41e"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/df94628e-562a-4212-b9f1-6eb255031e82">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/3701078b-4fbe-4669-8b2c-448f142e63fe"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/d83d8854-1589-4da7-b689-20468e94d09f"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/11765265-4e66-418b-961d-544360d2b5a0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/c59dd7f2-8986-4406-a08f-dd55a1636f6d">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/6d43ebe7-a9cf-4520-bba2-53084b6e1de7"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/3414c94c-371c-4c3b-b6fb-ac2a31ca7e90"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/0fc387d3-6922-47aa-8fb6-234fa5a50418">
    <rdfs:label>carbamazepine-hydroxynefazodone DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/c16557b8-9f4c-485b-aa61-5f5928efc487">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/4fbb857a-065c-4c14-a950-60a4e2137534">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/17c3a02c-2a9d-4786-a7ce-1cea9d3e7609"/>
    <rdfs:label>ritonavir-rivaroxaban drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/638f4910-f821-4bfc-b3aa-39e9d9c0c0ed"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/9992ef3e-e126-426c-88f8-6433d49b7302">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/e27fe75e-e85f-4cd4-9c4b-9da01aaa8e43"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/a7dc7ad1-5c1f-488e-a22b-698102726e5b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/ca6fc921-2153-48c0-a405-cae85a2914c2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/7415f0ef-885d-4606-ba53-4f5554751588">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/d8405d00-9b23-4d0f-a30b-924433f34622">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/beb5f7c5-75c0-40de-b6a9-ba70a626ba82">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/d9bbd2d8-2146-405a-b2c0-e0b9db5af319"/>
    <rdfs:label>ambrisentan-warfarin drug package auc  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/bfa599e7-f076-4801-8d04-3d807eb73727"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/114acfed-c984-4ce7-9a5c-e3edfb761953">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/fecab007-5301-4365-aa8f-10834650f972"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/6e2a2740-deb4-416f-b173-1c11a7bcfacf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/1fc3159f-d497-4f9f-a8bf-a73503c54d77">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/54c23983-43cf-4bee-bd4d-90795c1e135b"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/df859daf-d6a0-4259-91b2-a8c38aa9b14a"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/1b942040-74a0-41d1-974d-a1142ef7e9a8"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/47a9598d-76a0-4b56-9aea-0f5332f69fe1"/>
    <rdfs:label>sertraline-cisapride interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/0cf07a79-eaca-4309-9138-bc2f5a492907">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/0a52e8b7-c95f-4ebf-8a3d-a821842da3a8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/5bdefe20-28a2-4fb1-9e46-9624388d4079">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/267a2710-7609-4ad3-b349-5b9955dd7898">
    <obo:OBI_0001937>400/100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/c6162111-0a50-4e0c-979b-5db2f60ba885"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/95c73558-29c6-457e-9b95-2c44ca0e845e">
    <rdf:type rdf:resource="obo:RxNorm_73178"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/211a7c8d-5f2c-4aa2-bb32-cf584f8ab386">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/c47518ba-b1f9-491c-96fc-0f989280487f"/>
    <rdfs:label>38 Percent </rdfs:label>
    <obo:OBI_0001937>38</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/eebc18ff-2bbd-4ed9-b5b4-fcf0fe82171c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/99755f07-86d4-4d1e-9c08-9cf22be15ace">
    <rdfs:label>sertraline-zolpidem DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/37dfe445-6045-4860-82cc-6c5da38e13e7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e6f05658-e3bd-4413-af83-720e936f3435">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/3e4e9021-ce25-4456-8687-c6b27eba52b9"/>
    <rdfs:label>ticagrelor-dabigatran drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/1cde2fe1-1d39-40aa-bbd3-4cd7fe69bb0d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/68f8c743-62e0-4df3-a142-cd3976beab70">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/a358650b-1691-43b7-b701-c08c4d5852c6"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/d63a7d7b-f942-40cd-84a5-a32388036b4c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/f32831d4-da9a-48a7-ae67-199437504ffd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/ac42e97d-317e-4df4-9275-ca20165d797c">
    <rdf:type rdf:resource="obo:RxNorm_31565"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/8b1f7f2f-050e-4813-8935-2f20c2a3bce4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/27c5f5f0-70c0-4b6a-beae-f2d553b5fbf1">
    <rdfs:label>fluvoxamine-duloxetine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/e3a2e0da-4360-4933-a2ed-c239b8c7659b">
    <rdfs:label>Fluvoxamine-alosetron DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/e5e98bdb-955d-42ff-b34e-f44494a9f585">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/d51598b1-192f-4787-9e24-30ecc3afa510">
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/729675ce-7029-4352-b1f7-87f9ebd18146"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/1d7882cd-beda-412f-bd35-528f80069658">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/eb031b2a-9110-4539-8bc9-da3eef7bc45e"/>
    <rdfs:label>20 Percent </rdfs:label>
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/f3110f78-0c49-43ee-9b08-15fd45f39b2a">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/c203ae74-329d-4e3d-924c-9dbd8f6be14b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/93b49760-8a72-4dbc-bc4f-2acc11c07d0d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/be26d186-e05e-4f36-875e-11b0b52d63c9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/70cccd96-266c-49ca-a78f-e9c40a214d8a">
    <rdfs:label>Rifampin-atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/a5be37e2-0602-4843-bf80-74a870c31d6b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/c4112905-32d3-4118-a940-521d6aeff56d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/3425ea46-6356-4eb1-8cfc-8d97b3fb2a62"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/4610a90b-2b8f-4425-ba55-4b48d82b5751">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/e132fbd8-106e-463d-a406-0cfeb9d4cb9a">
    <rdfs:label>Diltiazem-Atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/a2e3232a-6e47-4552-b4dc-3ac01b819e35">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/0e04198b-12d1-42f6-89d0-18aa0586124c">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/38085ce6-04ed-4f4b-a8e8-ffe5f3c7ac4b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/88b24d66-b8d7-4ccd-9457-6f295bca65ec"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/d4b11581-1d21-4c6f-a06b-9efb99b9afea"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/dd0bf265-597c-4675-bb5e-f3ac34f4745c">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/59065a10-03e8-4242-ab82-96545716e2f2"/>
    <rdfs:label>ABILIFY-paroxetine CR drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/e1120b05-ddbb-4e1d-865c-583da3d39286"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/555985a0-f88f-4353-a03f-47912ff0b148">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/fd486a4d-fd47-47e5-a0ea-e7217cdd980a">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/fd9978b1-6095-4e58-9cdb-2448a53aafc4"/>
    <rdfs:label>17 Percent </rdfs:label>
    <obo:OBI_0001937>17</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/798cbd23-0b08-4903-8d02-303d064d7b57">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/93658087-eb59-4277-acf2-5c182a508179"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/b06ea772-28ca-4254-a1f2-62a97d39a970"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/322dacf1-8e47-452e-b234-1301652c7866">
    <rdf:type rdf:resource="obo:RxNorm_1439824"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/758dde50-adac-42f0-93a7-bdf61a2107dc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/b98641e4-94ec-4c2e-a952-e6edc9d85654">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/79567f6e-833c-418b-b235-d2cc63d6e5d2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/2c1d5d67-4bdf-4f4c-aab3-26c56ee50460">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/21f3e5a1-48ec-45a3-ad79-a6939b86930f">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/bef2d228-b9cf-4065-a6ab-57f061c8f70e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/f6e3871f-3fd0-42c0-8795-bd9d8ad8e260"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/c154c56e-66ec-40c6-997b-114a0446f715"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/26f1ef73-c96e-4a8b-969f-555f2e6ddb0f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/6faf09e2-fe8b-4761-9881-162df6d2e114">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/7c5f27f0-1f37-4eb3-aec1-e7f76a63fedf"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/2448455a-6823-4215-a27f-4044c8faa118"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/de9052b3-7652-434f-9797-6e07ef654c8e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/373adb27-2827-4094-a7fd-7069748dd970"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/a9cef03a-7e7b-4316-9aa2-a8d11d939151"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/df062075-90e3-4912-bc50-2aed1d7e5766">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/8421583d-c510-4977-b401-45992920bf65"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/c47c2107-45b4-4fdb-bb30-141ae5f15898"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/986670d5-3e75-41de-9f5b-5f3e127c4d3b"/>
    <rdfs:label>risperidone-valproate interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/3eb85019-932b-43b1-90b3-ead196924c5b">
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/9b3236ab-6576-4d00-ae40-316c6e6921de"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/f5bfa07c-0206-4883-a219-b10557d81821">
    <rdfs:label>fimasartan-atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/041bd646-ec64-41b3-be04-f77b286580cb">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/e6ec73a4-d1fc-4962-a32a-59a2847aa3fd"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/2b9b0c9b-6408-4a9e-b046-3838c77172f4"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/e2bc8818-d621-4b1c-b39e-7ca52e0d3306"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/ec5fbcca-97b3-48e1-8622-f544473f147f">
    <rdf:type rdf:resource="obo:RxNorm_36437"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/cbbfc020-fb83-4ac0-a287-11e0a9880810">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/OBI_0000576">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/e53c7a51-d624-4ca8-ab80-b9218a39b248">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/d823ce24-1938-4ddb-bb16-374ac14ac25b"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/7bfa13b9-c346-4748-97d3-5d61b1c2a179"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/86627efd-0e10-4506-9fe9-dadc55ccb789">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/11b92c69-6361-4e3c-97c4-06a39f0026d2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/1e733fd4-30c6-4156-9fd2-87bfcd65cb6e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/08f3b417-e877-43fa-83c6-83ee04d0ad55"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/19446387-5cfa-436f-a986-8044e1a10f10">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/4a72e9d4-0b7a-4450-8d56-1183c7c4fba0">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/5218cea2-f3b9-4f2e-b5f5-9cfb7a7f5b9f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/9919ccff-fc96-40bf-90f0-aa503f5ada9e"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/4239bb4c-8a6b-4ad0-9ba5-e942a5ea3a23">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/6bd8ea0b-860f-487f-a78d-6071b921d683">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/52fd3542-48ab-4e8f-90ff-7ca842c805c5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/8c05f609-ecea-410d-ae39-9de12cb2d47a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/930a2646-f3bf-43a1-bab0-38e017497df2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/dd172577-9fb3-4585-9243-2894ae7fe7e5"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/b06af83b-f3b1-49a6-8648-08d5d386a821">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/4cd94f1e-6744-4770-9c52-437bbb7260d1"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/d23bbff2-02c2-4ead-94b1-cb4a148b05d1"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/8ff96cc0-aa91-4a32-acea-b9b72a21d2a2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/dbe8dd00-963c-4b52-9d65-c2fcddcdf296">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/70df8e7f-e7fe-4195-b2e6-49b889126ab5">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/d210e26e-2b32-4c79-a1a3-49bf621ca9d7"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/4025d067-1ed1-4c72-b840-713c8cd94ab3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/d277d365-ff99-4e89-b24c-554ab412b714">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/7cd4a1ab-fa64-407e-ac7a-a70925ee16eb"/>
    <rdfs:label>27 Percent </rdfs:label>
    <obo:OBI_0001937>27</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/37e5269a-d014-4063-845d-30cbe2517c8c">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/2528b0d7-8da6-420c-8c2a-f40840252956"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/e1ec432b-ef74-4ed0-adbb-effc36322ead">
    <rdfs:label>desipramine-HO-NEF DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/baa81b04-6858-4c2d-8054-140b10d7c17a">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/db6a5215-3f55-4da4-a28e-536e40a38509"/>
    <rdfs:label>1.19 Fold </rdfs:label>
    <obo:OBI_0001937>1.19</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/9a0c64ad-ccf8-4b90-b26d-ffd0c279347c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/1e1ded64-cc16-478d-9711-403322daa22e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/bc05b1fa-7531-4448-a367-d556f4e66b69">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/47a9598d-76a0-4b56-9aea-0f5332f69fe1">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/c57e1551-7196-46b6-a691-49311d175349"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/9f81cb1b-9829-4613-9266-b5b26094630f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/11657804-972f-4b61-9560-d19c9200c7ed">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/3c52129f-29ac-48f8-a77c-6dba4770f8a3"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/bad545bb-354f-4df8-a2d2-f4370a9c4337"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/cbd714a0-34e3-471d-8345-238ad35eb402">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/d2324817-5b39-4249-a6f1-d906b334e32c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/fa3becb4-42ac-47db-8f19-7d2ab7dd0b11"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/e866c84d-5844-40af-a56b-4d488a3163e2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/ef81afcb-4c23-4ec5-b9b3-2e94a49b2095">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/62237e73-c6ab-4cc1-b727-f47099b63adc">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/698a103b-8afb-4f29-8bda-01013ed68cd1"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/6db386d8-7579-4146-99b0-8d9a4d1a490c"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/641578df-a70b-47b8-b704-de230e7c36a1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/68514770-bbc3-4cc5-9ee1-ab2982cf0b4c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/c830974e-f9a0-465e-a538-f1a866d26020">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/4af0cdc5-e3c6-4cbc-a25b-f8e3c598126f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/d306d761-f8f3-420e-bfaa-08dff5a1c418"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/ee179152-6742-45bd-8eb3-261a841e6ae8">
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/f30e5914-bd21-45cb-a475-f56f1297475e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/b31d30cf-e251-43b7-a75e-c44c15d5e043">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/4159cab6-5861-463c-906e-dce477f1d9ba"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/e116fc6c-0371-4afd-8674-d56a019dc631"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/0528a723-a957-48d2-a622-e742d2080d6b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/a5aaffb2-92b8-4c5a-870a-baed3f459c4d">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/49391e53-d600-4fed-ac1b-ca734a6476ac"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/d59e070a-83e1-4215-bc90-3dca99c03b8a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/9495d346-c911-4f60-b208-b038130449a7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/0808ea61-b317-4eb9-9b26-6638c1a83667">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/cbd714a0-34e3-471d-8345-238ad35eb402"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/99f97de2-2181-4d7a-b0ce-66121fb56d8e"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/255ae469-53f8-465c-ab48-c6aa3300d1cd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/6b2b16ec-a127-41db-b55e-4d79fd2ede54">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/b699ab1e-5490-4741-9b5b-49d9b602ef36">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/f9e554dc-3858-4dc2-8d22-620112857fad"/>
    <rdfs:label>80 Percent </rdfs:label>
    <obo:OBI_0001937>80</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/1bfea671-896a-4987-9155-6a29cfb646e0">
    <rdfs:label>Amlodipine-Atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/1cd5a4cf-e133-49ab-af1e-713a9dcc6b24">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/e0457f0c-4b84-4374-b7c2-c3ff54b8c295">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/a4bbacd2-66c9-4b75-8648-d0e75b25a236"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/38c6da15-0685-48a7-b631-dc64d0173cf5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/c0c7a1da-931b-4089-9c76-be1db0e38767"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/2897cc0b-3d58-4594-b6ac-d38ec6598361">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/c365edbc-a649-40bd-8c95-647b1db0b1b2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/cd17e2cf-a636-4eb5-9368-f89377cfb243">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/8090e060-0e28-43c5-8f71-51d0a11962b2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/3f60abdf-f95a-4927-b3a4-045adf19bb99">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/0c5cf354-a855-469f-9b79-c147d09ef90b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/260bc181-902d-4961-afb3-1e2b0a846493">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/e98a14a0-a3b4-4950-9fb9-35703e5f65f8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/cf8f2d10-bba5-47ea-b20d-0b1e1f492841">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/25fa121d-0cff-41cc-a66d-3cef8c47cf7c"/>
    <rdfs:label>95.8 UNK </rdfs:label>
    <obo:OBI_0001937>95.8</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/02155cf6-1ebf-45e5-9b3d-b037fd11fa1b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/0b57b13f-0fe3-4d42-8fcb-849fe2ec31a4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/2a97a190-46f5-4650-8ff0-5bd6b81ba6df">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/86b5a345-da6b-423e-bf25-2cc6be5219f8">
    <rdfs:label>rifampicin-rivaroxaban DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/55b45150-0747-48da-a308-5244624024ab">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/127c1bc6-b8e7-4365-a12d-528506abbd01"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/7d4a5d7d-b15d-4b5d-bcff-aed8ce4e24ee"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/22e01b45-66b7-4cde-ba4a-13f03ba43fe1">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/84d32dd0-1bbc-47e6-b10f-3c4c59389aa4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/2795daf5-a8d0-4f20-b6d4-9156e07b6ac3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/f13883db-f997-44b2-b165-fbb83dba4290">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/e7188977-cb46-4d8f-9afa-8fab41a57625"/>
    <rdfs:label>56 Percent </rdfs:label>
    <obo:OBI_0001937>56</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/2758d427-dccf-4c70-8b88-d2c116e045b2">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/b1dc5374-6923-4656-8c31-789b48eb985c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/879ca4e8-ebba-4e01-ae6b-dbfa993c04cd"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/d5a93f89-e7cc-4671-a5e9-e697f11a9c64"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/7ba34334-8067-4a9c-845d-1a56f192df74">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/b7684c18-1cda-4ac4-be85-0841c5fd3247"/>
    <rdfs:label>cimetidine-threohydrobupropion and erythrohydrobupropion drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/8992027c-9fe2-45bd-b246-98376a68e1d5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/f4197b18-cdeb-442b-8d5d-1676039a91db">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/53c57cc8-82aa-44a7-b2c7-d41bd3624b7f">
    <rdfs:label>S-warfarin-nefazodone DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/a5cca383-ff3f-48a5-b0c8-60a3cd4526a1">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/beb5f7c5-75c0-40de-b6a9-ba70a626ba82"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/fcfec356-682f-4589-a984-946b1365a568"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/55495589-b729-4986-bd8e-337db5a7194d"/>
    <rdfs:label>ambrisentan-warfarin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/8fba2c2d-4649-40c9-a072-f245a92ea772">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/31a51e31-e48f-4dd7-bc02-bb71f65cd6e1"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/90bec411-5700-40a3-911a-05e5f054d191"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/4a3f3b54-903a-414f-883e-b8004ce590a7"/>
    <rdfs:label>buspirone-nefazodone interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/3e2edbc9-cb17-4f5b-b423-7b6f9ea0eb91">
    <rdf:type rdf:resource="obo:RxNorm_31565"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/ac50d2ee-5a05-4b80-8611-8922dc2d96fe">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/334c266a-37dc-4c4e-b974-a4d00784e86b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/d9b4e08d-7bca-4259-b2a7-f1b2c5fe2843"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/d9f7c72f-4a8d-4eb6-aab0-77374cb1753c"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/60660d83-5aa0-4d73-96f5-b3d06bb28cba">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/bad545bb-354f-4df8-a2d2-f4370a9c4337">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/a5d8cfb8-305a-46e6-a1df-73ac80b932b9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/ceb117fe-c444-4767-aa4c-e74999bcf546">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/ebbacc2f-0b22-4a76-8283-1e1c691904c5">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/facf01a3-fd53-4473-a516-cf3b57eb55b4"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/18e736c9-fe0c-4506-b18f-23c8cf1f6dd6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/333d0ec1-1b93-4957-a8df-758e2bdc491a">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/617fac7b-d888-4280-8d62-6ff9c7a85bee"/>
    <rdfs:label>1.6 Fold </rdfs:label>
    <obo:OBI_0001937>1.6</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/f9b868da-2497-4bb3-8070-458e735d9974">
    <obo:OBI_0001937>180</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/2a786adb-d9ab-4b7e-a708-23b6671f5ae2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/a9fb95dc-270f-4e13-a94b-5b7af6faf311">
    <obo:OBI_0001937>30</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/95191168-c1aa-436b-b0a4-0e62667cdc12"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/26935a44-5a59-4d56-a125-eb9dd68bf988">
    <obo:OBI_0001937>60</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/2d2d92bd-90e2-422e-b8ec-2550d673d972"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/a1c9a7a4-d724-45c3-8cb4-6ca7afd586fc">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/26b158b7-82c5-4bec-949e-85bc0b8dd5cc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/ecf3e141-f469-4984-b029-dbe774120490">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/0de27741-ceb6-4ff0-b6f2-96528a1766ee"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/e98a14a0-a3b4-4950-9fb9-35703e5f65f8"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/53fdae2c-e2ba-499a-98ae-17b9f5b1b21e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/0d4b92c6-5292-4590-b7ef-91efcad3ebf1"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/66ba18db-0f84-4c93-89a1-08771d8717c0"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/b3006dff-6339-47e7-a517-1b1cedb8eaf1">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/1644eb45-81e8-49ad-bf92-1fbe9dd0a2fa"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/bef81c0b-8b84-4107-ad7c-77a630a6d4d5"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/bfd832aa-7b88-4863-adc2-491b61565e46">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/ffb4fd64-dac6-4237-99b5-a449b6528d00"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/d54df87a-53b0-4dca-be07-299d6d941a32"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/3d62ea64-561e-4542-a1df-3612a747a3da"/>
    <rdfs:label>fluoxetine-triazole-dione interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a2676f0b-c846-43f0-b299-f17240eb3bd2">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/087cd06a-b894-4af5-b49f-ad82574e8118"/>
    <rdfs:label>4.3 Percent </rdfs:label>
    <obo:OBI_0001937>4.3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/3b63c437-b838-45b8-afa6-a998ba91a486">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/d4d4f7a4-46b1-49c9-bc9d-ee5e4cfb5608">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/4ff1a94b-fa6f-493e-a5e8-5f7d451f173f">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/3d658302-0e51-4acf-a61a-9068eb6360ed"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/73328c6d-53fa-4791-a7d3-5da3e469ec83"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/1e525708-641e-4dc2-8da5-7be555f17c62">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/c8d37d70-2709-43d1-881f-ceddbc80ab89">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/44ae643a-3e0c-4f1e-8d9b-c0060de52b85">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/9f2115df-47bb-4d72-b937-ed8aef272f3e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/942ee7d8-7e5d-47fe-a11e-a1bd223c5104"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/2175e104-b48a-4547-9933-a56f8247ae23">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/bb4901dc-9f13-4579-a79f-575a6fb1a6d8"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/06dffb90-7f48-4241-97d7-caa842212a69"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/c82d3a51-dcc6-4eca-8238-73a81b604071"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/a6d40270-3797-42e0-97f5-3acb4738da58">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/aeaeb7d0-d918-4562-b4d1-ed4486a4dced">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/f9e67626-a36a-49c1-a1e9-068ecc61d23b"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/1903f1b6-cd14-4bd2-938a-e78c5f4aef8b">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/b0603ebc-2c2a-46be-864b-4eeff93ddc58"/>
    <rdfs:label>nefazodone-buspirone drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/5a915a49-832a-4240-afd4-0e8abf228601"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/04b9cc00-a362-4b2f-a1e8-6099c4b04c59">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/dd90d421-3b64-463b-92ef-bc7a0353f68e">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/efc66e1d-a1fb-4d4d-afc5-a5c5390c3a14"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/ffaf8fd9-3935-4fe2-bfce-f94931b481be">
    <rdf:type rdf:resource="obo:RxNorm_15996"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/8fa8220e-ecec-4da9-b9fb-ef21b34e6a87">
    <rdf:type rdf:resource="obo:RxNorm_36437"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/b0603ebc-2c2a-46be-864b-4eeff93ddc58">
    <rdfs:label>nefazodone-buspirone DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/c678d252-7ef0-437a-b274-8206d2d49b6e">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/9851855f-90d6-4fed-a24e-6d579861f534"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/eeb87e57-4c8d-40f4-9ffc-342c5779866e"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/4f49420b-adb8-4856-9cf5-3bc4320cfe8a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/1704fb0b-ef04-4ca0-a056-f9bd2cde9eba">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/68fb9765-ab5d-499f-8bed-18187d99079f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/92f7774c-2f06-4c5c-9055-b494b67f4543">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/a5be37e2-0602-4843-bf80-74a870c31d6b"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/c722056a-96ee-4aa2-9f7b-8d989d50a768"/>
    <rdfs:label>amiodarone-warfarin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/806408cd-7155-459e-9700-d656396620bf">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/bc9be44f-57e4-454a-9dcc-602ea6fa2c37">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/38c8e837-b349-4157-a12c-9363813bb2f3">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/63ed3831-96fd-47a4-a6f5-bba67f036745"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/595a34f2-cabe-4be9-8587-8d5ac978d026"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/62575534-cf53-4d83-a4ad-c564c4e869ee">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/67371079-c78e-4d32-8f45-c6790fd921ba"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/29c638ec-b536-492f-b855-13cdaffb894c"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/222ef4c0-df60-4aff-b57c-d830d526fb8d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/0e20dd7a-f814-4433-824f-733416234f03">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/c20456eb-5a1b-4fc4-ab10-616e65c84b02"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/aad0be41-8592-476a-80bd-b58cbaa4b5ba">
    <rdfs:label>clarithromycin-rivaroxaban DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/39423dc5-0832-4dfd-8858-3d51a485c2e9">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/b2191d98-f9bb-4d36-bfd1-d849d705dd0a"/>
    <rdfs:label>Fluvoxamine-tizanidine drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/528d867a-5710-4ad7-a12c-0474f1712968"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/ab708708-833f-4958-8821-2c1d1d2ebbc1">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/d7380c24-8abc-4bfd-9402-a6d41a6b5878"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/cec9a630-d1dc-4096-96f8-d057397cbbf9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/1ef85e30-6de4-4d53-ab5a-0ce2c9f1f5df">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/86fc0f5b-a5b1-42b1-846a-6d62410d393d"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/a3d6bf09-70ce-485b-9c39-c217b351445c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/b1624e1c-92e5-4197-aca3-b8228473126f">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/e6626689-c232-41d1-aecd-3e4bffb4a516"/>
    <rdfs:label>quinidine-dabigatran drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/01733842-7c6a-4ebc-b3ab-a58589961529"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/af92d88e-a592-4b15-94b6-0348e3791eea">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/64d4da89-a45c-4e33-8316-dddefe2e91bb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/212d5bc1-9a38-4573-b4c1-b94fd6d98f90">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/eebd9eee-079a-475e-8c55-4f6e1a97aba0">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/d74b2149-223e-4aa8-9e88-69bf3a1dbe92"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/61e22507-2b75-4539-af20-2c0233350538">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/bd18272c-6dbe-4fe3-b6f8-e41eae6a5c49">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/89306b85-c4f9-4627-9834-1c3ac4a64675"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/9c2b47cb-22c2-49b8-957d-16f5f1d5fc29"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/27977aff-b023-4137-a531-08bc6b98ac54"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/3c52129f-29ac-48f8-a77c-6dba4770f8a3">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/c55b81d5-b896-41b7-b642-621127f5dee7"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/28b94737-ead6-4bfc-8d2c-159ef615b623"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/cf64fe92-f635-48bf-952e-552af28df189"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/6d76ccf5-3da9-449e-8db1-76abca7df33e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/ef14a46f-4d3d-44c4-b59e-547e55b7fa27">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/360d84f8-b853-4539-8a3c-e9968a95907d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/84b6902c-3a1f-4e93-af50-8f97ca904d75"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/15d6907d-f580-4ddc-ab15-74c059c1426a">
    <rdfs:label>pravastatin-indinavir DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/1d2e2af9-07db-4ccc-9afc-58e925fdcf29">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/0b6c0cd4-aa39-439c-9710-aa8c669503c1">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/b4ddf33c-c37d-4b15-abdc-aec96fe55a1b"/>
    <rdfs:label>2.53 Fold </rdfs:label>
    <obo:OBI_0001937>2.53</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/8d4ac256-224a-478a-88b7-5e2dbe79d4d0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/995697f8-4c18-4aa9-964d-397e960b5a49">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/c77482ca-adb6-4e4c-9f12-b73bf0fde70e">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/ba0da8da-d1ca-4ed7-b344-2b860c3cf08a"/>
    <rdfs:label>nefazodone-alprazolam drug package halflife Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/694aaa5f-bb11-42fb-bbb6-09c2e0877dbd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/928ccefa-94b8-4933-9abe-b4372c501aa0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/21a851b1-5607-46ee-b32f-d11d072e261f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/11f2b32f-43fd-4d86-8166-528954c58f8f">
    <rdf:type rdf:resource="obo:RxNorm_10438"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/d34f92be-4842-426b-9ced-9e5d22e57876">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/ff6eb4c6-e74f-4d44-a900-72939411a408">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/d2dc99b8-9739-4590-93bc-368f34f52b1f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/d7da9feb-fa3a-4f4e-b7f3-c455ba2e6a31">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/ac542df8-dbae-46a0-bf48-da59adffce38"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/c0e8847e-e2c1-4c94-afeb-fce29c3bf5e0">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/1fbd7e5f-cb40-4b4c-b12d-bc30640fabbe"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/6f0b5de3-32f7-454a-9512-f40b60b7dccd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/2448455a-6823-4215-a27f-4044c8faa118">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/5845324b-7696-4378-85ea-0276eac780fc">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/5586a5b6-f815-4c3d-9ebe-e200c87fdab9"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/6e0b2484-73a6-4dac-ae85-8f223f3ddd16">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/9d41c35e-b1cd-4af2-bba3-a5cc4af87e34">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/d5f1155d-1815-4ab4-81ca-956ba0cb1eb7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/8421583d-c510-4977-b401-45992920bf65">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/dab0c71d-5147-4398-ba68-42c405a9fd81"/>
    <rdfs:label>risperidone-valproate drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/1d7882cd-beda-412f-bd35-528f80069658"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/942ee7d8-7e5d-47fe-a11e-a1bd223c5104">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/a026d260-e887-496f-8c1d-b6e3024cc381">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/abb2662b-2d82-4071-97f0-d158bbe13055">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/3e2bf812-a637-4989-b368-6cb3e0c3fa26">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/d974a5bd-7efe-4de7-a306-ec1a86213db7"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/b610a7aa-16d1-4364-9eb0-f3546155e28b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/3de4ac56-19ee-4c41-b95e-9377b9e11a28">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/9f7943fd-9bec-4db7-a7c3-7e86d2e8d05b"/>
    <rdfs:label>ketoconazole-eszopiclone drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/1fc53bf9-475f-498d-a48c-a62521eace41"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/a456dac5-61ca-493c-a218-197bbc23280f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/19f1ef43-ea91-488f-af03-657dfcc69228">
    <obo:OBI_0001937>Unk</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/f394e762-8da6-40ad-ab85-805917fcfc4e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/506f137e-e01f-44a7-b61b-899d32aab1d4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/160ec5e8-e297-44e8-8ca8-2a40232a0cc4">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/c25d7594-76a5-4512-9633-7ee9e0b6f508"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/aa0029d6-93e8-4276-afe1-0069121fe5d5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/081b51ba-46d5-4c56-b7ef-9f419f2826e2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/a9924e77-5b80-4b14-9844-3af86f98491a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/3df2643c-edc1-4f34-819d-d224bee28a64">
    <rdf:type rdf:resource="obo:MeSH_C092333"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/e2a4d0b2-9ef0-423b-b03d-2488be873c6d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/a089022a-516d-4a10-92ad-1df94c643310">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/f1971ab2-ccec-4c80-a495-97cbafe539fc"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/d4b6fce5-1469-4fed-a0cb-bcf8f2615f7d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/b53dc756-b4cb-4f36-820e-5cb52ac13b86">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/c777f075-b01f-4549-9401-3408c1b72c56"/>
    <rdfs:label>carbamazepine-mirtazapine drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/5b05d79a-0a1f-4ce4-b466-01e85fd7ec1a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/d6d5f621-e5a3-4f26-bf31-38ff0f9cf4b4">
    <rdf:type rdf:resource="obo:RxNorm_35636"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/4804fd71-b5c2-4432-b585-b04af20a835f">
    <rdfs:label>paroxetine-P88 DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/851688ef-4b50-4415-9b6a-155bdbdee8e4">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/0b0d7dbf-8118-4185-9673-1e7ef9400c94"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/c23105c5-dde2-454a-b903-5de079e4a01a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/f18e2c9c-f836-430c-9363-1125301c2015">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/b6539e89-d74d-4873-9d08-773f6fcf5f98"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/6022ef34-8655-4940-bd28-746d1200ccb7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/42d2a863-fdba-428a-a298-fb3196506be2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/3535d478-5f43-4792-9380-05573a9b589d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/39995613-1717-4bc1-bbc0-58f99da7f847">
    <rdf:type rdf:resource="obo:RxNorm_1114195"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/469851c4-4c04-47f2-b33f-16413a28ed9d">
    <rdfs:label>ketoconazole-P88 DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/92a58b4f-6595-4035-9330-8b9c64b1b9e1">
    <rdfs:label>nefazodone-haloperidol DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/bfd719c6-7c9d-455a-9749-e16fafe423d5">
    <rdf:type rdf:resource="obo:RxNorm_36437"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/163a186d-8c98-4c39-9fd8-5be2e83e974a">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/0176b286-4b70-4602-9967-70aecbaa861f"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/9ef96ed2-d431-4f2f-a857-d7723c823878"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/3ec97292-2d4d-44fc-adcd-77ab780c6bfe">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/16663ac5-2c3d-4b2d-8068-beda0b6d4920"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/27453a25-084e-4629-aad4-20e54e243184"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/d6d5f621-e5a3-4f26-bf31-38ff0f9cf4b4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/3d370ef3-12c0-4b2f-abf3-c154423a0362">
    <rdf:type rdf:resource="obo:RxNorm_358274"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/5cc9d774-38b6-44bb-bf5d-0f88aa5c7c57">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/d9473d9a-8690-4e9d-a620-afa0b7c530ab">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/8be631ad-8542-47ea-92b6-3c74dca46eda">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/76df9d4f-2900-44da-a58c-ea282804c996"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/f9ee1cba-7490-41bc-9f67-98c254998c3f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/ffb85533-42b1-4bd9-8d12-ba219b4e9ba8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/63a4857f-29ce-45bf-85c7-d5fd9687f95d">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/8d652514-559f-4da7-a39a-d9e11fbfc995"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/9c1997d5-da1d-4a39-bf94-fd5cbb9ca590"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/fa57b449-ae30-47bd-b436-c19a4df25f6e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/1faa111c-e1fc-454e-89f8-2586f0214dd6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/8965be8e-40bf-4bf4-8912-c962da6f85bd">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/9975ea37-11d6-4918-9d25-fe292bb69923"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/907cacaf-2218-4d63-a1bc-160d332ee44a"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/70673163-3e88-49af-a827-9ab49f3beb7a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/f30e3ec1-c172-4a11-ab35-d473c56b6471">
    <rdf:type rdf:resource="obo:RxNorm_1114195"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/34ceccf9-2916-43a9-8985-071eccf6eacb">
    <rdfs:label>fluoxetine-P95 DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/f3e9b9a8-618e-47fd-b074-e199248a7156">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/fdb1bf5f-7fd3-401b-b45b-337d3d63048f">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/7be9f38b-d3b1-42eb-a7e7-0ce21cf1acd5"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/5a155ff2-c209-42fb-aa0f-4d5939d9587e"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/2fc25f7f-65ee-45ca-a535-b099540ea968"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/a9af0431-eac7-44b8-84aa-17b9d219f6a7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/511b0deb-4dc2-438c-8317-494add0e0112">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/9bf97af0-2693-49c9-8edf-2a3e5277fca4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/04824e71-2c1d-4056-afd6-dc6a36dc7da7">
    <rdfs:label>Carbamazepine-olanzapine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/13c121b5-a0bf-46fc-a071-a43674cdfeac">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/5d20a00a-a651-452a-94bd-e5210bae8ace"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/393cc7e3-44ce-4de5-8e85-3a9b367eb92b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/e1c20e98-1ce8-4713-a626-bc4cf9c8ca01"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/a0560c5d-a4b8-4173-bad7-a3b363789fd2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/3b33fab1-7222-4f7a-97e0-6255c633af93">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/84a3ec1c-f917-4ca8-ac94-c7a6c1977089">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/550b89a6-c0b8-42b8-bb35-9439bf387518"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/dd4f1029-be00-43ea-a26a-0a4d5ebc2316"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/50651583-9277-4439-a9b8-0bfcf72582e8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/42f51c29-e32d-46eb-8753-777878e1d0bd">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/7cd5e418-0578-4fed-9712-308e9a1e587f"/>
    <rdfs:label>49 Percent </rdfs:label>
    <obo:OBI_0001937>49</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/37b75830-a39c-4256-9448-ac452b737d94">
    <rdf:type rdf:resource="obo:RxNorm_11289"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/68a09574-39cf-4566-823c-2f2be3909c21">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/e15612f9-07b1-4c66-8b58-c52e62895d4c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/b26732a1-7d13-4013-bad2-da84143048cc">
    <rdfs:label>divalproex sodium-INVEGA DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/ce2ee3a0-2693-421b-9c14-9e38af13f479">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/a7d58a85-c189-40ac-a10c-cffd5ad2b6de">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/5d81ef11-f452-40bd-ac6e-feaf279beb22">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/cd1416bc-1ef5-433d-8f01-61764f2c6e9c"/>
    <rdfs:label>40 Percent </rdfs:label>
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/a37d4e27-2311-44d6-9d71-9b4ca787a9d4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/1e86e93a-0e71-460c-8e4e-0cda6252029f">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/45a19674-6a80-460b-b476-9813db82cc2d"/>
    <rdfs:label>102.3 UNK </rdfs:label>
    <obo:OBI_0001937>102.3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/78c31c8c-2769-417b-a691-bf837a8663dd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/bdf6ccb5-572d-4af6-a547-e853365b2d3d">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/0b57b13f-0fe3-4d42-8fcb-849fe2ec31a4"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/fa8e1185-00d7-4466-9687-53cac22e02cb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/a00b5939-2823-46a9-93f1-31d206a993b7">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/0c7a9872-1e6f-43c2-9b5e-2476151adf56"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/404f38ed-b21a-4f32-8d02-48479c850b86"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/b524dc25-eedf-4531-80b8-5b0c4949745d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/d35de974-f232-476a-8114-a2424fcffece"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/5f4c4ec9-765d-4a88-b712-ffe9022fca79"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/d92be064-f5f8-4641-a861-bbef2efb9f85">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/4f4177e1-0d57-452d-aa9f-7c5922cf4b1b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/08feefa3-9ca4-46e1-bfae-0af35aaf7c1a"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/1d32ce87-2fe6-463d-841e-392537ac6d40">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/d99be735-59f1-42f7-8428-1244e9fa782c"/>
    <rdfs:label>fluvoxamine maleate-propranolol drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/71376e69-d445-41b6-8fbf-47289739ea1c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/4caa3355-3ea8-4ee6-a1dc-f866c5e341ca">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/3e9d4769-f473-4b1e-99bd-f3c748754f86">
    <obo:OBI_0001937>400</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/5ea6c7a4-cb32-42fe-82a2-19ccf96d69da"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/86220f3f-299d-45db-8ce3-ccf19c7f9536">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/8c4f9c5c-5e8e-4a29-9dec-3da30240a7c1">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/967b295b-cd1e-4980-a912-79ba39a16550"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/6e2e8986-91d3-4d9a-ac30-76131c675ea3"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/f9e67626-a36a-49c1-a1e9-068ecc61d23b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/6d621b18-4d44-4225-a466-02955225af32">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/ca1c8389-1815-4981-a9f4-51691638b157"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/11ae4554-44d3-4bbe-acf3-af7f88818c29"/>
    <rdfs:label>atorvastatin-Nelfinavir interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/e159e617-a0dd-4050-bd40-d530d1da80d7">
    <obo:OBI_0001937>Unk</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/8eba358c-b599-47c5-b58f-ccb63771bc58"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/469df909-f8f0-49af-8965-b3bf4eba3e54">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/59422f4c-d44c-4d4b-8b5e-ed44e12ded71"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/22dbac2d-1116-4588-bf71-25a7408ed71c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/370dfee4-d744-4395-89ee-4206ba0d8edb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/3bb6b761-09de-42a7-ad35-5b52981b2ff9">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/e7869174-c596-4c4b-bccb-daafb88e5b28"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/07909617-4026-41c8-a309-c495deddfdaa"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/223c5083-0dc1-47e1-994c-97c1d5fe0b1b">
    <rdf:type rdf:resource="obo:RxNorm_325646"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/98720410-2cb3-4b34-930e-847a25d5a836">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/66c3bbd5-e469-44ce-b0bb-0796cae32ace">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/b0a1fb8d-c539-4d07-9315-3d4685a1d475"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/eeccd973-4be4-4522-bafc-6e088cf5090b"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/72238c7b-2939-4a68-b8d0-dda46a043df9"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/4daf9589-601b-477b-90bf-e06ee4d3e216"/>
    <rdfs:label>high-dose ASA-Edoxaban interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/598447eb-fd4a-464b-901e-8e61cf37e9f0">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/56c95373-9391-4f95-966d-784d3432dc7b"/>
    <rdfs:label>74 Percent </rdfs:label>
    <obo:OBI_0001937>74</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/dea1f07e-f0e7-442a-920d-1948c56f1d07">
    <rdf:type rdf:resource="obo:RxNorm_1546356"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/1e543e08-011e-4611-9a50-991fa45da9f8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/5a29d70e-49a9-4659-99c9-5043cd317932">
    <rdf:type rdf:resource="obo:RxNorm_2002"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/9f7943fd-9bec-4db7-a7c3-7e86d2e8d05b">
    <rdfs:label>ketoconazole-eszopiclone DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/56be8156-4cc5-4690-ab03-88ea23cc76f7">
    <rdfs:label>ketoconazole-zolpidem DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/bf98b7e4-1e61-44da-989b-ca53b4ba6120">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/411268c8-416e-4fc9-b822-56ad27f246f1"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/8d24b300-19ad-40bd-8bac-8f59d0438c46"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/d99c1c2d-5444-42c4-8e04-c05fd5333fb9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/cc719a1a-29cb-469e-abd6-8edec0c896ef">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/ce161a28-79a1-49dc-91ce-bea91cf00133"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/35c1fa25-b22e-4ccb-87f8-fbafbbc0cfbd"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/aa4365f7-a90c-47b5-bf7f-98176b45d37d">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/87d4ca3c-df0a-4adb-9583-fd951d52f104"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/e8dbc6a2-459c-4d05-aa1c-a1771e009b6a">
    <rdfs:label>alitretinoin-ciclosporin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/5254b8d6-6516-4927-b0d8-ab47fddb4616">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/8e0d4c88-e34c-4117-9a67-3f3298d01e2f"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/655c00a3-69a5-46b0-8db4-08c14bd9049d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/a0f7aa12-9f73-421d-b2cf-60fac651fa4f">
    <rdf:type rdf:resource="obo:RxNorm_3247"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/f219ce0e-1c8e-445a-b500-4038affa70ba">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/98196f24-d42d-4ce2-b5a4-8db4e1981a31">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/cdba2ef0-7faa-4c37-b0e8-be0fe363bc93">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/115fa996-d20a-4821-a8ad-c63b05bbab1d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/33f4f726-af0f-4e96-8b5e-cc8a27ff6242">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/e0c322c3-ab25-4d92-90ae-89db0a5184aa">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/b166fc5e-f056-45ca-acb9-4c07c20921e4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/116a8e16-f129-4b05-8faa-7c838da9736f">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/57da8204-13f2-4343-a21c-08a838945168"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/cf0720d2-bffd-4328-8ac2-f7555a3ae0ac"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a0e5d419-bd45-4e66-ba5f-a8a32736dcc2">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/0cf07a79-eaca-4309-9138-bc2f5a492907"/>
    <rdfs:label>1.3 Fold </rdfs:label>
    <obo:OBI_0001937>1.3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/7b276e0f-6c72-45cf-8b99-6c66596ede57">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/0ab439eb-034b-4961-88f6-8bed947ea771"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/3fee38bf-9e71-4d4c-a631-86876e0926bd"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/88f23773-311d-48b3-8eb8-7db0a0aeb102"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/95cd014e-d63f-4fc2-a5b2-76dd5f77bc80">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/8a6ab728-a99e-4d75-b6dd-c0e81d852f06"/>
    <rdfs:label>2 Fold </rdfs:label>
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/PATO_0000125">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/ba6c83df-14a1-46ce-9f70-2208e8b51765">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/5240d513-147f-4765-ba9e-4dbbe1b20cc0">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/b96ca8b0-2494-4c8f-9c32-bac0fbed6268"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/3298c97a-cc21-4041-819a-bbd07db15e74"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/11210c64-305c-4224-adf5-c5fef82f55dc">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/51ad759d-529e-46b3-ba5b-79af8805c641"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/50b779b8-f891-4f3f-b4a9-9b03c4240412"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/b1dc5374-6923-4656-8c31-789b48eb985c">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/a456dac5-61ca-493c-a218-197bbc23280f"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/a1c9a7a4-d724-45c3-8cb4-6ca7afd586fc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/ef0a709d-8600-4ba1-a7cc-c7a867a2a412">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/c58ad560-3e5e-4074-9a62-6442901b422b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/43ba5cff-eb07-4855-8f13-4c6aa27fdee0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/5d20a00a-a651-452a-94bd-e5210bae8ace">
    <rdf:type rdf:resource="obo:RxNorm_8331"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/c03ec363-352d-4302-88d7-a03aa900aabf">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/61b4f09d-3bac-4346-9293-764531352a75"/>
    <rdfs:label>nefazodone-digoxin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/e413056b-b953-42f2-b7ff-99e697548145"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/afa426a6-d6a9-4c4d-8832-b006050458d2">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/b708f5f0-323e-4fa8-9703-33807d450a9a"/>
    <rdfs:label>ketoconazole-dabigatran drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/4b31baaf-fa95-4973-843e-f0b3364d8a8b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a38e8943-09f6-464f-9c29-66d0e12cd4f5">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/cead34e8-6320-4a63-a041-228c411c4156"/>
    <rdfs:label>2 to 3 Fold </rdfs:label>
    <obo:OBI_0001937>2 to 3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/79b7039c-c2e5-489e-8117-a711d683c81b">
    <rdf:type rdf:resource="obo:RxNorm_683693"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/a85a0917-ecf2-41fc-a1ce-b71527b9980d">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/fa2f2593-afce-49b2-b681-6d9cf8c19d59"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/0a774898-ac14-4a4b-a23b-69e9f0b6a50b"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/5e7ab9b1-0f77-45ae-92fb-a3faf9381723"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/efebadda-5271-4547-94a8-a4a2aece28e2">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/47e8bb28-4884-443e-baf1-8178b739da00"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/d3b6afd0-432d-42a9-98ac-c32654852523"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/6649b5d1-c6d9-487b-a010-203e4336a5a3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/94f21eff-918e-44e5-85b6-97671996e3e8">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/837d21a7-15f3-4071-a74c-e61716abd7d9"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/1218b922-a077-4f0d-a194-5a6b7fbe8978"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/2f25d616-97a2-4b02-b824-8c95bf1359e4"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/08561e22-fa11-450a-a05a-c3d66bb35fbd"/>
    <rdfs:label>lopinavir/ritonavir-Rosuvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/3df1cee7-ec62-4634-83fc-01d583b41f8a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/9ad4a3bd-3b90-4762-bb9f-3cd4d96946c4"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/ef23c6d3-4d85-4e3c-a612-4a71f7700c42"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/ecf3e141-f469-4984-b029-dbe774120490"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/f8344db0-073b-41ba-99f0-1f3e836b2c01"/>
    <rdfs:label>ritonavir-bupropion interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/c2f3ed95-bdc2-489f-ab04-7eff395c4fc5">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/2f79021f-0222-4066-ad22-590ce4cce624"/>
    <rdfs:label>lopinavir/ritonavir-hydroxybupropion drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/7adcff61-6138-4af3-aa77-890ea517d769"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/34e31329-1eee-4f9f-95ab-f94e181d27d4">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/0e3fb43e-d33b-42c4-90ea-81151dd049ce">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/71780f4a-3100-4466-81ce-14d0612d8d76"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/8c302989-6717-4f23-a3ec-ca7beda339ad"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/dab87e2b-0a96-4c08-8d10-e02e3c04d739">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/6eef1003-1f51-4bb5-932e-2f2768344198">
    <obo:OBI_0001937>60</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/44bf2d3f-6ecf-47ac-96a1-44e7faaef9ff"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/908bbfb7-6a4e-4ddb-8438-f5b513ecd7ba">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/23bf996c-f205-4eaf-889c-2503cf3276c8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/8116d608-1b1c-490e-90da-2d448838796c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/552ee652-c89d-47a9-8858-a20ff9831262">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/7d9b3858-75ec-4d0a-b941-2072c7960477"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/1c544e89-ded3-4265-a8c3-846064b6cf05"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/f2cd38c4-7b27-4388-94c6-a7a5df7ef597"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/a2a233b5-b4cd-4941-a654-1833b7f990b5"/>
    <rdfs:label>simvastatin-bosentan interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/2c008dec-2113-4863-ba76-f7649e0495fe">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/058cbf24-b6ff-40b6-ba99-896c14d7621f"/>
    <rdfs:label>ketoconazole-P95 drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/e5124ea0-40af-476d-8840-c2b2d4012d56"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/743c1c2a-d6fd-4b5d-844b-81a5efef621c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/a718e4a8-2066-4e67-b854-4872382d1c8b">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/dfe8b068-9eab-414b-bcfa-8cda9bc332b2"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/04dace1b-3773-404b-b140-a02313ec2a35">
    <rdf:type rdf:resource="obo:RxNorm_1191"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/fff50b05-231d-457c-81be-8a2104bba01a">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/df4acb21-a55d-4a23-a514-98fae04ddaf3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/08561e22-fa11-450a-a05a-c3d66bb35fbd">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/b766072c-683b-49d7-8cc4-cd47a286cf43"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/9e3edc75-3db4-4858-b975-cb4ebba15751"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/0a529ed4-a10e-4e01-8a0e-969e420a6d61">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/564583cf-ca77-4a20-a701-96cf8cfebc79">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/436938b3-04d0-41cc-b31c-964a6a1db87e">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/dc7d8d55-56cd-4f6d-b9dd-c5ec28a73385"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/433cdcbc-b624-4085-b800-0d4851d0a37f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/746ea678-305c-466a-a791-6b6b73ded7e0">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/3c80cb4f-6641-424f-8322-cf9b3414f315"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/64d4da89-a45c-4e33-8316-dddefe2e91bb"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/96fba297-0d01-46bd-b7b8-79c560fe5324"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/b600c33d-a3d6-4348-9e40-dc677384ac5f">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/8a61b321-cff7-4613-b535-644f768d4af9"/>
    <rdfs:label>nefazodone-simvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/df40fd2f-5cf7-424d-ab6a-b0b32e2af925"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/d8b68ba1-b7f9-4c7a-8c8c-ad5ad67c2294">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/041bd646-ec64-41b3-be04-f77b286580cb"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/294918a2-e63e-4d83-b450-3da65fa0ad45"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/006519e9-247c-4a76-bfba-fe90bbaedf65">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/aed3ae9c-3292-4cb6-a219-1323b8540025">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/78f6b038-5536-42af-8273-2110062fc9b3">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/43f9ac45-89d0-4948-ba23-6dc126158877"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/94adccad-e200-4dfd-b044-0a081f49e26f">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/e6907fab-619c-42bf-8575-da6e82fa9f99"/>
    <rdfs:label>8.7 Fold </rdfs:label>
    <obo:OBI_0001937>8.7</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/31bf9436-f4dd-4a42-aac7-aae95f10a4d2">
    <rdf:type rdf:resource="obo:RxNorm_6135"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/afb0c7a5-7170-4eba-9608-7e9b005a6ffa">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/a95b657f-a844-4ad3-b902-c37a20eb16e9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/2dcb4d24-f284-4380-9cf1-ba557cfbe155">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/6cb9127e-6873-48cd-87f9-2092a90f7592"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/8a64c6d4-a915-4ea9-bb0c-26c3937af218"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/e0afe98c-76f5-471c-9fd9-0da6fc1df7db">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/8f8d0902-edde-47ac-a82b-f38cb4210822"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/48f52c47-8bd6-4c7a-8aec-3d49e97d4cf3">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/a21edd74-7534-48bf-b170-227bc4a29fef"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/e7336772-ccb9-4ea6-abe0-78b3c532847d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/78230948-70ad-4776-9cb1-f16e7b6a1d08">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/f04d51bb-cad2-470b-86e7-47903d4c6247"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/35360b8f-d3c9-433f-bd7a-beb68bfaf9bd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/3eef4ea9-937e-4931-afb5-a536ee4ec018">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/d8a6aafe-d67f-45f1-ab17-48d3f7172e87"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/be26d186-e05e-4f36-875e-11b0b52d63c9">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/8c341043-7456-49c9-8dc0-70c0d9026c44"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/eebd9eee-079a-475e-8c55-4f6e1a97aba0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/981dec8b-5984-4903-8013-69d3fbb110e4">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/2d289899-a6e2-4d44-b877-761f2dff5df1"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/0c22ad3f-e6bd-4655-ac4c-17ab94f3d996"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/3668d9ec-f3ff-408e-98fc-37e46fba4976">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/36b3dc88-1418-45a1-ba9e-b1873cd38f4a">
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/2e071571-4cca-4534-bb6a-1b7d0a7d025c"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/36d00689-3842-4c60-904c-4e727fc9de73"/>
    <rdfs:label>Gemfibrozil-atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/3ee0ea9f-7a93-4c6d-8e52-b2fffb9273d2">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/2f400be8-67fe-4d49-81a2-8afa4e26d36f"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/c2670224-95b5-4b94-830a-83575dfca4fd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/55e59a6f-bd13-4f77-9186-f8f10e678233">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/87d4ca3c-df0a-4adb-9583-fd951d52f104">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/8dd3974e-e262-45a4-bdd3-f9b9a66d21d8">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/ab8b54e7-930c-4a5d-84a3-72b70405b864"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/7f7f519d-b0d4-4cd7-9f38-61d0d33dd4a3"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/37eb3be2-ecbd-499a-b0d1-f04336bb6d9a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/ee4653e4-43ff-4f7b-8116-2cac14ae0405">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/01166835-db80-4bfb-b302-3afc8dde324f"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/f3862e77-2559-4a74-b1de-d4a42e4ac3a2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/7ab650ec-8847-4237-9f37-0ea6dc7e48b6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/ad3daf4e-869f-44b6-9bd4-709b8053c469">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/18e736c9-fe0c-4506-b18f-23c8cf1f6dd6">
    <obo:OBI_0001937>20-40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/01fc502f-d615-4c9b-89f2-adaae0c53ee0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/8de8a1e8-a23f-4e86-b5e5-137226fdd4b1">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/3e0a529a-d040-4daf-9c52-60b3b1e5269d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/0f41aae1-3e8a-4db0-88e6-e4b112e51cea">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/60b990a3-7509-47aa-b62c-88365eb4ac15"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/142cc809-bd6c-4dd5-8d26-45441b620b51"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/fcd421bd-d04f-4a30-b060-6c73b2a3a004">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/d2076eca-6017-4d67-b961-a4299d9c8282">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/5d4b1ede-8d55-4ad5-9b8a-96b46ad6bfaa"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/76216ce0-0fb6-49f6-a1b3-0c330c45e90b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/dd170d8f-5316-48b4-98c9-e067181473a0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/225e7035-ce56-4b1f-859d-4a2a06242327">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/8b54f6c4-3f3c-40e3-a9e4-2ffe6c428bb4">
    <obo:OBI_0001937>25</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/a447966a-b3a4-4532-9419-1397ab9571e4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/2514ad54-827d-4a00-b3d1-f5d6cfeb7671">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/02623eb3-325a-4448-a3b9-23074fdeafc3"/>
    <rdfs:label>escitalopram-desipramine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/98ec9d7c-4fe6-4306-9f0b-53a3bb6e849d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/0b760834-6a1d-47c9-b8a6-10b2766e6275">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/42028dd6-e6e7-4c0d-870a-a67afb3d5923"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/fd2025ab-eabe-4df3-b953-d726aebe254d">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/c38eb161-9ad8-41bb-9849-eb24bd03c1d2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/087814de-7282-4a54-93de-18031d1774ae"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/1b82f7c3-8cfd-4af4-9dd0-53c871ad07dd"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/33268528-8050-406a-8dfc-c8556db232a1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/b415938a-f9e4-498f-8844-818a6378c9dd">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/14e9bde0-521d-49bf-b07d-6b2ac3c00ae5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/36280d77-29a8-44bd-9b7a-54ca1f68e463">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/4dd05737-c49d-481a-839b-5e6a55041eaa"/>
    <rdfs:label>819.2 Percent </rdfs:label>
    <obo:OBI_0001937>819.2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/626261b6-c095-4094-a67e-c9b3c47b2c34">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/c6a9b70c-9d90-45b1-9ff4-f77161d0b6ee">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/e84357fa-047a-4129-87fb-73e46fa018c3"/>
    <rdfs:label>35 Percent </rdfs:label>
    <obo:OBI_0001937>35</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/d1535424-6ec7-4d70-8cee-c6063af793ae">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/88b0f06c-e65d-4aaf-95ec-199f05d9796d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/d9a74ca3-6173-4306-84fa-fe02ba5a98f4"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/65d8cf15-db9c-4cad-af24-171a16e9c346"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/723c0ed5-c7f2-4eb4-bb61-e37b52492c01">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/254dda43-5931-4b9a-a856-f814cf86ac61">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/0b6c0cd4-aa39-439c-9710-aa8c669503c1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/18535d33-5a6a-4182-85ea-18b0d448d0cc">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/9d0715a1-d4b0-4e98-a772-2e6b75dc7200"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/6cb9127e-6873-48cd-87f9-2092a90f7592">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/f644552f-298e-436c-90f8-0c6f339074b2">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/263a10ec-8bc0-449e-8d82-c1ab5180e006"/>
    <rdfs:label>ketoconazole-rivaroxaban drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/aa6eeb14-41f0-45ab-a74a-eb4802045de0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/1dd32c3b-d6c1-4e24-8236-0bcbc7cf1034">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/f5d604fc-4eab-400e-96e2-410f6374be4c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/dba94a8f-3e3c-4a14-8cfc-8a662eeed03e"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/d59e4976-cae5-4135-ba72-80fdf7359425">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/56519862-f9b8-4f7c-af7e-eaffe79e7975">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/12f52971-f22a-4d63-bd82-74688290dff3"/>
    <rdfs:label>50 Percent </rdfs:label>
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/a868c204-b602-467b-b619-dbeebe6d3ac5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/23ab830b-b30f-47f6-b1f6-3d3fc9297f86">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/a2c11060-e1e4-4653-8584-7b290c595883"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/0231108c-2c3e-4042-987b-e52829215041"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/5ee2cac4-7ab3-42cc-89b4-4c414a3290f9"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/a2155a8c-c42c-4fe3-93ef-8cfbe07404d9"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/f962a578-7f62-4e1a-8948-878da276ec16"/>
    <rdfs:label>nefazodone-triazolam interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/c3570118-7fe1-47e1-ab61-a9bacb16975f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/aa0029d6-93e8-4276-afe1-0069121fe5d5">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/1d2e2af9-07db-4ccc-9afc-58e925fdcf29"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/c849866f-cba8-41eb-9b95-2890c645668a">
    <rdf:type rdf:resource="obo:RxNorm_2541"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/0f692ec9-94a8-47aa-b134-53d87ccf0805">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/0948f0fc-2f80-446e-a439-9c3781b32d49"/>
    <rdfs:label>nefazodone-alprazolam drug package halflife Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/19dcc526-0b31-4692-8d48-c39a3c3a7143"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/fea2121b-3522-4b10-8eaf-941db4cabf10">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/a198114d-f9c3-45c0-9fe4-1cab1b75b344"/>
    <rdfs:label>40 Percent </rdfs:label>
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/ccaa23bf-f7bb-4348-81f6-4b2f829f62fc">
    <rdf:type rdf:resource="obo:RxNorm_9384"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/b7d03af7-ba69-4d5b-8cce-c2dd22ece0f5">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/630b15ad-df4d-48f0-b0a6-8ca1632a42d6">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/018d414c-c2e6-4bbf-a02e-111adccc320c"/>
    <rdfs:label>paroxetine-pimozide drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/3f649c35-1b1c-4a89-ae09-48e35ec03cb8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/4b18820b-734f-44f1-bea3-468edabb542f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/050bf134-98a9-4f83-ad71-9d9f78faaba0">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/787afdb3-a6ae-4836-aacc-70e0ba8f79e0"/>
    <rdfs:label>2.3 Fold </rdfs:label>
    <obo:OBI_0001937>2.3</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/8517598b-91a3-4902-ae4a-59d59f40e312">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/3358fd7c-02dc-4608-9c75-85b415cdd565">
    <rdf:type rdf:resource="obo:RxNorm_1546356"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/fefd0cbe-e8bc-4e18-85ab-e76380679c41">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/7ac79a22-9bd2-4fc0-bf9f-f268cadac770">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/9c1997d5-da1d-4a39-bf94-fd5cbb9ca590">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/5dfafccf-f4ab-4db7-8a4d-59ef81fc1ca7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/5fa17a03-8c2a-4d5f-be4e-3213af47fc93">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/de47395b-117e-4a19-ab97-81e7098191ca">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/96de6b1a-2e1b-4bef-87f6-8c6e7b9152db"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/f03673c5-ede9-4c8e-9c2e-d079635428f1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/e8012f46-95df-4fa8-8afa-84b5ef9d8510">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/8d0d79c7-575d-4a29-942e-f7855c149d8d">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/130229eb-fa04-4277-a5cc-9e97a548b7ab"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/c019c96b-2af0-406f-a715-06206ddf3d15"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/3534b536-af87-4f0f-8b3d-11d305614d36"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/75d90925-62b2-4e47-a438-5e22a27f1ed0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/22379ecb-3c72-4cf2-9699-7247357e73a4">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/235234a0-8357-4834-8a59-143f7b740bcb"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/8a016732-d67a-4dfc-9a2b-4f37cc1c2301"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/ad4fd5ec-519d-4b22-8969-51a80c8a05b4">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/25fda15b-6c98-4a33-91eb-5a3767ab0ac2"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/3400514c-4750-4d16-86bb-c25c07d30c97"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/50b779b8-f891-4f3f-b4a9-9b03c4240412">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/9b7ca5cd-3a2c-4978-b0a0-9104f6c253fc">
    <rdfs:label>digoxin-aliskiren DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/99a1d7a4-f49f-4a87-8dfc-8752cf1ac791">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/f6ec967e-a773-4b90-8891-56f56b6234be">
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/61e39b89-5749-4313-8eab-646a275b509f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/851897c1-96a7-42e0-9201-3dd66ca232b1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/01c9c24a-e3cb-4328-9996-4660004fc888">
    <rdfs:label>paroxetine-procyclidine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/8528e0a2-8d0e-4fb2-b6d5-271fb54cd533">
    <rdf:type rdf:resource="obo:RxNorm_134527"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/5695979c-3041-4281-99a0-db65afe3fa13">
    <rdfs:label>carbamazepine-selegiline DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/35ab1ca8-7a82-45b0-aca8-18348863d5d9">
    <rdfs:label>clopidogrel-fluvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/c70b26b6-6bb2-4b7b-b517-562929b87ac0">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/7c1dcd1d-2245-479b-ae4b-843db5b5d86c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/3d59640b-f901-4089-86d8-e77473b6e4dc">
    <obo:OBI_0001937>80</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/201160c2-1488-455c-b5f0-27d99d0a9ca0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/acdbef4a-410f-4182-bf54-600d2e744966">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/ee4a42ca-5cea-4cd3-a9b9-a3fe2fd9296b">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/155d34e5-26ab-474f-82b5-2997c3f998be"/>
    <rdfs:label>1.12 Fold </rdfs:label>
    <obo:OBI_0001937>1.12</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/24adceec-a284-4beb-b696-057028436ed6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/ec049dbb-deca-47f2-a5af-978e712d8e8d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/0db2e311-4d97-4272-bc2c-48b99ccbcfb9"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/127dd3e1-c17d-46a3-a560-1ea42557bff2"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/b8686e7c-f2af-485d-9481-773b6b01044f">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/16177e48-c49c-424d-a0bc-8201e2004e41"/>
    <rdfs:label>Cimetidine-Atorvastatin drug package auc  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/be0680ae-c827-4ed5-98b5-dd1d310671cc"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/6b668cc2-fad5-4a7c-95fa-00c89821edc2">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/ea43a98d-1537-4389-99f9-7111c5b4fc5a"/>
    <rdfs:label>1.27 Fold </rdfs:label>
    <obo:OBI_0001937>1.27</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/99f0682f-6302-4a79-adab-244a837045a4">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/1a0e71f5-5946-4afb-a252-3c289656e036"/>
    <rdfs:label>34 Percent </rdfs:label>
    <obo:OBI_0001937>34</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/040fbf53-b3af-4764-aed0-356c90587369">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/3d9a29ed-f976-4d53-a4a8-5fdbfd1796a6">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/e757c9b9-dba6-437e-b33c-84175a869a46"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/dd131d51-4f5f-4ea8-a590-83d6a331c3aa">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/79f7d6e3-eba3-4ad3-9883-bc15a5356cd0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/7213521b-e129-41c7-bb69-0c42a4d90486">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/5a7a4ac4-0499-467d-ba29-98783fb3d753">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/05261182-2bd1-46eb-ad25-2ce3aa60a826"/>
    <rdfs:label>citalopram-ketoconazole drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/0081ef3a-ea35-466c-b353-77030ab76db9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/ef23c6d3-4d85-4e3c-a612-4a71f7700c42">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/27f25646-9f9e-4420-9596-94d5154631c6"/>
    <rdfs:label>ritonavir-bupropion drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/878651d7-2e91-4634-a64d-08044826cf94"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/27453a25-084e-4629-aad4-20e54e243184">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/f41d3fa9-a6a9-4797-890b-2994eb6b1843">
    <rdfs:label>simvastatin-vildagliptin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/7068a14f-1e55-42ec-b8e4-cfe2b37a80c2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/f87af97e-841c-4f9a-b508-941ee2b8bea3">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/a8fbf5ee-d594-4ace-a9ac-f80eefb41ae1"/>
    <rdfs:label>warfarin-ambrisentan drug package auc  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/afb8bee8-5c9e-46ea-bf25-35807b3216ac"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/d3696276-6989-468f-a32a-68c2ce0d71bc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/2eccee82-42f9-4f7b-9f74-712cdab87d24">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/4cf8bb1b-4b58-4c79-b9e5-e75a639ae453"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/a07bb575-0600-4c49-a0b7-4abd82380b01"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/5240d513-147f-4765-ba9e-4dbbe1b20cc0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/4b3a6894-d348-47fb-9ce5-88a8a2b81372">
    <obo:OBI_0001937>5</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/c0e5549a-0ee2-40aa-95b4-96608c00e5bf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/2d289899-a6e2-4d44-b877-761f2dff5df1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/4942d2cf-5b1c-4eee-8b10-d925c7fbcb22">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/bb4901dc-9f13-4579-a79f-575a6fb1a6d8">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/37dfe445-6045-4860-82cc-6c5da38e13e7"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/e7667cb3-d0d2-4c7b-b76c-d54b2d012935"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/26e2cd76-41bc-41ab-b7a6-a47f71c98f9b">
    <rdfs:label>cimetidine-mirtazapine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/8538b0f0-1759-4907-8bf0-5acade6609b2">
    <obo:OBI_0001937>500</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/a7d58a85-c189-40ac-a10c-cffd5ad2b6de"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/aba77994-c01e-44a3-82cf-e81637d4c10e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/e2971bb0-ae0f-4c29-a7a7-ca2fac8f1363"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/fe297c4d-eecd-4247-8910-cd1ae890d00a"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/89979cb4-0ae1-462a-aee2-0341c46dfd97">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/b7a6da50-54a9-4279-a597-d667791785a8">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/48c2e6a3-7a30-4567-a369-0e4ee2bea81e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/ead49966-66a9-4608-a69e-d619d3689f90"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/3400514c-4750-4d16-86bb-c25c07d30c97">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/79ed4eb9-bc12-497b-95e6-eb8c6e81e782"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/8d3b360d-b72d-4a83-90bc-6330cfeb9a5b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/f2d4d48c-2116-40fa-9d7a-907dac17dd2f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/fa67ad8f-572f-47d9-9e23-c1778aa27f59">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/f3048158-6c30-48bf-b971-11636561db77">
    <rdfs:label>buspirone-hydroxynefazodone DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/dc1faed7-5f05-4eb2-a422-c2904450a657">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/590e1d87-6830-4729-b18e-89d060c1cbd6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/df20f340-7b29-4459-bd85-72cbb5496c67">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/1be5692e-4757-4c32-b14f-abfe0d7adf50"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/6780bad0-4805-4d74-9c29-79bed14af240"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/1c6a5ba8-0e7a-4297-b9a6-157634746fc6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/ada7b581-f012-4938-bb6a-723def0ee30f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/74205c47-293a-4f68-8cf8-695563b4273e">
    <rdf:type rdf:resource="obo:RxNorm_72625"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/5f7f53ae-ebb7-4c59-9d73-2cfec051576e">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/fd9b5c48-8148-47aa-9a70-64579497cae8"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/3ef2e2d5-629b-4def-9bab-e58f6321eb3d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/eeccd973-4be4-4522-bafc-6e088cf5090b">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/aeb7c1ef-5bd4-4870-8308-12da31cf1d56"/>
    <rdfs:label>high-dose ASA-Edoxaban drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/1a8d0782-4c88-47c2-ab55-d5e79293bed7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/be86bbc0-ccdf-484c-a156-5f6d1b54f94a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/b15b010a-6a99-4b3c-8729-f0e1560b0ac5"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/c468d6c2-51cd-404d-bc61-d073b3983d36"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/e89e2092-7489-40e4-964e-c59412e7f371"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/30dc5e43-9617-4ba5-8d6b-32a65c23c20e"/>
    <rdfs:label>atorvastatin-verapamil interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/14dfa926-ea7f-4d74-b0c5-dacf7c75fd29">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/95bf839e-eea4-49a1-9031-3f455fd94d94"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/62575534-cf53-4d83-a4ad-c564c4e869ee"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/dc334269-1317-4905-b636-9d4e116b8aca"/>
    <rdfs:label>ritonavir-erythrohydrobupropion interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/4d418939-633c-45e4-967a-01799a5fca90">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/27990eb5-e630-4d77-bc3d-e3238a7382a3"/>
    <rdfs:label>42 Percent </rdfs:label>
    <obo:OBI_0001937>42</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/5a008c93-1ce1-4c17-8215-698e6c6a8ef1">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/19fd0c28-96a5-4e66-933f-c44b56b6cf50"/>
    <rdfs:label>17 Percent </rdfs:label>
    <obo:OBI_0001937>17</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/62d82b63-f404-4210-96ab-b4b25c5bd7b2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/111280b1-d2e4-4a63-b1eb-7f4447c02781">
    <rdf:type rdf:resource="obo:RxNorm_301542"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/788572ed-f807-49a8-8c9a-eefacc3f3ed9">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/87fbc485-c1f1-4ac5-8bc7-0af148ce550f"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/5a677cf9-f949-4bef-9f36-d131f71aa956"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/14be4227-b744-463c-8d34-d1363798c49b">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/9a02ebc0-7b90-4ff8-bef9-f274076e16e9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/cd31190f-d480-4063-af73-09e7d52329a8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/e26faf29-4408-46c3-8f96-c12d00d764b9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/d526b9d0-ecfd-45c6-bec3-cb90998ce687">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/7e959055-9ce1-4edb-8757-32b1e9c05199"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/91ffa844-488d-45af-8110-ca2eb0860697"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/235234a0-8357-4834-8a59-143f7b740bcb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/e7667cb3-d0d2-4c7b-b76c-d54b2d012935">
    <obo:OBI_0001937>600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/d0e130a9-aeef-41f7-827a-54201bc11b5a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/353c3bc0-3c01-4b09-b5a9-07e60b75352b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/1d7dbae1-761a-4f1f-9e9a-feaa1c715221"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/0fd472a6-2b25-4a4f-b2d1-c73faad3dd1c"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/67f007c5-986c-4696-9339-3e2efa639c0c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/a221ee14-38c0-4e3b-99a2-4edf51a06d3c"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/a82495b0-9046-478a-b7b8-8bf6ad4de940"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/ce2ee12d-ce95-468c-8c24-82786031ea37"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/8c05f609-ecea-410d-ae39-9de12cb2d47a"/>
    <rdfs:label>carbamazepine-selegiline interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/a16daec8-a8ed-4f27-9a80-42e858621d58">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/d8c8ce49-5d9e-4d6e-b635-eb4a11ab9b35">
    <rdf:type rdf:resource="obo:RxNorm_35255"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/8efb58fb-7133-4877-9ee5-571723dec16b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/7409a27c-5b6c-43c8-8c68-1141cd8be3d9"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/767b5284-477c-4ee5-8b56-b3faedda6ac7"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/4ccfdb8d-17fb-43ac-8d26-2f03375fd45b">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/7e9400ac-db65-419e-b3bf-3426c4e3143c"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/fca1bc35-2373-4c00-a771-133a1164be0b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/ff2dd303-f3b5-455a-8919-bedcf51b7d9d">
    <rdfs:label>duloxetine-warfarin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/6e3a162b-4627-40d1-b16b-baa2da0f0cc1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/8c7df13c-9277-4fa7-a3fe-0d20cc7d0064">
    <rdf:type rdf:resource="obo:RxNorm_36567"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/44a9d844-edd4-4eb8-86fe-54b534289342">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/3d9f09f5-d9f6-4f86-9d48-c70cddaa71ea"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/0c5faaff-40d1-4e2d-ad85-618db15c691f"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/6969667d-a55c-43fc-adfb-d8a8f6af2452"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/9c99533f-a098-48d2-835c-17e4af8ce9f3"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/11657804-972f-4b61-9560-d19c9200c7ed"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/e83eee6f-042f-479b-bdb9-94306cafbe2e"/>
    <rdfs:label>fluconazole-rivaroxaban interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/bfbb3ccf-76ce-45eb-9fc9-7c0450e5be8d">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/701ba154-f2e5-41de-8ab0-cd4a5bc52d49"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/73371035-838f-4e33-8e9f-a17c4dff5b3a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/fc3423e7-d85b-491b-93f7-f998c6f0162f">
    <rdfs:label>low-dose ASA-Edoxaban DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/06d24018-a5fd-4311-990e-952deafec586">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/b7aa27b4-66c5-45c4-998d-c54c87008d22">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/44ee0cde-c997-4921-b904-ae1eb597c333"/>
    <rdfs:label>desvenlafaxine succinate-desipramine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/5a008c93-1ce1-4c17-8215-698e6c6a8ef1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/32cb48bd-7532-4e52-a3b3-b2388d6025ea">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/efebadda-5271-4547-94a8-a4a2aece28e2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/2722b84e-b131-4cc2-bcbd-f363c4d82682"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/cc4c74db-8ace-4289-90ad-6dc06200b700">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/84cc089c-7171-40cf-9a90-ae32c6daefaa">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/31a51e31-e48f-4dd7-bc02-bb71f65cd6e1">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/b3b72143-5fed-411b-b2ce-2061c6271493"/>
    <rdfs:label>buspirone-nefazodone drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/812278b9-01a4-4c5e-8422-3ed7635ce0b0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://purl.obolibrary.org/obo/DIDEO_00000001">
    <rdf:type rdf:resource="http://www.w3.org/2000/01/rdf-schema#Class"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/7d1fd459-7b4e-4fde-ac52-99d0960f304e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/5f4430ba-3aae-4f9f-8951-82ddab607017">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/eb8c84ed-c78e-42bb-ae1d-5ef3a67d288c"/>
    <rdfs:label>Fluoxetine-olanzapine drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/9b6c25fd-c8de-4494-b2c7-b7baedb3daad"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/5b9cac7a-68c2-4f71-a826-0992d17a405b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/4cace9a6-74ee-494e-ae17-d499ccd468cf">
    <rdf:type rdf:resource="obo:RxNorm_4493"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/bf570f6a-92c4-401c-bcc9-f49092c896c0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/45b39f73-e0f0-4461-a8d3-41ad2aaebb85">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/78a30733-6461-4693-a735-6c1adb9e27ac">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/ef48e527-8a81-467c-bc7e-893e72bc306d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/cc57cea4-e2b3-4656-a999-19d0463958c1">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/5b7e81ba-f139-461e-b940-e885d655965a"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/54652f31-1f44-4ed7-8264-f49292111dec"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/3d5b0921-84bc-4814-bdd8-565203e2705f"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/cc719a1a-29cb-469e-abd6-8edec0c896ef"/>
    <rdfs:label>sertraline-pimozide interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/299bf320-be50-48c4-ad4c-905e0b427110">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/95c73558-29c6-457e-9b95-2c44ca0e845e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/8c09547b-d974-4e0a-950f-c2c9840846e3"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/4a5ba02f-ef9a-4374-ae2e-69fe7661da93"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/6c4d10e4-1cbb-495e-bda7-043d6f13afe5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/6f4baa9d-04f8-4d39-9f39-f575a410f9e1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/ee9bbf64-6924-4f1c-900f-af0c31b3e4f6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/cccf8414-0b16-445a-bf75-7f2b6cb604b7">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/454e5020-a1a6-4133-9372-07c7544e1785"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/1f87579b-e60d-49d6-a2ce-ff09b95acc2f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/ea66ac68-a44c-485e-9768-95575e2294ce"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/50dd69b8-0a08-451e-9dff-026ed96a5188">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/36228cc3-b98c-4d8e-ab9e-ea1c2fdaae31"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/f6ec967e-a773-4b90-8891-56f56b6234be"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/55a118c6-34a2-4c62-bc72-a3d6f56edbf4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/da3c6ef1-4997-4548-b947-3d29aefc3a0f">
    <rdf:type rdf:resource="obo:RxNorm_42355"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/617856b3-fa0d-4775-b3a4-a3825b54e014">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/18de3096-6120-4dac-878b-f4da33354e4a">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/6086c2e9-723c-4abf-b222-d902c07b295b"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/1a02eb7f-600d-4d95-9ebe-c428a31febe6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/f20b0c58-29fc-4668-ad7c-8db94b2b262a">
    <obo:OBI_0001937>10</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/608f16bb-ecee-4a14-91d9-850bdc2beb77"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/dcb02c87-c884-43ee-b507-e868d9d11a74">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/c6a14a4f-7dbe-4e2a-addb-a1eee10c7424"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/39bb8f91-cb3d-4974-9658-ce3fc04e7396"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/b77e7aba-bfa2-4d6e-8aa5-7f3aad2248ae">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/53906f94-023c-4c72-939d-684496fb1ee2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/4ab2d7d6-c996-41a3-bd6c-3157a73ffb1d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/8f8d0902-edde-47ac-a82b-f38cb4210822">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/a773840a-2196-49a0-a206-51f320219e15">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/a5260e05-89c6-4fda-b230-784e26b652fc"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/0cc11c42-0804-472c-95ca-71c17e1fbdad"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/4c9544cb-4250-4a39-9e33-874009ff86b5"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/110efbe9-342e-4c41-a40c-e421f6d7c905">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/1432f67f-76fe-47ed-a656-181f9868c48c"/>
    <rdfs:label>nefazodone-propranolol drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/10934541-adf0-4595-9d13-084163909db2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/d35579f5-5556-4811-9f4c-8b74561bc263">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/0841e0f6-f327-48be-a809-ab248b17c3f2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/7c74e5a0-3dc7-4085-b464-30888c2f1154">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/3827715f-52fc-4e45-a2bf-7d921c42596a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/f124c7f1-5ec6-4982-989c-8afb80cff13c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/7391b61e-5279-4f40-a857-209b419d7fe0"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/974183e6-6a80-42ac-a9bf-b06a0dc24031"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/df62d687-3128-4b2b-b737-0eb26032fa3f"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/d8e06f01-e114-4c6b-a345-f6a7a694b95a"/>
    <rdfs:label>Fluvoxamine-alosetron interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/9cb1d3e9-03b1-4718-86ec-b9676d5da89a">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/e2a4d0b2-9ef0-423b-b03d-2488be873c6d"/>
    <rdfs:label>unchanged UNK </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/1099595d-5a8c-48f3-92e1-ac8e041f81ee">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/d22a482f-6120-4fb5-86af-d9301a7a32a2">
    <obo:OBI_0001937>2</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/80836706-e198-4a6b-9b25-00f01aeff53e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/5f8d2384-72c8-4e26-93bc-c80ec8e6e586">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/7edd2f2e-8946-4272-b109-98970aa73259"/>
    <rdfs:label>paroxetine-desipramine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/23f16a51-63b4-444b-95f4-9316169c8065"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/683847df-46d2-4042-9d6c-eff4cd873562">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/f7a9e64a-1ceb-4bae-81e5-fdaa3afc3446"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/15056856-9e15-4b30-b311-c4868f99d82f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/ce86d8b7-1ae3-4c10-a6b0-2a22a999c07e">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/50f15fc9-3e18-4371-ad57-2144743b6732"/>
    <rdfs:label>citalopram-ketoconazole drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/d8c4e675-efbf-4f88-ab0c-cabe0589a7f4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/e43f10e7-ee70-4390-8166-4cbb76685b83">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/6e52b175-6328-4d25-ba7d-940169197d58">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/5b3f699e-9f66-4c62-b03c-4cac4bfd6279">
    <rdf:type rdf:resource="obo:RxNorm_1546356"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/a3d6bf09-70ce-485b-9c39-c217b351445c">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/b7312ad0-efab-4e48-b0e3-9f52fa73cf5e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/d35ba66f-9416-40e3-a377-3b117a0a008d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/e96c6008-cc2f-4d17-8e80-a53bdcf190e0">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/49494a2a-0d10-4b34-9164-6a2d7694b970"/>
    <rdfs:label>Cyclosporine-atorvastatin drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/94adccad-e200-4dfd-b044-0a081f49e26f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/52ef3b4b-e49a-4b01-bd76-7d73f758f2a6">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/1bb2206a-219d-4f31-96db-0427edbdcd60"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/2bf2ec18-3d2c-48a9-8745-3f60a93d3037">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/2816af32-28b3-40e3-92f1-bdb4bd6f6ae1"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/2c58c49e-2689-4669-8270-8a5ece1147ca"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/a19a462e-7bcd-4fd2-ae3c-f0ecf488d69e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/4015c3f1-479b-4f66-a478-fa55386637e2">
    <rdf:type rdf:resource="obo:RxNorm_596554"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/1f388a55-28e1-4976-a8f7-e56189395393">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/0fc0fa7f-e2b0-463a-875f-8bfcd6eba15e"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/267a2710-7609-4ad3-b349-5b9955dd7898"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/5c31ac52-3993-4811-b231-c20c8b2bf19b">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/db6e0da8-5326-4aa9-a589-6aa605033021"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/1f863d91-bf08-4205-99ae-5bf1a0dd9699"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/aa370437-5862-4189-8ce3-49a449c10d9e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/a4db88ef-51c3-4113-8cea-c3dd0a38a15d"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/b0505456-03ea-44b6-98b5-b57073610efc"/>
    <rdfs:label>ticagrelor-simvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/6f9133b0-9d94-4a3b-8eb4-4058aa2b3d71">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/7409a27c-5b6c-43c8-8c68-1141cd8be3d9">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/59c029c2-a630-4e0b-889c-19d8a0da53d2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/d6242d5d-cf11-4949-a892-b5f85625ee42"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/29acd8f3-bc25-4442-9695-96948b154247"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/dcdd5dc6-fa91-4440-b64f-648651d82d73">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/f6c062e5-37cd-4830-9683-6d44e85f6d78">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/eba3a401-27aa-486e-9fbc-a518320632c6">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/cebb49b9-c1ca-4521-bfba-cbb085f64249"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/e30a30b8-4d54-41fa-bf29-3d6f160147b2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/b1dfc512-0400-4684-bead-3df47ebd5110">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/e5cee616-a4b3-46fb-ae79-3395ce0ac427">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/27009cec-3e1e-4e79-869c-12287a053f36"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/4bfd235a-5ec7-4200-8a46-a2cb533acd0e"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/30fcaee2-2340-4dae-83fa-e73129f0347d">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/3b4614f4-12fd-4a1d-b5a7-3149cec5cef4"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/987c38ae-b11e-4455-9368-bf8d673e3f45"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/c5a5aadd-ce49-491e-9b6f-ea00db8818cf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/910c708d-284e-4c25-b2af-e075993ec8d2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/8fca1fc6-e449-4b9a-9036-dd851c713237">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/cdb4f475-bdb5-4f2b-a8b3-59bd5e324139"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/d267641d-130e-4270-a9a1-583d8a82b745"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/411661a7-26a2-4bcf-bf14-2391e69237f4"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/470d2cf9-fa65-4248-9a91-ab101f57bb13"/>
    <rdfs:label>phenytoin-paroxetine interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/2eb5a224-76a4-477f-95a7-67d2e926bd82">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/004208e3-78cf-4fc0-9a2d-8048c5a80009"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/19b3911b-7a6a-469c-ac7d-7b862722df8f"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/5943fdfa-480e-40ff-b186-11e07fb5e827"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/afd71fa7-25f6-42a7-a566-2f4097144030"/>
    <rdfs:label>rifampin-dabigatran interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/2f5377a0-6130-4e43-9dd6-f6536c4b357a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/0dd4cb13-ec6c-4d91-91a9-8ca73ec6d2a0">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/90a04167-be1f-48ab-845f-ce14d054331e"/>
    <rdfs:label>3 to 4 Fold </rdfs:label>
    <obo:OBI_0001937>3 to 4</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/268c8482-1e2f-4055-b2bf-2a4fc4ae0f0c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/f37c5665-5aab-4504-a863-3b8cbe2b8794">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/5a681b1a-9009-449b-b717-b1994d52ded2">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/e093bd0d-978a-4ee4-8943-e54079be78fb"/>
    <rdfs:label>74 Percent </rdfs:label>
    <obo:OBI_0001937>74</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/d1d4eaac-deba-497b-a767-64791543efec">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/04f121d3-ba6f-4ae9-9dae-557fa76cb772"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/2e94421f-24a5-4de2-a61e-9b8bfee57fbb"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/e521b36b-5ba5-4be6-980c-04cfcc6bb210"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/dabd0fd7-1a86-4ad8-8ce8-b54d6deae658">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/9212c94b-5e5d-4706-bcd3-664123552b29"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/417bca06-f461-4cd1-932b-d576b0dd1c99"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/ab52caa7-41a1-47b7-b0bf-79354f55dadf"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/d161518d-c5f6-434c-b25e-38c4947e1d87"/>
    <rdfs:label>ticagrelor-dabigatran interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/15f026e1-1e0d-41e9-926b-6c775b347d97">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/166bc93c-e80c-481f-8d33-0316f605eaeb">
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/1e1ded64-cc16-478d-9711-403322daa22e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/6daf43df-62c6-458e-bfce-bc56a3cdd7ab">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/a1b62266-855e-4733-8f5b-b43ec97380d8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/64f100ef-fbb7-46ff-b61c-87a2721890df">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/2c6c4251-9ffc-4df5-ab03-25c5f7fa1444">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/22554bf5-83c4-49ea-b77b-8c4942c74d0b">
    <rdfs:label>fluvoxamine-ramelteon DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/d9ba6f19-b414-48f9-922c-8e22f1ba72ae">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/8cae1583-54e7-46b6-a956-247c1b37fb25">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/51ef6080-dc2f-44d7-a75c-82cd99836bc9">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/e4582cb1-d3ec-44dd-8e3a-e58ddffa4ae2"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/6deffa57-5564-44de-9846-3b33fec40fa9"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/00d9fb93-2119-4496-89d1-97925bb2d3b5"/>
    <rdfs:label>nefazodone-simvastatin acid interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/6e9fa35d-4674-449c-b06e-b4a06c7aacc7">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/2aff703d-0502-4be7-8299-70adc337321c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/fd1dd8d2-1b83-498f-9b4c-7f64726fe02a"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/322dacf1-8e47-452e-b234-1301652c7866"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/161fae7c-7b61-48f3-a086-da5919609a3d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/869b8faf-d1e1-4c47-958d-181a921f8bc6">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/9dc74b12-6e53-43cb-826b-d02b881f8880"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/23dcc326-10dc-4f45-839e-5b4fa4c528fb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/ce9635f3-d426-4e38-98a1-e2c91789e455">
    <rdf:type rdf:resource="obo:RxNorm_4719"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/5ce0de96-c4e4-4662-b8e3-c1faa4eabdde">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/b153b37c-d59e-4680-8a80-3ee7c6307623"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/0f4fc334-33e8-49dc-914e-90acc5b69799"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/06f3ea65-daf3-464d-a6ef-9bae5d082873">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/081cf9c9-fbaa-4284-90db-68597630b562"/>
    <rdfs:label>19 Percent </rdfs:label>
    <obo:OBI_0001937>19</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/8e30a8c3-c5e8-4876-8ba9-90c3944803ce">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/ff5468dc-a574-4392-9307-4a477723cbee"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/46be9fd4-a28a-4daa-96fa-4494ad009d9f"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/c856b01a-b2f9-454d-a366-7fce95da152a">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/a9af0431-eac7-44b8-84aa-17b9d219f6a7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/9919ccff-fc96-40bf-90f0-aa503f5ada9e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/5f0223bd-9012-4f13-8ff7-ca25f9c50fb4">
    <rdf:type rdf:resource="obo:RxNorm_596"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/3298c97a-cc21-4041-819a-bbd07db15e74">
    <obo:OBI_0001937>5</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/a0acc275-7299-4213-9648-65f062eb2734"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/e34b77a3-3c34-49bf-8029-f291144d6cf1">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/08895af8-5ead-48ef-b08d-e9630550ac2c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/a13aabff-4c04-4df0-b7eb-8a338bc88366"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/00248bf6-8dff-4be4-a6f3-5ec6cd1f1262">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/18587a1d-9a3f-40f2-9f2f-6acb15fef0cd">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/90b2ddae-60f5-4333-8167-e03a4eb29053"/>
    <rdfs:label>efavirenz-hydroxybupropion drug package auc  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/c6982837-4e56-4b6e-9cd8-69a17153eda4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/ad03202d-2546-4002-9537-578e1108fd58">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/ada7b581-f012-4938-bb6a-723def0ee30f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/a38f4268-9bb0-42be-a5a6-e14de42e0700">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/7f0f4a57-a277-45b1-9beb-ed47f02f543b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/770b1e43-a7fc-4f34-b811-254732639345">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/b8686e7c-f2af-485d-9481-773b6b01044f"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/6b59f784-edee-4fb2-ac4d-42b6c532915e"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/a279136c-dcd1-450c-b720-5bc435929542"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/4af0cf64-4a66-4ed0-87f0-7a5885db89ad"/>
    <rdfs:label>Cimetidine-Atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/914a9a72-527b-4727-8b51-eedf656b2485">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/62708a1e-a91b-4791-9725-bb7d2fbba3cf"/>
    <rdfs:label>50 Percent </rdfs:label>
    <obo:OBI_0001937>50</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/d62d3e78-e1b3-4ca5-8302-409fff5fe759">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/ed463ab3-c87a-4bca-bdd4-b4bcc6646220"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/9d564005-6b89-4227-93b0-1aa0c739e3eb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/7bf8a52e-75ff-4b92-9365-41fb6abd58c3">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/133553e1-a457-4678-93be-f77f6cf120c3"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/2213d8cb-2980-4188-8371-b86775f17b07"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/b08479e1-f45b-4bbe-9f86-e6148a3088bf"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/481ea044-0492-4d67-8be5-a56b01c84028">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/ffaf8fd9-3935-4fe2-bfce-f94931b481be"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/85d4abef-58a1-4776-902e-5ff037fdf8cc"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/82db4252-7744-4b63-a5c5-a778a68cec18"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/9ecaf000-68fa-4b7a-942b-e8b320eb6bb1">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/6d7bbf31-6da4-4746-b09c-44d7b7c26eeb"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/080b7243-5227-4c15-8c1f-a5c98620a87a"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/9ee3efe2-7471-4e10-9194-1d2a1102642e">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/4ec2da87-f6c5-4ddd-8cbe-43056a80884b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/fe682f32-6781-4964-9cd9-e792739c4913"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/7c32dd9b-5bb1-4e1c-9c3b-c77073f84f69">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/92f0ad7a-5fcd-42b6-9a1c-99e10cd05bc7"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/1daa8ac7-b374-4f80-83ae-85c248ef21d0"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/c849866f-cba8-41eb-9b95-2890c645668a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/d3394f37-b444-4f83-9f9d-3cd9a93a821b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/88b24d66-b8d7-4ccd-9457-6f295bca65ec">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/48c257e9-c5dd-43ff-b6e6-4005153d3ade">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/e6626689-c232-41d1-aecd-3e4bffb4a516"/>
    <rdfs:label>quinidine-dabigatran drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/f13883db-f997-44b2-b165-fbb83dba4290"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/e68e84a6-14b7-4779-9425-127e0b57d9bd">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/174475f7-9f02-4a7c-bf39-61824235615b"/>
    <rdfs:label>123 Percent </rdfs:label>
    <obo:OBI_0001937>123</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/f51c57fa-3a39-4d26-b384-fcb2d5a32db1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/43403e41-0d6e-4c6a-a8df-1984be0563d8">
    <rdf:type rdf:resource="obo:RxNorm_42463"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/6eb03266-ea4c-4034-9c76-a34b678f8370">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/8e328195-ed44-4839-a3d3-82a45d3c3567"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/655ce857-ed43-483c-9948-dcfc31177bbf"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/0d7c3bb0-7055-4a99-8375-11589ad9b277"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/6196140a-b5d4-46e8-a47b-7ce4006bbd90">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/f2b0dc29-1739-44b4-96a8-05e9885e2f0d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/5b050d52-1896-482e-b5f2-2b699d010955">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/56be8156-4cc5-4690-ab03-88ea23cc76f7"/>
    <rdfs:label>ketoconazole-zolpidem drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/73de74ec-f776-42ed-8209-e83723dd1357"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/e970391a-9376-4807-a1b3-888a8eea85ef">
    <rdf:type rdf:resource="obo:RxNorm_73178"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/4bdcc8ab-8ede-4514-8277-2d3c31aacf79">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/1a7ae759-c67f-4b1d-907f-f04aa3eb1501"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/f73e10f1-679c-4fe1-8599-c903ddb9a9f3"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/9efc9721-9932-46a7-9a15-aad314287456"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/03a59941-f2ca-494d-98f2-edc6e4ac1453">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/ef387208-2ab5-420f-92be-ce77d4797647"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/c75f164d-08e4-43fe-a9af-877c7f4893de"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/728e60ee-e8c7-4884-8503-a1c4ab661184">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/24e8a9a6-bedb-435d-92cc-f4294314f795">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/e1ae0d89-203f-4660-8f3a-1fcc33f85cf1"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/87216a9e-309d-40b1-9af5-d7ed7ae10e43"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/7890b2ea-bd63-4377-92b5-ee390f2b8fc1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/f7e83ec7-ec62-478e-b7f8-27b289550762">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/36ac76dd-795f-4ec5-bbda-3a3e3d42bc26"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/a0d01676-d55c-42a7-a7f5-c555de44755e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/0868e290-daaf-4e99-856a-a6dafa5ced2a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/4c5b85fc-8da9-4cc5-84ff-14c6f5ff5003"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/8d72f15a-7644-48ac-abcf-8e1a302a063e"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/44fb585a-9d52-4d24-89f4-ab0afde230ed">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/1d75a33d-6fa8-4c5d-9820-83f9922186ad"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/7455a829-e94d-4e77-87f2-b2ecddfa1d70"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/d20e2563-7225-424c-b873-bbde7abffc0c">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/9640a21b-30e1-40f9-906f-7227a58d9bd1"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/8fbb45af-e1ac-4f2c-857d-6bd16403be0e"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/bf7f7b54-55d9-415e-b7b2-98f4060b6e53"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/e2b8a536-898e-4615-868f-4fbeca0f96b7">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/13e98390-323c-459b-9511-3b1f5e2bec9e"/>
    <rdfs:label>9.36 Fold </rdfs:label>
    <obo:OBI_0001937>9.36</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/aafd3dd1-482e-4904-82f5-ab7f22c52866">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/ffd573a5-1110-4c08-80d9-8f5a62768fef"/>
    <rdfs:label>citalopram-desipramine drug package auc Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/e01f19d4-66d9-4b9d-8f79-4d2cf415f93c"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/91638688-c922-4d23-b4dd-73dad92fe8f2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/9d11cb04-c314-42f3-bd0f-0e683d58c1c3">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/16c9d402-8809-4f68-a4dd-839309e00834"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/1daaa386-1a0e-4da0-a42f-a00dfe746ba8"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/74a08199-1248-49cc-a96e-8d20bd385de5">
    <rdf:type rdf:resource="obo:RxNorm_11289"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/fa3becb4-42ac-47db-8f19-7d2ab7dd0b11">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/817842a7-f723-4bf1-bf7a-4842b7807da7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/041a11ab-36ce-474e-8ef8-891b8cca2398">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/b5d56245-884c-42b2-b8ed-763cdf888fca"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/5411408e-041e-4983-bc6a-3bcefd230068"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/94b891cf-2f7a-45a9-87bf-2841a0166ae6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/b1a44c3a-3998-4467-9ffe-755e551d89b0">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/1df6eec0-e1e9-4627-8e41-45135fb569b1"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/3581157a-f82e-4a64-a40d-030f82a2e713"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/5f7f53ae-ebb7-4c59-9d73-2cfec051576e"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/aced7616-3fa4-4631-8020-f1950719ac0a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/92ba0c52-3a4c-4833-937b-e2137a93a3f8"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/566e2909-dfc8-4cec-9e60-af661252006c"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/deb61bec-ee2d-4759-982e-983fb9dc8877"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/25595753-b724-4d65-989b-f0090ac7490a"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/4810d3be-596d-4942-967e-7d72d08e1b2d"/>
    <rdfs:label>digoxin-aliskiren interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/ea6f7bf0-8b93-41f2-9463-6f74e1138fc0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/a8a390ee-d5e5-4d9a-8777-3c3cce81bf6a">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/35f4870b-df9c-4a35-89cd-64e84f262e22"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/b661e049-941d-4e61-b8ef-32d9abd58ac1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/93b49760-8a72-4dbc-bc4f-2acc11c07d0d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/9d874bea-3bc7-4fb9-b0da-5d62bcb39ca9">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/db8ba1d0-4749-4e30-bb61-8808d83881f9">
    <obo:OBI_0001937>2 to 9</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/09eeb01c-cf5e-4023-a3f7-61ad958f8770"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/234da9d5-285c-4b04-847e-4b859056a6d0">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/860be9c3-fe51-41ca-b90c-30bc7624cc5d"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/25af63a8-3e3e-45b7-9c8d-1c11c20a4155"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/8d7bb40f-3885-482d-84eb-50bcf187e862">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/52e9fb5c-1d8f-4773-ba45-ef7044e12791">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/66ba18db-0f84-4c93-89a1-08771d8717c0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/59422f4c-d44c-4d4b-8b5e-ed44e12ded71">
    <rdf:type rdf:resource="obo:RxNorm_42355"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/a2ee078f-dcf9-49da-a0c1-16bdb512ecf8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/1e733fd4-30c6-4156-9fd2-87bfcd65cb6e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/58fc8aee-754d-4f75-bdb6-badd88f89b1d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/93d06dc4-311b-47b5-8761-e7e649186346"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/146369ec-f893-4994-8499-426b72aa76bd"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/7325e51f-454b-432b-8d2d-5e9ba12a2ece">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/ca592355-0cb4-4621-aad2-be7499b8abd4">
    <rdfs:label>fluvoxamine-tacrine DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/b0518506-f327-4af8-9c91-be419549e6a3">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/2c008dec-2113-4863-ba76-f7649e0495fe"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/28d2e995-b0ff-4a6a-9de8-356399d985fe"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/fcd6f9eb-1fe6-4733-9052-bc017b3e84ab"/>
    <rdfs:label>ketoconazole-P95 interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/999ba9a9-cb46-492b-a901-920c0b60c960">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/fd94e014-96bf-40a5-904c-bd849da17be5">
    <obo:OBI_0001937>150</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/f06cea21-94c4-4762-a153-25a7b5ec3511"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/81a56c49-e8be-4e0a-a6cf-27d89365ee5e">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/d06b7c2f-8d98-4b4d-a825-cdc2105b46f3">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/18587a1d-9a3f-40f2-9f2f-6acb15fef0cd"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/f904f503-2c21-4094-a135-a556f61a92f8"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/d9b9e831-91ea-4501-b9ce-1357e7ff4066"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/353c3bc0-3c01-4b09-b5a9-07e60b75352b"/>
    <rdfs:label>efavirenz-hydroxybupropion interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/ea3b6998-b013-4bf3-b13c-f660a97746ac">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/ff6eb4c6-e74f-4d44-a900-72939411a408"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/41bf16f5-7314-40cd-916a-bc730e0bbbea"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/a47e081e-4dfc-4ca0-8db3-ec9f63c76e9e">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/6b039447-d2d5-4ee6-97c0-4f5493d2b51d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/3203be8d-b6a7-4c43-a102-f4a397d96850">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/103979b1-58f4-4817-8118-29eaf64a5cac">
    <rdfs:label>efavirenz-bupropion DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/55ef2e8f-1ee7-47f6-a6a2-0dbad052fed7">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/e7ffaef4-6681-4f66-8d1b-f317b6d319c7"/>
    <rdfs:label>atorvastatin-aliskiren drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/10d7272c-fcd5-434a-bfdb-8b3ead28f780"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/1399622e-faa0-4fb8-a220-b42bbe6254ce">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/828c6845-b048-4bc6-b720-a6c1a1c030fc"/>
    <rdfs:label>38 Percent </rdfs:label>
    <obo:OBI_0001937>38</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/e6ec73a4-d1fc-4962-a32a-59a2847aa3fd">
    <rdf:type rdf:resource="obo:RxNorm_81864"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/c6807e8a-0b7d-4cb3-bf70-4b7c07536b33">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/76522839-892e-4cfc-9f5e-c4bc036c0ef3"/>
    <rdfs:label>80 Percent </rdfs:label>
    <obo:OBI_0001937>80</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/f1aeb7ca-f994-4ba2-b8ec-0109ef379510">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/8e32e90e-2e90-4123-9b8e-b8351baa6926"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/63d3289d-5f15-4c3a-9664-26fd1bea94d4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/98d02cd7-ef99-4260-b586-9790b3478bd8">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/34e31329-1eee-4f9f-95ab-f94e181d27d4"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/e3e62e3b-37f5-4815-b994-438125d65081"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/547ef569-4f1c-4513-a79b-167eb128998f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/0ab439eb-034b-4961-88f6-8bed947ea771">
    <rdf:type rdf:resource="obo:RxNorm_2556"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/8f1fa790-0c5c-4b26-91ab-1cb3344dc937">
    <rdf:type rdf:resource="obo:RxNorm_72625"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/afc38902-b2c6-4f7b-ba41-cba09bfa78a8">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/a4aafa01-a7f6-4a5a-834c-8188f41c86b2"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/e3c5fe17-8793-417c-942a-8314233ac584"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/0a1319b8-de06-46fc-ad76-0f0183f943c6">
    <rdf:type rdf:resource="obo:RxNorm_83367"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/87fbc485-c1f1-4ac5-8bc7-0af148ce550f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/a1a59908-0351-4bfe-a5f8-3fadc350ea8c">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/6e4e19ce-a58c-4f82-a75a-6b71155d2f97"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/26cba1b6-cb6c-4064-b11f-6378789b219e"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/f32764a7-e89d-4c0b-bbf0-15c940c8a7f1">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/83d23fe9-8f85-477d-83e4-8f1b3d60f03b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/590e1d87-6830-4729-b18e-89d060c1cbd6"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/9595725f-0a1d-4544-aa37-a0a3f3be943f"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/f45df5e8-2cc9-46e5-8003-fd44a0da5ec0">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/2f400be8-67fe-4d49-81a2-8afa4e26d36f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/801fda3c-5089-499f-8516-13daee554a6a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/fe86b2c7-23ad-48fa-ae3c-e1af8481de90"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/e6f05658-e3bd-4413-af83-720e936f3435"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/408319fc-03a9-4c02-b84f-4a8cb4834f91"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/3c4bfe87-7899-4c79-98ca-425e698f8dcb"/>
    <rdfs:label>ticagrelor-dabigatran interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/04c4ab18-36e5-4c63-afc5-dfee4194c197">
    <rdfs:label>vildagliptin-simvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/63acca56-a5f2-4928-80f5-b65e87cb52ce">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/895b13b6-ff68-4ad8-ab15-8b2526982ada"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/9053bcc0-a290-4dea-9b8f-73236cab08c2"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/59b9d8aa-ebab-440c-bbc0-a7be460de61f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/8916f4e1-81e7-4033-a3c2-953d96de68f8">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/d19e1416-757f-46a5-b98f-ca24480f63a8">
    <rdfs:label>erythromycin-zaleplon DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/ac3f7ece-093b-4259-8d05-e5b74a0edec3">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/c35e6440-4b58-4981-9f02-15f04f869cce">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/5df55dfc-3c51-4920-b1ab-3c0449fe199f"/>
    <rdfs:label>lopinavir/ritonavir-bupropion drug package cmax Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/35501f67-3a74-4b1c-8dd2-12a19b1d1e7a"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/62cef6a3-a179-45f7-9bd5-be7ea5c731f0">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/72669bde-8996-4be6-97ac-93266630fdbb"/>
    <rdfs:label>2.2 Fold </rdfs:label>
    <obo:OBI_0001937>2.2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/61c039d3-2bdc-4401-84eb-d5cb91008a49">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/4b4d5cb2-9225-4cb5-934f-24cf150e6733"/>
    <rdfs:label>4 Fold </rdfs:label>
    <obo:OBI_0001937>4</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/b96ca8b0-2494-4c8f-9c32-bac0fbed6268">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/101bba84-6979-49eb-9eb3-419b60dc97f4">
    <obo:OBI_0001937>300 or 600</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/9d874bea-3bc7-4fb9-b0da-5d62bcb39ca9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/239a5ddc-ec8c-4fc5-8c2a-bca68aed1452">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/9334aa74-0a7c-4361-9877-61e5657d74d6"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/9fac4825-9550-4d77-8545-5c4135688c7b"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/af24be4b-0ce0-4475-ad78-bc834f8dfbb0"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/63acca56-a5f2-4928-80f5-b65e87cb52ce"/>
    <rdfs:label>clopidogrel-bupropion interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/bf3da30b-65c6-4a20-9171-7e32a40474d6">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/498e0dba-c8ba-4d10-8755-a6a54f638d7b"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/23900ecb-9aa5-4012-af45-3df876bc947b"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/3bd56f51-841c-424c-a36c-8e9098f200b7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/ed032d5e-9d42-4214-b633-55de936fb27b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/aa21c512-f206-4090-8db0-2649f569242f">
    <obo:OBI_0001937>300</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/a1b62266-855e-4733-8f5b-b43ec97380d8"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/005cfa8b-8d3e-49a1-93bf-ed114ff624d2">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/f77470cc-f5fe-4c7a-85f3-29b9f3c1197c"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/cff6bc11-ea05-41fe-8826-73a7cd514640"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/beae3aad-a88f-49cd-aa1b-478158b9f10b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/d7a63d92-ac1e-426d-a65f-395929a07392">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/b17244e2-bbae-45f8-86c9-5a53b8c442ee"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/1bffb90e-8475-4355-be41-607f956ffe3b"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/022fd1d6-4ce3-4936-a777-956dc2c50924">
    <rdf:type rdf:resource="obo:RxNorm_8134"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/2722b84e-b131-4cc2-bcbd-f363c4d82682">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/724345ec-b3f5-405d-a77d-cb7d35ae370d">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/dc3b9a20-99e8-4101-80f6-aa8121a7cd5c"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/c9acb12c-8f8f-4e26-86fa-0b10463ea944"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/35b0e1c1-9b28-482c-b31d-1116c9227ec4"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-measurement-datum/ae2e20be-9dc5-426a-9c6a-24528213a80e">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/precipitant-mass/14ba3217-9e86-46cc-9394-4a2afe2bd1ec"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/precipitant-value-specification/0c590691-a65c-4cce-a1c3-5fefb7d74865"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/1fe2fe8e-f72b-4521-90e6-7cc44cf82ba3">
    <obo:OBI_0001937>500</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/c2d27cd8-7067-43b9-93f8-d9092660afa7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/bc39b31a-3576-4ec4-9b78-4db9eee860f4">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/28831a36-b8f6-43cf-b99a-80f9a1719d3e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/46a768b1-ed99-4606-9a40-59f360ab10f8"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/f7e83ec7-ec62-478e-b7f8-27b289550762"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/ff8f464b-d1db-49ae-af0e-b5ff3a8b22ee">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/b44a4a98-19c4-4042-9961-d0d110407c04"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/1b05351e-f965-409b-bbe7-5cae22684297"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/6fec0f2b-00c9-4943-b75d-748524793db0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/f4b10917-af2a-4091-b812-407497686f78">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/9a567300-9e9a-4528-84e4-e9112beed4d6">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/bab45b7c-a3c5-40ad-b2c7-1ef50f79d9d7"/>
    <rdfs:label>ticlopidine-bupropion drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/211a7c8d-5f2c-4aa2-bb32-cf584f8ab386"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/53f64e0b-896f-4e29-9f70-f56e1b7167f8">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/a2acead3-27c0-4e0e-9f45-967c38ebe80b"/>
    <rdfs:label>29 Percent </rdfs:label>
    <obo:OBI_0001937>29</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-precipitant/1c66b199-ef69-4cb2-b78d-4d0482838757">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/p-scattered-molecular-aggregate/5e7b9aeb-9808-496f-b770-c313c7091b00"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-drug-role/798b6f83-7a4d-441e-bf55-578a17a70b6e"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/eb90b8b4-6b46-432c-ae91-8db3f5956868">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/9912a715-8c1e-48bd-a81b-0fb89a0d4c19">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/f0e74d9e-0dd9-4c82-9bfe-629517cd1aab"/>
    <rdfs:label>40 Percent </rdfs:label>
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/3095e519-1866-4a17-95f6-f1c54038835a">
    <obo:OBI_0001937>25</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/9d1261be-ebb6-4805-800a-6917000d9ce0"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/ba75c8b8-62ec-4208-a18f-8761c08feffa">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/5e58a28e-0826-473f-a733-20deff44ccdc"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/65900665-d70c-4695-9e4a-69e3a5ce2388"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/15d9bdfa-24ea-446a-9b07-8a3f20594e80"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/b7684c18-1cda-4ac4-be85-0841c5fd3247">
    <rdfs:label>cimetidine-threohydrobupropion and erythrohydrobupropion DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/1bf845fb-0bdf-46ec-922b-aa1509d4b944">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/f1971ab2-ccec-4c80-a495-97cbafe539fc">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/d0577924-3821-4988-94ba-846173793448">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/d5bc1ce8-945e-4790-927f-3a8837a43295"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/97c02f11-a9bc-4984-b545-2bdefac3edf3"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/c5beeb14-f455-4ec8-b52b-05efd592ae53"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/9fe6a987-27c5-4df4-8752-3d14e76f1dc1">
    <obo:OBI_0001937>5</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/b00b0b55-4293-42d8-91d2-03fd1b5ba177"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/23f2471f-fd1a-4d63-9ee7-9412237d0da5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/e44d4ef5-0e89-46c5-b928-78d58333eaff">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/e933c049-1bd4-488f-b08e-1f3449441dc5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/077c2826-5fab-4797-9249-4ff85a00faf7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/6adbd84b-6d86-4cf9-a731-c6ab0ae05d87">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/64a08b0d-1bee-4a82-99c9-539b5e092223"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/e159e617-a0dd-4050-bd40-d530d1da80d7"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/a447966a-b3a4-4532-9419-1397ab9571e4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/35eec514-dbbd-429f-8d00-60aff3e75d31">
    <obo:OBI_0001937>20</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/74f05ef9-07dc-43fb-8f95-38eb157e4a33"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/13d8c9df-fdc7-4b52-81a9-503956ee4654">
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/11851848-4943-477c-bac6-b54af16e52f1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/37d51499-d478-493a-8053-37e69d098e1b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/554d7c37-47d1-4b67-84ea-a38eeabb3854">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/0d4b92c6-5292-4590-b7ef-91efcad3ebf1">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/e79a50cd-318e-4a8a-a066-646576b0d205"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/507b3449-d956-4e47-93f8-301e1ea60e4c"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/37b75830-a39c-4256-9448-ac452b737d94"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/aeba037f-90ec-4539-85c0-141ccfed3056">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/d023dbd0-854f-462d-8511-92834e6db0ff">
    <obo:OBI_0001937>250</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/66f3524a-786f-4b5c-9ca6-e4f87719b7eb"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/23573fc9-62c7-4e47-95b7-6679ccb11bdc">
    <obo:OBI_0001937>40</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/e77f6178-e104-4e0e-b005-64fff3e90488"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/7d93551d-5399-48ae-bc2f-034298b1d19a">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/49494a2a-0d10-4b34-9164-6a2d7694b970"/>
    <rdfs:label>Cyclosporine-atorvastatin drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/6d381aca-f82c-437c-b497-b41ab56dc813"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/0a972fbd-c8c4-47a4-b682-818cb146455a">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/c231e45d-41fb-4b78-a7f7-c525d0eda437">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/116a8e16-f129-4b05-8faa-7c838da9736f"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/6879f54a-b0f4-46dd-9fc5-4fc496a787b9"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/a59aa33c-7d2c-462e-99ae-6cda6582bfba"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/bcb101b8-f04c-4641-91f6-09d18e3acc2a">
    <obo:OBI_0001937>200</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/91110d6d-1612-458b-ac69-3d6cdd2847ab"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/a90bb9e3-6931-4893-86b4-0a37ce41d991">
    <rdf:type rdf:resource="obo:RxNorm_36567"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/79f4ca34-9edf-4b7a-8688-a8e8cb5ffde5">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/15c53c18-cc2b-459c-a59c-8b4264af55da">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/6c05fefe-205a-4014-a1a6-eb8ba4b19805">
    <rdfs:label>buspirone-mCPP DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-milligram/f9a4e952-8d3f-49e9-8b1c-ea0d096655d6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/bb91182c-f82b-4216-b9f8-96d029a75c7c">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/05261182-2bd1-46eb-ad25-2ce3aa60a826"/>
    <rdfs:label>citalopram-ketoconazole drug package auc Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/9c7518ca-112e-4d53-a468-be97d434e01d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/ddb91906-316a-41ee-8a4c-23ca51f28855">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/357bf344-cc0a-43b7-a76e-285e5716688f">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/o-scattered-molecular-aggregate/a7cdd65f-2172-4e45-b511-37b8eaa165ae">
    <obo:RO_0002351 rdf:resource="http://dikb.org/object-drug/5f0223bd-9012-4f13-8ff7-ca25f9c50fb4"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-active-ingredient/a04f74ff-ad17-4a46-bd27-19cd93105ed7"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-value-measurement-datum/ecbc2d2d-cd27-4692-9719-01beb66c10f9"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/14ae3f86-3a0e-4311-bd22-2891e69b9e71">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/56be8156-4cc5-4690-ab03-88ea23cc76f7"/>
    <rdfs:label>ketoconazole-zolpidem drug package cmax Increase information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/0904b475-e502-4151-ad49-f155e518fab2"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/6e62a11c-dff5-4b13-974b-3f9c9c61ca5b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/1b8b9d34-5ac3-49f3-8949-b81fe86ce238">
    <rdfs:label>sertraline-pimozide DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug/8accfe57-aa6b-443d-9707-41a54270167e">
    <rdf:type rdf:resource="obo:RxNorm_32968"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/566e2909-dfc8-4cec-9e60-af661252006c">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/9b7ca5cd-3a2c-4978-b0a0-9104f6c253fc"/>
    <rdfs:label>digoxin-aliskiren drug package cmax  information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/f853df85-cb07-4d17-9fb5-38db641a5d73"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/f5bba366-05b0-40be-a3d7-54dfd154ed9a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/ef009048-0651-4570-811e-09130860a154"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/9d11cb04-c314-42f3-bd0f-0e683d58c1c3"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/e892a313-1a7b-45ae-820b-b5d22aed1f95"/>
    <rdfs:label>paroxetine-9-hydroxyrisperidone interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/7f456144-f23d-49af-8d70-1ead3caba906">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/bfa599e7-f076-4801-8d04-3d807eb73727">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/f6c062e5-37cd-4830-9683-6d44e85f6d78"/>
    <rdfs:label>unchanged  </rdfs:label>
    <obo:OBI_0001937>unchanged</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/b16c5da7-94a9-428f-acb9-3150e3b571cd">
    <obo:OBI_0001937>300</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/cc3982e2-4ca6-47a9-8afb-f236fdbea641"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/f2cd38c4-7b27-4388-94c6-a7a5df7ef597">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/b40021cf-f149-4775-8c33-bb0ac496e60a"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/06f2eaa2-40b3-4200-9233-f1c58db81fc4"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/edb0583b-3ffd-4c90-aafc-0f7374fb821d">
    <rdf:type rdf:resource="obo:RxNorm_38400"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/bfa5cb82-b74d-401d-a386-63ac83d70190">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/62fbee30-a001-438f-8d28-32eceab148fb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/5a6a65a2-f950-40db-b8fc-3f7157f4334b">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/268be147-6319-4707-ba61-c716f359880f"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/89f34c37-8308-4c5f-9711-c91eca0aef5d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/50f15fc9-3e18-4371-ad57-2144743b6732">
    <rdfs:label>citalopram-ketoconazole DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/a2155a8c-c42c-4fe3-93ef-8cfbe07404d9">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/62fccb55-7c7a-4d9c-939d-a43eedff8205"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/b863a93a-3081-4119-896d-ecacae0f6c9e"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/66941e62-2ee3-47db-9e93-48e9a398bb3d">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/c483f249-c7dd-4ba8-a7df-90f8ee0ecbea"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/85ad8856-e669-4ea7-b648-289087d35efc"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/b2740b75-d67b-4490-9fea-222f4e91973c"/>
    <rdfs:label>fluoxetine-mCPP interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/a02462e1-a867-431b-bb63-6f25d26d7ebb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/d2a08818-407a-47c6-8937-efef370b58c6">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/614b3e51-077f-45ae-ac31-1334f13f0d4a">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/abda9fe3-3ec3-4e77-bed7-f66b989ba770"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/7610fd77-8c1f-43c5-b3fb-779ef671605f"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/61ec80b4-38d7-49fe-b83a-80b2c33aea00"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/3a9734bc-9cb2-4225-a38d-37ca60bb5a4b"/>
    <rdfs:label>Erythromycin-Atorvastatin interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/fc3f7a6f-998c-49e6-a1db-2be28f9c4aad">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/467afb1d-6a1c-40a0-b34a-703309087772">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/bcbdbcda-f3dc-41b2-85a9-5d629bdd19ac"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/7068a14f-1e55-42ec-b8e4-cfe2b37a80c2"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/2f7ec1d6-5c3c-4bf7-b9e1-5b9d1bf10c89"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/b7e584c3-2827-4e91-9ceb-b767f487cdb2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/6119db24-f3fb-4e77-9d06-ecfa4c18ea16">
    <rdf:type rdf:resource="obo:RxNorm_6918"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/8b5a312c-6fab-4855-949f-adfc9263f9ff">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/b0fe8722-e98a-4910-8dce-d3a95e5cd68a">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/6e865c68-0e92-48a9-8ea6-3f33ed5fa342"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/4ff85aa6-adf5-43c5-a2cc-c092d8d5ac91"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/b9f9aa63-bc7c-4462-ad7b-e5cb3d4ea384"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/91ffa844-488d-45af-8110-ca2eb0860697">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/bearer-object/8317c55f-493f-4070-9af3-20da6a712026">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/o-scattered-molecular-aggregate/98d02cd7-ef99-4260-b586-9790b3478bd8"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/object-drug-role/11d902d8-6a43-4b4a-a752-d04e03a946bf"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/2df0b141-99aa-4e67-a821-e5baf6dc54b7">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/method/ebe7bec8-645b-49d3-a131-b520b3c440c4">
    <rdfs:label>Telaprevir-atorvastatin DDI clinical trial</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000124"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/ee035928-8bc4-4a52-88b1-886b10010d27">
    <obo:OBI_0001937>UNK</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/d9473d9a-8690-4e9d-a620-afa0b7c530ab"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-drug-role/37d4a1a0-b8e6-4630-a8b6-3d3de71bbcbb">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/8c7eae66-f099-4dc1-971a-352e924dad9b">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-active-ingredient/57a5a611-5c7f-46fc-ab07-db66a27e7617">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type-has-part/442692ee-152d-465e-ab7b-827ab5e0269c">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000187"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/a1f7c223-0ec0-4787-b054-612dfe0e99d2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/p-scattered-molecular-aggregate/02f04371-1479-4c7a-8efd-df7f3ab4785a">
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-value-measurement-datum/ae2e20be-9dc5-426a-9c6a-24528213a80e"/>
    <obo:RO_0000053 rdf:resource="http://dikb.org/precipitant-active-ingredient/99c59547-9568-4cdd-9edc-35731012508a"/>
    <obo:RO_0002351 rdf:resource="http://dikb.org/precipitant-drug/97188515-3e76-493c-a563-6d31febbed82"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0000576"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/assertion/19c7379b-cd8c-49f5-9e74-1b43fe21b448">
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/d99d4abc-b3aa-407c-b55b-ffca4b24e5c9"/>
    <obo:BFO_0000051 rdf:resource="http://dikb.org/data-ratio/0a3efc59-73b8-47f1-b409-fb69f232e407"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-object/97c4f8e2-1dee-4ba5-b8ed-56356b5f146a"/>
    <obo:IAO_0000136 rdf:resource="http://dikb.org/bearer-precipitant/a00b5939-2823-46a9-93f1-31d206a993b7"/>
    <rdfs:label>fluoxetine-estazolam interaction description</rdfs:label>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000001"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/cda31cec-5859-40dd-b26b-bfde9922443c">
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/6f96c216-e7ca-4b75-9427-e463efcb15c1"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/a9a1ca53-c8ba-4430-8ac6-b64b528da916">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/abc519a0-b097-4c34-82fc-6bc00115502d"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-mass/54b2409d-d4ff-4817-a2df-4f9d00e246c1">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-measurement-datum/c0c7a1da-931b-4089-9c76-be1db0e38767">
    <obo:IAO_0000221 rdf:resource="http://dikb.org/object-mass/04d6cc30-49b2-4c72-a8fe-7a910f55fcce"/>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/object-value-specification/59e2fa68-28bc-486d-8ed3-1bb3f6600296"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/IAO_0000109"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-milligram/80d27b3e-32e5-4f57-88bc-876307a49b89">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/UO_0000022"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug/1145b078-7549-4be1-8e00-2a33691b3050">
    <rdf:type rdf:resource="obo:RxNorm_1114195"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/eb987b81-4609-4422-926e-dc6eddab6e64">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-drug-role/153c1a03-2c0e-4598-8a3a-5cd55a0fbe5d">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000013"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio-type/42db92e4-07e1-4acc-9fa1-152aab7124a6">
    <obo:OBI_0000051 rdf:resource="http://dikb.org/data-ratio-type-has-part/c3c6093c-e1b3-411e-bd83-22c94349c029"/>
    <rdfs:label>2.2 Fold </rdfs:label>
    <obo:OBI_0001937>2.2</obo:OBI_0001937>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-mass/3ee69d0e-5017-4d89-a462-4e061b1c5ed2">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/PATO_0000125"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-active-ingredient/4a14476f-5f3b-41ea-b6fd-e2fbd7edacf4">
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DRON_00000028"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/object-value-specification/e7336772-ccb9-4ea6-abe0-78b3c532847d">
    <obo:OBI_0001937>100</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/object-milligram/082986ac-555b-4eec-9239-1e538789d4b6"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/data-ratio/7de8ee04-a7c6-457c-8fb9-97b6ae02e100">
    <obo:OBI_0000312 rdf:resource="http://dikb.org/method/263a10ec-8bc0-449e-8d82-c1ab5180e006"/>
    <rdfs:label>ketoconazole-rivaroxaban drug package clearance Decrease information</rdfs:label>
    <obo:OBI_0001937 rdf:resource="http://dikb.org/data-ratio-type/71112a9e-1980-40d3-b459-231556eee660"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/DIDEO_00000050"/>
  </rdf:Description>
  <rdf:Description rdf:about="http://dikb.org/precipitant-value-specification/26b68121-a318-417e-92da-b589843163c2">
    <obo:OBI_0001937>90</obo:OBI_0001937>
    <obo:IAO_0000039 rdf:resource="http://dikb.org/precipitant-milligram/5e7cefaa-1167-4229-b9a8-7371092c637b"/>
    <rdf:type rdf:resource="http://purl.obolibrary.org/obo/OBI_0001933"/>
  </rdf:Description>
</rdf:RDF>
